Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:oedema'
(id=11962024 ; fe=en:oedema ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=117795 creation date=2019-01-05 touchdate=2025-07-25 19:59:06.000)
≈ 4390 relations sortantes

  1. en:oedema -- r_associated #0: 63 / 1 -> en:chemosis
    n1=en:oedema | n2=en:chemosis | rel=r_associated | relid=0 | w=63
  2. en:oedema -- r_associated #0: 63 / 1 -> en:increased fatty and connective tissue in skeletal muscle
    n1=en:oedema | n2=en:increased fatty and connective tissue in skeletal muscle | rel=r_associated | relid=0 | w=63
  3. en:oedema -- r_associated #0: 63 / 1 -> en:myopathic pattern on emg
    n1=en:oedema | n2=en:myopathic pattern on emg | rel=r_associated | relid=0 | w=63
  4. en:oedema -- r_associated #0: 63 / 1 -> en:myopathic pattern seen on emg (in some patients)
    n1=en:oedema | n2=en:myopathic pattern seen on emg (in some patients) | rel=r_associated | relid=0 | w=63
  5. en:oedema -- r_associated #0: 63 / 1 -> en:patients may have distal or proximal muscle weakness, or both
    n1=en:oedema | n2=en:patients may have distal or proximal muscle weakness, or both | rel=r_associated | relid=0 | w=63
  6. en:oedema -- r_associated #0: 63 / 1 -> en:skin infection
    n1=en:oedema | n2=en:skin infection | rel=r_associated | relid=0 | w=63
  7. en:oedema -- r_associated #0: 62 / 0.984 -> en:decreased urocanic acid in stratum corneum
    n1=en:oedema | n2=en:decreased urocanic acid in stratum corneum | rel=r_associated | relid=0 | w=62
  8. en:oedema -- r_associated #0: 62 / 0.984 -> en:hidradenitis suppurativa (rare)
    n1=en:oedema | n2=en:hidradenitis suppurativa (rare) | rel=r_associated | relid=0 | w=62
  9. en:oedema -- r_associated #0: 62 / 0.984 -> en:most evident on lower legs
    n1=en:oedema | n2=en:most evident on lower legs | rel=r_associated | relid=0 | w=62
  10. en:oedema -- r_associated #0: 62 / 0.984 -> en:neck skin
    n1=en:oedema | n2=en:neck skin | rel=r_associated | relid=0 | w=62
  11. en:oedema -- r_associated #0: 61 / 0.968 -> en:mitochondrial complex iii deficiency (disorder)
    n1=en:oedema | n2=en:mitochondrial complex iii deficiency (disorder) | rel=r_associated | relid=0 | w=61
  12. en:oedema -- r_associated #0: 61 / 0.968 -> en:nervous system finding
    n1=en:oedema | n2=en:nervous system finding | rel=r_associated | relid=0 | w=61
  13. en:oedema -- r_associated #0: 61 / 0.968 -> en:s. epidermidis only microorganism isolated
    n1=en:oedema | n2=en:s. epidermidis only microorganism isolated | rel=r_associated | relid=0 | w=61
  14. en:oedema -- r_associated #0: 61 / 0.968 -> en:short rib-polydactyly syndrome, beemer type
    n1=en:oedema | n2=en:short rib-polydactyly syndrome, beemer type | rel=r_associated | relid=0 | w=61
  15. en:oedema -- r_associated #0: 61 / 0.968 -> en:white scaling skin, most prominent over upper and lower extremities
    n1=en:oedema | n2=en:white scaling skin, most prominent over upper and lower extremities | rel=r_associated | relid=0 | w=61
  16. en:oedema -- r_associated #0: 60 / 0.952 -> en:abscesses (in skin folds that carry terminal hairs and apocrine glands including axillae, groin, anal fold, mons pubis, and scalp, but not face)
    n1=en:oedema | n2=en:abscesses (in skin folds that carry terminal hairs and apocrine glands including axillae, groin, anal fold, mons pubis, and scalp, but not face) | rel=r_associated | relid=0 | w=60
  17. en:oedema -- r_associated #0: 60 / 0.952 -> en:b-symptoms
    n1=en:oedema | n2=en:b-symptoms | rel=r_associated | relid=0 | w=60
  18. en:oedema -- r_associated #0: 60 / 0.952 -> en:decreased thiamine pyrophosphate
    n1=en:oedema | n2=en:decreased thiamine pyrophosphate | rel=r_associated | relid=0 | w=60
  19. en:oedema -- r_associated #0: 60 / 0.952 -> en:infra-orbital crease
    n1=en:oedema | n2=en:infra-orbital crease | rel=r_associated | relid=0 | w=60
  20. en:oedema -- r_associated #0: 60 / 0.952 -> en:normal sweat electrolytes
    n1=en:oedema | n2=en:normal sweat electrolytes | rel=r_associated | relid=0 | w=60
  21. en:oedema -- r_associated #0: 60 / 0.952 -> en:predominantly lower limb lymphedema
    n1=en:oedema | n2=en:predominantly lower limb lymphedema | rel=r_associated | relid=0 | w=60
  22. en:oedema -- r_associated #0: 60 / 0.952 -> en:recurrent skin abscesses
    n1=en:oedema | n2=en:recurrent skin abscesses | rel=r_associated | relid=0 | w=60
  23. en:oedema -- r_associated #0: 59 / 0.937 -> en:accumulation of pas-positive polyglucosan material seen on muscle biopsy
    n1=en:oedema | n2=en:accumulation of pas-positive polyglucosan material seen on muscle biopsy | rel=r_associated | relid=0 | w=59
  24. en:oedema -- r_associated #0: 59 / 0.937 -> en:menstrual edema
    n1=en:oedema | n2=en:menstrual edema | rel=r_associated | relid=0 | w=59
  25. en:oedema -- r_associated #0: 59 / 0.937 -> en:thick facial skin
    n1=en:oedema | n2=en:thick facial skin | rel=r_associated | relid=0 | w=59
  26. en:oedema -- r_associated #0: 58 / 0.921 -> en:candida diaper dermatitis
    n1=en:oedema | n2=en:candida diaper dermatitis | rel=r_associated | relid=0 | w=58
  27. en:oedema -- r_associated #0: 58 / 0.921 -> en:hematologic and lymphocytic disorder
    n1=en:oedema | n2=en:hematologic and lymphocytic disorder | rel=r_associated | relid=0 | w=58
  28. en:oedema -- r_associated #0: 58 / 0.921 -> en:no mucosal vesicles
    n1=en:oedema | n2=en:no mucosal vesicles | rel=r_associated | relid=0 | w=58
  29. en:oedema -- r_associated #0: 57 / 0.905 -> en:abnormal finger flexion creases
    n1=en:oedema | n2=en:abnormal finger flexion creases | rel=r_associated | relid=0 | w=57
  30. en:oedema -- r_associated #0: 57 / 0.905 -> en:dermatitis ichthyosiform
    n1=en:oedema | n2=en:dermatitis ichthyosiform | rel=r_associated | relid=0 | w=57
  31. en:oedema -- r_associated #0: 57 / 0.905 -> en:hydrops of allantois
    n1=en:oedema | n2=en:hydrops of allantois | rel=r_associated | relid=0 | w=57
  32. en:oedema -- r_associated #0: 57 / 0.905 -> en:penile swelling
    n1=en:oedema | n2=en:penile swelling | rel=r_associated | relid=0 | w=57
  33. en:oedema -- r_associated #0: 57 / 0.905 -> en:urticaria pigmentosa or cutaneous mastocytosis (in patients with kit mutations)
    n1=en:oedema | n2=en:urticaria pigmentosa or cutaneous mastocytosis (in patients with kit mutations) | rel=r_associated | relid=0 | w=57
  34. en:oedema -- r_associated #0: 56 / 0.889 -> en:myosin storage myopathy (in some patients)
    n1=en:oedema | n2=en:myosin storage myopathy (in some patients) | rel=r_associated | relid=0 | w=56
  35. en:oedema -- r_associated #0: 56 / 0.889 -> en:pseudoathletic appearance with prominent muscles before disease onset
    n1=en:oedema | n2=en:pseudoathletic appearance with prominent muscles before disease onset | rel=r_associated | relid=0 | w=56
  36. en:oedema -- r_associated #0: 56 / 0.889 -> oedémacié
    n1=en:oedema | n2=oedémacié | rel=r_associated | relid=0 | w=56
  37. en:oedema -- r_associated #0: 55 / 0.873 -> en:abnormal glycosylation of alpha-dystroglycan seen on muscle biopsy
    n1=en:oedema | n2=en:abnormal glycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=55
  38. en:oedema -- r_associated #0: 55 / 0.873 -> en:absence of gamma-sarcoglycan protein
    n1=en:oedema | n2=en:absence of gamma-sarcoglycan protein | rel=r_associated | relid=0 | w=55
  39. en:oedema -- r_associated #0: 55 / 0.873 -> en:amyotrophy of the upper limbs (in some patients)
    n1=en:oedema | n2=en:amyotrophy of the upper limbs (in some patients) | rel=r_associated | relid=0 | w=55
  40. en:oedema -- r_associated #0: 55 / 0.873 -> en:ascites (in some patients)
    n1=en:oedema | n2=en:ascites (in some patients) | rel=r_associated | relid=0 | w=55
  41. en:oedema -- r_associated #0: 55 / 0.873 -> en:chilblains
    n1=en:oedema | n2=en:chilblains | rel=r_associated | relid=0 | w=55
  42. en:oedema -- r_associated #0: 55 / 0.873 -> en:contractures of distal lower limbs
    n1=en:oedema | n2=en:contractures of distal lower limbs | rel=r_associated | relid=0 | w=55
  43. en:oedema -- r_associated #0: 55 / 0.873 -> en:cutis laxa (infancy)
    n1=en:oedema | n2=en:cutis laxa (infancy) | rel=r_associated | relid=0 | w=55
  44. en:oedema -- r_associated #0: 55 / 0.873 -> en:discoid lupus in carriers or adults with mild disease
    n1=en:oedema | n2=en:discoid lupus in carriers or adults with mild disease | rel=r_associated | relid=0 | w=55
  45. en:oedema -- r_associated #0: 55 / 0.873 -> en:erythematous plaque
    n1=en:oedema | n2=en:erythematous plaque | rel=r_associated | relid=0 | w=55
  46. en:oedema -- r_associated #0: 55 / 0.873 -> en:gastrocnemius and soleus muscles most affected
    n1=en:oedema | n2=en:gastrocnemius and soleus muscles most affected | rel=r_associated | relid=0 | w=55
  47. en:oedema -- r_associated #0: 55 / 0.873 -> en:high altitude cerebral edema
    n1=en:oedema | n2=en:high altitude cerebral edema | rel=r_associated | relid=0 | w=55
  48. en:oedema -- r_associated #0: 55 / 0.873 -> en:ingrown toenail/other disease of nail
    n1=en:oedema | n2=en:ingrown toenail/other disease of nail | rel=r_associated | relid=0 | w=55
  49. en:oedema -- r_associated #0: 55 / 0.873 -> en:mild scarring
    n1=en:oedema | n2=en:mild scarring | rel=r_associated | relid=0 | w=55
  50. en:oedema -- r_associated #0: 55 / 0.873 -> en:muscle biopsy shows degenerating endplates and junctional folds
    n1=en:oedema | n2=en:muscle biopsy shows degenerating endplates and junctional folds | rel=r_associated | relid=0 | w=55
  51. en:oedema -- r_associated #0: 55 / 0.873 -> en:muscle biopsy shows neurogenic atrophy
    n1=en:oedema | n2=en:muscle biopsy shows neurogenic atrophy | rel=r_associated | relid=0 | w=55
  52. en:oedema -- r_associated #0: 55 / 0.873 -> en:muscle fibers appear as fetal myotubules
    n1=en:oedema | n2=en:muscle fibers appear as fetal myotubules | rel=r_associated | relid=0 | w=55
  53. en:oedema -- r_associated #0: 55 / 0.873 -> en:muscle hematoma
    n1=en:oedema | n2=en:muscle hematoma | rel=r_associated | relid=0 | w=55
  54. en:oedema -- r_associated #0: 55 / 0.873 -> en:muscle weakness, proximal, lower limbs (upper limbs may become affected later)
    n1=en:oedema | n2=en:muscle weakness, proximal, lower limbs (upper limbs may become affected later) | rel=r_associated | relid=0 | w=55
  55. en:oedema -- r_associated #0: 55 / 0.873 -> en:muscular dystrophy (in some patients)
    n1=en:oedema | n2=en:muscular dystrophy (in some patients) | rel=r_associated | relid=0 | w=55
  56. en:oedema -- r_associated #0: 55 / 0.873 -> en:myopathy, mild to severe
    n1=en:oedema | n2=en:myopathy, mild to severe | rel=r_associated | relid=0 | w=55
  57. en:oedema -- r_associated #0: 55 / 0.873 -> en:no ragged-red fibers
    n1=en:oedema | n2=en:no ragged-red fibers | rel=r_associated | relid=0 | w=55
  58. en:oedema -- r_associated #0: 55 / 0.873 -> en:nursing therapy
    n1=en:oedema | n2=en:nursing therapy | rel=r_associated | relid=0 | w=55
  59. en:oedema -- r_associated #0: 55 / 0.873 -> en:peripheral arterial disorder
    n1=en:oedema | n2=en:peripheral arterial disorder | rel=r_associated | relid=0 | w=55
  60. en:oedema -- r_associated #0: 55 / 0.873 -> en:peroneal muscle weakness
    n1=en:oedema | n2=en:peroneal muscle weakness | rel=r_associated | relid=0 | w=55
  61. en:oedema -- r_associated #0: 55 / 0.873 -> en:phakic corneal edema
    n1=en:oedema | n2=en:phakic corneal edema | rel=r_associated | relid=0 | w=55
  62. en:oedema -- r_associated #0: 55 / 0.873 -> en:proximal muscle weakness (85% of patients)
    n1=en:oedema | n2=en:proximal muscle weakness (85% of patients) | rel=r_associated | relid=0 | w=55
  63. en:oedema -- r_associated #0: 55 / 0.873 -> en:redundant skin
    n1=en:oedema | n2=en:redundant skin | rel=r_associated | relid=0 | w=55
  64. en:oedema -- r_associated #0: 55 / 0.873 -> en:respiratory muscles may be involved (more common in juvenile-onset)
    n1=en:oedema | n2=en:respiratory muscles may be involved (more common in juvenile-onset) | rel=r_associated | relid=0 | w=55
  65. en:oedema -- r_associated #0: 55 / 0.873 -> en:sclerodactyly
    n1=en:oedema | n2=en:sclerodactyly | rel=r_associated | relid=0 | w=55
  66. en:oedema -- r_associated #0: 55 / 0.873 -> en:seborrhea (35% of adults)
    n1=en:oedema | n2=en:seborrhea (35% of adults) | rel=r_associated | relid=0 | w=55
  67. en:oedema -- r_associated #0: 55 / 0.873 -> en:severe acne (23% of adults)
    n1=en:oedema | n2=en:severe acne (23% of adults) | rel=r_associated | relid=0 | w=55
  68. en:oedema -- r_associated #0: 55 / 0.873 -> en:streaming of the z-disk seen on electron microscopy
    n1=en:oedema | n2=en:streaming of the z-disk seen on electron microscopy | rel=r_associated | relid=0 | w=55
  69. en:oedema -- r_associated #0: 55 / 0.873 -> en:type ii fiber atrophy seen on muscle biopsy
    n1=en:oedema | n2=en:type ii fiber atrophy seen on muscle biopsy | rel=r_associated | relid=0 | w=55
  70. en:oedema -- r_associated #0: 55 / 0.873 -> en:upper limb involvement occurs later or not at all
    n1=en:oedema | n2=en:upper limb involvement occurs later or not at all | rel=r_associated | relid=0 | w=55
  71. en:oedema -- r_associated #0: 55 / 0.873 -> en:vacuoles are autophagocytic
    n1=en:oedema | n2=en:vacuoles are autophagocytic | rel=r_associated | relid=0 | w=55
  72. en:oedema -- r_associated #0: 55 / 0.873 -> en:vacuoles predominantly in type 2 fibers seen on muscle biopsy
    n1=en:oedema | n2=en:vacuoles predominantly in type 2 fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=55
  73. en:oedema -- r_associated #0: 54 / 0.857 -> bulle
    (vésicule)
    n1=en:oedema | n2=bulle
    (vésicule)
    | rel=r_associated | relid=0 | w=54
  74. en:oedema -- r_associated #0: 54 / 0.857 -> en:acetazolamide may worsen symptoms
    n1=en:oedema | n2=en:acetazolamide may worsen symptoms | rel=r_associated | relid=0 | w=54
  75. en:oedema -- r_associated #0: 54 / 0.857 -> en:annular erythematous edematous plaques
    n1=en:oedema | n2=en:annular erythematous edematous plaques | rel=r_associated | relid=0 | w=54
  76. en:oedema -- r_associated #0: 54 / 0.857 -> en:atopy
    n1=en:oedema | n2=en:atopy | rel=r_associated | relid=0 | w=54
  77. en:oedema -- r_associated #0: 54 / 0.857 -> en:attacks relieved by potassium administration
    n1=en:oedema | n2=en:attacks relieved by potassium administration | rel=r_associated | relid=0 | w=54
  78. en:oedema -- r_associated #0: 54 / 0.857 -> en:calf muscle hypertrophy
    n1=en:oedema | n2=en:calf muscle hypertrophy | rel=r_associated | relid=0 | w=54
  79. en:oedema -- r_associated #0: 54 / 0.857 -> en:central nuclei
    n1=en:oedema | n2=en:central nuclei | rel=r_associated | relid=0 | w=54
  80. en:oedema -- r_associated #0: 54 / 0.857 -> en:chaddock's reflex
    n1=en:oedema | n2=en:chaddock's reflex | rel=r_associated | relid=0 | w=54
  81. en:oedema -- r_associated #0: 54 / 0.857 -> en:clinical signs of congenital syphilis:find:pt:^patient:nom:cdc.cs
    n1=en:oedema | n2=en:clinical signs of congenital syphilis:find:pt:^patient:nom:cdc.cs | rel=r_associated | relid=0 | w=54
  82. en:oedema -- r_associated #0: 54 / 0.857 -> en:congenital muscular dystrophy (disorder)
    n1=en:oedema | n2=en:congenital muscular dystrophy (disorder) | rel=r_associated | relid=0 | w=54
  83. en:oedema -- r_associated #0: 54 / 0.857 -> en:cutaneous mastocytosis
    n1=en:oedema | n2=en:cutaneous mastocytosis | rel=r_associated | relid=0 | w=54
  84. en:oedema -- r_associated #0: 54 / 0.857 -> en:cysts may disappear on their own (10%)
    n1=en:oedema | n2=en:cysts may disappear on their own (10%) | rel=r_associated | relid=0 | w=54
  85. en:oedema -- r_associated #0: 54 / 0.857 -> en:decreased collagen vi
    n1=en:oedema | n2=en:decreased collagen vi | rel=r_associated | relid=0 | w=54
  86. en:oedema -- r_associated #0: 54 / 0.857 -> en:decreased cytochrome c oxidase activity
    n1=en:oedema | n2=en:decreased cytochrome c oxidase activity | rel=r_associated | relid=0 | w=54
  87. en:oedema -- r_associated #0: 54 / 0.857 -> en:decreased muscle mass, especially distally
    n1=en:oedema | n2=en:decreased muscle mass, especially distally | rel=r_associated | relid=0 | w=54
  88. en:oedema -- r_associated #0: 54 / 0.857 -> en:dyshidrosis [pompholyx]
    n1=en:oedema | n2=en:dyshidrosis [pompholyx] | rel=r_associated | relid=0 | w=54
  89. en:oedema -- r_associated #0: 54 / 0.857 -> en:edema of dorsum of hands and feet
    n1=en:oedema | n2=en:edema of dorsum of hands and feet | rel=r_associated | relid=0 | w=54
  90. en:oedema -- r_associated #0: 54 / 0.857 -> en:edema of mouth
    n1=en:oedema | n2=en:edema of mouth | rel=r_associated | relid=0 | w=54
  91. en:oedema -- r_associated #0: 54 / 0.857 -> en:emg shows myopathic and neurogenic changes
    n1=en:oedema | n2=en:emg shows myopathic and neurogenic changes | rel=r_associated | relid=0 | w=54
  92. en:oedema -- r_associated #0: 54 / 0.857 -> en:fatty deposition
    n1=en:oedema | n2=en:fatty deposition | rel=r_associated | relid=0 | w=54
  93. en:oedema -- r_associated #0: 54 / 0.857 -> en:generalized muscle contractions, episodic
    n1=en:oedema | n2=en:generalized muscle contractions, episodic | rel=r_associated | relid=0 | w=54
  94. en:oedema -- r_associated #0: 54 / 0.857 -> en:genetic aspects
    n1=en:oedema | n2=en:genetic aspects | rel=r_associated | relid=0 | w=54
  95. en:oedema -- r_associated #0: 54 / 0.857 -> en:giant pigmented hairy nevus, often in lumbosacral distribution hair may not be present
    n1=en:oedema | n2=en:giant pigmented hairy nevus, often in lumbosacral distribution hair may not be present | rel=r_associated | relid=0 | w=54
  96. en:oedema -- r_associated #0: 54 / 0.857 -> en:gowers sign (in some patients)
    n1=en:oedema | n2=en:gowers sign (in some patients) | rel=r_associated | relid=0 | w=54
  97. en:oedema -- r_associated #0: 54 / 0.857 -> en:hypergammaglobulinemia
    n1=en:oedema | n2=en:hypergammaglobulinemia | rel=r_associated | relid=0 | w=54
  98. en:oedema -- r_associated #0: 54 / 0.857 -> en:hyperpigmented/hypopigmented macules (dorsum hands and feet, face)
    n1=en:oedema | n2=en:hyperpigmented/hypopigmented macules (dorsum hands and feet, face) | rel=r_associated | relid=0 | w=54
  99. en:oedema -- r_associated #0: 54 / 0.857 -> en:immunology aspects
    n1=en:oedema | n2=en:immunology aspects | rel=r_associated | relid=0 | w=54
  100. en:oedema -- r_associated #0: 54 / 0.857 -> en:inclusion body myopathy
    n1=en:oedema | n2=en:inclusion body myopathy | rel=r_associated | relid=0 | w=54
  101. en:oedema -- r_associated #0: 54 / 0.857 -> en:loss of facial adipose tissue
    n1=en:oedema | n2=en:loss of facial adipose tissue | rel=r_associated | relid=0 | w=54
  102. en:oedema -- r_associated #0: 54 / 0.857 -> en:lower limbs more often affected
    n1=en:oedema | n2=en:lower limbs more often affected | rel=r_associated | relid=0 | w=54
  103. en:oedema -- r_associated #0: 54 / 0.857 -> en:ludington's sign
    n1=en:oedema | n2=en:ludington's sign | rel=r_associated | relid=0 | w=54
  104. en:oedema -- r_associated #0: 54 / 0.857 -> en:massengill disposable douche baking soda,vag
    n1=en:oedema | n2=en:massengill disposable douche baking soda,vag | rel=r_associated | relid=0 | w=54
  105. en:oedema -- r_associated #0: 54 / 0.857 -> en:mild-to-severe pterygia
    n1=en:oedema | n2=en:mild-to-severe pterygia | rel=r_associated | relid=0 | w=54
  106. en:oedema -- r_associated #0: 54 / 0.857 -> en:mitochondrial complex iii deficiency, isolated, seen on muscle biopsy
    n1=en:oedema | n2=en:mitochondrial complex iii deficiency, isolated, seen on muscle biopsy | rel=r_associated | relid=0 | w=54
  107. en:oedema -- r_associated #0: 54 / 0.857 -> en:muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes
    n1=en:oedema | n2=en:muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes | rel=r_associated | relid=0 | w=54
  108. en:oedema -- r_associated #0: 54 / 0.857 -> en:muscle cramps at rest
    n1=en:oedema | n2=en:muscle cramps at rest | rel=r_associated | relid=0 | w=54
  109. en:oedema -- r_associated #0: 54 / 0.857 -> en:muscle wasting in lower limbs
    n1=en:oedema | n2=en:muscle wasting in lower limbs | rel=r_associated | relid=0 | w=54
  110. en:oedema -- r_associated #0: 54 / 0.857 -> en:myofibromatosis
    n1=en:oedema | n2=en:myofibromatosis | rel=r_associated | relid=0 | w=54
  111. en:oedema -- r_associated #0: 54 / 0.857 -> en:named sign of abdomen
    n1=en:oedema | n2=en:named sign of abdomen | rel=r_associated | relid=0 | w=54
  112. en:oedema -- r_associated #0: 54 / 0.857 -> en:neonatal jaundice
    n1=en:oedema | n2=en:neonatal jaundice | rel=r_associated | relid=0 | w=54
  113. en:oedema -- r_associated #0: 54 / 0.857 -> en:neurogenic abnormalities seen on emg
    n1=en:oedema | n2=en:neurogenic abnormalities seen on emg | rel=r_associated | relid=0 | w=54
  114. en:oedema -- r_associated #0: 54 / 0.857 -> en:neurologic manifestations
    n1=en:oedema | n2=en:neurologic manifestations | rel=r_associated | relid=0 | w=54
  115. en:oedema -- r_associated #0: 54 / 0.857 -> en:no systemic vascular lesions
    n1=en:oedema | n2=en:no systemic vascular lesions | rel=r_associated | relid=0 | w=54
  116. en:oedema -- r_associated #0: 54 / 0.857 -> en:o/e - nasal mucosa edematous
    n1=en:oedema | n2=en:o/e - nasal mucosa edematous | rel=r_associated | relid=0 | w=54
  117. en:oedema -- r_associated #0: 54 / 0.857 -> en:periorbital edema of right eye
    n1=en:oedema | n2=en:periorbital edema of right eye | rel=r_associated | relid=0 | w=54
  118. en:oedema -- r_associated #0: 54 / 0.857 -> en:pretibial myxedema
    n1=en:oedema | n2=en:pretibial myxedema | rel=r_associated | relid=0 | w=54
  119. en:oedema -- r_associated #0: 54 / 0.857 -> en:proximal weakness
    n1=en:oedema | n2=en:proximal weakness | rel=r_associated | relid=0 | w=54
  120. en:oedema -- r_associated #0: 54 / 0.857 -> en:pterygia of neck (in some patients)
    n1=en:oedema | n2=en:pterygia of neck (in some patients) | rel=r_associated | relid=0 | w=54
  121. en:oedema -- r_associated #0: 54 / 0.857 -> en:rash, urticarial, episodic
    n1=en:oedema | n2=en:rash, urticarial, episodic | rel=r_associated | relid=0 | w=54
  122. en:oedema -- r_associated #0: 54 / 0.857 -> en:renal colic
    n1=en:oedema | n2=en:renal colic | rel=r_associated | relid=0 | w=54
  123. en:oedema -- r_associated #0: 54 / 0.857 -> en:skeletal muscle damage
    n1=en:oedema | n2=en:skeletal muscle damage | rel=r_associated | relid=0 | w=54
  124. en:oedema -- r_associated #0: 54 / 0.857 -> en:sparing of flexure areas, palms, and soles
    n1=en:oedema | n2=en:sparing of flexure areas, palms, and soles | rel=r_associated | relid=0 | w=54
  125. en:oedema -- r_associated #0: 54 / 0.857 -> en:stutter
    n1=en:oedema | n2=en:stutter | rel=r_associated | relid=0 | w=54
  126. en:oedema -- r_associated #0: 54 / 0.857 -> en:thickened skin over flexor surface of proximal phalanges
    n1=en:oedema | n2=en:thickened skin over flexor surface of proximal phalanges | rel=r_associated | relid=0 | w=54
  127. en:oedema -- r_associated #0: 54 / 0.857 -> en:thickening of the fascial structures of the palm and fingers
    n1=en:oedema | n2=en:thickening of the fascial structures of the palm and fingers | rel=r_associated | relid=0 | w=54
  128. en:oedema -- r_associated #0: 54 / 0.857 -> en:tubular aggregates mainly in type 2 fibers and are subsarcolemmal or intermyofibrillar and stain for nadh-tetrazolium reductase
    n1=en:oedema | n2=en:tubular aggregates mainly in type 2 fibers and are subsarcolemmal or intermyofibrillar and stain for nadh-tetrazolium reductase | rel=r_associated | relid=0 | w=54
  129. en:oedema -- r_associated #0: 54 / 0.857 -> en:unilateral erythema and scaling (present at birth or soon after birth, face is spared)
    n1=en:oedema | n2=en:unilateral erythema and scaling (present at birth or soon after birth, face is spared) | rel=r_associated | relid=0 | w=54
  130. en:oedema -- r_associated #0: 54 / 0.857 -> en:vascular disorder
    n1=en:oedema | n2=en:vascular disorder | rel=r_associated | relid=0 | w=54
  131. en:oedema -- r_associated #0: 52 / 0.825 -> bulle
    n1=en:oedema | n2=bulle | rel=r_associated | relid=0 | w=52
  132. en:oedema -- r_associated #0: 52 / 0.825 -> en:blistering of hands, elbows, feet, knees
    n1=en:oedema | n2=en:blistering of hands, elbows, feet, knees | rel=r_associated | relid=0 | w=52
  133. en:oedema -- r_associated #0: 52 / 0.825 -> en:cdisc send fetal pathology findings result terminology
    n1=en:oedema | n2=en:cdisc send fetal pathology findings result terminology | rel=r_associated | relid=0 | w=52
  134. en:oedema -- r_associated #0: 52 / 0.825 -> en:cores have abrupt borders within normal regions of the muscle fiber
    n1=en:oedema | n2=en:cores have abrupt borders within normal regions of the muscle fiber | rel=r_associated | relid=0 | w=52
  135. en:oedema -- r_associated #0: 52 / 0.825 -> en:cutaneous piloleiomyomas (may be single or multiple)
    n1=en:oedema | n2=en:cutaneous piloleiomyomas (may be single or multiple) | rel=r_associated | relid=0 | w=52
  136. en:oedema -- r_associated #0: 52 / 0.825 -> en:cyanosis
    n1=en:oedema | n2=en:cyanosis | rel=r_associated | relid=0 | w=52
  137. en:oedema -- r_associated #0: 52 / 0.825 -> en:diffuse yellow-orange non-epidermolytic hyperkeratosis on palms and soles (palmoplantar keratoderma)
    n1=en:oedema | n2=en:diffuse yellow-orange non-epidermolytic hyperkeratosis on palms and soles (palmoplantar keratoderma) | rel=r_associated | relid=0 | w=52
  138. en:oedema -- r_associated #0: 52 / 0.825 -> en:doughy or puffy skin (in some patients)
    n1=en:oedema | n2=en:doughy or puffy skin (in some patients) | rel=r_associated | relid=0 | w=52
  139. en:oedema -- r_associated #0: 52 / 0.825 -> en:edema of lower eyelid
    n1=en:oedema | n2=en:edema of lower eyelid | rel=r_associated | relid=0 | w=52
  140. en:oedema -- r_associated #0: 52 / 0.825 -> en:edema of thumb
    n1=en:oedema | n2=en:edema of thumb | rel=r_associated | relid=0 | w=52
  141. en:oedema -- r_associated #0: 52 / 0.825 -> en:erythema
    n1=en:oedema | n2=en:erythema | rel=r_associated | relid=0 | w=52
  142. en:oedema -- r_associated #0: 52 / 0.825 -> en:fatty replacement
    n1=en:oedema | n2=en:fatty replacement | rel=r_associated | relid=0 | w=52
  143. en:oedema -- r_associated #0: 52 / 0.825 -> en:fiber-type variability
    n1=en:oedema | n2=en:fiber-type variability | rel=r_associated | relid=0 | w=52
  144. en:oedema -- r_associated #0: 52 / 0.825 -> en:hyperpigmented 2 to 5-mm macules mainly on the extremities
    n1=en:oedema | n2=en:hyperpigmented 2 to 5-mm macules mainly on the extremities | rel=r_associated | relid=0 | w=52
  145. en:oedema -- r_associated #0: 52 / 0.825 -> en:hyperpigmented spots on hands (especially palms), arms, feet (especially plantar areas), legs, and lips
    n1=en:oedema | n2=en:hyperpigmented spots on hands (especially palms), arms, feet (especially plantar areas), legs, and lips | rel=r_associated | relid=0 | w=52
  146. en:oedema -- r_associated #0: 52 / 0.825 -> en:lymphedema quality of life tool (leg) score
    n1=en:oedema | n2=en:lymphedema quality of life tool (leg) score | rel=r_associated | relid=0 | w=52
  147. en:oedema -- r_associated #0: 52 / 0.825 -> en:marked muscular hypertrophy
    n1=en:oedema | n2=en:marked muscular hypertrophy | rel=r_associated | relid=0 | w=52
  148. en:oedema -- r_associated #0: 52 / 0.825 -> en:muscle biopsy shows centralized nuclei
    n1=en:oedema | n2=en:muscle biopsy shows centralized nuclei | rel=r_associated | relid=0 | w=52
  149. en:oedema -- r_associated #0: 52 / 0.825 -> en:muscle biopsy shows hypoglycosylation of alpha-dystroglycan
    n1=en:oedema | n2=en:muscle biopsy shows hypoglycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=52
  150. en:oedema -- r_associated #0: 52 / 0.825 -> en:muscle cramps (also seen in some heterozygotes)
    n1=en:oedema | n2=en:muscle cramps (also seen in some heterozygotes) | rel=r_associated | relid=0 | w=52
  151. en:oedema -- r_associated #0: 52 / 0.825 -> en:muscle wasting, severe, primarily in the legs
    n1=en:oedema | n2=en:muscle wasting, severe, primarily in the legs | rel=r_associated | relid=0 | w=52
  152. en:oedema -- r_associated #0: 52 / 0.825 -> en:muscle weakness is predominantly of extremities and tongue
    n1=en:oedema | n2=en:muscle weakness is predominantly of extremities and tongue | rel=r_associated | relid=0 | w=52
  153. en:oedema -- r_associated #0: 52 / 0.825 -> en:neck muscle hypoplasia
    n1=en:oedema | n2=en:neck muscle hypoplasia | rel=r_associated | relid=0 | w=52
  154. en:oedema -- r_associated #0: 52 / 0.825 -> en:necrotic skin ulcers (in 1 patient)
    n1=en:oedema | n2=en:necrotic skin ulcers (in 1 patient) | rel=r_associated | relid=0 | w=52
  155. en:oedema -- r_associated #0: 52 / 0.825 -> en:neonatal hypotonia muscle biopsy shows pas-positive vacuoles
    n1=en:oedema | n2=en:neonatal hypotonia muscle biopsy shows pas-positive vacuoles | rel=r_associated | relid=0 | w=52
  156. en:oedema -- r_associated #0: 52 / 0.825 -> en:palmoplantar keratoderma (in some patients)
    n1=en:oedema | n2=en:palmoplantar keratoderma (in some patients) | rel=r_associated | relid=0 | w=52
  157. en:oedema -- r_associated #0: 52 / 0.825 -> en:pigmentary change in skin
    n1=en:oedema | n2=en:pigmentary change in skin | rel=r_associated | relid=0 | w=52
  158. en:oedema -- r_associated #0: 52 / 0.825 -> en:preservation of visceral, neck, and axillary fat pads
    n1=en:oedema | n2=en:preservation of visceral, neck, and axillary fat pads | rel=r_associated | relid=0 | w=52
  159. en:oedema -- r_associated #0: 52 / 0.825 -> en:reticular hyperpigmentation (neck)
    n1=en:oedema | n2=en:reticular hyperpigmentation (neck) | rel=r_associated | relid=0 | w=52
  160. en:oedema -- r_associated #0: 52 / 0.825 -> en:retinal edema due to type 2 diabetes mellitus
    n1=en:oedema | n2=en:retinal edema due to type 2 diabetes mellitus | rel=r_associated | relid=0 | w=52
  161. en:oedema -- r_associated #0: 52 / 0.825 -> en:shock
    n1=en:oedema | n2=en:shock | rel=r_associated | relid=0 | w=52
  162. en:oedema -- r_associated #0: 52 / 0.825 -> en:slow-healing wounds due to painless injuries
    n1=en:oedema | n2=en:slow-healing wounds due to painless injuries | rel=r_associated | relid=0 | w=52
  163. en:oedema -- r_associated #0: 52 / 0.825 -> en:sodium acetate anhydrous
    n1=en:oedema | n2=en:sodium acetate anhydrous | rel=r_associated | relid=0 | w=52
  164. en:oedema -- r_associated #0: 52 / 0.825 -> en:sodium chloride 0.854 meq/ml ophthalmic solution
    n1=en:oedema | n2=en:sodium chloride 0.854 meq/ml ophthalmic solution | rel=r_associated | relid=0 | w=52
  165. en:oedema -- r_associated #0: 52 / 0.825 -> en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy
    n1=en:oedema | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy | rel=r_associated | relid=0 | w=52
  166. en:oedema -- r_associated #0: 52 / 0.825 -> en:swelling of the hands and feet (in 1 patient)
    n1=en:oedema | n2=en:swelling of the hands and feet (in 1 patient) | rel=r_associated | relid=0 | w=52
  167. en:oedema -- r_associated #0: 52 / 0.825 -> en:trisodium citrate dihydrate
    n1=en:oedema | n2=en:trisodium citrate dihydrate | rel=r_associated | relid=0 | w=52
  168. en:oedema -- r_associated #0: 52 / 0.825 -> en:ulcers often lead to infection and amputation
    n1=en:oedema | n2=en:ulcers often lead to infection and amputation | rel=r_associated | relid=0 | w=52
  169. en:oedema -- r_associated #0: 51 / 0.81 -> en:abnormal axons with sprouting and swelling
    n1=en:oedema | n2=en:abnormal axons with sprouting and swelling | rel=r_associated | relid=0 | w=51
  170. en:oedema -- r_associated #0: 51 / 0.81 -> en:absence of skin creases over distal interphalangeal (dip) joints
    n1=en:oedema | n2=en:absence of skin creases over distal interphalangeal (dip) joints | rel=r_associated | relid=0 | w=51
  171. en:oedema -- r_associated #0: 51 / 0.81 -> en:absent axonal flare response after intradermal histamine injection
    n1=en:oedema | n2=en:absent axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=51
  172. en:oedema -- r_associated #0: 51 / 0.81 -> en:asymmetric, linear skin defects (anterior face and neck)
    n1=en:oedema | n2=en:asymmetric, linear skin defects (anterior face and neck) | rel=r_associated | relid=0 | w=51
  173. en:oedema -- r_associated #0: 51 / 0.81 -> en:blood
    n1=en:oedema | n2=en:blood | rel=r_associated | relid=0 | w=51
  174. en:oedema -- r_associated #0: 51 / 0.81 -> en:cafe-noir spots (trunk)
    n1=en:oedema | n2=en:cafe-noir spots (trunk) | rel=r_associated | relid=0 | w=51
  175. en:oedema -- r_associated #0: 51 / 0.81 -> en:chin dimples
    n1=en:oedema | n2=en:chin dimples | rel=r_associated | relid=0 | w=51
  176. en:oedema -- r_associated #0: 51 / 0.81 -> en:decreased lipoic acid
    n1=en:oedema | n2=en:decreased lipoic acid | rel=r_associated | relid=0 | w=51
  177. en:oedema -- r_associated #0: 51 / 0.81 -> en:decreased muscle mass in the thighs
    n1=en:oedema | n2=en:decreased muscle mass in the thighs | rel=r_associated | relid=0 | w=51
  178. en:oedema -- r_associated #0: 51 / 0.81 -> en:diastasis recti
    n1=en:oedema | n2=en:diastasis recti | rel=r_associated | relid=0 | w=51
  179. en:oedema -- r_associated #0: 51 / 0.81 -> en:dimples (over bowed limbs)
    n1=en:oedema | n2=en:dimples (over bowed limbs) | rel=r_associated | relid=0 | w=51
  180. en:oedema -- r_associated #0: 51 / 0.81 -> en:edema of back
    n1=en:oedema | n2=en:edema of back | rel=r_associated | relid=0 | w=51
  181. en:oedema -- r_associated #0: 51 / 0.81 -> en:edema of cornea of bilateral eyes
    n1=en:oedema | n2=en:edema of cornea of bilateral eyes | rel=r_associated | relid=0 | w=51
  182. en:oedema -- r_associated #0: 51 / 0.81 -> en:edematous hands and feet (1 patient)
    n1=en:oedema | n2=en:edematous hands and feet (1 patient) | rel=r_associated | relid=0 | w=51
  183. en:oedema -- r_associated #0: 51 / 0.81 -> en:fiber size variation seen on muscle biopsy
    n1=en:oedema | n2=en:fiber size variation seen on muscle biopsy | rel=r_associated | relid=0 | w=51
  184. en:oedema -- r_associated #0: 51 / 0.81 -> en:functional independence measure score
    n1=en:oedema | n2=en:functional independence measure score | rel=r_associated | relid=0 | w=51
  185. en:oedema -- r_associated #0: 51 / 0.81 -> en:gait unsteady
    n1=en:oedema | n2=en:gait unsteady | rel=r_associated | relid=0 | w=51
  186. en:oedema -- r_associated #0: 51 / 0.81 -> en:harlequin ichthyosis
    n1=en:oedema | n2=en:harlequin ichthyosis | rel=r_associated | relid=0 | w=51
  187. en:oedema -- r_associated #0: 51 / 0.81 -> en:hoarseness
    n1=en:oedema | n2=en:hoarseness | rel=r_associated | relid=0 | w=51
  188. en:oedema -- r_associated #0: 51 / 0.81 -> en:hyperhidrosis palmaris et plantaris
    n1=en:oedema | n2=en:hyperhidrosis palmaris et plantaris | rel=r_associated | relid=0 | w=51
  189. en:oedema -- r_associated #0: 51 / 0.81 -> en:hyperlactemia
    n1=en:oedema | n2=en:hyperlactemia | rel=r_associated | relid=0 | w=51
  190. en:oedema -- r_associated #0: 51 / 0.81 -> en:hypopigmented skin lesions
    n1=en:oedema | n2=en:hypopigmented skin lesions | rel=r_associated | relid=0 | w=51
  191. en:oedema -- r_associated #0: 51 / 0.81 -> en:impaired healing
    n1=en:oedema | n2=en:impaired healing | rel=r_associated | relid=0 | w=51
  192. en:oedema -- r_associated #0: 51 / 0.81 -> en:impaired heel-walking
    n1=en:oedema | n2=en:impaired heel-walking | rel=r_associated | relid=0 | w=51
  193. en:oedema -- r_associated #0: 51 / 0.81 -> en:increased fatty infiltration
    n1=en:oedema | n2=en:increased fatty infiltration | rel=r_associated | relid=0 | w=51
  194. en:oedema -- r_associated #0: 51 / 0.81 -> en:jaundice (harderoporphyria)
    n1=en:oedema | n2=en:jaundice (harderoporphyria) | rel=r_associated | relid=0 | w=51
  195. en:oedema -- r_associated #0: 51 / 0.81 -> en:lymphedema of upper and/or lower limbs (in some patients)
    n1=en:oedema | n2=en:lymphedema of upper and/or lower limbs (in some patients) | rel=r_associated | relid=0 | w=51
  196. en:oedema -- r_associated #0: 51 / 0.81 -> en:multiple mitochondrial dna (mtdna) deletions seen on muscle biopsy
    n1=en:oedema | n2=en:multiple mitochondrial dna (mtdna) deletions seen on muscle biopsy | rel=r_associated | relid=0 | w=51
  197. en:oedema -- r_associated #0: 51 / 0.81 -> en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan (dag1, 128239)
    n1=en:oedema | n2=en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan (dag1, 128239) | rel=r_associated | relid=0 | w=51
  198. en:oedema -- r_associated #0: 51 / 0.81 -> en:muscle mitochondria normal by histochemical analysis
    n1=en:oedema | n2=en:muscle mitochondria normal by histochemical analysis | rel=r_associated | relid=0 | w=51
  199. en:oedema -- r_associated #0: 51 / 0.81 -> en:myalgia, episodic
    n1=en:oedema | n2=en:myalgia, episodic | rel=r_associated | relid=0 | w=51
  200. en:oedema -- r_associated #0: 51 / 0.81 -> en:myotonia (delayed muscle relaxation after contraction)
    n1=en:oedema | n2=en:myotonia (delayed muscle relaxation after contraction) | rel=r_associated | relid=0 | w=51
  201. en:oedema -- r_associated #0: 51 / 0.81 -> en:no tanning
    n1=en:oedema | n2=en:no tanning | rel=r_associated | relid=0 | w=51
  202. en:oedema -- r_associated #0: 51 / 0.81 -> en:numerous 'confetti-like' scattered patches of normal skin
    n1=en:oedema | n2=en:numerous 'confetti-like' scattered patches of normal skin | rel=r_associated | relid=0 | w=51
  203. en:oedema -- r_associated #0: 51 / 0.81 -> en:pigmentary abnormalities (in some patients)
    n1=en:oedema | n2=en:pigmentary abnormalities (in some patients) | rel=r_associated | relid=0 | w=51
  204. en:oedema -- r_associated #0: 51 / 0.81 -> en:pitting edema
    n1=en:oedema | n2=en:pitting edema | rel=r_associated | relid=0 | w=51
  205. en:oedema -- r_associated #0: 51 / 0.81 -> en:poor wound healing
    n1=en:oedema | n2=en:poor wound healing | rel=r_associated | relid=0 | w=51
  206. en:oedema -- r_associated #0: 51 / 0.81 -> en:prenatal diagnosis by ultrasound
    n1=en:oedema | n2=en:prenatal diagnosis by ultrasound | rel=r_associated | relid=0 | w=51
  207. en:oedema -- r_associated #0: 51 / 0.81 -> en:prominent superficial veins
    n1=en:oedema | n2=en:prominent superficial veins | rel=r_associated | relid=0 | w=51
  208. en:oedema -- r_associated #0: 51 / 0.81 -> en:pseudophakia
    n1=en:oedema | n2=en:pseudophakia | rel=r_associated | relid=0 | w=51
  209. en:oedema -- r_associated #0: 51 / 0.81 -> en:sodium chloride 0.00342 meq/mg topical gel
    n1=en:oedema | n2=en:sodium chloride 0.00342 meq/mg topical gel | rel=r_associated | relid=0 | w=51
  210. en:oedema -- r_associated #0: 51 / 0.81 -> en:sodium chloride 0.9% eye drops
    n1=en:oedema | n2=en:sodium chloride 0.9% eye drops | rel=r_associated | relid=0 | w=51
  211. en:oedema -- r_associated #0: 51 / 0.81 -> en:systematized epidermal nevus
    n1=en:oedema | n2=en:systematized epidermal nevus | rel=r_associated | relid=0 | w=51
  212. en:oedema -- r_associated #0: 51 / 0.81 -> en:vasculitis
    n1=en:oedema | n2=en:vasculitis | rel=r_associated | relid=0 | w=51
  213. en:oedema -- r_associated #0: 51 / 0.81 -> en:walking may be limited
    n1=en:oedema | n2=en:walking may be limited | rel=r_associated | relid=0 | w=51
  214. en:oedema -- r_associated #0: 51 / 0.81 -> en:weakness
    n1=en:oedema | n2=en:weakness | rel=r_associated | relid=0 | w=51
  215. en:oedema -- r_associated #0: 51 / 0.81 -> oedème aigu du poumon
    n1=en:oedema | n2=oedème aigu du poumon | rel=r_associated | relid=0 | w=51
  216. en:oedema -- r_associated #0: 50 / 0.794 -> boursouflement
    n1=en:oedema | n2=boursouflement | rel=r_associated | relid=0 | w=50
  217. en:oedema -- r_associated #0: 50 / 0.794 -> en:'sloping' shoulders due to muscle atrophy
    n1=en:oedema | n2=en:'sloping' shoulders due to muscle atrophy | rel=r_associated | relid=0 | w=50
  218. en:oedema -- r_associated #0: 50 / 0.794 -> en:1. yellowish, flat papules (neck, antecubital and popliteal fossae, axillae, inguinal, and periumbilical areas)
    n1=en:oedema | n2=en:1. yellowish, flat papules (neck, antecubital and popliteal fossae, axillae, inguinal, and periumbilical areas) | rel=r_associated | relid=0 | w=50
  219. en:oedema -- r_associated #0: 50 / 0.794 -> en:abdominal pain
    n1=en:oedema | n2=en:abdominal pain | rel=r_associated | relid=0 | w=50
  220. en:oedema -- r_associated #0: 50 / 0.794 -> en:abnormal accumulation of fluid
    n1=en:oedema | n2=en:abnormal accumulation of fluid | rel=r_associated | relid=0 | w=50
  221. en:oedema -- r_associated #0: 50 / 0.794 -> en:abnormal aggregates of desmin and filamin c
    n1=en:oedema | n2=en:abnormal aggregates of desmin and filamin c | rel=r_associated | relid=0 | w=50
  222. en:oedema -- r_associated #0: 50 / 0.794 -> en:abnormal fat accumulation below the triceps (in some patients)
    n1=en:oedema | n2=en:abnormal fat accumulation below the triceps (in some patients) | rel=r_associated | relid=0 | w=50
  223. en:oedema -- r_associated #0: 50 / 0.794 -> en:abnormal fat distribution
    n1=en:oedema | n2=en:abnormal fat distribution | rel=r_associated | relid=0 | w=50
  224. en:oedema -- r_associated #0: 50 / 0.794 -> en:abnormal mitochondrial proliferation
    n1=en:oedema | n2=en:abnormal mitochondrial proliferation | rel=r_associated | relid=0 | w=50
  225. en:oedema -- r_associated #0: 50 / 0.794 -> en:abnormal pigmentation
    n1=en:oedema | n2=en:abnormal pigmentation | rel=r_associated | relid=0 | w=50
  226. en:oedema -- r_associated #0: 50 / 0.794 -> en:absence of caveolin-3 staining
    n1=en:oedema | n2=en:absence of caveolin-3 staining | rel=r_associated | relid=0 | w=50
  227. en:oedema -- r_associated #0: 50 / 0.794 -> en:absence of dermopathy
    n1=en:oedema | n2=en:absence of dermopathy | rel=r_associated | relid=0 | w=50
  228. en:oedema -- r_associated #0: 50 / 0.794 -> en:absence of muscle pseudohypertrophy
    n1=en:oedema | n2=en:absence of muscle pseudohypertrophy | rel=r_associated | relid=0 | w=50
  229. en:oedema -- r_associated #0: 50 / 0.794 -> en:absence of normal rete ridge pattern
    n1=en:oedema | n2=en:absence of normal rete ridge pattern | rel=r_associated | relid=0 | w=50
  230. en:oedema -- r_associated #0: 50 / 0.794 -> en:absent phalangeal crease
    n1=en:oedema | n2=en:absent phalangeal crease | rel=r_associated | relid=0 | w=50
  231. en:oedema -- r_associated #0: 50 / 0.794 -> en:acne
    n1=en:oedema | n2=en:acne | rel=r_associated | relid=0 | w=50
  232. en:oedema -- r_associated #0: 50 / 0.794 -> en:administrative statuses
    n1=en:oedema | n2=en:administrative statuses | rel=r_associated | relid=0 | w=50
  233. en:oedema -- r_associated #0: 50 / 0.794 -> en:alzheimer's disease assessment scale score
    n1=en:oedema | n2=en:alzheimer's disease assessment scale score | rel=r_associated | relid=0 | w=50
  234. en:oedema -- r_associated #0: 50 / 0.794 -> en:amorphous granulofilamentous material associated with z-discs
    n1=en:oedema | n2=en:amorphous granulofilamentous material associated with z-discs | rel=r_associated | relid=0 | w=50
  235. en:oedema -- r_associated #0: 50 / 0.794 -> en:aneurysm
    n1=en:oedema | n2=en:aneurysm | rel=r_associated | relid=0 | w=50
  236. en:oedema -- r_associated #0: 50 / 0.794 -> en:angulated atrophic fibers
    n1=en:oedema | n2=en:angulated atrophic fibers | rel=r_associated | relid=0 | w=50
  237. en:oedema -- r_associated #0: 50 / 0.794 -> en:aplasia of the sweat glands
    n1=en:oedema | n2=en:aplasia of the sweat glands | rel=r_associated | relid=0 | w=50
  238. en:oedema -- r_associated #0: 50 / 0.794 -> en:arm/shoulder muscle hypoplasia
    n1=en:oedema | n2=en:arm/shoulder muscle hypoplasia | rel=r_associated | relid=0 | w=50
  239. en:oedema -- r_associated #0: 50 / 0.794 -> en:arthritis
    n1=en:oedema | n2=en:arthritis | rel=r_associated | relid=0 | w=50
  240. en:oedema -- r_associated #0: 50 / 0.794 -> en:asymptomatic soft white spongy mucosal plaques with thick folded surfaces
    n1=en:oedema | n2=en:asymptomatic soft white spongy mucosal plaques with thick folded surfaces | rel=r_associated | relid=0 | w=50
  241. en:oedema -- r_associated #0: 50 / 0.794 -> en:atrophic scarring (rare)
    n1=en:oedema | n2=en:atrophic scarring (rare) | rel=r_associated | relid=0 | w=50
  242. en:oedema -- r_associated #0: 50 / 0.794 -> en:atrophy of the thenar and hypothenar muscles
    n1=en:oedema | n2=en:atrophy of the thenar and hypothenar muscles | rel=r_associated | relid=0 | w=50
  243. en:oedema -- r_associated #0: 50 / 0.794 -> en:attacks last 4 to 24 hours
    n1=en:oedema | n2=en:attacks last 4 to 24 hours | rel=r_associated | relid=0 | w=50
  244. en:oedema -- r_associated #0: 50 / 0.794 -> en:attacks usually decrease or disappear after age 40 years
    n1=en:oedema | n2=en:attacks usually decrease or disappear after age 40 years | rel=r_associated | relid=0 | w=50
  245. en:oedema -- r_associated #0: 50 / 0.794 -> en:bathing suit distribution of ichthyosis (in some patients)
    n1=en:oedema | n2=en:bathing suit distribution of ichthyosis (in some patients) | rel=r_associated | relid=0 | w=50
  246. en:oedema -- r_associated #0: 50 / 0.794 -> en:biceps aplasia
    n1=en:oedema | n2=en:biceps aplasia | rel=r_associated | relid=0 | w=50
  247. en:oedema -- r_associated #0: 50 / 0.794 -> en:bilateral foot drop
    n1=en:oedema | n2=en:bilateral foot drop | rel=r_associated | relid=0 | w=50
  248. en:oedema -- r_associated #0: 50 / 0.794 -> en:bilateral transverse palmar creases
    n1=en:oedema | n2=en:bilateral transverse palmar creases | rel=r_associated | relid=0 | w=50
  249. en:oedema -- r_associated #0: 50 / 0.794 -> en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers or in vacuoles
    n1=en:oedema | n2=en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers or in vacuoles | rel=r_associated | relid=0 | w=50
  250. en:oedema -- r_associated #0: 50 / 0.794 -> en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size
    n1=en:oedema | n2=en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size | rel=r_associated | relid=0 | w=50
  251. en:oedema -- r_associated #0: 50 / 0.794 -> en:bleeding diathesis
    n1=en:oedema | n2=en:bleeding diathesis | rel=r_associated | relid=0 | w=50
  252. en:oedema -- r_associated #0: 50 / 0.794 -> en:blistering, generalized, neonatal onset
    n1=en:oedema | n2=en:blistering, generalized, neonatal onset | rel=r_associated | relid=0 | w=50
  253. en:oedema -- r_associated #0: 50 / 0.794 -> en:blistering, recurrent, of the palms and soles
    n1=en:oedema | n2=en:blistering, recurrent, of the palms and soles | rel=r_associated | relid=0 | w=50
  254. en:oedema -- r_associated #0: 50 / 0.794 -> en:brown, warty keratotic papules (trunk, scalp, forehead, flexural areas)
    n1=en:oedema | n2=en:brown, warty keratotic papules (trunk, scalp, forehead, flexural areas) | rel=r_associated | relid=0 | w=50
  255. en:oedema -- r_associated #0: 50 / 0.794 -> en:calcification may occur
    n1=en:oedema | n2=en:calcification may occur | rel=r_associated | relid=0 | w=50
  256. en:oedema -- r_associated #0: 50 / 0.794 -> en:calf hypertrophy (uncommon)
    n1=en:oedema | n2=en:calf hypertrophy (uncommon) | rel=r_associated | relid=0 | w=50
  257. en:oedema -- r_associated #0: 50 / 0.794 -> en:candidiasis
    n1=en:oedema | n2=en:candidiasis | rel=r_associated | relid=0 | w=50
  258. en:oedema -- r_associated #0: 50 / 0.794 -> en:cap structures, when present, contain disorganized myofibrils and thickened z bands
    n1=en:oedema | n2=en:cap structures, when present, contain disorganized myofibrils and thickened z bands | rel=r_associated | relid=0 | w=50
  259. en:oedema -- r_associated #0: 50 / 0.794 -> en:cardiomyopathy
    n1=en:oedema | n2=en:cardiomyopathy | rel=r_associated | relid=0 | w=50
  260. en:oedema -- r_associated #0: 50 / 0.794 -> en:chronic candidiasis
    n1=en:oedema | n2=en:chronic candidiasis | rel=r_associated | relid=0 | w=50
  261. en:oedema -- r_associated #0: 50 / 0.794 -> en:chronic denervation seen on skeletal muscle biopsy
    n1=en:oedema | n2=en:chronic denervation seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=50
  262. en:oedema -- r_associated #0: 50 / 0.794 -> en:chronic pain
    n1=en:oedema | n2=en:chronic pain | rel=r_associated | relid=0 | w=50
  263. en:oedema -- r_associated #0: 50 / 0.794 -> en:clear gelatinous pterygia-like plaques of the nasal and temporal perilimbal bulbar conjunctiva
    n1=en:oedema | n2=en:clear gelatinous pterygia-like plaques of the nasal and temporal perilimbal bulbar conjunctiva | rel=r_associated | relid=0 | w=50
  264. en:oedema -- r_associated #0: 50 / 0.794 -> en:collar of stokes
    n1=en:oedema | n2=en:collar of stokes | rel=r_associated | relid=0 | w=50
  265. en:oedema -- r_associated #0: 50 / 0.794 -> en:combined mitochondrial respiratory chain deficiency (in most patients)
    n1=en:oedema | n2=en:combined mitochondrial respiratory chain deficiency (in most patients) | rel=r_associated | relid=0 | w=50
  266. en:oedema -- r_associated #0: 50 / 0.794 -> en:complication aspects
    n1=en:oedema | n2=en:complication aspects | rel=r_associated | relid=0 | w=50
  267. en:oedema -- r_associated #0: 50 / 0.794 -> en:connective tissue nevus
    n1=en:oedema | n2=en:connective tissue nevus | rel=r_associated | relid=0 | w=50
  268. en:oedema -- r_associated #0: 50 / 0.794 -> en:constitutional symptom
    n1=en:oedema | n2=en:constitutional symptom | rel=r_associated | relid=0 | w=50
  269. en:oedema -- r_associated #0: 50 / 0.794 -> en:cox-negative fibers
    n1=en:oedema | n2=en:cox-negative fibers | rel=r_associated | relid=0 | w=50
  270. en:oedema -- r_associated #0: 50 / 0.794 -> en:cutaneous and mucosal skin tags
    n1=en:oedema | n2=en:cutaneous and mucosal skin tags | rel=r_associated | relid=0 | w=50
  271. en:oedema -- r_associated #0: 50 / 0.794 -> en:cutaneous candidiasis
    n1=en:oedema | n2=en:cutaneous candidiasis | rel=r_associated | relid=0 | w=50
  272. en:oedema -- r_associated #0: 50 / 0.794 -> en:cutis marmorata telangiectatica congenita
    n1=en:oedema | n2=en:cutis marmorata telangiectatica congenita | rel=r_associated | relid=0 | w=50
  273. en:oedema -- r_associated #0: 50 / 0.794 -> en:cutis verticis gyrata (onset age 40)
    n1=en:oedema | n2=en:cutis verticis gyrata (onset age 40) | rel=r_associated | relid=0 | w=50
  274. en:oedema -- r_associated #0: 50 / 0.794 -> en:cytochrome-c oxidase deficiency
    n1=en:oedema | n2=en:cytochrome-c oxidase deficiency | rel=r_associated | relid=0 | w=50
  275. en:oedema -- r_associated #0: 50 / 0.794 -> en:dark pigmentation of knees and dorsum of hands and feet
    n1=en:oedema | n2=en:dark pigmentation of knees and dorsum of hands and feet | rel=r_associated | relid=0 | w=50
  276. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased activities of mitochondrial complexes i, ii, and iii
    n1=en:oedema | n2=en:decreased activities of mitochondrial complexes i, ii, and iii | rel=r_associated | relid=0 | w=50
  277. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased activity of cytochrome c oxidase seen on muscle biopsy
    n1=en:oedema | n2=en:decreased activity of cytochrome c oxidase seen on muscle biopsy | rel=r_associated | relid=0 | w=50
  278. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased ant1 protein (103220) in muscle tissue
    n1=en:oedema | n2=en:decreased ant1 protein (103220) in muscle tissue | rel=r_associated | relid=0 | w=50
  279. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased complex i activity (rare)
    n1=en:oedema | n2=en:decreased complex i activity (rare) | rel=r_associated | relid=0 | w=50
  280. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased histidase activity
    n1=en:oedema | n2=en:decreased histidase activity | rel=r_associated | relid=0 | w=50
  281. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased mitochondrial complex v activity
    n1=en:oedema | n2=en:decreased mitochondrial complex v activity | rel=r_associated | relid=0 | w=50
  282. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased mtdna
    n1=en:oedema | n2=en:decreased mtdna | rel=r_associated | relid=0 | w=50
  283. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased muscle action potential after warming affected muscle
    n1=en:oedema | n2=en:decreased muscle action potential after warming affected muscle | rel=r_associated | relid=0 | w=50
  284. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased muscle mass
    n1=en:oedema | n2=en:decreased muscle mass | rel=r_associated | relid=0 | w=50
  285. en:oedema -- r_associated #0: 50 / 0.794 -> en:decreased shoulder muscle mass
    n1=en:oedema | n2=en:decreased shoulder muscle mass | rel=r_associated | relid=0 | w=50
  286. en:oedema -- r_associated #0: 50 / 0.794 -> en:decremental response on 3-hz repetitive nerve stimulation
    n1=en:oedema | n2=en:decremental response on 3-hz repetitive nerve stimulation | rel=r_associated | relid=0 | w=50
  287. en:oedema -- r_associated #0: 50 / 0.794 -> en:deep palmar crease
    n1=en:oedema | n2=en:deep palmar crease | rel=r_associated | relid=0 | w=50
  288. en:oedema -- r_associated #0: 50 / 0.794 -> en:degenerate mitochondrial on em
    n1=en:oedema | n2=en:degenerate mitochondrial on em | rel=r_associated | relid=0 | w=50
  289. en:oedema -- r_associated #0: 50 / 0.794 -> en:degenerating fibers
    n1=en:oedema | n2=en:degenerating fibers | rel=r_associated | relid=0 | w=50
  290. en:oedema -- r_associated #0: 50 / 0.794 -> en:degrading mitochondria
    n1=en:oedema | n2=en:degrading mitochondria | rel=r_associated | relid=0 | w=50
  291. en:oedema -- r_associated #0: 50 / 0.794 -> en:delayed ambulation
    n1=en:oedema | n2=en:delayed ambulation | rel=r_associated | relid=0 | w=50
  292. en:oedema -- r_associated #0: 50 / 0.794 -> en:deltoid muscle hypoplasia
    n1=en:oedema | n2=en:deltoid muscle hypoplasia | rel=r_associated | relid=0 | w=50
  293. en:oedema -- r_associated #0: 50 / 0.794 -> en:dependent edema
    n1=en:oedema | n2=en:dependent edema | rel=r_associated | relid=0 | w=50
  294. en:oedema -- r_associated #0: 50 / 0.794 -> en:deposits immunoreactive to beta-amyloid protein
    n1=en:oedema | n2=en:deposits immunoreactive to beta-amyloid protein | rel=r_associated | relid=0 | w=50
  295. en:oedema -- r_associated #0: 50 / 0.794 -> en:derived from hair matrix cells
    n1=en:oedema | n2=en:derived from hair matrix cells | rel=r_associated | relid=0 | w=50
  296. en:oedema -- r_associated #0: 50 / 0.794 -> en:dermis thinning
    n1=en:oedema | n2=en:dermis thinning | rel=r_associated | relid=0 | w=50
  297. en:oedema -- r_associated #0: 50 / 0.794 -> en:diabetic foot
    n1=en:oedema | n2=en:diabetic foot | rel=r_associated | relid=0 | w=50
  298. en:oedema -- r_associated #0: 50 / 0.794 -> en:diabetic macular edema not clinically significant
    n1=en:oedema | n2=en:diabetic macular edema not clinically significant | rel=r_associated | relid=0 | w=50
  299. en:oedema -- r_associated #0: 50 / 0.794 -> en:dimples (chin, buttocks)
    n1=en:oedema | n2=en:dimples (chin, buttocks) | rel=r_associated | relid=0 | w=50
  300. en:oedema -- r_associated #0: 50 / 0.794 -> en:dimples over large joints
    n1=en:oedema | n2=en:dimples over large joints | rel=r_associated | relid=0 | w=50
  301. en:oedema -- r_associated #0: 50 / 0.794 -> en:dimples overlying contractures
    n1=en:oedema | n2=en:dimples overlying contractures | rel=r_associated | relid=0 | w=50
  302. en:oedema -- r_associated #0: 50 / 0.794 -> en:discrete 2 to 5-mm hyper- and hypopigmented macules
    n1=en:oedema | n2=en:discrete 2 to 5-mm hyper- and hypopigmented macules | rel=r_associated | relid=0 | w=50
  303. en:oedema -- r_associated #0: 50 / 0.794 -> en:disruption of the m-line
    n1=en:oedema | n2=en:disruption of the m-line | rel=r_associated | relid=0 | w=50
  304. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal leg muscle atrophy
    n1=en:oedema | n2=en:distal leg muscle atrophy | rel=r_associated | relid=0 | w=50
  305. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal limb muscle weakness, lower more than upper
    n1=en:oedema | n2=en:distal limb muscle weakness, lower more than upper | rel=r_associated | relid=0 | w=50
  306. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal muscle atrophy, lower limbs more severely affected than upper limbs
    n1=en:oedema | n2=en:distal muscle atrophy, lower limbs more severely affected than upper limbs | rel=r_associated | relid=0 | w=50
  307. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal muscle atrophy, predominantly lower limbs
    n1=en:oedema | n2=en:distal muscle atrophy, predominantly lower limbs | rel=r_associated | relid=0 | w=50
  308. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal muscle wasting due to peripheral neuropathy
    n1=en:oedema | n2=en:distal muscle wasting due to peripheral neuropathy | rel=r_associated | relid=0 | w=50
  309. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal muscle weakness
    n1=en:oedema | n2=en:distal muscle weakness | rel=r_associated | relid=0 | w=50
  310. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal muscle weakness occurs later
    n1=en:oedema | n2=en:distal muscle weakness occurs later | rel=r_associated | relid=0 | w=50
  311. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal muscular atrophy due to peripheral neuropathy
    n1=en:oedema | n2=en:distal muscular atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=50
  312. en:oedema -- r_associated #0: 50 / 0.794 -> en:distal myopathy (in 1 family)
    n1=en:oedema | n2=en:distal myopathy (in 1 family) | rel=r_associated | relid=0 | w=50
  313. en:oedema -- r_associated #0: 50 / 0.794 -> en:distress
    n1=en:oedema | n2=en:distress | rel=r_associated | relid=0 | w=50
  314. en:oedema -- r_associated #0: 50 / 0.794 -> en:drug effect disorder
    n1=en:oedema | n2=en:drug effect disorder | rel=r_associated | relid=0 | w=50
  315. en:oedema -- r_associated #0: 50 / 0.794 -> en:dry, scaly skin
    n1=en:oedema | n2=en:dry, scaly skin | rel=r_associated | relid=0 | w=50
  316. en:oedema -- r_associated #0: 50 / 0.794 -> en:ear, nose / throat observable
    n1=en:oedema | n2=en:ear, nose / throat observable | rel=r_associated | relid=0 | w=50
  317. en:oedema -- r_associated #0: 50 / 0.794 -> en:eczema, severe
    n1=en:oedema | n2=en:eczema, severe | rel=r_associated | relid=0 | w=50
  318. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema of buttock
    n1=en:oedema | n2=en:edema of buttock | rel=r_associated | relid=0 | w=50
  319. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema of cervix
    n1=en:oedema | n2=en:edema of cervix | rel=r_associated | relid=0 | w=50
  320. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema of lumbar cord
    n1=en:oedema | n2=en:edema of lumbar cord | rel=r_associated | relid=0 | w=50
  321. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema of thoracic cord
    n1=en:oedema | n2=en:edema of thoracic cord | rel=r_associated | relid=0 | w=50
  322. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema of upper eyelid
    n1=en:oedema | n2=en:edema of upper eyelid | rel=r_associated | relid=0 | w=50
  323. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema reoccurs with infections
    n1=en:oedema | n2=en:edema reoccurs with infections | rel=r_associated | relid=0 | w=50
  324. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema, generalized
    n1=en:oedema | n2=en:edema, generalized | rel=r_associated | relid=0 | w=50
  325. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema:find:pt:^patient:ord:mds
    n1=en:oedema | n2=en:edema:find:pt:^patient:ord:mds | rel=r_associated | relid=0 | w=50
  326. en:oedema -- r_associated #0: 50 / 0.794 -> en:edema:finding:point in time:^patient:ordinal
    n1=en:oedema | n2=en:edema:finding:point in time:^patient:ordinal | rel=r_associated | relid=0 | w=50
  327. en:oedema -- r_associated #0: 50 / 0.794 -> en:electromyogram abnormal
    n1=en:oedema | n2=en:electromyogram abnormal | rel=r_associated | relid=0 | w=50
  328. en:oedema -- r_associated #0: 50 / 0.794 -> en:elephantiasis
    n1=en:oedema | n2=en:elephantiasis | rel=r_associated | relid=0 | w=50
  329. en:oedema -- r_associated #0: 50 / 0.794 -> en:emg shows chronic denervation
    n1=en:oedema | n2=en:emg shows chronic denervation | rel=r_associated | relid=0 | w=50
  330. en:oedema -- r_associated #0: 50 / 0.794 -> en:emg shows myopathic or neurogenic changes
    n1=en:oedema | n2=en:emg shows myopathic or neurogenic changes | rel=r_associated | relid=0 | w=50
  331. en:oedema -- r_associated #0: 50 / 0.794 -> en:emg shows reduction of voluntary recruitment
    n1=en:oedema | n2=en:emg shows reduction of voluntary recruitment | rel=r_associated | relid=0 | w=50
  332. en:oedema -- r_associated #0: 50 / 0.794 -> en:endolymphatic hydrops
    n1=en:oedema | n2=en:endolymphatic hydrops | rel=r_associated | relid=0 | w=50
  333. en:oedema -- r_associated #0: 50 / 0.794 -> en:enuresis
    n1=en:oedema | n2=en:enuresis | rel=r_associated | relid=0 | w=50
  334. en:oedema -- r_associated #0: 50 / 0.794 -> en:erosion, generalized
    n1=en:oedema | n2=en:erosion, generalized | rel=r_associated | relid=0 | w=50
  335. en:oedema -- r_associated #0: 50 / 0.794 -> en:etiology aspects
    n1=en:oedema | n2=en:etiology aspects | rel=r_associated | relid=0 | w=50
  336. en:oedema -- r_associated #0: 50 / 0.794 -> en:excess fat, symmetrically located in buttocks and lower extremities to ankles
    n1=en:oedema | n2=en:excess fat, symmetrically located in buttocks and lower extremities to ankles | rel=r_associated | relid=0 | w=50
  337. en:oedema -- r_associated #0: 50 / 0.794 -> en:excess interdialytic weight gain
    n1=en:oedema | n2=en:excess interdialytic weight gain | rel=r_associated | relid=0 | w=50
  338. en:oedema -- r_associated #0: 50 / 0.794 -> en:excessive neutral fat and free fatty acids in type-i fibers
    n1=en:oedema | n2=en:excessive neutral fat and free fatty acids in type-i fibers | rel=r_associated | relid=0 | w=50
  339. en:oedema -- r_associated #0: 50 / 0.794 -> en:excessive skin wrinkling of palms and soles (in one patient)
    n1=en:oedema | n2=en:excessive skin wrinkling of palms and soles (in one patient) | rel=r_associated | relid=0 | w=50
  340. en:oedema -- r_associated #0: 50 / 0.794 -> en:excessive skin wrinkling on dorsum of hands and fingers
    n1=en:oedema | n2=en:excessive skin wrinkling on dorsum of hands and fingers | rel=r_associated | relid=0 | w=50
  341. en:oedema -- r_associated #0: 50 / 0.794 -> en:exertional fatigue
    n1=en:oedema | n2=en:exertional fatigue | rel=r_associated | relid=0 | w=50
  342. en:oedema -- r_associated #0: 50 / 0.794 -> en:extensor muscle weakness more severe than flexor muscle weakness
    n1=en:oedema | n2=en:extensor muscle weakness more severe than flexor muscle weakness | rel=r_associated | relid=0 | w=50
  343. en:oedema -- r_associated #0: 50 / 0.794 -> en:eysenck personality inventory score
    n1=en:oedema | n2=en:eysenck personality inventory score | rel=r_associated | relid=0 | w=50
  344. en:oedema -- r_associated #0: 50 / 0.794 -> en:facial diplegia
    n1=en:oedema | n2=en:facial diplegia | rel=r_associated | relid=0 | w=50
  345. en:oedema -- r_associated #0: 50 / 0.794 -> en:facial hemangioma
    n1=en:oedema | n2=en:facial hemangioma | rel=r_associated | relid=0 | w=50
  346. en:oedema -- r_associated #0: 50 / 0.794 -> en:facial pallor
    n1=en:oedema | n2=en:facial pallor | rel=r_associated | relid=0 | w=50
  347. en:oedema -- r_associated #0: 50 / 0.794 -> en:facial xanthomatous eruptions (rare)
    n1=en:oedema | n2=en:facial xanthomatous eruptions (rare) | rel=r_associated | relid=0 | w=50
  348. en:oedema -- r_associated #0: 50 / 0.794 -> en:familial progressive hyperpigmentation and hypopigmentation
    n1=en:oedema | n2=en:familial progressive hyperpigmentation and hypopigmentation | rel=r_associated | relid=0 | w=50
  349. en:oedema -- r_associated #0: 50 / 0.794 -> en:fatigue
    n1=en:oedema | n2=en:fatigue | rel=r_associated | relid=0 | w=50
  350. en:oedema -- r_associated #0: 50 / 0.794 -> en:fetal ascites
    n1=en:oedema | n2=en:fetal ascites | rel=r_associated | relid=0 | w=50
  351. en:oedema -- r_associated #0: 50 / 0.794 -> en:fetal bradycardia (in some patients)
    n1=en:oedema | n2=en:fetal bradycardia (in some patients) | rel=r_associated | relid=0 | w=50
  352. en:oedema -- r_associated #0: 50 / 0.794 -> en:fetal distress
    n1=en:oedema | n2=en:fetal distress | rel=r_associated | relid=0 | w=50
  353. en:oedema -- r_associated #0: 50 / 0.794 -> en:fever
    n1=en:oedema | n2=en:fever | rel=r_associated | relid=0 | w=50
  354. en:oedema -- r_associated #0: 50 / 0.794 -> en:fiber type variation seen on biopsy
    n1=en:oedema | n2=en:fiber type variation seen on biopsy | rel=r_associated | relid=0 | w=50
  355. en:oedema -- r_associated #0: 50 / 0.794 -> en:fibrillations in affected muscles
    n1=en:oedema | n2=en:fibrillations in affected muscles | rel=r_associated | relid=0 | w=50
  356. en:oedema -- r_associated #0: 50 / 0.794 -> en:flaccid weakness or paralysis, episodic attacks
    n1=en:oedema | n2=en:flaccid weakness or paralysis, episodic attacks | rel=r_associated | relid=0 | w=50
  357. en:oedema -- r_associated #0: 50 / 0.794 -> en:focal areas of z-band disarray devoid of mitochondria seen on electron microscopy
    n1=en:oedema | n2=en:focal areas of z-band disarray devoid of mitochondria seen on electron microscopy | rel=r_associated | relid=0 | w=50
  358. en:oedema -- r_associated #0: 50 / 0.794 -> en:forehead hyperpigmentation
    n1=en:oedema | n2=en:forehead hyperpigmentation | rel=r_associated | relid=0 | w=50
  359. en:oedema -- r_associated #0: 50 / 0.794 -> en:forewater
    n1=en:oedema | n2=en:forewater | rel=r_associated | relid=0 | w=50
  360. en:oedema -- r_associated #0: 50 / 0.794 -> en:fragmented mitochondrial network
    n1=en:oedema | n2=en:fragmented mitochondrial network | rel=r_associated | relid=0 | w=50
  361. en:oedema -- r_associated #0: 50 / 0.794 -> en:frontal hirsutism
    n1=en:oedema | n2=en:frontal hirsutism | rel=r_associated | relid=0 | w=50
  362. en:oedema -- r_associated #0: 50 / 0.794 -> en:general clinical state finding
    n1=en:oedema | n2=en:general clinical state finding | rel=r_associated | relid=0 | w=50
  363. en:oedema -- r_associated #0: 50 / 0.794 -> en:generalized hypotonia
    n1=en:oedema | n2=en:generalized hypotonia | rel=r_associated | relid=0 | w=50
  364. en:oedema -- r_associated #0: 50 / 0.794 -> en:generalized limb muscle atrophy
    n1=en:oedema | n2=en:generalized limb muscle atrophy | rel=r_associated | relid=0 | w=50
  365. en:oedema -- r_associated #0: 50 / 0.794 -> en:generalized rash
    n1=en:oedema | n2=en:generalized rash | rel=r_associated | relid=0 | w=50
  366. en:oedema -- r_associated #0: 50 / 0.794 -> en:glycogen depletion in skeletal muscle
    n1=en:oedema | n2=en:glycogen depletion in skeletal muscle | rel=r_associated | relid=0 | w=50
  367. en:oedema -- r_associated #0: 50 / 0.794 -> en:glycogenosis of skeletal muscle, mild (in some patients)
    n1=en:oedema | n2=en:glycogenosis of skeletal muscle, mild (in some patients) | rel=r_associated | relid=0 | w=50
  368. en:oedema -- r_associated #0: 50 / 0.794 -> en:greater sartorius involvement than gracilis involvement seen on mri
    n1=en:oedema | n2=en:greater sartorius involvement than gracilis involvement seen on mri | rel=r_associated | relid=0 | w=50
  369. en:oedema -- r_associated #0: 50 / 0.794 -> en:grip strength decreased
    n1=en:oedema | n2=en:grip strength decreased | rel=r_associated | relid=0 | w=50
  370. en:oedema -- r_associated #0: 50 / 0.794 -> en:hand and foot weakness
    n1=en:oedema | n2=en:hand and foot weakness | rel=r_associated | relid=0 | w=50
  371. en:oedema -- r_associated #0: 50 / 0.794 -> en:hangrip myotonia
    n1=en:oedema | n2=en:hangrip myotonia | rel=r_associated | relid=0 | w=50
  372. en:oedema -- r_associated #0: 50 / 0.794 -> en:head skin
    n1=en:oedema | n2=en:head skin | rel=r_associated | relid=0 | w=50
  373. en:oedema -- r_associated #0: 50 / 0.794 -> en:headache
    n1=en:oedema | n2=en:headache | rel=r_associated | relid=0 | w=50
  374. en:oedema -- r_associated #0: 50 / 0.794 -> en:heart disease in women
    n1=en:oedema | n2=en:heart disease in women | rel=r_associated | relid=0 | w=50
  375. en:oedema -- r_associated #0: 50 / 0.794 -> en:heart disorder
    n1=en:oedema | n2=en:heart disorder | rel=r_associated | relid=0 | w=50
  376. en:oedema -- r_associated #0: 50 / 0.794 -> en:heart malformation
    n1=en:oedema | n2=en:heart malformation | rel=r_associated | relid=0 | w=50
  377. en:oedema -- r_associated #0: 50 / 0.794 -> en:heartburn
    n1=en:oedema | n2=en:heartburn | rel=r_associated | relid=0 | w=50
  378. en:oedema -- r_associated #0: 50 / 0.794 -> en:hematoma
    n1=en:oedema | n2=en:hematoma | rel=r_associated | relid=0 | w=50
  379. en:oedema -- r_associated #0: 50 / 0.794 -> en:hereditary neuraxial edema
    n1=en:oedema | n2=en:hereditary neuraxial edema | rel=r_associated | relid=0 | w=50
  380. en:oedema -- r_associated #0: 50 / 0.794 -> en:hernia
    n1=en:oedema | n2=en:hernia | rel=r_associated | relid=0 | w=50
  381. en:oedema -- r_associated #0: 50 / 0.794 -> en:heterotopic bone formation in subcutaneous fat
    n1=en:oedema | n2=en:heterotopic bone formation in subcutaneous fat | rel=r_associated | relid=0 | w=50
  382. en:oedema -- r_associated #0: 50 / 0.794 -> en:hip flexor weakness
    n1=en:oedema | n2=en:hip flexor weakness | rel=r_associated | relid=0 | w=50
  383. en:oedema -- r_associated #0: 50 / 0.794 -> en:hirsutism
    n1=en:oedema | n2=en:hirsutism | rel=r_associated | relid=0 | w=50
  384. en:oedema -- r_associated #0: 50 / 0.794 -> en:histology shows 'cannonball' distribution of capillary-sized vessels in the dermis
    n1=en:oedema | n2=en:histology shows 'cannonball' distribution of capillary-sized vessels in the dermis | rel=r_associated | relid=0 | w=50
  385. en:oedema -- r_associated #0: 50 / 0.794 -> en:housing dependency scale score
    n1=en:oedema | n2=en:housing dependency scale score | rel=r_associated | relid=0 | w=50
  386. en:oedema -- r_associated #0: 50 / 0.794 -> en:hydrops fetalis (type ii, congenital)
    n1=en:oedema | n2=en:hydrops fetalis (type ii, congenital) | rel=r_associated | relid=0 | w=50
  387. en:oedema -- r_associated #0: 50 / 0.794 -> en:hyperemia
    n1=en:oedema | n2=en:hyperemia | rel=r_associated | relid=0 | w=50
  388. en:oedema -- r_associated #0: 50 / 0.794 -> en:hyperkeratosis of the palms and soles and esophageal papillomas
    n1=en:oedema | n2=en:hyperkeratosis of the palms and soles and esophageal papillomas | rel=r_associated | relid=0 | w=50
  389. en:oedema -- r_associated #0: 50 / 0.794 -> en:hyperkeratotic plaques on anterolateral ankle area (in some patients)
    n1=en:oedema | n2=en:hyperkeratotic plaques on anterolateral ankle area (in some patients) | rel=r_associated | relid=0 | w=50
  390. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypertonicity of the lower limbs
    n1=en:oedema | n2=en:hypertonicity of the lower limbs | rel=r_associated | relid=0 | w=50
  391. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypoalgesia
    n1=en:oedema | n2=en:hypoalgesia | rel=r_associated | relid=0 | w=50
  392. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypohidrosis or anhidrosis (in some patients)
    n1=en:oedema | n2=en:hypohidrosis or anhidrosis (in some patients) | rel=r_associated | relid=0 | w=50
  393. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypopigmented spots (less common)
    n1=en:oedema | n2=en:hypopigmented spots (less common) | rel=r_associated | relid=0 | w=50
  394. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypoplasia of muscle
    n1=en:oedema | n2=en:hypoplasia of muscle | rel=r_associated | relid=0 | w=50
  395. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypoplastic flexion creases
    n1=en:oedema | n2=en:hypoplastic flexion creases | rel=r_associated | relid=0 | w=50
  396. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypoplastic flexion creases dorsum of hand
    n1=en:oedema | n2=en:hypoplastic flexion creases dorsum of hand | rel=r_associated | relid=0 | w=50
  397. en:oedema -- r_associated #0: 50 / 0.794 -> en:hyporeflexia or areflexia
    n1=en:oedema | n2=en:hyporeflexia or areflexia | rel=r_associated | relid=0 | w=50
  398. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypothermia adverse event
    n1=en:oedema | n2=en:hypothermia adverse event | rel=r_associated | relid=0 | w=50
  399. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypotonia (2 patients)
    n1=en:oedema | n2=en:hypotonia (2 patients) | rel=r_associated | relid=0 | w=50
  400. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypotonia (cvs+)
    n1=en:oedema | n2=en:hypotonia (cvs+) | rel=r_associated | relid=0 | w=50
  401. en:oedema -- r_associated #0: 50 / 0.794 -> en:hypotonia, truncal and appendicular
    n1=en:oedema | n2=en:hypotonia, truncal and appendicular | rel=r_associated | relid=0 | w=50
  402. en:oedema -- r_associated #0: 50 / 0.794 -> en:idiopathic optic disc swelling
    n1=en:oedema | n2=en:idiopathic optic disc swelling | rel=r_associated | relid=0 | w=50
  403. en:oedema -- r_associated #0: 50 / 0.794 -> en:imaging shows progressive fatty infiltration of muscle
    n1=en:oedema | n2=en:imaging shows progressive fatty infiltration of muscle | rel=r_associated | relid=0 | w=50
  404. en:oedema -- r_associated #0: 50 / 0.794 -> en:increased endomysial connective tissue around muscle fibers
    n1=en:oedema | n2=en:increased endomysial connective tissue around muscle fibers | rel=r_associated | relid=0 | w=50
  405. en:oedema -- r_associated #0: 50 / 0.794 -> en:increased endomysial fibrosis
    n1=en:oedema | n2=en:increased endomysial fibrosis | rel=r_associated | relid=0 | w=50
  406. en:oedema -- r_associated #0: 50 / 0.794 -> en:increased fiber size variability
    n1=en:oedema | n2=en:increased fiber size variability | rel=r_associated | relid=0 | w=50
  407. en:oedema -- r_associated #0: 50 / 0.794 -> en:increased sputum excretion
    n1=en:oedema | n2=en:increased sputum excretion | rel=r_associated | relid=0 | w=50
  408. en:oedema -- r_associated #0: 50 / 0.794 -> en:independent walking may not be achieved
    n1=en:oedema | n2=en:independent walking may not be achieved | rel=r_associated | relid=0 | w=50
  409. en:oedema -- r_associated #0: 50 / 0.794 -> en:inner zone of enucleated 'shadow' cells
    n1=en:oedema | n2=en:inner zone of enucleated 'shadow' cells | rel=r_associated | relid=0 | w=50
  410. en:oedema -- r_associated #0: 50 / 0.794 -> en:intolerant of heat
    n1=en:oedema | n2=en:intolerant of heat | rel=r_associated | relid=0 | w=50
  411. en:oedema -- r_associated #0: 50 / 0.794 -> en:kanavel's four cardinal signs
    n1=en:oedema | n2=en:kanavel's four cardinal signs | rel=r_associated | relid=0 | w=50
  412. en:oedema -- r_associated #0: 50 / 0.794 -> en:keratinized, purple, nodular skin lesions (in 2 of 4 patients)
    n1=en:oedema | n2=en:keratinized, purple, nodular skin lesions (in 2 of 4 patients) | rel=r_associated | relid=0 | w=50
  413. en:oedema -- r_associated #0: 50 / 0.794 -> en:keratoderma, striated, on palms
    n1=en:oedema | n2=en:keratoderma, striated, on palms | rel=r_associated | relid=0 | w=50
  414. en:oedema -- r_associated #0: 50 / 0.794 -> en:keratosis pilaris (in some patients)
    n1=en:oedema | n2=en:keratosis pilaris (in some patients) | rel=r_associated | relid=0 | w=50
  415. en:oedema -- r_associated #0: 50 / 0.794 -> en:keratotic plaque, periorificial
    n1=en:oedema | n2=en:keratotic plaque, periorificial | rel=r_associated | relid=0 | w=50
  416. en:oedema -- r_associated #0: 50 / 0.794 -> en:kniest like dysplasia lethal
    n1=en:oedema | n2=en:kniest like dysplasia lethal | rel=r_associated | relid=0 | w=50
  417. en:oedema -- r_associated #0: 50 / 0.794 -> en:knuckle pads on dorsal finger and toe joints
    n1=en:oedema | n2=en:knuckle pads on dorsal finger and toe joints | rel=r_associated | relid=0 | w=50
  418. en:oedema -- r_associated #0: 50 / 0.794 -> en:kocher's sign
    n1=en:oedema | n2=en:kocher's sign | rel=r_associated | relid=0 | w=50
  419. en:oedema -- r_associated #0: 50 / 0.794 -> en:lack of integrin alpha-7 staining
    n1=en:oedema | n2=en:lack of integrin alpha-7 staining | rel=r_associated | relid=0 | w=50
  420. en:oedema -- r_associated #0: 50 / 0.794 -> en:lamellar ichthyosis
    n1=en:oedema | n2=en:lamellar ichthyosis | rel=r_associated | relid=0 | w=50
  421. en:oedema -- r_associated #0: 50 / 0.794 -> en:laryngeal edema
    n1=en:oedema | n2=en:laryngeal edema | rel=r_associated | relid=0 | w=50
  422. en:oedema -- r_associated #0: 50 / 0.794 -> en:limb weakness and atrophy
    n1=en:oedema | n2=en:limb weakness and atrophy | rel=r_associated | relid=0 | w=50
  423. en:oedema -- r_associated #0: 50 / 0.794 -> en:linear plaque-like scales (1 family)
    n1=en:oedema | n2=en:linear plaque-like scales (1 family) | rel=r_associated | relid=0 | w=50
  424. en:oedema -- r_associated #0: 50 / 0.794 -> en:linear porokeratosis (1 patient)
    n1=en:oedema | n2=en:linear porokeratosis (1 patient) | rel=r_associated | relid=0 | w=50
  425. en:oedema -- r_associated #0: 50 / 0.794 -> en:lipid droplets seen on muscle biopsy
    n1=en:oedema | n2=en:lipid droplets seen on muscle biopsy | rel=r_associated | relid=0 | w=50
  426. en:oedema -- r_associated #0: 50 / 0.794 -> en:lipoatrophy, generalized
    n1=en:oedema | n2=en:lipoatrophy, generalized | rel=r_associated | relid=0 | w=50
  427. en:oedema -- r_associated #0: 50 / 0.794 -> en:lipodystrophy, generalized, panniculitis-induced (in some)
    n1=en:oedema | n2=en:lipodystrophy, generalized, panniculitis-induced (in some) | rel=r_associated | relid=0 | w=50
  428. en:oedema -- r_associated #0: 50 / 0.794 -> en:localized cutaneous deposits of superficial fat
    n1=en:oedema | n2=en:localized cutaneous deposits of superficial fat | rel=r_associated | relid=0 | w=50
  429. en:oedema -- r_associated #0: 50 / 0.794 -> en:localized cutaneous necrobiosis lipoidica
    n1=en:oedema | n2=en:localized cutaneous necrobiosis lipoidica | rel=r_associated | relid=0 | w=50
  430. en:oedema -- r_associated #0: 50 / 0.794 -> en:loss of consciousness
    n1=en:oedema | n2=en:loss of consciousness | rel=r_associated | relid=0 | w=50
  431. en:oedema -- r_associated #0: 50 / 0.794 -> en:low muscle mass
    n1=en:oedema | n2=en:low muscle mass | rel=r_associated | relid=0 | w=50
  432. en:oedema -- r_associated #0: 50 / 0.794 -> en:low-amplitude compound muscle action potential (cmap)
    n1=en:oedema | n2=en:low-amplitude compound muscle action potential (cmap) | rel=r_associated | relid=0 | w=50
  433. en:oedema -- r_associated #0: 50 / 0.794 -> en:lower limb atrophy
    n1=en:oedema | n2=en:lower limb atrophy | rel=r_associated | relid=0 | w=50
  434. en:oedema -- r_associated #0: 50 / 0.794 -> en:maculopapular eruption, diffuse
    n1=en:oedema | n2=en:maculopapular eruption, diffuse | rel=r_associated | relid=0 | w=50
  435. en:oedema -- r_associated #0: 50 / 0.794 -> en:malar rash
    n1=en:oedema | n2=en:malar rash | rel=r_associated | relid=0 | w=50
  436. en:oedema -- r_associated #0: 50 / 0.794 -> en:manchester foot pain and disability index score
    n1=en:oedema | n2=en:manchester foot pain and disability index score | rel=r_associated | relid=0 | w=50
  437. en:oedema -- r_associated #0: 50 / 0.794 -> en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest
    n1=en:oedema | n2=en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest | rel=r_associated | relid=0 | w=50
  438. en:oedema -- r_associated #0: 50 / 0.794 -> en:metaplasia
    n1=en:oedema | n2=en:metaplasia | rel=r_associated | relid=0 | w=50
  439. en:oedema -- r_associated #0: 50 / 0.794 -> en:midface capillary hemangioma
    n1=en:oedema | n2=en:midface capillary hemangioma | rel=r_associated | relid=0 | w=50
  440. en:oedema -- r_associated #0: 50 / 0.794 -> en:midline facial capillary hemangioma
    n1=en:oedema | n2=en:midline facial capillary hemangioma | rel=r_associated | relid=0 | w=50
  441. en:oedema -- r_associated #0: 50 / 0.794 -> en:migratory plaques of thickened, sharply demarcated erythema and hyperkeratosis
    n1=en:oedema | n2=en:migratory plaques of thickened, sharply demarcated erythema and hyperkeratosis | rel=r_associated | relid=0 | w=50
  442. en:oedema -- r_associated #0: 50 / 0.794 -> en:mild localized pigmentation abnormalities
    n1=en:oedema | n2=en:mild localized pigmentation abnormalities | rel=r_associated | relid=0 | w=50
  443. en:oedema -- r_associated #0: 50 / 0.794 -> en:mild skin hyperextensibility
    n1=en:oedema | n2=en:mild skin hyperextensibility | rel=r_associated | relid=0 | w=50
  444. en:oedema -- r_associated #0: 50 / 0.794 -> en:mildly decreased cytochrome c oxidase activity
    n1=en:oedema | n2=en:mildly decreased cytochrome c oxidase activity | rel=r_associated | relid=0 | w=50
  445. en:oedema -- r_associated #0: 50 / 0.794 -> en:molluscum contagiosum
    n1=en:oedema | n2=en:molluscum contagiosum | rel=r_associated | relid=0 | w=50
  446. en:oedema -- r_associated #0: 50 / 0.794 -> en:motion sickness
    n1=en:oedema | n2=en:motion sickness | rel=r_associated | relid=0 | w=50
  447. en:oedema -- r_associated #0: 50 / 0.794 -> en:mri of the thighs shows fatty atrophy with preservation of the biceps femoris in the lateral compartment
    n1=en:oedema | n2=en:mri of the thighs shows fatty atrophy with preservation of the biceps femoris in the lateral compartment | rel=r_associated | relid=0 | w=50
  448. en:oedema -- r_associated #0: 50 / 0.794 -> en:mtdna deletions seen on muscle biopsy
    n1=en:oedema | n2=en:mtdna deletions seen on muscle biopsy | rel=r_associated | relid=0 | w=50
  449. en:oedema -- r_associated #0: 50 / 0.794 -> en:multiple nevi
    n1=en:oedema | n2=en:multiple nevi | rel=r_associated | relid=0 | w=50
  450. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle activity is electrically silent on emg
    n1=en:oedema | n2=en:muscle activity is electrically silent on emg | rel=r_associated | relid=0 | w=50
  451. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle atrophy (in some patients)
    n1=en:oedema | n2=en:muscle atrophy (in some patients) | rel=r_associated | relid=0 | w=50
  452. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle atrophy, primarily in the legs
    n1=en:oedema | n2=en:muscle atrophy, primarily in the legs | rel=r_associated | relid=0 | w=50
  453. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle atrophy, severe
    n1=en:oedema | n2=en:muscle atrophy, severe | rel=r_associated | relid=0 | w=50
  454. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows abnormal fiber size and variation
    n1=en:oedema | n2=en:muscle biopsy shows abnormal fiber size and variation | rel=r_associated | relid=0 | w=50
  455. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows decreased activity of cytochrome c oxidase
    n1=en:oedema | n2=en:muscle biopsy shows decreased activity of cytochrome c oxidase | rel=r_associated | relid=0 | w=50
  456. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity
    n1=en:oedema | n2=en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity | rel=r_associated | relid=0 | w=50
  457. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows decreased numbers of acetylcholine receptors (achr) in the postsynaptic membrane (less than 50% of normal)
    n1=en:oedema | n2=en:muscle biopsy shows decreased numbers of acetylcholine receptors (achr) in the postsynaptic membrane (less than 50% of normal) | rel=r_associated | relid=0 | w=50
  458. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows fibrosis and increased connective tissue
    n1=en:oedema | n2=en:muscle biopsy shows fibrosis and increased connective tissue | rel=r_associated | relid=0 | w=50
  459. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows lipid deposition
    n1=en:oedema | n2=en:muscle biopsy shows lipid deposition | rel=r_associated | relid=0 | w=50
  460. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows lipid droplets
    n1=en:oedema | n2=en:muscle biopsy shows lipid droplets | rel=r_associated | relid=0 | w=50
  461. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits
    n1=en:oedema | n2=en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits | rel=r_associated | relid=0 | w=50
  462. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows neurogenic atrophy affecting both fibers types
    n1=en:oedema | n2=en:muscle biopsy shows neurogenic atrophy affecting both fibers types | rel=r_associated | relid=0 | w=50
  463. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows pas-positive glycogen-containing vacuoles
    n1=en:oedema | n2=en:muscle biopsy shows pas-positive glycogen-containing vacuoles | rel=r_associated | relid=0 | w=50
  464. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows rimmed vacuoles
    n1=en:oedema | n2=en:muscle biopsy shows rimmed vacuoles | rel=r_associated | relid=0 | w=50
  465. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy shows type i fiber predominance
    n1=en:oedema | n2=en:muscle biopsy shows type i fiber predominance | rel=r_associated | relid=0 | w=50
  466. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle biopsy with small a-fibers, increased pas-positive material, and ringbinden (disoriented myofibrils)
    n1=en:oedema | n2=en:muscle biopsy with small a-fibers, increased pas-positive material, and ringbinden (disoriented myofibrils) | rel=r_associated | relid=0 | w=50
  467. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle fibers contain internal nuclei
    n1=en:oedema | n2=en:muscle fibers contain internal nuclei | rel=r_associated | relid=0 | w=50
  468. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle weakness (1 patient)
    n1=en:oedema | n2=en:muscle weakness (1 patient) | rel=r_associated | relid=0 | w=50
  469. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle weakness (cvs+)
    n1=en:oedema | n2=en:muscle weakness (cvs+) | rel=r_associated | relid=0 | w=50
  470. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle weakness (in 90% of patients)
    n1=en:oedema | n2=en:muscle weakness (in 90% of patients) | rel=r_associated | relid=0 | w=50
  471. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle weakness, proximal and distal
    n1=en:oedema | n2=en:muscle weakness, proximal and distal | rel=r_associated | relid=0 | w=50
  472. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle weakness, proximal and distal, affecting upper and lower limbs
    n1=en:oedema | n2=en:muscle weakness, proximal and distal, affecting upper and lower limbs | rel=r_associated | relid=0 | w=50
  473. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle weakness, proximal limb muscle, mild to moderate
    n1=en:oedema | n2=en:muscle weakness, proximal limb muscle, mild to moderate | rel=r_associated | relid=0 | w=50
  474. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle weakness, severe, diffuse
    n1=en:oedema | n2=en:muscle weakness, severe, diffuse | rel=r_associated | relid=0 | w=50
  475. en:oedema -- r_associated #0: 50 / 0.794 -> en:muscle weakness, severe, proximal and distal
    n1=en:oedema | n2=en:muscle weakness, severe, proximal and distal | rel=r_associated | relid=0 | w=50
  476. en:oedema -- r_associated #0: 50 / 0.794 -> en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures
    n1=en:oedema | n2=en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures | rel=r_associated | relid=0 | w=50
  477. en:oedema -- r_associated #0: 50 / 0.794 -> en:myopathic features seen on biopsy
    n1=en:oedema | n2=en:myopathic features seen on biopsy | rel=r_associated | relid=0 | w=50
  478. en:oedema -- r_associated #0: 50 / 0.794 -> en:myotonic discharges
    n1=en:oedema | n2=en:myotonic discharges | rel=r_associated | relid=0 | w=50
  479. en:oedema -- r_associated #0: 50 / 0.794 -> en:named respiratory sign of chest
    n1=en:oedema | n2=en:named respiratory sign of chest | rel=r_associated | relid=0 | w=50
  480. en:oedema -- r_associated #0: 50 / 0.794 -> en:named sign of joint
    n1=en:oedema | n2=en:named sign of joint | rel=r_associated | relid=0 | w=50
  481. en:oedema -- r_associated #0: 50 / 0.794 -> en:necrotic and regenerating muscle fibers
    n1=en:oedema | n2=en:necrotic and regenerating muscle fibers | rel=r_associated | relid=0 | w=50
  482. en:oedema -- r_associated #0: 50 / 0.794 -> en:nemaline bodies occur in type 1 fibers
    n1=en:oedema | n2=en:nemaline bodies occur in type 1 fibers | rel=r_associated | relid=0 | w=50
  483. en:oedema -- r_associated #0: 50 / 0.794 -> en:neonatal research network terminology
    n1=en:oedema | n2=en:neonatal research network terminology | rel=r_associated | relid=0 | w=50
  484. en:oedema -- r_associated #0: 50 / 0.794 -> en:neurogenic changes later in disease seen on emg
    n1=en:oedema | n2=en:neurogenic changes later in disease seen on emg | rel=r_associated | relid=0 | w=50
  485. en:oedema -- r_associated #0: 50 / 0.794 -> en:neurogenic changes seen on emg and biopsy
    n1=en:oedema | n2=en:neurogenic changes seen on emg and biopsy | rel=r_associated | relid=0 | w=50
  486. en:oedema -- r_associated #0: 50 / 0.794 -> en:nevus araneus
    n1=en:oedema | n2=en:nevus araneus | rel=r_associated | relid=0 | w=50
  487. en:oedema -- r_associated #0: 50 / 0.794 -> en:no edema present
    n1=en:oedema | n2=en:no edema present | rel=r_associated | relid=0 | w=50
  488. en:oedema -- r_associated #0: 50 / 0.794 -> en:no hemorrhage
    n1=en:oedema | n2=en:no hemorrhage | rel=r_associated | relid=0 | w=50
  489. en:oedema -- r_associated #0: 50 / 0.794 -> en:no myofibrillar abnormalities or protein aggregation
    n1=en:oedema | n2=en:no myofibrillar abnormalities or protein aggregation | rel=r_associated | relid=0 | w=50
  490. en:oedema -- r_associated #0: 50 / 0.794 -> en:no palmoplantar hyperkeratosis
    n1=en:oedema | n2=en:no palmoplantar hyperkeratosis | rel=r_associated | relid=0 | w=50
  491. en:oedema -- r_associated #0: 50 / 0.794 -> en:nodular lesion
    n1=en:oedema | n2=en:nodular lesion | rel=r_associated | relid=0 | w=50
  492. en:oedema -- r_associated #0: 50 / 0.794 -> en:non pruritic
    n1=en:oedema | n2=en:non pruritic | rel=r_associated | relid=0 | w=50
  493. en:oedema -- r_associated #0: 50 / 0.794 -> en:nonscarring blisters (hand, feet, forearms)
    n1=en:oedema | n2=en:nonscarring blisters (hand, feet, forearms) | rel=r_associated | relid=0 | w=50
  494. en:oedema -- r_associated #0: 50 / 0.794 -> en:nonspecific muscle fiber atrophy
    n1=en:oedema | n2=en:nonspecific muscle fiber atrophy | rel=r_associated | relid=0 | w=50
  495. en:oedema -- r_associated #0: 50 / 0.794 -> en:normal alpha-glucosidase or acid maltase activity (gaa, 606800)
    n1=en:oedema | n2=en:normal alpha-glucosidase or acid maltase activity (gaa, 606800) | rel=r_associated | relid=0 | w=50
  496. en:oedema -- r_associated #0: 50 / 0.794 -> en:normal mitochondrial morphology (1 patient)
    n1=en:oedema | n2=en:normal mitochondrial morphology (1 patient) | rel=r_associated | relid=0 | w=50
  497. en:oedema -- r_associated #0: 50 / 0.794 -> en:normal or increased adipose tissue around the neck
    n1=en:oedema | n2=en:normal or increased adipose tissue around the neck | rel=r_associated | relid=0 | w=50
  498. en:oedema -- r_associated #0: 50 / 0.794 -> en:numerous nevi
    n1=en:oedema | n2=en:numerous nevi | rel=r_associated | relid=0 | w=50
  499. en:oedema -- r_associated #0: 50 / 0.794 -> en:nutritional and metabolic diseases
    n1=en:oedema | n2=en:nutritional and metabolic diseases | rel=r_associated | relid=0 | w=50
  500. en:oedema -- r_associated #0: 50 / 0.794 -> en:o/e - edema of thighs
    n1=en:oedema | n2=en:o/e - edema of thighs | rel=r_associated | relid=0 | w=50
  501. en:oedema -- r_associated #0: 50 / 0.794 -> en:oligohydramnios
    n1=en:oedema | n2=en:oligohydramnios | rel=r_associated | relid=0 | w=50
  502. en:oedema -- r_associated #0: 50 / 0.794 -> en:oral manifestations
    n1=en:oedema | n2=en:oral manifestations | rel=r_associated | relid=0 | w=50
  503. en:oedema -- r_associated #0: 50 / 0.794 -> en:other dermatologic congenital anomalies
    n1=en:oedema | n2=en:other dermatologic congenital anomalies | rel=r_associated | relid=0 | w=50
  504. en:oedema -- r_associated #0: 50 / 0.794 -> en:painful muscle cramps
    n1=en:oedema | n2=en:painful muscle cramps | rel=r_associated | relid=0 | w=50
  505. en:oedema -- r_associated #0: 50 / 0.794 -> en:pallor of skin
    n1=en:oedema | n2=en:pallor of skin | rel=r_associated | relid=0 | w=50
  506. en:oedema -- r_associated #0: 50 / 0.794 -> en:palmar creases, fine to acrogeria-like
    n1=en:oedema | n2=en:palmar creases, fine to acrogeria-like | rel=r_associated | relid=0 | w=50
  507. en:oedema -- r_associated #0: 50 / 0.794 -> en:palmar erythema
    n1=en:oedema | n2=en:palmar erythema | rel=r_associated | relid=0 | w=50
  508. en:oedema -- r_associated #0: 50 / 0.794 -> en:palmar wrinkling
    n1=en:oedema | n2=en:palmar wrinkling | rel=r_associated | relid=0 | w=50
  509. en:oedema -- r_associated #0: 50 / 0.794 -> en:palmoplantar keratoderma, patchy (>50%)
    n1=en:oedema | n2=en:palmoplantar keratoderma, patchy (>50%) | rel=r_associated | relid=0 | w=50
  510. en:oedema -- r_associated #0: 50 / 0.794 -> en:papilledema
    n1=en:oedema | n2=en:papilledema | rel=r_associated | relid=0 | w=50
  511. en:oedema -- r_associated #0: 50 / 0.794 -> en:paradoxical myotonia (myotonia increases with exercise)
    n1=en:oedema | n2=en:paradoxical myotonia (myotonia increases with exercise) | rel=r_associated | relid=0 | w=50
  512. en:oedema -- r_associated #0: 50 / 0.794 -> en:partial lipodystrophy (abnormal distribution of adipose tissue)
    n1=en:oedema | n2=en:partial lipodystrophy (abnormal distribution of adipose tissue) | rel=r_associated | relid=0 | w=50
  513. en:oedema -- r_associated #0: 50 / 0.794 -> en:pebbly skin lesions on back, upper arms, and thigh
    n1=en:oedema | n2=en:pebbly skin lesions on back, upper arms, and thigh | rel=r_associated | relid=0 | w=50
  514. en:oedema -- r_associated #0: 50 / 0.794 -> en:percussion-induced muscle mounding (muscle rippling)
    n1=en:oedema | n2=en:percussion-induced muscle mounding (muscle rippling) | rel=r_associated | relid=0 | w=50
  515. en:oedema -- r_associated #0: 50 / 0.794 -> en:periodic edema
    n1=en:oedema | n2=en:periodic edema | rel=r_associated | relid=0 | w=50
  516. en:oedema -- r_associated #0: 50 / 0.794 -> en:peristomal skin
    n1=en:oedema | n2=en:peristomal skin | rel=r_associated | relid=0 | w=50
  517. en:oedema -- r_associated #0: 50 / 0.794 -> en:periventricular cerebrospinal fluid edema
    n1=en:oedema | n2=en:periventricular cerebrospinal fluid edema | rel=r_associated | relid=0 | w=50
  518. en:oedema -- r_associated #0: 50 / 0.794 -> en:petechiae (less common)
    n1=en:oedema | n2=en:petechiae (less common) | rel=r_associated | relid=0 | w=50
  519. en:oedema -- r_associated #0: 50 / 0.794 -> en:plethoric face
    n1=en:oedema | n2=en:plethoric face | rel=r_associated | relid=0 | w=50
  520. en:oedema -- r_associated #0: 50 / 0.794 -> en:polyhydramnios
    n1=en:oedema | n2=en:polyhydramnios | rel=r_associated | relid=0 | w=50
  521. en:oedema -- r_associated #0: 50 / 0.794 -> en:polyhydramnios (in perinatal or congenital neuromuscular forms)
    n1=en:oedema | n2=en:polyhydramnios (in perinatal or congenital neuromuscular forms) | rel=r_associated | relid=0 | w=50
  522. en:oedema -- r_associated #0: 50 / 0.794 -> en:polymyositis
    n1=en:oedema | n2=en:polymyositis | rel=r_associated | relid=0 | w=50
  523. en:oedema -- r_associated #0: 50 / 0.794 -> en:poor musculature
    n1=en:oedema | n2=en:poor musculature | rel=r_associated | relid=0 | w=50
  524. en:oedema -- r_associated #0: 50 / 0.794 -> en:postauricular crescent-shaped hypoplastic skin lesion
    n1=en:oedema | n2=en:postauricular crescent-shaped hypoplastic skin lesion | rel=r_associated | relid=0 | w=50
  525. en:oedema -- r_associated #0: 50 / 0.794 -> en:potassium sensitivity has been reported
    n1=en:oedema | n2=en:potassium sensitivity has been reported | rel=r_associated | relid=0 | w=50
  526. en:oedema -- r_associated #0: 50 / 0.794 -> en:predominance of oxidative fibers
    n1=en:oedema | n2=en:predominance of oxidative fibers | rel=r_associated | relid=0 | w=50
  527. en:oedema -- r_associated #0: 50 / 0.794 -> en:pregnancy induced hypertension with pulmonary edema
    n1=en:oedema | n2=en:pregnancy induced hypertension with pulmonary edema | rel=r_associated | relid=0 | w=50
  528. en:oedema -- r_associated #0: 50 / 0.794 -> en:premature aging (in some patients)
    n1=en:oedema | n2=en:premature aging (in some patients) | rel=r_associated | relid=0 | w=50
  529. en:oedema -- r_associated #0: 50 / 0.794 -> en:premature aging, mild
    n1=en:oedema | n2=en:premature aging, mild | rel=r_associated | relid=0 | w=50
  530. en:oedema -- r_associated #0: 50 / 0.794 -> en:prognosis/outlook finding
    n1=en:oedema | n2=en:prognosis/outlook finding | rel=r_associated | relid=0 | w=50
  531. en:oedema -- r_associated #0: 50 / 0.794 -> en:progressive generalized skin erosions
    n1=en:oedema | n2=en:progressive generalized skin erosions | rel=r_associated | relid=0 | w=50
  532. en:oedema -- r_associated #0: 50 / 0.794 -> en:progressive vitiligo
    n1=en:oedema | n2=en:progressive vitiligo | rel=r_associated | relid=0 | w=50
  533. en:oedema -- r_associated #0: 50 / 0.794 -> en:proliferative retinopathy with retinal edema due to type 2 diabetes mellitus
    n1=en:oedema | n2=en:proliferative retinopathy with retinal edema due to type 2 diabetes mellitus | rel=r_associated | relid=0 | w=50
  534. en:oedema -- r_associated #0: 50 / 0.794 -> en:prominent fingertip pads
    n1=en:oedema | n2=en:prominent fingertip pads | rel=r_associated | relid=0 | w=50
  535. en:oedema -- r_associated #0: 50 / 0.794 -> en:prominent veins, lower limbs
    n1=en:oedema | n2=en:prominent veins, lower limbs | rel=r_associated | relid=0 | w=50
  536. en:oedema -- r_associated #0: 50 / 0.794 -> en:proteinuria
    n1=en:oedema | n2=en:proteinuria | rel=r_associated | relid=0 | w=50
  537. en:oedema -- r_associated #0: 50 / 0.794 -> en:proximal muscle weakness occurs later
    n1=en:oedema | n2=en:proximal muscle weakness occurs later | rel=r_associated | relid=0 | w=50
  538. en:oedema -- r_associated #0: 50 / 0.794 -> en:proximal muscle weakness, lower limbs, mild
    n1=en:oedema | n2=en:proximal muscle weakness, lower limbs, mild | rel=r_associated | relid=0 | w=50
  539. en:oedema -- r_associated #0: 50 / 0.794 -> en:pruritus
    n1=en:oedema | n2=en:pruritus | rel=r_associated | relid=0 | w=50
  540. en:oedema -- r_associated #0: 50 / 0.794 -> en:pulmonary hypertension
    n1=en:oedema | n2=en:pulmonary hypertension | rel=r_associated | relid=0 | w=50
  541. en:oedema -- r_associated #0: 50 / 0.794 -> en:punctate vasculitis skin lesions
    n1=en:oedema | n2=en:punctate vasculitis skin lesions | rel=r_associated | relid=0 | w=50
  542. en:oedema -- r_associated #0: 50 / 0.794 -> en:pustulosis or pustular psoriasis, generalized
    n1=en:oedema | n2=en:pustulosis or pustular psoriasis, generalized | rel=r_associated | relid=0 | w=50
  543. en:oedema -- r_associated #0: 50 / 0.794 -> en:pyruvate oxidation defect
    n1=en:oedema | n2=en:pyruvate oxidation defect | rel=r_associated | relid=0 | w=50
  544. en:oedema -- r_associated #0: 50 / 0.794 -> en:ragged red fibers (in some patients)
    n1=en:oedema | n2=en:ragged red fibers (in some patients) | rel=r_associated | relid=0 | w=50
  545. en:oedema -- r_associated #0: 50 / 0.794 -> en:rash scaly
    n1=en:oedema | n2=en:rash scaly | rel=r_associated | relid=0 | w=50
  546. en:oedema -- r_associated #0: 50 / 0.794 -> en:respiratory system disorder
    n1=en:oedema | n2=en:respiratory system disorder | rel=r_associated | relid=0 | w=50
  547. en:oedema -- r_associated #0: 50 / 0.794 -> en:reticulate skin pigmentation
    n1=en:oedema | n2=en:reticulate skin pigmentation | rel=r_associated | relid=0 | w=50
  548. en:oedema -- r_associated #0: 50 / 0.794 -> en:reticulated skin pigmentation, predominantly on face, neck, chest, arms (94% male patients)
    n1=en:oedema | n2=en:reticulated skin pigmentation, predominantly on face, neck, chest, arms (94% male patients) | rel=r_associated | relid=0 | w=50
  549. en:oedema -- r_associated #0: 50 / 0.794 -> en:rh incompatibility
    n1=en:oedema | n2=en:rh incompatibility | rel=r_associated | relid=0 | w=50
  550. en:oedema -- r_associated #0: 50 / 0.794 -> en:rhabdomyolysis (in some patients) endocrine : hypogonadotropic hypogonadism (rare)
    n1=en:oedema | n2=en:rhabdomyolysis (in some patients) endocrine : hypogonadotropic hypogonadism (rare) | rel=r_associated | relid=0 | w=50
  551. en:oedema -- r_associated #0: 50 / 0.794 -> en:rigidity (uncommon)
    n1=en:oedema | n2=en:rigidity (uncommon) | rel=r_associated | relid=0 | w=50
  552. en:oedema -- r_associated #0: 50 / 0.794 -> en:roentgenographic
    n1=en:oedema | n2=en:roentgenographic | rel=r_associated | relid=0 | w=50
  553. en:oedema -- r_associated #0: 50 / 0.794 -> en:rough, thick palmar skin
    n1=en:oedema | n2=en:rough, thick palmar skin | rel=r_associated | relid=0 | w=50
  554. en:oedema -- r_associated #0: 50 / 0.794 -> en:scapuloperoneal amyotrophy
    n1=en:oedema | n2=en:scapuloperoneal amyotrophy | rel=r_associated | relid=0 | w=50
  555. en:oedema -- r_associated #0: 50 / 0.794 -> en:scapuloperoneal weakness
    n1=en:oedema | n2=en:scapuloperoneal weakness | rel=r_associated | relid=0 | w=50
  556. en:oedema -- r_associated #0: 50 / 0.794 -> en:scleredema adultorum
    n1=en:oedema | n2=en:scleredema adultorum | rel=r_associated | relid=0 | w=50
  557. en:oedema -- r_associated #0: 50 / 0.794 -> en:scleroderma assessment questionnaire score
    n1=en:oedema | n2=en:scleroderma assessment questionnaire score | rel=r_associated | relid=0 | w=50
  558. en:oedema -- r_associated #0: 50 / 0.794 -> en:sclerosis
    n1=en:oedema | n2=en:sclerosis | rel=r_associated | relid=0 | w=50
  559. en:oedema -- r_associated #0: 50 / 0.794 -> en:sebaceous gland
    n1=en:oedema | n2=en:sebaceous gland | rel=r_associated | relid=0 | w=50
  560. en:oedema -- r_associated #0: 50 / 0.794 -> en:secondary lymphedema
    n1=en:oedema | n2=en:secondary lymphedema | rel=r_associated | relid=0 | w=50
  561. en:oedema -- r_associated #0: 50 / 0.794 -> en:sensitivity to cold with paresthesias
    n1=en:oedema | n2=en:sensitivity to cold with paresthesias | rel=r_associated | relid=0 | w=50
  562. en:oedema -- r_associated #0: 50 / 0.794 -> en:seroma
    n1=en:oedema | n2=en:seroma | rel=r_associated | relid=0 | w=50
  563. en:oedema -- r_associated #0: 50 / 0.794 -> en:severe bullous blistering lesions
    n1=en:oedema | n2=en:severe bullous blistering lesions | rel=r_associated | relid=0 | w=50
  564. en:oedema -- r_associated #0: 50 / 0.794 -> en:severe form shows absence of spontaneous activity at birth
    n1=en:oedema | n2=en:severe form shows absence of spontaneous activity at birth | rel=r_associated | relid=0 | w=50
  565. en:oedema -- r_associated #0: 50 / 0.794 -> en:severe muscle wasting and atrophy, primarily in the legs
    n1=en:oedema | n2=en:severe muscle wasting and atrophy, primarily in the legs | rel=r_associated | relid=0 | w=50
  566. en:oedema -- r_associated #0: 50 / 0.794 -> en:shiny, taut, erythematous skin
    n1=en:oedema | n2=en:shiny, taut, erythematous skin | rel=r_associated | relid=0 | w=50
  567. en:oedema -- r_associated #0: 50 / 0.794 -> en:short and thickened z-discs
    n1=en:oedema | n2=en:short and thickened z-discs | rel=r_associated | relid=0 | w=50
  568. en:oedema -- r_associated #0: 50 / 0.794 -> en:shoulder muscle hypoplasia
    n1=en:oedema | n2=en:shoulder muscle hypoplasia | rel=r_associated | relid=0 | w=50
  569. en:oedema -- r_associated #0: 50 / 0.794 -> en:sickness
    n1=en:oedema | n2=en:sickness | rel=r_associated | relid=0 | w=50
  570. en:oedema -- r_associated #0: 50 / 0.794 -> en:single palmar crease
    n1=en:oedema | n2=en:single palmar crease | rel=r_associated | relid=0 | w=50
  571. en:oedema -- r_associated #0: 50 / 0.794 -> en:skeletal muscle biopsy showed mitochondrial complex i deficiency (1 family)
    n1=en:oedema | n2=en:skeletal muscle biopsy showed mitochondrial complex i deficiency (1 family) | rel=r_associated | relid=0 | w=50
  572. en:oedema -- r_associated #0: 50 / 0.794 -> en:skeletal muscle biopsy shows misplaced mitochondria
    n1=en:oedema | n2=en:skeletal muscle biopsy shows misplaced mitochondria | rel=r_associated | relid=0 | w=50
  573. en:oedema -- r_associated #0: 50 / 0.794 -> en:skeletal muscle tissue shows depletion of mitochondrial dna (mtdna)
    n1=en:oedema | n2=en:skeletal muscle tissue shows depletion of mitochondrial dna (mtdna) | rel=r_associated | relid=0 | w=50
  574. en:oedema -- r_associated #0: 50 / 0.794 -> en:skin absorption
    n1=en:oedema | n2=en:skin absorption | rel=r_associated | relid=0 | w=50
  575. en:oedema -- r_associated #0: 50 / 0.794 -> en:skin atrophy
    n1=en:oedema | n2=en:skin atrophy | rel=r_associated | relid=0 | w=50
  576. en:oedema -- r_associated #0: 50 / 0.794 -> en:skin atrophy (over nose and scalp sutural areas)
    n1=en:oedema | n2=en:skin atrophy (over nose and scalp sutural areas) | rel=r_associated | relid=0 | w=50
  577. en:oedema -- r_associated #0: 50 / 0.794 -> en:skin atrophy over affected bones
    n1=en:oedema | n2=en:skin atrophy over affected bones | rel=r_associated | relid=0 | w=50
  578. en:oedema -- r_associated #0: 50 / 0.794 -> en:skin cyst
    n1=en:oedema | n2=en:skin cyst | rel=r_associated | relid=0 | w=50
  579. en:oedema -- r_associated #0: 50 / 0.794 -> en:skin erosion
    n1=en:oedema | n2=en:skin erosion | rel=r_associated | relid=0 | w=50
  580. en:oedema -- r_associated #0: 50 / 0.794 -> en:skin fissure
    n1=en:oedema | n2=en:skin fissure | rel=r_associated | relid=0 | w=50
  581. en:oedema -- r_associated #0: 50 / 0.794 -> en:skin hyperlaxity (males)
    n1=en:oedema | n2=en:skin hyperlaxity (males) | rel=r_associated | relid=0 | w=50
  582. en:oedema -- r_associated #0: 50 / 0.794 -> en:small papules on sun-exposed areas
    n1=en:oedema | n2=en:small papules on sun-exposed areas | rel=r_associated | relid=0 | w=50
  583. en:oedema -- r_associated #0: 50 / 0.794 -> en:smooth, thin, dry skin
    n1=en:oedema | n2=en:smooth, thin, dry skin | rel=r_associated | relid=0 | w=50
  584. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium bicarbonate 1.26% infusion solution bag
    n1=en:oedema | n2=en:sodium bicarbonate 1.26% infusion solution bag | rel=r_associated | relid=0 | w=50
  585. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium bicarbonate 325 mg oral tablet
    n1=en:oedema | n2=en:sodium bicarbonate 325 mg oral tablet | rel=r_associated | relid=0 | w=50
  586. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium chloride 0.0769 meq/ml irrigation solution
    n1=en:oedema | n2=en:sodium chloride 0.0769 meq/ml irrigation solution | rel=r_associated | relid=0 | w=50
  587. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium chloride 0.154 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium chloride 0.154 meq/ml injectable solution | rel=r_associated | relid=0 | w=50
  588. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium chloride 0.65% gel,nasal
    n1=en:oedema | n2=en:sodium chloride 0.65% gel,nasal | rel=r_associated | relid=0 | w=50
  589. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium chloride 0.9% irrigation fluid 100ml sachet
    n1=en:oedema | n2=en:sodium chloride 0.9% irrigation fluid 100ml sachet | rel=r_associated | relid=0 | w=50
  590. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium chloride 0.9% processing soln
    n1=en:oedema | n2=en:sodium chloride 0.9% processing soln | rel=r_associated | relid=0 | w=50
  591. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium chloride 1000 mg delayed release oral tablet
    n1=en:oedema | n2=en:sodium chloride 1000 mg delayed release oral tablet | rel=r_associated | relid=0 | w=50
  592. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium chloride 2% ophthalmic solution
    n1=en:oedema | n2=en:sodium chloride 2% ophthalmic solution | rel=r_associated | relid=0 | w=50
  593. en:oedema -- r_associated #0: 50 / 0.794 -> en:sodium chloride 2250 mg oral tablet
    n1=en:oedema | n2=en:sodium chloride 2250 mg oral tablet | rel=r_associated | relid=0 | w=50
  594. en:oedema -- r_associated #0: 50 / 0.794 -> en:some subcutaneous adipose tissue may remain on upper arms
    n1=en:oedema | n2=en:some subcutaneous adipose tissue may remain on upper arms | rel=r_associated | relid=0 | w=50
  595. en:oedema -- r_associated #0: 50 / 0.794 -> en:split anchoring plaques of desmosomes in the granular layer (transmission electron microscopy (tem))
    n1=en:oedema | n2=en:split anchoring plaques of desmosomes in the granular layer (transmission electron microscopy (tem)) | rel=r_associated | relid=0 | w=50
  596. en:oedema -- r_associated #0: 50 / 0.794 -> en:spotted and reticulate pigmentation of flexural areas of skin
    n1=en:oedema | n2=en:spotted and reticulate pigmentation of flexural areas of skin | rel=r_associated | relid=0 | w=50
  597. en:oedema -- r_associated #0: 50 / 0.794 -> en:stasis ulcers
    n1=en:oedema | n2=en:stasis ulcers | rel=r_associated | relid=0 | w=50
  598. en:oedema -- r_associated #0: 50 / 0.794 -> en:subconjunctival edema
    n1=en:oedema | n2=en:subconjunctival edema | rel=r_associated | relid=0 | w=50
  599. en:oedema -- r_associated #0: 50 / 0.794 -> en:subcutaneous spheroids
    n1=en:oedema | n2=en:subcutaneous spheroids | rel=r_associated | relid=0 | w=50
  600. en:oedema -- r_associated #0: 50 / 0.794 -> en:subsarcolemmal accumulation of normal mitochondria (in some patients)
    n1=en:oedema | n2=en:subsarcolemmal accumulation of normal mitochondria (in some patients) | rel=r_associated | relid=0 | w=50
  601. en:oedema -- r_associated #0: 50 / 0.794 -> en:swelling non-inflammatory
    n1=en:oedema | n2=en:swelling non-inflammatory | rel=r_associated | relid=0 | w=50
  602. en:oedema -- r_associated #0: 50 / 0.794 -> en:symbol digit modalities test score
    n1=en:oedema | n2=en:symbol digit modalities test score | rel=r_associated | relid=0 | w=50
  603. en:oedema -- r_associated #0: 50 / 0.794 -> en:tanning possible
    n1=en:oedema | n2=en:tanning possible | rel=r_associated | relid=0 | w=50
  604. en:oedema -- r_associated #0: 50 / 0.794 -> en:telangiectasia
    n1=en:oedema | n2=en:telangiectasia | rel=r_associated | relid=0 | w=50
  605. en:oedema -- r_associated #0: 50 / 0.794 -> en:telangiectasia, particularly of the fingerpads and lips
    n1=en:oedema | n2=en:telangiectasia, particularly of the fingerpads and lips | rel=r_associated | relid=0 | w=50
  606. en:oedema -- r_associated #0: 50 / 0.794 -> en:tenderness of lower extremities
    n1=en:oedema | n2=en:tenderness of lower extremities | rel=r_associated | relid=0 | w=50
  607. en:oedema -- r_associated #0: 50 / 0.794 -> en:tetany
    n1=en:oedema | n2=en:tetany | rel=r_associated | relid=0 | w=50
  608. en:oedema -- r_associated #0: 50 / 0.794 -> en:thalassemia
    n1=en:oedema | n2=en:thalassemia | rel=r_associated | relid=0 | w=50
  609. en:oedema -- r_associated #0: 50 / 0.794 -> en:thick skin
    n1=en:oedema | n2=en:thick skin | rel=r_associated | relid=0 | w=50
  610. en:oedema -- r_associated #0: 50 / 0.794 -> en:thick, indurated skin over entire body
    n1=en:oedema | n2=en:thick, indurated skin over entire body | rel=r_associated | relid=0 | w=50
  611. en:oedema -- r_associated #0: 50 / 0.794 -> en:thickened nuchal skin fold
    n1=en:oedema | n2=en:thickened nuchal skin fold | rel=r_associated | relid=0 | w=50
  612. en:oedema -- r_associated #0: 50 / 0.794 -> en:thickened skin over the elbows and along the fingers
    n1=en:oedema | n2=en:thickened skin over the elbows and along the fingers | rel=r_associated | relid=0 | w=50
  613. en:oedema -- r_associated #0: 50 / 0.794 -> en:thickening of fascia of forearm
    n1=en:oedema | n2=en:thickening of fascia of forearm | rel=r_associated | relid=0 | w=50
  614. en:oedema -- r_associated #0: 50 / 0.794 -> en:thin, dry skin
    n1=en:oedema | n2=en:thin, dry skin | rel=r_associated | relid=0 | w=50
  615. en:oedema -- r_associated #0: 50 / 0.794 -> en:toe-walking gait
    n1=en:oedema | n2=en:toe-walking gait | rel=r_associated | relid=0 | w=50
  616. en:oedema -- r_associated #0: 50 / 0.794 -> en:transfusion associated circulatory overload
    n1=en:oedema | n2=en:transfusion associated circulatory overload | rel=r_associated | relid=0 | w=50
  617. en:oedema -- r_associated #0: 50 / 0.794 -> en:tubular aggregates (in some patients)
    n1=en:oedema | n2=en:tubular aggregates (in some patients) | rel=r_associated | relid=0 | w=50
  618. en:oedema -- r_associated #0: 50 / 0.794 -> en:tubular aggregates in muscle fibers may occur
    n1=en:oedema | n2=en:tubular aggregates in muscle fibers may occur | rel=r_associated | relid=0 | w=50
  619. en:oedema -- r_associated #0: 50 / 0.794 -> en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria
    n1=en:oedema | n2=en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | rel=r_associated | relid=0 | w=50
  620. en:oedema -- r_associated #0: 50 / 0.794 -> en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade)
    n1=en:oedema | n2=en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade) | rel=r_associated | relid=0 | w=50
  621. en:oedema -- r_associated #0: 50 / 0.794 -> en:usually occurs in the head and neck area
    n1=en:oedema | n2=en:usually occurs in the head and neck area | rel=r_associated | relid=0 | w=50
  622. en:oedema -- r_associated #0: 50 / 0.794 -> en:variability in fiber size
    n1=en:oedema | n2=en:variability in fiber size | rel=r_associated | relid=0 | w=50
  623. en:oedema -- r_associated #0: 50 / 0.794 -> en:verruca vulgaris
    n1=en:oedema | n2=en:verruca vulgaris | rel=r_associated | relid=0 | w=50
  624. en:oedema -- r_associated #0: 50 / 0.794 -> en:verrucous lesion
    n1=en:oedema | n2=en:verrucous lesion | rel=r_associated | relid=0 | w=50
  625. en:oedema -- r_associated #0: 50 / 0.794 -> en:vesicular lesions (inflammatory type b)
    n1=en:oedema | n2=en:vesicular lesions (inflammatory type b) | rel=r_associated | relid=0 | w=50
  626. en:oedema -- r_associated #0: 50 / 0.794 -> en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle)
    n1=en:oedema | n2=en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) | rel=r_associated | relid=0 | w=50
  627. en:oedema -- r_associated #0: 50 / 0.794 -> en:weakness, axial and limb muscles, upper limb muscles more affected than lower limbs
    n1=en:oedema | n2=en:weakness, axial and limb muscles, upper limb muscles more affected than lower limbs | rel=r_associated | relid=0 | w=50
  628. en:oedema -- r_associated #0: 50 / 0.794 -> en:wound observable
    n1=en:oedema | n2=en:wound observable | rel=r_associated | relid=0 | w=50
  629. en:oedema -- r_associated #0: 50 / 0.794 -> en:wrinkled abdominal skin
    n1=en:oedema | n2=en:wrinkled abdominal skin | rel=r_associated | relid=0 | w=50
  630. en:oedema -- r_associated #0: 50 / 0.794 -> en:wrinkled skin over dorsa of fingers
    n1=en:oedema | n2=en:wrinkled skin over dorsa of fingers | rel=r_associated | relid=0 | w=50
  631. en:oedema -- r_associated #0: 50 / 0.794 -> en:xanthoma
    n1=en:oedema | n2=en:xanthoma | rel=r_associated | relid=0 | w=50
  632. en:oedema -- r_associated #0: 50 / 0.794 -> masse et tuméfaction mammaire
    n1=en:oedema | n2=masse et tuméfaction mammaire | rel=r_associated | relid=0 | w=50
  633. en:oedema -- r_associated #0: 50 / 0.794 -> oedème cérébral
    n1=en:oedema | n2=oedème cérébral | rel=r_associated | relid=0 | w=50
  634. en:oedema -- r_associated #0: 50 / 0.794 -> oedèmes
    n1=en:oedema | n2=oedèmes | rel=r_associated | relid=0 | w=50
  635. en:oedema -- r_associated #0: 49 / 0.778 -> cloque
    n1=en:oedema | n2=cloque | rel=r_associated | relid=0 | w=49
  636. en:oedema -- r_associated #0: 49 / 0.778 -> en:a subset of patients develop bilateral weakness
    n1=en:oedema | n2=en:a subset of patients develop bilateral weakness | rel=r_associated | relid=0 | w=49
  637. en:oedema -- r_associated #0: 49 / 0.778 -> en:abnormal alignment of collagen bundles
    n1=en:oedema | n2=en:abnormal alignment of collagen bundles | rel=r_associated | relid=0 | w=49
  638. en:oedema -- r_associated #0: 49 / 0.778 -> en:abnormal blistering of the skin
    n1=en:oedema | n2=en:abnormal blistering of the skin | rel=r_associated | relid=0 | w=49
  639. en:oedema -- r_associated #0: 49 / 0.778 -> en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton
    n1=en:oedema | n2=en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton | rel=r_associated | relid=0 | w=49
  640. en:oedema -- r_associated #0: 49 / 0.778 -> en:abnormal irregular myofibrillar network
    n1=en:oedema | n2=en:abnormal irregular myofibrillar network | rel=r_associated | relid=0 | w=49
  641. en:oedema -- r_associated #0: 49 / 0.778 -> en:abnormal sarcoplasmic reticulum elements
    n1=en:oedema | n2=en:abnormal sarcoplasmic reticulum elements | rel=r_associated | relid=0 | w=49
  642. en:oedema -- r_associated #0: 49 / 0.778 -> en:abnormal sensitivity to uvb wavelengths by radiation monochromator skin testing
    n1=en:oedema | n2=en:abnormal sensitivity to uvb wavelengths by radiation monochromator skin testing | rel=r_associated | relid=0 | w=49
  643. en:oedema -- r_associated #0: 49 / 0.778 -> en:abnormal z bands
    n1=en:oedema | n2=en:abnormal z bands | rel=r_associated | relid=0 | w=49
  644. en:oedema -- r_associated #0: 49 / 0.778 -> en:absence of laminin alpha-2 chain in muscle
    n1=en:oedema | n2=en:absence of laminin alpha-2 chain in muscle | rel=r_associated | relid=0 | w=49
  645. en:oedema -- r_associated #0: 49 / 0.778 -> en:absence of some scapular muscles (less common)
    n1=en:oedema | n2=en:absence of some scapular muscles (less common) | rel=r_associated | relid=0 | w=49
  646. en:oedema -- r_associated #0: 49 / 0.778 -> en:absent dorsal skin creases over affected joints
    n1=en:oedema | n2=en:absent dorsal skin creases over affected joints | rel=r_associated | relid=0 | w=49
  647. en:oedema -- r_associated #0: 49 / 0.778 -> en:absent skin pigmentation
    n1=en:oedema | n2=en:absent skin pigmentation | rel=r_associated | relid=0 | w=49
  648. en:oedema -- r_associated #0: 49 / 0.778 -> en:acanthosis
    n1=en:oedema | n2=en:acanthosis | rel=r_associated | relid=0 | w=49
  649. en:oedema -- r_associated #0: 49 / 0.778 -> en:acrodermatitis enteropathica, transient, seen in breastfed offspring of affected mothers
    n1=en:oedema | n2=en:acrodermatitis enteropathica, transient, seen in breastfed offspring of affected mothers | rel=r_associated | relid=0 | w=49
  650. en:oedema -- r_associated #0: 49 / 0.778 -> en:acrokeratosis verruciformis-like lesions on dorsum of hands
    n1=en:oedema | n2=en:acrokeratosis verruciformis-like lesions on dorsum of hands | rel=r_associated | relid=0 | w=49
  651. en:oedema -- r_associated #0: 49 / 0.778 -> en:affected muscles show atrophy
    n1=en:oedema | n2=en:affected muscles show atrophy | rel=r_associated | relid=0 | w=49
  652. en:oedema -- r_associated #0: 49 / 0.778 -> en:albinism
    n1=en:oedema | n2=en:albinism | rel=r_associated | relid=0 | w=49
  653. en:oedema -- r_associated #0: 49 / 0.778 -> en:anatomic structures
    n1=en:oedema | n2=en:anatomic structures | rel=r_associated | relid=0 | w=49
  654. en:oedema -- r_associated #0: 49 / 0.778 -> en:angioedema
    n1=en:oedema | n2=en:angioedema | rel=r_associated | relid=0 | w=49
  655. en:oedema -- r_associated #0: 49 / 0.778 -> en:angiokeratoma corporis diffusum
    n1=en:oedema | n2=en:angiokeratoma corporis diffusum | rel=r_associated | relid=0 | w=49
  656. en:oedema -- r_associated #0: 49 / 0.778 -> en:anhidrosis, patchy, in some patients
    n1=en:oedema | n2=en:anhidrosis, patchy, in some patients | rel=r_associated | relid=0 | w=49
  657. en:oedema -- r_associated #0: 49 / 0.778 -> en:anhydrous trisodium citrate
    n1=en:oedema | n2=en:anhydrous trisodium citrate | rel=r_associated | relid=0 | w=49
  658. en:oedema -- r_associated #0: 49 / 0.778 -> en:antecubial webbing
    n1=en:oedema | n2=en:antecubial webbing | rel=r_associated | relid=0 | w=49
  659. en:oedema -- r_associated #0: 49 / 0.778 -> en:asthenia
    n1=en:oedema | n2=en:asthenia | rel=r_associated | relid=0 | w=49
  660. en:oedema -- r_associated #0: 49 / 0.778 -> en:asymmetric muscle involvement
    n1=en:oedema | n2=en:asymmetric muscle involvement | rel=r_associated | relid=0 | w=49
  661. en:oedema -- r_associated #0: 49 / 0.778 -> en:atopic dermatitis/eczema
    n1=en:oedema | n2=en:atopic dermatitis/eczema | rel=r_associated | relid=0 | w=49
  662. en:oedema -- r_associated #0: 49 / 0.778 -> en:atrophy of shins
    n1=en:oedema | n2=en:atrophy of shins | rel=r_associated | relid=0 | w=49
  663. en:oedema -- r_associated #0: 49 / 0.778 -> en:atypical nevi (>5mm with irregular edge and pigmentation)
    n1=en:oedema | n2=en:atypical nevi (>5mm with irregular edge and pigmentation) | rel=r_associated | relid=0 | w=49
  664. en:oedema -- r_associated #0: 49 / 0.778 -> en:axial weakness
    n1=en:oedema | n2=en:axial weakness | rel=r_associated | relid=0 | w=49
  665. en:oedema -- r_associated #0: 49 / 0.778 -> en:beck anxiety inventory score
    n1=en:oedema | n2=en:beck anxiety inventory score | rel=r_associated | relid=0 | w=49
  666. en:oedema -- r_associated #0: 49 / 0.778 -> en:biopsy shows dystrophic changes
    n1=en:oedema | n2=en:biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=49
  667. en:oedema -- r_associated #0: 49 / 0.778 -> en:blistering (fingers, toes, pinnae)
    n1=en:oedema | n2=en:blistering (fingers, toes, pinnae) | rel=r_associated | relid=0 | w=49
  668. en:oedema -- r_associated #0: 49 / 0.778 -> en:blistering at acral sites
    n1=en:oedema | n2=en:blistering at acral sites | rel=r_associated | relid=0 | w=49
  669. en:oedema -- r_associated #0: 49 / 0.778 -> en:bronchial anastomotic edema
    n1=en:oedema | n2=en:bronchial anastomotic edema | rel=r_associated | relid=0 | w=49
  670. en:oedema -- r_associated #0: 49 / 0.778 -> en:cafe au lait spots on trunk and extremities
    n1=en:oedema | n2=en:cafe au lait spots on trunk and extremities | rel=r_associated | relid=0 | w=49
  671. en:oedema -- r_associated #0: 49 / 0.778 -> en:calcific tendinopathy, early-onset (in some patients)
    n1=en:oedema | n2=en:calcific tendinopathy, early-onset (in some patients) | rel=r_associated | relid=0 | w=49
  672. en:oedema -- r_associated #0: 49 / 0.778 -> en:calcinosis cutis
    n1=en:oedema | n2=en:calcinosis cutis | rel=r_associated | relid=0 | w=49
  673. en:oedema -- r_associated #0: 49 / 0.778 -> en:calf muscle pseudohypertrophy
    n1=en:oedema | n2=en:calf muscle pseudohypertrophy | rel=r_associated | relid=0 | w=49
  674. en:oedema -- r_associated #0: 49 / 0.778 -> en:callier-azusa scale score
    n1=en:oedema | n2=en:callier-azusa scale score | rel=r_associated | relid=0 | w=49
  675. en:oedema -- r_associated #0: 49 / 0.778 -> en:cardiac rehabilitation
    n1=en:oedema | n2=en:cardiac rehabilitation | rel=r_associated | relid=0 | w=49
  676. en:oedema -- r_associated #0: 49 / 0.778 -> en:cardiac surgery procedures
    n1=en:oedema | n2=en:cardiac surgery procedures | rel=r_associated | relid=0 | w=49
  677. en:oedema -- r_associated #0: 49 / 0.778 -> en:carotid artery disorder
    n1=en:oedema | n2=en:carotid artery disorder | rel=r_associated | relid=0 | w=49
  678. en:oedema -- r_associated #0: 49 / 0.778 -> en:carpopedal spasm
    n1=en:oedema | n2=en:carpopedal spasm | rel=r_associated | relid=0 | w=49
  679. en:oedema -- r_associated #0: 49 / 0.778 -> en:central cores seen on muscle biopsy
    n1=en:oedema | n2=en:central cores seen on muscle biopsy | rel=r_associated | relid=0 | w=49
  680. en:oedema -- r_associated #0: 49 / 0.778 -> en:centralized nuclei, rare
    n1=en:oedema | n2=en:centralized nuclei, rare | rel=r_associated | relid=0 | w=49
  681. en:oedema -- r_associated #0: 49 / 0.778 -> en:chemically induced
    n1=en:oedema | n2=en:chemically induced | rel=r_associated | relid=0 | w=49
  682. en:oedema -- r_associated #0: 49 / 0.778 -> en:chest pain
    n1=en:oedema | n2=en:chest pain | rel=r_associated | relid=0 | w=49
  683. en:oedema -- r_associated #0: 49 / 0.778 -> en:chronic denervation seen on emg
    n1=en:oedema | n2=en:chronic denervation seen on emg | rel=r_associated | relid=0 | w=49
  684. en:oedema -- r_associated #0: 49 / 0.778 -> en:chronic myelogenous leukemia, bcr-abl1 positive
    n1=en:oedema | n2=en:chronic myelogenous leukemia, bcr-abl1 positive | rel=r_associated | relid=0 | w=49
  685. en:oedema -- r_associated #0: 49 / 0.778 -> en:cinema sign
    n1=en:oedema | n2=en:cinema sign | rel=r_associated | relid=0 | w=49
  686. en:oedema -- r_associated #0: 49 / 0.778 -> en:clinically significant macular edema
    n1=en:oedema | n2=en:clinically significant macular edema | rel=r_associated | relid=0 | w=49
  687. en:oedema -- r_associated #0: 49 / 0.778 -> en:coenzyme q10 deficiency, primary, 3
    n1=en:oedema | n2=en:coenzyme q10 deficiency, primary, 3 | rel=r_associated | relid=0 | w=49
  688. en:oedema -- r_associated #0: 49 / 0.778 -> en:congenital absence of skin in some areas (aplasia cutis)
    n1=en:oedema | n2=en:congenital absence of skin in some areas (aplasia cutis) | rel=r_associated | relid=0 | w=49
  689. en:oedema -- r_associated #0: 49 / 0.778 -> en:congenital absence of skin on some areas (aplasia cutis)
    n1=en:oedema | n2=en:congenital absence of skin on some areas (aplasia cutis) | rel=r_associated | relid=0 | w=49
  690. en:oedema -- r_associated #0: 49 / 0.778 -> en:congenital symmetrical palmoplantar keratosis
    n1=en:oedema | n2=en:congenital symmetrical palmoplantar keratosis | rel=r_associated | relid=0 | w=49
  691. en:oedema -- r_associated #0: 49 / 0.778 -> en:congestion
    n1=en:oedema | n2=en:congestion | rel=r_associated | relid=0 | w=49
  692. en:oedema -- r_associated #0: 49 / 0.778 -> en:connective tissue dysplasia
    n1=en:oedema | n2=en:connective tissue dysplasia | rel=r_associated | relid=0 | w=49
  693. en:oedema -- r_associated #0: 49 / 0.778 -> en:constipation
    n1=en:oedema | n2=en:constipation | rel=r_associated | relid=0 | w=49
  694. en:oedema -- r_associated #0: 49 / 0.778 -> en:cor pulmonale
    n1=en:oedema | n2=en:cor pulmonale | rel=r_associated | relid=0 | w=49
  695. en:oedema -- r_associated #0: 49 / 0.778 -> en:corneal edema due to wearing of contact lenses
    n1=en:oedema | n2=en:corneal edema due to wearing of contact lenses | rel=r_associated | relid=0 | w=49
  696. en:oedema -- r_associated #0: 49 / 0.778 -> en:creamy white skin
    n1=en:oedema | n2=en:creamy white skin | rel=r_associated | relid=0 | w=49
  697. en:oedema -- r_associated #0: 49 / 0.778 -> en:crossed leg raising sign
    n1=en:oedema | n2=en:crossed leg raising sign | rel=r_associated | relid=0 | w=49
  698. en:oedema -- r_associated #0: 49 / 0.778 -> en:cutaneous infections (staphylococcus aureus, herpes simplex)
    n1=en:oedema | n2=en:cutaneous infections (staphylococcus aureus, herpes simplex) | rel=r_associated | relid=0 | w=49
  699. en:oedema -- r_associated #0: 49 / 0.778 -> en:cutaneous leiomyomata (heterozygote carriers)
    n1=en:oedema | n2=en:cutaneous leiomyomata (heterozygote carriers) | rel=r_associated | relid=0 | w=49
  700. en:oedema -- r_associated #0: 49 / 0.778 -> en:cutaneous nevi flammei (limbs)
    n1=en:oedema | n2=en:cutaneous nevi flammei (limbs) | rel=r_associated | relid=0 | w=49
  701. en:oedema -- r_associated #0: 49 / 0.778 -> en:cutaneous vascular malformation
    n1=en:oedema | n2=en:cutaneous vascular malformation | rel=r_associated | relid=0 | w=49
  702. en:oedema -- r_associated #0: 49 / 0.778 -> en:cutis laxa
    n1=en:oedema | n2=en:cutis laxa | rel=r_associated | relid=0 | w=49
  703. en:oedema -- r_associated #0: 49 / 0.778 -> en:cylindromas, multiple (face, trunk and extremities)
    n1=en:oedema | n2=en:cylindromas, multiple (face, trunk and extremities) | rel=r_associated | relid=0 | w=49
  704. en:oedema -- r_associated #0: 49 / 0.778 -> en:cyst occur most often on the scalp (89%)
    n1=en:oedema | n2=en:cyst occur most often on the scalp (89%) | rel=r_associated | relid=0 | w=49
  705. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased activities of complexes i, iii, and iv, variable
    n1=en:oedema | n2=en:decreased activities of complexes i, iii, and iv, variable | rel=r_associated | relid=0 | w=49
  706. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased activity of complexes ii+iii
    n1=en:oedema | n2=en:decreased activity of complexes ii+iii | rel=r_associated | relid=0 | w=49
  707. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy
    n1=en:oedema | n2=en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy | rel=r_associated | relid=0 | w=49
  708. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased activity of mitochondrial complexes i and iv seen on skeletal muscle biopsy
    n1=en:oedema | n2=en:decreased activity of mitochondrial complexes i and iv seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=49
  709. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased activity of multiple mitochondrial respiratory complex enzymes
    n1=en:oedema | n2=en:decreased activity of multiple mitochondrial respiratory complex enzymes | rel=r_associated | relid=0 | w=49
  710. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased caveolin-3 expression on muscle biopsy
    n1=en:oedema | n2=en:decreased caveolin-3 expression on muscle biopsy | rel=r_associated | relid=0 | w=49
  711. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased coenzyme q10
    n1=en:oedema | n2=en:decreased coenzyme q10 | rel=r_associated | relid=0 | w=49
  712. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased coenzyme q10 content
    n1=en:oedema | n2=en:decreased coenzyme q10 content | rel=r_associated | relid=0 | w=49
  713. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased distal reflexes
    n1=en:oedema | n2=en:decreased distal reflexes | rel=r_associated | relid=0 | w=49
  714. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased glycosylation of alpha-dystroglycan seen on muscle biopsy
    n1=en:oedema | n2=en:decreased glycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=49
  715. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased intraepithelial nerve fiber density
    n1=en:oedema | n2=en:decreased intraepithelial nerve fiber density | rel=r_associated | relid=0 | w=49
  716. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased number of sweat pores
    n1=en:oedema | n2=en:decreased number of sweat pores | rel=r_associated | relid=0 | w=49
  717. en:oedema -- r_associated #0: 49 / 0.778 -> en:decreased sweating due to autonomic dysfunction
    n1=en:oedema | n2=en:decreased sweating due to autonomic dysfunction | rel=r_associated | relid=0 | w=49
  718. en:oedema -- r_associated #0: 49 / 0.778 -> en:deep vein thrombosis
    n1=en:oedema | n2=en:deep vein thrombosis | rel=r_associated | relid=0 | w=49
  719. en:oedema -- r_associated #0: 49 / 0.778 -> en:deficiency of mitochondrial complexes i, iii, and iv
    n1=en:oedema | n2=en:deficiency of mitochondrial complexes i, iii, and iv | rel=r_associated | relid=0 | w=49
  720. en:oedema -- r_associated #0: 49 / 0.778 -> en:dermal contractures (late complication)
    n1=en:oedema | n2=en:dermal contractures (late complication) | rel=r_associated | relid=0 | w=49
  721. en:oedema -- r_associated #0: 49 / 0.778 -> en:dermatitis (chronic or chronically relapsing, major feature)
    n1=en:oedema | n2=en:dermatitis (chronic or chronically relapsing, major feature) | rel=r_associated | relid=0 | w=49
  722. en:oedema -- r_associated #0: 49 / 0.778 -> en:developmental dimensional and diagnostic interview score
    n1=en:oedema | n2=en:developmental dimensional and diagnostic interview score | rel=r_associated | relid=0 | w=49
  723. en:oedema -- r_associated #0: 49 / 0.778 -> en:dietary approaches to stop hypertension diet
    n1=en:oedema | n2=en:dietary approaches to stop hypertension diet | rel=r_associated | relid=0 | w=49
  724. en:oedema -- r_associated #0: 49 / 0.778 -> en:difficulty in toe walking
    n1=en:oedema | n2=en:difficulty in toe walking | rel=r_associated | relid=0 | w=49
  725. en:oedema -- r_associated #0: 49 / 0.778 -> en:difficulty running and jumping
    n1=en:oedema | n2=en:difficulty running and jumping | rel=r_associated | relid=0 | w=49
  726. en:oedema -- r_associated #0: 49 / 0.778 -> en:diffuse pigmentary skin mottling, mild, on trunk and proximal limbs
    n1=en:oedema | n2=en:diffuse pigmentary skin mottling, mild, on trunk and proximal limbs | rel=r_associated | relid=0 | w=49
  727. en:oedema -- r_associated #0: 49 / 0.778 -> en:dilated scalp veins radiating from periphery of scalp defect
    n1=en:oedema | n2=en:dilated scalp veins radiating from periphery of scalp defect | rel=r_associated | relid=0 | w=49
  728. en:oedema -- r_associated #0: 49 / 0.778 -> en:distal atrophy of the legs
    n1=en:oedema | n2=en:distal atrophy of the legs | rel=r_associated | relid=0 | w=49
  729. en:oedema -- r_associated #0: 49 / 0.778 -> en:distal limb muscle weakness occurs later
    n1=en:oedema | n2=en:distal limb muscle weakness occurs later | rel=r_associated | relid=0 | w=49
  730. en:oedema -- r_associated #0: 49 / 0.778 -> en:distal lower limb anterior compartment weakness
    n1=en:oedema | n2=en:distal lower limb anterior compartment weakness | rel=r_associated | relid=0 | w=49
  731. en:oedema -- r_associated #0: 49 / 0.778 -> en:distal muscle atrophy due to peripheral neuropathy
    n1=en:oedema | n2=en:distal muscle atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=49
  732. en:oedema -- r_associated #0: 49 / 0.778 -> en:disturbance of skin sensation
    n1=en:oedema | n2=en:disturbance of skin sensation | rel=r_associated | relid=0 | w=49
  733. en:oedema -- r_associated #0: 49 / 0.778 -> en:dizziness
    n1=en:oedema | n2=en:dizziness | rel=r_associated | relid=0 | w=49
  734. en:oedema -- r_associated #0: 49 / 0.778 -> en:doorbell sign
    n1=en:oedema | n2=en:doorbell sign | rel=r_associated | relid=0 | w=49
  735. en:oedema -- r_associated #0: 49 / 0.778 -> en:duration of recurrence-free survival
    n1=en:oedema | n2=en:duration of recurrence-free survival | rel=r_associated | relid=0 | w=49
  736. en:oedema -- r_associated #0: 49 / 0.778 -> en:dysarthria
    n1=en:oedema | n2=en:dysarthria | rel=r_associated | relid=0 | w=49
  737. en:oedema -- r_associated #0: 49 / 0.778 -> en:dystrophic changes seen on skeletal muscle biopsy
    n1=en:oedema | n2=en:dystrophic changes seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=49
  738. en:oedema -- r_associated #0: 49 / 0.778 -> en:easily fatigued (finding)
    n1=en:oedema | n2=en:easily fatigued (finding) | rel=r_associated | relid=0 | w=49
  739. en:oedema -- r_associated #0: 49 / 0.778 -> en:ectodermal dystrophy
    n1=en:oedema | n2=en:ectodermal dystrophy | rel=r_associated | relid=0 | w=49
  740. en:oedema -- r_associated #0: 49 / 0.778 -> en:ectodermal symptoms
    n1=en:oedema | n2=en:ectodermal symptoms | rel=r_associated | relid=0 | w=49
  741. en:oedema -- r_associated #0: 49 / 0.778 -> en:eczema (8 of 23)
    n1=en:oedema | n2=en:eczema (8 of 23) | rel=r_associated | relid=0 | w=49
  742. en:oedema -- r_associated #0: 49 / 0.778 -> en:eczema (rare)
    n1=en:oedema | n2=en:eczema (rare) | rel=r_associated | relid=0 | w=49
  743. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema is present at birth and then slowly decreases
    n1=en:oedema | n2=en:edema is present at birth and then slowly decreases | rel=r_associated | relid=0 | w=49
  744. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema of dorsum of foot
    n1=en:oedema | n2=en:edema of dorsum of foot | rel=r_associated | relid=0 | w=49
  745. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema of extremity with extension to trunk
    n1=en:oedema | n2=en:edema of extremity with extension to trunk | rel=r_associated | relid=0 | w=49
  746. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema of finger
    n1=en:oedema | n2=en:edema of finger | rel=r_associated | relid=0 | w=49
  747. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema of glottis
    n1=en:oedema | n2=en:edema of glottis | rel=r_associated | relid=0 | w=49
  748. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema of hand
    n1=en:oedema | n2=en:edema of hand | rel=r_associated | relid=0 | w=49
  749. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema of thigh
    n1=en:oedema | n2=en:edema of thigh | rel=r_associated | relid=0 | w=49
  750. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema of vulva
    n1=en:oedema | n2=en:edema of vulva | rel=r_associated | relid=0 | w=49
  751. en:oedema -- r_associated #0: 49 / 0.778 -> en:edema, cardiac
    n1=en:oedema | n2=en:edema, cardiac | rel=r_associated | relid=0 | w=49
  752. en:oedema -- r_associated #0: 49 / 0.778 -> en:elastin-rich connective tissue nevi (elastoma)
    n1=en:oedema | n2=en:elastin-rich connective tissue nevi (elastoma) | rel=r_associated | relid=0 | w=49
  753. en:oedema -- r_associated #0: 49 / 0.778 -> en:elevated amniotic fluid alpha-fetoprotein
    n1=en:oedema | n2=en:elevated amniotic fluid alpha-fetoprotein | rel=r_associated | relid=0 | w=49
  754. en:oedema -- r_associated #0: 49 / 0.778 -> en:emg shows fibrillation potentials
    n1=en:oedema | n2=en:emg shows fibrillation potentials | rel=r_associated | relid=0 | w=49
  755. en:oedema -- r_associated #0: 49 / 0.778 -> en:emg shows myopathic pattern
    n1=en:oedema | n2=en:emg shows myopathic pattern | rel=r_associated | relid=0 | w=49
  756. en:oedema -- r_associated #0: 49 / 0.778 -> en:enlarged terminal cisternae of the sarcoplasmic reticulum
    n1=en:oedema | n2=en:enlarged terminal cisternae of the sarcoplasmic reticulum | rel=r_associated | relid=0 | w=49
  757. en:oedema -- r_associated #0: 49 / 0.778 -> en:epidermal derivative
    n1=en:oedema | n2=en:epidermal derivative | rel=r_associated | relid=0 | w=49
  758. en:oedema -- r_associated #0: 49 / 0.778 -> en:epidermolytic hyperkeratosis, mild
    n1=en:oedema | n2=en:epidermolytic hyperkeratosis, mild | rel=r_associated | relid=0 | w=49
  759. en:oedema -- r_associated #0: 49 / 0.778 -> en:excessive skin folds
    n1=en:oedema | n2=en:excessive skin folds | rel=r_associated | relid=0 | w=49
  760. en:oedema -- r_associated #0: 49 / 0.778 -> en:extreme skin fragility
    n1=en:oedema | n2=en:extreme skin fragility | rel=r_associated | relid=0 | w=49
  761. en:oedema -- r_associated #0: 49 / 0.778 -> en:eye manifestations
    n1=en:oedema | n2=en:eye manifestations | rel=r_associated | relid=0 | w=49
  762. en:oedema -- r_associated #0: 49 / 0.778 -> en:eyelid
    n1=en:oedema | n2=en:eyelid | rel=r_associated | relid=0 | w=49
  763. en:oedema -- r_associated #0: 49 / 0.778 -> en:facial erythema
    n1=en:oedema | n2=en:facial erythema | rel=r_associated | relid=0 | w=49
  764. en:oedema -- r_associated #0: 49 / 0.778 -> en:facial muscle atrophy
    n1=en:oedema | n2=en:facial muscle atrophy | rel=r_associated | relid=0 | w=49
  765. en:oedema -- r_associated #0: 49 / 0.778 -> en:facial muscle weakness and atrophy, progressive
    n1=en:oedema | n2=en:facial muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=49
  766. en:oedema -- r_associated #0: 49 / 0.778 -> en:fasciculations (less common)
    n1=en:oedema | n2=en:fasciculations (less common) | rel=r_associated | relid=0 | w=49
  767. en:oedema -- r_associated #0: 49 / 0.778 -> en:fat pad between achilles tendon and medial malleolus
    n1=en:oedema | n2=en:fat pad between achilles tendon and medial malleolus | rel=r_associated | relid=0 | w=49
  768. en:oedema -- r_associated #0: 49 / 0.778 -> en:fear of cancer of skin
    n1=en:oedema | n2=en:fear of cancer of skin | rel=r_associated | relid=0 | w=49
  769. en:oedema -- r_associated #0: 49 / 0.778 -> en:fetal growth retardation
    n1=en:oedema | n2=en:fetal growth retardation | rel=r_associated | relid=0 | w=49
  770. en:oedema -- r_associated #0: 49 / 0.778 -> en:fetal pads of digits
    n1=en:oedema | n2=en:fetal pads of digits | rel=r_associated | relid=0 | w=49
  771. en:oedema -- r_associated #0: 49 / 0.778 -> en:fetal polyuria
    n1=en:oedema | n2=en:fetal polyuria | rel=r_associated | relid=0 | w=49
  772. en:oedema -- r_associated #0: 49 / 0.778 -> en:fibromyalgia
    n1=en:oedema | n2=en:fibromyalgia | rel=r_associated | relid=0 | w=49
  773. en:oedema -- r_associated #0: 49 / 0.778 -> en:fibrous skin tumor of tuberous sclerosis
    n1=en:oedema | n2=en:fibrous skin tumor of tuberous sclerosis | rel=r_associated | relid=0 | w=49
  774. en:oedema -- r_associated #0: 49 / 0.778 -> en:finding
    n1=en:oedema | n2=en:finding | rel=r_associated | relid=0 | w=49
  775. en:oedema -- r_associated #0: 49 / 0.778 -> en:finding reported by subject or history provider
    n1=en:oedema | n2=en:finding reported by subject or history provider | rel=r_associated | relid=0 | w=49
  776. en:oedema -- r_associated #0: 49 / 0.778 -> en:fine white scales
    n1=en:oedema | n2=en:fine white scales | rel=r_associated | relid=0 | w=49
  777. en:oedema -- r_associated #0: 49 / 0.778 -> en:fine whitish scales (rare)
    n1=en:oedema | n2=en:fine whitish scales (rare) | rel=r_associated | relid=0 | w=49
  778. en:oedema -- r_associated #0: 49 / 0.778 -> en:fine, reticulate skin pigmentation (trunk, palm, and soles)
    n1=en:oedema | n2=en:fine, reticulate skin pigmentation (trunk, palm, and soles) | rel=r_associated | relid=0 | w=49
  779. en:oedema -- r_associated #0: 49 / 0.778 -> en:flares of erythema, scaling, and pustules
    n1=en:oedema | n2=en:flares of erythema, scaling, and pustules | rel=r_associated | relid=0 | w=49
  780. en:oedema -- r_associated #0: 49 / 0.778 -> en:fluid overload pulmonary edema
    n1=en:oedema | n2=en:fluid overload pulmonary edema | rel=r_associated | relid=0 | w=49
  781. en:oedema -- r_associated #0: 49 / 0.778 -> en:focal dermal aplasia/hypoplasia
    n1=en:oedema | n2=en:focal dermal aplasia/hypoplasia | rel=r_associated | relid=0 | w=49
  782. en:oedema -- r_associated #0: 49 / 0.778 -> en:focal excision of swollen brain
    n1=en:oedema | n2=en:focal excision of swollen brain | rel=r_associated | relid=0 | w=49
  783. en:oedema -- r_associated #0: 49 / 0.778 -> en:focal friction-related palmoplantar hyperkeratosis
    n1=en:oedema | n2=en:focal friction-related palmoplantar hyperkeratosis | rel=r_associated | relid=0 | w=49
  784. en:oedema -- r_associated #0: 49 / 0.778 -> en:focal lymphocytic and macrophage infiltrates on biopsy
    n1=en:oedema | n2=en:focal lymphocytic and macrophage infiltrates on biopsy | rel=r_associated | relid=0 | w=49
  785. en:oedema -- r_associated #0: 49 / 0.778 -> en:focal skin hypoplasia in face
    n1=en:oedema | n2=en:focal skin hypoplasia in face | rel=r_associated | relid=0 | w=49
  786. en:oedema -- r_associated #0: 49 / 0.778 -> en:follicular papule
    n1=en:oedema | n2=en:follicular papule | rel=r_associated | relid=0 | w=49
  787. en:oedema -- r_associated #0: 49 / 0.778 -> en:follows blaschko's lines
    n1=en:oedema | n2=en:follows blaschko's lines | rel=r_associated | relid=0 | w=49
  788. en:oedema -- r_associated #0: 49 / 0.778 -> en:forearm muscle weakness
    n1=en:oedema | n2=en:forearm muscle weakness | rel=r_associated | relid=0 | w=49
  789. en:oedema -- r_associated #0: 49 / 0.778 -> en:foster-kennedy syndrome
    n1=en:oedema | n2=en:foster-kennedy syndrome | rel=r_associated | relid=0 | w=49
  790. en:oedema -- r_associated #0: 49 / 0.778 -> en:fragmentation of the neuromuscular junction with pre- and postsynaptic defects
    n1=en:oedema | n2=en:fragmentation of the neuromuscular junction with pre- and postsynaptic defects | rel=r_associated | relid=0 | w=49
  791. en:oedema -- r_associated #0: 49 / 0.778 -> en:freckles in sun-exposed areas
    n1=en:oedema | n2=en:freckles in sun-exposed areas | rel=r_associated | relid=0 | w=49
  792. en:oedema -- r_associated #0: 49 / 0.778 -> en:frontal cutaneous lipoma
    n1=en:oedema | n2=en:frontal cutaneous lipoma | rel=r_associated | relid=0 | w=49
  793. en:oedema -- r_associated #0: 49 / 0.778 -> en:frontalis muscle weakness
    n1=en:oedema | n2=en:frontalis muscle weakness | rel=r_associated | relid=0 | w=49
  794. en:oedema -- r_associated #0: 49 / 0.778 -> en:functional observable
    n1=en:oedema | n2=en:functional observable | rel=r_associated | relid=0 | w=49
  795. en:oedema -- r_associated #0: 49 / 0.778 -> en:general characteristic of patient
    n1=en:oedema | n2=en:general characteristic of patient | rel=r_associated | relid=0 | w=49
  796. en:oedema -- r_associated #0: 49 / 0.778 -> en:generalized bronze hyperpigmentation (present at birth)
    n1=en:oedema | n2=en:generalized bronze hyperpigmentation (present at birth) | rel=r_associated | relid=0 | w=49
  797. en:oedema -- r_associated #0: 49 / 0.778 -> en:generalized muscle weakness
    n1=en:oedema | n2=en:generalized muscle weakness | rel=r_associated | relid=0 | w=49
  798. en:oedema -- r_associated #0: 49 / 0.778 -> en:handgrip myotonia
    n1=en:oedema | n2=en:handgrip myotonia | rel=r_associated | relid=0 | w=49
  799. en:oedema -- r_associated #0: 49 / 0.778 -> en:hangover from any alcohol or other drugs substance
    n1=en:oedema | n2=en:hangover from any alcohol or other drugs substance | rel=r_associated | relid=0 | w=49
  800. en:oedema -- r_associated #0: 49 / 0.778 -> en:hematomas, recurrent large subcutaneous
    n1=en:oedema | n2=en:hematomas, recurrent large subcutaneous | rel=r_associated | relid=0 | w=49
  801. en:oedema -- r_associated #0: 49 / 0.778 -> en:historical aspects qualifier
    n1=en:oedema | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=49
  802. en:oedema -- r_associated #0: 49 / 0.778 -> en:hoehn and yahr scale score
    n1=en:oedema | n2=en:hoehn and yahr scale score | rel=r_associated | relid=0 | w=49
  803. en:oedema -- r_associated #0: 49 / 0.778 -> en:honeycomb keratoderma
    n1=en:oedema | n2=en:honeycomb keratoderma | rel=r_associated | relid=0 | w=49
  804. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyaline plaques with absent oxidative activity
    n1=en:oedema | n2=en:hyaline plaques with absent oxidative activity | rel=r_associated | relid=0 | w=49
  805. en:oedema -- r_associated #0: 49 / 0.778 -> en:hydrops fetalis
    n1=en:oedema | n2=en:hydrops fetalis | rel=r_associated | relid=0 | w=49
  806. en:oedema -- r_associated #0: 49 / 0.778 -> en:hydrops fetalis, non-immune (rare)
    n1=en:oedema | n2=en:hydrops fetalis, non-immune (rare) | rel=r_associated | relid=0 | w=49
  807. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperextensible skin
    n1=en:oedema | n2=en:hyperextensible skin | rel=r_associated | relid=0 | w=49
  808. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperkeratosis on dorsal surface of fingers and toes (knuckle pads, in some patients)
    n1=en:oedema | n2=en:hyperkeratosis on dorsal surface of fingers and toes (knuckle pads, in some patients) | rel=r_associated | relid=0 | w=49
  809. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperkeratotic lesions of neck, elbows, knees, groin, genitalia, and buttocks
    n1=en:oedema | n2=en:hyperkeratotic lesions of neck, elbows, knees, groin, genitalia, and buttocks | rel=r_associated | relid=0 | w=49
  810. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperkeratotic papules, dark brown, on neck, chest, and back (in some patients)
    n1=en:oedema | n2=en:hyperkeratotic papules, dark brown, on neck, chest, and back (in some patients) | rel=r_associated | relid=0 | w=49
  811. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperkeratotic plaques (face, elbow, knees)
    n1=en:oedema | n2=en:hyperkeratotic plaques (face, elbow, knees) | rel=r_associated | relid=0 | w=49
  812. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperkeratotic plaques on trunk and limbs
    n1=en:oedema | n2=en:hyperkeratotic plaques on trunk and limbs | rel=r_associated | relid=0 | w=49
  813. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperpigmentation (knuckles, elbows, axillae, areolae, pubic area)
    n1=en:oedema | n2=en:hyperpigmentation (knuckles, elbows, axillae, areolae, pubic area) | rel=r_associated | relid=0 | w=49
  814. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperpigmentation associated with increased adrenocorticotropic hormone (acth)
    n1=en:oedema | n2=en:hyperpigmentation associated with increased adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=49
  815. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperpigmentation in sun-exposed areas
    n1=en:oedema | n2=en:hyperpigmentation in sun-exposed areas | rel=r_associated | relid=0 | w=49
  816. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperpigmented nevi and streak
    n1=en:oedema | n2=en:hyperpigmented nevi and streak | rel=r_associated | relid=0 | w=49
  817. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperpigmented rim with long fine hairs encircling the lesions (in some patients)
    n1=en:oedema | n2=en:hyperpigmented rim with long fine hairs encircling the lesions (in some patients) | rel=r_associated | relid=0 | w=49
  818. en:oedema -- r_associated #0: 49 / 0.778 -> en:hypertriglyceridemic waist
    n1=en:oedema | n2=en:hypertriglyceridemic waist | rel=r_associated | relid=0 | w=49
  819. en:oedema -- r_associated #0: 49 / 0.778 -> en:hypertrophy of calves (in 3 of 6 patients)
    n1=en:oedema | n2=en:hypertrophy of calves (in 3 of 6 patients) | rel=r_associated | relid=0 | w=49
  820. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperuricemia
    n1=en:oedema | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=49
  821. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyperventilation
    n1=en:oedema | n2=en:hyperventilation | rel=r_associated | relid=0 | w=49
  822. en:oedema -- r_associated #0: 49 / 0.778 -> en:hypohidrosis may be present
    n1=en:oedema | n2=en:hypohidrosis may be present | rel=r_associated | relid=0 | w=49
  823. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyponatremia with excess extracellular fluid volume
    n1=en:oedema | n2=en:hyponatremia with excess extracellular fluid volume | rel=r_associated | relid=0 | w=49
  824. en:oedema -- r_associated #0: 49 / 0.778 -> en:hypoplasia of latissimus dorsi muscle
    n1=en:oedema | n2=en:hypoplasia of latissimus dorsi muscle | rel=r_associated | relid=0 | w=49
  825. en:oedema -- r_associated #0: 49 / 0.778 -> en:hyporeflexia in affected muscles
    n1=en:oedema | n2=en:hyporeflexia in affected muscles | rel=r_associated | relid=0 | w=49
  826. en:oedema -- r_associated #0: 49 / 0.778 -> en:hypotonia (45%)
    n1=en:oedema | n2=en:hypotonia (45%) | rel=r_associated | relid=0 | w=49
  827. en:oedema -- r_associated #0: 49 / 0.778 -> en:hypotonia (patient a)
    n1=en:oedema | n2=en:hypotonia (patient a) | rel=r_associated | relid=0 | w=49
  828. en:oedema -- r_associated #0: 49 / 0.778 -> en:hypoxia adverse event
    n1=en:oedema | n2=en:hypoxia adverse event | rel=r_associated | relid=0 | w=49
  829. en:oedema -- r_associated #0: 49 / 0.778 -> en:ichthyosis, diffuse lamellar
    n1=en:oedema | n2=en:ichthyosis, diffuse lamellar | rel=r_associated | relid=0 | w=49
  830. en:oedema -- r_associated #0: 49 / 0.778 -> en:ichthyosis, generalized, with involvement of flexural folds
    n1=en:oedema | n2=en:ichthyosis, generalized, with involvement of flexural folds | rel=r_associated | relid=0 | w=49
  831. en:oedema -- r_associated #0: 49 / 0.778 -> en:idiopathic corneal edema
    n1=en:oedema | n2=en:idiopathic corneal edema | rel=r_associated | relid=0 | w=49
  832. en:oedema -- r_associated #0: 49 / 0.778 -> en:inclusions form a lobulated structure seen on electron microscopy
    n1=en:oedema | n2=en:inclusions form a lobulated structure seen on electron microscopy | rel=r_associated | relid=0 | w=49
  833. en:oedema -- r_associated #0: 49 / 0.778 -> en:increased adipose fibrosis
    n1=en:oedema | n2=en:increased adipose fibrosis | rel=r_associated | relid=0 | w=49
  834. en:oedema -- r_associated #0: 49 / 0.778 -> en:increased antibody level in blood
    n1=en:oedema | n2=en:increased antibody level in blood | rel=r_associated | relid=0 | w=49
  835. en:oedema -- r_associated #0: 49 / 0.778 -> en:increased connective tissue (in some patients)
    n1=en:oedema | n2=en:increased connective tissue (in some patients) | rel=r_associated | relid=0 | w=49
  836. en:oedema -- r_associated #0: 49 / 0.778 -> en:increased connective tissue and fat in muscles
    n1=en:oedema | n2=en:increased connective tissue and fat in muscles | rel=r_associated | relid=0 | w=49
  837. en:oedema -- r_associated #0: 49 / 0.778 -> en:increased globulin
    n1=en:oedema | n2=en:increased globulin | rel=r_associated | relid=0 | w=49
  838. en:oedema -- r_associated #0: 49 / 0.778 -> en:increased muscle tone (early in life)
    n1=en:oedema | n2=en:increased muscle tone (early in life) | rel=r_associated | relid=0 | w=49
  839. en:oedema -- r_associated #0: 49 / 0.778 -> en:increased subcutaneous truncal adipose tissue
    n1=en:oedema | n2=en:increased subcutaneous truncal adipose tissue | rel=r_associated | relid=0 | w=49
  840. en:oedema -- r_associated #0: 49 / 0.778 -> en:influenza
    n1=en:oedema | n2=en:influenza | rel=r_associated | relid=0 | w=49
  841. en:oedema -- r_associated #0: 49 / 0.778 -> en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin
    n1=en:oedema | n2=en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin | rel=r_associated | relid=0 | w=49
  842. en:oedema -- r_associated #0: 49 / 0.778 -> en:islands of uninvolved skin
    n1=en:oedema | n2=en:islands of uninvolved skin | rel=r_associated | relid=0 | w=49
  843. en:oedema -- r_associated #0: 49 / 0.778 -> en:joint pain adverse event
    n1=en:oedema | n2=en:joint pain adverse event | rel=r_associated | relid=0 | w=49
  844. en:oedema -- r_associated #0: 49 / 0.778 -> en:joint protection knowledge assessment score
    n1=en:oedema | n2=en:joint protection knowledge assessment score | rel=r_associated | relid=0 | w=49
  845. en:oedema -- r_associated #0: 49 / 0.778 -> en:kehr's sign
    n1=en:oedema | n2=en:kehr's sign | rel=r_associated | relid=0 | w=49
  846. en:oedema -- r_associated #0: 49 / 0.778 -> en:keratoacanthoma
    n1=en:oedema | n2=en:keratoacanthoma | rel=r_associated | relid=0 | w=49
  847. en:oedema -- r_associated #0: 49 / 0.778 -> en:knee dimple
    n1=en:oedema | n2=en:knee dimple | rel=r_associated | relid=0 | w=49
  848. en:oedema -- r_associated #0: 49 / 0.778 -> en:large brownish scales on lower extremities (in some patients)
    n1=en:oedema | n2=en:large brownish scales on lower extremities (in some patients) | rel=r_associated | relid=0 | w=49
  849. en:oedema -- r_associated #0: 49 / 0.778 -> en:large cafe au lait spots with irregular margins
    n1=en:oedema | n2=en:large cafe au lait spots with irregular margins | rel=r_associated | relid=0 | w=49
  850. en:oedema -- r_associated #0: 49 / 0.778 -> en:lentiginosis, generalized (in some patients)
    n1=en:oedema | n2=en:lentiginosis, generalized (in some patients) | rel=r_associated | relid=0 | w=49
  851. en:oedema -- r_associated #0: 49 / 0.778 -> en:lesions predominantly on face and limbs
    n1=en:oedema | n2=en:lesions predominantly on face and limbs | rel=r_associated | relid=0 | w=49
  852. en:oedema -- r_associated #0: 49 / 0.778 -> en:lichenoid plaques
    n1=en:oedema | n2=en:lichenoid plaques | rel=r_associated | relid=0 | w=49
  853. en:oedema -- r_associated #0: 49 / 0.778 -> en:light complexion
    n1=en:oedema | n2=en:light complexion | rel=r_associated | relid=0 | w=49
  854. en:oedema -- r_associated #0: 49 / 0.778 -> en:limb-girdle muscle weakness (2 families)
    n1=en:oedema | n2=en:limb-girdle muscle weakness (2 families) | rel=r_associated | relid=0 | w=49
  855. en:oedema -- r_associated #0: 49 / 0.778 -> en:linear hyperpigmentation
    n1=en:oedema | n2=en:linear hyperpigmentation | rel=r_associated | relid=0 | w=49
  856. en:oedema -- r_associated #0: 49 / 0.778 -> en:linear nevus sebaceous, often in midfacial area
    n1=en:oedema | n2=en:linear nevus sebaceous, often in midfacial area | rel=r_associated | relid=0 | w=49
  857. en:oedema -- r_associated #0: 49 / 0.778 -> en:linear or reticular hyperpigmentation
    n1=en:oedema | n2=en:linear or reticular hyperpigmentation | rel=r_associated | relid=0 | w=49
  858. en:oedema -- r_associated #0: 49 / 0.778 -> en:lipofibroma
    n1=en:oedema | n2=en:lipofibroma | rel=r_associated | relid=0 | w=49
  859. en:oedema -- r_associated #0: 49 / 0.778 -> en:livedo reticularis
    n1=en:oedema | n2=en:livedo reticularis | rel=r_associated | relid=0 | w=49
  860. en:oedema -- r_associated #0: 49 / 0.778 -> en:loss of sarcomeric striations
    n1=en:oedema | n2=en:loss of sarcomeric striations | rel=r_associated | relid=0 | w=49
  861. en:oedema -- r_associated #0: 49 / 0.778 -> en:loss of subcutaneous fat, particularly affecting the limbs
    n1=en:oedema | n2=en:loss of subcutaneous fat, particularly affecting the limbs | rel=r_associated | relid=0 | w=49
  862. en:oedema -- r_associated #0: 49 / 0.778 -> en:loss of truncal subcutaneous adipose tissue
    n1=en:oedema | n2=en:loss of truncal subcutaneous adipose tissue | rel=r_associated | relid=0 | w=49
  863. en:oedema -- r_associated #0: 49 / 0.778 -> en:lower limb muscle atrophy (in 2 of 3 families)
    n1=en:oedema | n2=en:lower limb muscle atrophy (in 2 of 3 families) | rel=r_associated | relid=0 | w=49
  864. en:oedema -- r_associated #0: 49 / 0.778 -> en:lumbar cushion (edema)
    n1=en:oedema | n2=en:lumbar cushion (edema) | rel=r_associated | relid=0 | w=49
  865. en:oedema -- r_associated #0: 49 / 0.778 -> en:lymphoscintigraphy shows impaired lymphatic uptake and drainage
    n1=en:oedema | n2=en:lymphoscintigraphy shows impaired lymphatic uptake and drainage | rel=r_associated | relid=0 | w=49
  866. en:oedema -- r_associated #0: 49 / 0.778 -> en:mallory-like bodies
    n1=en:oedema | n2=en:mallory-like bodies | rel=r_associated | relid=0 | w=49
  867. en:oedema -- r_associated #0: 49 / 0.778 -> en:marked skin pallor
    n1=en:oedema | n2=en:marked skin pallor | rel=r_associated | relid=0 | w=49
  868. en:oedema -- r_associated #0: 49 / 0.778 -> en:mature adipocytes
    n1=en:oedema | n2=en:mature adipocytes | rel=r_associated | relid=0 | w=49
  869. en:oedema -- r_associated #0: 49 / 0.778 -> en:mcburney's sign (finding)
    n1=en:oedema | n2=en:mcburney's sign (finding) | rel=r_associated | relid=0 | w=49
  870. en:oedema -- r_associated #0: 49 / 0.778 -> en:membrane breakage
    n1=en:oedema | n2=en:membrane breakage | rel=r_associated | relid=0 | w=49
  871. en:oedema -- r_associated #0: 49 / 0.778 -> en:merosin-positive biopsy
    n1=en:oedema | n2=en:merosin-positive biopsy | rel=r_associated | relid=0 | w=49
  872. en:oedema -- r_associated #0: 49 / 0.778 -> en:migratory rashes, painful
    n1=en:oedema | n2=en:migratory rashes, painful | rel=r_associated | relid=0 | w=49
  873. en:oedema -- r_associated #0: 49 / 0.778 -> en:mild distal muscle atrophy
    n1=en:oedema | n2=en:mild distal muscle atrophy | rel=r_associated | relid=0 | w=49
  874. en:oedema -- r_associated #0: 49 / 0.778 -> en:mild hyperkeratosis
    n1=en:oedema | n2=en:mild hyperkeratosis | rel=r_associated | relid=0 | w=49
  875. en:oedema -- r_associated #0: 49 / 0.778 -> en:mild-moderate bruisability
    n1=en:oedema | n2=en:mild-moderate bruisability | rel=r_associated | relid=0 | w=49
  876. en:oedema -- r_associated #0: 49 / 0.778 -> en:milia (less common)
    n1=en:oedema | n2=en:milia (less common) | rel=r_associated | relid=0 | w=49
  877. en:oedema -- r_associated #0: 49 / 0.778 -> en:minimal or absent scarring
    n1=en:oedema | n2=en:minimal or absent scarring | rel=r_associated | relid=0 | w=49
  878. en:oedema -- r_associated #0: 49 / 0.778 -> en:mitochondrial dna depletion (20 to 35% of normal) seen on skeletal muscle biopsy
    n1=en:oedema | n2=en:mitochondrial dna depletion (20 to 35% of normal) seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=49
  879. en:oedema -- r_associated #0: 49 / 0.778 -> en:mitochondrial myopathy, severe
    n1=en:oedema | n2=en:mitochondrial myopathy, severe | rel=r_associated | relid=0 | w=49
  880. en:oedema -- r_associated #0: 49 / 0.778 -> en:modified health assessment questionnaire score
    n1=en:oedema | n2=en:modified health assessment questionnaire score | rel=r_associated | relid=0 | w=49
  881. en:oedema -- r_associated #0: 49 / 0.778 -> en:moniliasis/candida (excluding x72 y75)
    n1=en:oedema | n2=en:moniliasis/candida (excluding x72 y75) | rel=r_associated | relid=0 | w=49
  882. en:oedema -- r_associated #0: 49 / 0.778 -> en:motor developmental delay
    n1=en:oedema | n2=en:motor developmental delay | rel=r_associated | relid=0 | w=49
  883. en:oedema -- r_associated #0: 49 / 0.778 -> en:mucosal lesions affecting all regions (i.e., oral, nasal, vaginal, anal, bladder, conjunctival regions)
    n1=en:oedema | n2=en:mucosal lesions affecting all regions (i.e., oral, nasal, vaginal, anal, bladder, conjunctival regions) | rel=r_associated | relid=0 | w=49
  884. en:oedema -- r_associated #0: 49 / 0.778 -> en:mulitple papules (1-2 mm skin colored and hyperpigmented)
    n1=en:oedema | n2=en:mulitple papules (1-2 mm skin colored and hyperpigmented) | rel=r_associated | relid=0 | w=49
  885. en:oedema -- r_associated #0: 49 / 0.778 -> en:multiple gingival papules
    n1=en:oedema | n2=en:multiple gingival papules | rel=r_associated | relid=0 | w=49
  886. en:oedema -- r_associated #0: 49 / 0.778 -> en:multiple nevi (face and torso)
    n1=en:oedema | n2=en:multiple nevi (face and torso) | rel=r_associated | relid=0 | w=49
  887. en:oedema -- r_associated #0: 49 / 0.778 -> en:multiple, asymptomatic dermal cysts (trunk, proximal extremities, neck, axillae, inguinal region, scalp)
    n1=en:oedema | n2=en:multiple, asymptomatic dermal cysts (trunk, proximal extremities, neck, axillae, inguinal region, scalp) | rel=r_associated | relid=0 | w=49
  888. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle atrophy, limb-girdle and proximal
    n1=en:oedema | n2=en:muscle atrophy, limb-girdle and proximal | rel=r_associated | relid=0 | w=49
  889. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsies show variation in fibrodiameter, internal nuclei, atrophy of type i fibers, focal loss of cross- striations, and cores of myofibrillar disruption with associated absence of mitochondria
    n1=en:oedema | n2=en:muscle biopsies show variation in fibrodiameter, internal nuclei, atrophy of type i fibers, focal loss of cross- striations, and cores of myofibrillar disruption with associated absence of mitochondria | rel=r_associated | relid=0 | w=49
  890. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows 'spheroid bodies' in type 1 muscle fibers
    n1=en:oedema | n2=en:muscle biopsy shows 'spheroid bodies' in type 1 muscle fibers | rel=r_associated | relid=0 | w=49
  891. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows atrophic fibers
    n1=en:oedema | n2=en:muscle biopsy shows atrophic fibers | rel=r_associated | relid=0 | w=49
  892. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows decreased or absent dysferlin staining
    n1=en:oedema | n2=en:muscle biopsy shows decreased or absent dysferlin staining | rel=r_associated | relid=0 | w=49
  893. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows dystrophic changes
    n1=en:oedema | n2=en:muscle biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=49
  894. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows enlargement of type i muscle fibers, consistent with denervation
    n1=en:oedema | n2=en:muscle biopsy shows enlargement of type i muscle fibers, consistent with denervation | rel=r_associated | relid=0 | w=49
  895. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows increased number of endplate regions distributed over increased span of muscle fiber
    n1=en:oedema | n2=en:muscle biopsy shows increased number of endplate regions distributed over increased span of muscle fiber | rel=r_associated | relid=0 | w=49
  896. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows inflammation with t cells
    n1=en:oedema | n2=en:muscle biopsy shows inflammation with t cells | rel=r_associated | relid=0 | w=49
  897. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows myofibrillar disruption
    n1=en:oedema | n2=en:muscle biopsy shows myofibrillar disruption | rel=r_associated | relid=0 | w=49
  898. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows myopathic or dystrophic changes
    n1=en:oedema | n2=en:muscle biopsy shows myopathic or dystrophic changes | rel=r_associated | relid=0 | w=49
  899. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows ragged red fibers
    n1=en:oedema | n2=en:muscle biopsy shows ragged red fibers | rel=r_associated | relid=0 | w=49
  900. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows sarcoplasmic or subsarcolemmal vacuoles in muscle fibers
    n1=en:oedema | n2=en:muscle biopsy shows sarcoplasmic or subsarcolemmal vacuoles in muscle fibers | rel=r_associated | relid=0 | w=49
  901. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows small nerve terminals
    n1=en:oedema | n2=en:muscle biopsy shows small nerve terminals | rel=r_associated | relid=0 | w=49
  902. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows small rounded fibers
    n1=en:oedema | n2=en:muscle biopsy shows small rounded fibers | rel=r_associated | relid=0 | w=49
  903. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle biopsy shows type 2 fiber atrophy
    n1=en:oedema | n2=en:muscle biopsy shows type 2 fiber atrophy | rel=r_associated | relid=0 | w=49
  904. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle cramps affect the upper and lower limbs
    n1=en:oedema | n2=en:muscle cramps affect the upper and lower limbs | rel=r_associated | relid=0 | w=49
  905. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle cramps, painful, recurrent
    n1=en:oedema | n2=en:muscle cramps, painful, recurrent | rel=r_associated | relid=0 | w=49
  906. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle fatigue
    n1=en:oedema | n2=en:muscle fatigue | rel=r_associated | relid=0 | w=49
  907. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle fibers may contain abnormal polysaccharide
    n1=en:oedema | n2=en:muscle fibers may contain abnormal polysaccharide | rel=r_associated | relid=0 | w=49
  908. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle hyperirritability
    n1=en:oedema | n2=en:muscle hyperirritability | rel=r_associated | relid=0 | w=49
  909. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle pain (less common)
    n1=en:oedema | n2=en:muscle pain (less common) | rel=r_associated | relid=0 | w=49
  910. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle wasting (especially legs and arms)
    n1=en:oedema | n2=en:muscle wasting (especially legs and arms) | rel=r_associated | relid=0 | w=49
  911. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle weakness (type i)
    n1=en:oedema | n2=en:muscle weakness (type i) | rel=r_associated | relid=0 | w=49
  912. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle weakness and atrophy, distal
    n1=en:oedema | n2=en:muscle weakness and atrophy, distal | rel=r_associated | relid=0 | w=49
  913. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle weakness due to peripheral neuropathy
    n1=en:oedema | n2=en:muscle weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=49
  914. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle weakness in forearm muscles
    n1=en:oedema | n2=en:muscle weakness in forearm muscles | rel=r_associated | relid=0 | w=49
  915. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle weakness lower limb
    n1=en:oedema | n2=en:muscle weakness lower limb | rel=r_associated | relid=0 | w=49
  916. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle weakness of proximal and distal upper and lower limbs
    n1=en:oedema | n2=en:muscle weakness of proximal and distal upper and lower limbs | rel=r_associated | relid=0 | w=49
  917. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle weakness, distal, restricted to the lower limbs
    n1=en:oedema | n2=en:muscle weakness, distal, restricted to the lower limbs | rel=r_associated | relid=0 | w=49
  918. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscle weakness, proximal, slowly progressive
    n1=en:oedema | n2=en:muscle weakness, proximal, slowly progressive | rel=r_associated | relid=0 | w=49
  919. en:oedema -- r_associated #0: 49 / 0.778 -> en:muscular hypotonia of the trunk
    n1=en:oedema | n2=en:muscular hypotonia of the trunk | rel=r_associated | relid=0 | w=49
  920. en:oedema -- r_associated #0: 49 / 0.778 -> en:myopathic changes seen muscle biopsy
    n1=en:oedema | n2=en:myopathic changes seen muscle biopsy | rel=r_associated | relid=0 | w=49
  921. en:oedema -- r_associated #0: 49 / 0.778 -> en:myopathic changes seen on biopsy
    n1=en:oedema | n2=en:myopathic changes seen on biopsy | rel=r_associated | relid=0 | w=49
  922. en:oedema -- r_associated #0: 49 / 0.778 -> en:myopathic changes seen on emg of affected muscle
    n1=en:oedema | n2=en:myopathic changes seen on emg of affected muscle | rel=r_associated | relid=0 | w=49
  923. en:oedema -- r_associated #0: 49 / 0.778 -> en:myopathy with abnormal lipid metabolism
    n1=en:oedema | n2=en:myopathy with abnormal lipid metabolism | rel=r_associated | relid=0 | w=49
  924. en:oedema -- r_associated #0: 49 / 0.778 -> en:named sensory sign
    n1=en:oedema | n2=en:named sensory sign | rel=r_associated | relid=0 | w=49
  925. en:oedema -- r_associated #0: 49 / 0.778 -> en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles)
    n1=en:oedema | n2=en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles) | rel=r_associated | relid=0 | w=49
  926. en:oedema -- r_associated #0: 49 / 0.778 -> en:neck flexor weakness
    n1=en:oedema | n2=en:neck flexor weakness | rel=r_associated | relid=0 | w=49
  927. en:oedema -- r_associated #0: 49 / 0.778 -> en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy
    n1=en:oedema | n2=en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=49
  928. en:oedema -- r_associated #0: 49 / 0.778 -> en:necrotic process
    n1=en:oedema | n2=en:necrotic process | rel=r_associated | relid=0 | w=49
  929. en:oedema -- r_associated #0: 49 / 0.778 -> en:nemaline myopathy (in 1 reported male)
    n1=en:oedema | n2=en:nemaline myopathy (in 1 reported male) | rel=r_associated | relid=0 | w=49
  930. en:oedema -- r_associated #0: 49 / 0.778 -> en:neonatal collodion skin
    n1=en:oedema | n2=en:neonatal collodion skin | rel=r_associated | relid=0 | w=49
  931. en:oedema -- r_associated #0: 49 / 0.778 -> en:nephrotic syndrome - nphs1 associated
    n1=en:oedema | n2=en:nephrotic syndrome - nphs1 associated | rel=r_associated | relid=0 | w=49
  932. en:oedema -- r_associated #0: 49 / 0.778 -> en:neurofibroma
    n1=en:oedema | n2=en:neurofibroma | rel=r_associated | relid=0 | w=49
  933. en:oedema -- r_associated #0: 49 / 0.778 -> en:new or worsening symptom
    n1=en:oedema | n2=en:new or worsening symptom | rel=r_associated | relid=0 | w=49
  934. en:oedema -- r_associated #0: 49 / 0.778 -> en:no ability to tan
    n1=en:oedema | n2=en:no ability to tan | rel=r_associated | relid=0 | w=49
  935. en:oedema -- r_associated #0: 49 / 0.778 -> en:normal muscle fiber (hcs)
    n1=en:oedema | n2=en:normal muscle fiber (hcs) | rel=r_associated | relid=0 | w=49
  936. en:oedema -- r_associated #0: 49 / 0.778 -> en:normal numbers of sweat glands
    n1=en:oedema | n2=en:normal numbers of sweat glands | rel=r_associated | relid=0 | w=49
  937. en:oedema -- r_associated #0: 49 / 0.778 -> en:normal or increased abdominal adipose tissue
    n1=en:oedema | n2=en:normal or increased abdominal adipose tissue | rel=r_associated | relid=0 | w=49
  938. en:oedema -- r_associated #0: 49 / 0.778 -> en:numbness, pain, and tingling of the fingers in response to cold
    n1=en:oedema | n2=en:numbness, pain, and tingling of the fingers in response to cold | rel=r_associated | relid=0 | w=49
  939. en:oedema -- r_associated #0: 49 / 0.778 -> en:o/e - abdominal edema
    n1=en:oedema | n2=en:o/e - abdominal edema | rel=r_associated | relid=0 | w=49
  940. en:oedema -- r_associated #0: 49 / 0.778 -> en:o/e - edema of feet
    n1=en:oedema | n2=en:o/e - edema of feet | rel=r_associated | relid=0 | w=49
  941. en:oedema -- r_associated #0: 49 / 0.778 -> en:o/e - sacral edema
    n1=en:oedema | n2=en:o/e - sacral edema | rel=r_associated | relid=0 | w=49
  942. en:oedema -- r_associated #0: 49 / 0.778 -> en:obligatory exercise questionnaire score
    n1=en:oedema | n2=en:obligatory exercise questionnaire score | rel=r_associated | relid=0 | w=49
  943. en:oedema -- r_associated #0: 49 / 0.778 -> en:optic disc edema
    n1=en:oedema | n2=en:optic disc edema | rel=r_associated | relid=0 | w=49
  944. en:oedema -- r_associated #0: 49 / 0.778 -> en:other changes in skin color
    n1=en:oedema | n2=en:other changes in skin color | rel=r_associated | relid=0 | w=49
  945. en:oedema -- r_associated #0: 49 / 0.778 -> en:other disorders of the skin and subcutaneous tissue
    n1=en:oedema | n2=en:other disorders of the skin and subcutaneous tissue | rel=r_associated | relid=0 | w=49
  946. en:oedema -- r_associated #0: 49 / 0.778 -> en:palmar hyperlinearity
    n1=en:oedema | n2=en:palmar hyperlinearity | rel=r_associated | relid=0 | w=49
  947. en:oedema -- r_associated #0: 49 / 0.778 -> en:palmoplantar cutis laxa
    n1=en:oedema | n2=en:palmoplantar cutis laxa | rel=r_associated | relid=0 | w=49
  948. en:oedema -- r_associated #0: 49 / 0.778 -> en:palmoplantar hyperlinearity
    n1=en:oedema | n2=en:palmoplantar hyperlinearity | rel=r_associated | relid=0 | w=49
  949. en:oedema -- r_associated #0: 49 / 0.778 -> en:pancreatic sign
    n1=en:oedema | n2=en:pancreatic sign | rel=r_associated | relid=0 | w=49
  950. en:oedema -- r_associated #0: 49 / 0.778 -> en:papilledema associated with increased intracranial pressure
    n1=en:oedema | n2=en:papilledema associated with increased intracranial pressure | rel=r_associated | relid=0 | w=49
  951. en:oedema -- r_associated #0: 49 / 0.778 -> en:papilledema of the right eye
    n1=en:oedema | n2=en:papilledema of the right eye | rel=r_associated | relid=0 | w=49
  952. en:oedema -- r_associated #0: 49 / 0.778 -> en:paralysis of the lower limbs (later)
    n1=en:oedema | n2=en:paralysis of the lower limbs (later) | rel=r_associated | relid=0 | w=49
  953. en:oedema -- r_associated #0: 49 / 0.778 -> en:parkinsonism
    n1=en:oedema | n2=en:parkinsonism | rel=r_associated | relid=0 | w=49
  954. en:oedema -- r_associated #0: 49 / 0.778 -> en:pathologic keratinization
    n1=en:oedema | n2=en:pathologic keratinization | rel=r_associated | relid=0 | w=49
  955. en:oedema -- r_associated #0: 49 / 0.778 -> en:pectoralis muscles may be less involved, leading to inward shrugging posture
    n1=en:oedema | n2=en:pectoralis muscles may be less involved, leading to inward shrugging posture | rel=r_associated | relid=0 | w=49
  956. en:oedema -- r_associated #0: 49 / 0.778 -> en:perioral erythema
    n1=en:oedema | n2=en:perioral erythema | rel=r_associated | relid=0 | w=49
  957. en:oedema -- r_associated #0: 49 / 0.778 -> en:peroneal muscle weakness and atrophy due to peripheral neuropathy
    n1=en:oedema | n2=en:peroneal muscle weakness and atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=49
  958. en:oedema -- r_associated #0: 49 / 0.778 -> en:petechia
    n1=en:oedema | n2=en:petechia | rel=r_associated | relid=0 | w=49
  959. en:oedema -- r_associated #0: 49 / 0.778 -> en:physical findings:find:pt:extremity:nom:nemsis
    n1=en:oedema | n2=en:physical findings:find:pt:extremity:nom:nemsis | rel=r_associated | relid=0 | w=49
  960. en:oedema -- r_associated #0: 49 / 0.778 -> en:pierson syndrome
    n1=en:oedema | n2=en:pierson syndrome | rel=r_associated | relid=0 | w=49
  961. en:oedema -- r_associated #0: 49 / 0.778 -> en:pigmentation abnormalities (1 family)
    n1=en:oedema | n2=en:pigmentation abnormalities (1 family) | rel=r_associated | relid=0 | w=49
  962. en:oedema -- r_associated #0: 49 / 0.778 -> en:pitted, perioral acneiform scars
    n1=en:oedema | n2=en:pitted, perioral acneiform scars | rel=r_associated | relid=0 | w=49
  963. en:oedema -- r_associated #0: 49 / 0.778 -> en:plaque-like facial hemangioma
    n1=en:oedema | n2=en:plaque-like facial hemangioma | rel=r_associated | relid=0 | w=49
  964. en:oedema -- r_associated #0: 49 / 0.778 -> en:poikiloderma (atrophic plaques with telangiectasia)
    n1=en:oedema | n2=en:poikiloderma (atrophic plaques with telangiectasia) | rel=r_associated | relid=0 | w=49
  965. en:oedema -- r_associated #0: 49 / 0.778 -> en:poor muscle build
    n1=en:oedema | n2=en:poor muscle build | rel=r_associated | relid=0 | w=49
  966. en:oedema -- r_associated #0: 49 / 0.778 -> en:poor sarcomeric structure (in some patients)
    n1=en:oedema | n2=en:poor sarcomeric structure (in some patients) | rel=r_associated | relid=0 | w=49
  967. en:oedema -- r_associated #0: 49 / 0.778 -> en:popliteal pterygium
    n1=en:oedema | n2=en:popliteal pterygium | rel=r_associated | relid=0 | w=49
  968. en:oedema -- r_associated #0: 49 / 0.778 -> en:post-upper airway obstruction pulmonary edema
    n1=en:oedema | n2=en:post-upper airway obstruction pulmonary edema | rel=r_associated | relid=0 | w=49
  969. en:oedema -- r_associated #0: 49 / 0.778 -> en:posterior midline scalp defects
    n1=en:oedema | n2=en:posterior midline scalp defects | rel=r_associated | relid=0 | w=49
  970. en:oedema -- r_associated #0: 49 / 0.778 -> en:postimmersion-submersion syndrome
    n1=en:oedema | n2=en:postimmersion-submersion syndrome | rel=r_associated | relid=0 | w=49
  971. en:oedema -- r_associated #0: 49 / 0.778 -> en:pregnancy risk factors:find:pt:^patient:nom:rhea
    n1=en:oedema | n2=en:pregnancy risk factors:find:pt:^patient:nom:rhea | rel=r_associated | relid=0 | w=49
  972. en:oedema -- r_associated #0: 49 / 0.778 -> en:preserved heel standing
    n1=en:oedema | n2=en:preserved heel standing | rel=r_associated | relid=0 | w=49
  973. en:oedema -- r_associated #0: 49 / 0.778 -> en:progression to proximal muscle weakness
    n1=en:oedema | n2=en:progression to proximal muscle weakness | rel=r_associated | relid=0 | w=49
  974. en:oedema -- r_associated #0: 49 / 0.778 -> en:progression to wheelchair in fourth decade
    n1=en:oedema | n2=en:progression to wheelchair in fourth decade | rel=r_associated | relid=0 | w=49
  975. en:oedema -- r_associated #0: 49 / 0.778 -> en:proximal lower limb muscle weakness, upper and lower (later onset)
    n1=en:oedema | n2=en:proximal lower limb muscle weakness, upper and lower (later onset) | rel=r_associated | relid=0 | w=49
  976. en:oedema -- r_associated #0: 49 / 0.778 -> en:proximal muscle weakness (in some patients)
    n1=en:oedema | n2=en:proximal muscle weakness (in some patients) | rel=r_associated | relid=0 | w=49
  977. en:oedema -- r_associated #0: 49 / 0.778 -> en:proximal muscle weakness, mild (in some patients)
    n1=en:oedema | n2=en:proximal muscle weakness, mild (in some patients) | rel=r_associated | relid=0 | w=49
  978. en:oedema -- r_associated #0: 49 / 0.778 -> en:proximal myopathy
    n1=en:oedema | n2=en:proximal myopathy | rel=r_associated | relid=0 | w=49
  979. en:oedema -- r_associated #0: 49 / 0.778 -> en:pruritus of skin lesions, severe
    n1=en:oedema | n2=en:pruritus of skin lesions, severe | rel=r_associated | relid=0 | w=49
  980. en:oedema -- r_associated #0: 49 / 0.778 -> en:pseudohypertrophy of muscle
    n1=en:oedema | n2=en:pseudohypertrophy of muscle | rel=r_associated | relid=0 | w=49
  981. en:oedema -- r_associated #0: 49 / 0.778 -> en:psoriasiform dermatitis (in some patients)
    n1=en:oedema | n2=en:psoriasiform dermatitis (in some patients) | rel=r_associated | relid=0 | w=49
  982. en:oedema -- r_associated #0: 49 / 0.778 -> en:psoriasis (in some patients)
    n1=en:oedema | n2=en:psoriasis (in some patients) | rel=r_associated | relid=0 | w=49
  983. en:oedema -- r_associated #0: 49 / 0.778 -> en:pterygium
    n1=en:oedema | n2=en:pterygium | rel=r_associated | relid=0 | w=49
  984. en:oedema -- r_associated #0: 49 / 0.778 -> en:pulmonary insufficiency following surgery
    n1=en:oedema | n2=en:pulmonary insufficiency following surgery | rel=r_associated | relid=0 | w=49
  985. en:oedema -- r_associated #0: 49 / 0.778 -> en:pulmonary insufficiency following trauma
    n1=en:oedema | n2=en:pulmonary insufficiency following trauma | rel=r_associated | relid=0 | w=49
  986. en:oedema -- r_associated #0: 49 / 0.778 -> en:pyoderma gangrenosum
    n1=en:oedema | n2=en:pyoderma gangrenosum | rel=r_associated | relid=0 | w=49
  987. en:oedema -- r_associated #0: 49 / 0.778 -> en:pyramidal skinfold of halluces
    n1=en:oedema | n2=en:pyramidal skinfold of halluces | rel=r_associated | relid=0 | w=49
  988. en:oedema -- r_associated #0: 49 / 0.778 -> en:quadriceps weakness
    n1=en:oedema | n2=en:quadriceps weakness | rel=r_associated | relid=0 | w=49
  989. en:oedema -- r_associated #0: 49 / 0.778 -> en:ragged-red fibers on muscle biopsy
    n1=en:oedema | n2=en:ragged-red fibers on muscle biopsy | rel=r_associated | relid=0 | w=49
  990. en:oedema -- r_associated #0: 49 / 0.778 -> en:raynaud phenomenon
    n1=en:oedema | n2=en:raynaud phenomenon | rel=r_associated | relid=0 | w=49
  991. en:oedema -- r_associated #0: 49 / 0.778 -> en:recurrent cellulitis
    n1=en:oedema | n2=en:recurrent cellulitis | rel=r_associated | relid=0 | w=49
  992. en:oedema -- r_associated #0: 49 / 0.778 -> en:redundant connective tissue
    n1=en:oedema | n2=en:redundant connective tissue | rel=r_associated | relid=0 | w=49
  993. en:oedema -- r_associated #0: 49 / 0.778 -> en:redundant folds
    n1=en:oedema | n2=en:redundant folds | rel=r_associated | relid=0 | w=49
  994. en:oedema -- r_associated #0: 49 / 0.778 -> en:regurgitation
    n1=en:oedema | n2=en:regurgitation | rel=r_associated | relid=0 | w=49
  995. en:oedema -- r_associated #0: 49 / 0.778 -> en:respiratory distress (congenital form)
    n1=en:oedema | n2=en:respiratory distress (congenital form) | rel=r_associated | relid=0 | w=49
  996. en:oedema -- r_associated #0: 49 / 0.778 -> en:reticular hyperpigmentation
    n1=en:oedema | n2=en:reticular hyperpigmentation | rel=r_associated | relid=0 | w=49
  997. en:oedema -- r_associated #0: 49 / 0.778 -> en:rhabdomyolysis, episodic
    n1=en:oedema | n2=en:rhabdomyolysis, episodic | rel=r_associated | relid=0 | w=49
  998. en:oedema -- r_associated #0: 49 / 0.778 -> en:rupture of muscle
    n1=en:oedema | n2=en:rupture of muscle | rel=r_associated | relid=0 | w=49
  999. en:oedema -- r_associated #0: 49 / 0.778 -> en:sarcomere disappearance seen on muscle biopsy
    n1=en:oedema | n2=en:sarcomere disappearance seen on muscle biopsy | rel=r_associated | relid=0 | w=49
  1000. en:oedema -- r_associated #0: 49 / 0.778 -> en:scalp defect
    n1=en:oedema | n2=en:scalp defect | rel=r_associated | relid=0 | w=49
  1001. en:oedema -- r_associated #0: 49 / 0.778 -> en:scalp erosions
    n1=en:oedema | n2=en:scalp erosions | rel=r_associated | relid=0 | w=49
  1002. en:oedema -- r_associated #0: 49 / 0.778 -> en:sclerotic soft tissue over affected bones
    n1=en:oedema | n2=en:sclerotic soft tissue over affected bones | rel=r_associated | relid=0 | w=49
  1003. en:oedema -- r_associated #0: 49 / 0.778 -> en:seborrheic keratosis-like papules
    n1=en:oedema | n2=en:seborrheic keratosis-like papules | rel=r_associated | relid=0 | w=49
  1004. en:oedema -- r_associated #0: 49 / 0.778 -> en:secondary corneal edema
    n1=en:oedema | n2=en:secondary corneal edema | rel=r_associated | relid=0 | w=49
  1005. en:oedema -- r_associated #0: 49 / 0.778 -> en:secondary loss of merosin and desmin
    n1=en:oedema | n2=en:secondary loss of merosin and desmin | rel=r_associated | relid=0 | w=49
  1006. en:oedema -- r_associated #0: 49 / 0.778 -> en:secondary myopathic changes
    n1=en:oedema | n2=en:secondary myopathic changes | rel=r_associated | relid=0 | w=49
  1007. en:oedema -- r_associated #0: 49 / 0.778 -> en:severe progressive ulceration of lower extremities
    n1=en:oedema | n2=en:severe progressive ulceration of lower extremities | rel=r_associated | relid=0 | w=49
  1008. en:oedema -- r_associated #0: 49 / 0.778 -> en:severely decreased or absent lamp2 protein
    n1=en:oedema | n2=en:severely decreased or absent lamp2 protein | rel=r_associated | relid=0 | w=49
  1009. en:oedema -- r_associated #0: 49 / 0.778 -> en:sharp midline demarcation
    n1=en:oedema | n2=en:sharp midline demarcation | rel=r_associated | relid=0 | w=49
  1010. en:oedema -- r_associated #0: 49 / 0.778 -> en:shivering
    n1=en:oedema | n2=en:shivering | rel=r_associated | relid=0 | w=49
  1011. en:oedema -- r_associated #0: 49 / 0.778 -> en:shortening of the fascial structures of the palm and fingers
    n1=en:oedema | n2=en:shortening of the fascial structures of the palm and fingers | rel=r_associated | relid=0 | w=49
  1012. en:oedema -- r_associated #0: 49 / 0.778 -> en:skeletal muscle biopsy shows decreased cytochrome c oxidase activity
    n1=en:oedema | n2=en:skeletal muscle biopsy shows decreased cytochrome c oxidase activity | rel=r_associated | relid=0 | w=49
  1013. en:oedema -- r_associated #0: 49 / 0.778 -> en:skeletal muscle tissue shows 14 to 45% depletion of mitochondrial dna (mtdna)
    n1=en:oedema | n2=en:skeletal muscle tissue shows 14 to 45% depletion of mitochondrial dna (mtdna) | rel=r_associated | relid=0 | w=49
  1014. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin appendages (periorbital, face, thorax, rarely on trunk)
    n1=en:oedema | n2=en:skin appendages (periorbital, face, thorax, rarely on trunk) | rel=r_associated | relid=0 | w=49
  1015. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin fissures (groin, axilla, neck)
    n1=en:oedema | n2=en:skin fissures (groin, axilla, neck) | rel=r_associated | relid=0 | w=49
  1016. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin may redden during episodes
    n1=en:oedema | n2=en:skin may redden during episodes | rel=r_associated | relid=0 | w=49
  1017. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin of right upper limb
    n1=en:oedema | n2=en:skin of right upper limb | rel=r_associated | relid=0 | w=49
  1018. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin of the extremity
    n1=en:oedema | n2=en:skin of the extremity | rel=r_associated | relid=0 | w=49
  1019. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin of the face
    n1=en:oedema | n2=en:skin of the face | rel=r_associated | relid=0 | w=49
  1020. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin of the lower limb and hip
    n1=en:oedema | n2=en:skin of the lower limb and hip | rel=r_associated | relid=0 | w=49
  1021. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin peeling/scaling (newborn)
    n1=en:oedema | n2=en:skin peeling/scaling (newborn) | rel=r_associated | relid=0 | w=49
  1022. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin photosensitivity
    n1=en:oedema | n2=en:skin photosensitivity | rel=r_associated | relid=0 | w=49
  1023. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin structure of back
    n1=en:oedema | n2=en:skin structure of back | rel=r_associated | relid=0 | w=49
  1024. en:oedema -- r_associated #0: 49 / 0.778 -> en:skin tags on the upper part of the auricle
    n1=en:oedema | n2=en:skin tags on the upper part of the auricle | rel=r_associated | relid=0 | w=49
  1025. en:oedema -- r_associated #0: 49 / 0.778 -> en:slowly progressive limb-girdle myopathy
    n1=en:oedema | n2=en:slowly progressive limb-girdle myopathy | rel=r_associated | relid=0 | w=49
  1026. en:oedema -- r_associated #0: 49 / 0.778 -> en:smooth muscle may also become involved
    n1=en:oedema | n2=en:smooth muscle may also become involved | rel=r_associated | relid=0 | w=49
  1027. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium acetate
    n1=en:oedema | n2=en:sodium acetate | rel=r_associated | relid=0 | w=49
  1028. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium acetate 5 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium acetate 5 meq/ml injectable solution | rel=r_associated | relid=0 | w=49
  1029. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium bicarbonate 0.893 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium bicarbonate 0.893 meq/ml injectable solution | rel=r_associated | relid=0 | w=49
  1030. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium bicarbonate 650 mg oral tablet
    n1=en:oedema | n2=en:sodium bicarbonate 650 mg oral tablet | rel=r_associated | relid=0 | w=49
  1031. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium chloride 0.0684 meq/ml nasal spray
    n1=en:oedema | n2=en:sodium chloride 0.0684 meq/ml nasal spray | rel=r_associated | relid=0 | w=49
  1032. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium chloride 0.154 meq/ml nasal spray
    n1=en:oedema | n2=en:sodium chloride 0.154 meq/ml nasal spray | rel=r_associated | relid=0 | w=49
  1033. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium chloride 0.2% soln
    n1=en:oedema | n2=en:sodium chloride 0.2% soln | rel=r_associated | relid=0 | w=49
  1034. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium chloride 0.274 meq/ml irrigation solution
    n1=en:oedema | n2=en:sodium chloride 0.274 meq/ml irrigation solution | rel=r_associated | relid=0 | w=49
  1035. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium chloride 5% eye ointment
    n1=en:oedema | n2=en:sodium chloride 5% eye ointment | rel=r_associated | relid=0 | w=49
  1036. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium chloride soln,oph
    n1=en:oedema | n2=en:sodium chloride soln,oph | rel=r_associated | relid=0 | w=49
  1037. en:oedema -- r_associated #0: 49 / 0.778 -> en:sodium citrate 40 mg/ml oral solution
    n1=en:oedema | n2=en:sodium citrate 40 mg/ml oral solution | rel=r_associated | relid=0 | w=49
  1038. en:oedema -- r_associated #0: 49 / 0.778 -> en:soft tissue vascular malformations
    n1=en:oedema | n2=en:soft tissue vascular malformations | rel=r_associated | relid=0 | w=49
  1039. en:oedema -- r_associated #0: 49 / 0.778 -> en:splenomegaly
    n1=en:oedema | n2=en:splenomegaly | rel=r_associated | relid=0 | w=49
  1040. en:oedema -- r_associated #0: 49 / 0.778 -> en:stage 2 - skin papules, verrucous lesions, hyperkeratosis
    n1=en:oedema | n2=en:stage 2 - skin papules, verrucous lesions, hyperkeratosis | rel=r_associated | relid=0 | w=49
  1041. en:oedema -- r_associated #0: 49 / 0.778 -> en:stage 3 - skin hyperpigmentation
    n1=en:oedema | n2=en:stage 3 - skin hyperpigmentation | rel=r_associated | relid=0 | w=49
  1042. en:oedema -- r_associated #0: 49 / 0.778 -> en:superficial traumatic edema
    n1=en:oedema | n2=en:superficial traumatic edema | rel=r_associated | relid=0 | w=49
  1043. en:oedema -- r_associated #0: 49 / 0.778 -> en:superior rectus atrophy
    n1=en:oedema | n2=en:superior rectus atrophy | rel=r_associated | relid=0 | w=49
  1044. en:oedema -- r_associated #0: 49 / 0.778 -> en:sweat pore aplasia
    n1=en:oedema | n2=en:sweat pore aplasia | rel=r_associated | relid=0 | w=49
  1045. en:oedema -- r_associated #0: 49 / 0.778 -> en:symptom of head and neck region
    n1=en:oedema | n2=en:symptom of head and neck region | rel=r_associated | relid=0 | w=49
  1046. en:oedema -- r_associated #0: 49 / 0.778 -> en:syncope adverse event
    n1=en:oedema | n2=en:syncope adverse event | rel=r_associated | relid=0 | w=49
  1047. en:oedema -- r_associated #0: 49 / 0.778 -> en:telangiectases (palms, soles, scalp, scrotum, legs)
    n1=en:oedema | n2=en:telangiectases (palms, soles, scalp, scrotum, legs) | rel=r_associated | relid=0 | w=49
  1048. en:oedema -- r_associated #0: 49 / 0.778 -> en:telangiectasia on the cheeks
    n1=en:oedema | n2=en:telangiectasia on the cheeks | rel=r_associated | relid=0 | w=49
  1049. en:oedema -- r_associated #0: 49 / 0.778 -> en:transurethral resection syndrome
    n1=en:oedema | n2=en:transurethral resection syndrome | rel=r_associated | relid=0 | w=49
  1050. en:oedema -- r_associated #0: 49 / 0.778 -> en:tumors appear most often on sun-exposed regions
    n1=en:oedema | n2=en:tumors appear most often on sun-exposed regions | rel=r_associated | relid=0 | w=49
  1051. en:oedema -- r_associated #0: 49 / 0.778 -> en:tumors leave pitting scars
    n1=en:oedema | n2=en:tumors leave pitting scars | rel=r_associated | relid=0 | w=49
  1052. en:oedema -- r_associated #0: 49 / 0.778 -> en:tumors undergo spontaneous resolution over a period of months
    n1=en:oedema | n2=en:tumors undergo spontaneous resolution over a period of months | rel=r_associated | relid=0 | w=49
  1053. en:oedema -- r_associated #0: 49 / 0.778 -> en:type 2 fiber hypertrophy
    n1=en:oedema | n2=en:type 2 fiber hypertrophy | rel=r_associated | relid=0 | w=49
  1054. en:oedema -- r_associated #0: 49 / 0.778 -> en:ulceration
    n1=en:oedema | n2=en:ulceration | rel=r_associated | relid=0 | w=49
  1055. en:oedema -- r_associated #0: 49 / 0.778 -> en:ulcers, distal, painless, due to sensory neuropathy
    n1=en:oedema | n2=en:ulcers, distal, painless, due to sensory neuropathy | rel=r_associated | relid=0 | w=49
  1056. en:oedema -- r_associated #0: 49 / 0.778 -> en:upper limb muscle weakness may be more severe than lower limb weakness
    n1=en:oedema | n2=en:upper limb muscle weakness may be more severe than lower limb weakness | rel=r_associated | relid=0 | w=49
  1057. en:oedema -- r_associated #0: 49 / 0.778 -> en:urinary incontinence
    n1=en:oedema | n2=en:urinary incontinence | rel=r_associated | relid=0 | w=49
  1058. en:oedema -- r_associated #0: 49 / 0.778 -> en:urinary system symptoms nos
    n1=en:oedema | n2=en:urinary system symptoms nos | rel=r_associated | relid=0 | w=49
  1059. en:oedema -- r_associated #0: 49 / 0.778 -> en:valpar component work sample 17 pre-vocational readiness battery score
    n1=en:oedema | n2=en:valpar component work sample 17 pre-vocational readiness battery score | rel=r_associated | relid=0 | w=49
  1060. en:oedema -- r_associated #0: 49 / 0.778 -> en:variable fiber size
    n1=en:oedema | n2=en:variable fiber size | rel=r_associated | relid=0 | w=49
  1061. en:oedema -- r_associated #0: 49 / 0.778 -> en:variable number of lesions (1 to greater than 10)
    n1=en:oedema | n2=en:variable number of lesions (1 to greater than 10) | rel=r_associated | relid=0 | w=49
  1062. en:oedema -- r_associated #0: 49 / 0.778 -> en:velvety skin
    n1=en:oedema | n2=en:velvety skin | rel=r_associated | relid=0 | w=49
  1063. en:oedema -- r_associated #0: 49 / 0.778 -> en:viruses
    n1=en:oedema | n2=en:viruses | rel=r_associated | relid=0 | w=49
  1064. en:oedema -- r_associated #0: 49 / 0.778 -> en:visual analog scale score
    n1=en:oedema | n2=en:visual analog scale score | rel=r_associated | relid=0 | w=49
  1065. en:oedema -- r_associated #0: 49 / 0.778 -> en:visual discomfort
    n1=en:oedema | n2=en:visual discomfort | rel=r_associated | relid=0 | w=49
  1066. en:oedema -- r_associated #0: 49 / 0.778 -> en:vitiligo (rare)
    n1=en:oedema | n2=en:vitiligo (rare) | rel=r_associated | relid=0 | w=49
  1067. en:oedema -- r_associated #0: 49 / 0.778 -> en:water intoxication
    n1=en:oedema | n2=en:water intoxication | rel=r_associated | relid=0 | w=49
  1068. en:oedema -- r_associated #0: 49 / 0.778 -> en:water retention (finding)
    n1=en:oedema | n2=en:water retention (finding) | rel=r_associated | relid=0 | w=49
  1069. en:oedema -- r_associated #0: 49 / 0.778 -> en:weight change
    n1=en:oedema | n2=en:weight change | rel=r_associated | relid=0 | w=49
  1070. en:oedema -- r_associated #0: 49 / 0.778 -> en:white ash leaf-shaped macules
    n1=en:oedema | n2=en:white ash leaf-shaped macules | rel=r_associated | relid=0 | w=49
  1071. en:oedema -- r_associated #0: 49 / 0.778 -> en:wrinkling of skin on limbs
    n1=en:oedema | n2=en:wrinkling of skin on limbs | rel=r_associated | relid=0 | w=49
  1072. en:oedema -- r_associated #0: 49 / 0.778 -> en:wrinkly skin (13 of 22)
    n1=en:oedema | n2=en:wrinkly skin (13 of 22) | rel=r_associated | relid=0 | w=49
  1073. en:oedema -- r_associated #0: 49 / 0.778 -> en:xanthomas (in some patients)
    n1=en:oedema | n2=en:xanthomas (in some patients) | rel=r_associated | relid=0 | w=49
  1074. en:oedema -- r_associated #0: 49 / 0.778 -> en:xerosis (buttocks, extensor surfaces of extremities)
    n1=en:oedema | n2=en:xerosis (buttocks, extensor surfaces of extremities) | rel=r_associated | relid=0 | w=49
  1075. en:oedema -- r_associated #0: 49 / 0.778 -> en:z-band streaming
    n1=en:oedema | n2=en:z-band streaming | rel=r_associated | relid=0 | w=49
  1076. en:oedema -- r_associated #0: 49 / 0.778 -> oedème bleu
    n1=en:oedema | n2=oedème bleu | rel=r_associated | relid=0 | w=49
  1077. en:oedema -- r_associated #0: 49 / 0.778 -> oedème malin
    n1=en:oedema | n2=oedème malin | rel=r_associated | relid=0 | w=49
  1078. en:oedema -- r_associated #0: 49 / 0.778 -> phlébite
    n1=en:oedema | n2=phlébite | rel=r_associated | relid=0 | w=49
  1079. en:oedema -- r_associated #0: 48 / 0.762 -> bouffissure
    n1=en:oedema | n2=bouffissure | rel=r_associated | relid=0 | w=48
  1080. en:oedema -- r_associated #0: 48 / 0.762 -> boursoufflure
    n1=en:oedema | n2=boursoufflure | rel=r_associated | relid=0 | w=48
  1081. en:oedema -- r_associated #0: 48 / 0.762 -> bubon
    n1=en:oedema | n2=bubon | rel=r_associated | relid=0 | w=48
  1082. en:oedema -- r_associated #0: 48 / 0.762 -> en:'orange peel' skin
    n1=en:oedema | n2=en:'orange peel' skin | rel=r_associated | relid=0 | w=48
  1083. en:oedema -- r_associated #0: 48 / 0.762 -> en:2 ml sodium chloride 9 mg/ml prefilled syringe
    n1=en:oedema | n2=en:2 ml sodium chloride 9 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=48
  1084. en:oedema -- r_associated #0: 48 / 0.762 -> en:2. yellowish, flat plaques
    n1=en:oedema | n2=en:2. yellowish, flat plaques | rel=r_associated | relid=0 | w=48
  1085. en:oedema -- r_associated #0: 48 / 0.762 -> en:3 ml sodium chloride 9 mg/ml prefilled syringe
    n1=en:oedema | n2=en:3 ml sodium chloride 9 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=48
  1086. en:oedema -- r_associated #0: 48 / 0.762 -> en:70-gene signature classification
    n1=en:oedema | n2=en:70-gene signature classification | rel=r_associated | relid=0 | w=48
  1087. en:oedema -- r_associated #0: 48 / 0.762 -> en:abdominal wall edema
    n1=en:oedema | n2=en:abdominal wall edema | rel=r_associated | relid=0 | w=48
  1088. en:oedema -- r_associated #0: 48 / 0.762 -> en:abdominal wall muscle weakness (later onset)
    n1=en:oedema | n2=en:abdominal wall muscle weakness (later onset) | rel=r_associated | relid=0 | w=48
  1089. en:oedema -- r_associated #0: 48 / 0.762 -> en:abnormal iron deposition in mitochondria
    n1=en:oedema | n2=en:abnormal iron deposition in mitochondria | rel=r_associated | relid=0 | w=48
  1090. en:oedema -- r_associated #0: 48 / 0.762 -> en:absence of subcutaneous fat
    n1=en:oedema | n2=en:absence of subcutaneous fat | rel=r_associated | relid=0 | w=48
  1091. en:oedema -- r_associated #0: 48 / 0.762 -> en:absence of telethonin protein
    n1=en:oedema | n2=en:absence of telethonin protein | rel=r_associated | relid=0 | w=48
  1092. en:oedema -- r_associated #0: 48 / 0.762 -> en:acceptance of illness scale score
    n1=en:oedema | n2=en:acceptance of illness scale score | rel=r_associated | relid=0 | w=48
  1093. en:oedema -- r_associated #0: 48 / 0.762 -> en:accumulated lipid droplets seen on muscle biopsy
    n1=en:oedema | n2=en:accumulated lipid droplets seen on muscle biopsy | rel=r_associated | relid=0 | w=48
  1094. en:oedema -- r_associated #0: 48 / 0.762 -> en:accumulation of melanosomes in melanocytes
    n1=en:oedema | n2=en:accumulation of melanosomes in melanocytes | rel=r_associated | relid=0 | w=48
  1095. en:oedema -- r_associated #0: 48 / 0.762 -> en:acneform facial lesions
    n1=en:oedema | n2=en:acneform facial lesions | rel=r_associated | relid=0 | w=48
  1096. en:oedema -- r_associated #0: 48 / 0.762 -> en:acral keratosis
    n1=en:oedema | n2=en:acral keratosis | rel=r_associated | relid=0 | w=48
  1097. en:oedema -- r_associated #0: 48 / 0.762 -> en:acrocyanosis of the feet (in some patients)
    n1=en:oedema | n2=en:acrocyanosis of the feet (in some patients) | rel=r_associated | relid=0 | w=48
  1098. en:oedema -- r_associated #0: 48 / 0.762 -> en:acute myeloid leukemia
    n1=en:oedema | n2=en:acute myeloid leukemia | rel=r_associated | relid=0 | w=48
  1099. en:oedema -- r_associated #0: 48 / 0.762 -> en:adipose tissue shows many adipocytes with multiple small lipid droplets rather than a normal single lipid droplet
    n1=en:oedema | n2=en:adipose tissue shows many adipocytes with multiple small lipid droplets rather than a normal single lipid droplet | rel=r_associated | relid=0 | w=48
  1100. en:oedema -- r_associated #0: 48 / 0.762 -> en:adiposis on mri
    n1=en:oedema | n2=en:adiposis on mri | rel=r_associated | relid=0 | w=48
  1101. en:oedema -- r_associated #0: 48 / 0.762 -> en:adson's sign
    n1=en:oedema | n2=en:adson's sign | rel=r_associated | relid=0 | w=48
  1102. en:oedema -- r_associated #0: 48 / 0.762 -> en:albopapuloid lesions may occur
    n1=en:oedema | n2=en:albopapuloid lesions may occur | rel=r_associated | relid=0 | w=48
  1103. en:oedema -- r_associated #0: 48 / 0.762 -> en:ambulation difficulty
    n1=en:oedema | n2=en:ambulation difficulty | rel=r_associated | relid=0 | w=48
  1104. en:oedema -- r_associated #0: 48 / 0.762 -> en:amyloid deposition in muscle fibers occurs rarely
    n1=en:oedema | n2=en:amyloid deposition in muscle fibers occurs rarely | rel=r_associated | relid=0 | w=48
  1105. en:oedema -- r_associated #0: 48 / 0.762 -> en:anemia
    n1=en:oedema | n2=en:anemia | rel=r_associated | relid=0 | w=48
  1106. en:oedema -- r_associated #0: 48 / 0.762 -> en:angina
    n1=en:oedema | n2=en:angina | rel=r_associated | relid=0 | w=48
  1107. en:oedema -- r_associated #0: 48 / 0.762 -> en:angulated fibers
    n1=en:oedema | n2=en:angulated fibers | rel=r_associated | relid=0 | w=48
  1108. en:oedema -- r_associated #0: 48 / 0.762 -> en:anhidrosis (in patients with hsan2d)
    n1=en:oedema | n2=en:anhidrosis (in patients with hsan2d) | rel=r_associated | relid=0 | w=48
  1109. en:oedema -- r_associated #0: 48 / 0.762 -> en:aphakic corneal edema
    n1=en:oedema | n2=en:aphakic corneal edema | rel=r_associated | relid=0 | w=48
  1110. en:oedema -- r_associated #0: 48 / 0.762 -> en:aplasia cutis congenita
    n1=en:oedema | n2=en:aplasia cutis congenita | rel=r_associated | relid=0 | w=48
  1111. en:oedema -- r_associated #0: 48 / 0.762 -> en:areflexia of lower limbs
    n1=en:oedema | n2=en:areflexia of lower limbs | rel=r_associated | relid=0 | w=48
  1112. en:oedema -- r_associated #0: 48 / 0.762 -> en:asthmatoid wheeze
    n1=en:oedema | n2=en:asthmatoid wheeze | rel=r_associated | relid=0 | w=48
  1113. en:oedema -- r_associated #0: 48 / 0.762 -> en:asymptomatic
    n1=en:oedema | n2=en:asymptomatic | rel=r_associated | relid=0 | w=48
  1114. en:oedema -- r_associated #0: 48 / 0.762 -> en:atherosclerosis
    n1=en:oedema | n2=en:atherosclerosis | rel=r_associated | relid=0 | w=48
  1115. en:oedema -- r_associated #0: 48 / 0.762 -> en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise
    n1=en:oedema | n2=en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | rel=r_associated | relid=0 | w=48
  1116. en:oedema -- r_associated #0: 48 / 0.762 -> en:attacks precipitated by potassium
    n1=en:oedema | n2=en:attacks precipitated by potassium | rel=r_associated | relid=0 | w=48
  1117. en:oedema -- r_associated #0: 48 / 0.762 -> en:axillary pterygium, bilateral (in some patients)
    n1=en:oedema | n2=en:axillary pterygium, bilateral (in some patients) | rel=r_associated | relid=0 | w=48
  1118. en:oedema -- r_associated #0: 48 / 0.762 -> en:benign finding
    n1=en:oedema | n2=en:benign finding | rel=r_associated | relid=0 | w=48
  1119. en:oedema -- r_associated #0: 48 / 0.762 -> en:biological regulation
    n1=en:oedema | n2=en:biological regulation | rel=r_associated | relid=0 | w=48
  1120. en:oedema -- r_associated #0: 48 / 0.762 -> en:biopsy shows myopathy without vacuoles
    n1=en:oedema | n2=en:biopsy shows myopathy without vacuoles | rel=r_associated | relid=0 | w=48
  1121. en:oedema -- r_associated #0: 48 / 0.762 -> en:blotching pigmentation of the skin (in older children)
    n1=en:oedema | n2=en:blotching pigmentation of the skin (in older children) | rel=r_associated | relid=0 | w=48
  1122. en:oedema -- r_associated #0: 48 / 0.762 -> en:body odor
    n1=en:oedema | n2=en:body odor | rel=r_associated | relid=0 | w=48
  1123. en:oedema -- r_associated #0: 48 / 0.762 -> en:body temperature associated symptom
    n1=en:oedema | n2=en:body temperature associated symptom | rel=r_associated | relid=0 | w=48
  1124. en:oedema -- r_associated #0: 48 / 0.762 -> en:breast observable
    n1=en:oedema | n2=en:breast observable | rel=r_associated | relid=0 | w=48
  1125. en:oedema -- r_associated #0: 48 / 0.762 -> en:brown macules in a reticulate pattern (rare)
    n1=en:oedema | n2=en:brown macules in a reticulate pattern (rare) | rel=r_associated | relid=0 | w=48
  1126. en:oedema -- r_associated #0: 48 / 0.762 -> en:brudzinski's sign
    n1=en:oedema | n2=en:brudzinski's sign | rel=r_associated | relid=0 | w=48
  1127. en:oedema -- r_associated #0: 48 / 0.762 -> en:bryant's sign - shoulder
    n1=en:oedema | n2=en:bryant's sign - shoulder | rel=r_associated | relid=0 | w=48
  1128. en:oedema -- r_associated #0: 48 / 0.762 -> en:cafe au lait spots (in some patients)
    n1=en:oedema | n2=en:cafe au lait spots (in some patients) | rel=r_associated | relid=0 | w=48
  1129. en:oedema -- r_associated #0: 48 / 0.762 -> en:calcinosis cutis metastatica
    n1=en:oedema | n2=en:calcinosis cutis metastatica | rel=r_associated | relid=0 | w=48
  1130. en:oedema -- r_associated #0: 48 / 0.762 -> en:casq1-immunopositive inclusions
    n1=en:oedema | n2=en:casq1-immunopositive inclusions | rel=r_associated | relid=0 | w=48
  1131. en:oedema -- r_associated #0: 48 / 0.762 -> en:cavernous hemangioma
    n1=en:oedema | n2=en:cavernous hemangioma | rel=r_associated | relid=0 | w=48
  1132. en:oedema -- r_associated #0: 48 / 0.762 -> en:cellulitis over affected area
    n1=en:oedema | n2=en:cellulitis over affected area | rel=r_associated | relid=0 | w=48
  1133. en:oedema -- r_associated #0: 48 / 0.762 -> en:centor criteria score
    n1=en:oedema | n2=en:centor criteria score | rel=r_associated | relid=0 | w=48
  1134. en:oedema -- r_associated #0: 48 / 0.762 -> en:centrally located nuclei seen on muscle biopsy
    n1=en:oedema | n2=en:centrally located nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=48
  1135. en:oedema -- r_associated #0: 48 / 0.762 -> en:chief complaint
    n1=en:oedema | n2=en:chief complaint | rel=r_associated | relid=0 | w=48
  1136. en:oedema -- r_associated #0: 48 / 0.762 -> en:chills
    n1=en:oedema | n2=en:chills | rel=r_associated | relid=0 | w=48
  1137. en:oedema -- r_associated #0: 48 / 0.762 -> en:choking
    n1=en:oedema | n2=en:choking | rel=r_associated | relid=0 | w=48
  1138. en:oedema -- r_associated #0: 48 / 0.762 -> en:chronic eczematoid rash
    n1=en:oedema | n2=en:chronic eczematoid rash | rel=r_associated | relid=0 | w=48
  1139. en:oedema -- r_associated #0: 48 / 0.762 -> en:circumscribed nodular and tuberous pretibial myxedema
    n1=en:oedema | n2=en:circumscribed nodular and tuberous pretibial myxedema | rel=r_associated | relid=0 | w=48
  1140. en:oedema -- r_associated #0: 48 / 0.762 -> en:circumscribed transparent membrane on the scalp vertex may be ulcerated (other areas of the body are rarely involved)
    n1=en:oedema | n2=en:circumscribed transparent membrane on the scalp vertex may be ulcerated (other areas of the body are rarely involved) | rel=r_associated | relid=0 | w=48
  1141. en:oedema -- r_associated #0: 48 / 0.762 -> en:clinical stage finding
    n1=en:oedema | n2=en:clinical stage finding | rel=r_associated | relid=0 | w=48
  1142. en:oedema -- r_associated #0: 48 / 0.762 -> en:clumsiness
    n1=en:oedema | n2=en:clumsiness | rel=r_associated | relid=0 | w=48
  1143. en:oedema -- r_associated #0: 48 / 0.762 -> en:collodion membrane at birth
    n1=en:oedema | n2=en:collodion membrane at birth | rel=r_associated | relid=0 | w=48
  1144. en:oedema -- r_associated #0: 48 / 0.762 -> en:comedo
    n1=en:oedema | n2=en:comedo | rel=r_associated | relid=0 | w=48
  1145. en:oedema -- r_associated #0: 48 / 0.762 -> en:commotio retinae
    n1=en:oedema | n2=en:commotio retinae | rel=r_associated | relid=0 | w=48
  1146. en:oedema -- r_associated #0: 48 / 0.762 -> en:communication speech and language observable
    n1=en:oedema | n2=en:communication speech and language observable | rel=r_associated | relid=0 | w=48
  1147. en:oedema -- r_associated #0: 48 / 0.762 -> en:congenital erythrokeratodermia
    n1=en:oedema | n2=en:congenital erythrokeratodermia | rel=r_associated | relid=0 | w=48
  1148. en:oedema -- r_associated #0: 48 / 0.762 -> en:congenital or acquired anatomic abnormality
    n1=en:oedema | n2=en:congenital or acquired anatomic abnormality | rel=r_associated | relid=0 | w=48
  1149. en:oedema -- r_associated #0: 48 / 0.762 -> en:congophilic amyloid material
    n1=en:oedema | n2=en:congophilic amyloid material | rel=r_associated | relid=0 | w=48
  1150. en:oedema -- r_associated #0: 48 / 0.762 -> en:congophilic inclusions
    n1=en:oedema | n2=en:congophilic inclusions | rel=r_associated | relid=0 | w=48
  1151. en:oedema -- r_associated #0: 48 / 0.762 -> en:cord sign
    n1=en:oedema | n2=en:cord sign | rel=r_associated | relid=0 | w=48
  1152. en:oedema -- r_associated #0: 48 / 0.762 -> en:corneal edema
    n1=en:oedema | n2=en:corneal edema | rel=r_associated | relid=0 | w=48
  1153. en:oedema -- r_associated #0: 48 / 0.762 -> en:cough
    n1=en:oedema | n2=en:cough | rel=r_associated | relid=0 | w=48
  1154. en:oedema -- r_associated #0: 48 / 0.762 -> en:cutaneous albinism, tyrosinase-positive
    n1=en:oedema | n2=en:cutaneous albinism, tyrosinase-positive | rel=r_associated | relid=0 | w=48
  1155. en:oedema -- r_associated #0: 48 / 0.762 -> en:cutaneous capillary malformation
    n1=en:oedema | n2=en:cutaneous capillary malformation | rel=r_associated | relid=0 | w=48
  1156. en:oedema -- r_associated #0: 48 / 0.762 -> en:cutaneous vasculitis
    n1=en:oedema | n2=en:cutaneous vasculitis | rel=r_associated | relid=0 | w=48
  1157. en:oedema -- r_associated #0: 48 / 0.762 -> en:cutis aplasia, occipital
    n1=en:oedema | n2=en:cutis aplasia, occipital | rel=r_associated | relid=0 | w=48
  1158. en:oedema -- r_associated #0: 48 / 0.762 -> en:dawbarn's sign
    n1=en:oedema | n2=en:dawbarn's sign | rel=r_associated | relid=0 | w=48
  1159. en:oedema -- r_associated #0: 48 / 0.762 -> en:decreased activities of complexes i and iv
    n1=en:oedema | n2=en:decreased activities of complexes i and iv | rel=r_associated | relid=0 | w=48
  1160. en:oedema -- r_associated #0: 48 / 0.762 -> en:decreased activity of mitochondrial complex i
    n1=en:oedema | n2=en:decreased activity of mitochondrial complex i | rel=r_associated | relid=0 | w=48
  1161. en:oedema -- r_associated #0: 48 / 0.762 -> en:decreased core body temperature
    n1=en:oedema | n2=en:decreased core body temperature | rel=r_associated | relid=0 | w=48
  1162. en:oedema -- r_associated #0: 48 / 0.762 -> en:decreased mitochondrial complex iv activity (in some patients)
    n1=en:oedema | n2=en:decreased mitochondrial complex iv activity (in some patients) | rel=r_associated | relid=0 | w=48
  1163. en:oedema -- r_associated #0: 48 / 0.762 -> en:deep foot creases
    n1=en:oedema | n2=en:deep foot creases | rel=r_associated | relid=0 | w=48
  1164. en:oedema -- r_associated #0: 48 / 0.762 -> en:deep skin ulcers
    n1=en:oedema | n2=en:deep skin ulcers | rel=r_associated | relid=0 | w=48
  1165. en:oedema -- r_associated #0: 48 / 0.762 -> en:defects in mitochondria respiratory activities, mainly complexes i, ii, and iv
    n1=en:oedema | n2=en:defects in mitochondria respiratory activities, mainly complexes i, ii, and iv | rel=r_associated | relid=0 | w=48
  1166. en:oedema -- r_associated #0: 48 / 0.762 -> en:depigmented spots
    n1=en:oedema | n2=en:depigmented spots | rel=r_associated | relid=0 | w=48
  1167. en:oedema -- r_associated #0: 48 / 0.762 -> en:depletion of mitochondrial dna
    n1=en:oedema | n2=en:depletion of mitochondrial dna | rel=r_associated | relid=0 | w=48
  1168. en:oedema -- r_associated #0: 48 / 0.762 -> en:depth of history
    n1=en:oedema | n2=en:depth of history | rel=r_associated | relid=0 | w=48
  1169. en:oedema -- r_associated #0: 48 / 0.762 -> en:dermal translucency
    n1=en:oedema | n2=en:dermal translucency | rel=r_associated | relid=0 | w=48
  1170. en:oedema -- r_associated #0: 48 / 0.762 -> en:dermatitis
    n1=en:oedema | n2=en:dermatitis | rel=r_associated | relid=0 | w=48
  1171. en:oedema -- r_associated #0: 48 / 0.762 -> en:dermatomycoses
    n1=en:oedema | n2=en:dermatomycoses | rel=r_associated | relid=0 | w=48
  1172. en:oedema -- r_associated #0: 48 / 0.762 -> en:dermis
    n1=en:oedema | n2=en:dermis | rel=r_associated | relid=0 | w=48
  1173. en:oedema -- r_associated #0: 48 / 0.762 -> en:diabetic heart disease
    n1=en:oedema | n2=en:diabetic heart disease | rel=r_associated | relid=0 | w=48
  1174. en:oedema -- r_associated #0: 48 / 0.762 -> en:difficulty climbing stairs, jumping, running
    n1=en:oedema | n2=en:difficulty climbing stairs, jumping, running | rel=r_associated | relid=0 | w=48
  1175. en:oedema -- r_associated #0: 48 / 0.762 -> en:difficulty standing
    n1=en:oedema | n2=en:difficulty standing | rel=r_associated | relid=0 | w=48
  1176. en:oedema -- r_associated #0: 48 / 0.762 -> en:difficulty walking up stairs
    n1=en:oedema | n2=en:difficulty walking up stairs | rel=r_associated | relid=0 | w=48
  1177. en:oedema -- r_associated #0: 48 / 0.762 -> en:diminished sweating
    n1=en:oedema | n2=en:diminished sweating | rel=r_associated | relid=0 | w=48
  1178. en:oedema -- r_associated #0: 48 / 0.762 -> en:disorder characterized by edema
    n1=en:oedema | n2=en:disorder characterized by edema | rel=r_associated | relid=0 | w=48
  1179. en:oedema -- r_associated #0: 48 / 0.762 -> en:disorder of pericardium
    n1=en:oedema | n2=en:disorder of pericardium | rel=r_associated | relid=0 | w=48
  1180. en:oedema -- r_associated #0: 48 / 0.762 -> en:disorganization of the myofibrillar pattern
    n1=en:oedema | n2=en:disorganization of the myofibrillar pattern | rel=r_associated | relid=0 | w=48
  1181. en:oedema -- r_associated #0: 48 / 0.762 -> en:disruption in the basal lamina seen on skeletal muscle biopsy
    n1=en:oedema | n2=en:disruption in the basal lamina seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=48
  1182. en:oedema -- r_associated #0: 48 / 0.762 -> en:distal limb muscle weakness due to peripheral neuropathy
    n1=en:oedema | n2=en:distal limb muscle weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=48
  1183. en:oedema -- r_associated #0: 48 / 0.762 -> en:distal muscle weakness and atrophy, upper and lower limbs
    n1=en:oedema | n2=en:distal muscle weakness and atrophy, upper and lower limbs | rel=r_associated | relid=0 | w=48
  1184. en:oedema -- r_associated #0: 48 / 0.762 -> en:distal muscle weakness, mild
    n1=en:oedema | n2=en:distal muscle weakness, mild | rel=r_associated | relid=0 | w=48
  1185. en:oedema -- r_associated #0: 48 / 0.762 -> en:distorted triradii of palmar skin
    n1=en:oedema | n2=en:distorted triradii of palmar skin | rel=r_associated | relid=0 | w=48
  1186. en:oedema -- r_associated #0: 48 / 0.762 -> en:dry palmar skin
    n1=en:oedema | n2=en:dry palmar skin | rel=r_associated | relid=0 | w=48
  1187. en:oedema -- r_associated #0: 48 / 0.762 -> en:duroziez's murmur
    n1=en:oedema | n2=en:duroziez's murmur | rel=r_associated | relid=0 | w=48
  1188. en:oedema -- r_associated #0: 48 / 0.762 -> en:dyspepsia
    n1=en:oedema | n2=en:dyspepsia | rel=r_associated | relid=0 | w=48
  1189. en:oedema -- r_associated #0: 48 / 0.762 -> en:dystrophic features and atrophic fibers seen on muscle biopsy
    n1=en:oedema | n2=en:dystrophic features and atrophic fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=48
  1190. en:oedema -- r_associated #0: 48 / 0.762 -> en:early freckle-like lesions in exposed areas
    n1=en:oedema | n2=en:early freckle-like lesions in exposed areas | rel=r_associated | relid=0 | w=48
  1191. en:oedema -- r_associated #0: 48 / 0.762 -> en:easy fatigability
    n1=en:oedema | n2=en:easy fatigability | rel=r_associated | relid=0 | w=48
  1192. en:oedema -- r_associated #0: 48 / 0.762 -> en:ecchymoses common
    n1=en:oedema | n2=en:ecchymoses common | rel=r_associated | relid=0 | w=48
  1193. en:oedema -- r_associated #0: 48 / 0.762 -> en:ecchymosis
    n1=en:oedema | n2=en:ecchymosis | rel=r_associated | relid=0 | w=48
  1194. en:oedema -- r_associated #0: 48 / 0.762 -> en:ectodermal dysplasia
    n1=en:oedema | n2=en:ectodermal dysplasia | rel=r_associated | relid=0 | w=48
  1195. en:oedema -- r_associated #0: 48 / 0.762 -> en:edema of ear canal
    n1=en:oedema | n2=en:edema of ear canal | rel=r_associated | relid=0 | w=48
  1196. en:oedema -- r_associated #0: 48 / 0.762 -> en:edema of extremity of sudden onset
    n1=en:oedema | n2=en:edema of extremity of sudden onset | rel=r_associated | relid=0 | w=48
  1197. en:oedema -- r_associated #0: 48 / 0.762 -> en:edema of fetal chest wall
    n1=en:oedema | n2=en:edema of fetal chest wall | rel=r_associated | relid=0 | w=48
  1198. en:oedema -- r_associated #0: 48 / 0.762 -> en:edema of fetal scalp
    n1=en:oedema | n2=en:edema of fetal scalp | rel=r_associated | relid=0 | w=48
  1199. en:oedema -- r_associated #0: 48 / 0.762 -> en:edema of forearm
    n1=en:oedema | n2=en:edema of forearm | rel=r_associated | relid=0 | w=48
  1200. en:oedema -- r_associated #0: 48 / 0.762 -> en:edema of sole of foot
    n1=en:oedema | n2=en:edema of sole of foot | rel=r_associated | relid=0 | w=48
  1201. en:oedema -- r_associated #0: 48 / 0.762 -> en:edema, subcutaneous, generalized
    n1=en:oedema | n2=en:edema, subcutaneous, generalized | rel=r_associated | relid=0 | w=48
  1202. en:oedema -- r_associated #0: 48 / 0.762 -> en:effusion
    n1=en:oedema | n2=en:effusion | rel=r_associated | relid=0 | w=48
  1203. en:oedema -- r_associated #0: 48 / 0.762 -> en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae
    n1=en:oedema | n2=en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae | rel=r_associated | relid=0 | w=48
  1204. en:oedema -- r_associated #0: 48 / 0.762 -> en:elevated maternal serum alpha-fetoprotein
    n1=en:oedema | n2=en:elevated maternal serum alpha-fetoprotein | rel=r_associated | relid=0 | w=48
  1205. en:oedema -- r_associated #0: 48 / 0.762 -> en:emg may show neurogenic changes
    n1=en:oedema | n2=en:emg may show neurogenic changes | rel=r_associated | relid=0 | w=48
  1206. en:oedema -- r_associated #0: 48 / 0.762 -> en:emg shows increased insertion activity and fibrillation
    n1=en:oedema | n2=en:emg shows increased insertion activity and fibrillation | rel=r_associated | relid=0 | w=48
  1207. en:oedema -- r_associated #0: 48 / 0.762 -> en:emg shows myotonic changes
    n1=en:oedema | n2=en:emg shows myotonic changes | rel=r_associated | relid=0 | w=48
  1208. en:oedema -- r_associated #0: 48 / 0.762 -> en:enzyme activity finding
    n1=en:oedema | n2=en:enzyme activity finding | rel=r_associated | relid=0 | w=48
  1209. en:oedema -- r_associated #0: 48 / 0.762 -> en:episodic urticaria
    n1=en:oedema | n2=en:episodic urticaria | rel=r_associated | relid=0 | w=48
  1210. en:oedema -- r_associated #0: 48 / 0.762 -> en:erythematous, irregular netlike pattern of vessels
    n1=en:oedema | n2=en:erythematous, irregular netlike pattern of vessels | rel=r_associated | relid=0 | w=48
  1211. en:oedema -- r_associated #0: 48 / 0.762 -> en:eschar formation
    n1=en:oedema | n2=en:eschar formation | rel=r_associated | relid=0 | w=48
  1212. en:oedema -- r_associated #0: 48 / 0.762 -> en:exercise capacity decreased
    n1=en:oedema | n2=en:exercise capacity decreased | rel=r_associated | relid=0 | w=48
  1213. en:oedema -- r_associated #0: 48 / 0.762 -> en:exercise-induced muscle stiffness
    n1=en:oedema | n2=en:exercise-induced muscle stiffness | rel=r_associated | relid=0 | w=48
  1214. en:oedema -- r_associated #0: 48 / 0.762 -> en:extensive fatty infiltration on biopsy
    n1=en:oedema | n2=en:extensive fatty infiltration on biopsy | rel=r_associated | relid=0 | w=48
  1215. en:oedema -- r_associated #0: 48 / 0.762 -> en:extravasation
    n1=en:oedema | n2=en:extravasation | rel=r_associated | relid=0 | w=48
  1216. en:oedema -- r_associated #0: 48 / 0.762 -> en:eye/vision observable
    n1=en:oedema | n2=en:eye/vision observable | rel=r_associated | relid=0 | w=48
  1217. en:oedema -- r_associated #0: 48 / 0.762 -> en:eyelid margin cysts (apocrine hidrocystoma)
    n1=en:oedema | n2=en:eyelid margin cysts (apocrine hidrocystoma) | rel=r_associated | relid=0 | w=48
  1218. en:oedema -- r_associated #0: 48 / 0.762 -> en:facial midline hemangioma
    n1=en:oedema | n2=en:facial midline hemangioma | rel=r_associated | relid=0 | w=48
  1219. en:oedema -- r_associated #0: 48 / 0.762 -> en:fat pads on the hands and feet
    n1=en:oedema | n2=en:fat pads on the hands and feet | rel=r_associated | relid=0 | w=48
  1220. en:oedema -- r_associated #0: 48 / 0.762 -> en:fatty replacement in hip muscles and proximal muscles of the lower limb seen on mri
    n1=en:oedema | n2=en:fatty replacement in hip muscles and proximal muscles of the lower limb seen on mri | rel=r_associated | relid=0 | w=48
  1221. en:oedema -- r_associated #0: 48 / 0.762 -> en:fetal anuria
    n1=en:oedema | n2=en:fetal anuria | rel=r_associated | relid=0 | w=48
  1222. en:oedema -- r_associated #0: 48 / 0.762 -> en:fibrinogen in blood above reference range
    n1=en:oedema | n2=en:fibrinogen in blood above reference range | rel=r_associated | relid=0 | w=48
  1223. en:oedema -- r_associated #0: 48 / 0.762 -> en:fibrosis
    n1=en:oedema | n2=en:fibrosis | rel=r_associated | relid=0 | w=48
  1224. en:oedema -- r_associated #0: 48 / 0.762 -> en:fine whitish scaling on face and trunk
    n1=en:oedema | n2=en:fine whitish scaling on face and trunk | rel=r_associated | relid=0 | w=48
  1225. en:oedema -- r_associated #0: 48 / 0.762 -> en:flexion contractures of hands due to severe hyperkeratosis
    n1=en:oedema | n2=en:flexion contractures of hands due to severe hyperkeratosis | rel=r_associated | relid=0 | w=48
  1226. en:oedema -- r_associated #0: 48 / 0.762 -> en:follicular atrophoderma
    n1=en:oedema | n2=en:follicular atrophoderma | rel=r_associated | relid=0 | w=48
  1227. en:oedema -- r_associated #0: 48 / 0.762 -> en:follicular hyperkeratosis of occipital scalp, nape of neck, and extensor surfaces of upper limbs
    n1=en:oedema | n2=en:follicular hyperkeratosis of occipital scalp, nape of neck, and extensor surfaces of upper limbs | rel=r_associated | relid=0 | w=48
  1228. en:oedema -- r_associated #0: 48 / 0.762 -> en:follicular keratosis, generalized (in some patients)
    n1=en:oedema | n2=en:follicular keratosis, generalized (in some patients) | rel=r_associated | relid=0 | w=48
  1229. en:oedema -- r_associated #0: 48 / 0.762 -> en:folliculitis (back, axilla, pubic region)
    n1=en:oedema | n2=en:folliculitis (back, axilla, pubic region) | rel=r_associated | relid=0 | w=48
  1230. en:oedema -- r_associated #0: 48 / 0.762 -> en:foot callus
    n1=en:oedema | n2=en:foot callus | rel=r_associated | relid=0 | w=48
  1231. en:oedema -- r_associated #0: 48 / 0.762 -> en:fragile skin with atrophic scarring
    n1=en:oedema | n2=en:fragile skin with atrophic scarring | rel=r_associated | relid=0 | w=48
  1232. en:oedema -- r_associated #0: 48 / 0.762 -> en:freckled skin (in some less dark-skinned individuals)
    n1=en:oedema | n2=en:freckled skin (in some less dark-skinned individuals) | rel=r_associated | relid=0 | w=48
  1233. en:oedema -- r_associated #0: 48 / 0.762 -> en:generalized darkening of the skin
    n1=en:oedema | n2=en:generalized darkening of the skin | rel=r_associated | relid=0 | w=48
  1234. en:oedema -- r_associated #0: 48 / 0.762 -> en:generalized swelling/papules/lumps/masses
    n1=en:oedema | n2=en:generalized swelling/papules/lumps/masses | rel=r_associated | relid=0 | w=48
  1235. en:oedema -- r_associated #0: 48 / 0.762 -> en:gesell developmental observation revised score
    n1=en:oedema | n2=en:gesell developmental observation revised score | rel=r_associated | relid=0 | w=48
  1236. en:oedema -- r_associated #0: 48 / 0.762 -> en:gestational edema
    n1=en:oedema | n2=en:gestational edema | rel=r_associated | relid=0 | w=48
  1237. en:oedema -- r_associated #0: 48 / 0.762 -> en:giant granules in muscle cells
    n1=en:oedema | n2=en:giant granules in muscle cells | rel=r_associated | relid=0 | w=48
  1238. en:oedema -- r_associated #0: 48 / 0.762 -> en:gilbert syndrome
    n1=en:oedema | n2=en:gilbert syndrome | rel=r_associated | relid=0 | w=48
  1239. en:oedema -- r_associated #0: 48 / 0.762 -> en:glycogen deficiency in muscle fibers
    n1=en:oedema | n2=en:glycogen deficiency in muscle fibers | rel=r_associated | relid=0 | w=48
  1240. en:oedema -- r_associated #0: 48 / 0.762 -> en:granular deposits in the sarcomeres
    n1=en:oedema | n2=en:granular deposits in the sarcomeres | rel=r_associated | relid=0 | w=48
  1241. en:oedema -- r_associated #0: 48 / 0.762 -> en:graves' disease with pretibial myxedema and with thyrotoxic crisis
    n1=en:oedema | n2=en:graves' disease with pretibial myxedema and with thyrotoxic crisis | rel=r_associated | relid=0 | w=48
  1242. en:oedema -- r_associated #0: 48 / 0.762 -> en:hair observable
    n1=en:oedema | n2=en:hair observable | rel=r_associated | relid=0 | w=48
  1243. en:oedema -- r_associated #0: 48 / 0.762 -> en:heart diseases--prevention
    n1=en:oedema | n2=en:heart diseases--prevention | rel=r_associated | relid=0 | w=48
  1244. en:oedema -- r_associated #0: 48 / 0.762 -> en:hidrocystoma
    n1=en:oedema | n2=en:hidrocystoma | rel=r_associated | relid=0 | w=48
  1245. en:oedema -- r_associated #0: 48 / 0.762 -> en:hyaline deposition in dermis
    n1=en:oedema | n2=en:hyaline deposition in dermis | rel=r_associated | relid=0 | w=48
  1246. en:oedema -- r_associated #0: 48 / 0.762 -> en:hyperchloremia
    n1=en:oedema | n2=en:hyperchloremia | rel=r_associated | relid=0 | w=48
  1247. en:oedema -- r_associated #0: 48 / 0.762 -> en:hyperhidrosis (in some patients)
    n1=en:oedema | n2=en:hyperhidrosis (in some patients) | rel=r_associated | relid=0 | w=48
  1248. en:oedema -- r_associated #0: 48 / 0.762 -> en:hyperkeratosis of the palms (seen in recessive form)
    n1=en:oedema | n2=en:hyperkeratosis of the palms (seen in recessive form) | rel=r_associated | relid=0 | w=48
  1249. en:oedema -- r_associated #0: 48 / 0.762 -> en:hyperkeratotic plaques on anterior knee area (in some patients)
    n1=en:oedema | n2=en:hyperkeratotic plaques on anterior knee area (in some patients) | rel=r_associated | relid=0 | w=48
  1250. en:oedema -- r_associated #0: 48 / 0.762 -> en:hypertension
    n1=en:oedema | n2=en:hypertension | rel=r_associated | relid=0 | w=48
  1251. en:oedema -- r_associated #0: 48 / 0.762 -> en:hypertonia at birth
    n1=en:oedema | n2=en:hypertonia at birth | rel=r_associated | relid=0 | w=48
  1252. en:oedema -- r_associated #0: 48 / 0.762 -> en:hypertrophic scar
    n1=en:oedema | n2=en:hypertrophic scar | rel=r_associated | relid=0 | w=48
  1253. en:oedema -- r_associated #0: 48 / 0.762 -> en:hypohidrosis (in most patients)
    n1=en:oedema | n2=en:hypohidrosis (in most patients) | rel=r_associated | relid=0 | w=48
  1254. en:oedema -- r_associated #0: 48 / 0.762 -> en:hypopigmented skin patch
    n1=en:oedema | n2=en:hypopigmented skin patch | rel=r_associated | relid=0 | w=48
  1255. en:oedema -- r_associated #0: 48 / 0.762 -> en:hypoplastic dermal ridges
    n1=en:oedema | n2=en:hypoplastic dermal ridges | rel=r_associated | relid=0 | w=48
  1256. en:oedema -- r_associated #0: 48 / 0.762 -> en:hypoplastic-absent sebaceous glands
    n1=en:oedema | n2=en:hypoplastic-absent sebaceous glands | rel=r_associated | relid=0 | w=48
  1257. en:oedema -- r_associated #0: 48 / 0.762 -> en:hypotonia (in some patients)
    n1=en:oedema | n2=en:hypotonia (in some patients) | rel=r_associated | relid=0 | w=48
  1258. en:oedema -- r_associated #0: 48 / 0.762 -> en:ichthyosis (in some patients)
    n1=en:oedema | n2=en:ichthyosis (in some patients) | rel=r_associated | relid=0 | w=48
  1259. en:oedema -- r_associated #0: 48 / 0.762 -> en:inability to run
    n1=en:oedema | n2=en:inability to run | rel=r_associated | relid=0 | w=48
  1260. en:oedema -- r_associated #0: 48 / 0.762 -> en:inclusions stain positively with nitroblue tetrazolium (nbt)
    n1=en:oedema | n2=en:inclusions stain positively with nitroblue tetrazolium (nbt) | rel=r_associated | relid=0 | w=48
  1261. en:oedema -- r_associated #0: 48 / 0.762 -> en:incontinence
    n1=en:oedema | n2=en:incontinence | rel=r_associated | relid=0 | w=48
  1262. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased central nucleation
    n1=en:oedema | n2=en:increased central nucleation | rel=r_associated | relid=0 | w=48
  1263. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased internal nuclei in skeletal muscle fibers
    n1=en:oedema | n2=en:increased internal nuclei in skeletal muscle fibers | rel=r_associated | relid=0 | w=48
  1264. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased intraabdominal fat
    n1=en:oedema | n2=en:increased intraabdominal fat | rel=r_associated | relid=0 | w=48
  1265. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased lysosomal glycogen
    n1=en:oedema | n2=en:increased lysosomal glycogen | rel=r_associated | relid=0 | w=48
  1266. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased muscle glycogen content
    n1=en:oedema | n2=en:increased muscle glycogen content | rel=r_associated | relid=0 | w=48
  1267. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased muscle tone at birth
    n1=en:oedema | n2=en:increased muscle tone at birth | rel=r_associated | relid=0 | w=48
  1268. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased numbers of type 1 fibers
    n1=en:oedema | n2=en:increased numbers of type 1 fibers | rel=r_associated | relid=0 | w=48
  1269. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased t-2 signal in muscles of lower extremities on mri (in some patients)
    n1=en:oedema | n2=en:increased t-2 signal in muscles of lower extremities on mri (in some patients) | rel=r_associated | relid=0 | w=48
  1270. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased variability in muscle fiber diameter
    n1=en:oedema | n2=en:increased variability in muscle fiber diameter | rel=r_associated | relid=0 | w=48
  1271. en:oedema -- r_associated #0: 48 / 0.762 -> en:increased variability of fiber size seen on muscle biopsy
    n1=en:oedema | n2=en:increased variability of fiber size seen on muscle biopsy | rel=r_associated | relid=0 | w=48
  1272. en:oedema -- r_associated #0: 48 / 0.762 -> en:infected finger/toe/paronychia
    n1=en:oedema | n2=en:infected finger/toe/paronychia | rel=r_associated | relid=0 | w=48
  1273. en:oedema -- r_associated #0: 48 / 0.762 -> en:inflammatory cells absent
    n1=en:oedema | n2=en:inflammatory cells absent | rel=r_associated | relid=0 | w=48
  1274. en:oedema -- r_associated #0: 48 / 0.762 -> en:inflammatory edema reaction
    n1=en:oedema | n2=en:inflammatory edema reaction | rel=r_associated | relid=0 | w=48
  1275. en:oedema -- r_associated #0: 48 / 0.762 -> en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates
    n1=en:oedema | n2=en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates | rel=r_associated | relid=0 | w=48
  1276. en:oedema -- r_associated #0: 48 / 0.762 -> en:internal nuclei seen on muscle biopsy
    n1=en:oedema | n2=en:internal nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=48
  1277. en:oedema -- r_associated #0: 48 / 0.762 -> en:involves upper and lower proximal muscles
    n1=en:oedema | n2=en:involves upper and lower proximal muscles | rel=r_associated | relid=0 | w=48
  1278. en:oedema -- r_associated #0: 48 / 0.762 -> en:jaundice (1 patient)
    n1=en:oedema | n2=en:jaundice (1 patient) | rel=r_associated | relid=0 | w=48
  1279. en:oedema -- r_associated #0: 48 / 0.762 -> en:jaundice (in some patients)
    n1=en:oedema | n2=en:jaundice (in some patients) | rel=r_associated | relid=0 | w=48
  1280. en:oedema -- r_associated #0: 48 / 0.762 -> en:jaundice due to hemolytic anemia
    n1=en:oedema | n2=en:jaundice due to hemolytic anemia | rel=r_associated | relid=0 | w=48
  1281. en:oedema -- r_associated #0: 48 / 0.762 -> en:jitter
    n1=en:oedema | n2=en:jitter | rel=r_associated | relid=0 | w=48
  1282. en:oedema -- r_associated #0: 48 / 0.762 -> en:juvenile colloid milium
    n1=en:oedema | n2=en:juvenile colloid milium | rel=r_associated | relid=0 | w=48
  1283. en:oedema -- r_associated #0: 48 / 0.762 -> en:keratoderma, mutilating, of palms and soles
    n1=en:oedema | n2=en:keratoderma, mutilating, of palms and soles | rel=r_associated | relid=0 | w=48
  1284. en:oedema -- r_associated #0: 48 / 0.762 -> en:lack of facial subcutaneous fat
    n1=en:oedema | n2=en:lack of facial subcutaneous fat | rel=r_associated | relid=0 | w=48
  1285. en:oedema -- r_associated #0: 48 / 0.762 -> en:lack of perspiration
    n1=en:oedema | n2=en:lack of perspiration | rel=r_associated | relid=0 | w=48
  1286. en:oedema -- r_associated #0: 48 / 0.762 -> en:large nevus (greater than 10 cm)
    n1=en:oedema | n2=en:large nevus (greater than 10 cm) | rel=r_associated | relid=0 | w=48
  1287. en:oedema -- r_associated #0: 48 / 0.762 -> en:lentigines may be congenital or develop in first months to years of life
    n1=en:oedema | n2=en:lentigines may be congenital or develop in first months to years of life | rel=r_associated | relid=0 | w=48
  1288. en:oedema -- r_associated #0: 48 / 0.762 -> en:lesions become soft and paler with age
    n1=en:oedema | n2=en:lesions become soft and paler with age | rel=r_associated | relid=0 | w=48
  1289. en:oedema -- r_associated #0: 48 / 0.762 -> en:lighter skin color
    n1=en:oedema | n2=en:lighter skin color | rel=r_associated | relid=0 | w=48
  1290. en:oedema -- r_associated #0: 48 / 0.762 -> en:limb weakness, proximal followed by distal
    n1=en:oedema | n2=en:limb weakness, proximal followed by distal | rel=r_associated | relid=0 | w=48
  1291. en:oedema -- r_associated #0: 48 / 0.762 -> en:limb-girdle muscle weakness, proximal, upper greater than lower
    n1=en:oedema | n2=en:limb-girdle muscle weakness, proximal, upper greater than lower | rel=r_associated | relid=0 | w=48
  1292. en:oedema -- r_associated #0: 48 / 0.762 -> en:limited dermatologic function
    n1=en:oedema | n2=en:limited dermatologic function | rel=r_associated | relid=0 | w=48
  1293. en:oedema -- r_associated #0: 48 / 0.762 -> en:lipedema
    n1=en:oedema | n2=en:lipedema | rel=r_associated | relid=0 | w=48
  1294. en:oedema -- r_associated #0: 48 / 0.762 -> en:lipoatrophy (lower face, upper limb, buttock)
    n1=en:oedema | n2=en:lipoatrophy (lower face, upper limb, buttock) | rel=r_associated | relid=0 | w=48
  1295. en:oedema -- r_associated #0: 48 / 0.762 -> en:localized edema
    n1=en:oedema | n2=en:localized edema | rel=r_associated | relid=0 | w=48
  1296. en:oedema -- r_associated #0: 48 / 0.762 -> en:loss of ability to walk in early childhood
    n1=en:oedema | n2=en:loss of ability to walk in early childhood | rel=r_associated | relid=0 | w=48
  1297. en:oedema -- r_associated #0: 48 / 0.762 -> en:loss of antigravity strength
    n1=en:oedema | n2=en:loss of antigravity strength | rel=r_associated | relid=0 | w=48
  1298. en:oedema -- r_associated #0: 48 / 0.762 -> en:low maximum workload on exercise testing
    n1=en:oedema | n2=en:low maximum workload on exercise testing | rel=r_associated | relid=0 | w=48
  1299. en:oedema -- r_associated #0: 48 / 0.762 -> en:lower and upper limbs affected
    n1=en:oedema | n2=en:lower and upper limbs affected | rel=r_associated | relid=0 | w=48
  1300. en:oedema -- r_associated #0: 48 / 0.762 -> en:lymphedema of the extremities
    n1=en:oedema | n2=en:lymphedema of the extremities | rel=r_associated | relid=0 | w=48
  1301. en:oedema -- r_associated #0: 48 / 0.762 -> en:lymphedema, hands (rare)
    n1=en:oedema | n2=en:lymphedema, hands (rare) | rel=r_associated | relid=0 | w=48
  1302. en:oedema -- r_associated #0: 48 / 0.762 -> en:lymphography shows hypoplasia of lymphatic vessels
    n1=en:oedema | n2=en:lymphography shows hypoplasia of lymphatic vessels | rel=r_associated | relid=0 | w=48
  1303. en:oedema -- r_associated #0: 48 / 0.762 -> en:macular hemangioma
    n1=en:oedema | n2=en:macular hemangioma | rel=r_associated | relid=0 | w=48
  1304. en:oedema -- r_associated #0: 48 / 0.762 -> en:migratory ichthyosiform dermatosis
    n1=en:oedema | n2=en:migratory ichthyosiform dermatosis | rel=r_associated | relid=0 | w=48
  1305. en:oedema -- r_associated #0: 48 / 0.762 -> en:mild cutaneous changes
    n1=en:oedema | n2=en:mild cutaneous changes | rel=r_associated | relid=0 | w=48
  1306. en:oedema -- r_associated #0: 48 / 0.762 -> en:mild decrease in mitochondrial respiratory chain activity
    n1=en:oedema | n2=en:mild decrease in mitochondrial respiratory chain activity | rel=r_associated | relid=0 | w=48
  1307. en:oedema -- r_associated #0: 48 / 0.762 -> en:mild variability in muscle fiber size
    n1=en:oedema | n2=en:mild variability in muscle fiber size | rel=r_associated | relid=0 | w=48
  1308. en:oedema -- r_associated #0: 48 / 0.762 -> en:milking sign
    n1=en:oedema | n2=en:milking sign | rel=r_associated | relid=0 | w=48
  1309. en:oedema -- r_associated #0: 48 / 0.762 -> en:minicores (in some)
    n1=en:oedema | n2=en:minicores (in some) | rel=r_associated | relid=0 | w=48
  1310. en:oedema -- r_associated #0: 48 / 0.762 -> en:mitochondria dna deletion
    n1=en:oedema | n2=en:mitochondria dna deletion | rel=r_associated | relid=0 | w=48
  1311. en:oedema -- r_associated #0: 48 / 0.762 -> en:mitochondrial dna depletion (in some)
    n1=en:oedema | n2=en:mitochondrial dna depletion (in some) | rel=r_associated | relid=0 | w=48
  1312. en:oedema -- r_associated #0: 48 / 0.762 -> en:mitochondrial dna depletion, severe
    n1=en:oedema | n2=en:mitochondrial dna depletion, severe | rel=r_associated | relid=0 | w=48
  1313. en:oedema -- r_associated #0: 48 / 0.762 -> en:mottled pigmentation
    n1=en:oedema | n2=en:mottled pigmentation | rel=r_associated | relid=0 | w=48
  1314. en:oedema -- r_associated #0: 48 / 0.762 -> en:mottled pigmentation of the trunk and proximal extremities
    n1=en:oedema | n2=en:mottled pigmentation of the trunk and proximal extremities | rel=r_associated | relid=0 | w=48
  1315. en:oedema -- r_associated #0: 48 / 0.762 -> en:multiple lentigines
    n1=en:oedema | n2=en:multiple lentigines | rel=r_associated | relid=0 | w=48
  1316. en:oedema -- r_associated #0: 48 / 0.762 -> en:multiple mitochondrial dna (mtdna) deletions (in most cases)
    n1=en:oedema | n2=en:multiple mitochondrial dna (mtdna) deletions (in most cases) | rel=r_associated | relid=0 | w=48
  1317. en:oedema -- r_associated #0: 48 / 0.762 -> en:multiple skin tags
    n1=en:oedema | n2=en:multiple skin tags | rel=r_associated | relid=0 | w=48
  1318. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle aches, cramps
    n1=en:oedema | n2=en:muscle aches, cramps | rel=r_associated | relid=0 | w=48
  1319. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy may show mild kinetic abnormalities of the achr
    n1=en:oedema | n2=en:muscle biopsy may show mild kinetic abnormalities of the achr | rel=r_associated | relid=0 | w=48
  1320. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy shows abnormal mitochondria
    n1=en:oedema | n2=en:muscle biopsy shows abnormal mitochondria | rel=r_associated | relid=0 | w=48
  1321. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy shows chronic and active denervation
    n1=en:oedema | n2=en:muscle biopsy shows chronic and active denervation | rel=r_associated | relid=0 | w=48
  1322. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy shows decreased postsynaptic areas of clefts and folds
    n1=en:oedema | n2=en:muscle biopsy shows decreased postsynaptic areas of clefts and folds | rel=r_associated | relid=0 | w=48
  1323. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy shows deficiency of mitochondrial respiratory enzymes i, iii, iv, and iv
    n1=en:oedema | n2=en:muscle biopsy shows deficiency of mitochondrial respiratory enzymes i, iii, iv, and iv | rel=r_associated | relid=0 | w=48
  1324. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy shows glycogen storage
    n1=en:oedema | n2=en:muscle biopsy shows glycogen storage | rel=r_associated | relid=0 | w=48
  1325. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy shows hypotrophy of type 1 muscle fibers
    n1=en:oedema | n2=en:muscle biopsy shows hypotrophy of type 1 muscle fibers | rel=r_associated | relid=0 | w=48
  1326. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei
    n1=en:oedema | n2=en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei | rel=r_associated | relid=0 | w=48
  1327. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle biopsy shows variation in fiber size
    n1=en:oedema | n2=en:muscle biopsy shows variation in fiber size | rel=r_associated | relid=0 | w=48
  1328. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle cramps during exercise
    n1=en:oedema | n2=en:muscle cramps during exercise | rel=r_associated | relid=0 | w=48
  1329. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle fiber regeneration
    n1=en:oedema | n2=en:muscle fiber regeneration | rel=r_associated | relid=0 | w=48
  1330. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle fiber splitting (in some patients)
    n1=en:oedema | n2=en:muscle fiber splitting (in some patients) | rel=r_associated | relid=0 | w=48
  1331. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle fiber splitting and fibrosis seen on muscle biopsy
    n1=en:oedema | n2=en:muscle fiber splitting and fibrosis seen on muscle biopsy | rel=r_associated | relid=0 | w=48
  1332. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle fibers are immunoreactive for desmin and vimentin
    n1=en:oedema | n2=en:muscle fibers are immunoreactive for desmin and vimentin | rel=r_associated | relid=0 | w=48
  1333. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle hypertrophy
    n1=en:oedema | n2=en:muscle hypertrophy | rel=r_associated | relid=0 | w=48
  1334. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle hypertrophy (meb)
    n1=en:oedema | n2=en:muscle hypertrophy (meb) | rel=r_associated | relid=0 | w=48
  1335. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle mounding
    n1=en:oedema | n2=en:muscle mounding | rel=r_associated | relid=0 | w=48
  1336. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle pain after exercise
    n1=en:oedema | n2=en:muscle pain after exercise | rel=r_associated | relid=0 | w=48
  1337. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle pain and cramping on exertion
    n1=en:oedema | n2=en:muscle pain and cramping on exertion | rel=r_associated | relid=0 | w=48
  1338. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle stiffness (in older patients)
    n1=en:oedema | n2=en:muscle stiffness (in older patients) | rel=r_associated | relid=0 | w=48
  1339. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle strength and bulk is preserved
    n1=en:oedema | n2=en:muscle strength and bulk is preserved | rel=r_associated | relid=0 | w=48
  1340. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle weakness and atrophy, progressive
    n1=en:oedema | n2=en:muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=48
  1341. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle weakness increases with age
    n1=en:oedema | n2=en:muscle weakness increases with age | rel=r_associated | relid=0 | w=48
  1342. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle weakness of the face and neck, mild to moderate
    n1=en:oedema | n2=en:muscle weakness of the face and neck, mild to moderate | rel=r_associated | relid=0 | w=48
  1343. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle weakness usually does not occur
    n1=en:oedema | n2=en:muscle weakness usually does not occur | rel=r_associated | relid=0 | w=48
  1344. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle weakness, predominantly proximal (in some patients)
    n1=en:oedema | n2=en:muscle weakness, predominantly proximal (in some patients) | rel=r_associated | relid=0 | w=48
  1345. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscle weakness, symmetric, proximal, lower limbs
    n1=en:oedema | n2=en:muscle weakness, symmetric, proximal, lower limbs | rel=r_associated | relid=0 | w=48
  1346. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscular dystrophy
    n1=en:oedema | n2=en:muscular dystrophy | rel=r_associated | relid=0 | w=48
  1347. en:oedema -- r_associated #0: 48 / 0.762 -> en:muscular dystrophy with variable age of onset (infancy to young adult)
    n1=en:oedema | n2=en:muscular dystrophy with variable age of onset (infancy to young adult) | rel=r_associated | relid=0 | w=48
  1348. en:oedema -- r_associated #0: 48 / 0.762 -> en:mutilating skin deformity
    n1=en:oedema | n2=en:mutilating skin deformity | rel=r_associated | relid=0 | w=48
  1349. en:oedema -- r_associated #0: 48 / 0.762 -> en:myofibrillar myopathy
    n1=en:oedema | n2=en:myofibrillar myopathy | rel=r_associated | relid=0 | w=48
  1350. en:oedema -- r_associated #0: 48 / 0.762 -> en:myopathy
    n1=en:oedema | n2=en:myopathy | rel=r_associated | relid=0 | w=48
  1351. en:oedema -- r_associated #0: 48 / 0.762 -> en:myotonia
    n1=en:oedema | n2=en:myotonia | rel=r_associated | relid=0 | w=48
  1352. en:oedema -- r_associated #0: 48 / 0.762 -> en:myotonia improves with continued activity ('warm-up phenomenon')
    n1=en:oedema | n2=en:myotonia improves with continued activity ('warm-up phenomenon') | rel=r_associated | relid=0 | w=48
  1353. en:oedema -- r_associated #0: 48 / 0.762 -> en:myotonia seen on emg
    n1=en:oedema | n2=en:myotonia seen on emg | rel=r_associated | relid=0 | w=48
  1354. en:oedema -- r_associated #0: 48 / 0.762 -> en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise
    n1=en:oedema | n2=en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise | rel=r_associated | relid=0 | w=48
  1355. en:oedema -- r_associated #0: 48 / 0.762 -> en:named sign of anus
    n1=en:oedema | n2=en:named sign of anus | rel=r_associated | relid=0 | w=48
  1356. en:oedema -- r_associated #0: 48 / 0.762 -> en:named sign of balance
    n1=en:oedema | n2=en:named sign of balance | rel=r_associated | relid=0 | w=48
  1357. en:oedema -- r_associated #0: 48 / 0.762 -> en:named sign of coordination
    n1=en:oedema | n2=en:named sign of coordination | rel=r_associated | relid=0 | w=48
  1358. en:oedema -- r_associated #0: 48 / 0.762 -> en:named sign of heart
    n1=en:oedema | n2=en:named sign of heart | rel=r_associated | relid=0 | w=48
  1359. en:oedema -- r_associated #0: 48 / 0.762 -> en:named sign of skeletal muscle
    n1=en:oedema | n2=en:named sign of skeletal muscle | rel=r_associated | relid=0 | w=48
  1360. en:oedema -- r_associated #0: 48 / 0.762 -> en:nemaline rods may be observed
    n1=en:oedema | n2=en:nemaline rods may be observed | rel=r_associated | relid=0 | w=48
  1361. en:oedema -- r_associated #0: 48 / 0.762 -> en:neonatal blisters and erosions
    n1=en:oedema | n2=en:neonatal blisters and erosions | rel=r_associated | relid=0 | w=48
  1362. en:oedema -- r_associated #0: 48 / 0.762 -> en:neonatal cyanosis
    n1=en:oedema | n2=en:neonatal cyanosis | rel=r_associated | relid=0 | w=48
  1363. en:oedema -- r_associated #0: 48 / 0.762 -> en:neonatal hypertonias
    n1=en:oedema | n2=en:neonatal hypertonias | rel=r_associated | relid=0 | w=48
  1364. en:oedema -- r_associated #0: 48 / 0.762 -> en:nephrotic syndrome, type 3
    n1=en:oedema | n2=en:nephrotic syndrome, type 3 | rel=r_associated | relid=0 | w=48
  1365. en:oedema -- r_associated #0: 48 / 0.762 -> en:nerve conduction studies normal
    n1=en:oedema | n2=en:nerve conduction studies normal | rel=r_associated | relid=0 | w=48
  1366. en:oedema -- r_associated #0: 48 / 0.762 -> en:no erythema
    n1=en:oedema | n2=en:no erythema | rel=r_associated | relid=0 | w=48
  1367. en:oedema -- r_associated #0: 48 / 0.762 -> en:no increased bruisability
    n1=en:oedema | n2=en:no increased bruisability | rel=r_associated | relid=0 | w=48
  1368. en:oedema -- r_associated #0: 48 / 0.762 -> en:no scarring
    n1=en:oedema | n2=en:no scarring | rel=r_associated | relid=0 | w=48
  1369. en:oedema -- r_associated #0: 48 / 0.762 -> en:non-high-risk proliferative diabetic retinopathy with clinically significant macular edema
    n1=en:oedema | n2=en:non-high-risk proliferative diabetic retinopathy with clinically significant macular edema | rel=r_associated | relid=0 | w=48
  1370. en:oedema -- r_associated #0: 48 / 0.762 -> en:nonmelanoma skin cancer (in some patients)
    n1=en:oedema | n2=en:nonmelanoma skin cancer (in some patients) | rel=r_associated | relid=0 | w=48
  1371. en:oedema -- r_associated #0: 48 / 0.762 -> en:normal or decreased facial and neck adipose tissue
    n1=en:oedema | n2=en:normal or decreased facial and neck adipose tissue | rel=r_associated | relid=0 | w=48
  1372. en:oedema -- r_associated #0: 48 / 0.762 -> en:normal or increased facial and neck adipose tissue
    n1=en:oedema | n2=en:normal or increased facial and neck adipose tissue | rel=r_associated | relid=0 | w=48
  1373. en:oedema -- r_associated #0: 48 / 0.762 -> en:normal or increased truncal adipose tissue
    n1=en:oedema | n2=en:normal or increased truncal adipose tissue | rel=r_associated | relid=0 | w=48
  1374. en:oedema -- r_associated #0: 48 / 0.762 -> en:normal skin
    n1=en:oedema | n2=en:normal skin | rel=r_associated | relid=0 | w=48
  1375. en:oedema -- r_associated #0: 48 / 0.762 -> en:normal skin (no palmoplantar keratoderma)
    n1=en:oedema | n2=en:normal skin (no palmoplantar keratoderma) | rel=r_associated | relid=0 | w=48
  1376. en:oedema -- r_associated #0: 48 / 0.762 -> en:normal sweat glands
    n1=en:oedema | n2=en:normal sweat glands | rel=r_associated | relid=0 | w=48
  1377. en:oedema -- r_associated #0: 48 / 0.762 -> en:nutritional management
    n1=en:oedema | n2=en:nutritional management | rel=r_associated | relid=0 | w=48
  1378. en:oedema -- r_associated #0: 48 / 0.762 -> en:o/e - edema of ankles
    n1=en:oedema | n2=en:o/e - edema of ankles | rel=r_associated | relid=0 | w=48
  1379. en:oedema -- r_associated #0: 48 / 0.762 -> en:o/e - periorbital edema
    n1=en:oedema | n2=en:o/e - periorbital edema | rel=r_associated | relid=0 | w=48
  1380. en:oedema -- r_associated #0: 48 / 0.762 -> en:occasional cafe-au-lait spots
    n1=en:oedema | n2=en:occasional cafe-au-lait spots | rel=r_associated | relid=0 | w=48
  1381. en:oedema -- r_associated #0: 48 / 0.762 -> en:odoriferous,, hypertrophic plaques
    n1=en:oedema | n2=en:odoriferous,, hypertrophic plaques | rel=r_associated | relid=0 | w=48
  1382. en:oedema -- r_associated #0: 48 / 0.762 -> en:oedema due to hepatic disease
    n1=en:oedema | n2=en:oedema due to hepatic disease | rel=r_associated | relid=0 | w=48
  1383. en:oedema -- r_associated #0: 48 / 0.762 -> en:oligohydramnios in some cases
    n1=en:oedema | n2=en:oligohydramnios in some cases | rel=r_associated | relid=0 | w=48
  1384. en:oedema -- r_associated #0: 48 / 0.762 -> en:oligohydramnios, severe
    n1=en:oedema | n2=en:oligohydramnios, severe | rel=r_associated | relid=0 | w=48
  1385. en:oedema -- r_associated #0: 48 / 0.762 -> en:omega sign (skin finding)
    n1=en:oedema | n2=en:omega sign (skin finding) | rel=r_associated | relid=0 | w=48
  1386. en:oedema -- r_associated #0: 48 / 0.762 -> en:onset birth-newborn period
    n1=en:oedema | n2=en:onset birth-newborn period | rel=r_associated | relid=0 | w=48
  1387. en:oedema -- r_associated #0: 48 / 0.762 -> en:onset of lymphedema around puberty
    n1=en:oedema | n2=en:onset of lymphedema around puberty | rel=r_associated | relid=0 | w=48
  1388. en:oedema -- r_associated #0: 48 / 0.762 -> en:other symptoms involving abdomen and pelvis
    n1=en:oedema | n2=en:other symptoms involving abdomen and pelvis | rel=r_associated | relid=0 | w=48
  1389. en:oedema -- r_associated #0: 48 / 0.762 -> en:overhydration
    n1=en:oedema | n2=en:overhydration | rel=r_associated | relid=0 | w=48
  1390. en:oedema -- r_associated #0: 48 / 0.762 -> en:overlapping lesion of skin
    n1=en:oedema | n2=en:overlapping lesion of skin | rel=r_associated | relid=0 | w=48
  1391. en:oedema -- r_associated #0: 48 / 0.762 -> en:pallor and flushing
    n1=en:oedema | n2=en:pallor and flushing | rel=r_associated | relid=0 | w=48
  1392. en:oedema -- r_associated #0: 48 / 0.762 -> en:palmoplantar hyperhidrosis (in some patients)
    n1=en:oedema | n2=en:palmoplantar hyperhidrosis (in some patients) | rel=r_associated | relid=0 | w=48
  1393. en:oedema -- r_associated #0: 48 / 0.762 -> en:palmoplantar hyperlinearity, marked
    n1=en:oedema | n2=en:palmoplantar hyperlinearity, marked | rel=r_associated | relid=0 | w=48
  1394. en:oedema -- r_associated #0: 48 / 0.762 -> en:palmoplantar keratoderma, diffuse (in some patients)
    n1=en:oedema | n2=en:palmoplantar keratoderma, diffuse (in some patients) | rel=r_associated | relid=0 | w=48
  1395. en:oedema -- r_associated #0: 48 / 0.762 -> en:palmoplantar pits
    n1=en:oedema | n2=en:palmoplantar pits | rel=r_associated | relid=0 | w=48
  1396. en:oedema -- r_associated #0: 48 / 0.762 -> en:papilledema associated with retinal disorder
    n1=en:oedema | n2=en:papilledema associated with retinal disorder | rel=r_associated | relid=0 | w=48
  1397. en:oedema -- r_associated #0: 48 / 0.762 -> en:papillomatosis of affected area
    n1=en:oedema | n2=en:papillomatosis of affected area | rel=r_associated | relid=0 | w=48
  1398. en:oedema -- r_associated #0: 48 / 0.762 -> en:parasitology
    n1=en:oedema | n2=en:parasitology | rel=r_associated | relid=0 | w=48
  1399. en:oedema -- r_associated #0: 48 / 0.762 -> en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue)
    n1=en:oedema | n2=en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue) | rel=r_associated | relid=0 | w=48
  1400. en:oedema -- r_associated #0: 48 / 0.762 -> en:patients achieve independent ambulation, but may lose it
    n1=en:oedema | n2=en:patients achieve independent ambulation, but may lose it | rel=r_associated | relid=0 | w=48
  1401. en:oedema -- r_associated #0: 48 / 0.762 -> en:pelvic muscle involvement occurs later
    n1=en:oedema | n2=en:pelvic muscle involvement occurs later | rel=r_associated | relid=0 | w=48
  1402. en:oedema -- r_associated #0: 48 / 0.762 -> en:perianal erythema
    n1=en:oedema | n2=en:perianal erythema | rel=r_associated | relid=0 | w=48
  1403. en:oedema -- r_associated #0: 48 / 0.762 -> en:personality change
    n1=en:oedema | n2=en:personality change | rel=r_associated | relid=0 | w=48
  1404. en:oedema -- r_associated #0: 48 / 0.762 -> en:physical findings:find:pt:macula.left:nom:ophthalmoscopy
    n1=en:oedema | n2=en:physical findings:find:pt:macula.left:nom:ophthalmoscopy | rel=r_associated | relid=0 | w=48
  1405. en:oedema -- r_associated #0: 48 / 0.762 -> en:pilo-sebaceous apparatus
    n1=en:oedema | n2=en:pilo-sebaceous apparatus | rel=r_associated | relid=0 | w=48
  1406. en:oedema -- r_associated #0: 48 / 0.762 -> en:pilonidal cyst/fistula
    n1=en:oedema | n2=en:pilonidal cyst/fistula | rel=r_associated | relid=0 | w=48
  1407. en:oedema -- r_associated #0: 48 / 0.762 -> en:pityriasis alba
    n1=en:oedema | n2=en:pityriasis alba | rel=r_associated | relid=0 | w=48
  1408. en:oedema -- r_associated #0: 48 / 0.762 -> en:placenta edematous
    n1=en:oedema | n2=en:placenta edematous | rel=r_associated | relid=0 | w=48
  1409. en:oedema -- r_associated #0: 48 / 0.762 -> en:planar xanthomas (detroit type 107680.0011)
    n1=en:oedema | n2=en:planar xanthomas (detroit type 107680.0011) | rel=r_associated | relid=0 | w=48
  1410. en:oedema -- r_associated #0: 48 / 0.762 -> en:plantar keratoderma (in some patients)
    n1=en:oedema | n2=en:plantar keratoderma (in some patients) | rel=r_associated | relid=0 | w=48
  1411. en:oedema -- r_associated #0: 48 / 0.762 -> en:polyhydramnios (congenital form)
    n1=en:oedema | n2=en:polyhydramnios (congenital form) | rel=r_associated | relid=0 | w=48
  1412. en:oedema -- r_associated #0: 48 / 0.762 -> en:polyhydramnios (severe form)
    n1=en:oedema | n2=en:polyhydramnios (severe form) | rel=r_associated | relid=0 | w=48
  1413. en:oedema -- r_associated #0: 48 / 0.762 -> en:popeye sign
    n1=en:oedema | n2=en:popeye sign | rel=r_associated | relid=0 | w=48
  1414. en:oedema -- r_associated #0: 48 / 0.762 -> en:popliteal pterygium, bilateral
    n1=en:oedema | n2=en:popliteal pterygium, bilateral | rel=r_associated | relid=0 | w=48
  1415. en:oedema -- r_associated #0: 48 / 0.762 -> en:porokeratosis
    n1=en:oedema | n2=en:porokeratosis | rel=r_associated | relid=0 | w=48
  1416. en:oedema -- r_associated #0: 48 / 0.762 -> en:postoperative pulmonary edema
    n1=en:oedema | n2=en:postoperative pulmonary edema | rel=r_associated | relid=0 | w=48
  1417. en:oedema -- r_associated #0: 48 / 0.762 -> en:pregnancy, childbirth / puerperium observable
    n1=en:oedema | n2=en:pregnancy, childbirth / puerperium observable | rel=r_associated | relid=0 | w=48
  1418. en:oedema -- r_associated #0: 48 / 0.762 -> en:premature aging syndrome
    n1=en:oedema | n2=en:premature aging syndrome | rel=r_associated | relid=0 | w=48
  1419. en:oedema -- r_associated #0: 48 / 0.762 -> en:presyncope
    n1=en:oedema | n2=en:presyncope | rel=r_associated | relid=0 | w=48
  1420. en:oedema -- r_associated #0: 48 / 0.762 -> en:progressive distal and proximal symmetric limb weakness
    n1=en:oedema | n2=en:progressive distal and proximal symmetric limb weakness | rel=r_associated | relid=0 | w=48
  1421. en:oedema -- r_associated #0: 48 / 0.762 -> en:proliferating cells show nuclear expression of lymphoid enhancer binding factor-1 (lef1, 153245)
    n1=en:oedema | n2=en:proliferating cells show nuclear expression of lymphoid enhancer binding factor-1 (lef1, 153245) | rel=r_associated | relid=0 | w=48
  1422. en:oedema -- r_associated #0: 48 / 0.762 -> en:proliferative diabetic retinopathy - high risk with clinically significant macular edema
    n1=en:oedema | n2=en:proliferative diabetic retinopathy - high risk with clinically significant macular edema | rel=r_associated | relid=0 | w=48
  1423. en:oedema -- r_associated #0: 48 / 0.762 -> en:prolonged capillary refill
    n1=en:oedema | n2=en:prolonged capillary refill | rel=r_associated | relid=0 | w=48
  1424. en:oedema -- r_associated #0: 48 / 0.762 -> en:proximal amyotrophy
    n1=en:oedema | n2=en:proximal amyotrophy | rel=r_associated | relid=0 | w=48
  1425. en:oedema -- r_associated #0: 48 / 0.762 -> en:proximal and distal muscle atrophy in lower limbs
    n1=en:oedema | n2=en:proximal and distal muscle atrophy in lower limbs | rel=r_associated | relid=0 | w=48
  1426. en:oedema -- r_associated #0: 48 / 0.762 -> en:pruritic hyperkeratotic scars (in some patients)
    n1=en:oedema | n2=en:pruritic hyperkeratotic scars (in some patients) | rel=r_associated | relid=0 | w=48
  1427. en:oedema -- r_associated #0: 48 / 0.762 -> en:pseudoainhum of fifth toes
    n1=en:oedema | n2=en:pseudoainhum of fifth toes | rel=r_associated | relid=0 | w=48
  1428. en:oedema -- r_associated #0: 48 / 0.762 -> en:psoriasiform skin lesions
    n1=en:oedema | n2=en:psoriasiform skin lesions | rel=r_associated | relid=0 | w=48
  1429. en:oedema -- r_associated #0: 48 / 0.762 -> en:pterygium (elbows and knees)
    n1=en:oedema | n2=en:pterygium (elbows and knees) | rel=r_associated | relid=0 | w=48
  1430. en:oedema -- r_associated #0: 48 / 0.762 -> en:punch-like skin defects
    n1=en:oedema | n2=en:punch-like skin defects | rel=r_associated | relid=0 | w=48
  1431. en:oedema -- r_associated #0: 48 / 0.762 -> en:punctate keratitis
    n1=en:oedema | n2=en:punctate keratitis | rel=r_associated | relid=0 | w=48
  1432. en:oedema -- r_associated #0: 48 / 0.762 -> en:punctate keratoses (palms and soles)
    n1=en:oedema | n2=en:punctate keratoses (palms and soles) | rel=r_associated | relid=0 | w=48
  1433. en:oedema -- r_associated #0: 48 / 0.762 -> en:pyrogenic reaction
    n1=en:oedema | n2=en:pyrogenic reaction | rel=r_associated | relid=0 | w=48
  1434. en:oedema -- r_associated #0: 48 / 0.762 -> en:quadriceps muscle spared
    n1=en:oedema | n2=en:quadriceps muscle spared | rel=r_associated | relid=0 | w=48
  1435. en:oedema -- r_associated #0: 48 / 0.762 -> en:rare disorder
    n1=en:oedema | n2=en:rare disorder | rel=r_associated | relid=0 | w=48
  1436. en:oedema -- r_associated #0: 48 / 0.762 -> en:rare necrotic fibers
    n1=en:oedema | n2=en:rare necrotic fibers | rel=r_associated | relid=0 | w=48
  1437. en:oedema -- r_associated #0: 48 / 0.762 -> en:rash, episodic
    n1=en:oedema | n2=en:rash, episodic | rel=r_associated | relid=0 | w=48
  1438. en:oedema -- r_associated #0: 48 / 0.762 -> en:raynaud phenomenon (in some patients)
    n1=en:oedema | n2=en:raynaud phenomenon (in some patients) | rel=r_associated | relid=0 | w=48
  1439. en:oedema -- r_associated #0: 48 / 0.762 -> en:reason for nonvaccination
    n1=en:oedema | n2=en:reason for nonvaccination | rel=r_associated | relid=0 | w=48
  1440. en:oedema -- r_associated #0: 48 / 0.762 -> en:recurrent inflammatory breast carcinoma
    n1=en:oedema | n2=en:recurrent inflammatory breast carcinoma | rel=r_associated | relid=0 | w=48
  1441. en:oedema -- r_associated #0: 48 / 0.762 -> en:red-ragged fibers (2p21del)
    n1=en:oedema | n2=en:red-ragged fibers (2p21del) | rel=r_associated | relid=0 | w=48
  1442. en:oedema -- r_associated #0: 48 / 0.762 -> en:redundant skin in infancy
    n1=en:oedema | n2=en:redundant skin in infancy | rel=r_associated | relid=0 | w=48
  1443. en:oedema -- r_associated #0: 48 / 0.762 -> en:relative muscle weakness, especially in pelvic girdle
    n1=en:oedema | n2=en:relative muscle weakness, especially in pelvic girdle | rel=r_associated | relid=0 | w=48
  1444. en:oedema -- r_associated #0: 48 / 0.762 -> en:relative sparing of the rectus femoris
    n1=en:oedema | n2=en:relative sparing of the rectus femoris | rel=r_associated | relid=0 | w=48
  1445. en:oedema -- r_associated #0: 48 / 0.762 -> en:residual postinflammatory hyperpigmentation, moderate
    n1=en:oedema | n2=en:residual postinflammatory hyperpigmentation, moderate | rel=r_associated | relid=0 | w=48
  1446. en:oedema -- r_associated #0: 48 / 0.762 -> en:reticulate hyperpigmentation (primarily trunk)
    n1=en:oedema | n2=en:reticulate hyperpigmentation (primarily trunk) | rel=r_associated | relid=0 | w=48
  1447. en:oedema -- r_associated #0: 48 / 0.762 -> en:reticulate hyperpigmented macules which darken over time and appear initially on dorsa of hands and feet but progress to flexor aspects of proximal extremities
    n1=en:oedema | n2=en:reticulate hyperpigmented macules which darken over time and appear initially on dorsa of hands and feet but progress to flexor aspects of proximal extremities | rel=r_associated | relid=0 | w=48
  1448. en:oedema -- r_associated #0: 48 / 0.762 -> en:reticulate ichthyosis (in some patients)
    n1=en:oedema | n2=en:reticulate ichthyosis (in some patients) | rel=r_associated | relid=0 | w=48
  1449. en:oedema -- r_associated #0: 48 / 0.762 -> en:ring fibers
    n1=en:oedema | n2=en:ring fibers | rel=r_associated | relid=0 | w=48
  1450. en:oedema -- r_associated #0: 48 / 0.762 -> en:rubbery feel of the nose and chin
    n1=en:oedema | n2=en:rubbery feel of the nose and chin | rel=r_associated | relid=0 | w=48
  1451. en:oedema -- r_associated #0: 48 / 0.762 -> en:sacral dimple
    n1=en:oedema | n2=en:sacral dimple | rel=r_associated | relid=0 | w=48
  1452. en:oedema -- r_associated #0: 48 / 0.762 -> en:scales on scalp (in some patients)
    n1=en:oedema | n2=en:scales on scalp (in some patients) | rel=r_associated | relid=0 | w=48
  1453. en:oedema -- r_associated #0: 48 / 0.762 -> en:scaly skin rash over the perineum
    n1=en:oedema | n2=en:scaly skin rash over the perineum | rel=r_associated | relid=0 | w=48
  1454. en:oedema -- r_associated #0: 48 / 0.762 -> en:schwannoma
    n1=en:oedema | n2=en:schwannoma | rel=r_associated | relid=0 | w=48
  1455. en:oedema -- r_associated #0: 48 / 0.762 -> en:sebaceous gland tumors
    n1=en:oedema | n2=en:sebaceous gland tumors | rel=r_associated | relid=0 | w=48
  1456. en:oedema -- r_associated #0: 48 / 0.762 -> en:sebaceous hyperplasia
    n1=en:oedema | n2=en:sebaceous hyperplasia | rel=r_associated | relid=0 | w=48
  1457. en:oedema -- r_associated #0: 48 / 0.762 -> en:secondary hypertrophy
    n1=en:oedema | n2=en:secondary hypertrophy | rel=r_associated | relid=0 | w=48
  1458. en:oedema -- r_associated #0: 48 / 0.762 -> en:self-healing collodion baby (in some patients)
    n1=en:oedema | n2=en:self-healing collodion baby (in some patients) | rel=r_associated | relid=0 | w=48
  1459. en:oedema -- r_associated #0: 48 / 0.762 -> en:severe muscle hypotonia at birth
    n1=en:oedema | n2=en:severe muscle hypotonia at birth | rel=r_associated | relid=0 | w=48
  1460. en:oedema -- r_associated #0: 48 / 0.762 -> en:severe muscular hypotonia
    n1=en:oedema | n2=en:severe muscular hypotonia | rel=r_associated | relid=0 | w=48
  1461. en:oedema -- r_associated #0: 48 / 0.762 -> en:shallow indolent cutaneous ulcers (in some patients)
    n1=en:oedema | n2=en:shallow indolent cutaneous ulcers (in some patients) | rel=r_associated | relid=0 | w=48
  1462. en:oedema -- r_associated #0: 48 / 0.762 -> en:shortening of various muscle-tendon groups in legs
    n1=en:oedema | n2=en:shortening of various muscle-tendon groups in legs | rel=r_associated | relid=0 | w=48
  1463. en:oedema -- r_associated #0: 48 / 0.762 -> en:shoulder-pad sign
    n1=en:oedema | n2=en:shoulder-pad sign | rel=r_associated | relid=0 | w=48
  1464. en:oedema -- r_associated #0: 48 / 0.762 -> en:sign or symptom
    n1=en:oedema | n2=en:sign or symptom | rel=r_associated | relid=0 | w=48
  1465. en:oedema -- r_associated #0: 48 / 0.762 -> en:signs of denervation seen on biopsy
    n1=en:oedema | n2=en:signs of denervation seen on biopsy | rel=r_associated | relid=0 | w=48
  1466. en:oedema -- r_associated #0: 48 / 0.762 -> en:skeletal muscle biopsy shows impaired respiratory oxidation
    n1=en:oedema | n2=en:skeletal muscle biopsy shows impaired respiratory oxidation | rel=r_associated | relid=0 | w=48
  1467. en:oedema -- r_associated #0: 48 / 0.762 -> en:skeletal muscle shows dystrophic changes
    n1=en:oedema | n2=en:skeletal muscle shows dystrophic changes | rel=r_associated | relid=0 | w=48
  1468. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin
    n1=en:oedema | n2=en:skin | rel=r_associated | relid=0 | w=48
  1469. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin blisters and erosions (neck, perianal, submaxillary, groin, axilla, popliteal fossa)
    n1=en:oedema | n2=en:skin blisters and erosions (neck, perianal, submaxillary, groin, axilla, popliteal fossa) | rel=r_associated | relid=0 | w=48
  1470. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin flushing, episodic, associated with pain
    n1=en:oedema | n2=en:skin flushing, episodic, associated with pain | rel=r_associated | relid=0 | w=48
  1471. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin hyperpigmentation
    n1=en:oedema | n2=en:skin hyperpigmentation | rel=r_associated | relid=0 | w=48
  1472. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin lesions follow the lines of blaschko
    n1=en:oedema | n2=en:skin lesions follow the lines of blaschko | rel=r_associated | relid=0 | w=48
  1473. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin manifestations
    n1=en:oedema | n2=en:skin manifestations | rel=r_associated | relid=0 | w=48
  1474. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin mottling due to poor perfusion
    n1=en:oedema | n2=en:skin mottling due to poor perfusion | rel=r_associated | relid=0 | w=48
  1475. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin of the lip
    n1=en:oedema | n2=en:skin of the lip | rel=r_associated | relid=0 | w=48
  1476. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin part
    n1=en:oedema | n2=en:skin part | rel=r_associated | relid=0 | w=48
  1477. en:oedema -- r_associated #0: 48 / 0.762 -> en:skin tags on genitalia (in some patients)
    n1=en:oedema | n2=en:skin tags on genitalia (in some patients) | rel=r_associated | relid=0 | w=48
  1478. en:oedema -- r_associated #0: 48 / 0.762 -> en:slim, muscular build (in some patients)
    n1=en:oedema | n2=en:slim, muscular build (in some patients) | rel=r_associated | relid=0 | w=48
  1479. en:oedema -- r_associated #0: 48 / 0.762 -> en:slow motor responses to sudden events (i.e., falling)
    n1=en:oedema | n2=en:slow motor responses to sudden events (i.e., falling) | rel=r_associated | relid=0 | w=48
  1480. en:oedema -- r_associated #0: 48 / 0.762 -> en:small areas of alopecia
    n1=en:oedema | n2=en:small areas of alopecia | rel=r_associated | relid=0 | w=48
  1481. en:oedema -- r_associated #0: 48 / 0.762 -> en:small conically shaped papules (1 to 3 mm in diameter) located on face, neck, trunk, and limbs
    n1=en:oedema | n2=en:small conically shaped papules (1 to 3 mm in diameter) located on face, neck, trunk, and limbs | rel=r_associated | relid=0 | w=48
  1482. en:oedema -- r_associated #0: 48 / 0.762 -> en:smooth, waxy, thick skin over palms and soles, desquamating in large flakes
    n1=en:oedema | n2=en:smooth, waxy, thick skin over palms and soles, desquamating in large flakes | rel=r_associated | relid=0 | w=48
  1483. en:oedema -- r_associated #0: 48 / 0.762 -> en:sodium bicarbonate
    n1=en:oedema | n2=en:sodium bicarbonate | rel=r_associated | relid=0 | w=48
  1484. en:oedema -- r_associated #0: 48 / 0.762 -> en:sodium bicarbonate 5% injection solution ampule
    n1=en:oedema | n2=en:sodium bicarbonate 5% injection solution ampule | rel=r_associated | relid=0 | w=48
  1485. en:oedema -- r_associated #0: 48 / 0.762 -> en:sodium chloride 0.0684 meq/ml nasal solution
    n1=en:oedema | n2=en:sodium chloride 0.0684 meq/ml nasal solution | rel=r_associated | relid=0 | w=48
  1486. en:oedema -- r_associated #0: 48 / 0.762 -> en:sodium chloride 0.0855 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium chloride 0.0855 meq/ml injectable solution | rel=r_associated | relid=0 | w=48
  1487. en:oedema -- r_associated #0: 48 / 0.762 -> en:sodium chloride 0.154 meq/ml inhalant solution [nebu-sol]
    n1=en:oedema | n2=en:sodium chloride 0.154 meq/ml inhalant solution [nebu-sol] | rel=r_associated | relid=0 | w=48
  1488. en:oedema -- r_associated #0: 48 / 0.762 -> en:sodium chloride 0.45g/100 ml injection solution 1000ml bag
    n1=en:oedema | n2=en:sodium chloride 0.45g/100 ml injection solution 1000ml bag | rel=r_associated | relid=0 | w=48
  1489. en:oedema -- r_associated #0: 48 / 0.762 -> en:sodium chloride 0.513 meq/ml inhalant solution
    n1=en:oedema | n2=en:sodium chloride 0.513 meq/ml inhalant solution | rel=r_associated | relid=0 | w=48
  1490. en:oedema -- r_associated #0: 48 / 0.762 -> en:sodium chloride 0.9% nose drops
    n1=en:oedema | n2=en:sodium chloride 0.9% nose drops | rel=r_associated | relid=0 | w=48
  1491. en:oedema -- r_associated #0: 48 / 0.762 -> en:soft skin
    n1=en:oedema | n2=en:soft skin | rel=r_associated | relid=0 | w=48
  1492. en:oedema -- r_associated #0: 48 / 0.762 -> en:soft thin skin
    n1=en:oedema | n2=en:soft thin skin | rel=r_associated | relid=0 | w=48
  1493. en:oedema -- r_associated #0: 48 / 0.762 -> en:sparing of the anterior tibial compartment
    n1=en:oedema | n2=en:sparing of the anterior tibial compartment | rel=r_associated | relid=0 | w=48
  1494. en:oedema -- r_associated #0: 48 / 0.762 -> en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy')
    n1=en:oedema | n2=en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy') | rel=r_associated | relid=0 | w=48
  1495. en:oedema -- r_associated #0: 48 / 0.762 -> en:spontaneous hematomas
    n1=en:oedema | n2=en:spontaneous hematomas | rel=r_associated | relid=0 | w=48
  1496. en:oedema -- r_associated #0: 48 / 0.762 -> en:squamous pityriasiform appearance of scalp
    n1=en:oedema | n2=en:squamous pityriasiform appearance of scalp | rel=r_associated | relid=0 | w=48
  1497. en:oedema -- r_associated #0: 48 / 0.762 -> en:stage iiib inflammatory breast carcinoma
    n1=en:oedema | n2=en:stage iiib inflammatory breast carcinoma | rel=r_associated | relid=0 | w=48
  1498. en:oedema -- r_associated #0: 48 / 0.762 -> en:sterile abscesses at site of parenteral injection
    n1=en:oedema | n2=en:sterile abscesses at site of parenteral injection | rel=r_associated | relid=0 | w=48
  1499. en:oedema -- r_associated #0: 48 / 0.762 -> en:stiffness
    n1=en:oedema | n2=en:stiffness | rel=r_associated | relid=0 | w=48
  1500. en:oedema -- r_associated #0: 48 / 0.762 -> en:stoma site oedema
    n1=en:oedema | n2=en:stoma site oedema | rel=r_associated | relid=0 | w=48
  1501. en:oedema -- r_associated #0: 48 / 0.762 -> en:striated keratoderma of palms (in some patients)
    n1=en:oedema | n2=en:striated keratoderma of palms (in some patients) | rel=r_associated | relid=0 | w=48
  1502. en:oedema -- r_associated #0: 48 / 0.762 -> en:stromal corneal edema
    n1=en:oedema | n2=en:stromal corneal edema | rel=r_associated | relid=0 | w=48
  1503. en:oedema -- r_associated #0: 48 / 0.762 -> en:structurally abnormal mitochondria
    n1=en:oedema | n2=en:structurally abnormal mitochondria | rel=r_associated | relid=0 | w=48
  1504. en:oedema -- r_associated #0: 48 / 0.762 -> en:subcutaneous nodules (interphalangeal joints, knees, feet, elbows, pretibial)
    n1=en:oedema | n2=en:subcutaneous nodules (interphalangeal joints, knees, feet, elbows, pretibial) | rel=r_associated | relid=0 | w=48
  1505. en:oedema -- r_associated #0: 48 / 0.762 -> en:subcutaneous papules in infancy
    n1=en:oedema | n2=en:subcutaneous papules in infancy | rel=r_associated | relid=0 | w=48
  1506. en:oedema -- r_associated #0: 48 / 0.762 -> en:subungual fibroma
    n1=en:oedema | n2=en:subungual fibroma | rel=r_associated | relid=0 | w=48
  1507. en:oedema -- r_associated #0: 48 / 0.762 -> en:suppurative scalp nodules
    n1=en:oedema | n2=en:suppurative scalp nodules | rel=r_associated | relid=0 | w=48
  1508. en:oedema -- r_associated #0: 48 / 0.762 -> en:swollen nasal mucosa (finding)
    n1=en:oedema | n2=en:swollen nasal mucosa (finding) | rel=r_associated | relid=0 | w=48
  1509. en:oedema -- r_associated #0: 48 / 0.762 -> en:taunt skin
    n1=en:oedema | n2=en:taunt skin | rel=r_associated | relid=0 | w=48
  1510. en:oedema -- r_associated #0: 48 / 0.762 -> en:taxonomic
    n1=en:oedema | n2=en:taxonomic | rel=r_associated | relid=0 | w=48
  1511. en:oedema -- r_associated #0: 48 / 0.762 -> en:telangiectasias in both sun-exposed and sun-protected areas
    n1=en:oedema | n2=en:telangiectasias in both sun-exposed and sun-protected areas | rel=r_associated | relid=0 | w=48
  1512. en:oedema -- r_associated #0: 48 / 0.762 -> en:tenderness
    n1=en:oedema | n2=en:tenderness | rel=r_associated | relid=0 | w=48
  1513. en:oedema -- r_associated #0: 48 / 0.762 -> en:tendon tears
    n1=en:oedema | n2=en:tendon tears | rel=r_associated | relid=0 | w=48
  1514. en:oedema -- r_associated #0: 48 / 0.762 -> en:therapy outcome measure score
    n1=en:oedema | n2=en:therapy outcome measure score | rel=r_associated | relid=0 | w=48
  1515. en:oedema -- r_associated #0: 48 / 0.762 -> en:thick, calloused skin
    n1=en:oedema | n2=en:thick, calloused skin | rel=r_associated | relid=0 | w=48
  1516. en:oedema -- r_associated #0: 48 / 0.762 -> en:thick, waxy skin of palms and soles with well-defined erythematous border
    n1=en:oedema | n2=en:thick, waxy skin of palms and soles with well-defined erythematous border | rel=r_associated | relid=0 | w=48
  1517. en:oedema -- r_associated #0: 48 / 0.762 -> en:thickened subcutaneous tissue
    n1=en:oedema | n2=en:thickened subcutaneous tissue | rel=r_associated | relid=0 | w=48
  1518. en:oedema -- r_associated #0: 48 / 0.762 -> en:thin, velvety skin
    n1=en:oedema | n2=en:thin, velvety skin | rel=r_associated | relid=0 | w=48
  1519. en:oedema -- r_associated #0: 48 / 0.762 -> en:transient neonatal hypotonia (less common)
    n1=en:oedema | n2=en:transient neonatal hypotonia (less common) | rel=r_associated | relid=0 | w=48
  1520. en:oedema -- r_associated #0: 48 / 0.762 -> en:transverse distal crease across palm
    n1=en:oedema | n2=en:transverse distal crease across palm | rel=r_associated | relid=0 | w=48
  1521. en:oedema -- r_associated #0: 48 / 0.762 -> en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles
    n1=en:oedema | n2=en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles | rel=r_associated | relid=0 | w=48
  1522. en:oedema -- r_associated #0: 48 / 0.762 -> en:triglycerides
    n1=en:oedema | n2=en:triglycerides | rel=r_associated | relid=0 | w=48
  1523. en:oedema -- r_associated #0: 48 / 0.762 -> en:tubular aggregates seen on muscle biopsy
    n1=en:oedema | n2=en:tubular aggregates seen on muscle biopsy | rel=r_associated | relid=0 | w=48
  1524. en:oedema -- r_associated #0: 48 / 0.762 -> en:tumors are locally invasive
    n1=en:oedema | n2=en:tumors are locally invasive | rel=r_associated | relid=0 | w=48
  1525. en:oedema -- r_associated #0: 48 / 0.762 -> en:type 1 fiber predominance seen on muscle biopsy
    n1=en:oedema | n2=en:type 1 fiber predominance seen on muscle biopsy | rel=r_associated | relid=0 | w=48
  1526. en:oedema -- r_associated #0: 48 / 0.762 -> en:type 2 fiber atrophy see on biopsy
    n1=en:oedema | n2=en:type 2 fiber atrophy see on biopsy | rel=r_associated | relid=0 | w=48
  1527. en:oedema -- r_associated #0: 48 / 0.762 -> en:ulcerations of distal extremities
    n1=en:oedema | n2=en:ulcerations of distal extremities | rel=r_associated | relid=0 | w=48
  1528. en:oedema -- r_associated #0: 48 / 0.762 -> en:ulcers, distal, due to sensory neuropathy
    n1=en:oedema | n2=en:ulcers, distal, due to sensory neuropathy | rel=r_associated | relid=0 | w=48
  1529. en:oedema -- r_associated #0: 48 / 0.762 -> en:umbilical cord bleeding
    n1=en:oedema | n2=en:umbilical cord bleeding | rel=r_associated | relid=0 | w=48
  1530. en:oedema -- r_associated #0: 48 / 0.762 -> en:umbilical cord.placenta
    n1=en:oedema | n2=en:umbilical cord.placenta | rel=r_associated | relid=0 | w=48
  1531. en:oedema -- r_associated #0: 48 / 0.762 -> en:umbilical hernia
    n1=en:oedema | n2=en:umbilical hernia | rel=r_associated | relid=0 | w=48
  1532. en:oedema -- r_associated #0: 48 / 0.762 -> en:urticaria due to cold
    n1=en:oedema | n2=en:urticaria due to cold | rel=r_associated | relid=0 | w=48
  1533. en:oedema -- r_associated #0: 48 / 0.762 -> en:urticaria pigmentosa/maculopapular cutaneous mastocytosis
    n1=en:oedema | n2=en:urticaria pigmentosa/maculopapular cutaneous mastocytosis | rel=r_associated | relid=0 | w=48
  1534. en:oedema -- r_associated #0: 48 / 0.762 -> en:usually a unilateral disorder
    n1=en:oedema | n2=en:usually a unilateral disorder | rel=r_associated | relid=0 | w=48
  1535. en:oedema -- r_associated #0: 48 / 0.762 -> en:usually no myopathic changes on biopsy
    n1=en:oedema | n2=en:usually no myopathic changes on biopsy | rel=r_associated | relid=0 | w=48
  1536. en:oedema -- r_associated #0: 48 / 0.762 -> en:vacuolar membranes immunostain with sarcolemmal proteins
    n1=en:oedema | n2=en:vacuolar membranes immunostain with sarcolemmal proteins | rel=r_associated | relid=0 | w=48
  1537. en:oedema -- r_associated #0: 48 / 0.762 -> en:vascular access site oedema
    n1=en:oedema | n2=en:vascular access site oedema | rel=r_associated | relid=0 | w=48
  1538. en:oedema -- r_associated #0: 48 / 0.762 -> en:velopharyngeal muscle weakness
    n1=en:oedema | n2=en:velopharyngeal muscle weakness | rel=r_associated | relid=0 | w=48
  1539. en:oedema -- r_associated #0: 48 / 0.762 -> en:velvety texture
    n1=en:oedema | n2=en:velvety texture | rel=r_associated | relid=0 | w=48
  1540. en:oedema -- r_associated #0: 48 / 0.762 -> en:ventilation or perfusion signs and symptoms
    n1=en:oedema | n2=en:ventilation or perfusion signs and symptoms | rel=r_associated | relid=0 | w=48
  1541. en:oedema -- r_associated #0: 48 / 0.762 -> en:vertical crease in fourth interdigital space
    n1=en:oedema | n2=en:vertical crease in fourth interdigital space | rel=r_associated | relid=0 | w=48
  1542. en:oedema -- r_associated #0: 48 / 0.762 -> en:vesicular lesions, congenital bilateral, between ear and corner of mouth
    n1=en:oedema | n2=en:vesicular lesions, congenital bilateral, between ear and corner of mouth | rel=r_associated | relid=0 | w=48
  1543. en:oedema -- r_associated #0: 48 / 0.762 -> en:volume excess, primary hormone excess
    n1=en:oedema | n2=en:volume excess, primary hormone excess | rel=r_associated | relid=0 | w=48
  1544. en:oedema -- r_associated #0: 48 / 0.762 -> en:weakness may be exacerbated by illness or stress
    n1=en:oedema | n2=en:weakness may be exacerbated by illness or stress | rel=r_associated | relid=0 | w=48
  1545. en:oedema -- r_associated #0: 48 / 0.762 -> en:weakness of neck muscles may occur later
    n1=en:oedema | n2=en:weakness of neck muscles may occur later | rel=r_associated | relid=0 | w=48
  1546. en:oedema -- r_associated #0: 48 / 0.762 -> en:weakness of the anterior tibial muscle and toe extensors
    n1=en:oedema | n2=en:weakness of the anterior tibial muscle and toe extensors | rel=r_associated | relid=0 | w=48
  1547. en:oedema -- r_associated #0: 48 / 0.762 -> en:weight loss
    n1=en:oedema | n2=en:weight loss | rel=r_associated | relid=0 | w=48
  1548. en:oedema -- r_associated #0: 48 / 0.762 -> en:widespread retinal edema
    n1=en:oedema | n2=en:widespread retinal edema | rel=r_associated | relid=0 | w=48
  1549. en:oedema -- r_associated #0: 48 / 0.762 -> inflation
    n1=en:oedema | n2=inflation | rel=r_associated | relid=0 | w=48
  1550. en:oedema -- r_associated #0: 48 / 0.762 -> médecine
    n1=en:oedema | n2=médecine | rel=r_associated | relid=0 | w=48
  1551. en:oedema -- r_associated #0: 48 / 0.762 -> néoplasme
    n1=en:oedema | n2=néoplasme | rel=r_associated | relid=0 | w=48
  1552. en:oedema -- r_associated #0: 48 / 0.762 -> oedémateux
    n1=en:oedema | n2=oedémateux | rel=r_associated | relid=0 | w=48
  1553. en:oedema -- r_associated #0: 48 / 0.762 -> Oedème
    n1=en:oedema | n2=Oedème | rel=r_associated | relid=0 | w=48
  1554. en:oedema -- r_associated #0: 48 / 0.762 -> oedème angioneurotique
    n1=en:oedema | n2=oedème angioneurotique | rel=r_associated | relid=0 | w=48
  1555. en:oedema -- r_associated #0: 48 / 0.762 -> oedème de Berlin
    n1=en:oedema | n2=oedème de Berlin | rel=r_associated | relid=0 | w=48
  1556. en:oedema -- r_associated #0: 48 / 0.762 -> tuméfaction
    n1=en:oedema | n2=tuméfaction | rel=r_associated | relid=0 | w=48
  1557. en:oedema -- r_associated #0: 48 / 0.762 -> tumeur
    n1=en:oedema | n2=tumeur | rel=r_associated | relid=0 | w=48
  1558. en:oedema -- r_associated #0: 47 / 0.746 -> œdème de la moelle osseuse transitoire
    n1=en:oedema | n2=œdème de la moelle osseuse transitoire | rel=r_associated | relid=0 | w=47
  1559. en:oedema -- r_associated #0: 47 / 0.746 -> dilatation
    n1=en:oedema | n2=dilatation | rel=r_associated | relid=0 | w=47
  1560. en:oedema -- r_associated #0: 47 / 0.746 -> en:abdominal muscle hypoplasia
    n1=en:oedema | n2=en:abdominal muscle hypoplasia | rel=r_associated | relid=0 | w=47
  1561. en:oedema -- r_associated #0: 47 / 0.746 -> en:abnormal jitter seen on emg
    n1=en:oedema | n2=en:abnormal jitter seen on emg | rel=r_associated | relid=0 | w=47
  1562. en:oedema -- r_associated #0: 47 / 0.746 -> en:abnormal mitochondria in skeletal muscle biopsy
    n1=en:oedema | n2=en:abnormal mitochondria in skeletal muscle biopsy | rel=r_associated | relid=0 | w=47
  1563. en:oedema -- r_associated #0: 47 / 0.746 -> en:abnormal muscle fibers with amorphous, granular, or hyaline deposits
    n1=en:oedema | n2=en:abnormal muscle fibers with amorphous, granular, or hyaline deposits | rel=r_associated | relid=0 | w=47
  1564. en:oedema -- r_associated #0: 47 / 0.746 -> en:abnormal virilization
    n1=en:oedema | n2=en:abnormal virilization | rel=r_associated | relid=0 | w=47
  1565. en:oedema -- r_associated #0: 47 / 0.746 -> en:absence of spontaneous activity at birth (severe form)
    n1=en:oedema | n2=en:absence of spontaneous activity at birth (severe form) | rel=r_associated | relid=0 | w=47
  1566. en:oedema -- r_associated #0: 47 / 0.746 -> en:absent-mild skin hyperextensibility
    n1=en:oedema | n2=en:absent-mild skin hyperextensibility | rel=r_associated | relid=0 | w=47
  1567. en:oedema -- r_associated #0: 47 / 0.746 -> en:accumulation of abnormal mitochondria
    n1=en:oedema | n2=en:accumulation of abnormal mitochondria | rel=r_associated | relid=0 | w=47
  1568. en:oedema -- r_associated #0: 47 / 0.746 -> en:accumulation of fluid
    n1=en:oedema | n2=en:accumulation of fluid | rel=r_associated | relid=0 | w=47
  1569. en:oedema -- r_associated #0: 47 / 0.746 -> en:alimentary edema
    n1=en:oedema | n2=en:alimentary edema | rel=r_associated | relid=0 | w=47
  1570. en:oedema -- r_associated #0: 47 / 0.746 -> en:alpha fetoprotein increased
    n1=en:oedema | n2=en:alpha fetoprotein increased | rel=r_associated | relid=0 | w=47
  1571. en:oedema -- r_associated #0: 47 / 0.746 -> en:angulated atrophic muscle fibers
    n1=en:oedema | n2=en:angulated atrophic muscle fibers | rel=r_associated | relid=0 | w=47
  1572. en:oedema -- r_associated #0: 47 / 0.746 -> en:anhydrotic ectodermal dysplasias
    n1=en:oedema | n2=en:anhydrotic ectodermal dysplasias | rel=r_associated | relid=0 | w=47
  1573. en:oedema -- r_associated #0: 47 / 0.746 -> en:animal/human bite
    n1=en:oedema | n2=en:animal/human bite | rel=r_associated | relid=0 | w=47
  1574. en:oedema -- r_associated #0: 47 / 0.746 -> en:anterior tibial muscles first involved
    n1=en:oedema | n2=en:anterior tibial muscles first involved | rel=r_associated | relid=0 | w=47
  1575. en:oedema -- r_associated #0: 47 / 0.746 -> en:apoptotic nuclei
    n1=en:oedema | n2=en:apoptotic nuclei | rel=r_associated | relid=0 | w=47
  1576. en:oedema -- r_associated #0: 47 / 0.746 -> en:areflexia due to muscle weakness
    n1=en:oedema | n2=en:areflexia due to muscle weakness | rel=r_associated | relid=0 | w=47
  1577. en:oedema -- r_associated #0: 47 / 0.746 -> en:atrophic muscle fiber on biopsy
    n1=en:oedema | n2=en:atrophic muscle fiber on biopsy | rel=r_associated | relid=0 | w=47
  1578. en:oedema -- r_associated #0: 47 / 0.746 -> en:atrophic scarring (less common)
    n1=en:oedema | n2=en:atrophic scarring (less common) | rel=r_associated | relid=0 | w=47
  1579. en:oedema -- r_associated #0: 47 / 0.746 -> en:atrophy
    n1=en:oedema | n2=en:atrophy | rel=r_associated | relid=0 | w=47
  1580. en:oedema -- r_associated #0: 47 / 0.746 -> en:atrophy of type 1 and type 2 fibers
    n1=en:oedema | n2=en:atrophy of type 1 and type 2 fibers | rel=r_associated | relid=0 | w=47
  1581. en:oedema -- r_associated #0: 47 / 0.746 -> en:axillary apocrine gland hypoplasia
    n1=en:oedema | n2=en:axillary apocrine gland hypoplasia | rel=r_associated | relid=0 | w=47
  1582. en:oedema -- r_associated #0: 47 / 0.746 -> en:axillary pterygia
    n1=en:oedema | n2=en:axillary pterygia | rel=r_associated | relid=0 | w=47
  1583. en:oedema -- r_associated #0: 47 / 0.746 -> en:basaloid follicular harmartomas
    n1=en:oedema | n2=en:basaloid follicular harmartomas | rel=r_associated | relid=0 | w=47
  1584. en:oedema -- r_associated #0: 47 / 0.746 -> en:berardinelli-seip congenital lipodystrophy
    n1=en:oedema | n2=en:berardinelli-seip congenital lipodystrophy | rel=r_associated | relid=0 | w=47
  1585. en:oedema -- r_associated #0: 47 / 0.746 -> en:bilateral palmar simian creases
    n1=en:oedema | n2=en:bilateral palmar simian creases | rel=r_associated | relid=0 | w=47
  1586. en:oedema -- r_associated #0: 47 / 0.746 -> en:blistering, recurrent
    n1=en:oedema | n2=en:blistering, recurrent | rel=r_associated | relid=0 | w=47
  1587. en:oedema -- r_associated #0: 47 / 0.746 -> en:blood vessel structure of skin
    n1=en:oedema | n2=en:blood vessel structure of skin | rel=r_associated | relid=0 | w=47
  1588. en:oedema -- r_associated #0: 47 / 0.746 -> en:blood, heart and circulation
    n1=en:oedema | n2=en:blood, heart and circulation | rel=r_associated | relid=0 | w=47
  1589. en:oedema -- r_associated #0: 47 / 0.746 -> en:bluish skin nodules
    n1=en:oedema | n2=en:bluish skin nodules | rel=r_associated | relid=0 | w=47
  1590. en:oedema -- r_associated #0: 47 / 0.746 -> en:body region observable
    n1=en:oedema | n2=en:body region observable | rel=r_associated | relid=0 | w=47
  1591. en:oedema -- r_associated #0: 47 / 0.746 -> en:brain aneurysm
    n1=en:oedema | n2=en:brain aneurysm | rel=r_associated | relid=0 | w=47
  1592. en:oedema -- r_associated #0: 47 / 0.746 -> en:breaks in epidermal ridges of palms and fingers
    n1=en:oedema | n2=en:breaks in epidermal ridges of palms and fingers | rel=r_associated | relid=0 | w=47
  1593. en:oedema -- r_associated #0: 47 / 0.746 -> en:brown-mclean syndrome
    n1=en:oedema | n2=en:brown-mclean syndrome | rel=r_associated | relid=0 | w=47
  1594. en:oedema -- r_associated #0: 47 / 0.746 -> en:brownish-black macules on dorsa of hands and feet (in some patients)
    n1=en:oedema | n2=en:brownish-black macules on dorsa of hands and feet (in some patients) | rel=r_associated | relid=0 | w=47
  1595. en:oedema -- r_associated #0: 47 / 0.746 -> en:bulbar weakness
    n1=en:oedema | n2=en:bulbar weakness | rel=r_associated | relid=0 | w=47
  1596. en:oedema -- r_associated #0: 47 / 0.746 -> en:burning sensation
    n1=en:oedema | n2=en:burning sensation | rel=r_associated | relid=0 | w=47
  1597. en:oedema -- r_associated #0: 47 / 0.746 -> en:cafe-au-lait spots may or may not be present
    n1=en:oedema | n2=en:cafe-au-lait spots may or may not be present | rel=r_associated | relid=0 | w=47
  1598. en:oedema -- r_associated #0: 47 / 0.746 -> en:calf and thigh cramping muscle pains
    n1=en:oedema | n2=en:calf and thigh cramping muscle pains | rel=r_associated | relid=0 | w=47
  1599. en:oedema -- r_associated #0: 47 / 0.746 -> en:capillary leak syndrome
    n1=en:oedema | n2=en:capillary leak syndrome | rel=r_associated | relid=0 | w=47
  1600. en:oedema -- r_associated #0: 47 / 0.746 -> en:carbuncle/furuncle
    n1=en:oedema | n2=en:carbuncle/furuncle | rel=r_associated | relid=0 | w=47
  1601. en:oedema -- r_associated #0: 47 / 0.746 -> en:cardiovascular observable
    n1=en:oedema | n2=en:cardiovascular observable | rel=r_associated | relid=0 | w=47
  1602. en:oedema -- r_associated #0: 47 / 0.746 -> en:cellulitis or infection may occur
    n1=en:oedema | n2=en:cellulitis or infection may occur | rel=r_associated | relid=0 | w=47
  1603. en:oedema -- r_associated #0: 47 / 0.746 -> en:cerebriform connective tissue nevus
    n1=en:oedema | n2=en:cerebriform connective tissue nevus | rel=r_associated | relid=0 | w=47
  1604. en:oedema -- r_associated #0: 47 / 0.746 -> en:changes in skin texture
    n1=en:oedema | n2=en:changes in skin texture | rel=r_associated | relid=0 | w=47
  1605. en:oedema -- r_associated #0: 47 / 0.746 -> en:chronic edema
    n1=en:oedema | n2=en:chronic edema | rel=r_associated | relid=0 | w=47
  1606. en:oedema -- r_associated #0: 47 / 0.746 -> en:chronic granulomatous nodules (rare)
    n1=en:oedema | n2=en:chronic granulomatous nodules (rare) | rel=r_associated | relid=0 | w=47
  1607. en:oedema -- r_associated #0: 47 / 0.746 -> en:chronobiologic state
    n1=en:oedema | n2=en:chronobiologic state | rel=r_associated | relid=0 | w=47
  1608. en:oedema -- r_associated #0: 47 / 0.746 -> en:clavus formation (rare)
    n1=en:oedema | n2=en:clavus formation (rare) | rel=r_associated | relid=0 | w=47
  1609. en:oedema -- r_associated #0: 47 / 0.746 -> en:coarse skin
    n1=en:oedema | n2=en:coarse skin | rel=r_associated | relid=0 | w=47
  1610. en:oedema -- r_associated #0: 47 / 0.746 -> en:combined oxidative phosphorylation deficiency, complexes i and iv
    n1=en:oedema | n2=en:combined oxidative phosphorylation deficiency, complexes i and iv | rel=r_associated | relid=0 | w=47
  1611. en:oedema -- r_associated #0: 47 / 0.746 -> en:concussion and edema of cervical spinal cord
    n1=en:oedema | n2=en:concussion and edema of cervical spinal cord | rel=r_associated | relid=0 | w=47
  1612. en:oedema -- r_associated #0: 47 / 0.746 -> en:confetti-like hypopigmented macules
    n1=en:oedema | n2=en:confetti-like hypopigmented macules | rel=r_associated | relid=0 | w=47
  1613. en:oedema -- r_associated #0: 47 / 0.746 -> en:congenital mesh qualifier
    n1=en:oedema | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=47
  1614. en:oedema -- r_associated #0: 47 / 0.746 -> en:conjunctival edema
    n1=en:oedema | n2=en:conjunctival edema | rel=r_associated | relid=0 | w=47
  1615. en:oedema -- r_associated #0: 47 / 0.746 -> en:contraception method of partner
    n1=en:oedema | n2=en:contraception method of partner | rel=r_associated | relid=0 | w=47
  1616. en:oedema -- r_associated #0: 47 / 0.746 -> en:corneal sensitivity
    n1=en:oedema | n2=en:corneal sensitivity | rel=r_associated | relid=0 | w=47
  1617. en:oedema -- r_associated #0: 47 / 0.746 -> en:corneal stromal wrinkles
    n1=en:oedema | n2=en:corneal stromal wrinkles | rel=r_associated | relid=0 | w=47
  1618. en:oedema -- r_associated #0: 47 / 0.746 -> en:corns and callus
    n1=en:oedema | n2=en:corns and callus | rel=r_associated | relid=0 | w=47
  1619. en:oedema -- r_associated #0: 47 / 0.746 -> en:courvoisier's sign
    n1=en:oedema | n2=en:courvoisier's sign | rel=r_associated | relid=0 | w=47
  1620. en:oedema -- r_associated #0: 47 / 0.746 -> en:cutaneous lichen amyloidosis
    n1=en:oedema | n2=en:cutaneous lichen amyloidosis | rel=r_associated | relid=0 | w=47
  1621. en:oedema -- r_associated #0: 47 / 0.746 -> en:cyanosis (25%)
    n1=en:oedema | n2=en:cyanosis (25%) | rel=r_associated | relid=0 | w=47
  1622. en:oedema -- r_associated #0: 47 / 0.746 -> en:cysts may become infected (15%)
    n1=en:oedema | n2=en:cysts may become infected (15%) | rel=r_associated | relid=0 | w=47
  1623. en:oedema -- r_associated #0: 47 / 0.746 -> en:cysts may gradually increase in size
    n1=en:oedema | n2=en:cysts may gradually increase in size | rel=r_associated | relid=0 | w=47
  1624. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased achilles reflex
    n1=en:oedema | n2=en:decreased achilles reflex | rel=r_associated | relid=0 | w=47
  1625. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased achr at the endplate
    n1=en:oedema | n2=en:decreased achr at the endplate | rel=r_associated | relid=0 | w=47
  1626. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased activities of mitochondrial complexes i, iii, and iv
    n1=en:oedema | n2=en:decreased activities of mitochondrial complexes i, iii, and iv | rel=r_associated | relid=0 | w=47
  1627. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased activities of several mitochondrial respiratory enzymes
    n1=en:oedema | n2=en:decreased activities of several mitochondrial respiratory enzymes | rel=r_associated | relid=0 | w=47
  1628. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased amplitude of miniature endplate potentials (mepp)
    n1=en:oedema | n2=en:decreased amplitude of miniature endplate potentials (mepp) | rel=r_associated | relid=0 | w=47
  1629. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased exercise tolerance
    n1=en:oedema | n2=en:decreased exercise tolerance | rel=r_associated | relid=0 | w=47
  1630. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased hand grip strength
    n1=en:oedema | n2=en:decreased hand grip strength | rel=r_associated | relid=0 | w=47
  1631. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased muscle mitochondrial aconitase
    n1=en:oedema | n2=en:decreased muscle mitochondrial aconitase | rel=r_associated | relid=0 | w=47
  1632. en:oedema -- r_associated #0: 47 / 0.746 -> en:decreased muscle succinate dehydrogenase
    n1=en:oedema | n2=en:decreased muscle succinate dehydrogenase | rel=r_associated | relid=0 | w=47
  1633. en:oedema -- r_associated #0: 47 / 0.746 -> en:deep finger muscle weakness
    n1=en:oedema | n2=en:deep finger muscle weakness | rel=r_associated | relid=0 | w=47
  1634. en:oedema -- r_associated #0: 47 / 0.746 -> en:deep fissures of skin creases
    n1=en:oedema | n2=en:deep fissures of skin creases | rel=r_associated | relid=0 | w=47
  1635. en:oedema -- r_associated #0: 47 / 0.746 -> en:delayed motor development (cvs+)
    n1=en:oedema | n2=en:delayed motor development (cvs+) | rel=r_associated | relid=0 | w=47
  1636. en:oedema -- r_associated #0: 47 / 0.746 -> en:deposition of calcium phosphate crystals in skin and subcutaneous tissues
    n1=en:oedema | n2=en:deposition of calcium phosphate crystals in skin and subcutaneous tissues | rel=r_associated | relid=0 | w=47
  1637. en:oedema -- r_associated #0: 47 / 0.746 -> en:dermal melanocytosis
    n1=en:oedema | n2=en:dermal melanocytosis | rel=r_associated | relid=0 | w=47
  1638. en:oedema -- r_associated #0: 47 / 0.746 -> en:dermatitis acidemica
    n1=en:oedema | n2=en:dermatitis acidemica | rel=r_associated | relid=0 | w=47
  1639. en:oedema -- r_associated #0: 47 / 0.746 -> en:dermatitis, infectious, due to immunodeficiency
    n1=en:oedema | n2=en:dermatitis, infectious, due to immunodeficiency | rel=r_associated | relid=0 | w=47
  1640. en:oedema -- r_associated #0: 47 / 0.746 -> en:dermatitis, symmetric pattern
    n1=en:oedema | n2=en:dermatitis, symmetric pattern | rel=r_associated | relid=0 | w=47
  1641. en:oedema -- r_associated #0: 47 / 0.746 -> en:diagnosis aspect
    n1=en:oedema | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=47
  1642. en:oedema -- r_associated #0: 47 / 0.746 -> en:diaphoresis
    n1=en:oedema | n2=en:diaphoresis | rel=r_associated | relid=0 | w=47
  1643. en:oedema -- r_associated #0: 47 / 0.746 -> en:diarrhea
    n1=en:oedema | n2=en:diarrhea | rel=r_associated | relid=0 | w=47
  1644. en:oedema -- r_associated #0: 47 / 0.746 -> en:difficulty walking and climbing stairs
    n1=en:oedema | n2=en:difficulty walking and climbing stairs | rel=r_associated | relid=0 | w=47
  1645. en:oedema -- r_associated #0: 47 / 0.746 -> en:difficulty walking on heels occurs prior to difficulty walking on toes
    n1=en:oedema | n2=en:difficulty walking on heels occurs prior to difficulty walking on toes | rel=r_associated | relid=0 | w=47
  1646. en:oedema -- r_associated #0: 47 / 0.746 -> en:disease or disorder
    n1=en:oedema | n2=en:disease or disorder | rel=r_associated | relid=0 | w=47
  1647. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal amyotrophy (hands and feet)
    n1=en:oedema | n2=en:distal amyotrophy (hands and feet) | rel=r_associated | relid=0 | w=47
  1648. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle atrophy (1 patient)
    n1=en:oedema | n2=en:distal muscle atrophy (1 patient) | rel=r_associated | relid=0 | w=47
  1649. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle atrophy (lower limbs more affected than upper limbs)
    n1=en:oedema | n2=en:distal muscle atrophy (lower limbs more affected than upper limbs) | rel=r_associated | relid=0 | w=47
  1650. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle atrophy due to neurologic disease
    n1=en:oedema | n2=en:distal muscle atrophy due to neurologic disease | rel=r_associated | relid=0 | w=47
  1651. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles)
    n1=en:oedema | n2=en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles) | rel=r_associated | relid=0 | w=47
  1652. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle weakness due to neuropathy
    n1=en:oedema | n2=en:distal muscle weakness due to neuropathy | rel=r_associated | relid=0 | w=47
  1653. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle weakness may occur
    n1=en:oedema | n2=en:distal muscle weakness may occur | rel=r_associated | relid=0 | w=47
  1654. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle weakness, affecting the lower limbs
    n1=en:oedema | n2=en:distal muscle weakness, affecting the lower limbs | rel=r_associated | relid=0 | w=47
  1655. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle weakness, lower limbs more severely affected than upper limbs
    n1=en:oedema | n2=en:distal muscle weakness, lower limbs more severely affected than upper limbs | rel=r_associated | relid=0 | w=47
  1656. en:oedema -- r_associated #0: 47 / 0.746 -> en:distal muscle weakness, upper and lower limbs
    n1=en:oedema | n2=en:distal muscle weakness, upper and lower limbs | rel=r_associated | relid=0 | w=47
  1657. en:oedema -- r_associated #0: 47 / 0.746 -> en:doughy skin
    n1=en:oedema | n2=en:doughy skin | rel=r_associated | relid=0 | w=47
  1658. en:oedema -- r_associated #0: 47 / 0.746 -> en:dry, stiff skin
    n1=en:oedema | n2=en:dry, stiff skin | rel=r_associated | relid=0 | w=47
  1659. en:oedema -- r_associated #0: 47 / 0.746 -> en:dystrophic changes occur later
    n1=en:oedema | n2=en:dystrophic changes occur later | rel=r_associated | relid=0 | w=47
  1660. en:oedema -- r_associated #0: 47 / 0.746 -> en:dystrophic features
    n1=en:oedema | n2=en:dystrophic features | rel=r_associated | relid=0 | w=47
  1661. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema at birth
    n1=en:oedema | n2=en:edema at birth | rel=r_associated | relid=0 | w=47
  1662. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema bullosum vesicae
    n1=en:oedema | n2=en:edema bullosum vesicae | rel=r_associated | relid=0 | w=47
  1663. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema of all toes
    n1=en:oedema | n2=en:edema of all toes | rel=r_associated | relid=0 | w=47
  1664. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema of clitoris
    n1=en:oedema | n2=en:edema of clitoris | rel=r_associated | relid=0 | w=47
  1665. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema of cornea of right eye
    n1=en:oedema | n2=en:edema of cornea of right eye | rel=r_associated | relid=0 | w=47
  1666. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema of lower extremity
    n1=en:oedema | n2=en:edema of lower extremity | rel=r_associated | relid=0 | w=47
  1667. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema of nipple
    n1=en:oedema | n2=en:edema of nipple | rel=r_associated | relid=0 | w=47
  1668. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema of oral vestibule
    n1=en:oedema | n2=en:edema of oral vestibule | rel=r_associated | relid=0 | w=47
  1669. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema of penis
    n1=en:oedema | n2=en:edema of penis | rel=r_associated | relid=0 | w=47
  1670. en:oedema -- r_associated #0: 47 / 0.746 -> en:edema, familial idiopathic, prepubertal
    n1=en:oedema | n2=en:edema, familial idiopathic, prepubertal | rel=r_associated | relid=0 | w=47
  1671. en:oedema -- r_associated #0: 47 / 0.746 -> en:elastosis perforans serpiginosa
    n1=en:oedema | n2=en:elastosis perforans serpiginosa | rel=r_associated | relid=0 | w=47
  1672. en:oedema -- r_associated #0: 47 / 0.746 -> en:elbow dimples
    n1=en:oedema | n2=en:elbow dimples | rel=r_associated | relid=0 | w=47
  1673. en:oedema -- r_associated #0: 47 / 0.746 -> en:emg shows denervation
    n1=en:oedema | n2=en:emg shows denervation | rel=r_associated | relid=0 | w=47
  1674. en:oedema -- r_associated #0: 47 / 0.746 -> en:emg shows myopathic changes
    n1=en:oedema | n2=en:emg shows myopathic changes | rel=r_associated | relid=0 | w=47
  1675. en:oedema -- r_associated #0: 47 / 0.746 -> en:emg shows myopathic features
    n1=en:oedema | n2=en:emg shows myopathic features | rel=r_associated | relid=0 | w=47
  1676. en:oedema -- r_associated #0: 47 / 0.746 -> en:emg shows myotonic discharges in the absence of clinical myotonia
    n1=en:oedema | n2=en:emg shows myotonic discharges in the absence of clinical myotonia | rel=r_associated | relid=0 | w=47
  1677. en:oedema -- r_associated #0: 47 / 0.746 -> en:emg shows polyphasic continuous motor unit discharges
    n1=en:oedema | n2=en:emg shows polyphasic continuous motor unit discharges | rel=r_associated | relid=0 | w=47
  1678. en:oedema -- r_associated #0: 47 / 0.746 -> en:endocrine system signs and symptoms
    n1=en:oedema | n2=en:endocrine system signs and symptoms | rel=r_associated | relid=0 | w=47
  1679. en:oedema -- r_associated #0: 47 / 0.746 -> en:endomysial fibrosis
    n1=en:oedema | n2=en:endomysial fibrosis | rel=r_associated | relid=0 | w=47
  1680. en:oedema -- r_associated #0: 47 / 0.746 -> en:eosinophilic disorder
    n1=en:oedema | n2=en:eosinophilic disorder | rel=r_associated | relid=0 | w=47
  1681. en:oedema -- r_associated #0: 47 / 0.746 -> en:erythematous rash (in some patients)
    n1=en:oedema | n2=en:erythematous rash (in some patients) | rel=r_associated | relid=0 | w=47
  1682. en:oedema -- r_associated #0: 47 / 0.746 -> en:exertional leg pain
    n1=en:oedema | n2=en:exertional leg pain | rel=r_associated | relid=0 | w=47
  1683. en:oedema -- r_associated #0: 47 / 0.746 -> en:exposure as collected domain
    n1=en:oedema | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=47
  1684. en:oedema -- r_associated #0: 47 / 0.746 -> en:exudative edema
    n1=en:oedema | n2=en:exudative edema | rel=r_associated | relid=0 | w=47
  1685. en:oedema -- r_associated #0: 47 / 0.746 -> en:face arm speech test score
    n1=en:oedema | n2=en:face arm speech test score | rel=r_associated | relid=0 | w=47
  1686. en:oedema -- r_associated #0: 47 / 0.746 -> en:facial capillary hemangioma
    n1=en:oedema | n2=en:facial capillary hemangioma | rel=r_associated | relid=0 | w=47
  1687. en:oedema -- r_associated #0: 47 / 0.746 -> en:facial muscle weakness
    n1=en:oedema | n2=en:facial muscle weakness | rel=r_associated | relid=0 | w=47
  1688. en:oedema -- r_associated #0: 47 / 0.746 -> en:fair skin
    n1=en:oedema | n2=en:fair skin | rel=r_associated | relid=0 | w=47
  1689. en:oedema -- r_associated #0: 47 / 0.746 -> en:falls risk assessment score for the elderly (observable entity)
    n1=en:oedema | n2=en:falls risk assessment score for the elderly (observable entity) | rel=r_associated | relid=0 | w=47
  1690. en:oedema -- r_associated #0: 47 / 0.746 -> en:fat accumulation in the suprabuttock area
    n1=en:oedema | n2=en:fat accumulation in the suprabuttock area | rel=r_associated | relid=0 | w=47
  1691. en:oedema -- r_associated #0: 47 / 0.746 -> en:fatty degeneration of muscle seen on mri
    n1=en:oedema | n2=en:fatty degeneration of muscle seen on mri | rel=r_associated | relid=0 | w=47
  1692. en:oedema -- r_associated #0: 47 / 0.746 -> en:feminization
    n1=en:oedema | n2=en:feminization | rel=r_associated | relid=0 | w=47
  1693. en:oedema -- r_associated #0: 47 / 0.746 -> en:filamentous inclusions in muscle fibers
    n1=en:oedema | n2=en:filamentous inclusions in muscle fibers | rel=r_associated | relid=0 | w=47
  1694. en:oedema -- r_associated #0: 47 / 0.746 -> en:finding by site
    n1=en:oedema | n2=en:finding by site | rel=r_associated | relid=0 | w=47
  1695. en:oedema -- r_associated #0: 47 / 0.746 -> en:firm muscles
    n1=en:oedema | n2=en:firm muscles | rel=r_associated | relid=0 | w=47
  1696. en:oedema -- r_associated #0: 47 / 0.746 -> en:fissuring of palms and/or soles in hot or cold weather
    n1=en:oedema | n2=en:fissuring of palms and/or soles in hot or cold weather | rel=r_associated | relid=0 | w=47
  1697. en:oedema -- r_associated #0: 47 / 0.746 -> en:flu-like symptoms
    n1=en:oedema | n2=en:flu-like symptoms | rel=r_associated | relid=0 | w=47
  1698. en:oedema -- r_associated #0: 47 / 0.746 -> en:flushing
    n1=en:oedema | n2=en:flushing | rel=r_associated | relid=0 | w=47
  1699. en:oedema -- r_associated #0: 47 / 0.746 -> en:focal loss of cross striations on muscle biopsy
    n1=en:oedema | n2=en:focal loss of cross striations on muscle biopsy | rel=r_associated | relid=0 | w=47
  1700. en:oedema -- r_associated #0: 47 / 0.746 -> en:focal scalp defects with alopecia
    n1=en:oedema | n2=en:focal scalp defects with alopecia | rel=r_associated | relid=0 | w=47
  1701. en:oedema -- r_associated #0: 47 / 0.746 -> en:follicular atrophoderma (in some patients)
    n1=en:oedema | n2=en:follicular atrophoderma (in some patients) | rel=r_associated | relid=0 | w=47
  1702. en:oedema -- r_associated #0: 47 / 0.746 -> en:foot extensor muscle weakness (later onset)
    n1=en:oedema | n2=en:foot extensor muscle weakness (later onset) | rel=r_associated | relid=0 | w=47
  1703. en:oedema -- r_associated #0: 47 / 0.746 -> en:fragile skin
    n1=en:oedema | n2=en:fragile skin | rel=r_associated | relid=0 | w=47
  1704. en:oedema -- r_associated #0: 47 / 0.746 -> en:frostbitten hands
    n1=en:oedema | n2=en:frostbitten hands | rel=r_associated | relid=0 | w=47
  1705. en:oedema -- r_associated #0: 47 / 0.746 -> en:gait disturbance
    n1=en:oedema | n2=en:gait disturbance | rel=r_associated | relid=0 | w=47
  1706. en:oedema -- r_associated #0: 47 / 0.746 -> en:generalized amyoplasia
    n1=en:oedema | n2=en:generalized amyoplasia | rel=r_associated | relid=0 | w=47
  1707. en:oedema -- r_associated #0: 47 / 0.746 -> en:generalized hypopigmentation
    n1=en:oedema | n2=en:generalized hypopigmentation | rel=r_associated | relid=0 | w=47
  1708. en:oedema -- r_associated #0: 47 / 0.746 -> en:generalized neonatal hypotonia
    n1=en:oedema | n2=en:generalized neonatal hypotonia | rel=r_associated | relid=0 | w=47
  1709. en:oedema -- r_associated #0: 47 / 0.746 -> en:gingival edema
    n1=en:oedema | n2=en:gingival edema | rel=r_associated | relid=0 | w=47
  1710. en:oedema -- r_associated #0: 47 / 0.746 -> en:gingival hyperkeratosis
    n1=en:oedema | n2=en:gingival hyperkeratosis | rel=r_associated | relid=0 | w=47
  1711. en:oedema -- r_associated #0: 47 / 0.746 -> en:glabellar hemangioma
    n1=en:oedema | n2=en:glabellar hemangioma | rel=r_associated | relid=0 | w=47
  1712. en:oedema -- r_associated #0: 47 / 0.746 -> en:glossocele
    n1=en:oedema | n2=en:glossocele | rel=r_associated | relid=0 | w=47
  1713. en:oedema -- r_associated #0: 47 / 0.746 -> en:gowers sign
    n1=en:oedema | n2=en:gowers sign | rel=r_associated | relid=0 | w=47
  1714. en:oedema -- r_associated #0: 47 / 0.746 -> en:gowers sign present
    n1=en:oedema | n2=en:gowers sign present | rel=r_associated | relid=0 | w=47
  1715. en:oedema -- r_associated #0: 47 / 0.746 -> en:granulomatous dermatitis
    n1=en:oedema | n2=en:granulomatous dermatitis | rel=r_associated | relid=0 | w=47
  1716. en:oedema -- r_associated #0: 47 / 0.746 -> en:hand dermatitis (non-allergic, irritant)
    n1=en:oedema | n2=en:hand dermatitis (non-allergic, irritant) | rel=r_associated | relid=0 | w=47
  1717. en:oedema -- r_associated #0: 47 / 0.746 -> en:hand muscle atrophy
    n1=en:oedema | n2=en:hand muscle atrophy | rel=r_associated | relid=0 | w=47
  1718. en:oedema -- r_associated #0: 47 / 0.746 -> en:hemangioma
    n1=en:oedema | n2=en:hemangioma | rel=r_associated | relid=0 | w=47
  1719. en:oedema -- r_associated #0: 47 / 0.746 -> en:hemangiomas (facial, glabellar)
    n1=en:oedema | n2=en:hemangiomas (facial, glabellar) | rel=r_associated | relid=0 | w=47
  1720. en:oedema -- r_associated #0: 47 / 0.746 -> en:hemangiomata, especially thorax and upper abdomen
    n1=en:oedema | n2=en:hemangiomata, especially thorax and upper abdomen | rel=r_associated | relid=0 | w=47
  1721. en:oedema -- r_associated #0: 47 / 0.746 -> en:hemorrhagic blisters
    n1=en:oedema | n2=en:hemorrhagic blisters | rel=r_associated | relid=0 | w=47
  1722. en:oedema -- r_associated #0: 47 / 0.746 -> en:hip abductor weakness and atrophy
    n1=en:oedema | n2=en:hip abductor weakness and atrophy | rel=r_associated | relid=0 | w=47
  1723. en:oedema -- r_associated #0: 47 / 0.746 -> en:hip fracture probability score using world health organization fracture risk assessment tool
    n1=en:oedema | n2=en:hip fracture probability score using world health organization fracture risk assessment tool | rel=r_associated | relid=0 | w=47
  1724. en:oedema -- r_associated #0: 47 / 0.746 -> en:histology shows exterior zone of densely packed, small basophilic cells
    n1=en:oedema | n2=en:histology shows exterior zone of densely packed, small basophilic cells | rel=r_associated | relid=0 | w=47
  1725. en:oedema -- r_associated #0: 47 / 0.746 -> en:home falls and accidents screening tool score
    n1=en:oedema | n2=en:home falls and accidents screening tool score | rel=r_associated | relid=0 | w=47
  1726. en:oedema -- r_associated #0: 47 / 0.746 -> en:hoover's sign
    n1=en:oedema | n2=en:hoover's sign | rel=r_associated | relid=0 | w=47
  1727. en:oedema -- r_associated #0: 47 / 0.746 -> en:hot flashes
    n1=en:oedema | n2=en:hot flashes | rel=r_associated | relid=0 | w=47
  1728. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyaline inclusion
    n1=en:oedema | n2=en:hyaline inclusion | rel=r_associated | relid=0 | w=47
  1729. en:oedema -- r_associated #0: 47 / 0.746 -> en:hydrosalpinx (disease)
    n1=en:oedema | n2=en:hydrosalpinx (disease) | rel=r_associated | relid=0 | w=47
  1730. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperactive deep tendon reflexes
    n1=en:oedema | n2=en:hyperactive deep tendon reflexes | rel=r_associated | relid=0 | w=47
  1731. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperactivity
    n1=en:oedema | n2=en:hyperactivity | rel=r_associated | relid=0 | w=47
  1732. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperhidrosis of plantar surface (in some patients)
    n1=en:oedema | n2=en:hyperhidrosis of plantar surface (in some patients) | rel=r_associated | relid=0 | w=47
  1733. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperkeratosis
    n1=en:oedema | n2=en:hyperkeratosis | rel=r_associated | relid=0 | w=47
  1734. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperkeratotic cutaneous vascular lesions
    n1=en:oedema | n2=en:hyperkeratotic cutaneous vascular lesions | rel=r_associated | relid=0 | w=47
  1735. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperkeratotic plaques
    n1=en:oedema | n2=en:hyperkeratotic plaques | rel=r_associated | relid=0 | w=47
  1736. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperpigmented nevi
    n1=en:oedema | n2=en:hyperpigmented nevi | rel=r_associated | relid=0 | w=47
  1737. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperpigmented patches (in some patients)
    n1=en:oedema | n2=en:hyperpigmented patches (in some patients) | rel=r_associated | relid=0 | w=47
  1738. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperpigmented skin lesions (in some patients)
    n1=en:oedema | n2=en:hyperpigmented skin lesions (in some patients) | rel=r_associated | relid=0 | w=47
  1739. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperpigmented skin patches (face, neck, trunk, limbs, lip, oral mucosa, palms, and soles)
    n1=en:oedema | n2=en:hyperpigmented skin patches (face, neck, trunk, limbs, lip, oral mucosa, palms, and soles) | rel=r_associated | relid=0 | w=47
  1740. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperpigmented/hypopigmented macules (trunk, extremities, occasionally face)
    n1=en:oedema | n2=en:hyperpigmented/hypopigmented macules (trunk, extremities, occasionally face) | rel=r_associated | relid=0 | w=47
  1741. en:oedema -- r_associated #0: 47 / 0.746 -> en:hyperthermia
    n1=en:oedema | n2=en:hyperthermia | rel=r_associated | relid=0 | w=47
  1742. en:oedema -- r_associated #0: 47 / 0.746 -> en:hypohidrosis (in some patients)
    n1=en:oedema | n2=en:hypohidrosis (in some patients) | rel=r_associated | relid=0 | w=47
  1743. en:oedema -- r_associated #0: 47 / 0.746 -> en:hypoplasia of infraspinatus muscle
    n1=en:oedema | n2=en:hypoplasia of infraspinatus muscle | rel=r_associated | relid=0 | w=47
  1744. en:oedema -- r_associated #0: 47 / 0.746 -> en:hypotonic
    n1=en:oedema | n2=en:hypotonic | rel=r_associated | relid=0 | w=47
  1745. en:oedema -- r_associated #0: 47 / 0.746 -> en:ichthyosiform erythroderma, congenital
    n1=en:oedema | n2=en:ichthyosiform erythroderma, congenital | rel=r_associated | relid=0 | w=47
  1746. en:oedema -- r_associated #0: 47 / 0.746 -> en:ichthyosis (in contiguous gene syndrome patients)
    n1=en:oedema | n2=en:ichthyosis (in contiguous gene syndrome patients) | rel=r_associated | relid=0 | w=47
  1747. en:oedema -- r_associated #0: 47 / 0.746 -> en:ichthyosis of scalp and flexural areas
    n1=en:oedema | n2=en:ichthyosis of scalp and flexural areas | rel=r_associated | relid=0 | w=47
  1748. en:oedema -- r_associated #0: 47 / 0.746 -> en:ichthyosis, generalized, including flexures
    n1=en:oedema | n2=en:ichthyosis, generalized, including flexures | rel=r_associated | relid=0 | w=47
  1749. en:oedema -- r_associated #0: 47 / 0.746 -> en:imaging shows muscle atrophy and fatty replacement
    n1=en:oedema | n2=en:imaging shows muscle atrophy and fatty replacement | rel=r_associated | relid=0 | w=47
  1750. en:oedema -- r_associated #0: 47 / 0.746 -> en:immunoreactivity for z-disk proteins
    n1=en:oedema | n2=en:immunoreactivity for z-disk proteins | rel=r_associated | relid=0 | w=47
  1751. en:oedema -- r_associated #0: 47 / 0.746 -> en:impetigo
    n1=en:oedema | n2=en:impetigo | rel=r_associated | relid=0 | w=47
  1752. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased amniotic fluid
    n1=en:oedema | n2=en:increased amniotic fluid | rel=r_associated | relid=0 | w=47
  1753. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased connective tissue
    n1=en:oedema | n2=en:increased connective tissue | rel=r_associated | relid=0 | w=47
  1754. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased echo intensity in affected muscles
    n1=en:oedema | n2=en:increased echo intensity in affected muscles | rel=r_associated | relid=0 | w=47
  1755. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased glycogen
    n1=en:oedema | n2=en:increased glycogen | rel=r_associated | relid=0 | w=47
  1756. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased lipid droplets and abnormal mitochondria
    n1=en:oedema | n2=en:increased lipid droplets and abnormal mitochondria | rel=r_associated | relid=0 | w=47
  1757. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased mitochondria seen on muscle biopsy
    n1=en:oedema | n2=en:increased mitochondria seen on muscle biopsy | rel=r_associated | relid=0 | w=47
  1758. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased number of skin folds (neck, abdomen, axillae)
    n1=en:oedema | n2=en:increased number of skin folds (neck, abdomen, axillae) | rel=r_associated | relid=0 | w=47
  1759. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased staining for myotilin, dystrophin, desmin
    n1=en:oedema | n2=en:increased staining for myotilin, dystrophin, desmin | rel=r_associated | relid=0 | w=47
  1760. en:oedema -- r_associated #0: 47 / 0.746 -> en:increased variation in fiber size seen on muscle biopsy
    n1=en:oedema | n2=en:increased variation in fiber size seen on muscle biopsy | rel=r_associated | relid=0 | w=47
  1761. en:oedema -- r_associated #0: 47 / 0.746 -> en:infantile axial hypotonia
    n1=en:oedema | n2=en:infantile axial hypotonia | rel=r_associated | relid=0 | w=47
  1762. en:oedema -- r_associated #0: 47 / 0.746 -> en:inflammatory breast carcinoma
    n1=en:oedema | n2=en:inflammatory breast carcinoma | rel=r_associated | relid=0 | w=47
  1763. en:oedema -- r_associated #0: 47 / 0.746 -> en:inguinal freckling
    n1=en:oedema | n2=en:inguinal freckling | rel=r_associated | relid=0 | w=47
  1764. en:oedema -- r_associated #0: 47 / 0.746 -> en:inguinal hernia
    n1=en:oedema | n2=en:inguinal hernia | rel=r_associated | relid=0 | w=47
  1765. en:oedema -- r_associated #0: 47 / 0.746 -> en:ischemic cerebrovascular accident
    n1=en:oedema | n2=en:ischemic cerebrovascular accident | rel=r_associated | relid=0 | w=47
  1766. en:oedema -- r_associated #0: 47 / 0.746 -> en:jaundice
    n1=en:oedema | n2=en:jaundice | rel=r_associated | relid=0 | w=47
  1767. en:oedema -- r_associated #0: 47 / 0.746 -> en:jaundice (not of newborn)
    n1=en:oedema | n2=en:jaundice (not of newborn) | rel=r_associated | relid=0 | w=47
  1768. en:oedema -- r_associated #0: 47 / 0.746 -> en:jaundice (sometimes onset in the neonatal period)
    n1=en:oedema | n2=en:jaundice (sometimes onset in the neonatal period) | rel=r_associated | relid=0 | w=47
  1769. en:oedema -- r_associated #0: 47 / 0.746 -> en:joint effusion
    n1=en:oedema | n2=en:joint effusion | rel=r_associated | relid=0 | w=47
  1770. en:oedema -- r_associated #0: 47 / 0.746 -> en:keloid formation
    n1=en:oedema | n2=en:keloid formation | rel=r_associated | relid=0 | w=47
  1771. en:oedema -- r_associated #0: 47 / 0.746 -> en:keratoderma of soles at pressure points
    n1=en:oedema | n2=en:keratoderma of soles at pressure points | rel=r_associated | relid=0 | w=47
  1772. en:oedema -- r_associated #0: 47 / 0.746 -> en:kidney sweat
    n1=en:oedema | n2=en:kidney sweat | rel=r_associated | relid=0 | w=47
  1773. en:oedema -- r_associated #0: 47 / 0.746 -> en:laceration/cut
    n1=en:oedema | n2=en:laceration/cut | rel=r_associated | relid=0 | w=47
  1774. en:oedema -- r_associated #0: 47 / 0.746 -> en:lack of adipose tissue on limbs and femorogluteal regions
    n1=en:oedema | n2=en:lack of adipose tissue on limbs and femorogluteal regions | rel=r_associated | relid=0 | w=47
  1775. en:oedema -- r_associated #0: 47 / 0.746 -> en:lack of chilblain lesions
    n1=en:oedema | n2=en:lack of chilblain lesions | rel=r_associated | relid=0 | w=47
  1776. en:oedema -- r_associated #0: 47 / 0.746 -> en:lack of epidermal ridges on palms and soles
    n1=en:oedema | n2=en:lack of epidermal ridges on palms and soles | rel=r_associated | relid=0 | w=47
  1777. en:oedema -- r_associated #0: 47 / 0.746 -> en:landy donnai syndrome
    n1=en:oedema | n2=en:landy donnai syndrome | rel=r_associated | relid=0 | w=47
  1778. en:oedema -- r_associated #0: 47 / 0.746 -> en:large hard compact painful masses of keratin at sites of recurrent friction on palms and soles
    n1=en:oedema | n2=en:large hard compact painful masses of keratin at sites of recurrent friction on palms and soles | rel=r_associated | relid=0 | w=47
  1779. en:oedema -- r_associated #0: 47 / 0.746 -> en:leak
    n1=en:oedema | n2=en:leak | rel=r_associated | relid=0 | w=47
  1780. en:oedema -- r_associated #0: 47 / 0.746 -> en:lesions follow the lines of blaschko
    n1=en:oedema | n2=en:lesions follow the lines of blaschko | rel=r_associated | relid=0 | w=47
  1781. en:oedema -- r_associated #0: 47 / 0.746 -> en:lesions often follow blaschko lines
    n1=en:oedema | n2=en:lesions often follow blaschko lines | rel=r_associated | relid=0 | w=47
  1782. en:oedema -- r_associated #0: 47 / 0.746 -> en:leukoplakia
    n1=en:oedema | n2=en:leukoplakia | rel=r_associated | relid=0 | w=47
  1783. en:oedema -- r_associated #0: 47 / 0.746 -> en:lichenified lesions
    n1=en:oedema | n2=en:lichenified lesions | rel=r_associated | relid=0 | w=47
  1784. en:oedema -- r_associated #0: 47 / 0.746 -> en:lipid accumulation in muscle tissue
    n1=en:oedema | n2=en:lipid accumulation in muscle tissue | rel=r_associated | relid=0 | w=47
  1785. en:oedema -- r_associated #0: 47 / 0.746 -> en:lipid and glycogen accumulation
    n1=en:oedema | n2=en:lipid and glycogen accumulation | rel=r_associated | relid=0 | w=47
  1786. en:oedema -- r_associated #0: 47 / 0.746 -> en:lipodystrophy
    n1=en:oedema | n2=en:lipodystrophy | rel=r_associated | relid=0 | w=47
  1787. en:oedema -- r_associated #0: 47 / 0.746 -> en:lipohypoplasia
    n1=en:oedema | n2=en:lipohypoplasia | rel=r_associated | relid=0 | w=47
  1788. en:oedema -- r_associated #0: 47 / 0.746 -> en:localized cellulitis
    n1=en:oedema | n2=en:localized cellulitis | rel=r_associated | relid=0 | w=47
  1789. en:oedema -- r_associated #0: 47 / 0.746 -> en:localized symmetric fixed, yellow- or red-brown hyperkeratotic plaques (extensor surface of extremities, buttocks, and lateral trunk)
    n1=en:oedema | n2=en:localized symmetric fixed, yellow- or red-brown hyperkeratotic plaques (extensor surface of extremities, buttocks, and lateral trunk) | rel=r_associated | relid=0 | w=47
  1790. en:oedema -- r_associated #0: 47 / 0.746 -> en:loose skin at birth
    n1=en:oedema | n2=en:loose skin at birth | rel=r_associated | relid=0 | w=47
  1791. en:oedema -- r_associated #0: 47 / 0.746 -> en:loose volor skin of hands
    n1=en:oedema | n2=en:loose volor skin of hands | rel=r_associated | relid=0 | w=47
  1792. en:oedema -- r_associated #0: 47 / 0.746 -> en:loss of independent ambulation around age 12 years
    n1=en:oedema | n2=en:loss of independent ambulation around age 12 years | rel=r_associated | relid=0 | w=47
  1793. en:oedema -- r_associated #0: 47 / 0.746 -> en:loss of subcutaneous adipose tissue from upper limbs and trunk
    n1=en:oedema | n2=en:loss of subcutaneous adipose tissue from upper limbs and trunk | rel=r_associated | relid=0 | w=47
  1794. en:oedema -- r_associated #0: 47 / 0.746 -> en:lymphangiectasia
    n1=en:oedema | n2=en:lymphangiectasia | rel=r_associated | relid=0 | w=47
  1795. en:oedema -- r_associated #0: 47 / 0.746 -> en:lymphangioma
    n1=en:oedema | n2=en:lymphangioma | rel=r_associated | relid=0 | w=47
  1796. en:oedema -- r_associated #0: 47 / 0.746 -> en:lymphedema of lower extremity
    n1=en:oedema | n2=en:lymphedema of lower extremity | rel=r_associated | relid=0 | w=47
  1797. en:oedema -- r_associated #0: 47 / 0.746 -> en:macular edema
    n1=en:oedema | n2=en:macular edema | rel=r_associated | relid=0 | w=47
  1798. en:oedema -- r_associated #0: 47 / 0.746 -> en:malaise
    n1=en:oedema | n2=en:malaise | rel=r_associated | relid=0 | w=47
  1799. en:oedema -- r_associated #0: 47 / 0.746 -> en:malar flush
    n1=en:oedema | n2=en:malar flush | rel=r_associated | relid=0 | w=47
  1800. en:oedema -- r_associated #0: 47 / 0.746 -> en:marked bruisability
    n1=en:oedema | n2=en:marked bruisability | rel=r_associated | relid=0 | w=47
  1801. en:oedema -- r_associated #0: 47 / 0.746 -> en:michigan hand outcomes questionnaire score
    n1=en:oedema | n2=en:michigan hand outcomes questionnaire score | rel=r_associated | relid=0 | w=47
  1802. en:oedema -- r_associated #0: 47 / 0.746 -> en:mild lamellar ichthyosis
    n1=en:oedema | n2=en:mild lamellar ichthyosis | rel=r_associated | relid=0 | w=47
  1803. en:oedema -- r_associated #0: 47 / 0.746 -> en:mild weakness of the small hand muscles
    n1=en:oedema | n2=en:mild weakness of the small hand muscles | rel=r_associated | relid=0 | w=47
  1804. en:oedema -- r_associated #0: 47 / 0.746 -> en:mitochondria are placed at the periphery of muscle fibers
    n1=en:oedema | n2=en:mitochondria are placed at the periphery of muscle fibers | rel=r_associated | relid=0 | w=47
  1805. en:oedema -- r_associated #0: 47 / 0.746 -> en:multiple asymptomatic papules with atrophic white scar-like centers surrounded by telangiectatic borders
    n1=en:oedema | n2=en:multiple asymptomatic papules with atrophic white scar-like centers surrounded by telangiectatic borders | rel=r_associated | relid=0 | w=47
  1806. en:oedema -- r_associated #0: 47 / 0.746 -> en:multiple nevi (up to hundreds)
    n1=en:oedema | n2=en:multiple nevi (up to hundreds) | rel=r_associated | relid=0 | w=47
  1807. en:oedema -- r_associated #0: 47 / 0.746 -> en:multiple, red-blue, soft, compressible vascular papules or macules (especially on trunk or upper arms)
    n1=en:oedema | n2=en:multiple, red-blue, soft, compressible vascular papules or macules (especially on trunk or upper arms) | rel=r_associated | relid=0 | w=47
  1808. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle atrophy (1 patient)
    n1=en:oedema | n2=en:muscle atrophy (1 patient) | rel=r_associated | relid=0 | w=47
  1809. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle atrophy in the limbs
    n1=en:oedema | n2=en:muscle atrophy in the limbs | rel=r_associated | relid=0 | w=47
  1810. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle atrophy, distal, particularly affecting the hands muscle biopsy shows variation in fiber size
    n1=en:oedema | n2=en:muscle atrophy, distal, particularly affecting the hands muscle biopsy shows variation in fiber size | rel=r_associated | relid=0 | w=47
  1811. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers
    n1=en:oedema | n2=en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers | rel=r_associated | relid=0 | w=47
  1812. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows decreased secondary clefts
    n1=en:oedema | n2=en:muscle biopsy shows decreased secondary clefts | rel=r_associated | relid=0 | w=47
  1813. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei
    n1=en:oedema | n2=en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei | rel=r_associated | relid=0 | w=47
  1814. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows dystrophic features
    n1=en:oedema | n2=en:muscle biopsy shows dystrophic features | rel=r_associated | relid=0 | w=47
  1815. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows endplate myopathy (see details under neurologic heading)
    n1=en:oedema | n2=en:muscle biopsy shows endplate myopathy (see details under neurologic heading) | rel=r_associated | relid=0 | w=47
  1816. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows fiber type variation (in some patients)
    n1=en:oedema | n2=en:muscle biopsy shows fiber type variation (in some patients) | rel=r_associated | relid=0 | w=47
  1817. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes
    n1=en:oedema | n2=en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes | rel=r_associated | relid=0 | w=47
  1818. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows merosin (156225)-positive muscle fibers
    n1=en:oedema | n2=en:muscle biopsy shows merosin (156225)-positive muscle fibers | rel=r_associated | relid=0 | w=47
  1819. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows necrotic and regenerating fibers
    n1=en:oedema | n2=en:muscle biopsy shows necrotic and regenerating fibers | rel=r_associated | relid=0 | w=47
  1820. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows nemaline bodies (rods) on gomori trichrome staining
    n1=en:oedema | n2=en:muscle biopsy shows nemaline bodies (rods) on gomori trichrome staining | rel=r_associated | relid=0 | w=47
  1821. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows poor development of the postsynaptic membrane
    n1=en:oedema | n2=en:muscle biopsy shows poor development of the postsynaptic membrane | rel=r_associated | relid=0 | w=47
  1822. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows sarcoplasmic pas-positive vacuoles
    n1=en:oedema | n2=en:muscle biopsy shows sarcoplasmic pas-positive vacuoles | rel=r_associated | relid=0 | w=47
  1823. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers
    n1=en:oedema | n2=en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers | rel=r_associated | relid=0 | w=47
  1824. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle biopsy shows type 1 fiber predominance
    n1=en:oedema | n2=en:muscle biopsy shows type 1 fiber predominance | rel=r_associated | relid=0 | w=47
  1825. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle coenzyme q deficiency
    n1=en:oedema | n2=en:muscle coenzyme q deficiency | rel=r_associated | relid=0 | w=47
  1826. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle cramp
    n1=en:oedema | n2=en:muscle cramp | rel=r_associated | relid=0 | w=47
  1827. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle cramps may affect jaw muscles
    n1=en:oedema | n2=en:muscle cramps may affect jaw muscles | rel=r_associated | relid=0 | w=47
  1828. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness
    n1=en:oedema | n2=en:muscle weakness | rel=r_associated | relid=0 | w=47
  1829. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness following prolonged exercise
    n1=en:oedema | n2=en:muscle weakness following prolonged exercise | rel=r_associated | relid=0 | w=47
  1830. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, congenital
    n1=en:oedema | n2=en:muscle weakness, congenital | rel=r_associated | relid=0 | w=47
  1831. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, distal, particularly affecting the hands
    n1=en:oedema | n2=en:muscle weakness, distal, particularly affecting the hands | rel=r_associated | relid=0 | w=47
  1832. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, episodic
    n1=en:oedema | n2=en:muscle weakness, episodic | rel=r_associated | relid=0 | w=47
  1833. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, limb-girdle (lower and upper limbs may be affected)
    n1=en:oedema | n2=en:muscle weakness, limb-girdle (lower and upper limbs may be affected) | rel=r_associated | relid=0 | w=47
  1834. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, predominantly proximal
    n1=en:oedema | n2=en:muscle weakness, predominantly proximal | rel=r_associated | relid=0 | w=47
  1835. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, proximal and distal (predominant lower limb involvement)
    n1=en:oedema | n2=en:muscle weakness, proximal and distal (predominant lower limb involvement) | rel=r_associated | relid=0 | w=47
  1836. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, proximal greater than distal
    n1=en:oedema | n2=en:muscle weakness, proximal greater than distal | rel=r_associated | relid=0 | w=47
  1837. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, proximal, distal, and axial, severe
    n1=en:oedema | n2=en:muscle weakness, proximal, distal, and axial, severe | rel=r_associated | relid=0 | w=47
  1838. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, proximal, limb-girdle
    n1=en:oedema | n2=en:muscle weakness, proximal, limb-girdle | rel=r_associated | relid=0 | w=47
  1839. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscle weakness, severe, axial and proximal predominance
    n1=en:oedema | n2=en:muscle weakness, severe, axial and proximal predominance | rel=r_associated | relid=0 | w=47
  1840. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscles have a woody consistency on palpation
    n1=en:oedema | n2=en:muscles have a woody consistency on palpation | rel=r_associated | relid=0 | w=47
  1841. en:oedema -- r_associated #0: 47 / 0.746 -> en:muscular weakness, improving in infancy (medical research council muscle score of 3 to 4)
    n1=en:oedema | n2=en:muscular weakness, improving in infancy (medical research council muscle score of 3 to 4) | rel=r_associated | relid=0 | w=47
  1842. en:oedema -- r_associated #0: 47 / 0.746 -> en:myalgia with febrile episodes (rare)
    n1=en:oedema | n2=en:myalgia with febrile episodes (rare) | rel=r_associated | relid=0 | w=47
  1843. en:oedema -- r_associated #0: 47 / 0.746 -> en:myofibrillar lesions
    n1=en:oedema | n2=en:myofibrillar lesions | rel=r_associated | relid=0 | w=47
  1844. en:oedema -- r_associated #0: 47 / 0.746 -> en:myopathic findings on biopsy have been occasionally reported
    n1=en:oedema | n2=en:myopathic findings on biopsy have been occasionally reported | rel=r_associated | relid=0 | w=47
  1845. en:oedema -- r_associated #0: 47 / 0.746 -> en:myopathy (in some patients)
    n1=en:oedema | n2=en:myopathy (in some patients) | rel=r_associated | relid=0 | w=47
  1846. en:oedema -- r_associated #0: 47 / 0.746 -> en:myositis (in some patients)
    n1=en:oedema | n2=en:myositis (in some patients) | rel=r_associated | relid=0 | w=47
  1847. en:oedema -- r_associated #0: 47 / 0.746 -> en:myotonia is present in majority of cases
    n1=en:oedema | n2=en:myotonia is present in majority of cases | rel=r_associated | relid=0 | w=47
  1848. en:oedema -- r_associated #0: 47 / 0.746 -> en:myotonia is usually not seen
    n1=en:oedema | n2=en:myotonia is usually not seen | rel=r_associated | relid=0 | w=47
  1849. en:oedema -- r_associated #0: 47 / 0.746 -> en:myxedema (untreated hypothyroidism)
    n1=en:oedema | n2=en:myxedema (untreated hypothyroidism) | rel=r_associated | relid=0 | w=47
  1850. en:oedema -- r_associated #0: 47 / 0.746 -> en:named sign of gallbladder
    n1=en:oedema | n2=en:named sign of gallbladder | rel=r_associated | relid=0 | w=47
  1851. en:oedema -- r_associated #0: 47 / 0.746 -> en:neck and proximal limb muscle myopathy
    n1=en:oedema | n2=en:neck and proximal limb muscle myopathy | rel=r_associated | relid=0 | w=47
  1852. en:oedema -- r_associated #0: 47 / 0.746 -> en:netherton syndrome
    n1=en:oedema | n2=en:netherton syndrome | rel=r_associated | relid=0 | w=47
  1853. en:oedema -- r_associated #0: 47 / 0.746 -> en:neurogenic changes seen on emg
    n1=en:oedema | n2=en:neurogenic changes seen on emg | rel=r_associated | relid=0 | w=47
  1854. en:oedema -- r_associated #0: 47 / 0.746 -> en:nevus flammeus (eyelids and nape of neck)
    n1=en:oedema | n2=en:nevus flammeus (eyelids and nape of neck) | rel=r_associated | relid=0 | w=47
  1855. en:oedema -- r_associated #0: 47 / 0.746 -> en:no easy bruisability
    n1=en:oedema | n2=en:no easy bruisability | rel=r_associated | relid=0 | w=47
  1856. en:oedema -- r_associated #0: 47 / 0.746 -> en:no ichthyosis
    n1=en:oedema | n2=en:no ichthyosis | rel=r_associated | relid=0 | w=47
  1857. en:oedema -- r_associated #0: 47 / 0.746 -> en:no muscle weakness
    n1=en:oedema | n2=en:no muscle weakness | rel=r_associated | relid=0 | w=47
  1858. en:oedema -- r_associated #0: 47 / 0.746 -> en:non immune hydrops in newborn
    n1=en:oedema | n2=en:non immune hydrops in newborn | rel=r_associated | relid=0 | w=47
  1859. en:oedema -- r_associated #0: 47 / 0.746 -> en:non-pitting edema
    n1=en:oedema | n2=en:non-pitting edema | rel=r_associated | relid=0 | w=47
  1860. en:oedema -- r_associated #0: 47 / 0.746 -> en:non-purpuric punctate and linear erythematous rash
    n1=en:oedema | n2=en:non-purpuric punctate and linear erythematous rash | rel=r_associated | relid=0 | w=47
  1861. en:oedema -- r_associated #0: 47 / 0.746 -> en:noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy
    n1=en:oedema | n2=en:noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=47
  1862. en:oedema -- r_associated #0: 47 / 0.746 -> en:normal dystrophin immunostaining
    n1=en:oedema | n2=en:normal dystrophin immunostaining | rel=r_associated | relid=0 | w=47
  1863. en:oedema -- r_associated #0: 47 / 0.746 -> en:normal sweating
    n1=en:oedema | n2=en:normal sweating | rel=r_associated | relid=0 | w=47
  1864. en:oedema -- r_associated #0: 47 / 0.746 -> en:nuclear clumps
    n1=en:oedema | n2=en:nuclear clumps | rel=r_associated | relid=0 | w=47
  1865. en:oedema -- r_associated #0: 47 / 0.746 -> en:o/e - edema
    n1=en:oedema | n2=en:o/e - edema | rel=r_associated | relid=0 | w=47
  1866. en:oedema -- r_associated #0: 47 / 0.746 -> en:o/e - scrotal edema
    n1=en:oedema | n2=en:o/e - scrotal edema | rel=r_associated | relid=0 | w=47
  1867. en:oedema -- r_associated #0: 47 / 0.746 -> en:other injury to skin
    n1=en:oedema | n2=en:other injury to skin | rel=r_associated | relid=0 | w=47
  1868. en:oedema -- r_associated #0: 47 / 0.746 -> en:other localized skin infection
    n1=en:oedema | n2=en:other localized skin infection | rel=r_associated | relid=0 | w=47
  1869. en:oedema -- r_associated #0: 47 / 0.746 -> en:overweight
    n1=en:oedema | n2=en:overweight | rel=r_associated | relid=0 | w=47
  1870. en:oedema -- r_associated #0: 47 / 0.746 -> en:pain / sensation observable
    n1=en:oedema | n2=en:pain / sensation observable | rel=r_associated | relid=0 | w=47
  1871. en:oedema -- r_associated #0: 47 / 0.746 -> en:pallor (in some patients)
    n1=en:oedema | n2=en:pallor (in some patients) | rel=r_associated | relid=0 | w=47
  1872. en:oedema -- r_associated #0: 47 / 0.746 -> en:palmar nevi
    n1=en:oedema | n2=en:palmar nevi | rel=r_associated | relid=0 | w=47
  1873. en:oedema -- r_associated #0: 47 / 0.746 -> en:palmoplantar epidermolytic hyperkeratosis along blaschko lines (rare)
    n1=en:oedema | n2=en:palmoplantar epidermolytic hyperkeratosis along blaschko lines (rare) | rel=r_associated | relid=0 | w=47
  1874. en:oedema -- r_associated #0: 47 / 0.746 -> en:palmoplantar keratosis with erythema and scale
    n1=en:oedema | n2=en:palmoplantar keratosis with erythema and scale | rel=r_associated | relid=0 | w=47
  1875. en:oedema -- r_associated #0: 47 / 0.746 -> en:pelvic girdle weakness
    n1=en:oedema | n2=en:pelvic girdle weakness | rel=r_associated | relid=0 | w=47
  1876. en:oedema -- r_associated #0: 47 / 0.746 -> en:penile venereal edema
    n1=en:oedema | n2=en:penile venereal edema | rel=r_associated | relid=0 | w=47
  1877. en:oedema -- r_associated #0: 47 / 0.746 -> en:percussion myotonias
    n1=en:oedema | n2=en:percussion myotonias | rel=r_associated | relid=0 | w=47
  1878. en:oedema -- r_associated #0: 47 / 0.746 -> en:perineal intertrigo
    n1=en:oedema | n2=en:perineal intertrigo | rel=r_associated | relid=0 | w=47
  1879. en:oedema -- r_associated #0: 47 / 0.746 -> en:pharmacotherapeutic
    n1=en:oedema | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=47
  1880. en:oedema -- r_associated #0: 47 / 0.746 -> en:photosensitivity (harderoporphyria and hcp)
    n1=en:oedema | n2=en:photosensitivity (harderoporphyria and hcp) | rel=r_associated | relid=0 | w=47
  1881. en:oedema -- r_associated #0: 47 / 0.746 -> en:physical symptom
    n1=en:oedema | n2=en:physical symptom | rel=r_associated | relid=0 | w=47
  1882. en:oedema -- r_associated #0: 47 / 0.746 -> en:pigmentary abnormalities
    n1=en:oedema | n2=en:pigmentary abnormalities | rel=r_associated | relid=0 | w=47
  1883. en:oedema -- r_associated #0: 47 / 0.746 -> en:pilomatricoma
    n1=en:oedema | n2=en:pilomatricoma | rel=r_associated | relid=0 | w=47
  1884. en:oedema -- r_associated #0: 47 / 0.746 -> en:plantar blistering
    n1=en:oedema | n2=en:plantar blistering | rel=r_associated | relid=0 | w=47
  1885. en:oedema -- r_associated #0: 47 / 0.746 -> en:plexiform neurofibroma (76%)
    n1=en:oedema | n2=en:plexiform neurofibroma (76%) | rel=r_associated | relid=0 | w=47
  1886. en:oedema -- r_associated #0: 47 / 0.746 -> en:poorly defined palmar creases
    n1=en:oedema | n2=en:poorly defined palmar creases | rel=r_associated | relid=0 | w=47
  1887. en:oedema -- r_associated #0: 47 / 0.746 -> en:port wine stain
    n1=en:oedema | n2=en:port wine stain | rel=r_associated | relid=0 | w=47
  1888. en:oedema -- r_associated #0: 47 / 0.746 -> en:postoperative hemorrhage
    n1=en:oedema | n2=en:postoperative hemorrhage | rel=r_associated | relid=0 | w=47
  1889. en:oedema -- r_associated #0: 47 / 0.746 -> en:pretibial pigmented granulomatous plaques
    n1=en:oedema | n2=en:pretibial pigmented granulomatous plaques | rel=r_associated | relid=0 | w=47
  1890. en:oedema -- r_associated #0: 47 / 0.746 -> en:primary myopathic changes seen on emg
    n1=en:oedema | n2=en:primary myopathic changes seen on emg | rel=r_associated | relid=0 | w=47
  1891. en:oedema -- r_associated #0: 47 / 0.746 -> en:progeric skin changes
    n1=en:oedema | n2=en:progeric skin changes | rel=r_associated | relid=0 | w=47
  1892. en:oedema -- r_associated #0: 47 / 0.746 -> en:progression of skin lesions -
    n1=en:oedema | n2=en:progression of skin lesions - | rel=r_associated | relid=0 | w=47
  1893. en:oedema -- r_associated #0: 47 / 0.746 -> en:proximal limb muscle weakness (occurs later)
    n1=en:oedema | n2=en:proximal limb muscle weakness (occurs later) | rel=r_associated | relid=0 | w=47
  1894. en:oedema -- r_associated #0: 47 / 0.746 -> en:proximal lower limb amyotrophy
    n1=en:oedema | n2=en:proximal lower limb amyotrophy | rel=r_associated | relid=0 | w=47
  1895. en:oedema -- r_associated #0: 47 / 0.746 -> en:proximal muscles more often affected
    n1=en:oedema | n2=en:proximal muscles more often affected | rel=r_associated | relid=0 | w=47
  1896. en:oedema -- r_associated #0: 47 / 0.746 -> en:prurigo
    n1=en:oedema | n2=en:prurigo | rel=r_associated | relid=0 | w=47
  1897. en:oedema -- r_associated #0: 47 / 0.746 -> en:pruritis, intense
    n1=en:oedema | n2=en:pruritis, intense | rel=r_associated | relid=0 | w=47
  1898. en:oedema -- r_associated #0: 47 / 0.746 -> en:psoriasiform plaques
    n1=en:oedema | n2=en:psoriasiform plaques | rel=r_associated | relid=0 | w=47
  1899. en:oedema -- r_associated #0: 47 / 0.746 -> en:pustular lesion
    n1=en:oedema | n2=en:pustular lesion | rel=r_associated | relid=0 | w=47
  1900. en:oedema -- r_associated #0: 47 / 0.746 -> en:pyoderma
    n1=en:oedema | n2=en:pyoderma | rel=r_associated | relid=0 | w=47
  1901. en:oedema -- r_associated #0: 47 / 0.746 -> en:ragged-red fibers seen on muscle biopsy
    n1=en:oedema | n2=en:ragged-red fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=47
  1902. en:oedema -- r_associated #0: 47 / 0.746 -> en:red, cracking, peeling skin at birth
    n1=en:oedema | n2=en:red, cracking, peeling skin at birth | rel=r_associated | relid=0 | w=47
  1903. en:oedema -- r_associated #0: 47 / 0.746 -> en:reduced ankle dorsiflexion
    n1=en:oedema | n2=en:reduced ankle dorsiflexion | rel=r_associated | relid=0 | w=47
  1904. en:oedema -- r_associated #0: 47 / 0.746 -> en:reduced muscle bulk
    n1=en:oedema | n2=en:reduced muscle bulk | rel=r_associated | relid=0 | w=47
  1905. en:oedema -- r_associated #0: 47 / 0.746 -> en:reduced muscle mass
    n1=en:oedema | n2=en:reduced muscle mass | rel=r_associated | relid=0 | w=47
  1906. en:oedema -- r_associated #0: 47 / 0.746 -> en:redundancy of basal lamina with accumulated debris
    n1=en:oedema | n2=en:redundancy of basal lamina with accumulated debris | rel=r_associated | relid=0 | w=47
  1907. en:oedema -- r_associated #0: 47 / 0.746 -> en:relative sparing of the tibialis anterior
    n1=en:oedema | n2=en:relative sparing of the tibialis anterior | rel=r_associated | relid=0 | w=47
  1908. en:oedema -- r_associated #0: 47 / 0.746 -> en:respiratory observable
    n1=en:oedema | n2=en:respiratory observable | rel=r_associated | relid=0 | w=47
  1909. en:oedema -- r_associated #0: 47 / 0.746 -> en:reticulocytosis
    n1=en:oedema | n2=en:reticulocytosis | rel=r_associated | relid=0 | w=47
  1910. en:oedema -- r_associated #0: 47 / 0.746 -> en:rhabdomyolysis may occur
    n1=en:oedema | n2=en:rhabdomyolysis may occur | rel=r_associated | relid=0 | w=47
  1911. en:oedema -- r_associated #0: 47 / 0.746 -> en:rimmed vacuoles with basophilic granular material
    n1=en:oedema | n2=en:rimmed vacuoles with basophilic granular material | rel=r_associated | relid=0 | w=47
  1912. en:oedema -- r_associated #0: 47 / 0.746 -> en:sacral edema
    n1=en:oedema | n2=en:sacral edema | rel=r_associated | relid=0 | w=47
  1913. en:oedema -- r_associated #0: 47 / 0.746 -> en:sacral striae
    n1=en:oedema | n2=en:sacral striae | rel=r_associated | relid=0 | w=47
  1914. en:oedema -- r_associated #0: 47 / 0.746 -> en:scabies and other acariases
    n1=en:oedema | n2=en:scabies and other acariases | rel=r_associated | relid=0 | w=47
  1915. en:oedema -- r_associated #0: 47 / 0.746 -> en:scalding burn
    n1=en:oedema | n2=en:scalding burn | rel=r_associated | relid=0 | w=47
  1916. en:oedema -- r_associated #0: 47 / 0.746 -> en:scalp
    n1=en:oedema | n2=en:scalp | rel=r_associated | relid=0 | w=47
  1917. en:oedema -- r_associated #0: 47 / 0.746 -> en:scalp dryness
    n1=en:oedema | n2=en:scalp dryness | rel=r_associated | relid=0 | w=47
  1918. en:oedema -- r_associated #0: 47 / 0.746 -> en:scalp sinus formation
    n1=en:oedema | n2=en:scalp sinus formation | rel=r_associated | relid=0 | w=47
  1919. en:oedema -- r_associated #0: 47 / 0.746 -> en:scapular muscle atrophy
    n1=en:oedema | n2=en:scapular muscle atrophy | rel=r_associated | relid=0 | w=47
  1920. en:oedema -- r_associated #0: 47 / 0.746 -> en:scarring (late complication)
    n1=en:oedema | n2=en:scarring (late complication) | rel=r_associated | relid=0 | w=47
  1921. en:oedema -- r_associated #0: 47 / 0.746 -> en:severe atopic dermatitis
    n1=en:oedema | n2=en:severe atopic dermatitis | rel=r_associated | relid=0 | w=47
  1922. en:oedema -- r_associated #0: 47 / 0.746 -> en:severe disability within 20 years of onset
    n1=en:oedema | n2=en:severe disability within 20 years of onset | rel=r_associated | relid=0 | w=47
  1923. en:oedema -- r_associated #0: 47 / 0.746 -> en:severe facial acne (in female patient)
    n1=en:oedema | n2=en:severe facial acne (in female patient) | rel=r_associated | relid=0 | w=47
  1924. en:oedema -- r_associated #0: 47 / 0.746 -> en:severe photosensitivity
    n1=en:oedema | n2=en:severe photosensitivity | rel=r_associated | relid=0 | w=47
  1925. en:oedema -- r_associated #0: 47 / 0.746 -> en:shagreen patch
    n1=en:oedema | n2=en:shagreen patch | rel=r_associated | relid=0 | w=47
  1926. en:oedema -- r_associated #0: 47 / 0.746 -> en:shoulder weakness and atrophy
    n1=en:oedema | n2=en:shoulder weakness and atrophy | rel=r_associated | relid=0 | w=47
  1927. en:oedema -- r_associated #0: 47 / 0.746 -> en:single, bilateral, symmetric papular/nodular lesion in the midline plantar region of the heel (0.5 - 1 cm diameter)
    n1=en:oedema | n2=en:single, bilateral, symmetric papular/nodular lesion in the midline plantar region of the heel (0.5 - 1 cm diameter) | rel=r_associated | relid=0 | w=47
  1928. en:oedema -- r_associated #0: 47 / 0.746 -> en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers
    n1=en:oedema | n2=en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers | rel=r_associated | relid=0 | w=47
  1929. en:oedema -- r_associated #0: 47 / 0.746 -> en:skin blisters
    n1=en:oedema | n2=en:skin blisters | rel=r_associated | relid=0 | w=47
  1930. en:oedema -- r_associated #0: 47 / 0.746 -> en:skin dimple over apex of long bone angulation
    n1=en:oedema | n2=en:skin dimple over apex of long bone angulation | rel=r_associated | relid=0 | w=47
  1931. en:oedema -- r_associated #0: 47 / 0.746 -> en:skin of left lower limb
    n1=en:oedema | n2=en:skin of left lower limb | rel=r_associated | relid=0 | w=47
  1932. en:oedema -- r_associated #0: 47 / 0.746 -> en:small hemorrhagic blisters on hands
    n1=en:oedema | n2=en:small hemorrhagic blisters on hands | rel=r_associated | relid=0 | w=47
  1933. en:oedema -- r_associated #0: 47 / 0.746 -> en:small or absent axon terminals
    n1=en:oedema | n2=en:small or absent axon terminals | rel=r_associated | relid=0 | w=47
  1934. en:oedema -- r_associated #0: 47 / 0.746 -> en:small pterygia (axillary, popliteal)
    n1=en:oedema | n2=en:small pterygia (axillary, popliteal) | rel=r_associated | relid=0 | w=47
  1935. en:oedema -- r_associated #0: 47 / 0.746 -> en:small, angulated muscle fibers seen on muscle biopsy
    n1=en:oedema | n2=en:small, angulated muscle fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=47
  1936. en:oedema -- r_associated #0: 47 / 0.746 -> en:sodium acetate 4 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium acetate 4 meq/ml injectable solution | rel=r_associated | relid=0 | w=47
  1937. en:oedema -- r_associated #0: 47 / 0.746 -> en:sodium bicarbonate 4.2% infusion solution bag
    n1=en:oedema | n2=en:sodium bicarbonate 4.2% infusion solution bag | rel=r_associated | relid=0 | w=47
  1938. en:oedema -- r_associated #0: 47 / 0.746 -> en:sodium bicarbonate 42 mg/ml inhalant solution
    n1=en:oedema | n2=en:sodium bicarbonate 42 mg/ml inhalant solution | rel=r_associated | relid=0 | w=47
  1939. en:oedema -- r_associated #0: 47 / 0.746 -> en:sodium chloride 0.0769 meq/ml inhalant solution
    n1=en:oedema | n2=en:sodium chloride 0.0769 meq/ml inhalant solution | rel=r_associated | relid=0 | w=47
  1940. en:oedema -- r_associated #0: 47 / 0.746 -> en:sodium chloride 0.111 meq/ml nasal spray
    n1=en:oedema | n2=en:sodium chloride 0.111 meq/ml nasal spray | rel=r_associated | relid=0 | w=47
  1941. en:oedema -- r_associated #0: 47 / 0.746 -> en:soft, doughy skin
    n1=en:oedema | n2=en:soft, doughy skin | rel=r_associated | relid=0 | w=47
  1942. en:oedema -- r_associated #0: 47 / 0.746 -> en:soft, redundant skin (especially facial)
    n1=en:oedema | n2=en:soft, redundant skin (especially facial) | rel=r_associated | relid=0 | w=47
  1943. en:oedema -- r_associated #0: 47 / 0.746 -> en:soft, thin skin (1 family)
    n1=en:oedema | n2=en:soft, thin skin (1 family) | rel=r_associated | relid=0 | w=47
  1944. en:oedema -- r_associated #0: 47 / 0.746 -> en:soft, velvety skin
    n1=en:oedema | n2=en:soft, velvety skin | rel=r_associated | relid=0 | w=47
  1945. en:oedema -- r_associated #0: 47 / 0.746 -> en:spheroids
    n1=en:oedema | n2=en:spheroids | rel=r_associated | relid=0 | w=47
  1946. en:oedema -- r_associated #0: 47 / 0.746 -> en:spiky hyperkeratosis
    n1=en:oedema | n2=en:spiky hyperkeratosis | rel=r_associated | relid=0 | w=47
  1947. en:oedema -- r_associated #0: 47 / 0.746 -> en:spontaneous, non-scarring healing
    n1=en:oedema | n2=en:spontaneous, non-scarring healing | rel=r_associated | relid=0 | w=47
  1948. en:oedema -- r_associated #0: 47 / 0.746 -> en:spotty hypopigmentation
    n1=en:oedema | n2=en:spotty hypopigmentation | rel=r_associated | relid=0 | w=47
  1949. en:oedema -- r_associated #0: 47 / 0.746 -> en:sputum excretion difficulty
    n1=en:oedema | n2=en:sputum excretion difficulty | rel=r_associated | relid=0 | w=47
  1950. en:oedema -- r_associated #0: 47 / 0.746 -> en:starfish-like acral keratoses (knuckles)
    n1=en:oedema | n2=en:starfish-like acral keratoses (knuckles) | rel=r_associated | relid=0 | w=47
  1951. en:oedema -- r_associated #0: 47 / 0.746 -> en:subcutaneous ossifications
    n1=en:oedema | n2=en:subcutaneous ossifications | rel=r_associated | relid=0 | w=47
  1952. en:oedema -- r_associated #0: 47 / 0.746 -> en:subcutaneous scalp cysts
    n1=en:oedema | n2=en:subcutaneous scalp cysts | rel=r_associated | relid=0 | w=47
  1953. en:oedema -- r_associated #0: 47 / 0.746 -> en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions
    n1=en:oedema | n2=en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions | rel=r_associated | relid=0 | w=47
  1954. en:oedema -- r_associated #0: 47 / 0.746 -> en:subsarcolemmal hyaline bodies in 25-30% type i fibers only
    n1=en:oedema | n2=en:subsarcolemmal hyaline bodies in 25-30% type i fibers only | rel=r_associated | relid=0 | w=47
  1955. en:oedema -- r_associated #0: 47 / 0.746 -> en:subsarcolemmal lipofuscin-positive deposits
    n1=en:oedema | n2=en:subsarcolemmal lipofuscin-positive deposits | rel=r_associated | relid=0 | w=47
  1956. en:oedema -- r_associated #0: 47 / 0.746 -> en:superficial skin peeling (limited to dorsa of hands and feet)
    n1=en:oedema | n2=en:superficial skin peeling (limited to dorsa of hands and feet) | rel=r_associated | relid=0 | w=47
  1957. en:oedema -- r_associated #0: 47 / 0.746 -> en:superficial, firm, circumscribed nodule
    n1=en:oedema | n2=en:superficial, firm, circumscribed nodule | rel=r_associated | relid=0 | w=47
  1958. en:oedema -- r_associated #0: 47 / 0.746 -> en:sweating
    n1=en:oedema | n2=en:sweating | rel=r_associated | relid=0 | w=47
  1959. en:oedema -- r_associated #0: 47 / 0.746 -> en:telangiectases in sun-exposed and nonexposed skin
    n1=en:oedema | n2=en:telangiectases in sun-exposed and nonexposed skin | rel=r_associated | relid=0 | w=47
  1960. en:oedema -- r_associated #0: 47 / 0.746 -> en:tendinous and tuberous xanthoma
    n1=en:oedema | n2=en:tendinous and tuberous xanthoma | rel=r_associated | relid=0 | w=47
  1961. en:oedema -- r_associated #0: 47 / 0.746 -> en:testicular hydrocele
    n1=en:oedema | n2=en:testicular hydrocele | rel=r_associated | relid=0 | w=47
  1962. en:oedema -- r_associated #0: 47 / 0.746 -> en:thenar muscle atrophy
    n1=en:oedema | n2=en:thenar muscle atrophy | rel=r_associated | relid=0 | w=47
  1963. en:oedema -- r_associated #0: 47 / 0.746 -> en:thick palmar fascia
    n1=en:oedema | n2=en:thick palmar fascia | rel=r_associated | relid=0 | w=47
  1964. en:oedema -- r_associated #0: 47 / 0.746 -> en:thin, hyperpigmented skin
    n1=en:oedema | n2=en:thin, hyperpigmented skin | rel=r_associated | relid=0 | w=47
  1965. en:oedema -- r_associated #0: 47 / 0.746 -> en:thin, translucent skin
    n1=en:oedema | n2=en:thin, translucent skin | rel=r_associated | relid=0 | w=47
  1966. en:oedema -- r_associated #0: 47 / 0.746 -> en:thin, transparent skin (hands and feet)
    n1=en:oedema | n2=en:thin, transparent skin (hands and feet) | rel=r_associated | relid=0 | w=47
  1967. en:oedema -- r_associated #0: 47 / 0.746 -> en:transient edema
    n1=en:oedema | n2=en:transient edema | rel=r_associated | relid=0 | w=47
  1968. en:oedema -- r_associated #0: 47 / 0.746 -> en:transient erysipelas-like erythematous rash
    n1=en:oedema | n2=en:transient erysipelas-like erythematous rash | rel=r_associated | relid=0 | w=47
  1969. en:oedema -- r_associated #0: 47 / 0.746 -> en:traumatic generalized cerebral edema
    n1=en:oedema | n2=en:traumatic generalized cerebral edema | rel=r_associated | relid=0 | w=47
  1970. en:oedema -- r_associated #0: 47 / 0.746 -> en:trunk muscle atrophy
    n1=en:oedema | n2=en:trunk muscle atrophy | rel=r_associated | relid=0 | w=47
  1971. en:oedema -- r_associated #0: 47 / 0.746 -> en:tubular aggregates in type 2 skeletal muscle fibers
    n1=en:oedema | n2=en:tubular aggregates in type 2 skeletal muscle fibers | rel=r_associated | relid=0 | w=47
  1972. en:oedema -- r_associated #0: 47 / 0.746 -> en:tubulofilamentous inclusions
    n1=en:oedema | n2=en:tubulofilamentous inclusions | rel=r_associated | relid=0 | w=47
  1973. en:oedema -- r_associated #0: 47 / 0.746 -> en:type 1 fiber atrophy seen on muscle biopsy
    n1=en:oedema | n2=en:type 1 fiber atrophy seen on muscle biopsy | rel=r_associated | relid=0 | w=47
  1974. en:oedema -- r_associated #0: 47 / 0.746 -> en:type ii fiber predominance
    n1=en:oedema | n2=en:type ii fiber predominance | rel=r_associated | relid=0 | w=47
  1975. en:oedema -- r_associated #0: 47 / 0.746 -> en:ubiquinone decreased
    n1=en:oedema | n2=en:ubiquinone decreased | rel=r_associated | relid=0 | w=47
  1976. en:oedema -- r_associated #0: 47 / 0.746 -> en:ulcer observable
    n1=en:oedema | n2=en:ulcer observable | rel=r_associated | relid=0 | w=47
  1977. en:oedema -- r_associated #0: 47 / 0.746 -> en:unable to walk
    n1=en:oedema | n2=en:unable to walk | rel=r_associated | relid=0 | w=47
  1978. en:oedema -- r_associated #0: 47 / 0.746 -> en:urticaria
    n1=en:oedema | n2=en:urticaria | rel=r_associated | relid=0 | w=47
  1979. en:oedema -- r_associated #0: 47 / 0.746 -> en:use of ultrasonography
    n1=en:oedema | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=47
  1980. en:oedema -- r_associated #0: 47 / 0.746 -> en:vacuolar myopathy may occur
    n1=en:oedema | n2=en:vacuolar myopathy may occur | rel=r_associated | relid=0 | w=47
  1981. en:oedema -- r_associated #0: 47 / 0.746 -> en:variably decreased activities of mitochondrial respiratory complexes i, ii, and iv
    n1=en:oedema | n2=en:variably decreased activities of mitochondrial respiratory complexes i, ii, and iv | rel=r_associated | relid=0 | w=47
  1982. en:oedema -- r_associated #0: 47 / 0.746 -> en:vasculitis rash
    n1=en:oedema | n2=en:vasculitis rash | rel=r_associated | relid=0 | w=47
  1983. en:oedema -- r_associated #0: 47 / 0.746 -> en:verrucae (warts), multiple
    n1=en:oedema | n2=en:verrucae (warts), multiple | rel=r_associated | relid=0 | w=47
  1984. en:oedema -- r_associated #0: 47 / 0.746 -> en:vesicles, congenital, on fingers and soles
    n1=en:oedema | n2=en:vesicles, congenital, on fingers and soles | rel=r_associated | relid=0 | w=47
  1985. en:oedema -- r_associated #0: 47 / 0.746 -> en:visceral edema
    n1=en:oedema | n2=en:visceral edema | rel=r_associated | relid=0 | w=47
  1986. en:oedema -- r_associated #0: 47 / 0.746 -> en:vitiligo (1 patient)
    n1=en:oedema | n2=en:vitiligo (1 patient) | rel=r_associated | relid=0 | w=47
  1987. en:oedema -- r_associated #0: 47 / 0.746 -> en:voice alteration
    n1=en:oedema | n2=en:voice alteration | rel=r_associated | relid=0 | w=47
  1988. en:oedema -- r_associated #0: 47 / 0.746 -> en:voice handicap index score
    n1=en:oedema | n2=en:voice handicap index score | rel=r_associated | relid=0 | w=47
  1989. en:oedema -- r_associated #0: 47 / 0.746 -> en:warty thickening of flexural skin
    n1=en:oedema | n2=en:warty thickening of flexural skin | rel=r_associated | relid=0 | w=47
  1990. en:oedema -- r_associated #0: 47 / 0.746 -> en:water thesaurismosis
    n1=en:oedema | n2=en:water thesaurismosis | rel=r_associated | relid=0 | w=47
  1991. en:oedema -- r_associated #0: 47 / 0.746 -> en:weakness of anterior compartment tibial muscles
    n1=en:oedema | n2=en:weakness of anterior compartment tibial muscles | rel=r_associated | relid=0 | w=47
  1992. en:oedema -- r_associated #0: 47 / 0.746 -> en:weakness of the extensor muscles of the hands (initially)
    n1=en:oedema | n2=en:weakness of the extensor muscles of the hands (initially) | rel=r_associated | relid=0 | w=47
  1993. en:oedema -- r_associated #0: 47 / 0.746 -> en:well-defined erythematous border
    n1=en:oedema | n2=en:well-defined erythematous border | rel=r_associated | relid=0 | w=47
  1994. en:oedema -- r_associated #0: 47 / 0.746 -> en:wide, thin scars
    n1=en:oedema | n2=en:wide, thin scars | rel=r_associated | relid=0 | w=47
  1995. en:oedema -- r_associated #0: 47 / 0.746 -> en:winged scapula
    n1=en:oedema | n2=en:winged scapula | rel=r_associated | relid=0 | w=47
  1996. en:oedema -- r_associated #0: 47 / 0.746 -> en:wrinkled face
    n1=en:oedema | n2=en:wrinkled face | rel=r_associated | relid=0 | w=47
  1997. en:oedema -- r_associated #0: 47 / 0.746 -> en:wrinkled skin over fingers
    n1=en:oedema | n2=en:wrinkled skin over fingers | rel=r_associated | relid=0 | w=47
  1998. en:oedema -- r_associated #0: 47 / 0.746 -> en:z-disks with abnormal homogeneous material
    n1=en:oedema | n2=en:z-disks with abnormal homogeneous material | rel=r_associated | relid=0 | w=47
  1999. en:oedema -- r_associated #0: 47 / 0.746 -> épanchement articulaire
    n1=en:oedema | n2=épanchement articulaire | rel=r_associated | relid=0 | w=47
  2000. en:oedema -- r_associated #0: 47 / 0.746 -> maladies
    n1=en:oedema | n2=maladies | rel=r_associated | relid=0 | w=47
  2001. en:oedema -- r_associated #0: 47 / 0.746 -> oedématie
    n1=en:oedema | n2=oedématie | rel=r_associated | relid=0 | w=47
  2002. en:oedema -- r_associated #0: 47 / 0.746 -> oedème de Calabar
    n1=en:oedema | n2=oedème de Calabar | rel=r_associated | relid=0 | w=47
  2003. en:oedema -- r_associated #0: 47 / 0.746 -> oedème papillaire
    n1=en:oedema | n2=oedème papillaire | rel=r_associated | relid=0 | w=47
  2004. en:oedema -- r_associated #0: 47 / 0.746 -> rétention
    n1=en:oedema | n2=rétention | rel=r_associated | relid=0 | w=47
  2005. en:oedema -- r_associated #0: 46 / 0.73 -> anasarque
    (Nom)
    n1=en:oedema | n2=anasarque
    (Nom)
    | rel=r_associated | relid=0 | w=46
  2006. en:oedema -- r_associated #0: 46 / 0.73 -> en:1-5mm dark lentigines (especially neck and trunk)
    n1=en:oedema | n2=en:1-5mm dark lentigines (especially neck and trunk) | rel=r_associated | relid=0 | w=46
  2007. en:oedema -- r_associated #0: 46 / 0.73 -> en:3. lax, wrinkled skin
    n1=en:oedema | n2=en:3. lax, wrinkled skin | rel=r_associated | relid=0 | w=46
  2008. en:oedema -- r_associated #0: 46 / 0.73 -> en:abnormal fat accumulation in the back (in some patients)
    n1=en:oedema | n2=en:abnormal fat accumulation in the back (in some patients) | rel=r_associated | relid=0 | w=46
  2009. en:oedema -- r_associated #0: 46 / 0.73 -> en:abnormal secretion
    n1=en:oedema | n2=en:abnormal secretion | rel=r_associated | relid=0 | w=46
  2010. en:oedema -- r_associated #0: 46 / 0.73 -> en:abnormalities in myofibril organization
    n1=en:oedema | n2=en:abnormalities in myofibril organization | rel=r_associated | relid=0 | w=46
  2011. en:oedema -- r_associated #0: 46 / 0.73 -> en:absence of pretibial myxedema
    n1=en:oedema | n2=en:absence of pretibial myxedema | rel=r_associated | relid=0 | w=46
  2012. en:oedema -- r_associated #0: 46 / 0.73 -> en:absence of skin creases over proximal interphalangeal (pip) joints
    n1=en:oedema | n2=en:absence of skin creases over proximal interphalangeal (pip) joints | rel=r_associated | relid=0 | w=46
  2013. en:oedema -- r_associated #0: 46 / 0.73 -> en:acanthosis nigricans (in some patients)
    n1=en:oedema | n2=en:acanthosis nigricans (in some patients) | rel=r_associated | relid=0 | w=46
  2014. en:oedema -- r_associated #0: 46 / 0.73 -> en:acanthosis nigricans, axillary (in male patient)
    n1=en:oedema | n2=en:acanthosis nigricans, axillary (in male patient) | rel=r_associated | relid=0 | w=46
  2015. en:oedema -- r_associated #0: 46 / 0.73 -> en:acquire ability to walk and jump in childhood, but motor regression occurs later
    n1=en:oedema | n2=en:acquire ability to walk and jump in childhood, but motor regression occurs later | rel=r_associated | relid=0 | w=46
  2016. en:oedema -- r_associated #0: 46 / 0.73 -> en:acquired partial lipodystrophy
    n1=en:oedema | n2=en:acquired partial lipodystrophy | rel=r_associated | relid=0 | w=46
  2017. en:oedema -- r_associated #0: 46 / 0.73 -> en:acrocyanosis
    n1=en:oedema | n2=en:acrocyanosis | rel=r_associated | relid=0 | w=46
  2018. en:oedema -- r_associated #0: 46 / 0.73 -> en:akathisia
    n1=en:oedema | n2=en:akathisia | rel=r_associated | relid=0 | w=46
  2019. en:oedema -- r_associated #0: 46 / 0.73 -> en:amniotic fluid
    n1=en:oedema | n2=en:amniotic fluid | rel=r_associated | relid=0 | w=46
  2020. en:oedema -- r_associated #0: 46 / 0.73 -> en:amyotrophy of the lower limbs (in some patients)
    n1=en:oedema | n2=en:amyotrophy of the lower limbs (in some patients) | rel=r_associated | relid=0 | w=46
  2021. en:oedema -- r_associated #0: 46 / 0.73 -> en:anasarca
    n1=en:oedema | n2=en:anasarca | rel=r_associated | relid=0 | w=46
  2022. en:oedema -- r_associated #0: 46 / 0.73 -> en:annular lesions (3 mm to 1 cm in diameter) located on the face, neck, trunk and limbs
    n1=en:oedema | n2=en:annular lesions (3 mm to 1 cm in diameter) located on the face, neck, trunk and limbs | rel=r_associated | relid=0 | w=46
  2023. en:oedema -- r_associated #0: 46 / 0.73 -> en:anticoagulant agent
    n1=en:oedema | n2=en:anticoagulant agent | rel=r_associated | relid=0 | w=46
  2024. en:oedema -- r_associated #0: 46 / 0.73 -> en:aplasia cutis of the scalp
    n1=en:oedema | n2=en:aplasia cutis of the scalp | rel=r_associated | relid=0 | w=46
  2025. en:oedema -- r_associated #0: 46 / 0.73 -> en:aplasia/hypoplastia of the eccrine sweat glands
    n1=en:oedema | n2=en:aplasia/hypoplastia of the eccrine sweat glands | rel=r_associated | relid=0 | w=46
  2026. en:oedema -- r_associated #0: 46 / 0.73 -> en:apnea adverse event
    n1=en:oedema | n2=en:apnea adverse event | rel=r_associated | relid=0 | w=46
  2027. en:oedema -- r_associated #0: 46 / 0.73 -> en:ascitis
    n1=en:oedema | n2=en:ascitis | rel=r_associated | relid=0 | w=46
  2028. en:oedema -- r_associated #0: 46 / 0.73 -> en:atrophic scar
    n1=en:oedema | n2=en:atrophic scar | rel=r_associated | relid=0 | w=46
  2029. en:oedema -- r_associated #0: 46 / 0.73 -> en:atrophy of neck muscles may occur later
    n1=en:oedema | n2=en:atrophy of neck muscles may occur later | rel=r_associated | relid=0 | w=46
  2030. en:oedema -- r_associated #0: 46 / 0.73 -> en:atrophy of upper girdle muscles
    n1=en:oedema | n2=en:atrophy of upper girdle muscles | rel=r_associated | relid=0 | w=46
  2031. en:oedema -- r_associated #0: 46 / 0.73 -> en:attacks of weakness
    n1=en:oedema | n2=en:attacks of weakness | rel=r_associated | relid=0 | w=46
  2032. en:oedema -- r_associated #0: 46 / 0.73 -> en:baldness/losing hair
    n1=en:oedema | n2=en:baldness/losing hair | rel=r_associated | relid=0 | w=46
  2033. en:oedema -- r_associated #0: 46 / 0.73 -> en:behcet syndrome
    n1=en:oedema | n2=en:behcet syndrome | rel=r_associated | relid=0 | w=46
  2034. en:oedema -- r_associated #0: 46 / 0.73 -> en:bilateral facial weakness (congenital form)
    n1=en:oedema | n2=en:bilateral facial weakness (congenital form) | rel=r_associated | relid=0 | w=46
  2035. en:oedema -- r_associated #0: 46 / 0.73 -> en:biopsy muscle normal
    n1=en:oedema | n2=en:biopsy muscle normal | rel=r_associated | relid=0 | w=46
  2036. en:oedema -- r_associated #0: 46 / 0.73 -> en:biopsy shows degenerative changes consistent with myopathy
    n1=en:oedema | n2=en:biopsy shows degenerative changes consistent with myopathy | rel=r_associated | relid=0 | w=46
  2037. en:oedema -- r_associated #0: 46 / 0.73 -> en:blanching of the fingers in response to cold
    n1=en:oedema | n2=en:blanching of the fingers in response to cold | rel=r_associated | relid=0 | w=46
  2038. en:oedema -- r_associated #0: 46 / 0.73 -> en:blister
    n1=en:oedema | n2=en:blister | rel=r_associated | relid=0 | w=46
  2039. en:oedema -- r_associated #0: 46 / 0.73 -> en:blistering occurs in clusters ('herpetiform', 'arcuate')
    n1=en:oedema | n2=en:blistering occurs in clusters ('herpetiform', 'arcuate') | rel=r_associated | relid=0 | w=46
  2040. en:oedema -- r_associated #0: 46 / 0.73 -> en:blood clot
    n1=en:oedema | n2=en:blood clot | rel=r_associated | relid=0 | w=46
  2041. en:oedema -- r_associated #0: 46 / 0.73 -> en:blood transfusion and donation
    n1=en:oedema | n2=en:blood transfusion and donation | rel=r_associated | relid=0 | w=46
  2042. en:oedema -- r_associated #0: 46 / 0.73 -> en:blood, lymphatics/immune system observable
    n1=en:oedema | n2=en:blood, lymphatics/immune system observable | rel=r_associated | relid=0 | w=46
  2043. en:oedema -- r_associated #0: 46 / 0.73 -> en:bluish-red border demarcating transition to normal skin
    n1=en:oedema | n2=en:bluish-red border demarcating transition to normal skin | rel=r_associated | relid=0 | w=46
  2044. en:oedema -- r_associated #0: 46 / 0.73 -> en:body water excess
    n1=en:oedema | n2=en:body water excess | rel=r_associated | relid=0 | w=46
  2045. en:oedema -- r_associated #0: 46 / 0.73 -> en:bovine atypical interstitial pneumonia
    n1=en:oedema | n2=en:bovine atypical interstitial pneumonia | rel=r_associated | relid=0 | w=46
  2046. en:oedema -- r_associated #0: 46 / 0.73 -> en:c/o: a swelling
    n1=en:oedema | n2=en:c/o: a swelling | rel=r_associated | relid=0 | w=46
  2047. en:oedema -- r_associated #0: 46 / 0.73 -> en:calf muscle discomfort
    n1=en:oedema | n2=en:calf muscle discomfort | rel=r_associated | relid=0 | w=46
  2048. en:oedema -- r_associated #0: 46 / 0.73 -> en:capillary hemangioma (in 1 patient)
    n1=en:oedema | n2=en:capillary hemangioma (in 1 patient) | rel=r_associated | relid=0 | w=46
  2049. en:oedema -- r_associated #0: 46 / 0.73 -> en:capillary malformations, small, multiple, diffuse
    n1=en:oedema | n2=en:capillary malformations, small, multiple, diffuse | rel=r_associated | relid=0 | w=46
  2050. en:oedema -- r_associated #0: 46 / 0.73 -> en:cellulitis
    n1=en:oedema | n2=en:cellulitis | rel=r_associated | relid=0 | w=46
  2051. en:oedema -- r_associated #0: 46 / 0.73 -> en:cerebral edema
    n1=en:oedema | n2=en:cerebral edema | rel=r_associated | relid=0 | w=46
  2052. en:oedema -- r_associated #0: 46 / 0.73 -> en:chronic mucocutaneous candidiasis
    n1=en:oedema | n2=en:chronic mucocutaneous candidiasis | rel=r_associated | relid=0 | w=46
  2053. en:oedema -- r_associated #0: 46 / 0.73 -> en:chronic weakness
    n1=en:oedema | n2=en:chronic weakness | rel=r_associated | relid=0 | w=46
  2054. en:oedema -- r_associated #0: 46 / 0.73 -> en:cicatrization
    n1=en:oedema | n2=en:cicatrization | rel=r_associated | relid=0 | w=46
  2055. en:oedema -- r_associated #0: 46 / 0.73 -> en:clinical history and observation findings
    n1=en:oedema | n2=en:clinical history and observation findings | rel=r_associated | relid=0 | w=46
  2056. en:oedema -- r_associated #0: 46 / 0.73 -> en:coccygeal skin tags
    n1=en:oedema | n2=en:coccygeal skin tags | rel=r_associated | relid=0 | w=46
  2057. en:oedema -- r_associated #0: 46 / 0.73 -> en:coenzyme q10 deficiency
    n1=en:oedema | n2=en:coenzyme q10 deficiency | rel=r_associated | relid=0 | w=46
  2058. en:oedema -- r_associated #0: 46 / 0.73 -> en:collodion membrane at birth (1 patient)
    n1=en:oedema | n2=en:collodion membrane at birth (1 patient) | rel=r_associated | relid=0 | w=46
  2059. en:oedema -- r_associated #0: 46 / 0.73 -> en:color of skin or mucosa
    n1=en:oedema | n2=en:color of skin or mucosa | rel=r_associated | relid=0 | w=46
  2060. en:oedema -- r_associated #0: 46 / 0.73 -> en:combined oxidative phosphorylation deficiency 5
    n1=en:oedema | n2=en:combined oxidative phosphorylation deficiency 5 | rel=r_associated | relid=0 | w=46
  2061. en:oedema -- r_associated #0: 46 / 0.73 -> en:concussion and edema of lumbar spinal cord
    n1=en:oedema | n2=en:concussion and edema of lumbar spinal cord | rel=r_associated | relid=0 | w=46
  2062. en:oedema -- r_associated #0: 46 / 0.73 -> en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years)
    n1=en:oedema | n2=en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years) | rel=r_associated | relid=0 | w=46
  2063. en:oedema -- r_associated #0: 46 / 0.73 -> en:cores or minicores
    n1=en:oedema | n2=en:cores or minicores | rel=r_associated | relid=0 | w=46
  2064. en:oedema -- r_associated #0: 46 / 0.73 -> en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber
    n1=en:oedema | n2=en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber | rel=r_associated | relid=0 | w=46
  2065. en:oedema -- r_associated #0: 46 / 0.73 -> en:crusting erythematous dermatitis
    n1=en:oedema | n2=en:crusting erythematous dermatitis | rel=r_associated | relid=0 | w=46
  2066. en:oedema -- r_associated #0: 46 / 0.73 -> en:cutaneous dimples (knees, elbows, shoulders)
    n1=en:oedema | n2=en:cutaneous dimples (knees, elbows, shoulders) | rel=r_associated | relid=0 | w=46
  2067. en:oedema -- r_associated #0: 46 / 0.73 -> en:cutaneous folliculitis
    n1=en:oedema | n2=en:cutaneous folliculitis | rel=r_associated | relid=0 | w=46
  2068. en:oedema -- r_associated #0: 46 / 0.73 -> en:cutaneous laxity (rare)
    n1=en:oedema | n2=en:cutaneous laxity (rare) | rel=r_associated | relid=0 | w=46
  2069. en:oedema -- r_associated #0: 46 / 0.73 -> en:cutaneous syndactyly
    n1=en:oedema | n2=en:cutaneous syndactyly | rel=r_associated | relid=0 | w=46
  2070. en:oedema -- r_associated #0: 46 / 0.73 -> en:cutis laxa, hands and feet (present at birth)
    n1=en:oedema | n2=en:cutis laxa, hands and feet (present at birth) | rel=r_associated | relid=0 | w=46
  2071. en:oedema -- r_associated #0: 46 / 0.73 -> en:cyanosis due to methemoglobinemia
    n1=en:oedema | n2=en:cyanosis due to methemoglobinemia | rel=r_associated | relid=0 | w=46
  2072. en:oedema -- r_associated #0: 46 / 0.73 -> en:cysts may be multiple (70%)
    n1=en:oedema | n2=en:cysts may be multiple (70%) | rel=r_associated | relid=0 | w=46
  2073. en:oedema -- r_associated #0: 46 / 0.73 -> en:cytochrome c oxidase-negative fibers
    n1=en:oedema | n2=en:cytochrome c oxidase-negative fibers | rel=r_associated | relid=0 | w=46
  2074. en:oedema -- r_associated #0: 46 / 0.73 -> en:darkly pigmented skin
    n1=en:oedema | n2=en:darkly pigmented skin | rel=r_associated | relid=0 | w=46
  2075. en:oedema -- r_associated #0: 46 / 0.73 -> en:deafferentation
    n1=en:oedema | n2=en:deafferentation | rel=r_associated | relid=0 | w=46
  2076. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased ability to run
    n1=en:oedema | n2=en:decreased ability to run | rel=r_associated | relid=0 | w=46
  2077. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased activity of mitochondrial respiratory complexes i, iii, and iv in muscle tissue
    n1=en:oedema | n2=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv in muscle tissue | rel=r_associated | relid=0 | w=46
  2078. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased activity of respiratory complex ii+iii
    n1=en:oedema | n2=en:decreased activity of respiratory complex ii+iii | rel=r_associated | relid=0 | w=46
  2079. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased cytochrome c oxidase (cox) activity and protein
    n1=en:oedema | n2=en:decreased cytochrome c oxidase (cox) activity and protein | rel=r_associated | relid=0 | w=46
  2080. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased cytochrome c oxidase staining
    n1=en:oedema | n2=en:decreased cytochrome c oxidase staining | rel=r_associated | relid=0 | w=46
  2081. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased glutamate oxidation (about 63% of normal)
    n1=en:oedema | n2=en:decreased glutamate oxidation (about 63% of normal) | rel=r_associated | relid=0 | w=46
  2082. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased immunostaining for alpha-sarcoglycan
    n1=en:oedema | n2=en:decreased immunostaining for alpha-sarcoglycan | rel=r_associated | relid=0 | w=46
  2083. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased lactate clearance from muscle after exercise (reported in 1 patient)
    n1=en:oedema | n2=en:decreased lactate clearance from muscle after exercise (reported in 1 patient) | rel=r_associated | relid=0 | w=46
  2084. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased levels and activity of mitochondrial respiratory complexes i and iv
    n1=en:oedema | n2=en:decreased levels and activity of mitochondrial respiratory complexes i and iv | rel=r_associated | relid=0 | w=46
  2085. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased muscle mass (predominantly in lower extremities)
    n1=en:oedema | n2=en:decreased muscle mass (predominantly in lower extremities) | rel=r_associated | relid=0 | w=46
  2086. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased numbers of type 2b fibers
    n1=en:oedema | n2=en:decreased numbers of type 2b fibers | rel=r_associated | relid=0 | w=46
  2087. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased postsynaptic length
    n1=en:oedema | n2=en:decreased postsynaptic length | rel=r_associated | relid=0 | w=46
  2088. en:oedema -- r_associated #0: 46 / 0.73 -> en:decreased sweating of palms and soles
    n1=en:oedema | n2=en:decreased sweating of palms and soles | rel=r_associated | relid=0 | w=46
  2089. en:oedema -- r_associated #0: 46 / 0.73 -> en:decremental response to repetitive stimulation at neuromuscular junction
    n1=en:oedema | n2=en:decremental response to repetitive stimulation at neuromuscular junction | rel=r_associated | relid=0 | w=46
  2090. en:oedema -- r_associated #0: 46 / 0.73 -> en:deep plantar creases
    n1=en:oedema | n2=en:deep plantar creases | rel=r_associated | relid=0 | w=46
  2091. en:oedema -- r_associated #0: 46 / 0.73 -> en:deficiency of mitochondrial respiratory enzymes seen on muscle biopsy
    n1=en:oedema | n2=en:deficiency of mitochondrial respiratory enzymes seen on muscle biopsy | rel=r_associated | relid=0 | w=46
  2092. en:oedema -- r_associated #0: 46 / 0.73 -> en:degenerating nerve terminals
    n1=en:oedema | n2=en:degenerating nerve terminals | rel=r_associated | relid=0 | w=46
  2093. en:oedema -- r_associated #0: 46 / 0.73 -> en:degeneration of basal epidermal cells
    n1=en:oedema | n2=en:degeneration of basal epidermal cells | rel=r_associated | relid=0 | w=46
  2094. en:oedema -- r_associated #0: 46 / 0.73 -> en:dehydration
    n1=en:oedema | n2=en:dehydration | rel=r_associated | relid=0 | w=46
  2095. en:oedema -- r_associated #0: 46 / 0.73 -> en:dermatophytosis
    n1=en:oedema | n2=en:dermatophytosis | rel=r_associated | relid=0 | w=46
  2096. en:oedema -- r_associated #0: 46 / 0.73 -> en:dermatophytosis, chronic deep dermatophytosis (in some patients)
    n1=en:oedema | n2=en:dermatophytosis, chronic deep dermatophytosis (in some patients) | rel=r_associated | relid=0 | w=46
  2097. en:oedema -- r_associated #0: 46 / 0.73 -> en:diffuse hyperkeratosis (in some patients)
    n1=en:oedema | n2=en:diffuse hyperkeratosis (in some patients) | rel=r_associated | relid=0 | w=46
  2098. en:oedema -- r_associated #0: 46 / 0.73 -> en:diffuse telangiectasis
    n1=en:oedema | n2=en:diffuse telangiectasis | rel=r_associated | relid=0 | w=46
  2099. en:oedema -- r_associated #0: 46 / 0.73 -> en:disruption of sarcomeres with disorganization of the z band
    n1=en:oedema | n2=en:disruption of sarcomeres with disorganization of the z band | rel=r_associated | relid=0 | w=46
  2100. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal amyotrophy
    n1=en:oedema | n2=en:distal amyotrophy | rel=r_associated | relid=0 | w=46
  2101. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal limb muscle weakness (less common)
    n1=en:oedema | n2=en:distal limb muscle weakness (less common) | rel=r_associated | relid=0 | w=46
  2102. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal lower limb amyotrophy
    n1=en:oedema | n2=en:distal lower limb amyotrophy | rel=r_associated | relid=0 | w=46
  2103. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal muscle atrophy due to denervation
    n1=en:oedema | n2=en:distal muscle atrophy due to denervation | rel=r_associated | relid=0 | w=46
  2104. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal muscle atrophy, affecting the lower limbs
    n1=en:oedema | n2=en:distal muscle atrophy, affecting the lower limbs | rel=r_associated | relid=0 | w=46
  2105. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal muscle weakness due to peripheral neuropathy
    n1=en:oedema | n2=en:distal muscle weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=46
  2106. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal muscle weakness, predominantly affecting the lower limbs
    n1=en:oedema | n2=en:distal muscle weakness, predominantly affecting the lower limbs | rel=r_associated | relid=0 | w=46
  2107. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal muscle weakness, predominantly lower limbs
    n1=en:oedema | n2=en:distal muscle weakness, predominantly lower limbs | rel=r_associated | relid=0 | w=46
  2108. en:oedema -- r_associated #0: 46 / 0.73 -> en:distal muscles may be affected
    n1=en:oedema | n2=en:distal muscles may be affected | rel=r_associated | relid=0 | w=46
  2109. en:oedema -- r_associated #0: 46 / 0.73 -> en:dorsal hand wrinkling
    n1=en:oedema | n2=en:dorsal hand wrinkling | rel=r_associated | relid=0 | w=46
  2110. en:oedema -- r_associated #0: 46 / 0.73 -> en:draining sinuses (late complication)
    n1=en:oedema | n2=en:draining sinuses (late complication) | rel=r_associated | relid=0 | w=46
  2111. en:oedema -- r_associated #0: 46 / 0.73 -> en:drug interaction
    n1=en:oedema | n2=en:drug interaction | rel=r_associated | relid=0 | w=46
  2112. en:oedema -- r_associated #0: 46 / 0.73 -> en:dystrophic changes on biopsy
    n1=en:oedema | n2=en:dystrophic changes on biopsy | rel=r_associated | relid=0 | w=46
  2113. en:oedema -- r_associated #0: 46 / 0.73 -> en:dystrophic features seen on muscle biopsy
    n1=en:oedema | n2=en:dystrophic features seen on muscle biopsy | rel=r_associated | relid=0 | w=46
  2114. en:oedema -- r_associated #0: 46 / 0.73 -> en:eczema
    n1=en:oedema | n2=en:eczema | rel=r_associated | relid=0 | w=46
  2115. en:oedema -- r_associated #0: 46 / 0.73 -> en:eczema (face and flexural areas)
    n1=en:oedema | n2=en:eczema (face and flexural areas) | rel=r_associated | relid=0 | w=46
  2116. en:oedema -- r_associated #0: 46 / 0.73 -> en:eczema (in some patients)
    n1=en:oedema | n2=en:eczema (in some patients) | rel=r_associated | relid=0 | w=46
  2117. en:oedema -- r_associated #0: 46 / 0.73 -> en:edema
    n1=en:oedema | n2=en:edema | rel=r_associated | relid=0 | w=46
  2118. en:oedema -- r_associated #0: 46 / 0.73 -> en:edema of entire limb
    n1=en:oedema | n2=en:edema of entire limb | rel=r_associated | relid=0 | w=46
  2119. en:oedema -- r_associated #0: 46 / 0.73 -> en:edema of extremity
    n1=en:oedema | n2=en:edema of extremity | rel=r_associated | relid=0 | w=46
  2120. en:oedema -- r_associated #0: 46 / 0.73 -> en:edema of male genital organs
    n1=en:oedema | n2=en:edema of male genital organs | rel=r_associated | relid=0 | w=46
  2121. en:oedema -- r_associated #0: 46 / 0.73 -> en:edema of newborn
    n1=en:oedema | n2=en:edema of newborn | rel=r_associated | relid=0 | w=46
  2122. en:oedema -- r_associated #0: 46 / 0.73 -> en:edema of sacral cord
    n1=en:oedema | n2=en:edema of sacral cord | rel=r_associated | relid=0 | w=46
  2123. en:oedema -- r_associated #0: 46 / 0.73 -> en:edema of scrotum
    n1=en:oedema | n2=en:edema of scrotum | rel=r_associated | relid=0 | w=46
  2124. en:oedema -- r_associated #0: 46 / 0.73 -> en:edema of spinal cord
    n1=en:oedema | n2=en:edema of spinal cord | rel=r_associated | relid=0 | w=46
  2125. en:oedema -- r_associated #0: 46 / 0.73 -> en:electron microscopy showed z-disk streaming
    n1=en:oedema | n2=en:electron microscopy showed z-disk streaming | rel=r_associated | relid=0 | w=46
  2126. en:oedema -- r_associated #0: 46 / 0.73 -> en:endocrine, nutritional and metabolic observable
    n1=en:oedema | n2=en:endocrine, nutritional and metabolic observable | rel=r_associated | relid=0 | w=46
  2127. en:oedema -- r_associated #0: 46 / 0.73 -> en:enhanced secondary hyperalgesia and flare response on mustard oil application
    n1=en:oedema | n2=en:enhanced secondary hyperalgesia and flare response on mustard oil application | rel=r_associated | relid=0 | w=46
  2128. en:oedema -- r_associated #0: 46 / 0.73 -> en:enophthalmos
    n1=en:oedema | n2=en:enophthalmos | rel=r_associated | relid=0 | w=46
  2129. en:oedema -- r_associated #0: 46 / 0.73 -> en:epidermal nevus
    n1=en:oedema | n2=en:epidermal nevus | rel=r_associated | relid=0 | w=46
  2130. en:oedema -- r_associated #0: 46 / 0.73 -> en:epidermal ridges absent from palms and soles
    n1=en:oedema | n2=en:epidermal ridges absent from palms and soles | rel=r_associated | relid=0 | w=46
  2131. en:oedema -- r_associated #0: 46 / 0.73 -> en:epidermoid inclusion cysts
    n1=en:oedema | n2=en:epidermoid inclusion cysts | rel=r_associated | relid=0 | w=46
  2132. en:oedema -- r_associated #0: 46 / 0.73 -> en:erysipelas (in some patients)
    n1=en:oedema | n2=en:erysipelas (in some patients) | rel=r_associated | relid=0 | w=46
  2133. en:oedema -- r_associated #0: 46 / 0.73 -> en:erythema nodosum
    n1=en:oedema | n2=en:erythema nodosum | rel=r_associated | relid=0 | w=46
  2134. en:oedema -- r_associated #0: 46 / 0.73 -> en:erythema, residual painless
    n1=en:oedema | n2=en:erythema, residual painless | rel=r_associated | relid=0 | w=46
  2135. en:oedema -- r_associated #0: 46 / 0.73 -> en:erythematous nodular skin lesions
    n1=en:oedema | n2=en:erythematous nodular skin lesions | rel=r_associated | relid=0 | w=46
  2136. en:oedema -- r_associated #0: 46 / 0.73 -> en:erythroderma (in some patients)
    n1=en:oedema | n2=en:erythroderma (in some patients) | rel=r_associated | relid=0 | w=46
  2137. en:oedema -- r_associated #0: 46 / 0.73 -> en:erythroderma, patchy, on cheeks and chin (1/4 patients)
    n1=en:oedema | n2=en:erythroderma, patchy, on cheeks and chin (1/4 patients) | rel=r_associated | relid=0 | w=46
  2138. en:oedema -- r_associated #0: 46 / 0.73 -> en:evaluation finding
    n1=en:oedema | n2=en:evaluation finding | rel=r_associated | relid=0 | w=46
  2139. en:oedema -- r_associated #0: 46 / 0.73 -> en:excessive sucking
    n1=en:oedema | n2=en:excessive sucking | rel=r_associated | relid=0 | w=46
  2140. en:oedema -- r_associated #0: 46 / 0.73 -> en:exercise intolerance (also seen in some heterozygotes)
    n1=en:oedema | n2=en:exercise intolerance (also seen in some heterozygotes) | rel=r_associated | relid=0 | w=46
  2141. en:oedema -- r_associated #0: 46 / 0.73 -> en:exercise intolerance (cvs+)
    n1=en:oedema | n2=en:exercise intolerance (cvs+) | rel=r_associated | relid=0 | w=46
  2142. en:oedema -- r_associated #0: 46 / 0.73 -> en:exudate observable
    n1=en:oedema | n2=en:exudate observable | rel=r_associated | relid=0 | w=46
  2143. en:oedema -- r_associated #0: 46 / 0.73 -> en:face edema
    n1=en:oedema | n2=en:face edema | rel=r_associated | relid=0 | w=46
  2144. en:oedema -- r_associated #0: 46 / 0.73 -> en:fetal akinesia deformation sequence
    n1=en:oedema | n2=en:fetal akinesia deformation sequence | rel=r_associated | relid=0 | w=46
  2145. en:oedema -- r_associated #0: 46 / 0.73 -> en:fetal ascites without hydrops
    n1=en:oedema | n2=en:fetal ascites without hydrops | rel=r_associated | relid=0 | w=46
  2146. en:oedema -- r_associated #0: 46 / 0.73 -> en:fibrochondrogenesis 1
    n1=en:oedema | n2=en:fibrochondrogenesis 1 | rel=r_associated | relid=0 | w=46
  2147. en:oedema -- r_associated #0: 46 / 0.73 -> en:finding by method
    n1=en:oedema | n2=en:finding by method | rel=r_associated | relid=0 | w=46
  2148. en:oedema -- r_associated #0: 46 / 0.73 -> en:finding of grade
    n1=en:oedema | n2=en:finding of grade | rel=r_associated | relid=0 | w=46
  2149. en:oedema -- r_associated #0: 46 / 0.73 -> en:flexural skin
    n1=en:oedema | n2=en:flexural skin | rel=r_associated | relid=0 | w=46
  2150. en:oedema -- r_associated #0: 46 / 0.73 -> en:fluctuating edema level
    n1=en:oedema | n2=en:fluctuating edema level | rel=r_associated | relid=0 | w=46
  2151. en:oedema -- r_associated #0: 46 / 0.73 -> en:focal hyperkeratosis (in some patients)
    n1=en:oedema | n2=en:focal hyperkeratosis (in some patients) | rel=r_associated | relid=0 | w=46
  2152. en:oedema -- r_associated #0: 46 / 0.73 -> en:foreign body sensation
    n1=en:oedema | n2=en:foreign body sensation | rel=r_associated | relid=0 | w=46
  2153. en:oedema -- r_associated #0: 46 / 0.73 -> en:fragility with blistering (neonatal onset)
    n1=en:oedema | n2=en:fragility with blistering (neonatal onset) | rel=r_associated | relid=0 | w=46
  2154. en:oedema -- r_associated #0: 46 / 0.73 -> en:furrowed facial skin
    n1=en:oedema | n2=en:furrowed facial skin | rel=r_associated | relid=0 | w=46
  2155. en:oedema -- r_associated #0: 46 / 0.73 -> en:gait abnormalities (occurs later)
    n1=en:oedema | n2=en:gait abnormalities (occurs later) | rel=r_associated | relid=0 | w=46
  2156. en:oedema -- r_associated #0: 46 / 0.73 -> en:generalized amyotrophy
    n1=en:oedema | n2=en:generalized amyotrophy | rel=r_associated | relid=0 | w=46
  2157. en:oedema -- r_associated #0: 46 / 0.73 -> en:gestational edema without hypertension
    n1=en:oedema | n2=en:gestational edema without hypertension | rel=r_associated | relid=0 | w=46
  2158. en:oedema -- r_associated #0: 46 / 0.73 -> en:gluteal hypoplasia
    n1=en:oedema | n2=en:gluteal hypoplasia | rel=r_associated | relid=0 | w=46
  2159. en:oedema -- r_associated #0: 46 / 0.73 -> en:gower's eye sign
    n1=en:oedema | n2=en:gower's eye sign | rel=r_associated | relid=0 | w=46
  2160. en:oedema -- r_associated #0: 46 / 0.73 -> en:granular layer hyperplasia
    n1=en:oedema | n2=en:granular layer hyperplasia | rel=r_associated | relid=0 | w=46
  2161. en:oedema -- r_associated #0: 46 / 0.73 -> en:granulomatous dermatitis (in some patients)
    n1=en:oedema | n2=en:granulomatous dermatitis (in some patients) | rel=r_associated | relid=0 | w=46
  2162. en:oedema -- r_associated #0: 46 / 0.73 -> en:gravitational edema of leg
    n1=en:oedema | n2=en:gravitational edema of leg | rel=r_associated | relid=0 | w=46
  2163. en:oedema -- r_associated #0: 46 / 0.73 -> en:haemo-pak unit for plasmapheresis
    n1=en:oedema | n2=en:haemo-pak unit for plasmapheresis | rel=r_associated | relid=0 | w=46
  2164. en:oedema -- r_associated #0: 46 / 0.73 -> en:hamstring and quadriceps muscles mildly affected
    n1=en:oedema | n2=en:hamstring and quadriceps muscles mildly affected | rel=r_associated | relid=0 | w=46
  2165. en:oedema -- r_associated #0: 46 / 0.73 -> en:heel spur
    n1=en:oedema | n2=en:heel spur | rel=r_associated | relid=0 | w=46
  2166. en:oedema -- r_associated #0: 46 / 0.73 -> en:hemorrhagic cerebrovascular accident
    n1=en:oedema | n2=en:hemorrhagic cerebrovascular accident | rel=r_associated | relid=0 | w=46
  2167. en:oedema -- r_associated #0: 46 / 0.73 -> en:histochemically normal type-ii muscle fibers
    n1=en:oedema | n2=en:histochemically normal type-ii muscle fibers | rel=r_associated | relid=0 | w=46
  2168. en:oedema -- r_associated #0: 46 / 0.73 -> en:homans' sign
    n1=en:oedema | n2=en:homans' sign | rel=r_associated | relid=0 | w=46
  2169. en:oedema -- r_associated #0: 46 / 0.73 -> en:hydrops of gallbladder
    n1=en:oedema | n2=en:hydrops of gallbladder | rel=r_associated | relid=0 | w=46
  2170. en:oedema -- r_associated #0: 46 / 0.73 -> en:hyperextensible skin (in some patients)
    n1=en:oedema | n2=en:hyperextensible skin (in some patients) | rel=r_associated | relid=0 | w=46
  2171. en:oedema -- r_associated #0: 46 / 0.73 -> en:hyperkeratosis over edematous areas
    n1=en:oedema | n2=en:hyperkeratosis over edematous areas | rel=r_associated | relid=0 | w=46
  2172. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypertonia late
    n1=en:oedema | n2=en:hypertonia late | rel=r_associated | relid=0 | w=46
  2173. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypertrichosis
    n1=en:oedema | n2=en:hypertrichosis | rel=r_associated | relid=0 | w=46
  2174. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypertrophy of skin of soles
    n1=en:oedema | n2=en:hypertrophy of skin of soles | rel=r_associated | relid=0 | w=46
  2175. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypertrophy of the extensor digitorum brevis muscles
    n1=en:oedema | n2=en:hypertrophy of the extensor digitorum brevis muscles | rel=r_associated | relid=0 | w=46
  2176. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypohidrosis and/or heat intolerance
    n1=en:oedema | n2=en:hypohidrosis and/or heat intolerance | rel=r_associated | relid=0 | w=46
  2177. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypopigmentation in a reticular pattern primarily on flexural skin
    n1=en:oedema | n2=en:hypopigmentation in a reticular pattern primarily on flexural skin | rel=r_associated | relid=0 | w=46
  2178. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypoplastic biceps
    n1=en:oedema | n2=en:hypoplastic biceps | rel=r_associated | relid=0 | w=46
  2179. en:oedema -- r_associated #0: 46 / 0.73 -> en:hyporeflexia
    n1=en:oedema | n2=en:hyporeflexia | rel=r_associated | relid=0 | w=46
  2180. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypotension
    n1=en:oedema | n2=en:hypotension | rel=r_associated | relid=0 | w=46
  2181. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypothermia
    n1=en:oedema | n2=en:hypothermia | rel=r_associated | relid=0 | w=46
  2182. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypotonia, neonatal and later
    n1=en:oedema | n2=en:hypotonia, neonatal and later | rel=r_associated | relid=0 | w=46
  2183. en:oedema -- r_associated #0: 46 / 0.73 -> en:hypotrophy of type 1 fibers
    n1=en:oedema | n2=en:hypotrophy of type 1 fibers | rel=r_associated | relid=0 | w=46
  2184. en:oedema -- r_associated #0: 46 / 0.73 -> en:idiopathic edema
    n1=en:oedema | n2=en:idiopathic edema | rel=r_associated | relid=0 | w=46
  2185. en:oedema -- r_associated #0: 46 / 0.73 -> en:in cerebrospinal fluid
    n1=en:oedema | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=46
  2186. en:oedema -- r_associated #0: 46 / 0.73 -> en:inability to jump or squat
    n1=en:oedema | n2=en:inability to jump or squat | rel=r_associated | relid=0 | w=46
  2187. en:oedema -- r_associated #0: 46 / 0.73 -> en:inclusions are dnajb6-immunoreactive
    n1=en:oedema | n2=en:inclusions are dnajb6-immunoreactive | rel=r_associated | relid=0 | w=46
  2188. en:oedema -- r_associated #0: 46 / 0.73 -> en:increased blood volume
    n1=en:oedema | n2=en:increased blood volume | rel=r_associated | relid=0 | w=46
  2189. en:oedema -- r_associated #0: 46 / 0.73 -> en:increased endo- and perimysial connective tissue
    n1=en:oedema | n2=en:increased endo- and perimysial connective tissue | rel=r_associated | relid=0 | w=46
  2190. en:oedema -- r_associated #0: 46 / 0.73 -> en:increased fat and fibrous tissue
    n1=en:oedema | n2=en:increased fat and fibrous tissue | rel=r_associated | relid=0 | w=46
  2191. en:oedema -- r_associated #0: 46 / 0.73 -> en:increased fatigue
    n1=en:oedema | n2=en:increased fatigue | rel=r_associated | relid=0 | w=46
  2192. en:oedema -- r_associated #0: 46 / 0.73 -> en:increased lipid
    n1=en:oedema | n2=en:increased lipid | rel=r_associated | relid=0 | w=46
  2193. en:oedema -- r_associated #0: 46 / 0.73 -> en:increased muscle lipid content
    n1=en:oedema | n2=en:increased muscle lipid content | rel=r_associated | relid=0 | w=46
  2194. en:oedema -- r_associated #0: 46 / 0.73 -> en:increased numbers of abnormally-shaped mitochondria in subsarcolemmal areas
    n1=en:oedema | n2=en:increased numbers of abnormally-shaped mitochondria in subsarcolemmal areas | rel=r_associated | relid=0 | w=46
  2195. en:oedema -- r_associated #0: 46 / 0.73 -> en:injection site edema
    n1=en:oedema | n2=en:injection site edema | rel=r_associated | relid=0 | w=46
  2196. en:oedema -- r_associated #0: 46 / 0.73 -> en:intermyofibrillar and subsarcolemmal accumulation of electron-dense material (in some patients)
    n1=en:oedema | n2=en:intermyofibrillar and subsarcolemmal accumulation of electron-dense material (in some patients) | rel=r_associated | relid=0 | w=46
  2197. en:oedema -- r_associated #0: 46 / 0.73 -> en:internal nuclei seen on biopsy (in some patients)
    n1=en:oedema | n2=en:internal nuclei seen on biopsy (in some patients) | rel=r_associated | relid=0 | w=46
  2198. en:oedema -- r_associated #0: 46 / 0.73 -> en:intrauterine growth retardation (less than tenth percentile)
    n1=en:oedema | n2=en:intrauterine growth retardation (less than tenth percentile) | rel=r_associated | relid=0 | w=46
  2199. en:oedema -- r_associated #0: 46 / 0.73 -> en:irregular hyperpigmentation
    n1=en:oedema | n2=en:irregular hyperpigmentation | rel=r_associated | relid=0 | w=46
  2200. en:oedema -- r_associated #0: 46 / 0.73 -> en:irvine gass syndrome
    n1=en:oedema | n2=en:irvine gass syndrome | rel=r_associated | relid=0 | w=46
  2201. en:oedema -- r_associated #0: 46 / 0.73 -> en:jaundice, intermittent (in some patients)
    n1=en:oedema | n2=en:jaundice, intermittent (in some patients) | rel=r_associated | relid=0 | w=46
  2202. en:oedema -- r_associated #0: 46 / 0.73 -> en:keratosis pilaris
    n1=en:oedema | n2=en:keratosis pilaris | rel=r_associated | relid=0 | w=46
  2203. en:oedema -- r_associated #0: 46 / 0.73 -> en:ketoadipicaciduria
    n1=en:oedema | n2=en:ketoadipicaciduria | rel=r_associated | relid=0 | w=46
  2204. en:oedema -- r_associated #0: 46 / 0.73 -> en:lack of scarring
    n1=en:oedema | n2=en:lack of scarring | rel=r_associated | relid=0 | w=46
  2205. en:oedema -- r_associated #0: 46 / 0.73 -> en:larger brownish scaling on neck, buttocks, and legs
    n1=en:oedema | n2=en:larger brownish scaling on neck, buttocks, and legs | rel=r_associated | relid=0 | w=46
  2206. en:oedema -- r_associated #0: 46 / 0.73 -> en:left ventricular failure
    n1=en:oedema | n2=en:left ventricular failure | rel=r_associated | relid=0 | w=46
  2207. en:oedema -- r_associated #0: 46 / 0.73 -> en:leg cramps may occur with exercise
    n1=en:oedema | n2=en:leg cramps may occur with exercise | rel=r_associated | relid=0 | w=46
  2208. en:oedema -- r_associated #0: 46 / 0.73 -> en:leiomyomas are sensitive to light touch
    n1=en:oedema | n2=en:leiomyomas are sensitive to light touch | rel=r_associated | relid=0 | w=46
  2209. en:oedema -- r_associated #0: 46 / 0.73 -> en:lesions occur on the trunk, back, arms, legs, abdomen, buttocks
    n1=en:oedema | n2=en:lesions occur on the trunk, back, arms, legs, abdomen, buttocks | rel=r_associated | relid=0 | w=46
  2210. en:oedema -- r_associated #0: 46 / 0.73 -> en:leukemia
    n1=en:oedema | n2=en:leukemia | rel=r_associated | relid=0 | w=46
  2211. en:oedema -- r_associated #0: 46 / 0.73 -> en:levator palpebrae superioris atrophy
    n1=en:oedema | n2=en:levator palpebrae superioris atrophy | rel=r_associated | relid=0 | w=46
  2212. en:oedema -- r_associated #0: 46 / 0.73 -> en:lichenified skin
    n1=en:oedema | n2=en:lichenified skin | rel=r_associated | relid=0 | w=46
  2213. en:oedema -- r_associated #0: 46 / 0.73 -> en:limb-girdle muscular dystrophy
    n1=en:oedema | n2=en:limb-girdle muscular dystrophy | rel=r_associated | relid=0 | w=46
  2214. en:oedema -- r_associated #0: 46 / 0.73 -> en:linear arrays of macular hyperkeratoses in flexural areas
    n1=en:oedema | n2=en:linear arrays of macular hyperkeratoses in flexural areas | rel=r_associated | relid=0 | w=46
  2215. en:oedema -- r_associated #0: 46 / 0.73 -> en:lipoatrophy of trunk
    n1=en:oedema | n2=en:lipoatrophy of trunk | rel=r_associated | relid=0 | w=46
  2216. en:oedema -- r_associated #0: 46 / 0.73 -> en:lipodystrophy (in some patients)
    n1=en:oedema | n2=en:lipodystrophy (in some patients) | rel=r_associated | relid=0 | w=46
  2217. en:oedema -- r_associated #0: 46 / 0.73 -> en:lipohypoplasia, regional
    n1=en:oedema | n2=en:lipohypoplasia, regional | rel=r_associated | relid=0 | w=46
  2218. en:oedema -- r_associated #0: 46 / 0.73 -> en:lipomas or lipomatous masses (most cases)
    n1=en:oedema | n2=en:lipomas or lipomatous masses (most cases) | rel=r_associated | relid=0 | w=46
  2219. en:oedema -- r_associated #0: 46 / 0.73 -> en:livedo racemosa (usually on trunk and/or lower extremities)
    n1=en:oedema | n2=en:livedo racemosa (usually on trunk and/or lower extremities) | rel=r_associated | relid=0 | w=46
  2220. en:oedema -- r_associated #0: 46 / 0.73 -> en:local swelling/papules/lump/mass
    n1=en:oedema | n2=en:local swelling/papules/lump/mass | rel=r_associated | relid=0 | w=46
  2221. en:oedema -- r_associated #0: 46 / 0.73 -> en:loose connective tissue
    n1=en:oedema | n2=en:loose connective tissue | rel=r_associated | relid=0 | w=46
  2222. en:oedema -- r_associated #0: 46 / 0.73 -> en:loss of ambulation (in some patients)
    n1=en:oedema | n2=en:loss of ambulation (in some patients) | rel=r_associated | relid=0 | w=46
  2223. en:oedema -- r_associated #0: 46 / 0.73 -> en:loss of ambulation between third and sixth decade
    n1=en:oedema | n2=en:loss of ambulation between third and sixth decade | rel=r_associated | relid=0 | w=46
  2224. en:oedema -- r_associated #0: 46 / 0.73 -> en:loss of subcutaneous fat
    n1=en:oedema | n2=en:loss of subcutaneous fat | rel=r_associated | relid=0 | w=46
  2225. en:oedema -- r_associated #0: 46 / 0.73 -> en:low cardiac output
    n1=en:oedema | n2=en:low cardiac output | rel=r_associated | relid=0 | w=46
  2226. en:oedema -- r_associated #0: 46 / 0.73 -> en:lowenstein occupational therapy cognitive assessment score
    n1=en:oedema | n2=en:lowenstein occupational therapy cognitive assessment score | rel=r_associated | relid=0 | w=46
  2227. en:oedema -- r_associated #0: 46 / 0.73 -> en:lower limb muscle atrophy
    n1=en:oedema | n2=en:lower limb muscle atrophy | rel=r_associated | relid=0 | w=46
  2228. en:oedema -- r_associated #0: 46 / 0.73 -> en:lower limb muscle hypotrophy
    n1=en:oedema | n2=en:lower limb muscle hypotrophy | rel=r_associated | relid=0 | w=46
  2229. en:oedema -- r_associated #0: 46 / 0.73 -> en:lymphatic vessels present at the periphery of lesion
    n1=en:oedema | n2=en:lymphatic vessels present at the periphery of lesion | rel=r_associated | relid=0 | w=46
  2230. en:oedema -- r_associated #0: 46 / 0.73 -> en:lymphedema
    n1=en:oedema | n2=en:lymphedema | rel=r_associated | relid=0 | w=46
  2231. en:oedema -- r_associated #0: 46 / 0.73 -> en:lymphedema of the hands (in some patients)
    n1=en:oedema | n2=en:lymphedema of the hands (in some patients) | rel=r_associated | relid=0 | w=46
  2232. en:oedema -- r_associated #0: 46 / 0.73 -> en:many fibers with internal nuclei
    n1=en:oedema | n2=en:many fibers with internal nuclei | rel=r_associated | relid=0 | w=46
  2233. en:oedema -- r_associated #0: 46 / 0.73 -> en:marbled skin due to telangiectasia
    n1=en:oedema | n2=en:marbled skin due to telangiectasia | rel=r_associated | relid=0 | w=46
  2234. en:oedema -- r_associated #0: 46 / 0.73 -> en:mayers' lifestyle questionnaire (1) interpretation
    n1=en:oedema | n2=en:mayers' lifestyle questionnaire (1) interpretation | rel=r_associated | relid=0 | w=46
  2235. en:oedema -- r_associated #0: 46 / 0.73 -> en:mayers' lifestyle questionnaire (2) interpretation
    n1=en:oedema | n2=en:mayers' lifestyle questionnaire (2) interpretation | rel=r_associated | relid=0 | w=46
  2236. en:oedema -- r_associated #0: 46 / 0.73 -> en:mediastinal shift
    n1=en:oedema | n2=en:mediastinal shift | rel=r_associated | relid=0 | w=46
  2237. en:oedema -- r_associated #0: 46 / 0.73 -> en:melanocytic nevus
    n1=en:oedema | n2=en:melanocytic nevus | rel=r_associated | relid=0 | w=46
  2238. en:oedema -- r_associated #0: 46 / 0.73 -> en:mental state, behavior / psychosocial function observable
    n1=en:oedema | n2=en:mental state, behavior / psychosocial function observable | rel=r_associated | relid=0 | w=46
  2239. en:oedema -- r_associated #0: 46 / 0.73 -> en:metabolic aspects
    n1=en:oedema | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=46
  2240. en:oedema -- r_associated #0: 46 / 0.73 -> en:midfrontal capillary hemangioma
    n1=en:oedema | n2=en:midfrontal capillary hemangioma | rel=r_associated | relid=0 | w=46
  2241. en:oedema -- r_associated #0: 46 / 0.73 -> en:mild atrophic scarring
    n1=en:oedema | n2=en:mild atrophic scarring | rel=r_associated | relid=0 | w=46
  2242. en:oedema -- r_associated #0: 46 / 0.73 -> en:mild muscle weakness
    n1=en:oedema | n2=en:mild muscle weakness | rel=r_associated | relid=0 | w=46
  2243. en:oedema -- r_associated #0: 46 / 0.73 -> en:mild weakness
    n1=en:oedema | n2=en:mild weakness | rel=r_associated | relid=0 | w=46
  2244. en:oedema -- r_associated #0: 46 / 0.73 -> en:mirror syndrome
    n1=en:oedema | n2=en:mirror syndrome | rel=r_associated | relid=0 | w=46
  2245. en:oedema -- r_associated #0: 46 / 0.73 -> en:mitochondrial swelling
    n1=en:oedema | n2=en:mitochondrial swelling | rel=r_associated | relid=0 | w=46
  2246. en:oedema -- r_associated #0: 46 / 0.73 -> en:moderate scarring
    n1=en:oedema | n2=en:moderate scarring | rel=r_associated | relid=0 | w=46
  2247. en:oedema -- r_associated #0: 46 / 0.73 -> en:morbilliform eruption
    n1=en:oedema | n2=en:morbilliform eruption | rel=r_associated | relid=0 | w=46
  2248. en:oedema -- r_associated #0: 46 / 0.73 -> en:mri may show cervical spinal cord atrophy
    n1=en:oedema | n2=en:mri may show cervical spinal cord atrophy | rel=r_associated | relid=0 | w=46
  2249. en:oedema -- r_associated #0: 46 / 0.73 -> en:mri shows fatty replacement
    n1=en:oedema | n2=en:mri shows fatty replacement | rel=r_associated | relid=0 | w=46
  2250. en:oedema -- r_associated #0: 46 / 0.73 -> en:mri shows increased signal intensity in affected muscles consistent with fatty infiltration
    n1=en:oedema | n2=en:mri shows increased signal intensity in affected muscles consistent with fatty infiltration | rel=r_associated | relid=0 | w=46
  2251. en:oedema -- r_associated #0: 46 / 0.73 -> en:multiple facial papules
    n1=en:oedema | n2=en:multiple facial papules | rel=r_associated | relid=0 | w=46
  2252. en:oedema -- r_associated #0: 46 / 0.73 -> en:multiple mitochondrial respiratory enzymes deficiencies seen on biopsy
    n1=en:oedema | n2=en:multiple mitochondrial respiratory enzymes deficiencies seen on biopsy | rel=r_associated | relid=0 | w=46
  2253. en:oedema -- r_associated #0: 46 / 0.73 -> en:multiple papules (milium-like, comedo-like)
    n1=en:oedema | n2=en:multiple papules (milium-like, comedo-like) | rel=r_associated | relid=0 | w=46
  2254. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle atrophy restricted to the upper limb
    n1=en:oedema | n2=en:muscle atrophy restricted to the upper limb | rel=r_associated | relid=0 | w=46
  2255. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle atrophy, diffuse, severe
    n1=en:oedema | n2=en:muscle atrophy, diffuse, severe | rel=r_associated | relid=0 | w=46
  2256. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle atrophy, mild
    n1=en:oedema | n2=en:muscle atrophy, mild | rel=r_associated | relid=0 | w=46
  2257. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria
    n1=en:oedema | n2=en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria | rel=r_associated | relid=0 | w=46
  2258. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy shows core-like regions devoid of oxidative activity
    n1=en:oedema | n2=en:muscle biopsy shows core-like regions devoid of oxidative activity | rel=r_associated | relid=0 | w=46
  2259. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy shows fiber type disproportion
    n1=en:oedema | n2=en:muscle biopsy shows fiber type disproportion | rel=r_associated | relid=0 | w=46
  2260. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy shows mitochondrial paracrystalline inclusions
    n1=en:oedema | n2=en:muscle biopsy shows mitochondrial paracrystalline inclusions | rel=r_associated | relid=0 | w=46
  2261. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy shows multiple mitochondrial dna (mtdna) deletions
    n1=en:oedema | n2=en:muscle biopsy shows multiple mitochondrial dna (mtdna) deletions | rel=r_associated | relid=0 | w=46
  2262. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes
    n1=en:oedema | n2=en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes | rel=r_associated | relid=0 | w=46
  2263. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy shows peripheral accumulation of abnormal mitochondria
    n1=en:oedema | n2=en:muscle biopsy shows peripheral accumulation of abnormal mitochondria | rel=r_associated | relid=0 | w=46
  2264. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy shows ragged-red fibers with decreased cox activity
    n1=en:oedema | n2=en:muscle biopsy shows ragged-red fibers with decreased cox activity | rel=r_associated | relid=0 | w=46
  2265. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle biopsy shows type 2 fiber atrophy (see details under neurologic heading)
    n1=en:oedema | n2=en:muscle biopsy shows type 2 fiber atrophy (see details under neurologic heading) | rel=r_associated | relid=0 | w=46
  2266. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle fatigability
    n1=en:oedema | n2=en:muscle fatigability | rel=r_associated | relid=0 | w=46
  2267. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle hypertrophy of the lower extremities
    n1=en:oedema | n2=en:muscle hypertrophy of the lower extremities | rel=r_associated | relid=0 | w=46
  2268. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle pain and cramps following exercise
    n1=en:oedema | n2=en:muscle pain and cramps following exercise | rel=r_associated | relid=0 | w=46
  2269. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle weakness (in some patients)
    n1=en:oedema | n2=en:muscle weakness (in some patients) | rel=r_associated | relid=0 | w=46
  2270. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle weakness and atrophy, upper and lower limbs
    n1=en:oedema | n2=en:muscle weakness and atrophy, upper and lower limbs | rel=r_associated | relid=0 | w=46
  2271. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle weakness, primarily proximal
    n1=en:oedema | n2=en:muscle weakness, primarily proximal | rel=r_associated | relid=0 | w=46
  2272. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle weakness, proximal, pelvic girdle (in severe cases)
    n1=en:oedema | n2=en:muscle weakness, proximal, pelvic girdle (in severe cases) | rel=r_associated | relid=0 | w=46
  2273. en:oedema -- r_associated #0: 46 / 0.73 -> en:muscle weakness, proximal, upper and lower limbs affected
    n1=en:oedema | n2=en:muscle weakness, proximal, upper and lower limbs affected | rel=r_associated | relid=0 | w=46
  2274. en:oedema -- r_associated #0: 46 / 0.73 -> en:musculoskeletal observable
    n1=en:oedema | n2=en:musculoskeletal observable | rel=r_associated | relid=0 | w=46
  2275. en:oedema -- r_associated #0: 46 / 0.73 -> en:myocardial infarction
    n1=en:oedema | n2=en:myocardial infarction | rel=r_associated | relid=0 | w=46
  2276. en:oedema -- r_associated #0: 46 / 0.73 -> en:myofibromatosis affecting skin, muscle, bone, and viscera
    n1=en:oedema | n2=en:myofibromatosis affecting skin, muscle, bone, and viscera | rel=r_associated | relid=0 | w=46
  2277. en:oedema -- r_associated #0: 46 / 0.73 -> en:myopathic pattern seen on emg
    n1=en:oedema | n2=en:myopathic pattern seen on emg | rel=r_associated | relid=0 | w=46
  2278. en:oedema -- r_associated #0: 46 / 0.73 -> en:myopathy in approximately 45% of patients
    n1=en:oedema | n2=en:myopathy in approximately 45% of patients | rel=r_associated | relid=0 | w=46
  2279. en:oedema -- r_associated #0: 46 / 0.73 -> en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest)
    n1=en:oedema | n2=en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest) | rel=r_associated | relid=0 | w=46
  2280. en:oedema -- r_associated #0: 46 / 0.73 -> en:named sign of foot
    n1=en:oedema | n2=en:named sign of foot | rel=r_associated | relid=0 | w=46
  2281. en:oedema -- r_associated #0: 46 / 0.73 -> en:nausea and vomiting
    n1=en:oedema | n2=en:nausea and vomiting | rel=r_associated | relid=0 | w=46
  2282. en:oedema -- r_associated #0: 46 / 0.73 -> en:necrosis and degeneration seen on muscle biopsy
    n1=en:oedema | n2=en:necrosis and degeneration seen on muscle biopsy | rel=r_associated | relid=0 | w=46
  2283. en:oedema -- r_associated #0: 46 / 0.73 -> en:necrosis leading to amputation (in some patients)
    n1=en:oedema | n2=en:necrosis leading to amputation (in some patients) | rel=r_associated | relid=0 | w=46
  2284. en:oedema -- r_associated #0: 46 / 0.73 -> en:necrotic fibers
    n1=en:oedema | n2=en:necrotic fibers | rel=r_associated | relid=0 | w=46
  2285. en:oedema -- r_associated #0: 46 / 0.73 -> en:nemaline bodies are usually subsarcolemmal or sarcoplasmic
    n1=en:oedema | n2=en:nemaline bodies are usually subsarcolemmal or sarcoplasmic | rel=r_associated | relid=0 | w=46
  2286. en:oedema -- r_associated #0: 46 / 0.73 -> en:nemaline rods (rare)
    n1=en:oedema | n2=en:nemaline rods (rare) | rel=r_associated | relid=0 | w=46
  2287. en:oedema -- r_associated #0: 46 / 0.73 -> en:neonatal purpura fulminans
    n1=en:oedema | n2=en:neonatal purpura fulminans | rel=r_associated | relid=0 | w=46
  2288. en:oedema -- r_associated #0: 46 / 0.73 -> en:nephrotic syndrome, type 6
    n1=en:oedema | n2=en:nephrotic syndrome, type 6 | rel=r_associated | relid=0 | w=46
  2289. en:oedema -- r_associated #0: 46 / 0.73 -> en:neurogenic pulmonary edema
    n1=en:oedema | n2=en:neurogenic pulmonary edema | rel=r_associated | relid=0 | w=46
  2290. en:oedema -- r_associated #0: 46 / 0.73 -> en:neurological observable
    n1=en:oedema | n2=en:neurological observable | rel=r_associated | relid=0 | w=46
  2291. en:oedema -- r_associated #0: 46 / 0.73 -> en:nevus/mole
    n1=en:oedema | n2=en:nevus/mole | rel=r_associated | relid=0 | w=46
  2292. en:oedema -- r_associated #0: 46 / 0.73 -> en:nipple dermatitis
    n1=en:oedema | n2=en:nipple dermatitis | rel=r_associated | relid=0 | w=46
  2293. en:oedema -- r_associated #0: 46 / 0.73 -> en:no fetal hydrops
    n1=en:oedema | n2=en:no fetal hydrops | rel=r_associated | relid=0 | w=46
  2294. en:oedema -- r_associated #0: 46 / 0.73 -> en:no inflammatory or bullous skin lesions
    n1=en:oedema | n2=en:no inflammatory or bullous skin lesions | rel=r_associated | relid=0 | w=46
  2295. en:oedema -- r_associated #0: 46 / 0.73 -> en:no staining for oxidative enzymes
    n1=en:oedema | n2=en:no staining for oxidative enzymes | rel=r_associated | relid=0 | w=46
  2296. en:oedema -- r_associated #0: 46 / 0.73 -> en:normal neonatal period may occur before weakness is apparent
    n1=en:oedema | n2=en:normal neonatal period may occur before weakness is apparent | rel=r_associated | relid=0 | w=46
  2297. en:oedema -- r_associated #0: 46 / 0.73 -> en:normal or increased facial adipose tissue
    n1=en:oedema | n2=en:normal or increased facial adipose tissue | rel=r_associated | relid=0 | w=46
  2298. en:oedema -- r_associated #0: 46 / 0.73 -> en:normal phosphorylase kinase activity in muscle
    n1=en:oedema | n2=en:normal phosphorylase kinase activity in muscle | rel=r_associated | relid=0 | w=46
  2299. en:oedema -- r_associated #0: 46 / 0.73 -> en:numerous congenital melanocytic nevi
    n1=en:oedema | n2=en:numerous congenital melanocytic nevi | rel=r_associated | relid=0 | w=46
  2300. en:oedema -- r_associated #0: 46 / 0.73 -> en:numerous vacuole-like areas
    n1=en:oedema | n2=en:numerous vacuole-like areas | rel=r_associated | relid=0 | w=46
  2301. en:oedema -- r_associated #0: 46 / 0.73 -> en:o/e - edema of arms
    n1=en:oedema | n2=en:o/e - edema of arms | rel=r_associated | relid=0 | w=46
  2302. en:oedema -- r_associated #0: 46 / 0.73 -> en:oedema neonatal
    n1=en:oedema | n2=en:oedema neonatal | rel=r_associated | relid=0 | w=46
  2303. en:oedema -- r_associated #0: 46 / 0.73 -> en:other fluid overload
    n1=en:oedema | n2=en:other fluid overload | rel=r_associated | relid=0 | w=46
  2304. en:oedema -- r_associated #0: 46 / 0.73 -> en:other symptoms involving skin and integumentary tissues
    n1=en:oedema | n2=en:other symptoms involving skin and integumentary tissues | rel=r_associated | relid=0 | w=46
  2305. en:oedema -- r_associated #0: 46 / 0.73 -> en:pachyderma
    n1=en:oedema | n2=en:pachyderma | rel=r_associated | relid=0 | w=46
  2306. en:oedema -- r_associated #0: 46 / 0.73 -> en:pain
    n1=en:oedema | n2=en:pain | rel=r_associated | relid=0 | w=46
  2307. en:oedema -- r_associated #0: 46 / 0.73 -> en:pain or cramping during sustained manual activity
    n1=en:oedema | n2=en:pain or cramping during sustained manual activity | rel=r_associated | relid=0 | w=46
  2308. en:oedema -- r_associated #0: 46 / 0.73 -> en:painful swelling in fasciae
    n1=en:oedema | n2=en:painful swelling in fasciae | rel=r_associated | relid=0 | w=46
  2309. en:oedema -- r_associated #0: 46 / 0.73 -> en:pale-gray skin
    n1=en:oedema | n2=en:pale-gray skin | rel=r_associated | relid=0 | w=46
  2310. en:oedema -- r_associated #0: 46 / 0.73 -> en:pallor
    n1=en:oedema | n2=en:pallor | rel=r_associated | relid=0 | w=46
  2311. en:oedema -- r_associated #0: 46 / 0.73 -> en:palmoplantar keratoderma, mild (in homozygous patients)
    n1=en:oedema | n2=en:palmoplantar keratoderma, mild (in homozygous patients) | rel=r_associated | relid=0 | w=46
  2312. en:oedema -- r_associated #0: 46 / 0.73 -> en:palms, soles, and oral mucosa are not involved
    n1=en:oedema | n2=en:palms, soles, and oral mucosa are not involved | rel=r_associated | relid=0 | w=46
  2313. en:oedema -- r_associated #0: 46 / 0.73 -> en:papillomas (perioral, nasal, and anal regions)
    n1=en:oedema | n2=en:papillomas (perioral, nasal, and anal regions) | rel=r_associated | relid=0 | w=46
  2314. en:oedema -- r_associated #0: 46 / 0.73 -> en:papules, keratotic follicular
    n1=en:oedema | n2=en:papules, keratotic follicular | rel=r_associated | relid=0 | w=46
  2315. en:oedema -- r_associated #0: 46 / 0.73 -> en:papulosquamous erythematous plaques
    n1=en:oedema | n2=en:papulosquamous erythematous plaques | rel=r_associated | relid=0 | w=46
  2316. en:oedema -- r_associated #0: 46 / 0.73 -> en:patchy, reticular stains
    n1=en:oedema | n2=en:patchy, reticular stains | rel=r_associated | relid=0 | w=46
  2317. en:oedema -- r_associated #0: 46 / 0.73 -> en:patent ductus arteriosus - persisting type
    n1=en:oedema | n2=en:patent ductus arteriosus - persisting type | rel=r_associated | relid=0 | w=46
  2318. en:oedema -- r_associated #0: 46 / 0.73 -> en:patient problem codes fda cdrh
    n1=en:oedema | n2=en:patient problem codes fda cdrh | rel=r_associated | relid=0 | w=46
  2319. en:oedema -- r_associated #0: 46 / 0.73 -> en:paucity or absence of lymph nodes in the axillae and above the inguinal ligaments seen on scintilymphangiography
    n1=en:oedema | n2=en:paucity or absence of lymph nodes in the axillae and above the inguinal ligaments seen on scintilymphangiography | rel=r_associated | relid=0 | w=46
  2320. en:oedema -- r_associated #0: 46 / 0.73 -> en:pediatric adverse events terminology
    n1=en:oedema | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=46
  2321. en:oedema -- r_associated #0: 46 / 0.73 -> en:periorbital edema
    n1=en:oedema | n2=en:periorbital edema | rel=r_associated | relid=0 | w=46
  2322. en:oedema -- r_associated #0: 46 / 0.73 -> en:periorificial hyperkeratotic lesions
    n1=en:oedema | n2=en:periorificial hyperkeratotic lesions | rel=r_associated | relid=0 | w=46
  2323. en:oedema -- r_associated #0: 46 / 0.73 -> en:peritumoural oedema
    n1=en:oedema | n2=en:peritumoural oedema | rel=r_associated | relid=0 | w=46
  2324. en:oedema -- r_associated #0: 46 / 0.73 -> en:periwound description:find:pt:periwound:nom
    n1=en:oedema | n2=en:periwound description:find:pt:periwound:nom | rel=r_associated | relid=0 | w=46
  2325. en:oedema -- r_associated #0: 46 / 0.73 -> en:physiopathological
    n1=en:oedema | n2=en:physiopathological | rel=r_associated | relid=0 | w=46
  2326. en:oedema -- r_associated #0: 46 / 0.73 -> en:pigmentary changes on the shins (1 patient)
    n1=en:oedema | n2=en:pigmentary changes on the shins (1 patient) | rel=r_associated | relid=0 | w=46
  2327. en:oedema -- r_associated #0: 46 / 0.73 -> en:pigmentation
    n1=en:oedema | n2=en:pigmentation | rel=r_associated | relid=0 | w=46
  2328. en:oedema -- r_associated #0: 46 / 0.73 -> en:pityriasis rosea
    n1=en:oedema | n2=en:pityriasis rosea | rel=r_associated | relid=0 | w=46
  2329. en:oedema -- r_associated #0: 46 / 0.73 -> en:plantar hyperkeratosis
    n1=en:oedema | n2=en:plantar hyperkeratosis | rel=r_associated | relid=0 | w=46
  2330. en:oedema -- r_associated #0: 46 / 0.73 -> en:plantar softness
    n1=en:oedema | n2=en:plantar softness | rel=r_associated | relid=0 | w=46
  2331. en:oedema -- r_associated #0: 46 / 0.73 -> en:plaques, erythematous, covered with fine powdery scales
    n1=en:oedema | n2=en:plaques, erythematous, covered with fine powdery scales | rel=r_associated | relid=0 | w=46
  2332. en:oedema -- r_associated #0: 46 / 0.73 -> en:polyglucosan accumulation
    n1=en:oedema | n2=en:polyglucosan accumulation | rel=r_associated | relid=0 | w=46
  2333. en:oedema -- r_associated #0: 46 / 0.73 -> en:positive skin test reaction to seminal fluid
    n1=en:oedema | n2=en:positive skin test reaction to seminal fluid | rel=r_associated | relid=0 | w=46
  2334. en:oedema -- r_associated #0: 46 / 0.73 -> en:potential for excess fluid volume
    n1=en:oedema | n2=en:potential for excess fluid volume | rel=r_associated | relid=0 | w=46
  2335. en:oedema -- r_associated #0: 46 / 0.73 -> en:primarily affects trunk
    n1=en:oedema | n2=en:primarily affects trunk | rel=r_associated | relid=0 | w=46
  2336. en:oedema -- r_associated #0: 46 / 0.73 -> en:profuse pigmented skin lesions
    n1=en:oedema | n2=en:profuse pigmented skin lesions | rel=r_associated | relid=0 | w=46
  2337. en:oedema -- r_associated #0: 46 / 0.73 -> en:progressive cutis verticis gyrata
    n1=en:oedema | n2=en:progressive cutis verticis gyrata | rel=r_associated | relid=0 | w=46
  2338. en:oedema -- r_associated #0: 46 / 0.73 -> en:progressive interictal weakness is common
    n1=en:oedema | n2=en:progressive interictal weakness is common | rel=r_associated | relid=0 | w=46
  2339. en:oedema -- r_associated #0: 46 / 0.73 -> en:progressive muscle weakness
    n1=en:oedema | n2=en:progressive muscle weakness | rel=r_associated | relid=0 | w=46
  2340. en:oedema -- r_associated #0: 46 / 0.73 -> en:progressive proximal muscle involvement
    n1=en:oedema | n2=en:progressive proximal muscle involvement | rel=r_associated | relid=0 | w=46
  2341. en:oedema -- r_associated #0: 46 / 0.73 -> en:prominent superficial blood vessels
    n1=en:oedema | n2=en:prominent superficial blood vessels | rel=r_associated | relid=0 | w=46
  2342. en:oedema -- r_associated #0: 46 / 0.73 -> en:prominent superficial venous pattern
    n1=en:oedema | n2=en:prominent superficial venous pattern | rel=r_associated | relid=0 | w=46
  2343. en:oedema -- r_associated #0: 46 / 0.73 -> en:proximal muscle weakness
    n1=en:oedema | n2=en:proximal muscle weakness | rel=r_associated | relid=0 | w=46
  2344. en:oedema -- r_associated #0: 46 / 0.73 -> en:proximal muscles may be mildly affected
    n1=en:oedema | n2=en:proximal muscles may be mildly affected | rel=r_associated | relid=0 | w=46
  2345. en:oedema -- r_associated #0: 46 / 0.73 -> en:proximal upper limb amyotrophy
    n1=en:oedema | n2=en:proximal upper limb amyotrophy | rel=r_associated | relid=0 | w=46
  2346. en:oedema -- r_associated #0: 46 / 0.73 -> en:proximal weakness of the lower limbs with longer disease duration
    n1=en:oedema | n2=en:proximal weakness of the lower limbs with longer disease duration | rel=r_associated | relid=0 | w=46
  2347. en:oedema -- r_associated #0: 46 / 0.73 -> en:pruritus (inflammatory type b)
    n1=en:oedema | n2=en:pruritus (inflammatory type b) | rel=r_associated | relid=0 | w=46
  2348. en:oedema -- r_associated #0: 46 / 0.73 -> en:pruritus secondary to liver disease
    n1=en:oedema | n2=en:pruritus secondary to liver disease | rel=r_associated | relid=0 | w=46
  2349. en:oedema -- r_associated #0: 46 / 0.73 -> en:pseudoainhum
    n1=en:oedema | n2=en:pseudoainhum | rel=r_associated | relid=0 | w=46
  2350. en:oedema -- r_associated #0: 46 / 0.73 -> en:pseudoxanthomatous skin lesions (in some patients)
    n1=en:oedema | n2=en:pseudoxanthomatous skin lesions (in some patients) | rel=r_associated | relid=0 | w=46
  2351. en:oedema -- r_associated #0: 46 / 0.73 -> en:punctate palmoplantar keratoderma
    n1=en:oedema | n2=en:punctate palmoplantar keratoderma | rel=r_associated | relid=0 | w=46
  2352. en:oedema -- r_associated #0: 46 / 0.73 -> en:ragged red fibers seen on biopsy
    n1=en:oedema | n2=en:ragged red fibers seen on biopsy | rel=r_associated | relid=0 | w=46
  2353. en:oedema -- r_associated #0: 46 / 0.73 -> en:recurrent bacterial skin infections
    n1=en:oedema | n2=en:recurrent bacterial skin infections | rel=r_associated | relid=0 | w=46
  2354. en:oedema -- r_associated #0: 46 / 0.73 -> en:recurrent skin ulcerations (face, trunk, limbs)
    n1=en:oedema | n2=en:recurrent skin ulcerations (face, trunk, limbs) | rel=r_associated | relid=0 | w=46
  2355. en:oedema -- r_associated #0: 46 / 0.73 -> en:red-violet macular atrophy
    n1=en:oedema | n2=en:red-violet macular atrophy | rel=r_associated | relid=0 | w=46
  2356. en:oedema -- r_associated #0: 46 / 0.73 -> en:rehabilitation aspects
    n1=en:oedema | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=46
  2357. en:oedema -- r_associated #0: 46 / 0.73 -> en:residual hyperpigmentation
    n1=en:oedema | n2=en:residual hyperpigmentation | rel=r_associated | relid=0 | w=46
  2358. en:oedema -- r_associated #0: 46 / 0.73 -> en:residual slightly atrophic scarring
    n1=en:oedema | n2=en:residual slightly atrophic scarring | rel=r_associated | relid=0 | w=46
  2359. en:oedema -- r_associated #0: 46 / 0.73 -> en:respiratory tract diseases
    n1=en:oedema | n2=en:respiratory tract diseases | rel=r_associated | relid=0 | w=46
  2360. en:oedema -- r_associated #0: 46 / 0.73 -> en:retain some mechanical adipose tissue (joints, orbits, palms, soles)
    n1=en:oedema | n2=en:retain some mechanical adipose tissue (joints, orbits, palms, soles) | rel=r_associated | relid=0 | w=46
  2361. en:oedema -- r_associated #0: 46 / 0.73 -> en:reticular skin pigmentation (classic feature, nola3 patient)
    n1=en:oedema | n2=en:reticular skin pigmentation (classic feature, nola3 patient) | rel=r_associated | relid=0 | w=46
  2362. en:oedema -- r_associated #0: 46 / 0.73 -> en:reticulate hyperpigmentation (periocular, perioral, chest, neck, abdomen)
    n1=en:oedema | n2=en:reticulate hyperpigmentation (periocular, perioral, chest, neck, abdomen) | rel=r_associated | relid=0 | w=46
  2363. en:oedema -- r_associated #0: 46 / 0.73 -> en:reticulate hyperpigmentation composed of 1- to 5-mm light brown spots with clearly defined borders that may coalesce
    n1=en:oedema | n2=en:reticulate hyperpigmentation composed of 1- to 5-mm light brown spots with clearly defined borders that may coalesce | rel=r_associated | relid=0 | w=46
  2364. en:oedema -- r_associated #0: 46 / 0.73 -> en:rhabdomyolysis, episodic and recurrent
    n1=en:oedema | n2=en:rhabdomyolysis, episodic and recurrent | rel=r_associated | relid=0 | w=46
  2365. en:oedema -- r_associated #0: 46 / 0.73 -> en:scaly skin
    n1=en:oedema | n2=en:scaly skin | rel=r_associated | relid=0 | w=46
  2366. en:oedema -- r_associated #0: 46 / 0.73 -> en:scapular muscle weakness
    n1=en:oedema | n2=en:scapular muscle weakness | rel=r_associated | relid=0 | w=46
  2367. en:oedema -- r_associated #0: 46 / 0.73 -> en:scleroderma
    n1=en:oedema | n2=en:scleroderma | rel=r_associated | relid=0 | w=46
  2368. en:oedema -- r_associated #0: 46 / 0.73 -> en:scleroderma-like secondary cutaneous sclerosis
    n1=en:oedema | n2=en:scleroderma-like secondary cutaneous sclerosis | rel=r_associated | relid=0 | w=46
  2369. en:oedema -- r_associated #0: 46 / 0.73 -> en:seborrheic dermatitis in infancy
    n1=en:oedema | n2=en:seborrheic dermatitis in infancy | rel=r_associated | relid=0 | w=46
  2370. en:oedema -- r_associated #0: 46 / 0.73 -> en:secondary decrease of calpain-3 (capn3, 114240) protein expression in muscle
    n1=en:oedema | n2=en:secondary decrease of calpain-3 (capn3, 114240) protein expression in muscle | rel=r_associated | relid=0 | w=46
  2371. en:oedema -- r_associated #0: 46 / 0.73 -> en:secondary loss of sarcolemmal caveolin-3
    n1=en:oedema | n2=en:secondary loss of sarcolemmal caveolin-3 | rel=r_associated | relid=0 | w=46
  2372. en:oedema -- r_associated #0: 46 / 0.73 -> en:severe hydrops fetalis
    n1=en:oedema | n2=en:severe hydrops fetalis | rel=r_associated | relid=0 | w=46
  2373. en:oedema -- r_associated #0: 46 / 0.73 -> en:shortening of various muscle-tendon groups in feet
    n1=en:oedema | n2=en:shortening of various muscle-tendon groups in feet | rel=r_associated | relid=0 | w=46
  2374. en:oedema -- r_associated #0: 46 / 0.73 -> en:shrug sign
    n1=en:oedema | n2=en:shrug sign | rel=r_associated | relid=0 | w=46
  2375. en:oedema -- r_associated #0: 46 / 0.73 -> en:size variation (1 x 1 to 6 x 4 cm)
    n1=en:oedema | n2=en:size variation (1 x 1 to 6 x 4 cm) | rel=r_associated | relid=0 | w=46
  2376. en:oedema -- r_associated #0: 46 / 0.73 -> en:skeletal muscle shows decreased sarcoglycan proteins
    n1=en:oedema | n2=en:skeletal muscle shows decreased sarcoglycan proteins | rel=r_associated | relid=0 | w=46
  2377. en:oedema -- r_associated #0: 46 / 0.73 -> en:skin appendage structure
    n1=en:oedema | n2=en:skin appendage structure | rel=r_associated | relid=0 | w=46
  2378. en:oedema -- r_associated #0: 46 / 0.73 -> en:skin atrophy (especially over hands and feet)
    n1=en:oedema | n2=en:skin atrophy (especially over hands and feet) | rel=r_associated | relid=0 | w=46
  2379. en:oedema -- r_associated #0: 46 / 0.73 -> en:skin fragility with non-scarring blistering
    n1=en:oedema | n2=en:skin fragility with non-scarring blistering | rel=r_associated | relid=0 | w=46
  2380. en:oedema -- r_associated #0: 46 / 0.73 -> en:skin lacks elastic recoil
    n1=en:oedema | n2=en:skin lacks elastic recoil | rel=r_associated | relid=0 | w=46
  2381. en:oedema -- r_associated #0: 46 / 0.73 -> en:skin pigmentation - finding
    n1=en:oedema | n2=en:skin pigmentation - finding | rel=r_associated | relid=0 | w=46
  2382. en:oedema -- r_associated #0: 46 / 0.73 -> en:skin rough
    n1=en:oedema | n2=en:skin rough | rel=r_associated | relid=0 | w=46
  2383. en:oedema -- r_associated #0: 46 / 0.73 -> en:skin tag
    n1=en:oedema | n2=en:skin tag | rel=r_associated | relid=0 | w=46
  2384. en:oedema -- r_associated #0: 46 / 0.73 -> en:small, annular, anhidrotic keratotic lesions located predominantly on sun-exposed areas
    n1=en:oedema | n2=en:small, annular, anhidrotic keratotic lesions located predominantly on sun-exposed areas | rel=r_associated | relid=0 | w=46
  2385. en:oedema -- r_associated #0: 46 / 0.73 -> en:sodium chloride
    n1=en:oedema | n2=en:sodium chloride | rel=r_associated | relid=0 | w=46
  2386. en:oedema -- r_associated #0: 46 / 0.73 -> en:sodium chloride 0.0256 meq/ml irrigation solution
    n1=en:oedema | n2=en:sodium chloride 0.0256 meq/ml irrigation solution | rel=r_associated | relid=0 | w=46
  2387. en:oedema -- r_associated #0: 46 / 0.73 -> en:sodium chloride 0.342 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium chloride 0.342 meq/ml injectable solution | rel=r_associated | relid=0 | w=46
  2388. en:oedema -- r_associated #0: 46 / 0.73 -> en:sodium chloride 0.598 meq/ml inhalant solution
    n1=en:oedema | n2=en:sodium chloride 0.598 meq/ml inhalant solution | rel=r_associated | relid=0 | w=46
  2389. en:oedema -- r_associated #0: 46 / 0.73 -> en:sodium chloride 1.71 meq/ml inhalant solution
    n1=en:oedema | n2=en:sodium chloride 1.71 meq/ml inhalant solution | rel=r_associated | relid=0 | w=46
  2390. en:oedema -- r_associated #0: 46 / 0.73 -> en:sodium chloride 5% infusion solution bag
    n1=en:oedema | n2=en:sodium chloride 5% infusion solution bag | rel=r_associated | relid=0 | w=46
  2391. en:oedema -- r_associated #0: 46 / 0.73 -> en:sodium citrate 4% soln
    n1=en:oedema | n2=en:sodium citrate 4% soln | rel=r_associated | relid=0 | w=46
  2392. en:oedema -- r_associated #0: 46 / 0.73 -> en:sodium citrate 46.7% soln
    n1=en:oedema | n2=en:sodium citrate 46.7% soln | rel=r_associated | relid=0 | w=46
  2393. en:oedema -- r_associated #0: 46 / 0.73 -> en:soft tissue or tendinous calcinosis may occur
    n1=en:oedema | n2=en:soft tissue or tendinous calcinosis may occur | rel=r_associated | relid=0 | w=46
  2394. en:oedema -- r_associated #0: 46 / 0.73 -> en:spheroid bodies are composed of fine filamentous (myofibrillar) material
    n1=en:oedema | n2=en:spheroid bodies are composed of fine filamentous (myofibrillar) material | rel=r_associated | relid=0 | w=46
  2395. en:oedema -- r_associated #0: 46 / 0.73 -> en:stevens-johnson syndrome
    n1=en:oedema | n2=en:stevens-johnson syndrome | rel=r_associated | relid=0 | w=46
  2396. en:oedema -- r_associated #0: 46 / 0.73 -> en:subcutaneous fat markedly reduced
    n1=en:oedema | n2=en:subcutaneous fat markedly reduced | rel=r_associated | relid=0 | w=46
  2397. en:oedema -- r_associated #0: 46 / 0.73 -> en:subcutaneous infections, recurrent, with fistula formation
    n1=en:oedema | n2=en:subcutaneous infections, recurrent, with fistula formation | rel=r_associated | relid=0 | w=46
  2398. en:oedema -- r_associated #0: 46 / 0.73 -> en:subepidermal capillary ectasia
    n1=en:oedema | n2=en:subepidermal capillary ectasia | rel=r_associated | relid=0 | w=46
  2399. en:oedema -- r_associated #0: 46 / 0.73 -> en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy
    n1=en:oedema | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy | rel=r_associated | relid=0 | w=46
  2400. en:oedema -- r_associated #0: 46 / 0.73 -> en:suffocation
    n1=en:oedema | n2=en:suffocation | rel=r_associated | relid=0 | w=46
  2401. en:oedema -- r_associated #0: 46 / 0.73 -> en:swelling of body structure
    n1=en:oedema | n2=en:swelling of body structure | rel=r_associated | relid=0 | w=46
  2402. en:oedema -- r_associated #0: 46 / 0.73 -> en:swelling of the extremities, episodic
    n1=en:oedema | n2=en:swelling of the extremities, episodic | rel=r_associated | relid=0 | w=46
  2403. en:oedema -- r_associated #0: 46 / 0.73 -> en:symptom/complaint nails
    n1=en:oedema | n2=en:symptom/complaint nails | rel=r_associated | relid=0 | w=46
  2404. en:oedema -- r_associated #0: 46 / 0.73 -> en:symptoms involving nervous and musculoskeletal systems
    n1=en:oedema | n2=en:symptoms involving nervous and musculoskeletal systems | rel=r_associated | relid=0 | w=46
  2405. en:oedema -- r_associated #0: 46 / 0.73 -> en:telangiectasia on lips and oral mucosa
    n1=en:oedema | n2=en:telangiectasia on lips and oral mucosa | rel=r_associated | relid=0 | w=46
  2406. en:oedema -- r_associated #0: 46 / 0.73 -> en:temporal arteritis
    n1=en:oedema | n2=en:temporal arteritis | rel=r_associated | relid=0 | w=46
  2407. en:oedema -- r_associated #0: 46 / 0.73 -> en:tendency to overheat
    n1=en:oedema | n2=en:tendency to overheat | rel=r_associated | relid=0 | w=46
  2408. en:oedema -- r_associated #0: 46 / 0.73 -> en:therapeutic aspects
    n1=en:oedema | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=46
  2409. en:oedema -- r_associated #0: 46 / 0.73 -> en:thickened, furrowed skin
    n1=en:oedema | n2=en:thickened, furrowed skin | rel=r_associated | relid=0 | w=46
  2410. en:oedema -- r_associated #0: 46 / 0.73 -> en:thin skin
    n1=en:oedema | n2=en:thin skin | rel=r_associated | relid=0 | w=46
  2411. en:oedema -- r_associated #0: 46 / 0.73 -> en:thin, wrinkled skin
    n1=en:oedema | n2=en:thin, wrinkled skin | rel=r_associated | relid=0 | w=46
  2412. en:oedema -- r_associated #0: 46 / 0.73 -> en:tone does not appreciably change with age
    n1=en:oedema | n2=en:tone does not appreciably change with age | rel=r_associated | relid=0 | w=46
  2413. en:oedema -- r_associated #0: 46 / 0.73 -> en:total fluid volume increased
    n1=en:oedema | n2=en:total fluid volume increased | rel=r_associated | relid=0 | w=46
  2414. en:oedema -- r_associated #0: 46 / 0.73 -> en:transgression of hyperkeratosis to dorsum of hands and feet (in some patients)
    n1=en:oedema | n2=en:transgression of hyperkeratosis to dorsum of hands and feet (in some patients) | rel=r_associated | relid=0 | w=46
  2415. en:oedema -- r_associated #0: 46 / 0.73 -> en:transient, migratory sharply outlined erythema (in some patients)
    n1=en:oedema | n2=en:transient, migratory sharply outlined erythema (in some patients) | rel=r_associated | relid=0 | w=46
  2416. en:oedema -- r_associated #0: 46 / 0.73 -> en:triceps weakness
    n1=en:oedema | n2=en:triceps weakness | rel=r_associated | relid=0 | w=46
  2417. en:oedema -- r_associated #0: 46 / 0.73 -> en:type 1 fibers with inclusions containing myh7 protein aggregates
    n1=en:oedema | n2=en:type 1 fibers with inclusions containing myh7 protein aggregates | rel=r_associated | relid=0 | w=46
  2418. en:oedema -- r_associated #0: 46 / 0.73 -> en:ulcers, plantar
    n1=en:oedema | n2=en:ulcers, plantar | rel=r_associated | relid=0 | w=46
  2419. en:oedema -- r_associated #0: 46 / 0.73 -> en:vacuoles containing neutral lipids seen on muscle biopsy
    n1=en:oedema | n2=en:vacuoles containing neutral lipids seen on muscle biopsy | rel=r_associated | relid=0 | w=46
  2420. en:oedema -- r_associated #0: 46 / 0.73 -> en:valvular heart disorder
    n1=en:oedema | n2=en:valvular heart disorder | rel=r_associated | relid=0 | w=46
  2421. en:oedema -- r_associated #0: 46 / 0.73 -> en:variable deficiencies of mitochondrial respiratory chain complexes i, iii, and iv
    n1=en:oedema | n2=en:variable deficiencies of mitochondrial respiratory chain complexes i, iii, and iv | rel=r_associated | relid=0 | w=46
  2422. en:oedema -- r_associated #0: 46 / 0.73 -> en:variable deficiencies of mitochondrial respiratory chain enzymes
    n1=en:oedema | n2=en:variable deficiencies of mitochondrial respiratory chain enzymes | rel=r_associated | relid=0 | w=46
  2423. en:oedema -- r_associated #0: 46 / 0.73 -> en:variable skin syndactyly fingers and toes
    n1=en:oedema | n2=en:variable skin syndactyly fingers and toes | rel=r_associated | relid=0 | w=46
  2424. en:oedema -- r_associated #0: 46 / 0.73 -> en:variably decreased alpha-dystroglycan expression (dag, 128239)
    n1=en:oedema | n2=en:variably decreased alpha-dystroglycan expression (dag, 128239) | rel=r_associated | relid=0 | w=46
  2425. en:oedema -- r_associated #0: 46 / 0.73 -> en:varicose veins (reported in 1 family)
    n1=en:oedema | n2=en:varicose veins (reported in 1 family) | rel=r_associated | relid=0 | w=46
  2426. en:oedema -- r_associated #0: 46 / 0.73 -> en:venous angiectasia
    n1=en:oedema | n2=en:venous angiectasia | rel=r_associated | relid=0 | w=46
  2427. en:oedema -- r_associated #0: 46 / 0.73 -> en:verruca plantaris
    n1=en:oedema | n2=en:verruca plantaris | rel=r_associated | relid=0 | w=46
  2428. en:oedema -- r_associated #0: 46 / 0.73 -> en:vessels may form rounded nodules ('tufts')
    n1=en:oedema | n2=en:vessels may form rounded nodules ('tufts') | rel=r_associated | relid=0 | w=46
  2429. en:oedema -- r_associated #0: 46 / 0.73 -> en:waddling gait
    n1=en:oedema | n2=en:waddling gait | rel=r_associated | relid=0 | w=46
  2430. en:oedema -- r_associated #0: 46 / 0.73 -> en:weakness of ankle plantar flexion
    n1=en:oedema | n2=en:weakness of ankle plantar flexion | rel=r_associated | relid=0 | w=46
  2431. en:oedema -- r_associated #0: 46 / 0.73 -> en:weight gain adverse event
    n1=en:oedema | n2=en:weight gain adverse event | rel=r_associated | relid=0 | w=46
  2432. en:oedema -- r_associated #0: 46 / 0.73 -> en:white skin
    n1=en:oedema | n2=en:white skin | rel=r_associated | relid=0 | w=46
  2433. en:oedema -- r_associated #0: 46 / 0.73 -> en:z-disk streaming
    n1=en:oedema | n2=en:z-disk streaming | rel=r_associated | relid=0 | w=46
  2434. en:oedema -- r_associated #0: 46 / 0.73 -> inflammation
    n1=en:oedema | n2=inflammation | rel=r_associated | relid=0 | w=46
  2435. en:oedema -- r_associated #0: 46 / 0.73 -> oedème cardio-rénal
    n1=en:oedema | n2=oedème cardio-rénal | rel=r_associated | relid=0 | w=46
  2436. en:oedema -- r_associated #0: 46 / 0.73 -> oedème maculaire cystoïde
    n1=en:oedema | n2=oedème maculaire cystoïde | rel=r_associated | relid=0 | w=46
  2437. en:oedema -- r_associated #0: 46 / 0.73 -> oedème osseux
    n1=en:oedema | n2=oedème osseux | rel=r_associated | relid=0 | w=46
  2438. en:oedema -- r_associated #0: 46 / 0.73 -> oedème pulmonaire
    n1=en:oedema | n2=oedème pulmonaire | rel=r_associated | relid=0 | w=46
  2439. en:oedema -- r_associated #0: 46 / 0.73 -> oedème vasogénique
    n1=en:oedema | n2=oedème vasogénique | rel=r_associated | relid=0 | w=46
  2440. en:oedema -- r_associated #0: 46 / 0.73 -> résultats anormaux d'imagerie diagnostique
    n1=en:oedema | n2=résultats anormaux d'imagerie diagnostique | rel=r_associated | relid=0 | w=46
  2441. en:oedema -- r_associated #0: 46 / 0.73 -> rétention de liquide dans les tissus
    n1=en:oedema | n2=rétention de liquide dans les tissus | rel=r_associated | relid=0 | w=46
  2442. en:oedema -- r_associated #0: 45 / 0.714 -> en:biopsy shows nonspecific myopathy without rimmed vacuoles
    n1=en:oedema | n2=en:biopsy shows nonspecific myopathy without rimmed vacuoles | rel=r_associated | relid=0 | w=45
  2443. en:oedema -- r_associated #0: 45 / 0.714 -> en:blistering may be generalized or localized
    n1=en:oedema | n2=en:blistering may be generalized or localized | rel=r_associated | relid=0 | w=45
  2444. en:oedema -- r_associated #0: 45 / 0.714 -> en:chylothorax
    n1=en:oedema | n2=en:chylothorax | rel=r_associated | relid=0 | w=45
  2445. en:oedema -- r_associated #0: 45 / 0.714 -> en:coarse, thick skin (especially upper face and scalp)
    n1=en:oedema | n2=en:coarse, thick skin (especially upper face and scalp) | rel=r_associated | relid=0 | w=45
  2446. en:oedema -- r_associated #0: 45 / 0.714 -> en:cyanotic attacks in children
    n1=en:oedema | n2=en:cyanotic attacks in children | rel=r_associated | relid=0 | w=45
  2447. en:oedema -- r_associated #0: 45 / 0.714 -> en:decreased glycosylation of alpha-dystroglycan (dag1, 128239)
    n1=en:oedema | n2=en:decreased glycosylation of alpha-dystroglycan (dag1, 128239) | rel=r_associated | relid=0 | w=45
  2448. en:oedema -- r_associated #0: 45 / 0.714 -> en:distal limb muscle atrophy due to peripheral neuropathy
    n1=en:oedema | n2=en:distal limb muscle atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=45
  2449. en:oedema -- r_associated #0: 45 / 0.714 -> en:dry skin
    n1=en:oedema | n2=en:dry skin | rel=r_associated | relid=0 | w=45
  2450. en:oedema -- r_associated #0: 45 / 0.714 -> en:malignant hyperthermia syndrome
    n1=en:oedema | n2=en:malignant hyperthermia syndrome | rel=r_associated | relid=0 | w=45
  2451. en:oedema -- r_associated #0: 45 / 0.714 -> en:mild eczema
    n1=en:oedema | n2=en:mild eczema | rel=r_associated | relid=0 | w=45
  2452. en:oedema -- r_associated #0: 45 / 0.714 -> en:minicores extend full fiber diameter
    n1=en:oedema | n2=en:minicores extend full fiber diameter | rel=r_associated | relid=0 | w=45
  2453. en:oedema -- r_associated #0: 45 / 0.714 -> en:mitral valve prolapse
    n1=en:oedema | n2=en:mitral valve prolapse | rel=r_associated | relid=0 | w=45
  2454. en:oedema -- r_associated #0: 45 / 0.714 -> en:named sign of hand
    n1=en:oedema | n2=en:named sign of hand | rel=r_associated | relid=0 | w=45
  2455. en:oedema -- r_associated #0: 45 / 0.714 -> en:normal sweating capacity
    n1=en:oedema | n2=en:normal sweating capacity | rel=r_associated | relid=0 | w=45
  2456. en:oedema -- r_associated #0: 45 / 0.714 -> en:palmar pit
    n1=en:oedema | n2=en:palmar pit | rel=r_associated | relid=0 | w=45
  2457. en:oedema -- r_associated #0: 45 / 0.714 -> en:papillomatosis over edematous areas
    n1=en:oedema | n2=en:papillomatosis over edematous areas | rel=r_associated | relid=0 | w=45
  2458. en:oedema -- r_associated #0: 45 / 0.714 -> en:periorbital wrinkles
    n1=en:oedema | n2=en:periorbital wrinkles | rel=r_associated | relid=0 | w=45
  2459. en:oedema -- r_associated #0: 45 / 0.714 -> en:pterygia of elbows (in some patients)
    n1=en:oedema | n2=en:pterygia of elbows (in some patients) | rel=r_associated | relid=0 | w=45
  2460. en:oedema -- r_associated #0: 45 / 0.714 -> en:rectus abdominis muscle separation
    n1=en:oedema | n2=en:rectus abdominis muscle separation | rel=r_associated | relid=0 | w=45
  2461. en:oedema -- r_associated #0: 45 / 0.714 -> en:shortening of flexor profundus muscle-tendon unit
    n1=en:oedema | n2=en:shortening of flexor profundus muscle-tendon unit | rel=r_associated | relid=0 | w=45
  2462. en:oedema -- r_associated #0: 45 / 0.714 -> en:skeletal muscle biopsy shows dystrophic changes
    n1=en:oedema | n2=en:skeletal muscle biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=45
  2463. en:oedema -- r_associated #0: 44 / 0.698 -> boursouflure
    n1=en:oedema | n2=boursouflure | rel=r_associated | relid=0 | w=44
  2464. en:oedema -- r_associated #0: 44 / 0.698 -> en:'ice-pick marks'
    n1=en:oedema | n2=en:'ice-pick marks' | rel=r_associated | relid=0 | w=44
  2465. en:oedema -- r_associated #0: 44 / 0.698 -> en:50 ml sodium bicarbonate 1 meq/ml prefilled syringe
    n1=en:oedema | n2=en:50 ml sodium bicarbonate 1 meq/ml prefilled syringe | rel=r_associated | relid=0 | w=44
  2466. en:oedema -- r_associated #0: 44 / 0.698 -> en:a subset of patients have aggravation on cold exposure ('cold paresis')
    n1=en:oedema | n2=en:a subset of patients have aggravation on cold exposure ('cold paresis') | rel=r_associated | relid=0 | w=44
  2467. en:oedema -- r_associated #0: 44 / 0.698 -> en:aberrant skin dimples (elbows and knees)
    n1=en:oedema | n2=en:aberrant skin dimples (elbows and knees) | rel=r_associated | relid=0 | w=44
  2468. en:oedema -- r_associated #0: 44 / 0.698 -> en:abnormal mitochondria
    n1=en:oedema | n2=en:abnormal mitochondria | rel=r_associated | relid=0 | w=44
  2469. en:oedema -- r_associated #0: 44 / 0.698 -> en:abnormal vision
    n1=en:oedema | n2=en:abnormal vision | rel=r_associated | relid=0 | w=44
  2470. en:oedema -- r_associated #0: 44 / 0.698 -> en:abrasion/scratch/blister
    n1=en:oedema | n2=en:abrasion/scratch/blister | rel=r_associated | relid=0 | w=44
  2471. en:oedema -- r_associated #0: 44 / 0.698 -> en:absence of signs or symptoms
    n1=en:oedema | n2=en:absence of signs or symptoms | rel=r_associated | relid=0 | w=44
  2472. en:oedema -- r_associated #0: 44 / 0.698 -> en:absence of subcutaneous fat over entire body except buttocks, hips, and thighs
    n1=en:oedema | n2=en:absence of subcutaneous fat over entire body except buttocks, hips, and thighs | rel=r_associated | relid=0 | w=44
  2473. en:oedema -- r_associated #0: 44 / 0.698 -> en:absent fingerprints
    n1=en:oedema | n2=en:absent fingerprints | rel=r_associated | relid=0 | w=44
  2474. en:oedema -- r_associated #0: 44 / 0.698 -> en:acanthosis nigricans
    n1=en:oedema | n2=en:acanthosis nigricans | rel=r_associated | relid=0 | w=44
  2475. en:oedema -- r_associated #0: 44 / 0.698 -> en:acne, severe comedogenic
    n1=en:oedema | n2=en:acne, severe comedogenic | rel=r_associated | relid=0 | w=44
  2476. en:oedema -- r_associated #0: 44 / 0.698 -> en:acute lymphoblastic leukemia
    n1=en:oedema | n2=en:acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=44
  2477. en:oedema -- r_associated #0: 44 / 0.698 -> en:aggregates contain granular electron-dense material
    n1=en:oedema | n2=en:aggregates contain granular electron-dense material | rel=r_associated | relid=0 | w=44
  2478. en:oedema -- r_associated #0: 44 / 0.698 -> en:anhidrosis of the trunk and limbs 100% of the time
    n1=en:oedema | n2=en:anhidrosis of the trunk and limbs 100% of the time | rel=r_associated | relid=0 | w=44
  2479. en:oedema -- r_associated #0: 44 / 0.698 -> en:anhidrosis, patchy
    n1=en:oedema | n2=en:anhidrosis, patchy | rel=r_associated | relid=0 | w=44
  2480. en:oedema -- r_associated #0: 44 / 0.698 -> en:ankle clonus
    n1=en:oedema | n2=en:ankle clonus | rel=r_associated | relid=0 | w=44
  2481. en:oedema -- r_associated #0: 44 / 0.698 -> en:aphasia
    n1=en:oedema | n2=en:aphasia | rel=r_associated | relid=0 | w=44
  2482. en:oedema -- r_associated #0: 44 / 0.698 -> en:arborescent papillomas (axillae, periumbilical area, anus, vulva)
    n1=en:oedema | n2=en:arborescent papillomas (axillae, periumbilical area, anus, vulva) | rel=r_associated | relid=0 | w=44
  2483. en:oedema -- r_associated #0: 44 / 0.698 -> en:areas of hypopigmentation and hyperpigmentation that do not follow blaschko lines (in some patients)
    n1=en:oedema | n2=en:areas of hypopigmentation and hyperpigmentation that do not follow blaschko lines (in some patients) | rel=r_associated | relid=0 | w=44
  2484. en:oedema -- r_associated #0: 44 / 0.698 -> en:ascites
    n1=en:oedema | n2=en:ascites | rel=r_associated | relid=0 | w=44
  2485. en:oedema -- r_associated #0: 44 / 0.698 -> en:aston index score
    n1=en:oedema | n2=en:aston index score | rel=r_associated | relid=0 | w=44
  2486. en:oedema -- r_associated #0: 44 / 0.698 -> en:atrial septal defect
    n1=en:oedema | n2=en:atrial septal defect | rel=r_associated | relid=0 | w=44
  2487. en:oedema -- r_associated #0: 44 / 0.698 -> en:atrophic skin over ears
    n1=en:oedema | n2=en:atrophic skin over ears | rel=r_associated | relid=0 | w=44
  2488. en:oedema -- r_associated #0: 44 / 0.698 -> en:atrophy of anterior compartment tibial muscles
    n1=en:oedema | n2=en:atrophy of anterior compartment tibial muscles | rel=r_associated | relid=0 | w=44
  2489. en:oedema -- r_associated #0: 44 / 0.698 -> en:atrophy, neurogenic muscular
    n1=en:oedema | n2=en:atrophy, neurogenic muscular | rel=r_associated | relid=0 | w=44
  2490. en:oedema -- r_associated #0: 44 / 0.698 -> en:attacks precipitated by rest after exercise
    n1=en:oedema | n2=en:attacks precipitated by rest after exercise | rel=r_associated | relid=0 | w=44
  2491. en:oedema -- r_associated #0: 44 / 0.698 -> en:autophagic rimmed vacuoles
    n1=en:oedema | n2=en:autophagic rimmed vacuoles | rel=r_associated | relid=0 | w=44
  2492. en:oedema -- r_associated #0: 44 / 0.698 -> en:autosomal dominant cystoid macular edema
    n1=en:oedema | n2=en:autosomal dominant cystoid macular edema | rel=r_associated | relid=0 | w=44
  2493. en:oedema -- r_associated #0: 44 / 0.698 -> en:barany's sign
    n1=en:oedema | n2=en:barany's sign | rel=r_associated | relid=0 | w=44
  2494. en:oedema -- r_associated #0: 44 / 0.698 -> en:bayley scales of infant development score
    n1=en:oedema | n2=en:bayley scales of infant development score | rel=r_associated | relid=0 | w=44
  2495. en:oedema -- r_associated #0: 44 / 0.698 -> en:below normal body height
    n1=en:oedema | n2=en:below normal body height | rel=r_associated | relid=0 | w=44
  2496. en:oedema -- r_associated #0: 44 / 0.698 -> en:blistering erythematous rash
    n1=en:oedema | n2=en:blistering erythematous rash | rel=r_associated | relid=0 | w=44
  2497. en:oedema -- r_associated #0: 44 / 0.698 -> en:blistering, generalized, recurrent (occurs after mild physical trauma)
    n1=en:oedema | n2=en:blistering, generalized, recurrent (occurs after mild physical trauma) | rel=r_associated | relid=0 | w=44
  2498. en:oedema -- r_associated #0: 44 / 0.698 -> en:body substance discharge
    n1=en:oedema | n2=en:body substance discharge | rel=r_associated | relid=0 | w=44
  2499. en:oedema -- r_associated #0: 44 / 0.698 -> en:body temperature changes
    n1=en:oedema | n2=en:body temperature changes | rel=r_associated | relid=0 | w=44
  2500. en:oedema -- r_associated #0: 44 / 0.698 -> en:both type 1 and type 2 fiber predominance has been reported
    n1=en:oedema | n2=en:both type 1 and type 2 fiber predominance has been reported | rel=r_associated | relid=0 | w=44
  2501. en:oedema -- r_associated #0: 44 / 0.698 -> en:brain edema
    n1=en:oedema | n2=en:brain edema | rel=r_associated | relid=0 | w=44
  2502. en:oedema -- r_associated #0: 44 / 0.698 -> en:bridge between vertical and transverse proximal palmar flexion creases
    n1=en:oedema | n2=en:bridge between vertical and transverse proximal palmar flexion creases | rel=r_associated | relid=0 | w=44
  2503. en:oedema -- r_associated #0: 44 / 0.698 -> en:broad-based gait
    n1=en:oedema | n2=en:broad-based gait | rel=r_associated | relid=0 | w=44
  2504. en:oedema -- r_associated #0: 44 / 0.698 -> en:cafe au lait spot
    n1=en:oedema | n2=en:cafe au lait spot | rel=r_associated | relid=0 | w=44
  2505. en:oedema -- r_associated #0: 44 / 0.698 -> en:cafe au lait spots, multiple
    n1=en:oedema | n2=en:cafe au lait spots, multiple | rel=r_associated | relid=0 | w=44
  2506. en:oedema -- r_associated #0: 44 / 0.698 -> en:cafe-au-lait spots on chest and abdomen (rare)
    n1=en:oedema | n2=en:cafe-au-lait spots on chest and abdomen (rare) | rel=r_associated | relid=0 | w=44
  2507. en:oedema -- r_associated #0: 44 / 0.698 -> en:calculus finding
    n1=en:oedema | n2=en:calculus finding | rel=r_associated | relid=0 | w=44
  2508. en:oedema -- r_associated #0: 44 / 0.698 -> en:calf hypertrophy (early in the disease)
    n1=en:oedema | n2=en:calf hypertrophy (early in the disease) | rel=r_associated | relid=0 | w=44
  2509. en:oedema -- r_associated #0: 44 / 0.698 -> en:calf hypertrophy (in some patients)
    n1=en:oedema | n2=en:calf hypertrophy (in some patients) | rel=r_associated | relid=0 | w=44
  2510. en:oedema -- r_associated #0: 44 / 0.698 -> en:calf muscle enlargement
    n1=en:oedema | n2=en:calf muscle enlargement | rel=r_associated | relid=0 | w=44
  2511. en:oedema -- r_associated #0: 44 / 0.698 -> en:calf muscle weakness
    n1=en:oedema | n2=en:calf muscle weakness | rel=r_associated | relid=0 | w=44
  2512. en:oedema -- r_associated #0: 44 / 0.698 -> en:capillary hemangioma (forehead)
    n1=en:oedema | n2=en:capillary hemangioma (forehead) | rel=r_associated | relid=0 | w=44
  2513. en:oedema -- r_associated #0: 44 / 0.698 -> en:cardiac arrest
    n1=en:oedema | n2=en:cardiac arrest | rel=r_associated | relid=0 | w=44
  2514. en:oedema -- r_associated #0: 44 / 0.698 -> en:cardiovascular disorder
    n1=en:oedema | n2=en:cardiovascular disorder | rel=r_associated | relid=0 | w=44
  2515. en:oedema -- r_associated #0: 44 / 0.698 -> en:career interest test score
    n1=en:oedema | n2=en:career interest test score | rel=r_associated | relid=0 | w=44
  2516. en:oedema -- r_associated #0: 44 / 0.698 -> en:central atrophic area has a peripheral keratotic ridge
    n1=en:oedema | n2=en:central atrophic area has a peripheral keratotic ridge | rel=r_associated | relid=0 | w=44
  2517. en:oedema -- r_associated #0: 44 / 0.698 -> en:centrofacial/mucosal lentigines
    n1=en:oedema | n2=en:centrofacial/mucosal lentigines | rel=r_associated | relid=0 | w=44
  2518. en:oedema -- r_associated #0: 44 / 0.698 -> en:changes in sarcoplasmic reticulum and t-tubules
    n1=en:oedema | n2=en:changes in sarcoplasmic reticulum and t-tubules | rel=r_associated | relid=0 | w=44
  2519. en:oedema -- r_associated #0: 44 / 0.698 -> en:childhood health assessment questionnaire score
    n1=en:oedema | n2=en:childhood health assessment questionnaire score | rel=r_associated | relid=0 | w=44
  2520. en:oedema -- r_associated #0: 44 / 0.698 -> en:cholesterol
    n1=en:oedema | n2=en:cholesterol | rel=r_associated | relid=0 | w=44
  2521. en:oedema -- r_associated #0: 44 / 0.698 -> en:collagen-rich connective tissue nevi (dermatofibrosis lenticularis disseminata)
    n1=en:oedema | n2=en:collagen-rich connective tissue nevi (dermatofibrosis lenticularis disseminata) | rel=r_associated | relid=0 | w=44
  2522. en:oedema -- r_associated #0: 44 / 0.698 -> en:concussion and edema of thoracic spinal cord
    n1=en:oedema | n2=en:concussion and edema of thoracic spinal cord | rel=r_associated | relid=0 | w=44
  2523. en:oedema -- r_associated #0: 44 / 0.698 -> en:congophilic eosinophilic inclusions
    n1=en:oedema | n2=en:congophilic eosinophilic inclusions | rel=r_associated | relid=0 | w=44
  2524. en:oedema -- r_associated #0: 44 / 0.698 -> en:cores contain densely packed myofilaments
    n1=en:oedema | n2=en:cores contain densely packed myofilaments | rel=r_associated | relid=0 | w=44
  2525. en:oedema -- r_associated #0: 44 / 0.698 -> en:cutaneous 0.5 to 1.0 cm bluish and flesh-colored papules (rarely reported)
    n1=en:oedema | n2=en:cutaneous 0.5 to 1.0 cm bluish and flesh-colored papules (rarely reported) | rel=r_associated | relid=0 | w=44
  2526. en:oedema -- r_associated #0: 44 / 0.698 -> en:cutaneous melanoma
    n1=en:oedema | n2=en:cutaneous melanoma | rel=r_associated | relid=0 | w=44
  2527. en:oedema -- r_associated #0: 44 / 0.698 -> en:cutis marmorata (in some)
    n1=en:oedema | n2=en:cutis marmorata (in some) | rel=r_associated | relid=0 | w=44
  2528. en:oedema -- r_associated #0: 44 / 0.698 -> en:cyanosis during episodes
    n1=en:oedema | n2=en:cyanosis during episodes | rel=r_associated | relid=0 | w=44
  2529. en:oedema -- r_associated #0: 44 / 0.698 -> en:de- or hypo-pigmented macules (less common)
    n1=en:oedema | n2=en:de- or hypo-pigmented macules (less common) | rel=r_associated | relid=0 | w=44
  2530. en:oedema -- r_associated #0: 44 / 0.698 -> en:deauville five point scale score
    n1=en:oedema | n2=en:deauville five point scale score | rel=r_associated | relid=0 | w=44
  2531. en:oedema -- r_associated #0: 44 / 0.698 -> en:decreased activity and protein levels of respiratory chain complexes i, ii, iii, and iv
    n1=en:oedema | n2=en:decreased activity and protein levels of respiratory chain complexes i, ii, iii, and iv | rel=r_associated | relid=0 | w=44
  2532. en:oedema -- r_associated #0: 44 / 0.698 -> en:decreased activity of mitochondrial complex iii
    n1=en:oedema | n2=en:decreased activity of mitochondrial complex iii | rel=r_associated | relid=0 | w=44
  2533. en:oedema -- r_associated #0: 44 / 0.698 -> en:decreased activity of respiratory complex i+iii
    n1=en:oedema | n2=en:decreased activity of respiratory complex i+iii | rel=r_associated | relid=0 | w=44
  2534. en:oedema -- r_associated #0: 44 / 0.698 -> en:decreased fibrinolysis (finding)
    n1=en:oedema | n2=en:decreased fibrinolysis (finding) | rel=r_associated | relid=0 | w=44
  2535. en:oedema -- r_associated #0: 44 / 0.698 -> en:decreased mitochondria
    n1=en:oedema | n2=en:decreased mitochondria | rel=r_associated | relid=0 | w=44
  2536. en:oedema -- r_associated #0: 44 / 0.698 -> en:decreased or absent ankle reflexes
    n1=en:oedema | n2=en:decreased or absent ankle reflexes | rel=r_associated | relid=0 | w=44
  2537. en:oedema -- r_associated #0: 44 / 0.698 -> en:decrement of the compound muscle action potential on repetitive stimulation
    n1=en:oedema | n2=en:decrement of the compound muscle action potential on repetitive stimulation | rel=r_associated | relid=0 | w=44
  2538. en:oedema -- r_associated #0: 44 / 0.698 -> en:denervation of skeletal muscles
    n1=en:oedema | n2=en:denervation of skeletal muscles | rel=r_associated | relid=0 | w=44
  2539. en:oedema -- r_associated #0: 44 / 0.698 -> en:denuded postsynaptic regions
    n1=en:oedema | n2=en:denuded postsynaptic regions | rel=r_associated | relid=0 | w=44
  2540. en:oedema -- r_associated #0: 44 / 0.698 -> en:depigmentation/hyperpigmentation
    n1=en:oedema | n2=en:depigmentation/hyperpigmentation | rel=r_associated | relid=0 | w=44
  2541. en:oedema -- r_associated #0: 44 / 0.698 -> en:dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology
    n1=en:oedema | n2=en:dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology | rel=r_associated | relid=0 | w=44
  2542. en:oedema -- r_associated #0: 44 / 0.698 -> en:dermal ossification (osteoma cutis)
    n1=en:oedema | n2=en:dermal ossification (osteoma cutis) | rel=r_associated | relid=0 | w=44
  2543. en:oedema -- r_associated #0: 44 / 0.698 -> en:dermatitis (in some patients)
    n1=en:oedema | n2=en:dermatitis (in some patients) | rel=r_associated | relid=0 | w=44
  2544. en:oedema -- r_associated #0: 44 / 0.698 -> en:desquamation of skin soon after birth
    n1=en:oedema | n2=en:desquamation of skin soon after birth | rel=r_associated | relid=0 | w=44
  2545. en:oedema -- r_associated #0: 44 / 0.698 -> en:difficulty running
    n1=en:oedema | n2=en:difficulty running | rel=r_associated | relid=0 | w=44
  2546. en:oedema -- r_associated #0: 44 / 0.698 -> en:diffuse fetal skin edema
    n1=en:oedema | n2=en:diffuse fetal skin edema | rel=r_associated | relid=0 | w=44
  2547. en:oedema -- r_associated #0: 44 / 0.698 -> en:diffuse pretibial myxedema
    n1=en:oedema | n2=en:diffuse pretibial myxedema | rel=r_associated | relid=0 | w=44
  2548. en:oedema -- r_associated #0: 44 / 0.698 -> en:diffuse skin atrophy (especially dorsa of hands and feet)
    n1=en:oedema | n2=en:diffuse skin atrophy (especially dorsa of hands and feet) | rel=r_associated | relid=0 | w=44
  2549. en:oedema -- r_associated #0: 44 / 0.698 -> en:disruption plasma membrane (in some patients)
    n1=en:oedema | n2=en:disruption plasma membrane (in some patients) | rel=r_associated | relid=0 | w=44
  2550. en:oedema -- r_associated #0: 44 / 0.698 -> en:distal limb muscle atrophy (less common)
    n1=en:oedema | n2=en:distal limb muscle atrophy (less common) | rel=r_associated | relid=0 | w=44
  2551. en:oedema -- r_associated #0: 44 / 0.698 -> en:distal limb muscular atrophy due to peripheral neuropathy
    n1=en:oedema | n2=en:distal limb muscular atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=44
  2552. en:oedema -- r_associated #0: 44 / 0.698 -> en:distal lower limb muscle weakness
    n1=en:oedema | n2=en:distal lower limb muscle weakness | rel=r_associated | relid=0 | w=44
  2553. en:oedema -- r_associated #0: 44 / 0.698 -> en:distal muscle wasting, mild
    n1=en:oedema | n2=en:distal muscle wasting, mild | rel=r_associated | relid=0 | w=44
  2554. en:oedema -- r_associated #0: 44 / 0.698 -> en:distal muscle weakness, occurs initially
    n1=en:oedema | n2=en:distal muscle weakness, occurs initially | rel=r_associated | relid=0 | w=44
  2555. en:oedema -- r_associated #0: 44 / 0.698 -> en:distal skeletal muscle atrophy (after long disease duration)
    n1=en:oedema | n2=en:distal skeletal muscle atrophy (after long disease duration) | rel=r_associated | relid=0 | w=44
  2556. en:oedema -- r_associated #0: 44 / 0.698 -> en:dizziness adverse event
    n1=en:oedema | n2=en:dizziness adverse event | rel=r_associated | relid=0 | w=44
  2557. en:oedema -- r_associated #0: 44 / 0.698 -> en:dry, rough skin
    n1=en:oedema | n2=en:dry, rough skin | rel=r_associated | relid=0 | w=44
  2558. en:oedema -- r_associated #0: 44 / 0.698 -> en:dysphonia
    n1=en:oedema | n2=en:dysphonia | rel=r_associated | relid=0 | w=44
  2559. en:oedema -- r_associated #0: 44 / 0.698 -> en:dyspnea
    n1=en:oedema | n2=en:dyspnea | rel=r_associated | relid=0 | w=44
  2560. en:oedema -- r_associated #0: 44 / 0.698 -> en:easy bruisability of lower extremities
    n1=en:oedema | n2=en:easy bruisability of lower extremities | rel=r_associated | relid=0 | w=44
  2561. en:oedema -- r_associated #0: 44 / 0.698 -> en:easy bruising
    n1=en:oedema | n2=en:easy bruising | rel=r_associated | relid=0 | w=44
  2562. en:oedema -- r_associated #0: 44 / 0.698 -> en:easy fatigability with exercise
    n1=en:oedema | n2=en:easy fatigability with exercise | rel=r_associated | relid=0 | w=44
  2563. en:oedema -- r_associated #0: 44 / 0.698 -> en:easy fatigue
    n1=en:oedema | n2=en:easy fatigue | rel=r_associated | relid=0 | w=44
  2564. en:oedema -- r_associated #0: 44 / 0.698 -> en:edema limbs
    n1=en:oedema | n2=en:edema limbs | rel=r_associated | relid=0 | w=44
  2565. en:oedema -- r_associated #0: 44 / 0.698 -> en:edema of chest wall
    n1=en:oedema | n2=en:edema of chest wall | rel=r_associated | relid=0 | w=44
  2566. en:oedema -- r_associated #0: 44 / 0.698 -> en:edema of nasopharynx
    n1=en:oedema | n2=en:edema of nasopharynx | rel=r_associated | relid=0 | w=44
  2567. en:oedema -- r_associated #0: 44 / 0.698 -> en:edema trunk
    n1=en:oedema | n2=en:edema trunk | rel=r_associated | relid=0 | w=44
  2568. en:oedema -- r_associated #0: 44 / 0.698 -> en:edema, cytotoxic cerebral
    n1=en:oedema | n2=en:edema, cytotoxic cerebral | rel=r_associated | relid=0 | w=44
  2569. en:oedema -- r_associated #0: 44 / 0.698 -> en:effusion, unspecified joint
    n1=en:oedema | n2=en:effusion, unspecified joint | rel=r_associated | relid=0 | w=44
  2570. en:oedema -- r_associated #0: 44 / 0.698 -> en:electromyogram normal
    n1=en:oedema | n2=en:electromyogram normal | rel=r_associated | relid=0 | w=44
  2571. en:oedema -- r_associated #0: 44 / 0.698 -> en:electron microscopy shows dense material emanating from the z-disk
    n1=en:oedema | n2=en:electron microscopy shows dense material emanating from the z-disk | rel=r_associated | relid=0 | w=44
  2572. en:oedema -- r_associated #0: 44 / 0.698 -> en:elephantiasic pretibial myxedema
    n1=en:oedema | n2=en:elephantiasic pretibial myxedema | rel=r_associated | relid=0 | w=44
  2573. en:oedema -- r_associated #0: 44 / 0.698 -> en:embryologic
    n1=en:oedema | n2=en:embryologic | rel=r_associated | relid=0 | w=44
  2574. en:oedema -- r_associated #0: 44 / 0.698 -> en:emg shows neurogenic changes consistent with denervation
    n1=en:oedema | n2=en:emg shows neurogenic changes consistent with denervation | rel=r_associated | relid=0 | w=44
  2575. en:oedema -- r_associated #0: 44 / 0.698 -> en:endocarditis
    n1=en:oedema | n2=en:endocarditis | rel=r_associated | relid=0 | w=44
  2576. en:oedema -- r_associated #0: 44 / 0.698 -> en:enlarging abdomen
    n1=en:oedema | n2=en:enlarging abdomen | rel=r_associated | relid=0 | w=44
  2577. en:oedema -- r_associated #0: 44 / 0.698 -> en:epidermolysis bullosa dystrophica
    n1=en:oedema | n2=en:epidermolysis bullosa dystrophica | rel=r_associated | relid=0 | w=44
  2578. en:oedema -- r_associated #0: 44 / 0.698 -> en:equipment observable
    n1=en:oedema | n2=en:equipment observable | rel=r_associated | relid=0 | w=44
  2579. en:oedema -- r_associated #0: 44 / 0.698 -> en:erdheim-chester disease
    n1=en:oedema | n2=en:erdheim-chester disease | rel=r_associated | relid=0 | w=44
  2580. en:oedema -- r_associated #0: 44 / 0.698 -> en:erythema in affected areas
    n1=en:oedema | n2=en:erythema in affected areas | rel=r_associated | relid=0 | w=44
  2581. en:oedema -- r_associated #0: 44 / 0.698 -> en:erythema, cold-induced
    n1=en:oedema | n2=en:erythema, cold-induced | rel=r_associated | relid=0 | w=44
  2582. en:oedema -- r_associated #0: 44 / 0.698 -> en:erythematous ichthyotic skin with reticulate pattern
    n1=en:oedema | n2=en:erythematous ichthyotic skin with reticulate pattern | rel=r_associated | relid=0 | w=44
  2583. en:oedema -- r_associated #0: 44 / 0.698 -> en:erythematous papular skin eruption (infancy)
    n1=en:oedema | n2=en:erythematous papular skin eruption (infancy) | rel=r_associated | relid=0 | w=44
  2584. en:oedema -- r_associated #0: 44 / 0.698 -> en:erythematous squamous skin lesions
    n1=en:oedema | n2=en:erythematous squamous skin lesions | rel=r_associated | relid=0 | w=44
  2585. en:oedema -- r_associated #0: 44 / 0.698 -> en:erythropoietic protoporphyria
    n1=en:oedema | n2=en:erythropoietic protoporphyria | rel=r_associated | relid=0 | w=44
  2586. en:oedema -- r_associated #0: 44 / 0.698 -> en:ethnologic
    n1=en:oedema | n2=en:ethnologic | rel=r_associated | relid=0 | w=44
  2587. en:oedema -- r_associated #0: 44 / 0.698 -> en:excessive salt in sweat
    n1=en:oedema | n2=en:excessive salt in sweat | rel=r_associated | relid=0 | w=44
  2588. en:oedema -- r_associated #0: 44 / 0.698 -> en:exercise-induced myalgia
    n1=en:oedema | n2=en:exercise-induced myalgia | rel=r_associated | relid=0 | w=44
  2589. en:oedema -- r_associated #0: 44 / 0.698 -> en:facial angiofibroma (adenoma sebaceum)
    n1=en:oedema | n2=en:facial angiofibroma (adenoma sebaceum) | rel=r_associated | relid=0 | w=44
  2590. en:oedema -- r_associated #0: 44 / 0.698 -> en:facial milia
    n1=en:oedema | n2=en:facial milia | rel=r_associated | relid=0 | w=44
  2591. en:oedema -- r_associated #0: 44 / 0.698 -> en:fatty infiltration
    n1=en:oedema | n2=en:fatty infiltration | rel=r_associated | relid=0 | w=44
  2592. en:oedema -- r_associated #0: 44 / 0.698 -> en:fatty infiltration of affected muscles
    n1=en:oedema | n2=en:fatty infiltration of affected muscles | rel=r_associated | relid=0 | w=44
  2593. en:oedema -- r_associated #0: 44 / 0.698 -> en:fatty infiltration seen on muscle biopsy
    n1=en:oedema | n2=en:fatty infiltration seen on muscle biopsy | rel=r_associated | relid=0 | w=44
  2594. en:oedema -- r_associated #0: 44 / 0.698 -> en:fetal finding
    n1=en:oedema | n2=en:fetal finding | rel=r_associated | relid=0 | w=44
  2595. en:oedema -- r_associated #0: 44 / 0.698 -> en:fiber type grouping
    n1=en:oedema | n2=en:fiber type grouping | rel=r_associated | relid=0 | w=44
  2596. en:oedema -- r_associated #0: 44 / 0.698 -> en:fibrofolliculoma
    n1=en:oedema | n2=en:fibrofolliculoma | rel=r_associated | relid=0 | w=44
  2597. en:oedema -- r_associated #0: 44 / 0.698 -> en:fibroma
    n1=en:oedema | n2=en:fibroma | rel=r_associated | relid=0 | w=44
  2598. en:oedema -- r_associated #0: 44 / 0.698 -> en:fibrous nodule
    n1=en:oedema | n2=en:fibrous nodule | rel=r_associated | relid=0 | w=44
  2599. en:oedema -- r_associated #0: 44 / 0.698 -> en:fine white or greyish-white scales
    n1=en:oedema | n2=en:fine white or greyish-white scales | rel=r_associated | relid=0 | w=44
  2600. en:oedema -- r_associated #0: 44 / 0.698 -> en:fissures of soles (in some patients)
    n1=en:oedema | n2=en:fissures of soles (in some patients) | rel=r_associated | relid=0 | w=44
  2601. en:oedema -- r_associated #0: 44 / 0.698 -> en:florid red complexion (finding)
    n1=en:oedema | n2=en:florid red complexion (finding) | rel=r_associated | relid=0 | w=44
  2602. en:oedema -- r_associated #0: 44 / 0.698 -> en:generalized muscle weakness, proximal and distal
    n1=en:oedema | n2=en:generalized muscle weakness, proximal and distal | rel=r_associated | relid=0 | w=44
  2603. en:oedema -- r_associated #0: 44 / 0.698 -> en:gluteus maximus and thigh adductors most affected
    n1=en:oedema | n2=en:gluteus maximus and thigh adductors most affected | rel=r_associated | relid=0 | w=44
  2604. en:oedema -- r_associated #0: 44 / 0.698 -> en:glycogen accumulation seen on biopsy
    n1=en:oedema | n2=en:glycogen accumulation seen on biopsy | rel=r_associated | relid=0 | w=44
  2605. en:oedema -- r_associated #0: 44 / 0.698 -> en:glycosuria
    n1=en:oedema | n2=en:glycosuria | rel=r_associated | relid=0 | w=44
  2606. en:oedema -- r_associated #0: 44 / 0.698 -> en:halitosis
    n1=en:oedema | n2=en:halitosis | rel=r_associated | relid=0 | w=44
  2607. en:oedema -- r_associated #0: 44 / 0.698 -> en:health assessment questionnaire score
    n1=en:oedema | n2=en:health assessment questionnaire score | rel=r_associated | relid=0 | w=44
  2608. en:oedema -- r_associated #0: 44 / 0.698 -> en:heart murmur
    n1=en:oedema | n2=en:heart murmur | rel=r_associated | relid=0 | w=44
  2609. en:oedema -- r_associated #0: 44 / 0.698 -> en:heat stroke
    n1=en:oedema | n2=en:heat stroke | rel=r_associated | relid=0 | w=44
  2610. en:oedema -- r_associated #0: 44 / 0.698 -> en:hemoglobin barts
    n1=en:oedema | n2=en:hemoglobin barts | rel=r_associated | relid=0 | w=44
  2611. en:oedema -- r_associated #0: 44 / 0.698 -> en:hemorrhage
    n1=en:oedema | n2=en:hemorrhage | rel=r_associated | relid=0 | w=44
  2612. en:oedema -- r_associated #0: 44 / 0.698 -> en:hemorrhagic palmar and plantar macules (uncommon)
    n1=en:oedema | n2=en:hemorrhagic palmar and plantar macules (uncommon) | rel=r_associated | relid=0 | w=44
  2613. en:oedema -- r_associated #0: 44 / 0.698 -> en:herpes zoster
    n1=en:oedema | n2=en:herpes zoster | rel=r_associated | relid=0 | w=44
  2614. en:oedema -- r_associated #0: 44 / 0.698 -> en:hiv cdc category
    n1=en:oedema | n2=en:hiv cdc category | rel=r_associated | relid=0 | w=44
  2615. en:oedema -- r_associated #0: 44 / 0.698 -> en:hiv who class
    n1=en:oedema | n2=en:hiv who class | rel=r_associated | relid=0 | w=44
  2616. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperalgesia
    n1=en:oedema | n2=en:hyperalgesia | rel=r_associated | relid=0 | w=44
  2617. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperkeratosis (especially extensor surfaces)
    n1=en:oedema | n2=en:hyperkeratosis (especially extensor surfaces) | rel=r_associated | relid=0 | w=44
  2618. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperkeratosis (palms, soles, elbows, knees)
    n1=en:oedema | n2=en:hyperkeratosis (palms, soles, elbows, knees) | rel=r_associated | relid=0 | w=44
  2619. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperkeratosis, particularly on palms and soles of feet
    n1=en:oedema | n2=en:hyperkeratosis, particularly on palms and soles of feet | rel=r_associated | relid=0 | w=44
  2620. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperlinearity of palms (in some patients)
    n1=en:oedema | n2=en:hyperlinearity of palms (in some patients) | rel=r_associated | relid=0 | w=44
  2621. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperpigmentation in a reticular pattern primarily on flexural skin
    n1=en:oedema | n2=en:hyperpigmentation in a reticular pattern primarily on flexural skin | rel=r_associated | relid=0 | w=44
  2622. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperpigmented macules of variable size and shape located in a symmetrical pattern primarily on face, neck, trunk, and dorsa of hands and feet
    n1=en:oedema | n2=en:hyperpigmented macules of variable size and shape located in a symmetrical pattern primarily on face, neck, trunk, and dorsa of hands and feet | rel=r_associated | relid=0 | w=44
  2623. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperpigmented streaks following lines of blaschko
    n1=en:oedema | n2=en:hyperpigmented streaks following lines of blaschko | rel=r_associated | relid=0 | w=44
  2624. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperpigmented whorls
    n1=en:oedema | n2=en:hyperpigmented whorls | rel=r_associated | relid=0 | w=44
  2625. en:oedema -- r_associated #0: 44 / 0.698 -> en:hyperplasia
    n1=en:oedema | n2=en:hyperplasia | rel=r_associated | relid=0 | w=44
  2626. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypertonia
    n1=en:oedema | n2=en:hypertonia | rel=r_associated | relid=0 | w=44
  2627. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypertrichosis (scalp, arms, legs, back)
    n1=en:oedema | n2=en:hypertrichosis (scalp, arms, legs, back) | rel=r_associated | relid=0 | w=44
  2628. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypervolemia
    n1=en:oedema | n2=en:hypervolemia | rel=r_associated | relid=0 | w=44
  2629. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypoactive gag reflex
    n1=en:oedema | n2=en:hypoactive gag reflex | rel=r_associated | relid=0 | w=44
  2630. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypopigmentation spots
    n1=en:oedema | n2=en:hypopigmentation spots | rel=r_associated | relid=0 | w=44
  2631. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypopigmented macules
    n1=en:oedema | n2=en:hypopigmented macules | rel=r_associated | relid=0 | w=44
  2632. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypoplasia of cervical paravertebral muscles
    n1=en:oedema | n2=en:hypoplasia of cervical paravertebral muscles | rel=r_associated | relid=0 | w=44
  2633. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypoplasia of serratus anterior muscle
    n1=en:oedema | n2=en:hypoplasia of serratus anterior muscle | rel=r_associated | relid=0 | w=44
  2634. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypoplasia of supraspinatus muscle
    n1=en:oedema | n2=en:hypoplasia of supraspinatus muscle | rel=r_associated | relid=0 | w=44
  2635. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypoplasia of the hand muscles (29%)
    n1=en:oedema | n2=en:hypoplasia of the hand muscles (29%) | rel=r_associated | relid=0 | w=44
  2636. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypoplastic deltoids
    n1=en:oedema | n2=en:hypoplastic deltoids | rel=r_associated | relid=0 | w=44
  2637. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypoplastic sweat glands
    n1=en:oedema | n2=en:hypoplastic sweat glands | rel=r_associated | relid=0 | w=44
  2638. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypotonia
    n1=en:oedema | n2=en:hypotonia | rel=r_associated | relid=0 | w=44
  2639. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypotonia, axial, severe
    n1=en:oedema | n2=en:hypotonia, axial, severe | rel=r_associated | relid=0 | w=44
  2640. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypotonia, fixed
    n1=en:oedema | n2=en:hypotonia, fixed | rel=r_associated | relid=0 | w=44
  2641. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypotonia, mild
    n1=en:oedema | n2=en:hypotonia, mild | rel=r_associated | relid=0 | w=44
  2642. en:oedema -- r_associated #0: 44 / 0.698 -> en:hypotonia, mild (1 patient)
    n1=en:oedema | n2=en:hypotonia, mild (1 patient) | rel=r_associated | relid=0 | w=44
  2643. en:oedema -- r_associated #0: 44 / 0.698 -> en:ichthyosiform areas of skin (rare)
    n1=en:oedema | n2=en:ichthyosiform areas of skin (rare) | rel=r_associated | relid=0 | w=44
  2644. en:oedema -- r_associated #0: 44 / 0.698 -> en:ichthyosis
    n1=en:oedema | n2=en:ichthyosis | rel=r_associated | relid=0 | w=44
  2645. en:oedema -- r_associated #0: 44 / 0.698 -> en:ichthyosis (1 family)
    n1=en:oedema | n2=en:ichthyosis (1 family) | rel=r_associated | relid=0 | w=44
  2646. en:oedema -- r_associated #0: 44 / 0.698 -> en:impaired toe-walking
    n1=en:oedema | n2=en:impaired toe-walking | rel=r_associated | relid=0 | w=44
  2647. en:oedema -- r_associated #0: 44 / 0.698 -> en:impetigo-like eruptions
    n1=en:oedema | n2=en:impetigo-like eruptions | rel=r_associated | relid=0 | w=44
  2648. en:oedema -- r_associated #0: 44 / 0.698 -> en:impingement sign
    n1=en:oedema | n2=en:impingement sign | rel=r_associated | relid=0 | w=44
  2649. en:oedema -- r_associated #0: 44 / 0.698 -> en:inclusions are tdp43-immunoreactive
    n1=en:oedema | n2=en:inclusions are tdp43-immunoreactive | rel=r_associated | relid=0 | w=44
  2650. en:oedema -- r_associated #0: 44 / 0.698 -> en:increased mitochondria with rare paracrystalline inclusions
    n1=en:oedema | n2=en:increased mitochondria with rare paracrystalline inclusions | rel=r_associated | relid=0 | w=44
  2651. en:oedema -- r_associated #0: 44 / 0.698 -> en:increased muscle tone in the lower limbs
    n1=en:oedema | n2=en:increased muscle tone in the lower limbs | rel=r_associated | relid=0 | w=44
  2652. en:oedema -- r_associated #0: 44 / 0.698 -> en:increased perisarcolemmal calcium deposition
    n1=en:oedema | n2=en:increased perisarcolemmal calcium deposition | rel=r_associated | relid=0 | w=44
  2653. en:oedema -- r_associated #0: 44 / 0.698 -> en:increased visceral fat
    n1=en:oedema | n2=en:increased visceral fat | rel=r_associated | relid=0 | w=44
  2654. en:oedema -- r_associated #0: 44 / 0.698 -> en:inguinal pterygium, bilateral (in some patients)
    n1=en:oedema | n2=en:inguinal pterygium, bilateral (in some patients) | rel=r_associated | relid=0 | w=44
  2655. en:oedema -- r_associated #0: 44 / 0.698 -> en:insect bites
    n1=en:oedema | n2=en:insect bites | rel=r_associated | relid=0 | w=44
  2656. en:oedema -- r_associated #0: 44 / 0.698 -> en:integumentary system signs and symptoms
    n1=en:oedema | n2=en:integumentary system signs and symptoms | rel=r_associated | relid=0 | w=44
  2657. en:oedema -- r_associated #0: 44 / 0.698 -> en:intermittent generalized erythematous papular rash
    n1=en:oedema | n2=en:intermittent generalized erythematous papular rash | rel=r_associated | relid=0 | w=44
  2658. en:oedema -- r_associated #0: 44 / 0.698 -> en:internal nuclei
    n1=en:oedema | n2=en:internal nuclei | rel=r_associated | relid=0 | w=44
  2659. en:oedema -- r_associated #0: 44 / 0.698 -> en:intracytoplasmic vacuoles in basal keratinocytes (with negative oil red o-staining)
    n1=en:oedema | n2=en:intracytoplasmic vacuoles in basal keratinocytes (with negative oil red o-staining) | rel=r_associated | relid=0 | w=44
  2660. en:oedema -- r_associated #0: 44 / 0.698 -> en:jaundice (in some patients), resolved postpartum
    n1=en:oedema | n2=en:jaundice (in some patients), resolved postpartum | rel=r_associated | relid=0 | w=44
  2661. en:oedema -- r_associated #0: 44 / 0.698 -> en:jaundice, episodic
    n1=en:oedema | n2=en:jaundice, episodic | rel=r_associated | relid=0 | w=44
  2662. en:oedema -- r_associated #0: 44 / 0.698 -> en:jaundice, green
    n1=en:oedema | n2=en:jaundice, green | rel=r_associated | relid=0 | w=44
  2663. en:oedema -- r_associated #0: 44 / 0.698 -> en:keratoatrophoderma
    n1=en:oedema | n2=en:keratoatrophoderma | rel=r_associated | relid=0 | w=44
  2664. en:oedema -- r_associated #0: 44 / 0.698 -> en:large dark plate-like scales
    n1=en:oedema | n2=en:large dark plate-like scales | rel=r_associated | relid=0 | w=44
  2665. en:oedema -- r_associated #0: 44 / 0.698 -> en:lesion observable
    n1=en:oedema | n2=en:lesion observable | rel=r_associated | relid=0 | w=44
  2666. en:oedema -- r_associated #0: 44 / 0.698 -> en:lesions occur mainly on extremities, scalp, neck, and trunk
    n1=en:oedema | n2=en:lesions occur mainly on extremities, scalp, neck, and trunk | rel=r_associated | relid=0 | w=44
  2667. en:oedema -- r_associated #0: 44 / 0.698 -> en:lethal multiple pterygium syndrome
    n1=en:oedema | n2=en:lethal multiple pterygium syndrome | rel=r_associated | relid=0 | w=44
  2668. en:oedema -- r_associated #0: 44 / 0.698 -> en:limb muscle weakness, proximal, upper and lower
    n1=en:oedema | n2=en:limb muscle weakness, proximal, upper and lower | rel=r_associated | relid=0 | w=44
  2669. en:oedema -- r_associated #0: 44 / 0.698 -> en:limb muscular atrophy
    n1=en:oedema | n2=en:limb muscular atrophy | rel=r_associated | relid=0 | w=44
  2670. en:oedema -- r_associated #0: 44 / 0.698 -> en:lipoma
    n1=en:oedema | n2=en:lipoma | rel=r_associated | relid=0 | w=44
  2671. en:oedema -- r_associated #0: 44 / 0.698 -> en:localized superficial swelling, mass, or lump
    n1=en:oedema | n2=en:localized superficial swelling, mass, or lump | rel=r_associated | relid=0 | w=44
  2672. en:oedema -- r_associated #0: 44 / 0.698 -> en:longitudinal hyperkeratotic lesions along flexor surface of each finger, extending to palm
    n1=en:oedema | n2=en:longitudinal hyperkeratotic lesions along flexor surface of each finger, extending to palm | rel=r_associated | relid=0 | w=44
  2673. en:oedema -- r_associated #0: 44 / 0.698 -> en:loss of adipose tissue occurs around puberty
    n1=en:oedema | n2=en:loss of adipose tissue occurs around puberty | rel=r_associated | relid=0 | w=44
  2674. en:oedema -- r_associated #0: 44 / 0.698 -> en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs
    n1=en:oedema | n2=en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs | rel=r_associated | relid=0 | w=44
  2675. en:oedema -- r_associated #0: 44 / 0.698 -> en:lymphedema of lower limbs (in some patients)
    n1=en:oedema | n2=en:lymphedema of lower limbs (in some patients) | rel=r_associated | relid=0 | w=44
  2676. en:oedema -- r_associated #0: 44 / 0.698 -> en:macroglossia
    n1=en:oedema | n2=en:macroglossia | rel=r_associated | relid=0 | w=44
  2677. en:oedema -- r_associated #0: 44 / 0.698 -> en:maternal
    n1=en:oedema | n2=en:maternal | rel=r_associated | relid=0 | w=44
  2678. en:oedema -- r_associated #0: 44 / 0.698 -> en:mental and behavioral signs and symptoms
    n1=en:oedema | n2=en:mental and behavioral signs and symptoms | rel=r_associated | relid=0 | w=44
  2679. en:oedema -- r_associated #0: 44 / 0.698 -> en:mild atrophy of the proximal lower limbs
    n1=en:oedema | n2=en:mild atrophy of the proximal lower limbs | rel=r_associated | relid=0 | w=44
  2680. en:oedema -- r_associated #0: 44 / 0.698 -> en:mild diffuse ichthyosis
    n1=en:oedema | n2=en:mild diffuse ichthyosis | rel=r_associated | relid=0 | w=44
  2681. en:oedema -- r_associated #0: 44 / 0.698 -> en:mild hyperkeratosis of palms
    n1=en:oedema | n2=en:mild hyperkeratosis of palms | rel=r_associated | relid=0 | w=44
  2682. en:oedema -- r_associated #0: 44 / 0.698 -> en:mild proximal muscle weakness (<10% of patients)
    n1=en:oedema | n2=en:mild proximal muscle weakness (<10% of patients) | rel=r_associated | relid=0 | w=44
  2683. en:oedema -- r_associated #0: 44 / 0.698 -> en:mild tissue fragility
    n1=en:oedema | n2=en:mild tissue fragility | rel=r_associated | relid=0 | w=44
  2684. en:oedema -- r_associated #0: 44 / 0.698 -> en:mildly extensible skin
    n1=en:oedema | n2=en:mildly extensible skin | rel=r_associated | relid=0 | w=44
  2685. en:oedema -- r_associated #0: 44 / 0.698 -> en:milia (rare)
    n1=en:oedema | n2=en:milia (rare) | rel=r_associated | relid=0 | w=44
  2686. en:oedema -- r_associated #0: 44 / 0.698 -> en:mobility limitation
    n1=en:oedema | n2=en:mobility limitation | rel=r_associated | relid=0 | w=44
  2687. en:oedema -- r_associated #0: 44 / 0.698 -> en:motor clumsiness
    n1=en:oedema | n2=en:motor clumsiness | rel=r_associated | relid=0 | w=44
  2688. en:oedema -- r_associated #0: 44 / 0.698 -> en:mucosal observable
    n1=en:oedema | n2=en:mucosal observable | rel=r_associated | relid=0 | w=44
  2689. en:oedema -- r_associated #0: 44 / 0.698 -> en:multi-core congenital myopathy
    n1=en:oedema | n2=en:multi-core congenital myopathy | rel=r_associated | relid=0 | w=44
  2690. en:oedema -- r_associated #0: 44 / 0.698 -> en:multiple mitochondrial dna deletions
    n1=en:oedema | n2=en:multiple mitochondrial dna deletions | rel=r_associated | relid=0 | w=44
  2691. en:oedema -- r_associated #0: 44 / 0.698 -> en:multiple small nevi (rare)
    n1=en:oedema | n2=en:multiple small nevi (rare) | rel=r_associated | relid=0 | w=44
  2692. en:oedema -- r_associated #0: 44 / 0.698 -> en:multiple, small punctate keratoses (palms and soles)
    n1=en:oedema | n2=en:multiple, small punctate keratoses (palms and soles) | rel=r_associated | relid=0 | w=44
  2693. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle
    n1=en:oedema | n2=en:muscle | rel=r_associated | relid=0 | w=44
  2694. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle aches, intermittent
    n1=en:oedema | n2=en:muscle aches, intermittent | rel=r_associated | relid=0 | w=44
  2695. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle atrophy (variable)
    n1=en:oedema | n2=en:muscle atrophy (variable) | rel=r_associated | relid=0 | w=44
  2696. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle atrophy, progressive
    n1=en:oedema | n2=en:muscle atrophy, progressive | rel=r_associated | relid=0 | w=44
  2697. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle biopsy may show inflammatory changes
    n1=en:oedema | n2=en:muscle biopsy may show inflammatory changes | rel=r_associated | relid=0 | w=44
  2698. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle biopsy shows atrophy
    n1=en:oedema | n2=en:muscle biopsy shows atrophy | rel=r_associated | relid=0 | w=44
  2699. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan
    n1=en:oedema | n2=en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=44
  2700. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation
    n1=en:oedema | n2=en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation | rel=r_associated | relid=0 | w=44
  2701. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle biopsy shows mild dystrophic changes
    n1=en:oedema | n2=en:muscle biopsy shows mild dystrophic changes | rel=r_associated | relid=0 | w=44
  2702. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle biopsy shows pleomorphic hyaline, granular, and amorphous deposits that stain with gomori trichrome
    n1=en:oedema | n2=en:muscle biopsy shows pleomorphic hyaline, granular, and amorphous deposits that stain with gomori trichrome | rel=r_associated | relid=0 | w=44
  2703. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle biopsy shows preserved junctional folds
    n1=en:oedema | n2=en:muscle biopsy shows preserved junctional folds | rel=r_associated | relid=0 | w=44
  2704. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle fiber necrosis
    n1=en:oedema | n2=en:muscle fiber necrosis | rel=r_associated | relid=0 | w=44
  2705. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle hypertrophy may occur
    n1=en:oedema | n2=en:muscle hypertrophy may occur | rel=r_associated | relid=0 | w=44
  2706. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle pain with exercise (in older patients)
    n1=en:oedema | n2=en:muscle pain with exercise (in older patients) | rel=r_associated | relid=0 | w=44
  2707. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle paralysis, episodic
    n1=en:oedema | n2=en:muscle paralysis, episodic | rel=r_associated | relid=0 | w=44
  2708. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle soft, tissue
    n1=en:oedema | n2=en:muscle soft, tissue | rel=r_associated | relid=0 | w=44
  2709. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle spasm
    n1=en:oedema | n2=en:muscle spasm | rel=r_associated | relid=0 | w=44
  2710. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle wasting due to chronic denervation
    n1=en:oedema | n2=en:muscle wasting due to chronic denervation | rel=r_associated | relid=0 | w=44
  2711. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle wasting, progressive
    n1=en:oedema | n2=en:muscle wasting, progressive | rel=r_associated | relid=0 | w=44
  2712. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle weakness trunk
    n1=en:oedema | n2=en:muscle weakness trunk | rel=r_associated | relid=0 | w=44
  2713. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle weakness, lower limbs, during exercise
    n1=en:oedema | n2=en:muscle weakness, lower limbs, during exercise | rel=r_associated | relid=0 | w=44
  2714. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle weakness, mild, proximal and distal
    n1=en:oedema | n2=en:muscle weakness, mild, proximal and distal | rel=r_associated | relid=0 | w=44
  2715. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscle weakness, upper and lower limbs
    n1=en:oedema | n2=en:muscle weakness, upper and lower limbs | rel=r_associated | relid=0 | w=44
  2716. en:oedema -- r_associated #0: 44 / 0.698 -> en:muscles become hard and tender during exercise
    n1=en:oedema | n2=en:muscles become hard and tender during exercise | rel=r_associated | relid=0 | w=44
  2717. en:oedema -- r_associated #0: 44 / 0.698 -> en:myocardial stunning
    n1=en:oedema | n2=en:myocardial stunning | rel=r_associated | relid=0 | w=44
  2718. en:oedema -- r_associated #0: 44 / 0.698 -> en:myofibrillar disorganization
    n1=en:oedema | n2=en:myofibrillar disorganization | rel=r_associated | relid=0 | w=44
  2719. en:oedema -- r_associated #0: 44 / 0.698 -> en:myogenic profile on electromyography
    n1=en:oedema | n2=en:myogenic profile on electromyography | rel=r_associated | relid=0 | w=44
  2720. en:oedema -- r_associated #0: 44 / 0.698 -> en:myokymia
    n1=en:oedema | n2=en:myokymia | rel=r_associated | relid=0 | w=44
  2721. en:oedema -- r_associated #0: 44 / 0.698 -> en:myopathic changes seen on emg
    n1=en:oedema | n2=en:myopathic changes seen on emg | rel=r_associated | relid=0 | w=44
  2722. en:oedema -- r_associated #0: 44 / 0.698 -> en:myopathic changes seen on emg and muscle biopsy
    n1=en:oedema | n2=en:myopathic changes seen on emg and muscle biopsy | rel=r_associated | relid=0 | w=44
  2723. en:oedema -- r_associated #0: 44 / 0.698 -> en:myopathy (rare)
    n1=en:oedema | n2=en:myopathy (rare) | rel=r_associated | relid=0 | w=44
  2724. en:oedema -- r_associated #0: 44 / 0.698 -> en:myxedematous appearance
    n1=en:oedema | n2=en:myxedematous appearance | rel=r_associated | relid=0 | w=44
  2725. en:oedema -- r_associated #0: 44 / 0.698 -> en:named sign of lumbar spine
    n1=en:oedema | n2=en:named sign of lumbar spine | rel=r_associated | relid=0 | w=44
  2726. en:oedema -- r_associated #0: 44 / 0.698 -> en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic)
    n1=en:oedema | n2=en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic) | rel=r_associated | relid=0 | w=44
  2727. en:oedema -- r_associated #0: 44 / 0.698 -> en:neck muscle weakness
    n1=en:oedema | n2=en:neck muscle weakness | rel=r_associated | relid=0 | w=44
  2728. en:oedema -- r_associated #0: 44 / 0.698 -> en:necrotic and regenerating fibers
    n1=en:oedema | n2=en:necrotic and regenerating fibers | rel=r_associated | relid=0 | w=44
  2729. en:oedema -- r_associated #0: 44 / 0.698 -> en:nemaline rod formation
    n1=en:oedema | n2=en:nemaline rod formation | rel=r_associated | relid=0 | w=44
  2730. en:oedema -- r_associated #0: 44 / 0.698 -> en:neonatal acral blistering
    n1=en:oedema | n2=en:neonatal acral blistering | rel=r_associated | relid=0 | w=44
  2731. en:oedema -- r_associated #0: 44 / 0.698 -> en:nephrotic syndrome, type 9
    n1=en:oedema | n2=en:nephrotic syndrome, type 9 | rel=r_associated | relid=0 | w=44
  2732. en:oedema -- r_associated #0: 44 / 0.698 -> en:neurological signs and symptoms
    n1=en:oedema | n2=en:neurological signs and symptoms | rel=r_associated | relid=0 | w=44
  2733. en:oedema -- r_associated #0: 44 / 0.698 -> en:nevus flammeus of the forehead
    n1=en:oedema | n2=en:nevus flammeus of the forehead | rel=r_associated | relid=0 | w=44
  2734. en:oedema -- r_associated #0: 44 / 0.698 -> en:no abnormal skin pigmentation
    n1=en:oedema | n2=en:no abnormal skin pigmentation | rel=r_associated | relid=0 | w=44
  2735. en:oedema -- r_associated #0: 44 / 0.698 -> en:no hyperhidrosis
    n1=en:oedema | n2=en:no hyperhidrosis | rel=r_associated | relid=0 | w=44
  2736. en:oedema -- r_associated #0: 44 / 0.698 -> en:no muscle fiber necrosis
    n1=en:oedema | n2=en:no muscle fiber necrosis | rel=r_associated | relid=0 | w=44
  2737. en:oedema -- r_associated #0: 44 / 0.698 -> en:no rods
    n1=en:oedema | n2=en:no rods | rel=r_associated | relid=0 | w=44
  2738. en:oedema -- r_associated #0: 44 / 0.698 -> en:no uv-induced skin tumors
    n1=en:oedema | n2=en:no uv-induced skin tumors | rel=r_associated | relid=0 | w=44
  2739. en:oedema -- r_associated #0: 44 / 0.698 -> en:nocturia
    n1=en:oedema | n2=en:nocturia | rel=r_associated | relid=0 | w=44
  2740. en:oedema -- r_associated #0: 44 / 0.698 -> en:nodule
    n1=en:oedema | n2=en:nodule | rel=r_associated | relid=0 | w=44
  2741. en:oedema -- r_associated #0: 44 / 0.698 -> en:non-immune hydrops fetalis
    n1=en:oedema | n2=en:non-immune hydrops fetalis | rel=r_associated | relid=0 | w=44
  2742. en:oedema -- r_associated #0: 44 / 0.698 -> en:non-scarring skin blistering (hands, feet, elbow, knee - onset in adolescence)
    n1=en:oedema | n2=en:non-scarring skin blistering (hands, feet, elbow, knee - onset in adolescence) | rel=r_associated | relid=0 | w=44
  2743. en:oedema -- r_associated #0: 44 / 0.698 -> en:nonspecific myopathic changes seen on biopsy
    n1=en:oedema | n2=en:nonspecific myopathic changes seen on biopsy | rel=r_associated | relid=0 | w=44
  2744. en:oedema -- r_associated #0: 44 / 0.698 -> en:o/e - pulmonary edema
    n1=en:oedema | n2=en:o/e - pulmonary edema | rel=r_associated | relid=0 | w=44
  2745. en:oedema -- r_associated #0: 44 / 0.698 -> en:o/e - right eye clinically significant macular edema
    n1=en:oedema | n2=en:o/e - right eye clinically significant macular edema | rel=r_associated | relid=0 | w=44
  2746. en:oedema -- r_associated #0: 44 / 0.698 -> en:obesity adverse event
    n1=en:oedema | n2=en:obesity adverse event | rel=r_associated | relid=0 | w=44
  2747. en:oedema -- r_associated #0: 44 / 0.698 -> en:observation parameter
    n1=en:oedema | n2=en:observation parameter | rel=r_associated | relid=0 | w=44
  2748. en:oedema -- r_associated #0: 44 / 0.698 -> en:oedema like
    n1=en:oedema | n2=en:oedema like | rel=r_associated | relid=0 | w=44
  2749. en:oedema -- r_associated #0: 44 / 0.698 -> en:oedematous weight gain
    n1=en:oedema | n2=en:oedematous weight gain | rel=r_associated | relid=0 | w=44
  2750. en:oedema -- r_associated #0: 44 / 0.698 -> en:on examination - scrotal swelling - no transillumination
    n1=en:oedema | n2=en:on examination - scrotal swelling - no transillumination | rel=r_associated | relid=0 | w=44
  2751. en:oedema -- r_associated #0: 44 / 0.698 -> en:orbital swelling
    n1=en:oedema | n2=en:orbital swelling | rel=r_associated | relid=0 | w=44
  2752. en:oedema -- r_associated #0: 44 / 0.698 -> en:other/unspecified neoplasm skin
    n1=en:oedema | n2=en:other/unspecified neoplasm skin | rel=r_associated | relid=0 | w=44
  2753. en:oedema -- r_associated #0: 44 / 0.698 -> en:painful bluish-red papules or nodules (fingers, toes, nose, cheek, ears)
    n1=en:oedema | n2=en:painful bluish-red papules or nodules (fingers, toes, nose, cheek, ears) | rel=r_associated | relid=0 | w=44
  2754. en:oedema -- r_associated #0: 44 / 0.698 -> en:pallor during episodes
    n1=en:oedema | n2=en:pallor during episodes | rel=r_associated | relid=0 | w=44
  2755. en:oedema -- r_associated #0: 44 / 0.698 -> en:palmar keratosis
    n1=en:oedema | n2=en:palmar keratosis | rel=r_associated | relid=0 | w=44
  2756. en:oedema -- r_associated #0: 44 / 0.698 -> en:palmar telangiectasias (described in 1 family)
    n1=en:oedema | n2=en:palmar telangiectasias (described in 1 family) | rel=r_associated | relid=0 | w=44
  2757. en:oedema -- r_associated #0: 44 / 0.698 -> en:palmar xanthomas
    n1=en:oedema | n2=en:palmar xanthomas | rel=r_associated | relid=0 | w=44
  2758. en:oedema -- r_associated #0: 44 / 0.698 -> en:papules, firm, flat or dome-shaped, skin-colored some with a hair at or just outside the periphery and/or telangiectatic surface
    n1=en:oedema | n2=en:papules, firm, flat or dome-shaped, skin-colored some with a hair at or just outside the periphery and/or telangiectatic surface | rel=r_associated | relid=0 | w=44
  2759. en:oedema -- r_associated #0: 44 / 0.698 -> en:paracrystalline inclusions
    n1=en:oedema | n2=en:paracrystalline inclusions | rel=r_associated | relid=0 | w=44
  2760. en:oedema -- r_associated #0: 44 / 0.698 -> en:parakeratosis
    n1=en:oedema | n2=en:parakeratosis | rel=r_associated | relid=0 | w=44
  2761. en:oedema -- r_associated #0: 44 / 0.698 -> en:paraparesis
    n1=en:oedema | n2=en:paraparesis | rel=r_associated | relid=0 | w=44
  2762. en:oedema -- r_associated #0: 44 / 0.698 -> en:partial anhidrosis
    n1=en:oedema | n2=en:partial anhidrosis | rel=r_associated | relid=0 | w=44
  2763. en:oedema -- r_associated #0: 44 / 0.698 -> en:pectoralis hypoplasia
    n1=en:oedema | n2=en:pectoralis hypoplasia | rel=r_associated | relid=0 | w=44
  2764. en:oedema -- r_associated #0: 44 / 0.698 -> en:pedal edema
    n1=en:oedema | n2=en:pedal edema | rel=r_associated | relid=0 | w=44
  2765. en:oedema -- r_associated #0: 44 / 0.698 -> en:pediatric failure to thrive
    n1=en:oedema | n2=en:pediatric failure to thrive | rel=r_associated | relid=0 | w=44
  2766. en:oedema -- r_associated #0: 44 / 0.698 -> en:pelvic girdle muscle atrophy
    n1=en:oedema | n2=en:pelvic girdle muscle atrophy | rel=r_associated | relid=0 | w=44
  2767. en:oedema -- r_associated #0: 44 / 0.698 -> en:pelvic pain
    n1=en:oedema | n2=en:pelvic pain | rel=r_associated | relid=0 | w=44
  2768. en:oedema -- r_associated #0: 44 / 0.698 -> en:perfusion / dialysis observable
    n1=en:oedema | n2=en:perfusion / dialysis observable | rel=r_associated | relid=0 | w=44
  2769. en:oedema -- r_associated #0: 44 / 0.698 -> en:peripheral oedema neonatal
    n1=en:oedema | n2=en:peripheral oedema neonatal | rel=r_associated | relid=0 | w=44
  2770. en:oedema -- r_associated #0: 44 / 0.698 -> en:pharynx or nasopharynx edema
    n1=en:oedema | n2=en:pharynx or nasopharynx edema | rel=r_associated | relid=0 | w=44
  2771. en:oedema -- r_associated #0: 44 / 0.698 -> en:photosensitivity bullous dermatitis (1 patient)
    n1=en:oedema | n2=en:photosensitivity bullous dermatitis (1 patient) | rel=r_associated | relid=0 | w=44
  2772. en:oedema -- r_associated #0: 44 / 0.698 -> en:polypoid degeneration of vocal cord
    n1=en:oedema | n2=en:polypoid degeneration of vocal cord | rel=r_associated | relid=0 | w=44
  2773. en:oedema -- r_associated #0: 44 / 0.698 -> en:poor head control
    n1=en:oedema | n2=en:poor head control | rel=r_associated | relid=0 | w=44
  2774. en:oedema -- r_associated #0: 44 / 0.698 -> en:poor head control in infancy
    n1=en:oedema | n2=en:poor head control in infancy | rel=r_associated | relid=0 | w=44
  2775. en:oedema -- r_associated #0: 44 / 0.698 -> en:positive staining for complement c5b-9 membrane attack complex proteins within vacuoles, but not on muscle fiber membrane
    n1=en:oedema | n2=en:positive staining for complement c5b-9 membrane attack complex proteins within vacuoles, but not on muscle fiber membrane | rel=r_associated | relid=0 | w=44
  2776. en:oedema -- r_associated #0: 44 / 0.698 -> en:post vaccination syndrome
    n1=en:oedema | n2=en:post vaccination syndrome | rel=r_associated | relid=0 | w=44
  2777. en:oedema -- r_associated #0: 44 / 0.698 -> en:postexercise cmap amplitude facilitation
    n1=en:oedema | n2=en:postexercise cmap amplitude facilitation | rel=r_associated | relid=0 | w=44
  2778. en:oedema -- r_associated #0: 44 / 0.698 -> en:prepuce
    n1=en:oedema | n2=en:prepuce | rel=r_associated | relid=0 | w=44
  2779. en:oedema -- r_associated #0: 44 / 0.698 -> en:proliferation of fatty tissue in muscle (in some patients)
    n1=en:oedema | n2=en:proliferation of fatty tissue in muscle (in some patients) | rel=r_associated | relid=0 | w=44
  2780. en:oedema -- r_associated #0: 44 / 0.698 -> en:prominent involvement of the quadriceps femoris muscles
    n1=en:oedema | n2=en:prominent involvement of the quadriceps femoris muscles | rel=r_associated | relid=0 | w=44
  2781. en:oedema -- r_associated #0: 44 / 0.698 -> en:prominent muscular appearance
    n1=en:oedema | n2=en:prominent muscular appearance | rel=r_associated | relid=0 | w=44
  2782. en:oedema -- r_associated #0: 44 / 0.698 -> en:protein aggregates immunopositive for actin and desmin
    n1=en:oedema | n2=en:protein aggregates immunopositive for actin and desmin | rel=r_associated | relid=0 | w=44
  2783. en:oedema -- r_associated #0: 44 / 0.698 -> en:proximal muscle involvement may occur
    n1=en:oedema | n2=en:proximal muscle involvement may occur | rel=r_associated | relid=0 | w=44
  2784. en:oedema -- r_associated #0: 44 / 0.698 -> en:proximal muscle weakness (120270.0002)
    n1=en:oedema | n2=en:proximal muscle weakness (120270.0002) | rel=r_associated | relid=0 | w=44
  2785. en:oedema -- r_associated #0: 44 / 0.698 -> en:proximal muscle weakness (occasional)
    n1=en:oedema | n2=en:proximal muscle weakness (occasional) | rel=r_associated | relid=0 | w=44
  2786. en:oedema -- r_associated #0: 44 / 0.698 -> en:proximal muscle weakness in upper limbs
    n1=en:oedema | n2=en:proximal muscle weakness in upper limbs | rel=r_associated | relid=0 | w=44
  2787. en:oedema -- r_associated #0: 44 / 0.698 -> en:proximal muscle weakness, limb-girdle distribution
    n1=en:oedema | n2=en:proximal muscle weakness, limb-girdle distribution | rel=r_associated | relid=0 | w=44
  2788. en:oedema -- r_associated #0: 44 / 0.698 -> en:pruritic eczematous lesions
    n1=en:oedema | n2=en:pruritic eczematous lesions | rel=r_associated | relid=0 | w=44
  2789. en:oedema -- r_associated #0: 44 / 0.698 -> en:pruritic ichthyosis (onset birth to first several months)
    n1=en:oedema | n2=en:pruritic ichthyosis (onset birth to first several months) | rel=r_associated | relid=0 | w=44
  2790. en:oedema -- r_associated #0: 44 / 0.698 -> en:pruritus during pregnancy, resolves postpartum
    n1=en:oedema | n2=en:pruritus during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=44
  2791. en:oedema -- r_associated #0: 44 / 0.698 -> en:pruritus in affected areas
    n1=en:oedema | n2=en:pruritus in affected areas | rel=r_associated | relid=0 | w=44
  2792. en:oedema -- r_associated #0: 44 / 0.698 -> en:pseudophakic corneal edema
    n1=en:oedema | n2=en:pseudophakic corneal edema | rel=r_associated | relid=0 | w=44
  2793. en:oedema -- r_associated #0: 44 / 0.698 -> en:psoriasiform lesions (rare)
    n1=en:oedema | n2=en:psoriasiform lesions (rare) | rel=r_associated | relid=0 | w=44
  2794. en:oedema -- r_associated #0: 44 / 0.698 -> en:pterygia of axillae (in some patients)
    n1=en:oedema | n2=en:pterygia of axillae (in some patients) | rel=r_associated | relid=0 | w=44
  2795. en:oedema -- r_associated #0: 44 / 0.698 -> en:pterygia of groin (in some patients)
    n1=en:oedema | n2=en:pterygia of groin (in some patients) | rel=r_associated | relid=0 | w=44
  2796. en:oedema -- r_associated #0: 44 / 0.698 -> en:pulmonary edema
    n1=en:oedema | n2=en:pulmonary edema | rel=r_associated | relid=0 | w=44
  2797. en:oedema -- r_associated #0: 44 / 0.698 -> en:pulmonary insufficiency following shock
    n1=en:oedema | n2=en:pulmonary insufficiency following shock | rel=r_associated | relid=0 | w=44
  2798. en:oedema -- r_associated #0: 44 / 0.698 -> en:punctate palmoplantar hyperkeratosis (later onset)
    n1=en:oedema | n2=en:punctate palmoplantar hyperkeratosis (later onset) | rel=r_associated | relid=0 | w=44
  2799. en:oedema -- r_associated #0: 44 / 0.698 -> en:rare skin cancers
    n1=en:oedema | n2=en:rare skin cancers | rel=r_associated | relid=0 | w=44
  2800. en:oedema -- r_associated #0: 44 / 0.698 -> en:rash erythematous
    n1=en:oedema | n2=en:rash erythematous | rel=r_associated | relid=0 | w=44
  2801. en:oedema -- r_associated #0: 44 / 0.698 -> en:rash may or may not be pruritic
    n1=en:oedema | n2=en:rash may or may not be pruritic | rel=r_associated | relid=0 | w=44
  2802. en:oedema -- r_associated #0: 44 / 0.698 -> en:reason for assessment
    n1=en:oedema | n2=en:reason for assessment | rel=r_associated | relid=0 | w=44
  2803. en:oedema -- r_associated #0: 44 / 0.698 -> en:recovery between attacks
    n1=en:oedema | n2=en:recovery between attacks | rel=r_associated | relid=0 | w=44
  2804. en:oedema -- r_associated #0: 44 / 0.698 -> en:rectus medial atrophy
    n1=en:oedema | n2=en:rectus medial atrophy | rel=r_associated | relid=0 | w=44
  2805. en:oedema -- r_associated #0: 44 / 0.698 -> en:red, raised, scaly skin patches (elbows, knees, scalp)
    n1=en:oedema | n2=en:red, raised, scaly skin patches (elbows, knees, scalp) | rel=r_associated | relid=0 | w=44
  2806. en:oedema -- r_associated #0: 44 / 0.698 -> en:reduced axillary apocrine secretion
    n1=en:oedema | n2=en:reduced axillary apocrine secretion | rel=r_associated | relid=0 | w=44
  2807. en:oedema -- r_associated #0: 44 / 0.698 -> en:reduced skin elasticity
    n1=en:oedema | n2=en:reduced skin elasticity | rel=r_associated | relid=0 | w=44
  2808. en:oedema -- r_associated #0: 44 / 0.698 -> en:reduced sweating of palms and soles
    n1=en:oedema | n2=en:reduced sweating of palms and soles | rel=r_associated | relid=0 | w=44
  2809. en:oedema -- r_associated #0: 44 / 0.698 -> en:refusal to bear weight
    n1=en:oedema | n2=en:refusal to bear weight | rel=r_associated | relid=0 | w=44
  2810. en:oedema -- r_associated #0: 44 / 0.698 -> en:reinke's edema
    n1=en:oedema | n2=en:reinke's edema | rel=r_associated | relid=0 | w=44
  2811. en:oedema -- r_associated #0: 44 / 0.698 -> en:relatively preserved limb strength
    n1=en:oedema | n2=en:relatively preserved limb strength | rel=r_associated | relid=0 | w=44
  2812. en:oedema -- r_associated #0: 44 / 0.698 -> en:respiratory system signs and symptoms
    n1=en:oedema | n2=en:respiratory system signs and symptoms | rel=r_associated | relid=0 | w=44
  2813. en:oedema -- r_associated #0: 44 / 0.698 -> en:restlessness
    n1=en:oedema | n2=en:restlessness | rel=r_associated | relid=0 | w=44
  2814. en:oedema -- r_associated #0: 44 / 0.698 -> en:retinal edema due to type 1 diabetes mellitus
    n1=en:oedema | n2=en:retinal edema due to type 1 diabetes mellitus | rel=r_associated | relid=0 | w=44
  2815. en:oedema -- r_associated #0: 44 / 0.698 -> en:sacral dimple (in some patients)
    n1=en:oedema | n2=en:sacral dimple (in some patients) | rel=r_associated | relid=0 | w=44
  2816. en:oedema -- r_associated #0: 44 / 0.698 -> en:sarcoplasmic accumulation of electron-dense granulofilamentous material
    n1=en:oedema | n2=en:sarcoplasmic accumulation of electron-dense granulofilamentous material | rel=r_associated | relid=0 | w=44
  2817. en:oedema -- r_associated #0: 44 / 0.698 -> en:scleroderma-like change
    n1=en:oedema | n2=en:scleroderma-like change | rel=r_associated | relid=0 | w=44
  2818. en:oedema -- r_associated #0: 44 / 0.698 -> en:scleroderma-like skin, especially of face and distal extremities
    n1=en:oedema | n2=en:scleroderma-like skin, especially of face and distal extremities | rel=r_associated | relid=0 | w=44
  2819. en:oedema -- r_associated #0: 44 / 0.698 -> en:sclerosis of digits (in some patients)
    n1=en:oedema | n2=en:sclerosis of digits (in some patients) | rel=r_associated | relid=0 | w=44
  2820. en:oedema -- r_associated #0: 44 / 0.698 -> en:sebaceous cysts (buttocks and perineum)
    n1=en:oedema | n2=en:sebaceous cysts (buttocks and perineum) | rel=r_associated | relid=0 | w=44
  2821. en:oedema -- r_associated #0: 44 / 0.698 -> en:seborrheic dermatitis
    n1=en:oedema | n2=en:seborrheic dermatitis | rel=r_associated | relid=0 | w=44
  2822. en:oedema -- r_associated #0: 44 / 0.698 -> en:seborrheic dermatitis (1 family)
    n1=en:oedema | n2=en:seborrheic dermatitis (1 family) | rel=r_associated | relid=0 | w=44
  2823. en:oedema -- r_associated #0: 44 / 0.698 -> en:secondary myopathic features
    n1=en:oedema | n2=en:secondary myopathic features | rel=r_associated | relid=0 | w=44
  2824. en:oedema -- r_associated #0: 44 / 0.698 -> en:self-injury
    n1=en:oedema | n2=en:self-injury | rel=r_associated | relid=0 | w=44
  2825. en:oedema -- r_associated #0: 44 / 0.698 -> en:severe nonproliferative diabetic retinopathy with clinically significant macular edema
    n1=en:oedema | n2=en:severe nonproliferative diabetic retinopathy with clinically significant macular edema | rel=r_associated | relid=0 | w=44
  2826. en:oedema -- r_associated #0: 44 / 0.698 -> en:shoulder muscle weakness
    n1=en:oedema | n2=en:shoulder muscle weakness | rel=r_associated | relid=0 | w=44
  2827. en:oedema -- r_associated #0: 44 / 0.698 -> en:sign
    n1=en:oedema | n2=en:sign | rel=r_associated | relid=0 | w=44
  2828. en:oedema -- r_associated #0: 44 / 0.698 -> en:signs and symptoms, respiratory
    n1=en:oedema | n2=en:signs and symptoms, respiratory | rel=r_associated | relid=0 | w=44
  2829. en:oedema -- r_associated #0: 44 / 0.698 -> en:skeletal muscle biopsy shows fat droplets in sarcoplasm and mitochondria
    n1=en:oedema | n2=en:skeletal muscle biopsy shows fat droplets in sarcoplasm and mitochondria | rel=r_associated | relid=0 | w=44
  2830. en:oedema -- r_associated #0: 44 / 0.698 -> en:skeletal muscle biopsy shows minor variation in fiber size
    n1=en:oedema | n2=en:skeletal muscle biopsy shows minor variation in fiber size | rel=r_associated | relid=0 | w=44
  2831. en:oedema -- r_associated #0: 44 / 0.698 -> en:skeletal myopathy
    n1=en:oedema | n2=en:skeletal myopathy | rel=r_associated | relid=0 | w=44
  2832. en:oedema -- r_associated #0: 44 / 0.698 -> en:skin blistering, intermittent
    n1=en:oedema | n2=en:skin blistering, intermittent | rel=r_associated | relid=0 | w=44
  2833. en:oedema -- r_associated #0: 44 / 0.698 -> en:skin hypopigmentation
    n1=en:oedema | n2=en:skin hypopigmentation | rel=r_associated | relid=0 | w=44
  2834. en:oedema -- r_associated #0: 44 / 0.698 -> en:skin nodules - fingers, elbows, nose, ears (onset infancy-childhood)
    n1=en:oedema | n2=en:skin nodules - fingers, elbows, nose, ears (onset infancy-childhood) | rel=r_associated | relid=0 | w=44
  2835. en:oedema -- r_associated #0: 44 / 0.698 -> en:skin of female human body
    n1=en:oedema | n2=en:skin of female human body | rel=r_associated | relid=0 | w=44
  2836. en:oedema -- r_associated #0: 44 / 0.698 -> en:skin of right lower limb
    n1=en:oedema | n2=en:skin of right lower limb | rel=r_associated | relid=0 | w=44
  2837. en:oedema -- r_associated #0: 44 / 0.698 -> en:skin tags on palms (in some patients)
    n1=en:oedema | n2=en:skin tags on palms (in some patients) | rel=r_associated | relid=0 | w=44
  2838. en:oedema -- r_associated #0: 44 / 0.698 -> en:small rounded fibers
    n1=en:oedema | n2=en:small rounded fibers | rel=r_associated | relid=0 | w=44
  2839. en:oedema -- r_associated #0: 44 / 0.698 -> en:sodium chloride 0.154 meq/ml inhalant solution
    n1=en:oedema | n2=en:sodium chloride 0.154 meq/ml inhalant solution | rel=r_associated | relid=0 | w=44
  2840. en:oedema -- r_associated #0: 44 / 0.698 -> en:sodium chloride 1.2 meq/ml inhalant solution
    n1=en:oedema | n2=en:sodium chloride 1.2 meq/ml inhalant solution | rel=r_associated | relid=0 | w=44
  2841. en:oedema -- r_associated #0: 44 / 0.698 -> en:sodium chloride 1gm (topical) tab,soluble
    n1=en:oedema | n2=en:sodium chloride 1gm (topical) tab,soluble | rel=r_associated | relid=0 | w=44
  2842. en:oedema -- r_associated #0: 44 / 0.698 -> en:sodium citrate pwdr
    n1=en:oedema | n2=en:sodium citrate pwdr | rel=r_associated | relid=0 | w=44
  2843. en:oedema -- r_associated #0: 44 / 0.698 -> en:sparing of small hand and finger muscles
    n1=en:oedema | n2=en:sparing of small hand and finger muscles | rel=r_associated | relid=0 | w=44
  2844. en:oedema -- r_associated #0: 44 / 0.698 -> en:spasticity
    n1=en:oedema | n2=en:spasticity | rel=r_associated | relid=0 | w=44
  2845. en:oedema -- r_associated #0: 44 / 0.698 -> en:speech and communication disorders
    n1=en:oedema | n2=en:speech and communication disorders | rel=r_associated | relid=0 | w=44
  2846. en:oedema -- r_associated #0: 44 / 0.698 -> en:spiny follicular plugging
    n1=en:oedema | n2=en:spiny follicular plugging | rel=r_associated | relid=0 | w=44
  2847. en:oedema -- r_associated #0: 44 / 0.698 -> en:spiradenoma
    n1=en:oedema | n2=en:spiradenoma | rel=r_associated | relid=0 | w=44
  2848. en:oedema -- r_associated #0: 44 / 0.698 -> en:spontaneous bruising
    n1=en:oedema | n2=en:spontaneous bruising | rel=r_associated | relid=0 | w=44
  2849. en:oedema -- r_associated #0: 44 / 0.698 -> en:spotty hyperpigmentation
    n1=en:oedema | n2=en:spotty hyperpigmentation | rel=r_associated | relid=0 | w=44
  2850. en:oedema -- r_associated #0: 44 / 0.698 -> en:stage iv inflammatory breast carcinoma
    n1=en:oedema | n2=en:stage iv inflammatory breast carcinoma | rel=r_associated | relid=0 | w=44
  2851. en:oedema -- r_associated #0: 44 / 0.698 -> en:stiff skin
    n1=en:oedema | n2=en:stiff skin | rel=r_associated | relid=0 | w=44
  2852. en:oedema -- r_associated #0: 44 / 0.698 -> en:streaks and whorls
    n1=en:oedema | n2=en:streaks and whorls | rel=r_associated | relid=0 | w=44
  2853. en:oedema -- r_associated #0: 44 / 0.698 -> en:stress
    n1=en:oedema | n2=en:stress | rel=r_associated | relid=0 | w=44
  2854. en:oedema -- r_associated #0: 44 / 0.698 -> en:stretched skin
    n1=en:oedema | n2=en:stretched skin | rel=r_associated | relid=0 | w=44
  2855. en:oedema -- r_associated #0: 44 / 0.698 -> en:subcutaneous connective tissue nevi
    n1=en:oedema | n2=en:subcutaneous connective tissue nevi | rel=r_associated | relid=0 | w=44
  2856. en:oedema -- r_associated #0: 44 / 0.698 -> en:subcutaneous edema
    n1=en:oedema | n2=en:subcutaneous edema | rel=r_associated | relid=0 | w=44
  2857. en:oedema -- r_associated #0: 44 / 0.698 -> en:subcutaneous nodule
    n1=en:oedema | n2=en:subcutaneous nodule | rel=r_associated | relid=0 | w=44
  2858. en:oedema -- r_associated #0: 44 / 0.698 -> en:subcutaneous nodules (localized)(superficial)
    n1=en:oedema | n2=en:subcutaneous nodules (localized)(superficial) | rel=r_associated | relid=0 | w=44
  2859. en:oedema -- r_associated #0: 44 / 0.698 -> en:subglottic edema
    n1=en:oedema | n2=en:subglottic edema | rel=r_associated | relid=0 | w=44
  2860. en:oedema -- r_associated #0: 44 / 0.698 -> en:subsarcolemmal mitochondrial accumulation
    n1=en:oedema | n2=en:subsarcolemmal mitochondrial accumulation | rel=r_associated | relid=0 | w=44
  2861. en:oedema -- r_associated #0: 44 / 0.698 -> en:superficial generalized lifelong skin peeling (sparing palms and soles)
    n1=en:oedema | n2=en:superficial generalized lifelong skin peeling (sparing palms and soles) | rel=r_associated | relid=0 | w=44
  2862. en:oedema -- r_associated #0: 44 / 0.698 -> en:survival time
    n1=en:oedema | n2=en:survival time | rel=r_associated | relid=0 | w=44
  2863. en:oedema -- r_associated #0: 44 / 0.698 -> en:symmetrical, proximal limb muscle atrophy (pelvic, scapular, trunk muscles)
    n1=en:oedema | n2=en:symmetrical, proximal limb muscle atrophy (pelvic, scapular, trunk muscles) | rel=r_associated | relid=0 | w=44
  2864. en:oedema -- r_associated #0: 44 / 0.698 -> en:symptoms are progressive for a few years, and then become stationary
    n1=en:oedema | n2=en:symptoms are progressive for a few years, and then become stationary | rel=r_associated | relid=0 | w=44
  2865. en:oedema -- r_associated #0: 44 / 0.698 -> en:symptoms concerning nutrition, metabolism, and development
    n1=en:oedema | n2=en:symptoms concerning nutrition, metabolism, and development | rel=r_associated | relid=0 | w=44
  2866. en:oedema -- r_associated #0: 44 / 0.698 -> en:symptoms involving digestive system
    n1=en:oedema | n2=en:symptoms involving digestive system | rel=r_associated | relid=0 | w=44
  2867. en:oedema -- r_associated #0: 44 / 0.698 -> en:symptoms involving respiratory system and other chest symptoms
    n1=en:oedema | n2=en:symptoms involving respiratory system and other chest symptoms | rel=r_associated | relid=0 | w=44
  2868. en:oedema -- r_associated #0: 44 / 0.698 -> en:testicular mass
    n1=en:oedema | n2=en:testicular mass | rel=r_associated | relid=0 | w=44
  2869. en:oedema -- r_associated #0: 44 / 0.698 -> en:thenar eminence hypoplasia
    n1=en:oedema | n2=en:thenar eminence hypoplasia | rel=r_associated | relid=0 | w=44
  2870. en:oedema -- r_associated #0: 44 / 0.698 -> en:thick skin (66%)
    n1=en:oedema | n2=en:thick skin (66%) | rel=r_associated | relid=0 | w=44
  2871. en:oedema -- r_associated #0: 44 / 0.698 -> en:thick, loose, doughy skin
    n1=en:oedema | n2=en:thick, loose, doughy skin | rel=r_associated | relid=0 | w=44
  2872. en:oedema -- r_associated #0: 44 / 0.698 -> en:thick, relatively tight skin
    n1=en:oedema | n2=en:thick, relatively tight skin | rel=r_associated | relid=0 | w=44
  2873. en:oedema -- r_associated #0: 44 / 0.698 -> en:thickening of skin on the plantar and palmar surfaces
    n1=en:oedema | n2=en:thickening of skin on the plantar and palmar surfaces | rel=r_associated | relid=0 | w=44
  2874. en:oedema -- r_associated #0: 44 / 0.698 -> en:tibialis anterior muscle affected
    n1=en:oedema | n2=en:tibialis anterior muscle affected | rel=r_associated | relid=0 | w=44
  2875. en:oedema -- r_associated #0: 44 / 0.698 -> en:tight, glistening facial skin
    n1=en:oedema | n2=en:tight, glistening facial skin | rel=r_associated | relid=0 | w=44
  2876. en:oedema -- r_associated #0: 44 / 0.698 -> en:toxic diffuse goiter with pretibial myxedema
    n1=en:oedema | n2=en:toxic diffuse goiter with pretibial myxedema | rel=r_associated | relid=0 | w=44
  2877. en:oedema -- r_associated #0: 44 / 0.698 -> en:transfusion reaction due to excess volume
    n1=en:oedema | n2=en:transfusion reaction due to excess volume | rel=r_associated | relid=0 | w=44
  2878. en:oedema -- r_associated #0: 44 / 0.698 -> en:transient eosinophilic myositis (seen on muscle biopsy) in the first decade
    n1=en:oedema | n2=en:transient eosinophilic myositis (seen on muscle biopsy) in the first decade | rel=r_associated | relid=0 | w=44
  2879. en:oedema -- r_associated #0: 44 / 0.698 -> en:transient painful erysipelas-like lesions on lower leg and ankle
    n1=en:oedema | n2=en:transient painful erysipelas-like lesions on lower leg and ankle | rel=r_associated | relid=0 | w=44
  2880. en:oedema -- r_associated #0: 44 / 0.698 -> en:transitional zone of cells with gradual loss of nuclei
    n1=en:oedema | n2=en:transitional zone of cells with gradual loss of nuclei | rel=r_associated | relid=0 | w=44
  2881. en:oedema -- r_associated #0: 44 / 0.698 -> en:traumatic cerebral edema
    n1=en:oedema | n2=en:traumatic cerebral edema | rel=r_associated | relid=0 | w=44
  2882. en:oedema -- r_associated #0: 44 / 0.698 -> en:tremors subside over the first 2 to 3 months of life
    n1=en:oedema | n2=en:tremors subside over the first 2 to 3 months of life | rel=r_associated | relid=0 | w=44
  2883. en:oedema -- r_associated #0: 44 / 0.698 -> en:triceps aplasia
    n1=en:oedema | n2=en:triceps aplasia | rel=r_associated | relid=0 | w=44
  2884. en:oedema -- r_associated #0: 44 / 0.698 -> en:tubular aggregates mainly in type 1 fibers
    n1=en:oedema | n2=en:tubular aggregates mainly in type 1 fibers | rel=r_associated | relid=0 | w=44
  2885. en:oedema -- r_associated #0: 44 / 0.698 -> en:type i fibers with large, irregularly polygonal congophilic hyaline masses and nemaline rods consistent with nonlysosomal protein degradation
    n1=en:oedema | n2=en:type i fibers with large, irregularly polygonal congophilic hyaline masses and nemaline rods consistent with nonlysosomal protein degradation | rel=r_associated | relid=0 | w=44
  2886. en:oedema -- r_associated #0: 44 / 0.698 -> en:umbilical depression
    n1=en:oedema | n2=en:umbilical depression | rel=r_associated | relid=0 | w=44
  2887. en:oedema -- r_associated #0: 44 / 0.698 -> en:upper limb involvement may occur later
    n1=en:oedema | n2=en:upper limb involvement may occur later | rel=r_associated | relid=0 | w=44
  2888. en:oedema -- r_associated #0: 44 / 0.698 -> en:upper limb weakness
    n1=en:oedema | n2=en:upper limb weakness | rel=r_associated | relid=0 | w=44
  2889. en:oedema -- r_associated #0: 44 / 0.698 -> en:vertical creases of plantar surface between first and second toes
    n1=en:oedema | n2=en:vertical creases of plantar surface between first and second toes | rel=r_associated | relid=0 | w=44
  2890. en:oedema -- r_associated #0: 44 / 0.698 -> en:veterinary aspects
    n1=en:oedema | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=44
  2891. en:oedema -- r_associated #0: 44 / 0.698 -> en:volume excess, disturbed starling forces
    n1=en:oedema | n2=en:volume excess, disturbed starling forces | rel=r_associated | relid=0 | w=44
  2892. en:oedema -- r_associated #0: 44 / 0.698 -> en:walking delay
    n1=en:oedema | n2=en:walking delay | rel=r_associated | relid=0 | w=44
  2893. en:oedema -- r_associated #0: 44 / 0.698 -> en:warts, generalized (in some patients)
    n1=en:oedema | n2=en:warts, generalized (in some patients) | rel=r_associated | relid=0 | w=44
  2894. en:oedema -- r_associated #0: 44 / 0.698 -> en:weakness and wasting of the lower limbs
    n1=en:oedema | n2=en:weakness and wasting of the lower limbs | rel=r_associated | relid=0 | w=44
  2895. en:oedema -- r_associated #0: 44 / 0.698 -> en:weakness of all intrinsic hand muscles (later)
    n1=en:oedema | n2=en:weakness of all intrinsic hand muscles (later) | rel=r_associated | relid=0 | w=44
  2896. en:oedema -- r_associated #0: 44 / 0.698 -> en:weakness of the intrinsic hand muscles (in some patients)
    n1=en:oedema | n2=en:weakness of the intrinsic hand muscles (in some patients) | rel=r_associated | relid=0 | w=44
  2897. en:oedema -- r_associated #0: 44 / 0.698 -> en:well-circumscribed peeling of the skin on the hands, feet and neck (easily elicited by moisture and minor trauma)
    n1=en:oedema | n2=en:well-circumscribed peeling of the skin on the hands, feet and neck (easily elicited by moisture and minor trauma) | rel=r_associated | relid=0 | w=44
  2898. en:oedema -- r_associated #0: 44 / 0.698 -> en:white dermatographism
    n1=en:oedema | n2=en:white dermatographism | rel=r_associated | relid=0 | w=44
  2899. en:oedema -- r_associated #0: 44 / 0.698 -> en:wide variation in fiber size
    n1=en:oedema | n2=en:wide variation in fiber size | rel=r_associated | relid=0 | w=44
  2900. en:oedema -- r_associated #0: 44 / 0.698 -> en:wrist swelling
    n1=en:oedema | n2=en:wrist swelling | rel=r_associated | relid=0 | w=44
  2901. en:oedema -- r_associated #0: 44 / 0.698 -> en:xerostomia
    n1=en:oedema | n2=en:xerostomia | rel=r_associated | relid=0 | w=44
  2902. en:oedema -- r_associated #0: 44 / 0.698 -> en:yellow subcutaneous tissue covered by thin, scaly skin
    n1=en:oedema | n2=en:yellow subcutaneous tissue covered by thin, scaly skin | rel=r_associated | relid=0 | w=44
  2903. en:oedema -- r_associated #0: 44 / 0.698 -> en:z-line streaming see on electron microscopy
    n1=en:oedema | n2=en:z-line streaming see on electron microscopy | rel=r_associated | relid=0 | w=44
  2904. en:oedema -- r_associated #0: 44 / 0.698 -> gonflement d'un organe
    n1=en:oedema | n2=gonflement d'un organe | rel=r_associated | relid=0 | w=44
  2905. en:oedema -- r_associated #0: 44 / 0.698 -> hydrops
    n1=en:oedema | n2=hydrops | rel=r_associated | relid=0 | w=44
  2906. en:oedema -- r_associated #0: 44 / 0.698 -> maladie
    (médecine)
    n1=en:oedema | n2=maladie
    (médecine)
    | rel=r_associated | relid=0 | w=44
  2907. en:oedema -- r_associated #0: 44 / 0.698 -> masse et tuméfaction intra-abdominales ou pelviennes
    n1=en:oedema | n2=masse et tuméfaction intra-abdominales ou pelviennes | rel=r_associated | relid=0 | w=44
  2908. en:oedema -- r_associated #0: 44 / 0.698 -> oedème du poumon
    n1=en:oedema | n2=oedème du poumon | rel=r_associated | relid=0 | w=44
  2909. en:oedema -- r_associated #0: 44 / 0.698 -> stase
    n1=en:oedema | n2=stase | rel=r_associated | relid=0 | w=44
  2910. en:oedema -- r_associated #0: 44 / 0.698 -> syndrome de Berlin
    n1=en:oedema | n2=syndrome de Berlin | rel=r_associated | relid=0 | w=44
  2911. en:oedema -- r_associated #0: 44 / 0.698 -> tuméfaction intra-abdominale ou pelvienne
    n1=en:oedema | n2=tuméfaction intra-abdominale ou pelvienne | rel=r_associated | relid=0 | w=44
  2912. en:oedema -- r_associated #0: 43 / 0.683 -> œdème cérébral
    n1=en:oedema | n2=œdème cérébral | rel=r_associated | relid=0 | w=43
  2913. en:oedema -- r_associated #0: 43 / 0.683 -> anasarque
    n1=en:oedema | n2=anasarque | rel=r_associated | relid=0 | w=43
  2914. en:oedema -- r_associated #0: 43 / 0.683 ->
    un/le
    bleu

    n1=en:oedema | n2=
    un/le
    bleu
    | rel=r_associated | relid=0 | w=43
  2915. en:oedema -- r_associated #0: 43 / 0.683 -> bosse
    n1=en:oedema | n2=bosse | rel=r_associated | relid=0 | w=43
  2916. en:oedema -- r_associated #0: 43 / 0.683 -> en:abnormal aggregation of mitochondria
    n1=en:oedema | n2=en:abnormal aggregation of mitochondria | rel=r_associated | relid=0 | w=43
  2917. en:oedema -- r_associated #0: 43 / 0.683 -> en:abnormal distribution of subcutaneous fat
    n1=en:oedema | n2=en:abnormal distribution of subcutaneous fat | rel=r_associated | relid=0 | w=43
  2918. en:oedema -- r_associated #0: 43 / 0.683 -> en:absence of collagen vi immunostaining
    n1=en:oedema | n2=en:absence of collagen vi immunostaining | rel=r_associated | relid=0 | w=43
  2919. en:oedema -- r_associated #0: 43 / 0.683 -> en:absence of interphalangeal creases
    n1=en:oedema | n2=en:absence of interphalangeal creases | rel=r_associated | relid=0 | w=43
  2920. en:oedema -- r_associated #0: 43 / 0.683 -> en:absence of merosin in muscle
    n1=en:oedema | n2=en:absence of merosin in muscle | rel=r_associated | relid=0 | w=43
  2921. en:oedema -- r_associated #0: 43 / 0.683 -> en:absence of pectoralis minor muscle
    n1=en:oedema | n2=en:absence of pectoralis minor muscle | rel=r_associated | relid=0 | w=43
  2922. en:oedema -- r_associated #0: 43 / 0.683 -> en:absent distal interphalangeal creases
    n1=en:oedema | n2=en:absent distal interphalangeal creases | rel=r_associated | relid=0 | w=43
  2923. en:oedema -- r_associated #0: 43 / 0.683 -> en:acneiform lesions (rare)
    n1=en:oedema | n2=en:acneiform lesions (rare) | rel=r_associated | relid=0 | w=43
  2924. en:oedema -- r_associated #0: 43 / 0.683 -> en:adhalin deficiency seen on muscle biopsy
    n1=en:oedema | n2=en:adhalin deficiency seen on muscle biopsy | rel=r_associated | relid=0 | w=43
  2925. en:oedema -- r_associated #0: 43 / 0.683 -> en:amyotrophy, neurogenic
    n1=en:oedema | n2=en:amyotrophy, neurogenic | rel=r_associated | relid=0 | w=43
  2926. en:oedema -- r_associated #0: 43 / 0.683 -> en:angiokeratomas (soles)
    n1=en:oedema | n2=en:angiokeratomas (soles) | rel=r_associated | relid=0 | w=43
  2927. en:oedema -- r_associated #0: 43 / 0.683 -> en:angioplasty
    n1=en:oedema | n2=en:angioplasty | rel=r_associated | relid=0 | w=43
  2928. en:oedema -- r_associated #0: 43 / 0.683 -> en:anhidrosis over skin lesions (rare)
    n1=en:oedema | n2=en:anhidrosis over skin lesions (rare) | rel=r_associated | relid=0 | w=43
  2929. en:oedema -- r_associated #0: 43 / 0.683 -> en:anhydramnios
    n1=en:oedema | n2=en:anhydramnios | rel=r_associated | relid=0 | w=43
  2930. en:oedema -- r_associated #0: 43 / 0.683 -> en:anorexia adverse event
    n1=en:oedema | n2=en:anorexia adverse event | rel=r_associated | relid=0 | w=43
  2931. en:oedema -- r_associated #0: 43 / 0.683 -> en:anterior draw sign
    n1=en:oedema | n2=en:anterior draw sign | rel=r_associated | relid=0 | w=43
  2932. en:oedema -- r_associated #0: 43 / 0.683 -> en:aortic aneurysm
    n1=en:oedema | n2=en:aortic aneurysm | rel=r_associated | relid=0 | w=43
  2933. en:oedema -- r_associated #0: 43 / 0.683 -> en:aortic valve stenosis
    n1=en:oedema | n2=en:aortic valve stenosis | rel=r_associated | relid=0 | w=43
  2934. en:oedema -- r_associated #0: 43 / 0.683 -> en:arrhythmia
    n1=en:oedema | n2=en:arrhythmia | rel=r_associated | relid=0 | w=43
  2935. en:oedema -- r_associated #0: 43 / 0.683 -> en:aspects of mortality statistics
    n1=en:oedema | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=43
  2936. en:oedema -- r_associated #0: 43 / 0.683 -> en:aspects of radionuclide imaging
    n1=en:oedema | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=43
  2937. en:oedema -- r_associated #0: 43 / 0.683 -> en:asphyxia
    n1=en:oedema | n2=en:asphyxia | rel=r_associated | relid=0 | w=43
  2938. en:oedema -- r_associated #0: 43 / 0.683 -> en:atrophic muscle fibers
    n1=en:oedema | n2=en:atrophic muscle fibers | rel=r_associated | relid=0 | w=43
  2939. en:oedema -- r_associated #0: 43 / 0.683 -> en:atrophy of ankle and toe extensor (dorsiflexor) muscles
    n1=en:oedema | n2=en:atrophy of ankle and toe extensor (dorsiflexor) muscles | rel=r_associated | relid=0 | w=43
  2940. en:oedema -- r_associated #0: 43 / 0.683 -> en:attacks may present during or after sleep
    n1=en:oedema | n2=en:attacks may present during or after sleep | rel=r_associated | relid=0 | w=43
  2941. en:oedema -- r_associated #0: 43 / 0.683 -> en:attacks precipitated by cold temperature
    n1=en:oedema | n2=en:attacks precipitated by cold temperature | rel=r_associated | relid=0 | w=43
  2942. en:oedema -- r_associated #0: 43 / 0.683 -> en:atypical nevi often present in non-sun exposed areas
    n1=en:oedema | n2=en:atypical nevi often present in non-sun exposed areas | rel=r_associated | relid=0 | w=43
  2943. en:oedema -- r_associated #0: 43 / 0.683 -> en:autophagic vacuoles seen on biopsy (in some patients)
    n1=en:oedema | n2=en:autophagic vacuoles seen on biopsy (in some patients) | rel=r_associated | relid=0 | w=43
  2944. en:oedema -- r_associated #0: 43 / 0.683 -> en:axillary freckling
    n1=en:oedema | n2=en:axillary freckling | rel=r_associated | relid=0 | w=43
  2945. en:oedema -- r_associated #0: 43 / 0.683 -> en:bayonet sign
    n1=en:oedema | n2=en:bayonet sign | rel=r_associated | relid=0 | w=43
  2946. en:oedema -- r_associated #0: 43 / 0.683 -> en:biceps brachii atrophy
    n1=en:oedema | n2=en:biceps brachii atrophy | rel=r_associated | relid=0 | w=43
  2947. en:oedema -- r_associated #0: 43 / 0.683 -> en:bilateral single transverse palmar creases
    n1=en:oedema | n2=en:bilateral single transverse palmar creases | rel=r_associated | relid=0 | w=43
  2948. en:oedema -- r_associated #0: 43 / 0.683 -> en:biopsy of adipose tissue shows reduced adipocyte size
    n1=en:oedema | n2=en:biopsy of adipose tissue shows reduced adipocyte size | rel=r_associated | relid=0 | w=43
  2949. en:oedema -- r_associated #0: 43 / 0.683 -> en:blistering of palms in hot weather (in some patients)
    n1=en:oedema | n2=en:blistering of palms in hot weather (in some patients) | rel=r_associated | relid=0 | w=43
  2950. en:oedema -- r_associated #0: 43 / 0.683 -> en:blistering, mild (occurs mainly on ankles and feet and in response to trauma)
    n1=en:oedema | n2=en:blistering, mild (occurs mainly on ankles and feet and in response to trauma) | rel=r_associated | relid=0 | w=43
  2951. en:oedema -- r_associated #0: 43 / 0.683 -> en:blue nevus
    n1=en:oedema | n2=en:blue nevus | rel=r_associated | relid=0 | w=43
  2952. en:oedema -- r_associated #0: 43 / 0.683 -> en:body weight
    n1=en:oedema | n2=en:body weight | rel=r_associated | relid=0 | w=43
  2953. en:oedema -- r_associated #0: 43 / 0.683 -> en:buffalo hump (rare)
    n1=en:oedema | n2=en:buffalo hump (rare) | rel=r_associated | relid=0 | w=43
  2954. en:oedema -- r_associated #0: 43 / 0.683 -> en:bullous, pustular dermatitis of extremities, oral, anal, and genital areas
    n1=en:oedema | n2=en:bullous, pustular dermatitis of extremities, oral, anal, and genital areas | rel=r_associated | relid=0 | w=43
  2955. en:oedema -- r_associated #0: 43 / 0.683 -> en:cafe-au-lait spots (93%)
    n1=en:oedema | n2=en:cafe-au-lait spots (93%) | rel=r_associated | relid=0 | w=43
  2956. en:oedema -- r_associated #0: 43 / 0.683 -> en:calf muscle hypoplasia
    n1=en:oedema | n2=en:calf muscle hypoplasia | rel=r_associated | relid=0 | w=43
  2957. en:oedema -- r_associated #0: 43 / 0.683 -> en:calf pseudohypertrophy rare
    n1=en:oedema | n2=en:calf pseudohypertrophy rare | rel=r_associated | relid=0 | w=43
  2958. en:oedema -- r_associated #0: 43 / 0.683 -> en:calluses on weight-bearing areas of soles
    n1=en:oedema | n2=en:calluses on weight-bearing areas of soles | rel=r_associated | relid=0 | w=43
  2959. en:oedema -- r_associated #0: 43 / 0.683 -> en:cardiovascular system signs and symptoms
    n1=en:oedema | n2=en:cardiovascular system signs and symptoms | rel=r_associated | relid=0 | w=43
  2960. en:oedema -- r_associated #0: 43 / 0.683 -> en:chadwick's sign
    n1=en:oedema | n2=en:chadwick's sign | rel=r_associated | relid=0 | w=43
  2961. en:oedema -- r_associated #0: 43 / 0.683 -> en:chest tightness or pressure
    n1=en:oedema | n2=en:chest tightness or pressure | rel=r_associated | relid=0 | w=43
  2962. en:oedema -- r_associated #0: 43 / 0.683 -> en:chronic folliculitis
    n1=en:oedema | n2=en:chronic folliculitis | rel=r_associated | relid=0 | w=43
  2963. en:oedema -- r_associated #0: 43 / 0.683 -> en:chronic skin ulcer
    n1=en:oedema | n2=en:chronic skin ulcer | rel=r_associated | relid=0 | w=43
  2964. en:oedema -- r_associated #0: 43 / 0.683 -> en:claudication
    n1=en:oedema | n2=en:claudication | rel=r_associated | relid=0 | w=43
  2965. en:oedema -- r_associated #0: 43 / 0.683 -> en:clinical sign related to pregnancy
    n1=en:oedema | n2=en:clinical sign related to pregnancy | rel=r_associated | relid=0 | w=43
  2966. en:oedema -- r_associated #0: 43 / 0.683 -> en:complete mevalonate kinase deficiency
    n1=en:oedema | n2=en:complete mevalonate kinase deficiency | rel=r_associated | relid=0 | w=43
  2967. en:oedema -- r_associated #0: 43 / 0.683 -> en:complex v deficiency
    n1=en:oedema | n2=en:complex v deficiency | rel=r_associated | relid=0 | w=43
  2968. en:oedema -- r_associated #0: 43 / 0.683 -> en:congenital absence of skin in areas
    n1=en:oedema | n2=en:congenital absence of skin in areas | rel=r_associated | relid=0 | w=43
  2969. en:oedema -- r_associated #0: 43 / 0.683 -> en:congenital fiber-type disproportion
    n1=en:oedema | n2=en:congenital fiber-type disproportion | rel=r_associated | relid=0 | w=43
  2970. en:oedema -- r_associated #0: 43 / 0.683 -> en:congenital poikiloderma on face and exposed skin
    n1=en:oedema | n2=en:congenital poikiloderma on face and exposed skin | rel=r_associated | relid=0 | w=43
  2971. en:oedema -- r_associated #0: 43 / 0.683 -> en:congophilic deposits
    n1=en:oedema | n2=en:congophilic deposits | rel=r_associated | relid=0 | w=43
  2972. en:oedema -- r_associated #0: 43 / 0.683 -> en:congophilic staining
    n1=en:oedema | n2=en:congophilic staining | rel=r_associated | relid=0 | w=43
  2973. en:oedema -- r_associated #0: 43 / 0.683 -> en:contact dermatitis and other eczema
    n1=en:oedema | n2=en:contact dermatitis and other eczema | rel=r_associated | relid=0 | w=43
  2974. en:oedema -- r_associated #0: 43 / 0.683 -> en:contractures of upper limbs (in some patients)
    n1=en:oedema | n2=en:contractures of upper limbs (in some patients) | rel=r_associated | relid=0 | w=43
  2975. en:oedema -- r_associated #0: 43 / 0.683 -> en:cox-negative fibers seen on muscle biopsy
    n1=en:oedema | n2=en:cox-negative fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=43
  2976. en:oedema -- r_associated #0: 43 / 0.683 -> en:cutaneous hyperpigmentation (in some patients)
    n1=en:oedema | n2=en:cutaneous hyperpigmentation (in some patients) | rel=r_associated | relid=0 | w=43
  2977. en:oedema -- r_associated #0: 43 / 0.683 -> en:cutis marmorata (in some patients)
    n1=en:oedema | n2=en:cutis marmorata (in some patients) | rel=r_associated | relid=0 | w=43
  2978. en:oedema -- r_associated #0: 43 / 0.683 -> en:cutis marmorata (rare)
    n1=en:oedema | n2=en:cutis marmorata (rare) | rel=r_associated | relid=0 | w=43
  2979. en:oedema -- r_associated #0: 43 / 0.683 -> en:cylindromas, multiple (usually occur on the scalp, but may also occur on the face, trunk, and extremities)
    n1=en:oedema | n2=en:cylindromas, multiple (usually occur on the scalp, but may also occur on the face, trunk, and extremities) | rel=r_associated | relid=0 | w=43
  2980. en:oedema -- r_associated #0: 43 / 0.683 -> en:cysts are firm and smooth
    n1=en:oedema | n2=en:cysts are firm and smooth | rel=r_associated | relid=0 | w=43
  2981. en:oedema -- r_associated #0: 43 / 0.683 -> en:cysts may be solitary (30%)
    n1=en:oedema | n2=en:cysts may be solitary (30%) | rel=r_associated | relid=0 | w=43
  2982. en:oedema -- r_associated #0: 43 / 0.683 -> en:cytochemical and em muscle studies show large, bizarre mitochondria in striated muscle
    n1=en:oedema | n2=en:cytochemical and em muscle studies show large, bizarre mitochondria in striated muscle | rel=r_associated | relid=0 | w=43
  2983. en:oedema -- r_associated #0: 43 / 0.683 -> en:cytoplasmic inclusion bodies (finding)
    n1=en:oedema | n2=en:cytoplasmic inclusion bodies (finding) | rel=r_associated | relid=0 | w=43
  2984. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased activities of mitochondrial-encoded respiratory chain complexes
    n1=en:oedema | n2=en:decreased activities of mitochondrial-encoded respiratory chain complexes | rel=r_associated | relid=0 | w=43
  2985. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased activity of cytochrome c oxidase (in most cases)
    n1=en:oedema | n2=en:decreased activity of cytochrome c oxidase (in most cases) | rel=r_associated | relid=0 | w=43
  2986. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased adipose tissue around neck
    n1=en:oedema | n2=en:decreased adipose tissue around neck | rel=r_associated | relid=0 | w=43
  2987. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased caveolae in muscle tissue
    n1=en:oedema | n2=en:decreased caveolae in muscle tissue | rel=r_associated | relid=0 | w=43
  2988. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased caveolin-3 expression seen on muscle biopsy
    n1=en:oedema | n2=en:decreased caveolin-3 expression seen on muscle biopsy | rel=r_associated | relid=0 | w=43
  2989. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased density of calcium release units
    n1=en:oedema | n2=en:decreased density of calcium release units | rel=r_associated | relid=0 | w=43
  2990. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased endplate potential and amplitudes
    n1=en:oedema | n2=en:decreased endplate potential and amplitudes | rel=r_associated | relid=0 | w=43
  2991. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased flexion creases
    n1=en:oedema | n2=en:decreased flexion creases | rel=r_associated | relid=0 | w=43
  2992. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased glycosylation of alpha-dystroglycan
    n1=en:oedema | n2=en:decreased glycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=43
  2993. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased mitochondrial complex iii activity seen on muscle biopsy
    n1=en:oedema | n2=en:decreased mitochondrial complex iii activity seen on muscle biopsy | rel=r_associated | relid=0 | w=43
  2994. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased mitochondrial respiratory chain complex activity
    n1=en:oedema | n2=en:decreased mitochondrial respiratory chain complex activity | rel=r_associated | relid=0 | w=43
  2995. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased muscle density on imaging
    n1=en:oedema | n2=en:decreased muscle density on imaging | rel=r_associated | relid=0 | w=43
  2996. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased palmar creases
    n1=en:oedema | n2=en:decreased palmar creases | rel=r_associated | relid=0 | w=43
  2997. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased respiratory complex i+iii and ii+iii activity
    n1=en:oedema | n2=en:decreased respiratory complex i+iii and ii+iii activity | rel=r_associated | relid=0 | w=43
  2998. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased sarcolemmal immunostaining for ptrf
    n1=en:oedema | n2=en:decreased sarcolemmal immunostaining for ptrf | rel=r_associated | relid=0 | w=43
  2999. en:oedema -- r_associated #0: 43 / 0.683 -> en:decreased shank muscle mass
    n1=en:oedema | n2=en:decreased shank muscle mass | rel=r_associated | relid=0 | w=43
  3000. en:oedema -- r_associated #0: 43 / 0.683 -> en:decremental response of compound muscle action potential on repetitive nerve stimulation
    n1=en:oedema | n2=en:decremental response of compound muscle action potential on repetitive nerve stimulation | rel=r_associated | relid=0 | w=43
  3001. en:oedema -- r_associated #0: 43 / 0.683 -> en:deep skin creases in toes
    n1=en:oedema | n2=en:deep skin creases in toes | rel=r_associated | relid=0 | w=43
  3002. en:oedema -- r_associated #0: 43 / 0.683 -> en:degenerative changes with increased connective tissue
    n1=en:oedema | n2=en:degenerative changes with increased connective tissue | rel=r_associated | relid=0 | w=43
  3003. en:oedema -- r_associated #0: 43 / 0.683 -> en:degree of physical and psychological healing following burn
    n1=en:oedema | n2=en:degree of physical and psychological healing following burn | rel=r_associated | relid=0 | w=43
  3004. en:oedema -- r_associated #0: 43 / 0.683 -> en:dermatographism (dermatographic urticaria)
    n1=en:oedema | n2=en:dermatographism (dermatographic urticaria) | rel=r_associated | relid=0 | w=43
  3005. en:oedema -- r_associated #0: 43 / 0.683 -> en:desquamation
    n1=en:oedema | n2=en:desquamation | rel=r_associated | relid=0 | w=43
  3006. en:oedema -- r_associated #0: 43 / 0.683 -> en:difficulty rising from a squatting position
    n1=en:oedema | n2=en:difficulty rising from a squatting position | rel=r_associated | relid=0 | w=43
  3007. en:oedema -- r_associated #0: 43 / 0.683 -> en:difficulty running or inability to run
    n1=en:oedema | n2=en:difficulty running or inability to run | rel=r_associated | relid=0 | w=43
  3008. en:oedema -- r_associated #0: 43 / 0.683 -> en:difficulty walking, running, climbing stairs
    n1=en:oedema | n2=en:difficulty walking, running, climbing stairs | rel=r_associated | relid=0 | w=43
  3009. en:oedema -- r_associated #0: 43 / 0.683 -> en:diffuse skin wrinkling (especially dorsa of hands and feet)
    n1=en:oedema | n2=en:diffuse skin wrinkling (especially dorsa of hands and feet) | rel=r_associated | relid=0 | w=43
  3010. en:oedema -- r_associated #0: 43 / 0.683 -> en:digestive system observable
    n1=en:oedema | n2=en:digestive system observable | rel=r_associated | relid=0 | w=43
  3011. en:oedema -- r_associated #0: 43 / 0.683 -> en:disorganization of the neuromuscular junction
    n1=en:oedema | n2=en:disorganization of the neuromuscular junction | rel=r_associated | relid=0 | w=43
  3012. en:oedema -- r_associated #0: 43 / 0.683 -> en:distal limb muscle atrophy due to peripheral neuropathy (lower limbs are more affected than upper limbs)
    n1=en:oedema | n2=en:distal limb muscle atrophy due to peripheral neuropathy (lower limbs are more affected than upper limbs) | rel=r_associated | relid=0 | w=43
  3013. en:oedema -- r_associated #0: 43 / 0.683 -> en:distal muscle weakness and atrophy may occur, upper and lower limbs affected
    n1=en:oedema | n2=en:distal muscle weakness and atrophy may occur, upper and lower limbs affected | rel=r_associated | relid=0 | w=43
  3014. en:oedema -- r_associated #0: 43 / 0.683 -> en:distal weakness, upper and lower limbs (variable)
    n1=en:oedema | n2=en:distal weakness, upper and lower limbs (variable) | rel=r_associated | relid=0 | w=43
  3015. en:oedema -- r_associated #0: 43 / 0.683 -> en:dorsal and flexor muscles of the forearm are involved
    n1=en:oedema | n2=en:dorsal and flexor muscles of the forearm are involved | rel=r_associated | relid=0 | w=43
  3016. en:oedema -- r_associated #0: 43 / 0.683 -> en:duchenne muscular dystrophy (dmd, 310200) in 'complex' form
    n1=en:oedema | n2=en:duchenne muscular dystrophy (dmd, 310200) in 'complex' form | rel=r_associated | relid=0 | w=43
  3017. en:oedema -- r_associated #0: 43 / 0.683 -> en:dysphagia
    n1=en:oedema | n2=en:dysphagia | rel=r_associated | relid=0 | w=43
  3018. en:oedema -- r_associated #0: 43 / 0.683 -> en:dysseborrheic dermatitis
    n1=en:oedema | n2=en:dysseborrheic dermatitis | rel=r_associated | relid=0 | w=43
  3019. en:oedema -- r_associated #0: 43 / 0.683 -> en:dystrophic changes may be present
    n1=en:oedema | n2=en:dystrophic changes may be present | rel=r_associated | relid=0 | w=43
  3020. en:oedema -- r_associated #0: 43 / 0.683 -> en:early onset skin cancer (basal cell, squamous cell and malignant melanoma)
    n1=en:oedema | n2=en:early onset skin cancer (basal cell, squamous cell and malignant melanoma) | rel=r_associated | relid=0 | w=43
  3021. en:oedema -- r_associated #0: 43 / 0.683 -> en:eating feeding / drinking observable
    n1=en:oedema | n2=en:eating feeding / drinking observable | rel=r_associated | relid=0 | w=43
  3022. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema co-occurrent and due to nutritional deficiency
    n1=en:oedema | n2=en:edema co-occurrent and due to nutritional deficiency | rel=r_associated | relid=0 | w=43
  3023. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema of cervical cord
    n1=en:oedema | n2=en:edema of cervical cord | rel=r_associated | relid=0 | w=43
  3024. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema of cornea of left eye
    n1=en:oedema | n2=en:edema of cornea of left eye | rel=r_associated | relid=0 | w=43
  3025. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema of palm of hand
    n1=en:oedema | n2=en:edema of palm of hand | rel=r_associated | relid=0 | w=43
  3026. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema of pharynx
    n1=en:oedema | n2=en:edema of pharynx | rel=r_associated | relid=0 | w=43
  3027. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema of suprapubic region
    n1=en:oedema | n2=en:edema of suprapubic region | rel=r_associated | relid=0 | w=43
  3028. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema of the tongue
    n1=en:oedema | n2=en:edema of the tongue | rel=r_associated | relid=0 | w=43
  3029. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema of the upper extremity
    n1=en:oedema | n2=en:edema of the upper extremity | rel=r_associated | relid=0 | w=43
  3030. en:oedema -- r_associated #0: 43 / 0.683 -> en:edema of wrist
    n1=en:oedema | n2=en:edema of wrist | rel=r_associated | relid=0 | w=43
  3031. en:oedema -- r_associated #0: 43 / 0.683 -> en:effect of exposure to physical force
    n1=en:oedema | n2=en:effect of exposure to physical force | rel=r_associated | relid=0 | w=43
  3032. en:oedema -- r_associated #0: 43 / 0.683 -> en:electrophysiologic studies show abnormal inactivation and delayed repolarization of the scn4a sodium channel
    n1=en:oedema | n2=en:electrophysiologic studies show abnormal inactivation and delayed repolarization of the scn4a sodium channel | rel=r_associated | relid=0 | w=43
  3033. en:oedema -- r_associated #0: 43 / 0.683 -> en:elevated sed rate
    n1=en:oedema | n2=en:elevated sed rate | rel=r_associated | relid=0 | w=43
  3034. en:oedema -- r_associated #0: 43 / 0.683 -> en:emg shows high-frequency spontaneous discharges
    n1=en:oedema | n2=en:emg shows high-frequency spontaneous discharges | rel=r_associated | relid=0 | w=43
  3035. en:oedema -- r_associated #0: 43 / 0.683 -> en:emg shows neurogenic changes
    n1=en:oedema | n2=en:emg shows neurogenic changes | rel=r_associated | relid=0 | w=43
  3036. en:oedema -- r_associated #0: 43 / 0.683 -> en:emg shows spontaneous, repetitive electrical activity ('myotonic runs')
    n1=en:oedema | n2=en:emg shows spontaneous, repetitive electrical activity ('myotonic runs') | rel=r_associated | relid=0 | w=43
  3037. en:oedema -- r_associated #0: 43 / 0.683 -> en:empty delta sign
    n1=en:oedema | n2=en:empty delta sign | rel=r_associated | relid=0 | w=43
  3038. en:oedema -- r_associated #0: 43 / 0.683 -> en:enlarged mitochondria
    n1=en:oedema | n2=en:enlarged mitochondria | rel=r_associated | relid=0 | w=43
  3039. en:oedema -- r_associated #0: 43 / 0.683 -> en:epidemiologic
    n1=en:oedema | n2=en:epidemiologic | rel=r_associated | relid=0 | w=43
  3040. en:oedema -- r_associated #0: 43 / 0.683 -> en:epidermal inclusion cyst
    n1=en:oedema | n2=en:epidermal inclusion cyst | rel=r_associated | relid=0 | w=43
  3041. en:oedema -- r_associated #0: 43 / 0.683 -> en:epidermolysis bullosa simplex
    n1=en:oedema | n2=en:epidermolysis bullosa simplex | rel=r_associated | relid=0 | w=43
  3042. en:oedema -- r_associated #0: 43 / 0.683 -> en:epidermolytic palmoplantar keratoderma
    n1=en:oedema | n2=en:epidermolytic palmoplantar keratoderma | rel=r_associated | relid=0 | w=43
  3043. en:oedema -- r_associated #0: 43 / 0.683 -> en:episodic hyperhidrosis
    n1=en:oedema | n2=en:episodic hyperhidrosis | rel=r_associated | relid=0 | w=43
  3044. en:oedema -- r_associated #0: 43 / 0.683 -> en:erosion
    n1=en:oedema | n2=en:erosion | rel=r_associated | relid=0 | w=43
  3045. en:oedema -- r_associated #0: 43 / 0.683 -> en:erythema marginatum
    n1=en:oedema | n2=en:erythema marginatum | rel=r_associated | relid=0 | w=43
  3046. en:oedema -- r_associated #0: 43 / 0.683 -> en:erythema, mild to moderate (in some patients)
    n1=en:oedema | n2=en:erythema, mild to moderate (in some patients) | rel=r_associated | relid=0 | w=43
  3047. en:oedema -- r_associated #0: 43 / 0.683 -> en:erythematous malar rash
    n1=en:oedema | n2=en:erythematous malar rash | rel=r_associated | relid=0 | w=43
  3048. en:oedema -- r_associated #0: 43 / 0.683 -> en:erythematous skin blotching
    n1=en:oedema | n2=en:erythematous skin blotching | rel=r_associated | relid=0 | w=43
  3049. en:oedema -- r_associated #0: 43 / 0.683 -> en:erythroderma, generalized congenital
    n1=en:oedema | n2=en:erythroderma, generalized congenital | rel=r_associated | relid=0 | w=43
  3050. en:oedema -- r_associated #0: 43 / 0.683 -> en:erythrokeratodermia
    n1=en:oedema | n2=en:erythrokeratodermia | rel=r_associated | relid=0 | w=43
  3051. en:oedema -- r_associated #0: 43 / 0.683 -> en:evidence of reinnervation seen on emg (1 family)
    n1=en:oedema | n2=en:evidence of reinnervation seen on emg (1 family) | rel=r_associated | relid=0 | w=43
  3052. en:oedema -- r_associated #0: 43 / 0.683 -> en:exercise intolerance (less common)
    n1=en:oedema | n2=en:exercise intolerance (less common) | rel=r_associated | relid=0 | w=43
  3053. en:oedema -- r_associated #0: 43 / 0.683 -> en:facial muscle atrophy of involved side
    n1=en:oedema | n2=en:facial muscle atrophy of involved side | rel=r_associated | relid=0 | w=43
  3054. en:oedema -- r_associated #0: 43 / 0.683 -> en:fasciculation
    n1=en:oedema | n2=en:fasciculation | rel=r_associated | relid=0 | w=43
  3055. en:oedema -- r_associated #0: 43 / 0.683 -> en:fat pad
    n1=en:oedema | n2=en:fat pad | rel=r_associated | relid=0 | w=43
  3056. en:oedema -- r_associated #0: 43 / 0.683 -> en:fat pad anterior to malleolus
    n1=en:oedema | n2=en:fat pad anterior to malleolus | rel=r_associated | relid=0 | w=43
  3057. en:oedema -- r_associated #0: 43 / 0.683 -> en:fatigue impact scale score
    n1=en:oedema | n2=en:fatigue impact scale score | rel=r_associated | relid=0 | w=43
  3058. en:oedema -- r_associated #0: 43 / 0.683 -> en:fear of having other skin disease
    n1=en:oedema | n2=en:fear of having other skin disease | rel=r_associated | relid=0 | w=43
  3059. en:oedema -- r_associated #0: 43 / 0.683 -> en:fecal incontinence
    n1=en:oedema | n2=en:fecal incontinence | rel=r_associated | relid=0 | w=43
  3060. en:oedema -- r_associated #0: 43 / 0.683 -> en:fetal hydrops (in perinatal or congenital neuromuscular forms)
    n1=en:oedema | n2=en:fetal hydrops (in perinatal or congenital neuromuscular forms) | rel=r_associated | relid=0 | w=43
  3061. en:oedema -- r_associated #0: 43 / 0.683 -> en:fever, sweat, and hot flashes
    n1=en:oedema | n2=en:fever, sweat, and hot flashes | rel=r_associated | relid=0 | w=43
  3062. en:oedema -- r_associated #0: 43 / 0.683 -> en:fiber size variation
    n1=en:oedema | n2=en:fiber size variation | rel=r_associated | relid=0 | w=43
  3063. en:oedema -- r_associated #0: 43 / 0.683 -> en:fiber-type grouping pattern
    n1=en:oedema | n2=en:fiber-type grouping pattern | rel=r_associated | relid=0 | w=43
  3064. en:oedema -- r_associated #0: 43 / 0.683 -> en:fibrosis over affected area
    n1=en:oedema | n2=en:fibrosis over affected area | rel=r_associated | relid=0 | w=43
  3065. en:oedema -- r_associated #0: 43 / 0.683 -> en:fine greyish-white scales
    n1=en:oedema | n2=en:fine greyish-white scales | rel=r_associated | relid=0 | w=43
  3066. en:oedema -- r_associated #0: 43 / 0.683 -> en:fingerprints, absence of
    n1=en:oedema | n2=en:fingerprints, absence of | rel=r_associated | relid=0 | w=43
  3067. en:oedema -- r_associated #0: 43 / 0.683 -> en:floppy infant
    n1=en:oedema | n2=en:floppy infant | rel=r_associated | relid=0 | w=43
  3068. en:oedema -- r_associated #0: 43 / 0.683 -> en:focal keratoderma of soles (in some patients)
    n1=en:oedema | n2=en:focal keratoderma of soles (in some patients) | rel=r_associated | relid=0 | w=43
  3069. en:oedema -- r_associated #0: 43 / 0.683 -> en:focal segmental glomerulosclerosis 6
    n1=en:oedema | n2=en:focal segmental glomerulosclerosis 6 | rel=r_associated | relid=0 | w=43
  3070. en:oedema -- r_associated #0: 43 / 0.683 -> en:follicular hyperkeratosis
    n1=en:oedema | n2=en:follicular hyperkeratosis | rel=r_associated | relid=0 | w=43
  3071. en:oedema -- r_associated #0: 43 / 0.683 -> en:folliculitis
    n1=en:oedema | n2=en:folliculitis | rel=r_associated | relid=0 | w=43
  3072. en:oedema -- r_associated #0: 43 / 0.683 -> en:folliculitis of the scalp, trunk, and extensor surfaces of the extremities
    n1=en:oedema | n2=en:folliculitis of the scalp, trunk, and extensor surfaces of the extremities | rel=r_associated | relid=0 | w=43
  3073. en:oedema -- r_associated #0: 43 / 0.683 -> en:foot-drop
    n1=en:oedema | n2=en:foot-drop | rel=r_associated | relid=0 | w=43
  3074. en:oedema -- r_associated #0: 43 / 0.683 -> en:freckles
    n1=en:oedema | n2=en:freckles | rel=r_associated | relid=0 | w=43
  3075. en:oedema -- r_associated #0: 43 / 0.683 -> en:gait, drop foot
    n1=en:oedema | n2=en:gait, drop foot | rel=r_associated | relid=0 | w=43
  3076. en:oedema -- r_associated #0: 43 / 0.683 -> en:gangrene
    n1=en:oedema | n2=en:gangrene | rel=r_associated | relid=0 | w=43
  3077. en:oedema -- r_associated #0: 43 / 0.683 -> en:gastrointestinal gas
    n1=en:oedema | n2=en:gastrointestinal gas | rel=r_associated | relid=0 | w=43
  3078. en:oedema -- r_associated #0: 43 / 0.683 -> en:general physiological development observable
    n1=en:oedema | n2=en:general physiological development observable | rel=r_associated | relid=0 | w=43
  3079. en:oedema -- r_associated #0: 43 / 0.683 -> en:generalized bruising tendency
    n1=en:oedema | n2=en:generalized bruising tendency | rel=r_associated | relid=0 | w=43
  3080. en:oedema -- r_associated #0: 43 / 0.683 -> en:generalized erythema (inflammatory type b)
    n1=en:oedema | n2=en:generalized erythema (inflammatory type b) | rel=r_associated | relid=0 | w=43
  3081. en:oedema -- r_associated #0: 43 / 0.683 -> en:generalized muscular appearance from birth
    n1=en:oedema | n2=en:generalized muscular appearance from birth | rel=r_associated | relid=0 | w=43
  3082. en:oedema -- r_associated #0: 43 / 0.683 -> en:generalized skin wrinkling
    n1=en:oedema | n2=en:generalized skin wrinkling | rel=r_associated | relid=0 | w=43
  3083. en:oedema -- r_associated #0: 43 / 0.683 -> en:goodenough draw-a-man test score
    n1=en:oedema | n2=en:goodenough draw-a-man test score | rel=r_associated | relid=0 | w=43
  3084. en:oedema -- r_associated #0: 43 / 0.683 -> en:greater soleus involvement than gastrocnemii involvement seen on mri
    n1=en:oedema | n2=en:greater soleus involvement than gastrocnemii involvement seen on mri | rel=r_associated | relid=0 | w=43
  3085. en:oedema -- r_associated #0: 43 / 0.683 -> en:haemorrhage subcutaneous
    n1=en:oedema | n2=en:haemorrhage subcutaneous | rel=r_associated | relid=0 | w=43
  3086. en:oedema -- r_associated #0: 43 / 0.683 -> en:head drop due to neck muscle weakness
    n1=en:oedema | n2=en:head drop due to neck muscle weakness | rel=r_associated | relid=0 | w=43
  3087. en:oedema -- r_associated #0: 43 / 0.683 -> en:heat edema
    n1=en:oedema | n2=en:heat edema | rel=r_associated | relid=0 | w=43
  3088. en:oedema -- r_associated #0: 43 / 0.683 -> en:hemophilia
    n1=en:oedema | n2=en:hemophilia | rel=r_associated | relid=0 | w=43
  3089. en:oedema -- r_associated #0: 43 / 0.683 -> en:herpes simplex infections
    n1=en:oedema | n2=en:herpes simplex infections | rel=r_associated | relid=0 | w=43
  3090. en:oedema -- r_associated #0: 43 / 0.683 -> en:high sweat electrolyte
    n1=en:oedema | n2=en:high sweat electrolyte | rel=r_associated | relid=0 | w=43
  3091. en:oedema -- r_associated #0: 43 / 0.683 -> en:hyperalgesia to pressure
    n1=en:oedema | n2=en:hyperalgesia to pressure | rel=r_associated | relid=0 | w=43
  3092. en:oedema -- r_associated #0: 43 / 0.683 -> en:hyperglycemia
    n1=en:oedema | n2=en:hyperglycemia | rel=r_associated | relid=0 | w=43
  3093. en:oedema -- r_associated #0: 43 / 0.683 -> en:hyperhidrosis (hands and feet)
    n1=en:oedema | n2=en:hyperhidrosis (hands and feet) | rel=r_associated | relid=0 | w=43
  3094. en:oedema -- r_associated #0: 43 / 0.683 -> en:hyperhidrosis occurs during pain episodes
    n1=en:oedema | n2=en:hyperhidrosis occurs during pain episodes | rel=r_associated | relid=0 | w=43
  3095. en:oedema -- r_associated #0: 43 / 0.683 -> en:hyperkeratosis of pressure sites of palms and soles
    n1=en:oedema | n2=en:hyperkeratosis of pressure sites of palms and soles | rel=r_associated | relid=0 | w=43
  3096. en:oedema -- r_associated #0: 43 / 0.683 -> en:hyperkeratosis pilaris may occur
    n1=en:oedema | n2=en:hyperkeratosis pilaris may occur | rel=r_associated | relid=0 | w=43
  3097. en:oedema -- r_associated #0: 43 / 0.683 -> en:hyperkeratotic yellowish papules and plaques arranged linearly on palms and fingers
    n1=en:oedema | n2=en:hyperkeratotic yellowish papules and plaques arranged linearly on palms and fingers | rel=r_associated | relid=0 | w=43
  3098. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypertonicity (uncommon)
    n1=en:oedema | n2=en:hypertonicity (uncommon) | rel=r_associated | relid=0 | w=43
  3099. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypohidrosis
    n1=en:oedema | n2=en:hypohidrosis | rel=r_associated | relid=0 | w=43
  3100. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypohidrosis (in patients with hsan2d)
    n1=en:oedema | n2=en:hypohidrosis (in patients with hsan2d) | rel=r_associated | relid=0 | w=43
  3101. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypopigmented streaks
    n1=en:oedema | n2=en:hypopigmented streaks | rel=r_associated | relid=0 | w=43
  3102. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypothenar muscle atrophy
    n1=en:oedema | n2=en:hypothenar muscle atrophy | rel=r_associated | relid=0 | w=43
  3103. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypotonia, generalized (in some patients)
    n1=en:oedema | n2=en:hypotonia, generalized (in some patients) | rel=r_associated | relid=0 | w=43
  3104. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypotonia, infantile, severe
    n1=en:oedema | n2=en:hypotonia, infantile, severe | rel=r_associated | relid=0 | w=43
  3105. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypovolemia
    n1=en:oedema | n2=en:hypovolemia | rel=r_associated | relid=0 | w=43
  3106. en:oedema -- r_associated #0: 43 / 0.683 -> en:hypoxia
    n1=en:oedema | n2=en:hypoxia | rel=r_associated | relid=0 | w=43
  3107. en:oedema -- r_associated #0: 43 / 0.683 -> en:ichthyosis (rare)
    n1=en:oedema | n2=en:ichthyosis (rare) | rel=r_associated | relid=0 | w=43
  3108. en:oedema -- r_associated #0: 43 / 0.683 -> en:ichthyosis hystrix
    n1=en:oedema | n2=en:ichthyosis hystrix | rel=r_associated | relid=0 | w=43
  3109. en:oedema -- r_associated #0: 43 / 0.683 -> en:idiopathic scrotal edema
    n1=en:oedema | n2=en:idiopathic scrotal edema | rel=r_associated | relid=0 | w=43
  3110. en:oedema -- r_associated #0: 43 / 0.683 -> en:in urine
    n1=en:oedema | n2=en:in urine | rel=r_associated | relid=0 | w=43
  3111. en:oedema -- r_associated #0: 43 / 0.683 -> en:inability to stand on tiptoes
    n1=en:oedema | n2=en:inability to stand on tiptoes | rel=r_associated | relid=0 | w=43
  3112. en:oedema -- r_associated #0: 43 / 0.683 -> en:increased centralized nuclei
    n1=en:oedema | n2=en:increased centralized nuclei | rel=r_associated | relid=0 | w=43
  3113. en:oedema -- r_associated #0: 43 / 0.683 -> en:increased fibrinolysis (finding)
    n1=en:oedema | n2=en:increased fibrinolysis (finding) | rel=r_associated | relid=0 | w=43
  3114. en:oedema -- r_associated #0: 43 / 0.683 -> en:increased focal mitochondrial density
    n1=en:oedema | n2=en:increased focal mitochondrial density | rel=r_associated | relid=0 | w=43
  3115. en:oedema -- r_associated #0: 43 / 0.683 -> en:increased internal nuclei
    n1=en:oedema | n2=en:increased internal nuclei | rel=r_associated | relid=0 | w=43
  3116. en:oedema -- r_associated #0: 43 / 0.683 -> en:increased intramuscular fat
    n1=en:oedema | n2=en:increased intramuscular fat | rel=r_associated | relid=0 | w=43
  3117. en:oedema -- r_associated #0: 43 / 0.683 -> en:increased pigmented nevi
    n1=en:oedema | n2=en:increased pigmented nevi | rel=r_associated | relid=0 | w=43
  3118. en:oedema -- r_associated #0: 43 / 0.683 -> en:increased variation in muscle fiber diameter
    n1=en:oedema | n2=en:increased variation in muscle fiber diameter | rel=r_associated | relid=0 | w=43
  3119. en:oedema -- r_associated #0: 43 / 0.683 -> en:infraorbital fold (dennie-morgan lines)
    n1=en:oedema | n2=en:infraorbital fold (dennie-morgan lines) | rel=r_associated | relid=0 | w=43
  3120. en:oedema -- r_associated #0: 43 / 0.683 -> en:intercrural pterygium
    n1=en:oedema | n2=en:intercrural pterygium | rel=r_associated | relid=0 | w=43
  3121. en:oedema -- r_associated #0: 43 / 0.683 -> en:interosseus muscles involved
    n1=en:oedema | n2=en:interosseus muscles involved | rel=r_associated | relid=0 | w=43
  3122. en:oedema -- r_associated #0: 43 / 0.683 -> en:isolated mitochondrial complex iv deficiency seen on biopsy
    n1=en:oedema | n2=en:isolated mitochondrial complex iv deficiency seen on biopsy | rel=r_associated | relid=0 | w=43
  3123. en:oedema -- r_associated #0: 43 / 0.683 -> en:jaundice, neonatal (in some patients)
    n1=en:oedema | n2=en:jaundice, neonatal (in some patients) | rel=r_associated | relid=0 | w=43
  3124. en:oedema -- r_associated #0: 43 / 0.683 -> en:junctional epidermolysis bullosa
    n1=en:oedema | n2=en:junctional epidermolysis bullosa | rel=r_associated | relid=0 | w=43
  3125. en:oedema -- r_associated #0: 43 / 0.683 -> en:kawasaki disease
    n1=en:oedema | n2=en:kawasaki disease | rel=r_associated | relid=0 | w=43
  3126. en:oedema -- r_associated #0: 43 / 0.683 -> en:keloid
    n1=en:oedema | n2=en:keloid | rel=r_associated | relid=0 | w=43
  3127. en:oedema -- r_associated #0: 43 / 0.683 -> en:langerhans cell
    n1=en:oedema | n2=en:langerhans cell | rel=r_associated | relid=0 | w=43
  3128. en:oedema -- r_associated #0: 43 / 0.683 -> en:large hypertrophied fibers
    n1=en:oedema | n2=en:large hypertrophied fibers | rel=r_associated | relid=0 | w=43
  3129. en:oedema -- r_associated #0: 43 / 0.683 -> en:large lipid droplets
    n1=en:oedema | n2=en:large lipid droplets | rel=r_associated | relid=0 | w=43
  3130. en:oedema -- r_associated #0: 43 / 0.683 -> en:larger and darker scales on neck, elbows, and knees (in some patients)
    n1=en:oedema | n2=en:larger and darker scales on neck, elbows, and knees (in some patients) | rel=r_associated | relid=0 | w=43
  3131. en:oedema -- r_associated #0: 43 / 0.683 -> en:lentigenes
    n1=en:oedema | n2=en:lentigenes | rel=r_associated | relid=0 | w=43
  3132. en:oedema -- r_associated #0: 43 / 0.683 -> en:lentigines may be absent
    n1=en:oedema | n2=en:lentigines may be absent | rel=r_associated | relid=0 | w=43
  3133. en:oedema -- r_associated #0: 43 / 0.683 -> en:leukoplakia (in some patients)
    n1=en:oedema | n2=en:leukoplakia (in some patients) | rel=r_associated | relid=0 | w=43
  3134. en:oedema -- r_associated #0: 43 / 0.683 -> en:leukoplakia (seen in recessive form)
    n1=en:oedema | n2=en:leukoplakia (seen in recessive form) | rel=r_associated | relid=0 | w=43
  3135. en:oedema -- r_associated #0: 43 / 0.683 -> en:light-sensitive dermatitis
    n1=en:oedema | n2=en:light-sensitive dermatitis | rel=r_associated | relid=0 | w=43
  3136. en:oedema -- r_associated #0: 43 / 0.683 -> en:limb-girdle muscle atrophy
    n1=en:oedema | n2=en:limb-girdle muscle atrophy | rel=r_associated | relid=0 | w=43
  3137. en:oedema -- r_associated #0: 43 / 0.683 -> en:limb-girdle muscle weakness
    n1=en:oedema | n2=en:limb-girdle muscle weakness | rel=r_associated | relid=0 | w=43
  3138. en:oedema -- r_associated #0: 43 / 0.683 -> en:livedo
    n1=en:oedema | n2=en:livedo | rel=r_associated | relid=0 | w=43
  3139. en:oedema -- r_associated #0: 43 / 0.683 -> en:loss of gluteal adipose tissue
    n1=en:oedema | n2=en:loss of gluteal adipose tissue | rel=r_associated | relid=0 | w=43
  3140. en:oedema -- r_associated #0: 43 / 0.683 -> en:loss of lower-limb tendon reflexes
    n1=en:oedema | n2=en:loss of lower-limb tendon reflexes | rel=r_associated | relid=0 | w=43
  3141. en:oedema -- r_associated #0: 43 / 0.683 -> en:loss of subcutaneous and visceral adipose tissue, mild
    n1=en:oedema | n2=en:loss of subcutaneous and visceral adipose tissue, mild | rel=r_associated | relid=0 | w=43
  3142. en:oedema -- r_associated #0: 43 / 0.683 -> en:loss of subcutaneous fat, generalized
    n1=en:oedema | n2=en:loss of subcutaneous fat, generalized | rel=r_associated | relid=0 | w=43
  3143. en:oedema -- r_associated #0: 43 / 0.683 -> en:lymphedema of the lower limbs (swelling is confined to below the knees)
    n1=en:oedema | n2=en:lymphedema of the lower limbs (swelling is confined to below the knees) | rel=r_associated | relid=0 | w=43
  3144. en:oedema -- r_associated #0: 43 / 0.683 -> en:lymphedema, of upper and/or lower extremity (rare)
    n1=en:oedema | n2=en:lymphedema, of upper and/or lower extremity (rare) | rel=r_associated | relid=0 | w=43
  3145. en:oedema -- r_associated #0: 43 / 0.683 -> en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia)
    n1=en:oedema | n2=en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia) | rel=r_associated | relid=0 | w=43
  3146. en:oedema -- r_associated #0: 43 / 0.683 -> en:macular edema and retinopathy due to type 2 diabetes mellitus
    n1=en:oedema | n2=en:macular edema and retinopathy due to type 2 diabetes mellitus | rel=r_associated | relid=0 | w=43
  3147. en:oedema -- r_associated #0: 43 / 0.683 -> en:macular hypopigmented whorls, streaks, and patches
    n1=en:oedema | n2=en:macular hypopigmented whorls, streaks, and patches | rel=r_associated | relid=0 | w=43
  3148. en:oedema -- r_associated #0: 43 / 0.683 -> en:marked variability of fiber size
    n1=en:oedema | n2=en:marked variability of fiber size | rel=r_associated | relid=0 | w=43
  3149. en:oedema -- r_associated #0: 43 / 0.683 -> en:may have proximal muscle weakness later in the disease
    n1=en:oedema | n2=en:may have proximal muscle weakness later in the disease | rel=r_associated | relid=0 | w=43
  3150. en:oedema -- r_associated #0: 43 / 0.683 -> en:metabolic syndrome
    n1=en:oedema | n2=en:metabolic syndrome | rel=r_associated | relid=0 | w=43
  3151. en:oedema -- r_associated #0: 43 / 0.683 -> en:microbiological
    n1=en:oedema | n2=en:microbiological | rel=r_associated | relid=0 | w=43
  3152. en:oedema -- r_associated #0: 43 / 0.683 -> en:mildly decreased laminin alpha-2 expression (lama2, 156225)
    n1=en:oedema | n2=en:mildly decreased laminin alpha-2 expression (lama2, 156225) | rel=r_associated | relid=0 | w=43
  3153. en:oedema -- r_associated #0: 43 / 0.683 -> en:mildly reduced respiratory enzyme activities except for complex ii
    n1=en:oedema | n2=en:mildly reduced respiratory enzyme activities except for complex ii | rel=r_associated | relid=0 | w=43
  3154. en:oedema -- r_associated #0: 43 / 0.683 -> en:milia of upper face and ears (infancy)
    n1=en:oedema | n2=en:milia of upper face and ears (infancy) | rel=r_associated | relid=0 | w=43
  3155. en:oedema -- r_associated #0: 43 / 0.683 -> en:minicore regions are poorly defined and do not extend through entire fiber length
    n1=en:oedema | n2=en:minicore regions are poorly defined and do not extend through entire fiber length | rel=r_associated | relid=0 | w=43
  3156. en:oedema -- r_associated #0: 43 / 0.683 -> en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization
    n1=en:oedema | n2=en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization | rel=r_associated | relid=0 | w=43
  3157. en:oedema -- r_associated #0: 43 / 0.683 -> en:mitochondria show paracrystalline inclusions
    n1=en:oedema | n2=en:mitochondria show paracrystalline inclusions | rel=r_associated | relid=0 | w=43
  3158. en:oedema -- r_associated #0: 43 / 0.683 -> en:mitochondrial myopathy
    n1=en:oedema | n2=en:mitochondrial myopathy | rel=r_associated | relid=0 | w=43
  3159. en:oedema -- r_associated #0: 43 / 0.683 -> en:mitochondrial paracrystalline inclusion bodies
    n1=en:oedema | n2=en:mitochondrial paracrystalline inclusion bodies | rel=r_associated | relid=0 | w=43
  3160. en:oedema -- r_associated #0: 43 / 0.683 -> en:molluscoid pseudotumors
    n1=en:oedema | n2=en:molluscoid pseudotumors | rel=r_associated | relid=0 | w=43
  3161. en:oedema -- r_associated #0: 43 / 0.683 -> en:morbihan disease
    n1=en:oedema | n2=en:morbihan disease | rel=r_associated | relid=0 | w=43
  3162. en:oedema -- r_associated #0: 43 / 0.683 -> en:mri shows increased connective tissue and fat
    n1=en:oedema | n2=en:mri shows increased connective tissue and fat | rel=r_associated | relid=0 | w=43
  3163. en:oedema -- r_associated #0: 43 / 0.683 -> en:multiple pigmented moles
    n1=en:oedema | n2=en:multiple pigmented moles | rel=r_associated | relid=0 | w=43
  3164. en:oedema -- r_associated #0: 43 / 0.683 -> en:multiple, flat, skin-colored warty papules (2-4mm in diameter on dorsum hands, feet, knees, and elbows)
    n1=en:oedema | n2=en:multiple, flat, skin-colored warty papules (2-4mm in diameter on dorsum hands, feet, knees, and elbows) | rel=r_associated | relid=0 | w=43
  3165. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle atrophy (type i)
    n1=en:oedema | n2=en:muscle atrophy (type i) | rel=r_associated | relid=0 | w=43
  3166. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle atrophy appears later in disease course
    n1=en:oedema | n2=en:muscle atrophy appears later in disease course | rel=r_associated | relid=0 | w=43
  3167. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy is immunopositive for merosin (156225)
    n1=en:oedema | n2=en:muscle biopsy is immunopositive for merosin (156225) | rel=r_associated | relid=0 | w=43
  3168. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy shows cytochrome c oxidase-negative fibers
    n1=en:oedema | n2=en:muscle biopsy shows cytochrome c oxidase-negative fibers | rel=r_associated | relid=0 | w=43
  3169. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy shows disruption of the sarcolemmal membrane
    n1=en:oedema | n2=en:muscle biopsy shows disruption of the sarcolemmal membrane | rel=r_associated | relid=0 | w=43
  3170. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy shows dystrophic features (later in disease course)
    n1=en:oedema | n2=en:muscle biopsy shows dystrophic features (later in disease course) | rel=r_associated | relid=0 | w=43
  3171. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy shows dystrophic pattern
    n1=en:oedema | n2=en:muscle biopsy shows dystrophic pattern | rel=r_associated | relid=0 | w=43
  3172. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy shows loss of myofibrillar organization
    n1=en:oedema | n2=en:muscle biopsy shows loss of myofibrillar organization | rel=r_associated | relid=0 | w=43
  3173. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy shows myofibrillar changes
    n1=en:oedema | n2=en:muscle biopsy shows myofibrillar changes | rel=r_associated | relid=0 | w=43
  3174. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy shows neurogenic angulated fibers
    n1=en:oedema | n2=en:muscle biopsy shows neurogenic angulated fibers | rel=r_associated | relid=0 | w=43
  3175. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle biopsy shows type 1 fiber predominance and hypertrophy
    n1=en:oedema | n2=en:muscle biopsy shows type 1 fiber predominance and hypertrophy | rel=r_associated | relid=0 | w=43
  3176. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle hypertrophy in affected area
    n1=en:oedema | n2=en:muscle hypertrophy in affected area | rel=r_associated | relid=0 | w=43
  3177. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle shows lipid accumulation
    n1=en:oedema | n2=en:muscle shows lipid accumulation | rel=r_associated | relid=0 | w=43
  3178. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle stiffness or aching
    n1=en:oedema | n2=en:muscle stiffness or aching | rel=r_associated | relid=0 | w=43
  3179. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle weakness associated with fasting or infection
    n1=en:oedema | n2=en:muscle weakness associated with fasting or infection | rel=r_associated | relid=0 | w=43
  3180. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle weakness may affect upper limbs
    n1=en:oedema | n2=en:muscle weakness may affect upper limbs | rel=r_associated | relid=0 | w=43
  3181. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle weakness, distal more than proximal
    n1=en:oedema | n2=en:muscle weakness, distal more than proximal | rel=r_associated | relid=0 | w=43
  3182. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle weakness, hypokalemia-related
    n1=en:oedema | n2=en:muscle weakness, hypokalemia-related | rel=r_associated | relid=0 | w=43
  3183. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle weakness, limb-girdle, mild
    n1=en:oedema | n2=en:muscle weakness, limb-girdle, mild | rel=r_associated | relid=0 | w=43
  3184. en:oedema -- r_associated #0: 43 / 0.683 -> en:muscle weakness, variable
    n1=en:oedema | n2=en:muscle weakness, variable | rel=r_associated | relid=0 | w=43
  3185. en:oedema -- r_associated #0: 43 / 0.683 -> en:myalgia
    n1=en:oedema | n2=en:myalgia | rel=r_associated | relid=0 | w=43
  3186. en:oedema -- r_associated #0: 43 / 0.683 -> en:myalgia (in some patients)
    n1=en:oedema | n2=en:myalgia (in some patients) | rel=r_associated | relid=0 | w=43
  3187. en:oedema -- r_associated #0: 43 / 0.683 -> en:myasthenias
    n1=en:oedema | n2=en:myasthenias | rel=r_associated | relid=0 | w=43
  3188. en:oedema -- r_associated #0: 43 / 0.683 -> en:myoclonic spasms
    n1=en:oedema | n2=en:myoclonic spasms | rel=r_associated | relid=0 | w=43
  3189. en:oedema -- r_associated #0: 43 / 0.683 -> en:myogenic changes seen on emg
    n1=en:oedema | n2=en:myogenic changes seen on emg | rel=r_associated | relid=0 | w=43
  3190. en:oedema -- r_associated #0: 43 / 0.683 -> en:myopathy, mild
    n1=en:oedema | n2=en:myopathy, mild | rel=r_associated | relid=0 | w=43
  3191. en:oedema -- r_associated #0: 43 / 0.683 -> en:named sign of hip
    n1=en:oedema | n2=en:named sign of hip | rel=r_associated | relid=0 | w=43
  3192. en:oedema -- r_associated #0: 43 / 0.683 -> en:named sign of knee
    n1=en:oedema | n2=en:named sign of knee | rel=r_associated | relid=0 | w=43
  3193. en:oedema -- r_associated #0: 43 / 0.683 -> en:named sign of pelvis
    n1=en:oedema | n2=en:named sign of pelvis | rel=r_associated | relid=0 | w=43
  3194. en:oedema -- r_associated #0: 43 / 0.683 -> en:necrotic and atrophic fibers with centralized nuclei
    n1=en:oedema | n2=en:necrotic and atrophic fibers with centralized nuclei | rel=r_associated | relid=0 | w=43
  3195. en:oedema -- r_associated #0: 43 / 0.683 -> en:nemaline bodies
    n1=en:oedema | n2=en:nemaline bodies | rel=r_associated | relid=0 | w=43
  3196. en:oedema -- r_associated #0: 43 / 0.683 -> en:neurofibromas may or may not be present
    n1=en:oedema | n2=en:neurofibromas may or may not be present | rel=r_associated | relid=0 | w=43
  3197. en:oedema -- r_associated #0: 43 / 0.683 -> en:neurofibromas, cutaneous (86%)
    n1=en:oedema | n2=en:neurofibromas, cutaneous (86%) | rel=r_associated | relid=0 | w=43
  3198. en:oedema -- r_associated #0: 43 / 0.683 -> en:neurogenic atrophy seen on muscle biopsy
    n1=en:oedema | n2=en:neurogenic atrophy seen on muscle biopsy | rel=r_associated | relid=0 | w=43
  3199. en:oedema -- r_associated #0: 43 / 0.683 -> en:neuropathic process seen on muscle biopsy
    n1=en:oedema | n2=en:neuropathic process seen on muscle biopsy | rel=r_associated | relid=0 | w=43
  3200. en:oedema -- r_associated #0: 43 / 0.683 -> en:nevus flammus
    n1=en:oedema | n2=en:nevus flammus | rel=r_associated | relid=0 | w=43
  3201. en:oedema -- r_associated #0: 43 / 0.683 -> en:no abnormalities of sweating
    n1=en:oedema | n2=en:no abnormalities of sweating | rel=r_associated | relid=0 | w=43
  3202. en:oedema -- r_associated #0: 43 / 0.683 -> en:no eczema
    n1=en:oedema | n2=en:no eczema | rel=r_associated | relid=0 | w=43
  3203. en:oedema -- r_associated #0: 43 / 0.683 -> en:no lipodystrophy in face and neck
    n1=en:oedema | n2=en:no lipodystrophy in face and neck | rel=r_associated | relid=0 | w=43
  3204. en:oedema -- r_associated #0: 43 / 0.683 -> en:no skin hyperelasticity
    n1=en:oedema | n2=en:no skin hyperelasticity | rel=r_associated | relid=0 | w=43
  3205. en:oedema -- r_associated #0: 43 / 0.683 -> en:non-immune fetal hydrops (rare)
    n1=en:oedema | n2=en:non-immune fetal hydrops (rare) | rel=r_associated | relid=0 | w=43
  3206. en:oedema -- r_associated #0: 43 / 0.683 -> en:nonspecific myopathic changes without dystrophic or inflammatory changes seen on muscle biopsy
    n1=en:oedema | n2=en:nonspecific myopathic changes without dystrophic or inflammatory changes seen on muscle biopsy | rel=r_associated | relid=0 | w=43
  3207. en:oedema -- r_associated #0: 43 / 0.683 -> en:normal lamp2 staining (309060)
    n1=en:oedema | n2=en:normal lamp2 staining (309060) | rel=r_associated | relid=0 | w=43
  3208. en:oedema -- r_associated #0: 43 / 0.683 -> en:o/e - a swelling
    n1=en:oedema | n2=en:o/e - a swelling | rel=r_associated | relid=0 | w=43
  3209. en:oedema -- r_associated #0: 43 / 0.683 -> en:o/e - edema of legs
    n1=en:oedema | n2=en:o/e - edema of legs | rel=r_associated | relid=0 | w=43
  3210. en:oedema -- r_associated #0: 43 / 0.683 -> en:o/e - localization of sign
    n1=en:oedema | n2=en:o/e - localization of sign | rel=r_associated | relid=0 | w=43
  3211. en:oedema -- r_associated #0: 43 / 0.683 -> en:obesity
    n1=en:oedema | n2=en:obesity | rel=r_associated | relid=0 | w=43
  3212. en:oedema -- r_associated #0: 43 / 0.683 -> en:occurs in linear distribution
    n1=en:oedema | n2=en:occurs in linear distribution | rel=r_associated | relid=0 | w=43
  3213. en:oedema -- r_associated #0: 43 / 0.683 -> en:onset of weakness in hands and feet
    n1=en:oedema | n2=en:onset of weakness in hands and feet | rel=r_associated | relid=0 | w=43
  3214. en:oedema -- r_associated #0: 43 / 0.683 -> en:optic disc edema due to hypotony
    n1=en:oedema | n2=en:optic disc edema due to hypotony | rel=r_associated | relid=0 | w=43
  3215. en:oedema -- r_associated #0: 43 / 0.683 -> en:oral cavity, dental / salivary observable
    n1=en:oedema | n2=en:oral cavity, dental / salivary observable | rel=r_associated | relid=0 | w=43
  3216. en:oedema -- r_associated #0: 43 / 0.683 -> en:pacemakers and implantable defibrillators
    n1=en:oedema | n2=en:pacemakers and implantable defibrillators | rel=r_associated | relid=0 | w=43
  3217. en:oedema -- r_associated #0: 43 / 0.683 -> en:pain/tenderness of skin
    n1=en:oedema | n2=en:pain/tenderness of skin | rel=r_associated | relid=0 | w=43
  3218. en:oedema -- r_associated #0: 43 / 0.683 -> en:painful adipose tissue
    n1=en:oedema | n2=en:painful adipose tissue | rel=r_associated | relid=0 | w=43
  3219. en:oedema -- r_associated #0: 43 / 0.683 -> en:palmoplantar cutis gyrata
    n1=en:oedema | n2=en:palmoplantar cutis gyrata | rel=r_associated | relid=0 | w=43
  3220. en:oedema -- r_associated #0: 43 / 0.683 -> en:papilledema left eye
    n1=en:oedema | n2=en:papilledema left eye | rel=r_associated | relid=0 | w=43
  3221. en:oedema -- r_associated #0: 43 / 0.683 -> en:papillomatosis over affected area
    n1=en:oedema | n2=en:papillomatosis over affected area | rel=r_associated | relid=0 | w=43
  3222. en:oedema -- r_associated #0: 43 / 0.683 -> en:papillomatosis, reticular on the periphery, 1 to 2-mm growing to 4-5-mm and coalescing
    n1=en:oedema | n2=en:papillomatosis, reticular on the periphery, 1 to 2-mm growing to 4-5-mm and coalescing | rel=r_associated | relid=0 | w=43
  3223. en:oedema -- r_associated #0: 43 / 0.683 -> en:papular keratoderma, mild
    n1=en:oedema | n2=en:papular keratoderma, mild | rel=r_associated | relid=0 | w=43
  3224. en:oedema -- r_associated #0: 43 / 0.683 -> en:paradoxical sweating response (sweating induced by cold exposure, inability to sweat in hot weather)
    n1=en:oedema | n2=en:paradoxical sweating response (sweating induced by cold exposure, inability to sweat in hot weather) | rel=r_associated | relid=0 | w=43
  3225. en:oedema -- r_associated #0: 43 / 0.683 -> en:passive congestion
    n1=en:oedema | n2=en:passive congestion | rel=r_associated | relid=0 | w=43
  3226. en:oedema -- r_associated #0: 43 / 0.683 -> en:patchy muscle fiber degeneration
    n1=en:oedema | n2=en:patchy muscle fiber degeneration | rel=r_associated | relid=0 | w=43
  3227. en:oedema -- r_associated #0: 43 / 0.683 -> en:periarticular subcutaneous nodules
    n1=en:oedema | n2=en:periarticular subcutaneous nodules | rel=r_associated | relid=0 | w=43
  3228. en:oedema -- r_associated #0: 43 / 0.683 -> en:perinasal or perioral nonhealing crusting of the skin
    n1=en:oedema | n2=en:perinasal or perioral nonhealing crusting of the skin | rel=r_associated | relid=0 | w=43
  3229. en:oedema -- r_associated #0: 43 / 0.683 -> en:perinatal observable
    n1=en:oedema | n2=en:perinatal observable | rel=r_associated | relid=0 | w=43
  3230. en:oedema -- r_associated #0: 43 / 0.683 -> en:pigmented nevus
    n1=en:oedema | n2=en:pigmented nevus | rel=r_associated | relid=0 | w=43
  3231. en:oedema -- r_associated #0: 43 / 0.683 -> en:pits of palms and soles
    n1=en:oedema | n2=en:pits of palms and soles | rel=r_associated | relid=0 | w=43
  3232. en:oedema -- r_associated #0: 43 / 0.683 -> en:plaques immunoreactive for desmin and alpha-beta-crystallin
    n1=en:oedema | n2=en:plaques immunoreactive for desmin and alpha-beta-crystallin | rel=r_associated | relid=0 | w=43
  3233. en:oedema -- r_associated #0: 43 / 0.683 -> en:pleural effusion
    n1=en:oedema | n2=en:pleural effusion | rel=r_associated | relid=0 | w=43
  3234. en:oedema -- r_associated #0: 43 / 0.683 -> en:pleural effusion fluid
    n1=en:oedema | n2=en:pleural effusion fluid | rel=r_associated | relid=0 | w=43
  3235. en:oedema -- r_associated #0: 43 / 0.683 -> en:pneumatosis
    n1=en:oedema | n2=en:pneumatosis | rel=r_associated | relid=0 | w=43
  3236. en:oedema -- r_associated #0: 43 / 0.683 -> en:polyhydramnios (in some patients)
    n1=en:oedema | n2=en:polyhydramnios (in some patients) | rel=r_associated | relid=0 | w=43
  3237. en:oedema -- r_associated #0: 43 / 0.683 -> en:poor exercise tolerance
    n1=en:oedema | n2=en:poor exercise tolerance | rel=r_associated | relid=0 | w=43
  3238. en:oedema -- r_associated #0: 43 / 0.683 -> en:poor muscle bulk
    n1=en:oedema | n2=en:poor muscle bulk | rel=r_associated | relid=0 | w=43
  3239. en:oedema -- r_associated #0: 43 / 0.683 -> en:poroma
    n1=en:oedema | n2=en:poroma | rel=r_associated | relid=0 | w=43
  3240. en:oedema -- r_associated #0: 43 / 0.683 -> en:premature exertional muscle weakness
    n1=en:oedema | n2=en:premature exertional muscle weakness | rel=r_associated | relid=0 | w=43
  3241. en:oedema -- r_associated #0: 43 / 0.683 -> en:procedure related observable
    n1=en:oedema | n2=en:procedure related observable | rel=r_associated | relid=0 | w=43
  3242. en:oedema -- r_associated #0: 43 / 0.683 -> en:profuse sweating of the upper body induced by cold exposure
    n1=en:oedema | n2=en:profuse sweating of the upper body induced by cold exposure | rel=r_associated | relid=0 | w=43
  3243. en:oedema -- r_associated #0: 43 / 0.683 -> en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters)
    n1=en:oedema | n2=en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters) | rel=r_associated | relid=0 | w=43
  3244. en:oedema -- r_associated #0: 43 / 0.683 -> en:progressive proximal muscle weakness
    n1=en:oedema | n2=en:progressive proximal muscle weakness | rel=r_associated | relid=0 | w=43
  3245. en:oedema -- r_associated #0: 43 / 0.683 -> en:prominent veins on scalp, trunk, and/or extremities
    n1=en:oedema | n2=en:prominent veins on scalp, trunk, and/or extremities | rel=r_associated | relid=0 | w=43
  3246. en:oedema -- r_associated #0: 43 / 0.683 -> en:prominent venous markings
    n1=en:oedema | n2=en:prominent venous markings | rel=r_associated | relid=0 | w=43
  3247. en:oedema -- r_associated #0: 43 / 0.683 -> en:proximal lower limb muscle weakness, later (in some patients)
    n1=en:oedema | n2=en:proximal lower limb muscle weakness, later (in some patients) | rel=r_associated | relid=0 | w=43
  3248. en:oedema -- r_associated #0: 43 / 0.683 -> en:proximal muscle atrophy (in some patients)
    n1=en:oedema | n2=en:proximal muscle atrophy (in some patients) | rel=r_associated | relid=0 | w=43
  3249. en:oedema -- r_associated #0: 43 / 0.683 -> en:proximal muscle weakness and atrophy (may occur later)
    n1=en:oedema | n2=en:proximal muscle weakness and atrophy (may occur later) | rel=r_associated | relid=0 | w=43
  3250. en:oedema -- r_associated #0: 43 / 0.683 -> en:proximal muscle weakness in lower limbs
    n1=en:oedema | n2=en:proximal muscle weakness in lower limbs | rel=r_associated | relid=0 | w=43
  3251. en:oedema -- r_associated #0: 43 / 0.683 -> en:pruritus, episodic
    n1=en:oedema | n2=en:pruritus, episodic | rel=r_associated | relid=0 | w=43
  3252. en:oedema -- r_associated #0: 43 / 0.683 -> en:pterygium of elbow, bilateral (in some patients)
    n1=en:oedema | n2=en:pterygium of elbow, bilateral (in some patients) | rel=r_associated | relid=0 | w=43
  3253. en:oedema -- r_associated #0: 43 / 0.683 -> en:pulmonary edema caused by chemical fumes
    n1=en:oedema | n2=en:pulmonary edema caused by chemical fumes | rel=r_associated | relid=0 | w=43
  3254. en:oedema -- r_associated #0: 43 / 0.683 -> en:pulmonary edema due to hypoproteinemia
    n1=en:oedema | n2=en:pulmonary edema due to hypoproteinemia | rel=r_associated | relid=0 | w=43
  3255. en:oedema -- r_associated #0: 43 / 0.683 -> en:purpuric rash
    n1=en:oedema | n2=en:purpuric rash | rel=r_associated | relid=0 | w=43
  3256. en:oedema -- r_associated #0: 43 / 0.683 -> en:quadriceps atrophy (later onset)
    n1=en:oedema | n2=en:quadriceps atrophy (later onset) | rel=r_associated | relid=0 | w=43
  3257. en:oedema -- r_associated #0: 43 / 0.683 -> en:radiotherapeutic
    n1=en:oedema | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=43
  3258. en:oedema -- r_associated #0: 43 / 0.683 -> en:rash (erythematous macules or papules)
    n1=en:oedema | n2=en:rash (erythematous macules or papules) | rel=r_associated | relid=0 | w=43
  3259. en:oedema -- r_associated #0: 43 / 0.683 -> en:recurrent shingles
    n1=en:oedema | n2=en:recurrent shingles | rel=r_associated | relid=0 | w=43
  3260. en:oedema -- r_associated #0: 43 / 0.683 -> en:recurrent skin infections
    n1=en:oedema | n2=en:recurrent skin infections | rel=r_associated | relid=0 | w=43
  3261. en:oedema -- r_associated #0: 43 / 0.683 -> en:red mucosa
    n1=en:oedema | n2=en:red mucosa | rel=r_associated | relid=0 | w=43
  3262. en:oedema -- r_associated #0: 43 / 0.683 -> en:reduced activity of mitochondrial respiratory chains (1 family)
    n1=en:oedema | n2=en:reduced activity of mitochondrial respiratory chains (1 family) | rel=r_associated | relid=0 | w=43
  3263. en:oedema -- r_associated #0: 43 / 0.683 -> en:reproductive observable
    n1=en:oedema | n2=en:reproductive observable | rel=r_associated | relid=0 | w=43
  3264. en:oedema -- r_associated #0: 43 / 0.683 -> en:reticular pigmentation pattern
    n1=en:oedema | n2=en:reticular pigmentation pattern | rel=r_associated | relid=0 | w=43
  3265. en:oedema -- r_associated #0: 43 / 0.683 -> en:reticulated pigmentation (seen in recessive form)
    n1=en:oedema | n2=en:reticulated pigmentation (seen in recessive form) | rel=r_associated | relid=0 | w=43
  3266. en:oedema -- r_associated #0: 43 / 0.683 -> en:reversal of disease phenotype
    n1=en:oedema | n2=en:reversal of disease phenotype | rel=r_associated | relid=0 | w=43
  3267. en:oedema -- r_associated #0: 43 / 0.683 -> en:rhabdomyolysis with exercise (in older patients)
    n1=en:oedema | n2=en:rhabdomyolysis with exercise (in older patients) | rel=r_associated | relid=0 | w=43
  3268. en:oedema -- r_associated #0: 43 / 0.683 -> en:rhytide of forehead
    n1=en:oedema | n2=en:rhytide of forehead | rel=r_associated | relid=0 | w=43
  3269. en:oedema -- r_associated #0: 43 / 0.683 -> en:rimmed vacuoles
    n1=en:oedema | n2=en:rimmed vacuoles | rel=r_associated | relid=0 | w=43
  3270. en:oedema -- r_associated #0: 43 / 0.683 -> en:sacral dimple (2 patients)
    n1=en:oedema | n2=en:sacral dimple (2 patients) | rel=r_associated | relid=0 | w=43
  3271. en:oedema -- r_associated #0: 43 / 0.683 -> en:sclerodermatous skin changes
    n1=en:oedema | n2=en:sclerodermatous skin changes | rel=r_associated | relid=0 | w=43
  3272. en:oedema -- r_associated #0: 43 / 0.683 -> en:scrotum
    n1=en:oedema | n2=en:scrotum | rel=r_associated | relid=0 | w=43
  3273. en:oedema -- r_associated #0: 43 / 0.683 -> en:seatbelt sign
    n1=en:oedema | n2=en:seatbelt sign | rel=r_associated | relid=0 | w=43
  3274. en:oedema -- r_associated #0: 43 / 0.683 -> en:sebaceous cyst
    n1=en:oedema | n2=en:sebaceous cyst | rel=r_associated | relid=0 | w=43
  3275. en:oedema -- r_associated #0: 43 / 0.683 -> en:seborrheic dermatitis of scalp
    n1=en:oedema | n2=en:seborrheic dermatitis of scalp | rel=r_associated | relid=0 | w=43
  3276. en:oedema -- r_associated #0: 43 / 0.683 -> en:sensation of swelling
    n1=en:oedema | n2=en:sensation of swelling | rel=r_associated | relid=0 | w=43
  3277. en:oedema -- r_associated #0: 43 / 0.683 -> en:severe cystic acne
    n1=en:oedema | n2=en:severe cystic acne | rel=r_associated | relid=0 | w=43
  3278. en:oedema -- r_associated #0: 43 / 0.683 -> en:shoulder girdle weakness
    n1=en:oedema | n2=en:shoulder girdle weakness | rel=r_associated | relid=0 | w=43
  3279. en:oedema -- r_associated #0: 43 / 0.683 -> en:shoulder weakness
    n1=en:oedema | n2=en:shoulder weakness | rel=r_associated | relid=0 | w=43
  3280. en:oedema -- r_associated #0: 43 / 0.683 -> en:skin derivative
    n1=en:oedema | n2=en:skin derivative | rel=r_associated | relid=0 | w=43
  3281. en:oedema -- r_associated #0: 43 / 0.683 -> en:skin dimple (lower back)
    n1=en:oedema | n2=en:skin dimple (lower back) | rel=r_associated | relid=0 | w=43
  3282. en:oedema -- r_associated #0: 43 / 0.683 -> en:skin of left upper limb
    n1=en:oedema | n2=en:skin of left upper limb | rel=r_associated | relid=0 | w=43
  3283. en:oedema -- r_associated #0: 43 / 0.683 -> en:skin of the axilla
    n1=en:oedema | n2=en:skin of the axilla | rel=r_associated | relid=0 | w=43
  3284. en:oedema -- r_associated #0: 43 / 0.683 -> en:skin rash
    n1=en:oedema | n2=en:skin rash | rel=r_associated | relid=0 | w=43
  3285. en:oedema -- r_associated #0: 43 / 0.683 -> en:skin ulcer
    n1=en:oedema | n2=en:skin ulcer | rel=r_associated | relid=0 | w=43
  3286. en:oedema -- r_associated #0: 43 / 0.683 -> en:skin vessels with inversion of the usual osmiophilic pattern on electron microscopy
    n1=en:oedema | n2=en:skin vessels with inversion of the usual osmiophilic pattern on electron microscopy | rel=r_associated | relid=0 | w=43
  3287. en:oedema -- r_associated #0: 43 / 0.683 -> en:skin wrinkling (limited to dorsum of hands and feet and abdomen)
    n1=en:oedema | n2=en:skin wrinkling (limited to dorsum of hands and feet and abdomen) | rel=r_associated | relid=0 | w=43
  3288. en:oedema -- r_associated #0: 43 / 0.683 -> en:small and incompletely fused muscle fibers seen on biopsy
    n1=en:oedema | n2=en:small and incompletely fused muscle fibers seen on biopsy | rel=r_associated | relid=0 | w=43
  3289. en:oedema -- r_associated #0: 43 / 0.683 -> en:small nodular skin-tags
    n1=en:oedema | n2=en:small nodular skin-tags | rel=r_associated | relid=0 | w=43
  3290. en:oedema -- r_associated #0: 43 / 0.683 -> en:small, yellow papules (mouth, neck, axilla, elbows, groin, periumbilical region)
    n1=en:oedema | n2=en:small, yellow papules (mouth, neck, axilla, elbows, groin, periumbilical region) | rel=r_associated | relid=0 | w=43
  3291. en:oedema -- r_associated #0: 43 / 0.683 -> en:sodium acetate 2 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium acetate 2 meq/ml injectable solution | rel=r_associated | relid=0 | w=43
  3292. en:oedema -- r_associated #0: 43 / 0.683 -> en:sodium bicarbonate 0.476 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium bicarbonate 0.476 meq/ml injectable solution | rel=r_associated | relid=0 | w=43
  3293. en:oedema -- r_associated #0: 43 / 0.683 -> en:sodium chloride 0.111 meq/ml nasal solution
    n1=en:oedema | n2=en:sodium chloride 0.111 meq/ml nasal solution | rel=r_associated | relid=0 | w=43
  3294. en:oedema -- r_associated #0: 43 / 0.683 -> en:sodium chloride 0.154 meq/ml inhalant solution [broncho saline]
    n1=en:oedema | n2=en:sodium chloride 0.154 meq/ml inhalant solution [broncho saline] | rel=r_associated | relid=0 | w=43
  3295. en:oedema -- r_associated #0: 43 / 0.683 -> en:sodium chloride 0.513 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium chloride 0.513 meq/ml injectable solution | rel=r_associated | relid=0 | w=43
  3296. en:oedema -- r_associated #0: 43 / 0.683 -> en:sodium chloride 0.9%/methylparaben/propylparaben inj,tubex,2.5ml
    n1=en:oedema | n2=en:sodium chloride 0.9%/methylparaben/propylparaben inj,tubex,2.5ml | rel=r_associated | relid=0 | w=43
  3297. en:oedema -- r_associated #0: 43 / 0.683 -> en:sodium chloride 2.5 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium chloride 2.5 meq/ml injectable solution | rel=r_associated | relid=0 | w=43
  3298. en:oedema -- r_associated #0: 43 / 0.683 -> en:sodium citrate
    n1=en:oedema | n2=en:sodium citrate | rel=r_associated | relid=0 | w=43
  3299. en:oedema -- r_associated #0: 43 / 0.683 -> en:some patients never achieve ambulation
    n1=en:oedema | n2=en:some patients never achieve ambulation | rel=r_associated | relid=0 | w=43
  3300. en:oedema -- r_associated #0: 43 / 0.683 -> en:sparing of anterior tibialis muscle
    n1=en:oedema | n2=en:sparing of anterior tibialis muscle | rel=r_associated | relid=0 | w=43
  3301. en:oedema -- r_associated #0: 43 / 0.683 -> en:spurling sign
    n1=en:oedema | n2=en:spurling sign | rel=r_associated | relid=0 | w=43
  3302. en:oedema -- r_associated #0: 43 / 0.683 -> en:sterile pustules
    n1=en:oedema | n2=en:sterile pustules | rel=r_associated | relid=0 | w=43
  3303. en:oedema -- r_associated #0: 43 / 0.683 -> en:striae
    n1=en:oedema | n2=en:striae | rel=r_associated | relid=0 | w=43
  3304. en:oedema -- r_associated #0: 43 / 0.683 -> en:subcutaneous lipomas, well-circumscribed and painful
    n1=en:oedema | n2=en:subcutaneous lipomas, well-circumscribed and painful | rel=r_associated | relid=0 | w=43
  3305. en:oedema -- r_associated #0: 43 / 0.683 -> en:superficial swelling
    n1=en:oedema | n2=en:superficial swelling | rel=r_associated | relid=0 | w=43
  3306. en:oedema -- r_associated #0: 43 / 0.683 -> en:supraglottic edema
    n1=en:oedema | n2=en:supraglottic edema | rel=r_associated | relid=0 | w=43
  3307. en:oedema -- r_associated #0: 43 / 0.683 -> en:surgical aspects
    n1=en:oedema | n2=en:surgical aspects | rel=r_associated | relid=0 | w=43
  3308. en:oedema -- r_associated #0: 43 / 0.683 -> en:sweating, episodic
    n1=en:oedema | n2=en:sweating, episodic | rel=r_associated | relid=0 | w=43
  3309. en:oedema -- r_associated #0: 43 / 0.683 -> en:swelling
    n1=en:oedema | n2=en:swelling | rel=r_associated | relid=0 | w=43
  3310. en:oedema -- r_associated #0: 43 / 0.683 -> en:swelling on flushing of implanted venous access device
    n1=en:oedema | n2=en:swelling on flushing of implanted venous access device | rel=r_associated | relid=0 | w=43
  3311. en:oedema -- r_associated #0: 43 / 0.683 -> en:symmetrical muscle wasting
    n1=en:oedema | n2=en:symmetrical muscle wasting | rel=r_associated | relid=0 | w=43
  3312. en:oedema -- r_associated #0: 43 / 0.683 -> en:tachycardia
    n1=en:oedema | n2=en:tachycardia | rel=r_associated | relid=0 | w=43
  3313. en:oedema -- r_associated #0: 43 / 0.683 -> en:tan macules on glans penis and penile shaft
    n1=en:oedema | n2=en:tan macules on glans penis and penile shaft | rel=r_associated | relid=0 | w=43
  3314. en:oedema -- r_associated #0: 43 / 0.683 -> en:tearing
    n1=en:oedema | n2=en:tearing | rel=r_associated | relid=0 | w=43
  3315. en:oedema -- r_associated #0: 43 / 0.683 -> en:telangiectases (especially on tongue, lips, palate, face, conjunctiva, trunk, nail beds, fingers, and finger pads)
    n1=en:oedema | n2=en:telangiectases (especially on tongue, lips, palate, face, conjunctiva, trunk, nail beds, fingers, and finger pads) | rel=r_associated | relid=0 | w=43
  3316. en:oedema -- r_associated #0: 43 / 0.683 -> en:tendinous xanthomas presenting after age 20 years in heterozygotes, during first 4 years of life in homozygotes
    n1=en:oedema | n2=en:tendinous xanthomas presenting after age 20 years in heterozygotes, during first 4 years of life in homozygotes | rel=r_associated | relid=0 | w=43
  3317. en:oedema -- r_associated #0: 43 / 0.683 -> en:thenar amyotrophy (rare)
    n1=en:oedema | n2=en:thenar amyotrophy (rare) | rel=r_associated | relid=0 | w=43
  3318. en:oedema -- r_associated #0: 43 / 0.683 -> en:thigh hypertrophy
    n1=en:oedema | n2=en:thigh hypertrophy | rel=r_associated | relid=0 | w=43
  3319. en:oedema -- r_associated #0: 43 / 0.683 -> en:thin filament shortening and disorganization (in some patients)
    n1=en:oedema | n2=en:thin filament shortening and disorganization (in some patients) | rel=r_associated | relid=0 | w=43
  3320. en:oedema -- r_associated #0: 43 / 0.683 -> en:throat tightening
    n1=en:oedema | n2=en:throat tightening | rel=r_associated | relid=0 | w=43
  3321. en:oedema -- r_associated #0: 43 / 0.683 -> en:toe and foot dorsiflexor weakness
    n1=en:oedema | n2=en:toe and foot dorsiflexor weakness | rel=r_associated | relid=0 | w=43
  3322. en:oedema -- r_associated #0: 43 / 0.683 -> en:transient eczema
    n1=en:oedema | n2=en:transient eczema | rel=r_associated | relid=0 | w=43
  3323. en:oedema -- r_associated #0: 43 / 0.683 -> en:transient ischemic attack
    n1=en:oedema | n2=en:transient ischemic attack | rel=r_associated | relid=0 | w=43
  3324. en:oedema -- r_associated #0: 43 / 0.683 -> en:translucency, nuchal
    n1=en:oedema | n2=en:translucency, nuchal | rel=r_associated | relid=0 | w=43
  3325. en:oedema -- r_associated #0: 43 / 0.683 -> en:transplanted skin
    n1=en:oedema | n2=en:transplanted skin | rel=r_associated | relid=0 | w=43
  3326. en:oedema -- r_associated #0: 43 / 0.683 -> en:traumatic cerebral edema with open intracranial wound
    n1=en:oedema | n2=en:traumatic cerebral edema with open intracranial wound | rel=r_associated | relid=0 | w=43
  3327. en:oedema -- r_associated #0: 43 / 0.683 -> en:tuberous xanthoma
    n1=en:oedema | n2=en:tuberous xanthoma | rel=r_associated | relid=0 | w=43
  3328. en:oedema -- r_associated #0: 43 / 0.683 -> en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria
    n1=en:oedema | n2=en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | rel=r_associated | relid=0 | w=43
  3329. en:oedema -- r_associated #0: 43 / 0.683 -> en:type 1 fiber atrophy
    n1=en:oedema | n2=en:type 1 fiber atrophy | rel=r_associated | relid=0 | w=43
  3330. en:oedema -- r_associated #0: 43 / 0.683 -> en:type 2 fiber predominance
    n1=en:oedema | n2=en:type 2 fiber predominance | rel=r_associated | relid=0 | w=43
  3331. en:oedema -- r_associated #0: 43 / 0.683 -> en:type 2 muscle fiber predominance
    n1=en:oedema | n2=en:type 2 muscle fiber predominance | rel=r_associated | relid=0 | w=43
  3332. en:oedema -- r_associated #0: 43 / 0.683 -> en:upper and/or lower limbs may be affected
    n1=en:oedema | n2=en:upper and/or lower limbs may be affected | rel=r_associated | relid=0 | w=43
  3333. en:oedema -- r_associated #0: 43 / 0.683 -> en:uterine muscle may be stiff during pregnancy
    n1=en:oedema | n2=en:uterine muscle may be stiff during pregnancy | rel=r_associated | relid=0 | w=43
  3334. en:oedema -- r_associated #0: 43 / 0.683 -> en:uveitis related cystoid macular edema
    n1=en:oedema | n2=en:uveitis related cystoid macular edema | rel=r_associated | relid=0 | w=43
  3335. en:oedema -- r_associated #0: 43 / 0.683 -> en:vacuolar myopathy
    n1=en:oedema | n2=en:vacuolar myopathy | rel=r_associated | relid=0 | w=43
  3336. en:oedema -- r_associated #0: 43 / 0.683 -> en:vacuolated muscle fibers show reduplication of the basement membrane
    n1=en:oedema | n2=en:vacuolated muscle fibers show reduplication of the basement membrane | rel=r_associated | relid=0 | w=43
  3337. en:oedema -- r_associated #0: 43 / 0.683 -> en:vacuole membranes show atpase reactivity consistent with origin from the sarcoplasmic reticulum
    n1=en:oedema | n2=en:vacuole membranes show atpase reactivity consistent with origin from the sarcoplasmic reticulum | rel=r_associated | relid=0 | w=43
  3338. en:oedema -- r_associated #0: 43 / 0.683 -> en:vacuoles are autophagocytic and contain granular and membranous cellular debris
    n1=en:oedema | n2=en:vacuoles are autophagocytic and contain granular and membranous cellular debris | rel=r_associated | relid=0 | w=43
  3339. en:oedema -- r_associated #0: 43 / 0.683 -> en:venous stasis ulcer co-occurrent with edema of lower leg
    n1=en:oedema | n2=en:venous stasis ulcer co-occurrent with edema of lower leg | rel=r_associated | relid=0 | w=43
  3340. en:oedema -- r_associated #0: 43 / 0.683 -> en:vesiculopustular lesions
    n1=en:oedema | n2=en:vesiculopustular lesions | rel=r_associated | relid=0 | w=43
  3341. en:oedema -- r_associated #0: 43 / 0.683 -> en:volume excess, primary renal sodium retention
    n1=en:oedema | n2=en:volume excess, primary renal sodium retention | rel=r_associated | relid=0 | w=43
  3342. en:oedema -- r_associated #0: 43 / 0.683 -> en:wasted lower leg muscles
    n1=en:oedema | n2=en:wasted lower leg muscles | rel=r_associated | relid=0 | w=43
  3343. en:oedema -- r_associated #0: 43 / 0.683 -> en:water balance disorders
    n1=en:oedema | n2=en:water balance disorders | rel=r_associated | relid=0 | w=43
  3344. en:oedema -- r_associated #0: 43 / 0.683 -> en:weakness of long finger extensor muscles (occurs later)
    n1=en:oedema | n2=en:weakness of long finger extensor muscles (occurs later) | rel=r_associated | relid=0 | w=43
  3345. en:oedema -- r_associated #0: 43 / 0.683 -> en:well-circumscribed areas of nontender denuded skin on extremities
    n1=en:oedema | n2=en:well-circumscribed areas of nontender denuded skin on extremities | rel=r_associated | relid=0 | w=43
  3346. en:oedema -- r_associated #0: 43 / 0.683 -> en:white at birth
    n1=en:oedema | n2=en:white at birth | rel=r_associated | relid=0 | w=43
  3347. en:oedema -- r_associated #0: 43 / 0.683 -> en:yale swallow protocol score
    n1=en:oedema | n2=en:yale swallow protocol score | rel=r_associated | relid=0 | w=43
  3348. en:oedema -- r_associated #0: 43 / 0.683 -> en:yellow-orange colored skin
    n1=en:oedema | n2=en:yellow-orange colored skin | rel=r_associated | relid=0 | w=43
  3349. en:oedema -- r_associated #0: 43 / 0.683 -> enflure
    n1=en:oedema | n2=enflure | rel=r_associated | relid=0 | w=43
  3350. en:oedema -- r_associated #0: 43 / 0.683 -> gonflement
    n1=en:oedema | n2=gonflement | rel=r_associated | relid=0 | w=43
  3351. en:oedema -- r_associated #0: 43 / 0.683 -> hyperhydratation
    n1=en:oedema | n2=hyperhydratation | rel=r_associated | relid=0 | w=43
  3352. en:oedema -- r_associated #0: 43 / 0.683 -> oedème conjonctival
    n1=en:oedema | n2=oedème conjonctival | rel=r_associated | relid=0 | w=43
  3353. en:oedema -- r_associated #0: 43 / 0.683 -> oedème de Quincke
    n1=en:oedema | n2=oedème de Quincke | rel=r_associated | relid=0 | w=43
  3354. en:oedema -- r_associated #0: 43 / 0.683 -> oedème généralisé
    n1=en:oedema | n2=oedème généralisé | rel=r_associated | relid=0 | w=43
  3355. en:oedema -- r_associated #0: 43 / 0.683 -> oedème rétinien du pôle postérieur
    n1=en:oedema | n2=oedème rétinien du pôle postérieur | rel=r_associated | relid=0 | w=43
  3356. en:oedema -- r_associated #0: 42 / 0.667 -> adénopathies
    n1=en:oedema | n2=adénopathies | rel=r_associated | relid=0 | w=42
  3357. en:oedema -- r_associated #0: 42 / 0.667 -> adiposité localisée
    n1=en:oedema | n2=adiposité localisée | rel=r_associated | relid=0 | w=42
  3358. en:oedema -- r_associated #0: 42 / 0.667 -> autres tuméfactions et masses localisées de la peau et du tissu cellulaire sous-cutané
    n1=en:oedema | n2=autres tuméfactions et masses localisées de la peau et du tissu cellulaire sous-cutané | rel=r_associated | relid=0 | w=42
  3359. en:oedema -- r_associated #0: 42 / 0.667 -> bleu
    n1=en:oedema | n2=bleu | rel=r_associated | relid=0 | w=42
  3360. en:oedema -- r_associated #0: 42 / 0.667 -> en:'orange peel' skin (large pores)
    n1=en:oedema | n2=en:'orange peel' skin (large pores) | rel=r_associated | relid=0 | w=42
  3361. en:oedema -- r_associated #0: 42 / 0.667 -> en:abnormal breathing
    n1=en:oedema | n2=en:abnormal breathing | rel=r_associated | relid=0 | w=42
  3362. en:oedema -- r_associated #0: 42 / 0.667 -> en:abnormal fat accumulation in axillae (in some patients)
    n1=en:oedema | n2=en:abnormal fat accumulation in axillae (in some patients) | rel=r_associated | relid=0 | w=42
  3363. en:oedema -- r_associated #0: 42 / 0.667 -> en:abnormal fiber size variation seen on muscle biopsy
    n1=en:oedema | n2=en:abnormal fiber size variation seen on muscle biopsy | rel=r_associated | relid=0 | w=42
  3364. en:oedema -- r_associated #0: 42 / 0.667 -> en:abnormal subcutaneous fat tissue distribution
    n1=en:oedema | n2=en:abnormal subcutaneous fat tissue distribution | rel=r_associated | relid=0 | w=42
  3365. en:oedema -- r_associated #0: 42 / 0.667 -> en:abscess of skin and/or subcutaneous tissue
    n1=en:oedema | n2=en:abscess of skin and/or subcutaneous tissue | rel=r_associated | relid=0 | w=42
  3366. en:oedema -- r_associated #0: 42 / 0.667 -> en:absence of myotonia in infancy (congenital form)
    n1=en:oedema | n2=en:absence of myotonia in infancy (congenital form) | rel=r_associated | relid=0 | w=42
  3367. en:oedema -- r_associated #0: 42 / 0.667 -> en:acral ulcers
    n1=en:oedema | n2=en:acral ulcers | rel=r_associated | relid=0 | w=42
  3368. en:oedema -- r_associated #0: 42 / 0.667 -> en:acrogeria
    n1=en:oedema | n2=en:acrogeria | rel=r_associated | relid=0 | w=42
  3369. en:oedema -- r_associated #0: 42 / 0.667 -> en:adverse incident outcome categories
    n1=en:oedema | n2=en:adverse incident outcome categories | rel=r_associated | relid=0 | w=42
  3370. en:oedema -- r_associated #0: 42 / 0.667 -> en:affects distal limb and scalp
    n1=en:oedema | n2=en:affects distal limb and scalp | rel=r_associated | relid=0 | w=42
  3371. en:oedema -- r_associated #0: 42 / 0.667 -> en:allergic oedema
    n1=en:oedema | n2=en:allergic oedema | rel=r_associated | relid=0 | w=42
  3372. en:oedema -- r_associated #0: 42 / 0.667 -> en:amyotrophy affects c5 to t1 myotomes
    n1=en:oedema | n2=en:amyotrophy affects c5 to t1 myotomes | rel=r_associated | relid=0 | w=42
  3373. en:oedema -- r_associated #0: 42 / 0.667 -> en:angular atrophic fibers
    n1=en:oedema | n2=en:angular atrophic fibers | rel=r_associated | relid=0 | w=42
  3374. en:oedema -- r_associated #0: 42 / 0.667 -> en:anhidrosis
    n1=en:oedema | n2=en:anhidrosis | rel=r_associated | relid=0 | w=42
  3375. en:oedema -- r_associated #0: 42 / 0.667 -> en:ankle edema (finding)
    n1=en:oedema | n2=en:ankle edema (finding) | rel=r_associated | relid=0 | w=42
  3376. en:oedema -- r_associated #0: 42 / 0.667 -> en:aplasia cutis congenita on trunk or limbs
    n1=en:oedema | n2=en:aplasia cutis congenita on trunk or limbs | rel=r_associated | relid=0 | w=42
  3377. en:oedema -- r_associated #0: 42 / 0.667 -> en:aplastic anemia
    n1=en:oedema | n2=en:aplastic anemia | rel=r_associated | relid=0 | w=42
  3378. en:oedema -- r_associated #0: 42 / 0.667 -> en:application site edema
    n1=en:oedema | n2=en:application site edema | rel=r_associated | relid=0 | w=42
  3379. en:oedema -- r_associated #0: 42 / 0.667 -> en:ascending muscle weakness (beginning with feet and legs)
    n1=en:oedema | n2=en:ascending muscle weakness (beginning with feet and legs) | rel=r_associated | relid=0 | w=42
  3380. en:oedema -- r_associated #0: 42 / 0.667 -> en:associated sign
    n1=en:oedema | n2=en:associated sign | rel=r_associated | relid=0 | w=42
  3381. en:oedema -- r_associated #0: 42 / 0.667 -> en:atrophic calf muscles
    n1=en:oedema | n2=en:atrophic calf muscles | rel=r_associated | relid=0 | w=42
  3382. en:oedema -- r_associated #0: 42 / 0.667 -> en:atrophic scarring, severe
    n1=en:oedema | n2=en:atrophic scarring, severe | rel=r_associated | relid=0 | w=42
  3383. en:oedema -- r_associated #0: 42 / 0.667 -> en:atrophy of the small muscles in the hands and feet
    n1=en:oedema | n2=en:atrophy of the small muscles in the hands and feet | rel=r_associated | relid=0 | w=42
  3384. en:oedema -- r_associated #0: 42 / 0.667 -> en:atrophy, mild (in some cases)
    n1=en:oedema | n2=en:atrophy, mild (in some cases) | rel=r_associated | relid=0 | w=42
  3385. en:oedema -- r_associated #0: 42 / 0.667 -> en:autoamputation of digits
    n1=en:oedema | n2=en:autoamputation of digits | rel=r_associated | relid=0 | w=42
  3386. en:oedema -- r_associated #0: 42 / 0.667 -> en:autophagic vacuoles with multilamellar structures seen on electron microscopy
    n1=en:oedema | n2=en:autophagic vacuoles with multilamellar structures seen on electron microscopy | rel=r_associated | relid=0 | w=42
  3387. en:oedema -- r_associated #0: 42 / 0.667 -> en:autophagosome
    n1=en:oedema | n2=en:autophagosome | rel=r_associated | relid=0 | w=42
  3388. en:oedema -- r_associated #0: 42 / 0.667 -> en:axial hypotonia (in some patients)
    n1=en:oedema | n2=en:axial hypotonia (in some patients) | rel=r_associated | relid=0 | w=42
  3389. en:oedema -- r_associated #0: 42 / 0.667 -> en:balance observable
    n1=en:oedema | n2=en:balance observable | rel=r_associated | relid=0 | w=42
  3390. en:oedema -- r_associated #0: 42 / 0.667 -> en:biopsy shows defects in pyruvate oxidation
    n1=en:oedema | n2=en:biopsy shows defects in pyruvate oxidation | rel=r_associated | relid=0 | w=42
  3391. en:oedema -- r_associated #0: 42 / 0.667 -> en:biopsy shows myopathic and dystrophic changes
    n1=en:oedema | n2=en:biopsy shows myopathic and dystrophic changes | rel=r_associated | relid=0 | w=42
  3392. en:oedema -- r_associated #0: 42 / 0.667 -> en:blistering, generalized, recurrent, severe (occurs after mild physical trauma)
    n1=en:oedema | n2=en:blistering, generalized, recurrent, severe (occurs after mild physical trauma) | rel=r_associated | relid=0 | w=42
  3393. en:oedema -- r_associated #0: 42 / 0.667 -> en:blisters in sun-exposed areas
    n1=en:oedema | n2=en:blisters in sun-exposed areas | rel=r_associated | relid=0 | w=42
  3394. en:oedema -- r_associated #0: 42 / 0.667 -> en:blood platelet disorders
    n1=en:oedema | n2=en:blood platelet disorders | rel=r_associated | relid=0 | w=42
  3395. en:oedema -- r_associated #0: 42 / 0.667 -> en:body water (substance)
    n1=en:oedema | n2=en:body water (substance) | rel=r_associated | relid=0 | w=42
  3396. en:oedema -- r_associated #0: 42 / 0.667 -> en:bright copper-red coloration of skin (in darker-skinned individuals)
    n1=en:oedema | n2=en:bright copper-red coloration of skin (in darker-skinned individuals) | rel=r_associated | relid=0 | w=42
  3397. en:oedema -- r_associated #0: 42 / 0.667 -> en:bruise/contusion intact skin
    n1=en:oedema | n2=en:bruise/contusion intact skin | rel=r_associated | relid=0 | w=42
  3398. en:oedema -- r_associated #0: 42 / 0.667 -> en:by fourth decade, many patients need help with ambulation
    n1=en:oedema | n2=en:by fourth decade, many patients need help with ambulation | rel=r_associated | relid=0 | w=42
  3399. en:oedema -- r_associated #0: 42 / 0.667 -> en:cachexia
    n1=en:oedema | n2=en:cachexia | rel=r_associated | relid=0 | w=42
  3400. en:oedema -- r_associated #0: 42 / 0.667 -> en:cafe-au-lait spot (in 1/4 patients)
    n1=en:oedema | n2=en:cafe-au-lait spot (in 1/4 patients) | rel=r_associated | relid=0 | w=42
  3401. en:oedema -- r_associated #0: 42 / 0.667 -> en:calcified, ulcerating nodules
    n1=en:oedema | n2=en:calcified, ulcerating nodules | rel=r_associated | relid=0 | w=42
  3402. en:oedema -- r_associated #0: 42 / 0.667 -> en:calf hypertrophy (less common)
    n1=en:oedema | n2=en:calf hypertrophy (less common) | rel=r_associated | relid=0 | w=42
  3403. en:oedema -- r_associated #0: 42 / 0.667 -> en:cardiac resuscitation
    n1=en:oedema | n2=en:cardiac resuscitation | rel=r_associated | relid=0 | w=42
  3404. en:oedema -- r_associated #0: 42 / 0.667 -> en:cardiomyopathy is not a feature
    n1=en:oedema | n2=en:cardiomyopathy is not a feature | rel=r_associated | relid=0 | w=42
  3405. en:oedema -- r_associated #0: 42 / 0.667 -> en:centralized myonuclei
    n1=en:oedema | n2=en:centralized myonuclei | rel=r_associated | relid=0 | w=42
  3406. en:oedema -- r_associated #0: 42 / 0.667 -> en:centralized nuclei may be seen
    n1=en:oedema | n2=en:centralized nuclei may be seen | rel=r_associated | relid=0 | w=42
  3407. en:oedema -- r_associated #0: 42 / 0.667 -> en:cerebrovascular accident
    n1=en:oedema | n2=en:cerebrovascular accident | rel=r_associated | relid=0 | w=42
  3408. en:oedema -- r_associated #0: 42 / 0.667 -> en:chewing difficulty
    n1=en:oedema | n2=en:chewing difficulty | rel=r_associated | relid=0 | w=42
  3409. en:oedema -- r_associated #0: 42 / 0.667 -> en:chondrodysplasia punctata, x-linked dominant type
    n1=en:oedema | n2=en:chondrodysplasia punctata, x-linked dominant type | rel=r_associated | relid=0 | w=42
  3410. en:oedema -- r_associated #0: 42 / 0.667 -> en:clinical data interchange standards consortium terminology
    n1=en:oedema | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=42
  3411. en:oedema -- r_associated #0: 42 / 0.667 -> en:collodion membrane, self-healing (in some patients)
    n1=en:oedema | n2=en:collodion membrane, self-healing (in some patients) | rel=r_associated | relid=0 | w=42
  3412. en:oedema -- r_associated #0: 42 / 0.667 -> en:congenital absence of gluteal muscles
    n1=en:oedema | n2=en:congenital absence of gluteal muscles | rel=r_associated | relid=0 | w=42
  3413. en:oedema -- r_associated #0: 42 / 0.667 -> en:congenital ichthyosis
    n1=en:oedema | n2=en:congenital ichthyosis | rel=r_associated | relid=0 | w=42
  3414. en:oedema -- r_associated #0: 42 / 0.667 -> en:congenital localized absence of skin
    n1=en:oedema | n2=en:congenital localized absence of skin | rel=r_associated | relid=0 | w=42
  3415. en:oedema -- r_associated #0: 42 / 0.667 -> en:coronary artery disease
    n1=en:oedema | n2=en:coronary artery disease | rel=r_associated | relid=0 | w=42
  3416. en:oedema -- r_associated #0: 42 / 0.667 -> en:cox-deficient fibers
    n1=en:oedema | n2=en:cox-deficient fibers | rel=r_associated | relid=0 | w=42
  3417. en:oedema -- r_associated #0: 42 / 0.667 -> en:cox-depleted fibers
    n1=en:oedema | n2=en:cox-depleted fibers | rel=r_associated | relid=0 | w=42
  3418. en:oedema -- r_associated #0: 42 / 0.667 -> en:cysts occur less commonly on any part of the body where hair grows
    n1=en:oedema | n2=en:cysts occur less commonly on any part of the body where hair grows | rel=r_associated | relid=0 | w=42
  3419. en:oedema -- r_associated #0: 42 / 0.667 -> en:cysts over wrist and ankle joints
    n1=en:oedema | n2=en:cysts over wrist and ankle joints | rel=r_associated | relid=0 | w=42
  3420. en:oedema -- r_associated #0: 42 / 0.667 -> en:dark skin pigmentation
    n1=en:oedema | n2=en:dark skin pigmentation | rel=r_associated | relid=0 | w=42
  3421. en:oedema -- r_associated #0: 42 / 0.667 -> en:decreased coenzyme q10 levels in muscle
    n1=en:oedema | n2=en:decreased coenzyme q10 levels in muscle | rel=r_associated | relid=0 | w=42
  3422. en:oedema -- r_associated #0: 42 / 0.667 -> en:decreased expression of the vdac1 protein
    n1=en:oedema | n2=en:decreased expression of the vdac1 protein | rel=r_associated | relid=0 | w=42
  3423. en:oedema -- r_associated #0: 42 / 0.667 -> en:decreased muscle bulk
    n1=en:oedema | n2=en:decreased muscle bulk | rel=r_associated | relid=0 | w=42
  3424. en:oedema -- r_associated #0: 42 / 0.667 -> en:decreased muscle mass (especially of limbs)
    n1=en:oedema | n2=en:decreased muscle mass (especially of limbs) | rel=r_associated | relid=0 | w=42
  3425. en:oedema -- r_associated #0: 42 / 0.667 -> en:decreased postsynaptic folding at the neuromuscular junction
    n1=en:oedema | n2=en:decreased postsynaptic folding at the neuromuscular junction | rel=r_associated | relid=0 | w=42
  3426. en:oedema -- r_associated #0: 42 / 0.667 -> en:defects in lipoate-containing mitochondrial enzyme complexes
    n1=en:oedema | n2=en:defects in lipoate-containing mitochondrial enzyme complexes | rel=r_associated | relid=0 | w=42
  3427. en:oedema -- r_associated #0: 42 / 0.667 -> en:dependent edema after excess fat has been present for several years
    n1=en:oedema | n2=en:dependent edema after excess fat has been present for several years | rel=r_associated | relid=0 | w=42
  3428. en:oedema -- r_associated #0: 42 / 0.667 -> en:dermatitis herpetiformis
    n1=en:oedema | n2=en:dermatitis herpetiformis | rel=r_associated | relid=0 | w=42
  3429. en:oedema -- r_associated #0: 42 / 0.667 -> en:dermatitis, atopic
    n1=en:oedema | n2=en:dermatitis, atopic | rel=r_associated | relid=0 | w=42
  3430. en:oedema -- r_associated #0: 42 / 0.667 -> en:dermatitis, infectious, due to immunodeficiency impetigo
    n1=en:oedema | n2=en:dermatitis, infectious, due to immunodeficiency impetigo | rel=r_associated | relid=0 | w=42
  3431. en:oedema -- r_associated #0: 42 / 0.667 -> en:dermo-epidermal junction
    n1=en:oedema | n2=en:dermo-epidermal junction | rel=r_associated | relid=0 | w=42
  3432. en:oedema -- r_associated #0: 42 / 0.667 -> en:difficulty rising from chair
    n1=en:oedema | n2=en:difficulty rising from chair | rel=r_associated | relid=0 | w=42
  3433. en:oedema -- r_associated #0: 42 / 0.667 -> en:difficulty walking, running
    n1=en:oedema | n2=en:difficulty walking, running | rel=r_associated | relid=0 | w=42
  3434. en:oedema -- r_associated #0: 42 / 0.667 -> en:dimples (medial and lateral aspect of lower leg)
    n1=en:oedema | n2=en:dimples (medial and lateral aspect of lower leg) | rel=r_associated | relid=0 | w=42
  3435. en:oedema -- r_associated #0: 42 / 0.667 -> en:discoid rash
    n1=en:oedema | n2=en:discoid rash | rel=r_associated | relid=0 | w=42
  3436. en:oedema -- r_associated #0: 42 / 0.667 -> en:disruption of the sarcolemmal membrane seen on muscle biopsy
    n1=en:oedema | n2=en:disruption of the sarcolemmal membrane seen on muscle biopsy | rel=r_associated | relid=0 | w=42
  3437. en:oedema -- r_associated #0: 42 / 0.667 -> en:distal limb atrophy (upper and lower)
    n1=en:oedema | n2=en:distal limb atrophy (upper and lower) | rel=r_associated | relid=0 | w=42
  3438. en:oedema -- r_associated #0: 42 / 0.667 -> en:distal limb muscle weakness and atrophy
    n1=en:oedema | n2=en:distal limb muscle weakness and atrophy | rel=r_associated | relid=0 | w=42
  3439. en:oedema -- r_associated #0: 42 / 0.667 -> en:distal lower limb muscle weakness and atrophy
    n1=en:oedema | n2=en:distal lower limb muscle weakness and atrophy | rel=r_associated | relid=0 | w=42
  3440. en:oedema -- r_associated #0: 42 / 0.667 -> en:distal muscle atrophy, predominantly affecting the lower limbs
    n1=en:oedema | n2=en:distal muscle atrophy, predominantly affecting the lower limbs | rel=r_associated | relid=0 | w=42
  3441. en:oedema -- r_associated #0: 42 / 0.667 -> en:distinct odor of palms and soles
    n1=en:oedema | n2=en:distinct odor of palms and soles | rel=r_associated | relid=0 | w=42
  3442. en:oedema -- r_associated #0: 42 / 0.667 -> en:dizziness and vertigo
    n1=en:oedema | n2=en:dizziness and vertigo | rel=r_associated | relid=0 | w=42
  3443. en:oedema -- r_associated #0: 42 / 0.667 -> en:dry, bumpy skin
    n1=en:oedema | n2=en:dry, bumpy skin | rel=r_associated | relid=0 | w=42
  3444. en:oedema -- r_associated #0: 42 / 0.667 -> en:dysphasia
    n1=en:oedema | n2=en:dysphasia | rel=r_associated | relid=0 | w=42
  3445. en:oedema -- r_associated #0: 42 / 0.667 -> en:dystrophic changes seen on muscle biopsy
    n1=en:oedema | n2=en:dystrophic changes seen on muscle biopsy | rel=r_associated | relid=0 | w=42
  3446. en:oedema -- r_associated #0: 42 / 0.667 -> en:eczema (in 1 patient)
    n1=en:oedema | n2=en:eczema (in 1 patient) | rel=r_associated | relid=0 | w=42
  3447. en:oedema -- r_associated #0: 42 / 0.667 -> en:edema of breast
    n1=en:oedema | n2=en:edema of breast | rel=r_associated | relid=0 | w=42
  3448. en:oedema -- r_associated #0: 42 / 0.667 -> en:edema of calf
    n1=en:oedema | n2=en:edema of calf | rel=r_associated | relid=0 | w=42
  3449. en:oedema -- r_associated #0: 42 / 0.667 -> en:edema of dorsum of hand
    n1=en:oedema | n2=en:edema of dorsum of hand | rel=r_associated | relid=0 | w=42
  3450. en:oedema -- r_associated #0: 42 / 0.667 -> en:edema of elbow
    n1=en:oedema | n2=en:edema of elbow | rel=r_associated | relid=0 | w=42
  3451. en:oedema -- r_associated #0: 42 / 0.667 -> en:edema of knee
    n1=en:oedema | n2=en:edema of knee | rel=r_associated | relid=0 | w=42
  3452. en:oedema -- r_associated #0: 42 / 0.667 -> en:edema of lower leg
    n1=en:oedema | n2=en:edema of lower leg | rel=r_associated | relid=0 | w=42
  3453. en:oedema -- r_associated #0: 42 / 0.667 -> en:effusion, joint
    n1=en:oedema | n2=en:effusion, joint | rel=r_associated | relid=0 | w=42
  3454. en:oedema -- r_associated #0: 42 / 0.667 -> en:electromyography shows myotonic discharges
    n1=en:oedema | n2=en:electromyography shows myotonic discharges | rel=r_associated | relid=0 | w=42
  3455. en:oedema -- r_associated #0: 42 / 0.667 -> en:emg and muscle biopsy shows chronic denervation of the peripheral nerves
    n1=en:oedema | n2=en:emg and muscle biopsy shows chronic denervation of the peripheral nerves | rel=r_associated | relid=0 | w=42
  3456. en:oedema -- r_associated #0: 42 / 0.667 -> en:emg in myotonia permanens shows continuous myotonic activity
    n1=en:oedema | n2=en:emg in myotonia permanens shows continuous myotonic activity | rel=r_associated | relid=0 | w=42
  3457. en:oedema -- r_associated #0: 42 / 0.667 -> en:emg shows fibrillations
    n1=en:oedema | n2=en:emg shows fibrillations | rel=r_associated | relid=0 | w=42
  3458. en:oedema -- r_associated #0: 42 / 0.667 -> en:emg shows myopathy
    n1=en:oedema | n2=en:emg shows myopathy | rel=r_associated | relid=0 | w=42
  3459. en:oedema -- r_associated #0: 42 / 0.667 -> en:entire skin
    n1=en:oedema | n2=en:entire skin | rel=r_associated | relid=0 | w=42
  3460. en:oedema -- r_associated #0: 42 / 0.667 -> en:eosinophilic inclusions
    n1=en:oedema | n2=en:eosinophilic inclusions | rel=r_associated | relid=0 | w=42
  3461. en:oedema -- r_associated #0: 42 / 0.667 -> en:episodic weakness may or may not occur independent of myotonia
    n1=en:oedema | n2=en:episodic weakness may or may not occur independent of myotonia | rel=r_associated | relid=0 | w=42
  3462. en:oedema -- r_associated #0: 42 / 0.667 -> en:episodic, nonpruritic, nonurticarial, nonpitting edema
    n1=en:oedema | n2=en:episodic, nonpruritic, nonurticarial, nonpitting edema | rel=r_associated | relid=0 | w=42
  3463. en:oedema -- r_associated #0: 42 / 0.667 -> en:eruptive xanthoma
    n1=en:oedema | n2=en:eruptive xanthoma | rel=r_associated | relid=0 | w=42
  3464. en:oedema -- r_associated #0: 42 / 0.667 -> en:erysipelas
    n1=en:oedema | n2=en:erysipelas | rel=r_associated | relid=0 | w=42
  3465. en:oedema -- r_associated #0: 42 / 0.667 -> en:erythematous blotching, episodic
    n1=en:oedema | n2=en:erythematous blotching, episodic | rel=r_associated | relid=0 | w=42
  3466. en:oedema -- r_associated #0: 42 / 0.667 -> en:erythematous palmoplantar hyperkeratosis, progressive extending onto dorsum of hands and achilles tendon area
    n1=en:oedema | n2=en:erythematous palmoplantar hyperkeratosis, progressive extending onto dorsum of hands and achilles tendon area | rel=r_associated | relid=0 | w=42
  3467. en:oedema -- r_associated #0: 42 / 0.667 -> en:erythematous skin lesions in infancy
    n1=en:oedema | n2=en:erythematous skin lesions in infancy | rel=r_associated | relid=0 | w=42
  3468. en:oedema -- r_associated #0: 42 / 0.667 -> en:erythroderma
    n1=en:oedema | n2=en:erythroderma | rel=r_associated | relid=0 | w=42
  3469. en:oedema -- r_associated #0: 42 / 0.667 -> en:erythroderma, psoriasiform
    n1=en:oedema | n2=en:erythroderma, psoriasiform | rel=r_associated | relid=0 | w=42
  3470. en:oedema -- r_associated #0: 42 / 0.667 -> en:european league against rheumatism response criteria score
    n1=en:oedema | n2=en:european league against rheumatism response criteria score | rel=r_associated | relid=0 | w=42
  3471. en:oedema -- r_associated #0: 42 / 0.667 -> en:evidence of lymphatic rerouting
    n1=en:oedema | n2=en:evidence of lymphatic rerouting | rel=r_associated | relid=0 | w=42
  3472. en:oedema -- r_associated #0: 42 / 0.667 -> en:exercise-induced muscle fatigue
    n1=en:oedema | n2=en:exercise-induced muscle fatigue | rel=r_associated | relid=0 | w=42
  3473. en:oedema -- r_associated #0: 42 / 0.667 -> en:facial milia, congenital, especially on chin
    n1=en:oedema | n2=en:facial milia, congenital, especially on chin | rel=r_associated | relid=0 | w=42
  3474. en:oedema -- r_associated #0: 42 / 0.667 -> en:facial trichilemmomas
    n1=en:oedema | n2=en:facial trichilemmomas | rel=r_associated | relid=0 | w=42
  3475. en:oedema -- r_associated #0: 42 / 0.667 -> en:fasciculations (in some patients)
    n1=en:oedema | n2=en:fasciculations (in some patients) | rel=r_associated | relid=0 | w=42
  3476. en:oedema -- r_associated #0: 42 / 0.667 -> en:fetal pleural effusion
    n1=en:oedema | n2=en:fetal pleural effusion | rel=r_associated | relid=0 | w=42
  3477. en:oedema -- r_associated #0: 42 / 0.667 -> en:fine whitish scales over entire surface of skin
    n1=en:oedema | n2=en:fine whitish scales over entire surface of skin | rel=r_associated | relid=0 | w=42
  3478. en:oedema -- r_associated #0: 42 / 0.667 -> en:flexural acanthosis nigricans (females, childhood-early adolescence)
    n1=en:oedema | n2=en:flexural acanthosis nigricans (females, childhood-early adolescence) | rel=r_associated | relid=0 | w=42
  3479. en:oedema -- r_associated #0: 42 / 0.667 -> en:follicular atrophoderma affecting the dorsa of the hands and feet, the face, and extensor surfaces of the elbows and knees
    n1=en:oedema | n2=en:follicular atrophoderma affecting the dorsa of the hands and feet, the face, and extensor surfaces of the elbows and knees | rel=r_associated | relid=0 | w=42
  3480. en:oedema -- r_associated #0: 42 / 0.667 -> en:follicular hyperkeratosis (trunk and limbs)
    n1=en:oedema | n2=en:follicular hyperkeratosis (trunk and limbs) | rel=r_associated | relid=0 | w=42
  3481. en:oedema -- r_associated #0: 42 / 0.667 -> en:follicular hyperkeratotic papules
    n1=en:oedema | n2=en:follicular hyperkeratotic papules | rel=r_associated | relid=0 | w=42
  3482. en:oedema -- r_associated #0: 42 / 0.667 -> en:freckling may or may not be present
    n1=en:oedema | n2=en:freckling may or may not be present | rel=r_associated | relid=0 | w=42
  3483. en:oedema -- r_associated #0: 42 / 0.667 -> en:gastrointestinal hemorrhage
    n1=en:oedema | n2=en:gastrointestinal hemorrhage | rel=r_associated | relid=0 | w=42
  3484. en:oedema -- r_associated #0: 42 / 0.667 -> en:general symptom
    n1=en:oedema | n2=en:general symptom | rel=r_associated | relid=0 | w=42
  3485. en:oedema -- r_associated #0: 42 / 0.667 -> en:generalized dry skin with fine scaling but without erythema or blisters. (sparing of face)
    n1=en:oedema | n2=en:generalized dry skin with fine scaling but without erythema or blisters. (sparing of face) | rel=r_associated | relid=0 | w=42
  3486. en:oedema -- r_associated #0: 42 / 0.667 -> en:generalized ichthyosis
    n1=en:oedema | n2=en:generalized ichthyosis | rel=r_associated | relid=0 | w=42
  3487. en:oedema -- r_associated #0: 42 / 0.667 -> en:generalized muscle hypertrophy
    n1=en:oedema | n2=en:generalized muscle hypertrophy | rel=r_associated | relid=0 | w=42
  3488. en:oedema -- r_associated #0: 42 / 0.667 -> en:generalized muscle wasting
    n1=en:oedema | n2=en:generalized muscle wasting | rel=r_associated | relid=0 | w=42
  3489. en:oedema -- r_associated #0: 42 / 0.667 -> en:generalized muscle weakness (less common)
    n1=en:oedema | n2=en:generalized muscle weakness (less common) | rel=r_associated | relid=0 | w=42
  3490. en:oedema -- r_associated #0: 42 / 0.667 -> en:generalized weakness (adult-onset)
    n1=en:oedema | n2=en:generalized weakness (adult-onset) | rel=r_associated | relid=0 | w=42
  3491. en:oedema -- r_associated #0: 42 / 0.667 -> en:genital edema
    n1=en:oedema | n2=en:genital edema | rel=r_associated | relid=0 | w=42
  3492. en:oedema -- r_associated #0: 42 / 0.667 -> en:giant pigmented nevi, often in lumbosacral region
    n1=en:oedema | n2=en:giant pigmented nevi, often in lumbosacral region | rel=r_associated | relid=0 | w=42
  3493. en:oedema -- r_associated #0: 42 / 0.667 -> en:gynecological history
    n1=en:oedema | n2=en:gynecological history | rel=r_associated | relid=0 | w=42
  3494. en:oedema -- r_associated #0: 42 / 0.667 -> en:heart failure
    n1=en:oedema | n2=en:heart failure | rel=r_associated | relid=0 | w=42
  3495. en:oedema -- r_associated #0: 42 / 0.667 -> en:hemorrhagic pulmonary edema
    n1=en:oedema | n2=en:hemorrhagic pulmonary edema | rel=r_associated | relid=0 | w=42
  3496. en:oedema -- r_associated #0: 42 / 0.667 -> en:hindwater
    n1=en:oedema | n2=en:hindwater | rel=r_associated | relid=0 | w=42
  3497. en:oedema -- r_associated #0: 42 / 0.667 -> en:honeycomb palmoplantar keratoderma
    n1=en:oedema | n2=en:honeycomb palmoplantar keratoderma | rel=r_associated | relid=0 | w=42
  3498. en:oedema -- r_associated #0: 42 / 0.667 -> en:humeroperoneal weakness and atrophy
    n1=en:oedema | n2=en:humeroperoneal weakness and atrophy | rel=r_associated | relid=0 | w=42
  3499. en:oedema -- r_associated #0: 42 / 0.667 -> en:hutchinson's sign
    n1=en:oedema | n2=en:hutchinson's sign | rel=r_associated | relid=0 | w=42
  3500. en:oedema -- r_associated #0: 42 / 0.667 -> en:hydrops of placenta
    n1=en:oedema | n2=en:hydrops of placenta | rel=r_associated | relid=0 | w=42
  3501. en:oedema -- r_associated #0: 42 / 0.667 -> en:hyperhidrosis
    n1=en:oedema | n2=en:hyperhidrosis | rel=r_associated | relid=0 | w=42
  3502. en:oedema -- r_associated #0: 42 / 0.667 -> en:hyperkeratosis of weight-bearing areas of soles
    n1=en:oedema | n2=en:hyperkeratosis of weight-bearing areas of soles | rel=r_associated | relid=0 | w=42
  3503. en:oedema -- r_associated #0: 42 / 0.667 -> en:hyperkeratosis over affected area
    n1=en:oedema | n2=en:hyperkeratosis over affected area | rel=r_associated | relid=0 | w=42
  3504. en:oedema -- r_associated #0: 42 / 0.667 -> en:hyperkeratosis, focal, on the palms and soles (in adulthood in some)
    n1=en:oedema | n2=en:hyperkeratosis, focal, on the palms and soles (in adulthood in some) | rel=r_associated | relid=0 | w=42
  3505. en:oedema -- r_associated #0: 42 / 0.667 -> en:hyperpigmented lesions, 0.2-0.5 cm
    n1=en:oedema | n2=en:hyperpigmented lesions, 0.2-0.5 cm | rel=r_associated | relid=0 | w=42
  3506. en:oedema -- r_associated #0: 42 / 0.667 -> en:hypertrophic scarring (rare)
    n1=en:oedema | n2=en:hypertrophic scarring (rare) | rel=r_associated | relid=0 | w=42
  3507. en:oedema -- r_associated #0: 42 / 0.667 -> en:hypertrophy
    n1=en:oedema | n2=en:hypertrophy | rel=r_associated | relid=0 | w=42
  3508. en:oedema -- r_associated #0: 42 / 0.667 -> en:hypohidrosis/hyperhidrosis
    n1=en:oedema | n2=en:hypohidrosis/hyperhidrosis | rel=r_associated | relid=0 | w=42
  3509. en:oedema -- r_associated #0: 42 / 0.667 -> en:hypopigmented macules on neck, chest, and back (in some patients)
    n1=en:oedema | n2=en:hypopigmented macules on neck, chest, and back (in some patients) | rel=r_associated | relid=0 | w=42
  3510. en:oedema -- r_associated #0: 42 / 0.667 -> en:hypopigmented skin patches on arms (vitiligo)
    n1=en:oedema | n2=en:hypopigmented skin patches on arms (vitiligo) | rel=r_associated | relid=0 | w=42
  3511. en:oedema -- r_associated #0: 42 / 0.667 -> en:hypoplastic fingertip epidermal ridges
    n1=en:oedema | n2=en:hypoplastic fingertip epidermal ridges | rel=r_associated | relid=0 | w=42
  3512. en:oedema -- r_associated #0: 42 / 0.667 -> en:hypoplastic pilosebaceous units
    n1=en:oedema | n2=en:hypoplastic pilosebaceous units | rel=r_associated | relid=0 | w=42
  3513. en:oedema -- r_associated #0: 42 / 0.667 -> en:impaired mitochondrial respiration
    n1=en:oedema | n2=en:impaired mitochondrial respiration | rel=r_associated | relid=0 | w=42
  3514. en:oedema -- r_associated #0: 42 / 0.667 -> en:inability to sit or hold head up
    n1=en:oedema | n2=en:inability to sit or hold head up | rel=r_associated | relid=0 | w=42
  3515. en:oedema -- r_associated #0: 42 / 0.667 -> en:inclusions show positive immunostaining for sqstm1 and ubiquitin
    n1=en:oedema | n2=en:inclusions show positive immunostaining for sqstm1 and ubiquitin | rel=r_associated | relid=0 | w=42
  3516. en:oedema -- r_associated #0: 42 / 0.667 -> en:increased appetite (finding)
    n1=en:oedema | n2=en:increased appetite (finding) | rel=r_associated | relid=0 | w=42
  3517. en:oedema -- r_associated #0: 42 / 0.667 -> en:increased chloride levels in sweat
    n1=en:oedema | n2=en:increased chloride levels in sweat | rel=r_associated | relid=0 | w=42
  3518. en:oedema -- r_associated #0: 42 / 0.667 -> en:increased glycogen in muscle
    n1=en:oedema | n2=en:increased glycogen in muscle | rel=r_associated | relid=0 | w=42
  3519. en:oedema -- r_associated #0: 42 / 0.667 -> en:increased mast cells
    n1=en:oedema | n2=en:increased mast cells | rel=r_associated | relid=0 | w=42
  3520. en:oedema -- r_associated #0: 42 / 0.667 -> en:increased venous pressure
    n1=en:oedema | n2=en:increased venous pressure | rel=r_associated | relid=0 | w=42
  3521. en:oedema -- r_associated #0: 42 / 0.667 -> en:infantile muscular hypotonia
    n1=en:oedema | n2=en:infantile muscular hypotonia | rel=r_associated | relid=0 | w=42
  3522. en:oedema -- r_associated #0: 42 / 0.667 -> en:inflammatory swelling
    n1=en:oedema | n2=en:inflammatory swelling | rel=r_associated | relid=0 | w=42
  3523. en:oedema -- r_associated #0: 42 / 0.667 -> en:interfibrillar and subsarcolemmal vacuoles
    n1=en:oedema | n2=en:interfibrillar and subsarcolemmal vacuoles | rel=r_associated | relid=0 | w=42
  3524. en:oedema -- r_associated #0: 42 / 0.667 -> en:intermittent claudication
    n1=en:oedema | n2=en:intermittent claudication | rel=r_associated | relid=0 | w=42
  3525. en:oedema -- r_associated #0: 42 / 0.667 -> en:intravasation
    n1=en:oedema | n2=en:intravasation | rel=r_associated | relid=0 | w=42
  3526. en:oedema -- r_associated #0: 42 / 0.667 -> en:jaundice (less common)
    n1=en:oedema | n2=en:jaundice (less common) | rel=r_associated | relid=0 | w=42
  3527. en:oedema -- r_associated #0: 42 / 0.667 -> en:keloid formation in surgical scars
    n1=en:oedema | n2=en:keloid formation in surgical scars | rel=r_associated | relid=0 | w=42
  3528. en:oedema -- r_associated #0: 42 / 0.667 -> en:keratinocyte
    n1=en:oedema | n2=en:keratinocyte | rel=r_associated | relid=0 | w=42
  3529. en:oedema -- r_associated #0: 42 / 0.667 -> en:keratosis pilaris of arms and legs
    n1=en:oedema | n2=en:keratosis pilaris of arms and legs | rel=r_associated | relid=0 | w=42
  3530. en:oedema -- r_associated #0: 42 / 0.667 -> en:keratosis plantaris
    n1=en:oedema | n2=en:keratosis plantaris | rel=r_associated | relid=0 | w=42
  3531. en:oedema -- r_associated #0: 42 / 0.667 -> en:large adherent dark pigmented scales
    n1=en:oedema | n2=en:large adherent dark pigmented scales | rel=r_associated | relid=0 | w=42
  3532. en:oedema -- r_associated #0: 42 / 0.667 -> en:lasegue test response
    n1=en:oedema | n2=en:lasegue test response | rel=r_associated | relid=0 | w=42
  3533. en:oedema -- r_associated #0: 42 / 0.667 -> en:lassitude
    n1=en:oedema | n2=en:lassitude | rel=r_associated | relid=0 | w=42
  3534. en:oedema -- r_associated #0: 42 / 0.667 -> en:leg edema
    n1=en:oedema | n2=en:leg edema | rel=r_associated | relid=0 | w=42
  3535. en:oedema -- r_associated #0: 42 / 0.667 -> en:lesions appear on the trunk and limbs but the face, palms, soles, and mucosa are spared
    n1=en:oedema | n2=en:lesions appear on the trunk and limbs but the face, palms, soles, and mucosa are spared | rel=r_associated | relid=0 | w=42
  3536. en:oedema -- r_associated #0: 42 / 0.667 -> en:lesions are often brownish colored
    n1=en:oedema | n2=en:lesions are often brownish colored | rel=r_associated | relid=0 | w=42
  3537. en:oedema -- r_associated #0: 42 / 0.667 -> en:lichenification
    n1=en:oedema | n2=en:lichenification | rel=r_associated | relid=0 | w=42
  3538. en:oedema -- r_associated #0: 42 / 0.667 -> en:light skin pigmentation compared to unaffected sibs
    n1=en:oedema | n2=en:light skin pigmentation compared to unaffected sibs | rel=r_associated | relid=0 | w=42
  3539. en:oedema -- r_associated #0: 42 / 0.667 -> en:limb muscle weakness and atrophy, distal, neurogenic
    n1=en:oedema | n2=en:limb muscle weakness and atrophy, distal, neurogenic | rel=r_associated | relid=0 | w=42
  3540. en:oedema -- r_associated #0: 42 / 0.667 -> en:linear epidermal nevus (in some patients)
    n1=en:oedema | n2=en:linear epidermal nevus (in some patients) | rel=r_associated | relid=0 | w=42
  3541. en:oedema -- r_associated #0: 42 / 0.667 -> en:lipoma of skin and subcutaneous tissue of scalp
    n1=en:oedema | n2=en:lipoma of skin and subcutaneous tissue of scalp | rel=r_associated | relid=0 | w=42
  3542. en:oedema -- r_associated #0: 42 / 0.667 -> en:loose redundant skin (especially of dorsum of hands and feet and anterior abdominal wall)
    n1=en:oedema | n2=en:loose redundant skin (especially of dorsum of hands and feet and anterior abdominal wall) | rel=r_associated | relid=0 | w=42
  3543. en:oedema -- r_associated #0: 42 / 0.667 -> en:loss of subcutaneous adipose tissue from gluteal region
    n1=en:oedema | n2=en:loss of subcutaneous adipose tissue from gluteal region | rel=r_associated | relid=0 | w=42
  3544. en:oedema -- r_associated #0: 42 / 0.667 -> en:low erythrocyte sedimentation rate
    n1=en:oedema | n2=en:low erythrocyte sedimentation rate | rel=r_associated | relid=0 | w=42
  3545. en:oedema -- r_associated #0: 42 / 0.667 -> en:lower limb lymphedema (variable onset, age four to teens)
    n1=en:oedema | n2=en:lower limb lymphedema (variable onset, age four to teens) | rel=r_associated | relid=0 | w=42
  3546. en:oedema -- r_associated #0: 42 / 0.667 -> en:lymphatic diseases
    n1=en:oedema | n2=en:lymphatic diseases | rel=r_associated | relid=0 | w=42
  3547. en:oedema -- r_associated #0: 42 / 0.667 -> en:lymphedema (lower limb)
    n1=en:oedema | n2=en:lymphedema (lower limb) | rel=r_associated | relid=0 | w=42
  3548. en:oedema -- r_associated #0: 42 / 0.667 -> en:lymphedema quality of life tool (arm) score
    n1=en:oedema | n2=en:lymphedema quality of life tool (arm) score | rel=r_associated | relid=0 | w=42
  3549. en:oedema -- r_associated #0: 42 / 0.667 -> en:malaria
    n1=en:oedema | n2=en:malaria | rel=r_associated | relid=0 | w=42
  3550. en:oedema -- r_associated #0: 42 / 0.667 -> en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers
    n1=en:oedema | n2=en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers | rel=r_associated | relid=0 | w=42
  3551. en:oedema -- r_associated #0: 42 / 0.667 -> en:mast cell degranulation
    n1=en:oedema | n2=en:mast cell degranulation | rel=r_associated | relid=0 | w=42
  3552. en:oedema -- r_associated #0: 42 / 0.667 -> en:mechanically fragile skin
    n1=en:oedema | n2=en:mechanically fragile skin | rel=r_associated | relid=0 | w=42
  3553. en:oedema -- r_associated #0: 42 / 0.667 -> en:microcystic corneal edema
    n1=en:oedema | n2=en:microcystic corneal edema | rel=r_associated | relid=0 | w=42
  3554. en:oedema -- r_associated #0: 42 / 0.667 -> en:milky white skin
    n1=en:oedema | n2=en:milky white skin | rel=r_associated | relid=0 | w=42
  3555. en:oedema -- r_associated #0: 42 / 0.667 -> en:minimal subcutaneous fat
    n1=en:oedema | n2=en:minimal subcutaneous fat | rel=r_associated | relid=0 | w=42
  3556. en:oedema -- r_associated #0: 42 / 0.667 -> en:mitochondrial respiratory chain complex i, ii, and iii defect
    n1=en:oedema | n2=en:mitochondrial respiratory chain complex i, ii, and iii defect | rel=r_associated | relid=0 | w=42
  3557. en:oedema -- r_associated #0: 42 / 0.667 -> en:moderate erythroderma
    n1=en:oedema | n2=en:moderate erythroderma | rel=r_associated | relid=0 | w=42
  3558. en:oedema -- r_associated #0: 42 / 0.667 -> en:moderate to severe acne
    n1=en:oedema | n2=en:moderate to severe acne | rel=r_associated | relid=0 | w=42
  3559. en:oedema -- r_associated #0: 42 / 0.667 -> en:movement
    n1=en:oedema | n2=en:movement | rel=r_associated | relid=0 | w=42
  3560. en:oedema -- r_associated #0: 42 / 0.667 -> en:mri of the calves shows fatty atrophy with preservation of the medial gastrocnemius in the posteromedial compartment
    n1=en:oedema | n2=en:mri of the calves shows fatty atrophy with preservation of the medial gastrocnemius in the posteromedial compartment | rel=r_associated | relid=0 | w=42
  3561. en:oedema -- r_associated #0: 42 / 0.667 -> en:mtdna depletion seen on muscle biopsy
    n1=en:oedema | n2=en:mtdna depletion seen on muscle biopsy | rel=r_associated | relid=0 | w=42
  3562. en:oedema -- r_associated #0: 42 / 0.667 -> en:mucosal lesions
    n1=en:oedema | n2=en:mucosal lesions | rel=r_associated | relid=0 | w=42
  3563. en:oedema -- r_associated #0: 42 / 0.667 -> en:multiple palmar creases
    n1=en:oedema | n2=en:multiple palmar creases | rel=r_associated | relid=0 | w=42
  3564. en:oedema -- r_associated #0: 42 / 0.667 -> en:muromonab-cd3
    n1=en:oedema | n2=en:muromonab-cd3 | rel=r_associated | relid=0 | w=42
  3565. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle amyotrophy
    n1=en:oedema | n2=en:muscle amyotrophy | rel=r_associated | relid=0 | w=42
  3566. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle atrophy, especially quadriceps and forearm muscles
    n1=en:oedema | n2=en:muscle atrophy, especially quadriceps and forearm muscles | rel=r_associated | relid=0 | w=42
  3567. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle atrophy, mild, more proximal than distal
    n1=en:oedema | n2=en:muscle atrophy, mild, more proximal than distal | rel=r_associated | relid=0 | w=42
  3568. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle biopsy shows grouped atrophy
    n1=en:oedema | n2=en:muscle biopsy shows grouped atrophy | rel=r_associated | relid=0 | w=42
  3569. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle biopsy shows groups of small angulated fibers consistent with denervation
    n1=en:oedema | n2=en:muscle biopsy shows groups of small angulated fibers consistent with denervation | rel=r_associated | relid=0 | w=42
  3570. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle biopsy shows increased variation in fiber size
    n1=en:oedema | n2=en:muscle biopsy shows increased variation in fiber size | rel=r_associated | relid=0 | w=42
  3571. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle biopsy shows nemaline rods
    n1=en:oedema | n2=en:muscle biopsy shows nemaline rods | rel=r_associated | relid=0 | w=42
  3572. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle biopsy shows no dystrophic changes
    n1=en:oedema | n2=en:muscle biopsy shows no dystrophic changes | rel=r_associated | relid=0 | w=42
  3573. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle biopsy shows nonspecific myopathic changes
    n1=en:oedema | n2=en:muscle biopsy shows nonspecific myopathic changes | rel=r_associated | relid=0 | w=42
  3574. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers
    n1=en:oedema | n2=en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers | rel=r_associated | relid=0 | w=42
  3575. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle biopsy shows subsarcolemmal nemaline bodies (rods) on gomori trichrome staining
    n1=en:oedema | n2=en:muscle biopsy shows subsarcolemmal nemaline bodies (rods) on gomori trichrome staining | rel=r_associated | relid=0 | w=42
  3576. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle fiber splitting
    n1=en:oedema | n2=en:muscle fiber splitting | rel=r_associated | relid=0 | w=42
  3577. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle mri shows fatty infiltration
    n1=en:oedema | n2=en:muscle mri shows fatty infiltration | rel=r_associated | relid=0 | w=42
  3578. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle stiffness
    n1=en:oedema | n2=en:muscle stiffness | rel=r_associated | relid=0 | w=42
  3579. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle weakness after cooling or on warming affected muscle
    n1=en:oedema | n2=en:muscle weakness after cooling or on warming affected muscle | rel=r_associated | relid=0 | w=42
  3580. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle weakness and atrophy
    n1=en:oedema | n2=en:muscle weakness and atrophy | rel=r_associated | relid=0 | w=42
  3581. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle weakness is not a feature
    n1=en:oedema | n2=en:muscle weakness is not a feature | rel=r_associated | relid=0 | w=42
  3582. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle weakness of limb
    n1=en:oedema | n2=en:muscle weakness of limb | rel=r_associated | relid=0 | w=42
  3583. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle weakness restricted to the upper limb
    n1=en:oedema | n2=en:muscle weakness restricted to the upper limb | rel=r_associated | relid=0 | w=42
  3584. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle weakness, distal (in some patients)
    n1=en:oedema | n2=en:muscle weakness, distal (in some patients) | rel=r_associated | relid=0 | w=42
  3585. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs
    n1=en:oedema | n2=en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs | rel=r_associated | relid=0 | w=42
  3586. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscular appearance
    n1=en:oedema | n2=en:muscular appearance | rel=r_associated | relid=0 | w=42
  3587. en:oedema -- r_associated #0: 42 / 0.667 -> en:muscular rigidity
    n1=en:oedema | n2=en:muscular rigidity | rel=r_associated | relid=0 | w=42
  3588. en:oedema -- r_associated #0: 42 / 0.667 -> en:musset's sign
    n1=en:oedema | n2=en:musset's sign | rel=r_associated | relid=0 | w=42
  3589. en:oedema -- r_associated #0: 42 / 0.667 -> en:myofibrillar disintegration
    n1=en:oedema | n2=en:myofibrillar disintegration | rel=r_associated | relid=0 | w=42
  3590. en:oedema -- r_associated #0: 42 / 0.667 -> en:myopathic and neurogenic changes seen on emg
    n1=en:oedema | n2=en:myopathic and neurogenic changes seen on emg | rel=r_associated | relid=0 | w=42
  3591. en:oedema -- r_associated #0: 42 / 0.667 -> en:negative pressure pulmonary edema
    n1=en:oedema | n2=en:negative pressure pulmonary edema | rel=r_associated | relid=0 | w=42
  3592. en:oedema -- r_associated #0: 42 / 0.667 -> en:nemaline bodies are rarely intranuclear
    n1=en:oedema | n2=en:nemaline bodies are rarely intranuclear | rel=r_associated | relid=0 | w=42
  3593. en:oedema -- r_associated #0: 42 / 0.667 -> en:neonatal hypotonia
    n1=en:oedema | n2=en:neonatal hypotonia | rel=r_associated | relid=0 | w=42
  3594. en:oedema -- r_associated #0: 42 / 0.667 -> en:neurofibromas, subcutaneous (76%)
    n1=en:oedema | n2=en:neurofibromas, subcutaneous (76%) | rel=r_associated | relid=0 | w=42
  3595. en:oedema -- r_associated #0: 42 / 0.667 -> en:neurogenic changes
    n1=en:oedema | n2=en:neurogenic changes | rel=r_associated | relid=0 | w=42
  3596. en:oedema -- r_associated #0: 42 / 0.667 -> en:nevi flammei (philtrum, nape of neck, forehead)
    n1=en:oedema | n2=en:nevi flammei (philtrum, nape of neck, forehead) | rel=r_associated | relid=0 | w=42
  3597. en:oedema -- r_associated #0: 42 / 0.667 -> en:no dystrophic changes
    n1=en:oedema | n2=en:no dystrophic changes | rel=r_associated | relid=0 | w=42
  3598. en:oedema -- r_associated #0: 42 / 0.667 -> en:no palmoplantar keratosis
    n1=en:oedema | n2=en:no palmoplantar keratosis | rel=r_associated | relid=0 | w=42
  3599. en:oedema -- r_associated #0: 42 / 0.667 -> en:no staining for periodic acid schiff (pas)
    n1=en:oedema | n2=en:no staining for periodic acid schiff (pas) | rel=r_associated | relid=0 | w=42
  3600. en:oedema -- r_associated #0: 42 / 0.667 -> en:nodule show lipid-laden macrophages
    n1=en:oedema | n2=en:nodule show lipid-laden macrophages | rel=r_associated | relid=0 | w=42
  3601. en:oedema -- r_associated #0: 42 / 0.667 -> en:non-glabrous skin
    n1=en:oedema | n2=en:non-glabrous skin | rel=r_associated | relid=0 | w=42
  3602. en:oedema -- r_associated #0: 42 / 0.667 -> en:normal scarring
    n1=en:oedema | n2=en:normal scarring | rel=r_associated | relid=0 | w=42
  3603. en:oedema -- r_associated #0: 42 / 0.667 -> en:normal sensation
    n1=en:oedema | n2=en:normal sensation | rel=r_associated | relid=0 | w=42
  3604. en:oedema -- r_associated #0: 42 / 0.667 -> en:nose hemorrhage adverse event
    n1=en:oedema | n2=en:nose hemorrhage adverse event | rel=r_associated | relid=0 | w=42
  3605. en:oedema -- r_associated #0: 42 / 0.667 -> en:numerous pigmented freckles
    n1=en:oedema | n2=en:numerous pigmented freckles | rel=r_associated | relid=0 | w=42
  3606. en:oedema -- r_associated #0: 42 / 0.667 -> en:occasional neurofibromas
    n1=en:oedema | n2=en:occasional neurofibromas | rel=r_associated | relid=0 | w=42
  3607. en:oedema -- r_associated #0: 42 / 0.667 -> en:ocular bruit
    n1=en:oedema | n2=en:ocular bruit | rel=r_associated | relid=0 | w=42
  3608. en:oedema -- r_associated #0: 42 / 0.667 -> en:oedema aggravated
    n1=en:oedema | n2=en:oedema aggravated | rel=r_associated | relid=0 | w=42
  3609. en:oedema -- r_associated #0: 42 / 0.667 -> en:oily skin
    n1=en:oedema | n2=en:oily skin | rel=r_associated | relid=0 | w=42
  3610. en:oedema -- r_associated #0: 42 / 0.667 -> en:oligohydramnios (in some patients)
    n1=en:oedema | n2=en:oligohydramnios (in some patients) | rel=r_associated | relid=0 | w=42
  3611. en:oedema -- r_associated #0: 42 / 0.667 -> en:orthostatic acrocyanosis
    n1=en:oedema | n2=en:orthostatic acrocyanosis | rel=r_associated | relid=0 | w=42
  3612. en:oedema -- r_associated #0: 42 / 0.667 -> en:osteoporotic fracture probability score using world health organization fracture risk assessment tool
    n1=en:oedema | n2=en:osteoporotic fracture probability score using world health organization fracture risk assessment tool | rel=r_associated | relid=0 | w=42
  3613. en:oedema -- r_associated #0: 42 / 0.667 -> en:other mitochondrial complex enzyme activities may also be decreased
    n1=en:oedema | n2=en:other mitochondrial complex enzyme activities may also be decreased | rel=r_associated | relid=0 | w=42
  3614. en:oedema -- r_associated #0: 42 / 0.667 -> en:other symptom/complaint skin
    n1=en:oedema | n2=en:other symptom/complaint skin | rel=r_associated | relid=0 | w=42
  3615. en:oedema -- r_associated #0: 42 / 0.667 -> en:palmoplantar hyperkeratosis, severe
    n1=en:oedema | n2=en:palmoplantar hyperkeratosis, severe | rel=r_associated | relid=0 | w=42
  3616. en:oedema -- r_associated #0: 42 / 0.667 -> en:palmoplantar keratoderma
    n1=en:oedema | n2=en:palmoplantar keratoderma | rel=r_associated | relid=0 | w=42
  3617. en:oedema -- r_associated #0: 42 / 0.667 -> en:papilledema of bilateral eyes due to raised intracranial pressure
    n1=en:oedema | n2=en:papilledema of bilateral eyes due to raised intracranial pressure | rel=r_associated | relid=0 | w=42
  3618. en:oedema -- r_associated #0: 42 / 0.667 -> en:papillomatosis
    n1=en:oedema | n2=en:papillomatosis | rel=r_associated | relid=0 | w=42
  3619. en:oedema -- r_associated #0: 42 / 0.667 -> en:papillomatosis, confluent centrally, erythematous turning brown later
    n1=en:oedema | n2=en:papillomatosis, confluent centrally, erythematous turning brown later | rel=r_associated | relid=0 | w=42
  3620. en:oedema -- r_associated #0: 42 / 0.667 -> en:papular lesion
    n1=en:oedema | n2=en:papular lesion | rel=r_associated | relid=0 | w=42
  3621. en:oedema -- r_associated #0: 42 / 0.667 -> en:pectoralis major hypoplasia
    n1=en:oedema | n2=en:pectoralis major hypoplasia | rel=r_associated | relid=0 | w=42
  3622. en:oedema -- r_associated #0: 42 / 0.667 -> en:pediculosis/other skin infestation
    n1=en:oedema | n2=en:pediculosis/other skin infestation | rel=r_associated | relid=0 | w=42
  3623. en:oedema -- r_associated #0: 42 / 0.667 -> en:pericardial effusion body substance
    n1=en:oedema | n2=en:pericardial effusion body substance | rel=r_associated | relid=0 | w=42
  3624. en:oedema -- r_associated #0: 42 / 0.667 -> en:periorbital edema of left eye
    n1=en:oedema | n2=en:periorbital edema of left eye | rel=r_associated | relid=0 | w=42
  3625. en:oedema -- r_associated #0: 42 / 0.667 -> en:periorbital hyperpigmentation
    n1=en:oedema | n2=en:periorbital hyperpigmentation | rel=r_associated | relid=0 | w=42
  3626. en:oedema -- r_associated #0: 42 / 0.667 -> en:peripheral retinal edema
    n1=en:oedema | n2=en:peripheral retinal edema | rel=r_associated | relid=0 | w=42
  3627. en:oedema -- r_associated #0: 42 / 0.667 -> en:phagocytic vacuoles with degraded membranous material
    n1=en:oedema | n2=en:phagocytic vacuoles with degraded membranous material | rel=r_associated | relid=0 | w=42
  3628. en:oedema -- r_associated #0: 42 / 0.667 -> en:piebaldism
    n1=en:oedema | n2=en:piebaldism | rel=r_associated | relid=0 | w=42
  3629. en:oedema -- r_associated #0: 42 / 0.667 -> en:pilonidal cyst
    n1=en:oedema | n2=en:pilonidal cyst | rel=r_associated | relid=0 | w=42
  3630. en:oedema -- r_associated #0: 42 / 0.667 -> en:planar xanthomas in homozygotes
    n1=en:oedema | n2=en:planar xanthomas in homozygotes | rel=r_associated | relid=0 | w=42
  3631. en:oedema -- r_associated #0: 42 / 0.667 -> en:plantar pits
    n1=en:oedema | n2=en:plantar pits | rel=r_associated | relid=0 | w=42
  3632. en:oedema -- r_associated #0: 42 / 0.667 -> en:poikiloderma
    n1=en:oedema | n2=en:poikiloderma | rel=r_associated | relid=0 | w=42
  3633. en:oedema -- r_associated #0: 42 / 0.667 -> en:polyhydramnios (rare)
    n1=en:oedema | n2=en:polyhydramnios (rare) | rel=r_associated | relid=0 | w=42
  3634. en:oedema -- r_associated #0: 42 / 0.667 -> en:poor healing with abnormal scarring (in some patients)
    n1=en:oedema | n2=en:poor healing with abnormal scarring (in some patients) | rel=r_associated | relid=0 | w=42
  3635. en:oedema -- r_associated #0: 42 / 0.667 -> en:poor muscle mass
    n1=en:oedema | n2=en:poor muscle mass | rel=r_associated | relid=0 | w=42
  3636. en:oedema -- r_associated #0: 42 / 0.667 -> en:positive staining for atpase activity at ph of 4.3
    n1=en:oedema | n2=en:positive staining for atpase activity at ph of 4.3 | rel=r_associated | relid=0 | w=42
  3637. en:oedema -- r_associated #0: 42 / 0.667 -> en:primarily affects lower limbs
    n1=en:oedema | n2=en:primarily affects lower limbs | rel=r_associated | relid=0 | w=42
  3638. en:oedema -- r_associated #0: 42 / 0.667 -> en:progressive loss of facial adipose tissue
    n1=en:oedema | n2=en:progressive loss of facial adipose tissue | rel=r_associated | relid=0 | w=42
  3639. en:oedema -- r_associated #0: 42 / 0.667 -> en:progressive reticulate hyperpigmentation (axillae, groin, perineal, perianal)
    n1=en:oedema | n2=en:progressive reticulate hyperpigmentation (axillae, groin, perineal, perianal) | rel=r_associated | relid=0 | w=42
  3640. en:oedema -- r_associated #0: 42 / 0.667 -> en:prominent musculature
    n1=en:oedema | n2=en:prominent musculature | rel=r_associated | relid=0 | w=42
  3641. en:oedema -- r_associated #0: 42 / 0.667 -> en:prominent palmar flexion creases
    n1=en:oedema | n2=en:prominent palmar flexion creases | rel=r_associated | relid=0 | w=42
  3642. en:oedema -- r_associated #0: 42 / 0.667 -> en:prominent superficial blood vessels due to thin skin
    n1=en:oedema | n2=en:prominent superficial blood vessels due to thin skin | rel=r_associated | relid=0 | w=42
  3643. en:oedema -- r_associated #0: 42 / 0.667 -> en:prominent vasculature (nose and forehead)
    n1=en:oedema | n2=en:prominent vasculature (nose and forehead) | rel=r_associated | relid=0 | w=42
  3644. en:oedema -- r_associated #0: 42 / 0.667 -> en:prominent veins (especially over scalp and limbs)
    n1=en:oedema | n2=en:prominent veins (especially over scalp and limbs) | rel=r_associated | relid=0 | w=42
  3645. en:oedema -- r_associated #0: 42 / 0.667 -> en:prostration
    n1=en:oedema | n2=en:prostration | rel=r_associated | relid=0 | w=42
  3646. en:oedema -- r_associated #0: 42 / 0.667 -> en:proximal and distal muscle atrophy
    n1=en:oedema | n2=en:proximal and distal muscle atrophy | rel=r_associated | relid=0 | w=42
  3647. en:oedema -- r_associated #0: 42 / 0.667 -> en:proximal muscle weakness more severe than distal muscle weakness
    n1=en:oedema | n2=en:proximal muscle weakness more severe than distal muscle weakness | rel=r_associated | relid=0 | w=42
  3648. en:oedema -- r_associated #0: 42 / 0.667 -> en:pruritis, cold-induced
    n1=en:oedema | n2=en:pruritis, cold-induced | rel=r_associated | relid=0 | w=42
  3649. en:oedema -- r_associated #0: 42 / 0.667 -> en:pruritus (major feature)
    n1=en:oedema | n2=en:pruritus (major feature) | rel=r_associated | relid=0 | w=42
  3650. en:oedema -- r_associated #0: 42 / 0.667 -> en:pterygia of digits, neck, axillae, antecubital, popliteal, intercrural areas
    n1=en:oedema | n2=en:pterygia of digits, neck, axillae, antecubital, popliteal, intercrural areas | rel=r_associated | relid=0 | w=42
  3651. en:oedema -- r_associated #0: 42 / 0.667 -> en:pustular eruption
    n1=en:oedema | n2=en:pustular eruption | rel=r_associated | relid=0 | w=42
  3652. en:oedema -- r_associated #0: 42 / 0.667 -> en:ragged-red muscle fibers
    n1=en:oedema | n2=en:ragged-red muscle fibers | rel=r_associated | relid=0 | w=42
  3653. en:oedema -- r_associated #0: 42 / 0.667 -> en:reddish discoloration, episodic, associated with pain
    n1=en:oedema | n2=en:reddish discoloration, episodic, associated with pain | rel=r_associated | relid=0 | w=42
  3654. en:oedema -- r_associated #0: 42 / 0.667 -> en:reduced lower limb subcutaneous fat
    n1=en:oedema | n2=en:reduced lower limb subcutaneous fat | rel=r_associated | relid=0 | w=42
  3655. en:oedema -- r_associated #0: 42 / 0.667 -> en:replacement of myofibers with connective tissue
    n1=en:oedema | n2=en:replacement of myofibers with connective tissue | rel=r_associated | relid=0 | w=42
  3656. en:oedema -- r_associated #0: 42 / 0.667 -> en:reticulate pigmented skin abnormalities
    n1=en:oedema | n2=en:reticulate pigmented skin abnormalities | rel=r_associated | relid=0 | w=42
  3657. en:oedema -- r_associated #0: 42 / 0.667 -> en:reticulolinear skin defects over face and neck (4/4 patients)
    n1=en:oedema | n2=en:reticulolinear skin defects over face and neck (4/4 patients) | rel=r_associated | relid=0 | w=42
  3658. en:oedema -- r_associated #0: 42 / 0.667 -> en:retinal edemas
    n1=en:oedema | n2=en:retinal edemas | rel=r_associated | relid=0 | w=42
  3659. en:oedema -- r_associated #0: 42 / 0.667 -> en:rimmed vacuoles on biopsy
    n1=en:oedema | n2=en:rimmed vacuoles on biopsy | rel=r_associated | relid=0 | w=42
  3660. en:oedema -- r_associated #0: 42 / 0.667 -> en:sarcoplasmic inclusions
    n1=en:oedema | n2=en:sarcoplasmic inclusions | rel=r_associated | relid=0 | w=42
  3661. en:oedema -- r_associated #0: 42 / 0.667 -> en:secondary endolymphatic hydrops
    n1=en:oedema | n2=en:secondary endolymphatic hydrops | rel=r_associated | relid=0 | w=42
  3662. en:oedema -- r_associated #0: 42 / 0.667 -> en:seizure
    n1=en:oedema | n2=en:seizure | rel=r_associated | relid=0 | w=42
  3663. en:oedema -- r_associated #0: 42 / 0.667 -> en:severe polyhydramnios
    n1=en:oedema | n2=en:severe polyhydramnios | rel=r_associated | relid=0 | w=42
  3664. en:oedema -- r_associated #0: 42 / 0.667 -> en:shoulder girdle muscle atrophy
    n1=en:oedema | n2=en:shoulder girdle muscle atrophy | rel=r_associated | relid=0 | w=42
  3665. en:oedema -- r_associated #0: 42 / 0.667 -> en:shoulder girdle muscle weakness and atrophy, progressive
    n1=en:oedema | n2=en:shoulder girdle muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=42
  3666. en:oedema -- r_associated #0: 42 / 0.667 -> en:simian crease (in some patients)
    n1=en:oedema | n2=en:simian crease (in some patients) | rel=r_associated | relid=0 | w=42
  3667. en:oedema -- r_associated #0: 42 / 0.667 -> en:skeletal muscle may show less severe mtdna deletion
    n1=en:oedema | n2=en:skeletal muscle may show less severe mtdna deletion | rel=r_associated | relid=0 | w=42
  3668. en:oedema -- r_associated #0: 42 / 0.667 -> en:skeletal muscle weakness
    n1=en:oedema | n2=en:skeletal muscle weakness | rel=r_associated | relid=0 | w=42
  3669. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin biopsy shows noncaseating granulomas
    n1=en:oedema | n2=en:skin biopsy shows noncaseating granulomas | rel=r_associated | relid=0 | w=42
  3670. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin changes worse in areas of lower skin temperature
    n1=en:oedema | n2=en:skin changes worse in areas of lower skin temperature | rel=r_associated | relid=0 | w=42
  3671. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin necrosis
    n1=en:oedema | n2=en:skin necrosis | rel=r_associated | relid=0 | w=42
  3672. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin observable
    n1=en:oedema | n2=en:skin observable | rel=r_associated | relid=0 | w=42
  3673. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin of the scalp and neck
    n1=en:oedema | n2=en:skin of the scalp and neck | rel=r_associated | relid=0 | w=42
  3674. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin of the trunk
    n1=en:oedema | n2=en:skin of the trunk | rel=r_associated | relid=0 | w=42
  3675. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin of the upper limb and shoulder
    n1=en:oedema | n2=en:skin of the upper limb and shoulder | rel=r_associated | relid=0 | w=42
  3676. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin over joint surfaces of hands and feet is thick, red, and edematous
    n1=en:oedema | n2=en:skin over joint surfaces of hands and feet is thick, red, and edematous | rel=r_associated | relid=0 | w=42
  3677. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin sign from acute arsenic toxicity
    n1=en:oedema | n2=en:skin sign from acute arsenic toxicity | rel=r_associated | relid=0 | w=42
  3678. en:oedema -- r_associated #0: 42 / 0.667 -> en:skin vesicle
    n1=en:oedema | n2=en:skin vesicle | rel=r_associated | relid=0 | w=42
  3679. en:oedema -- r_associated #0: 42 / 0.667 -> en:sleep disorder
    n1=en:oedema | n2=en:sleep disorder | rel=r_associated | relid=0 | w=42
  3680. en:oedema -- r_associated #0: 42 / 0.667 -> en:sleepiness
    n1=en:oedema | n2=en:sleepiness | rel=r_associated | relid=0 | w=42
  3681. en:oedema -- r_associated #0: 42 / 0.667 -> en:slowly-progressive muscle wasting and weakness with humeroperoneal and scapuloperoneal distribution
    n1=en:oedema | n2=en:slowly-progressive muscle wasting and weakness with humeroperoneal and scapuloperoneal distribution | rel=r_associated | relid=0 | w=42
  3682. en:oedema -- r_associated #0: 42 / 0.667 -> en:small endplate
    n1=en:oedema | n2=en:small endplate | rel=r_associated | relid=0 | w=42
  3683. en:oedema -- r_associated #0: 42 / 0.667 -> en:small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk
    n1=en:oedema | n2=en:small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk | rel=r_associated | relid=0 | w=42
  3684. en:oedema -- r_associated #0: 42 / 0.667 -> en:sodium chloride 1000 mg oral tablet
    n1=en:oedema | n2=en:sodium chloride 1000 mg oral tablet | rel=r_associated | relid=0 | w=42
  3685. en:oedema -- r_associated #0: 42 / 0.667 -> en:sodium chloride 1080 mg oral tablet
    n1=en:oedema | n2=en:sodium chloride 1080 mg oral tablet | rel=r_associated | relid=0 | w=42
  3686. en:oedema -- r_associated #0: 42 / 0.667 -> en:sodium chloride 2 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium chloride 2 meq/ml injectable solution | rel=r_associated | relid=0 | w=42
  3687. en:oedema -- r_associated #0: 42 / 0.667 -> en:sodium chloride granules
    n1=en:oedema | n2=en:sodium chloride granules | rel=r_associated | relid=0 | w=42
  3688. en:oedema -- r_associated #0: 42 / 0.667 -> en:sodium chloride nasal solution
    n1=en:oedema | n2=en:sodium chloride nasal solution | rel=r_associated | relid=0 | w=42
  3689. en:oedema -- r_associated #0: 42 / 0.667 -> en:sodium citrate 3.5 meq/ml injectable solution
    n1=en:oedema | n2=en:sodium citrate 3.5 meq/ml injectable solution | rel=r_associated | relid=0 | w=42
  3690. en:oedema -- r_associated #0: 42 / 0.667 -> en:soft with easy bruising (in some patients)
    n1=en:oedema | n2=en:soft with easy bruising (in some patients) | rel=r_associated | relid=0 | w=42
  3691. en:oedema -- r_associated #0: 42 / 0.667 -> en:stage 4 - skin pallor, atrophy, and scarring
    n1=en:oedema | n2=en:stage 4 - skin pallor, atrophy, and scarring | rel=r_associated | relid=0 | w=42
  3692. en:oedema -- r_associated #0: 42 / 0.667 -> en:stasis
    n1=en:oedema | n2=en:stasis | rel=r_associated | relid=0 | w=42
  3693. en:oedema -- r_associated #0: 42 / 0.667 -> en:steatocystomas
    n1=en:oedema | n2=en:steatocystomas | rel=r_associated | relid=0 | w=42
  3694. en:oedema -- r_associated #0: 42 / 0.667 -> en:stokes-adams syndrome
    n1=en:oedema | n2=en:stokes-adams syndrome | rel=r_associated | relid=0 | w=42
  3695. en:oedema -- r_associated #0: 42 / 0.667 -> en:subcutaneous lipoma
    n1=en:oedema | n2=en:subcutaneous lipoma | rel=r_associated | relid=0 | w=42
  3696. en:oedema -- r_associated #0: 42 / 0.667 -> en:subcutaneous nontender firm nodules
    n1=en:oedema | n2=en:subcutaneous nontender firm nodules | rel=r_associated | relid=0 | w=42
  3697. en:oedema -- r_associated #0: 42 / 0.667 -> en:subcutaneous tumors, recurring
    n1=en:oedema | n2=en:subcutaneous tumors, recurring | rel=r_associated | relid=0 | w=42
  3698. en:oedema -- r_associated #0: 42 / 0.667 -> en:subsarcolemmal nemaline bodies (rods) on gomori trichrome staining
    n1=en:oedema | n2=en:subsarcolemmal nemaline bodies (rods) on gomori trichrome staining | rel=r_associated | relid=0 | w=42
  3699. en:oedema -- r_associated #0: 42 / 0.667 -> en:suprapubic skin
    n1=en:oedema | n2=en:suprapubic skin | rel=r_associated | relid=0 | w=42
  3700. en:oedema -- r_associated #0: 42 / 0.667 -> en:sweat gland
    n1=en:oedema | n2=en:sweat gland | rel=r_associated | relid=0 | w=42
  3701. en:oedema -- r_associated #0: 42 / 0.667 -> en:symptom
    n1=en:oedema | n2=en:symptom | rel=r_associated | relid=0 | w=42
  3702. en:oedema -- r_associated #0: 42 / 0.667 -> en:symptom/complaint of skin texture
    n1=en:oedema | n2=en:symptom/complaint of skin texture | rel=r_associated | relid=0 | w=42
  3703. en:oedema -- r_associated #0: 42 / 0.667 -> en:symptoms involving cardiovascular system
    n1=en:oedema | n2=en:symptoms involving cardiovascular system | rel=r_associated | relid=0 | w=42
  3704. en:oedema -- r_associated #0: 42 / 0.667 -> en:syncope
    n1=en:oedema | n2=en:syncope | rel=r_associated | relid=0 | w=42
  3705. en:oedema -- r_associated #0: 42 / 0.667 -> en:telangiectases (especially on tongue, lips, palate, fingers, face, conjunctiva, trunk, nail beds, and fingertips)
    n1=en:oedema | n2=en:telangiectases (especially on tongue, lips, palate, fingers, face, conjunctiva, trunk, nail beds, and fingertips) | rel=r_associated | relid=0 | w=42
  3706. en:oedema -- r_associated #0: 42 / 0.667 -> en:telangiectatic lesions
    n1=en:oedema | n2=en:telangiectatic lesions | rel=r_associated | relid=0 | w=42
  3707. en:oedema -- r_associated #0: 42 / 0.667 -> en:tight, rigid skin
    n1=en:oedema | n2=en:tight, rigid skin | rel=r_associated | relid=0 | w=42
  3708. en:oedema -- r_associated #0: 42 / 0.667 -> en:toxic exposure status
    n1=en:oedema | n2=en:toxic exposure status | rel=r_associated | relid=0 | w=42
  3709. en:oedema -- r_associated #0: 42 / 0.667 -> en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands
    n1=en:oedema | n2=en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands | rel=r_associated | relid=0 | w=42
  3710. en:oedema -- r_associated #0: 42 / 0.667 -> en:tubular aggregates seen on biopsy
    n1=en:oedema | n2=en:tubular aggregates seen on biopsy | rel=r_associated | relid=0 | w=42
  3711. en:oedema -- r_associated #0: 42 / 0.667 -> en:tubulofilamentous nuclear or cytoplasmic inclusions (15-18 nm)
    n1=en:oedema | n2=en:tubulofilamentous nuclear or cytoplasmic inclusions (15-18 nm) | rel=r_associated | relid=0 | w=42
  3712. en:oedema -- r_associated #0: 42 / 0.667 -> en:type 1 muscle fiber predominance
    n1=en:oedema | n2=en:type 1 muscle fiber predominance | rel=r_associated | relid=0 | w=42
  3713. en:oedema -- r_associated #0: 42 / 0.667 -> en:umbilical bleeding after birth
    n1=en:oedema | n2=en:umbilical bleeding after birth | rel=r_associated | relid=0 | w=42
  3714. en:oedema -- r_associated #0: 42 / 0.667 -> en:unprovoked bruising
    n1=en:oedema | n2=en:unprovoked bruising | rel=r_associated | relid=0 | w=42
  3715. en:oedema -- r_associated #0: 42 / 0.667 -> en:uric acid tophi
    n1=en:oedema | n2=en:uric acid tophi | rel=r_associated | relid=0 | w=42
  3716. en:oedema -- r_associated #0: 42 / 0.667 -> en:urogenital observable
    n1=en:oedema | n2=en:urogenital observable | rel=r_associated | relid=0 | w=42
  3717. en:oedema -- r_associated #0: 42 / 0.667 -> en:urological manifestations
    n1=en:oedema | n2=en:urological manifestations | rel=r_associated | relid=0 | w=42
  3718. en:oedema -- r_associated #0: 42 / 0.667 -> en:usually present on skin of neck, shoulders, or trunk
    n1=en:oedema | n2=en:usually present on skin of neck, shoulders, or trunk | rel=r_associated | relid=0 | w=42
  3719. en:oedema -- r_associated #0: 42 / 0.667 -> en:variable involvement of palms and soles
    n1=en:oedema | n2=en:variable involvement of palms and soles | rel=r_associated | relid=0 | w=42
  3720. en:oedema -- r_associated #0: 42 / 0.667 -> en:variation of fiber size and shape
    n1=en:oedema | n2=en:variation of fiber size and shape | rel=r_associated | relid=0 | w=42
  3721. en:oedema -- r_associated #0: 42 / 0.667 -> en:velvety, smooth skin
    n1=en:oedema | n2=en:velvety, smooth skin | rel=r_associated | relid=0 | w=42
  3722. en:oedema -- r_associated #0: 42 / 0.667 -> en:very severe nonproliferative diabetic retinopathy with clinically significant macular edema
    n1=en:oedema | n2=en:very severe nonproliferative diabetic retinopathy with clinically significant macular edema | rel=r_associated | relid=0 | w=42
  3723. en:oedema -- r_associated #0: 42 / 0.667 -> en:vesicles on scalp and skin filled with clear fluid and less than 1cm in diameter
    n1=en:oedema | n2=en:vesicles on scalp and skin filled with clear fluid and less than 1cm in diameter | rel=r_associated | relid=0 | w=42
  3724. en:oedema -- r_associated #0: 42 / 0.667 -> en:warfarin-induced skin necrosis
    n1=en:oedema | n2=en:warfarin-induced skin necrosis | rel=r_associated | relid=0 | w=42
  3725. en:oedema -- r_associated #0: 42 / 0.667 -> en:wasting, especially temporal, neck, and facial muscles
    n1=en:oedema | n2=en:wasting, especially temporal, neck, and facial muscles | rel=r_associated | relid=0 | w=42
  3726. en:oedema -- r_associated #0: 42 / 0.667 -> en:weak extraocular muscles
    n1=en:oedema | n2=en:weak extraocular muscles | rel=r_associated | relid=0 | w=42
  3727. en:oedema -- r_associated #0: 42 / 0.667 -> en:weakness of ankle and toe extensor (dorsiflexor) muscles
    n1=en:oedema | n2=en:weakness of ankle and toe extensor (dorsiflexor) muscles | rel=r_associated | relid=0 | w=42
  3728. en:oedema -- r_associated #0: 42 / 0.667 -> en:weakness of neck extensors (rare)
    n1=en:oedema | n2=en:weakness of neck extensors (rare) | rel=r_associated | relid=0 | w=42
  3729. en:oedema -- r_associated #0: 42 / 0.667 -> en:wound finding
    n1=en:oedema | n2=en:wound finding | rel=r_associated | relid=0 | w=42
  3730. en:oedema -- r_associated #0: 42 / 0.667 -> en:xerosis
    n1=en:oedema | n2=en:xerosis | rel=r_associated | relid=0 | w=42
  3731. en:oedema -- r_associated #0: 42 / 0.667 -> oedème rétinien
    n1=en:oedema | n2=oedème rétinien | rel=r_associated | relid=0 | w=42
  3732. en:oedema -- r_associated #0: 42 / 0.667 -> processus pathologique
    n1=en:oedema | n2=processus pathologique | rel=r_associated | relid=0 | w=42
  3733. en:oedema -- r_associated #0: 41 / 0.651 -> ballonnement
    n1=en:oedema | n2=ballonnement | rel=r_associated | relid=0 | w=41
  3734. en:oedema -- r_associated #0: 41 / 0.651 -> en:10 ml sodium chloride 9 mg/ml prefilled syringe
    n1=en:oedema | n2=en:10 ml sodium chloride 9 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=41
  3735. en:oedema -- r_associated #0: 41 / 0.651 -> en:5 ml sodium chloride 9 mg/ml prefilled syringe
    n1=en:oedema | n2=en:5 ml sodium chloride 9 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=41
  3736. en:oedema -- r_associated #0: 41 / 0.651 -> en:abnormal granulation tissue
    n1=en:oedema | n2=en:abnormal granulation tissue | rel=r_associated | relid=0 | w=41
  3737. en:oedema -- r_associated #0: 41 / 0.651 -> en:abnormal mitochondria with loss of cristae
    n1=en:oedema | n2=en:abnormal mitochondria with loss of cristae | rel=r_associated | relid=0 | w=41
  3738. en:oedema -- r_associated #0: 41 / 0.651 -> en:abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy
    n1=en:oedema | n2=en:abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy | rel=r_associated | relid=0 | w=41
  3739. en:oedema -- r_associated #0: 41 / 0.651 -> en:abnormal mitochondrial morphology
    n1=en:oedema | n2=en:abnormal mitochondrial morphology | rel=r_associated | relid=0 | w=41
  3740. en:oedema -- r_associated #0: 41 / 0.651 -> en:abnormal sweating due to autonomic dysfunction
    n1=en:oedema | n2=en:abnormal sweating due to autonomic dysfunction | rel=r_associated | relid=0 | w=41
  3741. en:oedema -- r_associated #0: 41 / 0.651 -> en:abscess formation
    n1=en:oedema | n2=en:abscess formation | rel=r_associated | relid=0 | w=41
  3742. en:oedema -- r_associated #0: 41 / 0.651 -> en:absence of all distal creases of second to fifth digits
    n1=en:oedema | n2=en:absence of all distal creases of second to fifth digits | rel=r_associated | relid=0 | w=41
  3743. en:oedema -- r_associated #0: 41 / 0.651 -> en:absence of necrosis
    n1=en:oedema | n2=en:absence of necrosis | rel=r_associated | relid=0 | w=41
  3744. en:oedema -- r_associated #0: 41 / 0.651 -> en:absent collecting duct system
    n1=en:oedema | n2=en:absent collecting duct system | rel=r_associated | relid=0 | w=41
  3745. en:oedema -- r_associated #0: 41 / 0.651 -> en:absent dermal ridges
    n1=en:oedema | n2=en:absent dermal ridges | rel=r_associated | relid=0 | w=41
  3746. en:oedema -- r_associated #0: 41 / 0.651 -> en:acanthosis nigricans (uncommon)
    n1=en:oedema | n2=en:acanthosis nigricans (uncommon) | rel=r_associated | relid=0 | w=41
  3747. en:oedema -- r_associated #0: 41 / 0.651 -> en:acanthosis nigricans in patients with diabetes
    n1=en:oedema | n2=en:acanthosis nigricans in patients with diabetes | rel=r_associated | relid=0 | w=41
  3748. en:oedema -- r_associated #0: 41 / 0.651 -> en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin
    n1=en:oedema | n2=en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin | rel=r_associated | relid=0 | w=41
  3749. en:oedema -- r_associated #0: 41 / 0.651 -> en:achondrogenesis type 1a
    n1=en:oedema | n2=en:achondrogenesis type 1a | rel=r_associated | relid=0 | w=41
  3750. en:oedema -- r_associated #0: 41 / 0.651 -> en:acral violaceous plaques and nodules
    n1=en:oedema | n2=en:acral violaceous plaques and nodules | rel=r_associated | relid=0 | w=41
  3751. en:oedema -- r_associated #0: 41 / 0.651 -> en:actinic (solar) keratosis
    n1=en:oedema | n2=en:actinic (solar) keratosis | rel=r_associated | relid=0 | w=41
  3752. en:oedema -- r_associated #0: 41 / 0.651 -> en:acute respiratory distress syndrome
    n1=en:oedema | n2=en:acute respiratory distress syndrome | rel=r_associated | relid=0 | w=41
  3753. en:oedema -- r_associated #0: 41 / 0.651 -> en:acute rhabdomyolysis
    n1=en:oedema | n2=en:acute rhabdomyolysis | rel=r_associated | relid=0 | w=41
  3754. en:oedema -- r_associated #0: 41 / 0.651 -> en:adverse incident contributing factor
    n1=en:oedema | n2=en:adverse incident contributing factor | rel=r_associated | relid=0 | w=41
  3755. en:oedema -- r_associated #0: 41 / 0.651 -> en:affects limbs and trunk
    n1=en:oedema | n2=en:affects limbs and trunk | rel=r_associated | relid=0 | w=41
  3756. en:oedema -- r_associated #0: 41 / 0.651 -> en:albinoidism
    n1=en:oedema | n2=en:albinoidism | rel=r_associated | relid=0 | w=41
  3757. en:oedema -- r_associated #0: 41 / 0.651 -> en:angiomatous lesions on the fingers, persistent
    n1=en:oedema | n2=en:angiomatous lesions on the fingers, persistent | rel=r_associated | relid=0 | w=41
  3758. en:oedema -- r_associated #0: 41 / 0.651 -> en:angioneurotic edema of larynx
    n1=en:oedema | n2=en:angioneurotic edema of larynx | rel=r_associated | relid=0 | w=41
  3759. en:oedema -- r_associated #0: 41 / 0.651 -> en:ankle reflex absent
    n1=en:oedema | n2=en:ankle reflex absent | rel=r_associated | relid=0 | w=41
  3760. en:oedema -- r_associated #0: 41 / 0.651 -> en:antihypertensive agent
    n1=en:oedema | n2=en:antihypertensive agent | rel=r_associated | relid=0 | w=41
  3761. en:oedema -- r_associated #0: 41 / 0.651 -> en:aplasia cutis congenita over posterior parietal area
    n1=en:oedema | n2=en:aplasia cutis congenita over posterior parietal area | rel=r_associated | relid=0 | w=41
  3762. en:oedema -- r_associated #0: 41 / 0.651 -> en:apraxias
    n1=en:oedema | n2=en:apraxias | rel=r_associated | relid=0 | w=41
  3763. en:oedema -- r_associated #0: 41 / 0.651 -> en:arteriovenous hemangioma
    n1=en:oedema | n2=en:arteriovenous hemangioma | rel=r_associated | relid=0 | w=41
  3764. en:oedema -- r_associated #0: 41 / 0.651 -> en:atrial fibrillation
    n1=en:oedema | n2=en:atrial fibrillation | rel=r_associated | relid=0 | w=41
  3765. en:oedema -- r_associated #0: 41 / 0.651 -> en:atrophy of the muscles in the anterior compartment of the lower leg
    n1=en:oedema | n2=en:atrophy of the muscles in the anterior compartment of the lower leg | rel=r_associated | relid=0 | w=41
  3766. en:oedema -- r_associated #0: 41 / 0.651 -> en:axial muscle hyperextension, episodic
    n1=en:oedema | n2=en:axial muscle hyperextension, episodic | rel=r_associated | relid=0 | w=41
  3767. en:oedema -- r_associated #0: 41 / 0.651 -> en:axial muscle weakness
    n1=en:oedema | n2=en:axial muscle weakness | rel=r_associated | relid=0 | w=41
  3768. en:oedema -- r_associated #0: 41 / 0.651 -> en:basal cell layer contains clumped keratin filaments
    n1=en:oedema | n2=en:basal cell layer contains clumped keratin filaments | rel=r_associated | relid=0 | w=41
  3769. en:oedema -- r_associated #0: 41 / 0.651 -> en:benign soft tissue developmental anomalies
    n1=en:oedema | n2=en:benign soft tissue developmental anomalies | rel=r_associated | relid=0 | w=41
  3770. en:oedema -- r_associated #0: 41 / 0.651 -> en:bilateral single palmar creases
    n1=en:oedema | n2=en:bilateral single palmar creases | rel=r_associated | relid=0 | w=41
  3771. en:oedema -- r_associated #0: 41 / 0.651 -> en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers
    n1=en:oedema | n2=en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers | rel=r_associated | relid=0 | w=41
  3772. en:oedema -- r_associated #0: 41 / 0.651 -> en:blistering skin lesions, recurrent
    n1=en:oedema | n2=en:blistering skin lesions, recurrent | rel=r_associated | relid=0 | w=41
  3773. en:oedema -- r_associated #0: 41 / 0.651 -> en:brownish macular and lentiginous lesions, disseminated, present on extremities, trunk, and neck
    n1=en:oedema | n2=en:brownish macular and lentiginous lesions, disseminated, present on extremities, trunk, and neck | rel=r_associated | relid=0 | w=41
  3774. en:oedema -- r_associated #0: 41 / 0.651 -> en:bruise
    n1=en:oedema | n2=en:bruise | rel=r_associated | relid=0 | w=41
  3775. en:oedema -- r_associated #0: 41 / 0.651 -> en:calf atrophy (later onset)
    n1=en:oedema | n2=en:calf atrophy (later onset) | rel=r_associated | relid=0 | w=41
  3776. en:oedema -- r_associated #0: 41 / 0.651 -> en:calf hypertrophy (reported in 1 family)
    n1=en:oedema | n2=en:calf hypertrophy (reported in 1 family) | rel=r_associated | relid=0 | w=41
  3777. en:oedema -- r_associated #0: 41 / 0.651 -> en:cardiac output, high
    n1=en:oedema | n2=en:cardiac output, high | rel=r_associated | relid=0 | w=41
  3778. en:oedema -- r_associated #0: 41 / 0.651 -> en:cardiovascular occlusion
    n1=en:oedema | n2=en:cardiovascular occlusion | rel=r_associated | relid=0 | w=41
  3779. en:oedema -- r_associated #0: 41 / 0.651 -> en:cdisc send non-neoplastic finding type terminology
    n1=en:oedema | n2=en:cdisc send non-neoplastic finding type terminology | rel=r_associated | relid=0 | w=41
  3780. en:oedema -- r_associated #0: 41 / 0.651 -> en:cdisc send terminology
    n1=en:oedema | n2=en:cdisc send terminology | rel=r_associated | relid=0 | w=41
  3781. en:oedema -- r_associated #0: 41 / 0.651 -> en:cellulitis due to immunodeficiency
    n1=en:oedema | n2=en:cellulitis due to immunodeficiency | rel=r_associated | relid=0 | w=41
  3782. en:oedema -- r_associated #0: 41 / 0.651 -> en:cellulitis, recurrent (rare)
    n1=en:oedema | n2=en:cellulitis, recurrent (rare) | rel=r_associated | relid=0 | w=41
  3783. en:oedema -- r_associated #0: 41 / 0.651 -> en:centrally nucleated skeletal muscle fibers
    n1=en:oedema | n2=en:centrally nucleated skeletal muscle fibers | rel=r_associated | relid=0 | w=41
  3784. en:oedema -- r_associated #0: 41 / 0.651 -> en:cerebral edema due to birth injury
    n1=en:oedema | n2=en:cerebral edema due to birth injury | rel=r_associated | relid=0 | w=41
  3785. en:oedema -- r_associated #0: 41 / 0.651 -> en:cerebral edemas, vasogenic
    n1=en:oedema | n2=en:cerebral edemas, vasogenic | rel=r_associated | relid=0 | w=41
  3786. en:oedema -- r_associated #0: 41 / 0.651 -> en:childhood leukemia
    n1=en:oedema | n2=en:childhood leukemia | rel=r_associated | relid=0 | w=41
  3787. en:oedema -- r_associated #0: 41 / 0.651 -> en:cleavage within basal keratinocytes
    n1=en:oedema | n2=en:cleavage within basal keratinocytes | rel=r_associated | relid=0 | w=41
  3788. en:oedema -- r_associated #0: 41 / 0.651 -> en:cold sensitivity has been reported
    n1=en:oedema | n2=en:cold sensitivity has been reported | rel=r_associated | relid=0 | w=41
  3789. en:oedema -- r_associated #0: 41 / 0.651 -> en:collodion membrane at birth (in most patients)
    n1=en:oedema | n2=en:collodion membrane at birth (in most patients) | rel=r_associated | relid=0 | w=41
  3790. en:oedema -- r_associated #0: 41 / 0.651 -> en:collodion membrane at birth (in some patients)
    n1=en:oedema | n2=en:collodion membrane at birth (in some patients) | rel=r_associated | relid=0 | w=41
  3791. en:oedema -- r_associated #0: 41 / 0.651 -> en:collodion skin
    n1=en:oedema | n2=en:collodion skin | rel=r_associated | relid=0 | w=41
  3792. en:oedema -- r_associated #0: 41 / 0.651 -> en:congenital palmoplantar keratosis
    n1=en:oedema | n2=en:congenital palmoplantar keratosis | rel=r_associated | relid=0 | w=41
  3793. en:oedema -- r_associated #0: 41 / 0.651 -> en:congenital, nonprogressive myopathy
    n1=en:oedema | n2=en:congenital, nonprogressive myopathy | rel=r_associated | relid=0 | w=41
  3794. en:oedema -- r_associated #0: 41 / 0.651 -> en:congestive heart failure
    n1=en:oedema | n2=en:congestive heart failure | rel=r_associated | relid=0 | w=41
  3795. en:oedema -- r_associated #0: 41 / 0.651 -> en:contact lens overwear syndrome
    n1=en:oedema | n2=en:contact lens overwear syndrome | rel=r_associated | relid=0 | w=41
  3796. en:oedema -- r_associated #0: 41 / 0.651 -> en:coprophagia
    n1=en:oedema | n2=en:coprophagia | rel=r_associated | relid=0 | w=41
  3797. en:oedema -- r_associated #0: 41 / 0.651 -> en:cores extend along length of muscle fiber
    n1=en:oedema | n2=en:cores extend along length of muscle fiber | rel=r_associated | relid=0 | w=41
  3798. en:oedema -- r_associated #0: 41 / 0.651 -> en:cormack and lehane system score
    n1=en:oedema | n2=en:cormack and lehane system score | rel=r_associated | relid=0 | w=41
  3799. en:oedema -- r_associated #0: 41 / 0.651 -> en:coronary artery bypass surgery
    n1=en:oedema | n2=en:coronary artery bypass surgery | rel=r_associated | relid=0 | w=41
  3800. en:oedema -- r_associated #0: 41 / 0.651 -> en:cranial muscles spared
    n1=en:oedema | n2=en:cranial muscles spared | rel=r_associated | relid=0 | w=41
  3801. en:oedema -- r_associated #0: 41 / 0.651 -> en:cutaneous leiomyosarcoma (rare)
    n1=en:oedema | n2=en:cutaneous leiomyosarcoma (rare) | rel=r_associated | relid=0 | w=41
  3802. en:oedema -- r_associated #0: 41 / 0.651 -> en:cutaneous syndactyly (less common)
    n1=en:oedema | n2=en:cutaneous syndactyly (less common) | rel=r_associated | relid=0 | w=41
  3803. en:oedema -- r_associated #0: 41 / 0.651 -> en:cutaneous telangiectases of face, upper chest, upper mid-back, upper extremities, and hands
    n1=en:oedema | n2=en:cutaneous telangiectases of face, upper chest, upper mid-back, upper extremities, and hands | rel=r_associated | relid=0 | w=41
  3804. en:oedema -- r_associated #0: 41 / 0.651 -> en:cutis gyrata
    n1=en:oedema | n2=en:cutis gyrata | rel=r_associated | relid=0 | w=41
  3805. en:oedema -- r_associated #0: 41 / 0.651 -> en:cutis laxa (especially hands and feet)
    n1=en:oedema | n2=en:cutis laxa (especially hands and feet) | rel=r_associated | relid=0 | w=41
  3806. en:oedema -- r_associated #0: 41 / 0.651 -> en:cutis marmorata
    n1=en:oedema | n2=en:cutis marmorata | rel=r_associated | relid=0 | w=41
  3807. en:oedema -- r_associated #0: 41 / 0.651 -> en:cylindromas usually occur on the scalp may coalesce into large 'turban tumors'
    n1=en:oedema | n2=en:cylindromas usually occur on the scalp may coalesce into large 'turban tumors' | rel=r_associated | relid=0 | w=41
  3808. en:oedema -- r_associated #0: 41 / 0.651 -> en:cystoid macular edema
    n1=en:oedema | n2=en:cystoid macular edema | rel=r_associated | relid=0 | w=41
  3809. en:oedema -- r_associated #0: 41 / 0.651 -> en:darier disease
    n1=en:oedema | n2=en:darier disease | rel=r_associated | relid=0 | w=41
  3810. en:oedema -- r_associated #0: 41 / 0.651 -> en:decreased acetylcholine receptors (achr) at endplate junctional folds (less common)
    n1=en:oedema | n2=en:decreased acetylcholine receptors (achr) at endplate junctional folds (less common) | rel=r_associated | relid=0 | w=41
  3811. en:oedema -- r_associated #0: 41 / 0.651 -> en:decreased activity of complex i and complex iv
    n1=en:oedema | n2=en:decreased activity of complex i and complex iv | rel=r_associated | relid=0 | w=41
  3812. en:oedema -- r_associated #0: 41 / 0.651 -> en:decreased mitochondrial respiratory activities (in some patients)
    n1=en:oedema | n2=en:decreased mitochondrial respiratory activities (in some patients) | rel=r_associated | relid=0 | w=41
  3813. en:oedema -- r_associated #0: 41 / 0.651 -> en:decreased muscle mass (especially in lower limbs)
    n1=en:oedema | n2=en:decreased muscle mass (especially in lower limbs) | rel=r_associated | relid=0 | w=41
  3814. en:oedema -- r_associated #0: 41 / 0.651 -> en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma
    n1=en:oedema | n2=en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma | rel=r_associated | relid=0 | w=41
  3815. en:oedema -- r_associated #0: 41 / 0.651 -> en:defect in glycosylation of alpha-dystroglycan seen on skeletal muscle biopsy
    n1=en:oedema | n2=en:defect in glycosylation of alpha-dystroglycan seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=41
  3816. en:oedema -- r_associated #0: 41 / 0.651 -> en:defective glycosylation of alpha-dystroglycan seen on biopsy
    n1=en:oedema | n2=en:defective glycosylation of alpha-dystroglycan seen on biopsy | rel=r_associated | relid=0 | w=41
  3817. en:oedema -- r_associated #0: 41 / 0.651 -> en:defective mitochondrial oxidative phosphorylation of multiple enzymes
    n1=en:oedema | n2=en:defective mitochondrial oxidative phosphorylation of multiple enzymes | rel=r_associated | relid=0 | w=41
  3818. en:oedema -- r_associated #0: 41 / 0.651 -> en:dense membranous structure surrounding nuclei on electron microscopy
    n1=en:oedema | n2=en:dense membranous structure surrounding nuclei on electron microscopy | rel=r_associated | relid=0 | w=41
  3819. en:oedema -- r_associated #0: 41 / 0.651 -> en:dependent acrocyanosis
    n1=en:oedema | n2=en:dependent acrocyanosis | rel=r_associated | relid=0 | w=41
  3820. en:oedema -- r_associated #0: 41 / 0.651 -> en:diabetic macular edema
    n1=en:oedema | n2=en:diabetic macular edema | rel=r_associated | relid=0 | w=41
  3821. en:oedema -- r_associated #0: 41 / 0.651 -> en:diaphoresis (with pheochromocytoma)
    n1=en:oedema | n2=en:diaphoresis (with pheochromocytoma) | rel=r_associated | relid=0 | w=41
  3822. en:oedema -- r_associated #0: 41 / 0.651 -> en:difficulty raising arms
    n1=en:oedema | n2=en:difficulty raising arms | rel=r_associated | relid=0 | w=41
  3823. en:oedema -- r_associated #0: 41 / 0.651 -> en:diffuse erythematous maculopapular rash
    n1=en:oedema | n2=en:diffuse erythematous maculopapular rash | rel=r_associated | relid=0 | w=41
  3824. en:oedema -- r_associated #0: 41 / 0.651 -> en:digestive system signs and symptoms
    n1=en:oedema | n2=en:digestive system signs and symptoms | rel=r_associated | relid=0 | w=41
  3825. en:oedema -- r_associated #0: 41 / 0.651 -> en:dimple overlying knee
    n1=en:oedema | n2=en:dimple overlying knee | rel=r_associated | relid=0 | w=41
  3826. en:oedema -- r_associated #0: 41 / 0.651 -> en:discomfort
    n1=en:oedema | n2=en:discomfort | rel=r_associated | relid=0 | w=41
  3827. en:oedema -- r_associated #0: 41 / 0.651 -> en:disorganized myofilaments seen on muscle biopsy
    n1=en:oedema | n2=en:disorganized myofilaments seen on muscle biopsy | rel=r_associated | relid=0 | w=41
  3828. en:oedema -- r_associated #0: 41 / 0.651 -> en:distal limb muscle atrophy, lower more than upper
    n1=en:oedema | n2=en:distal limb muscle atrophy, lower more than upper | rel=r_associated | relid=0 | w=41
  3829. en:oedema -- r_associated #0: 41 / 0.651 -> en:distal limb muscular weakness due to peripheral neuropathy
    n1=en:oedema | n2=en:distal limb muscular weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=41
  3830. en:oedema -- r_associated #0: 41 / 0.651 -> en:distal muscle atrophy due to neuropathy
    n1=en:oedema | n2=en:distal muscle atrophy due to neuropathy | rel=r_associated | relid=0 | w=41
  3831. en:oedema -- r_associated #0: 41 / 0.651 -> en:distal muscle weakness and atrophy
    n1=en:oedema | n2=en:distal muscle weakness and atrophy | rel=r_associated | relid=0 | w=41
  3832. en:oedema -- r_associated #0: 41 / 0.651 -> en:distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy
    n1=en:oedema | n2=en:distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy | rel=r_associated | relid=0 | w=41
  3833. en:oedema -- r_associated #0: 41 / 0.651 -> en:distal painless ulcers
    n1=en:oedema | n2=en:distal painless ulcers | rel=r_associated | relid=0 | w=41
  3834. en:oedema -- r_associated #0: 41 / 0.651 -> en:dry, thick skin
    n1=en:oedema | n2=en:dry, thick skin | rel=r_associated | relid=0 | w=41
  3835. en:oedema -- r_associated #0: 41 / 0.651 -> en:dystrophic changes
    n1=en:oedema | n2=en:dystrophic changes | rel=r_associated | relid=0 | w=41
  3836. en:oedema -- r_associated #0: 41 / 0.651 -> en:dystrophic changes, mild, seen on muscle biopsy
    n1=en:oedema | n2=en:dystrophic changes, mild, seen on muscle biopsy | rel=r_associated | relid=0 | w=41
  3837. en:oedema -- r_associated #0: 41 / 0.651 -> en:ear skin
    n1=en:oedema | n2=en:ear skin | rel=r_associated | relid=0 | w=41
  3838. en:oedema -- r_associated #0: 41 / 0.651 -> en:easy bruising (1 family)
    n1=en:oedema | n2=en:easy bruising (1 family) | rel=r_associated | relid=0 | w=41
  3839. en:oedema -- r_associated #0: 41 / 0.651 -> en:easy bruising (in some patients)
    n1=en:oedema | n2=en:easy bruising (in some patients) | rel=r_associated | relid=0 | w=41
  3840. en:oedema -- r_associated #0: 41 / 0.651 -> en:eczema (perifollicular accentuation)
    n1=en:oedema | n2=en:eczema (perifollicular accentuation) | rel=r_associated | relid=0 | w=41
  3841. en:oedema -- r_associated #0: 41 / 0.651 -> en:edema (hands and feet)
    n1=en:oedema | n2=en:edema (hands and feet) | rel=r_associated | relid=0 | w=41
  3842. en:oedema -- r_associated #0: 41 / 0.651 -> en:edema of eyelid
    n1=en:oedema | n2=en:edema of eyelid | rel=r_associated | relid=0 | w=41
  3843. en:oedema -- r_associated #0: 41 / 0.651 -> en:edema of prepuce
    n1=en:oedema | n2=en:edema of prepuce | rel=r_associated | relid=0 | w=41
  3844. en:oedema -- r_associated #0: 41 / 0.651 -> en:edema of upper arm
    n1=en:oedema | n2=en:edema of upper arm | rel=r_associated | relid=0 | w=41
  3845. en:oedema -- r_associated #0: 41 / 0.651 -> en:edema of uvula
    n1=en:oedema | n2=en:edema of uvula | rel=r_associated | relid=0 | w=41
  3846. en:oedema -- r_associated #0: 41 / 0.651 -> en:edema, generalized perinatal (in some patients)
    n1=en:oedema | n2=en:edema, generalized perinatal (in some patients) | rel=r_associated | relid=0 | w=41
  3847. en:oedema -- r_associated #0: 41 / 0.651 -> en:edema, not elsewhere classified in icd10cm
    n1=en:oedema | n2=en:edema, not elsewhere classified in icd10cm | rel=r_associated | relid=0 | w=41
  3848. en:oedema -- r_associated #0: 41 / 0.651 -> en:edematous skin
    n1=en:oedema | n2=en:edematous skin | rel=r_associated | relid=0 | w=41
  3849. en:oedema -- r_associated #0: 41 / 0.651 -> en:effusion of joint
    n1=en:oedema | n2=en:effusion of joint | rel=r_associated | relid=0 | w=41
  3850. en:oedema -- r_associated #0: 41 / 0.651 -> en:electromyographic decrements in some muscles
    n1=en:oedema | n2=en:electromyographic decrements in some muscles | rel=r_associated | relid=0 | w=41
  3851. en:oedema -- r_associated #0: 41 / 0.651 -> en:elevated amniotic alpha-fetoprotein in affected fetuses with encephalocele
    n1=en:oedema | n2=en:elevated amniotic alpha-fetoprotein in affected fetuses with encephalocele | rel=r_associated | relid=0 | w=41
  3852. en:oedema -- r_associated #0: 41 / 0.651 -> en:elevated chloride levels
    n1=en:oedema | n2=en:elevated chloride levels | rel=r_associated | relid=0 | w=41
  3853. en:oedema -- r_associated #0: 41 / 0.651 -> en:emg - repetitive muscle discharges
    n1=en:oedema | n2=en:emg - repetitive muscle discharges | rel=r_associated | relid=0 | w=41
  3854. en:oedema -- r_associated #0: 41 / 0.651 -> en:emg may show myopathic features
    n1=en:oedema | n2=en:emg may show myopathic features | rel=r_associated | relid=0 | w=41
  3855. en:oedema -- r_associated #0: 41 / 0.651 -> en:emg may showed myotonic discharges
    n1=en:oedema | n2=en:emg may showed myotonic discharges | rel=r_associated | relid=0 | w=41
  3856. en:oedema -- r_associated #0: 41 / 0.651 -> en:emg shows decremental compound muscle action potential (cmap) in response to repetitive nerve stimulation
    n1=en:oedema | n2=en:emg shows decremental compound muscle action potential (cmap) in response to repetitive nerve stimulation | rel=r_associated | relid=0 | w=41
  3857. en:oedema -- r_associated #0: 41 / 0.651 -> en:emg shows fasciculations
    n1=en:oedema | n2=en:emg shows fasciculations | rel=r_associated | relid=0 | w=41
  3858. en:oedema -- r_associated #0: 41 / 0.651 -> en:enlarged nuclei with central pallor
    n1=en:oedema | n2=en:enlarged nuclei with central pallor | rel=r_associated | relid=0 | w=41
  3859. en:oedema -- r_associated #0: 41 / 0.651 -> en:enlarged vesicles of sarcoplasmic reticulum origin
    n1=en:oedema | n2=en:enlarged vesicles of sarcoplasmic reticulum origin | rel=r_associated | relid=0 | w=41
  3860. en:oedema -- r_associated #0: 41 / 0.651 -> en:enzymology
    n1=en:oedema | n2=en:enzymology | rel=r_associated | relid=0 | w=41
  3861. en:oedema -- r_associated #0: 41 / 0.651 -> en:epidermal hyperkeratosis
    n1=en:oedema | n2=en:epidermal hyperkeratosis | rel=r_associated | relid=0 | w=41
  3862. en:oedema -- r_associated #0: 41 / 0.651 -> en:epidermis
    n1=en:oedema | n2=en:epidermis | rel=r_associated | relid=0 | w=41
  3863. en:oedema -- r_associated #0: 41 / 0.651 -> en:episodic cold-triggered erythrocyanosis of toes and fingers
    n1=en:oedema | n2=en:episodic cold-triggered erythrocyanosis of toes and fingers | rel=r_associated | relid=0 | w=41
  3864. en:oedema -- r_associated #0: 41 / 0.651 -> en:erythema, blisters, pustules (cyclical, explosive episodes)
    n1=en:oedema | n2=en:erythema, blisters, pustules (cyclical, explosive episodes) | rel=r_associated | relid=0 | w=41
  3865. en:oedema -- r_associated #0: 41 / 0.651 -> en:exercise-induced muscle cramps
    n1=en:oedema | n2=en:exercise-induced muscle cramps | rel=r_associated | relid=0 | w=41
  3866. en:oedema -- r_associated #0: 41 / 0.651 -> en:exercise-induced weakness
    n1=en:oedema | n2=en:exercise-induced weakness | rel=r_associated | relid=0 | w=41
  3867. en:oedema -- r_associated #0: 41 / 0.651 -> en:exophthalmos
    n1=en:oedema | n2=en:exophthalmos | rel=r_associated | relid=0 | w=41
  3868. en:oedema -- r_associated #0: 41 / 0.651 -> en:exophytic, red lesion
    n1=en:oedema | n2=en:exophytic, red lesion | rel=r_associated | relid=0 | w=41
  3869. en:oedema -- r_associated #0: 41 / 0.651 -> en:extensive cutaneous involvement rarely occurs
    n1=en:oedema | n2=en:extensive cutaneous involvement rarely occurs | rel=r_associated | relid=0 | w=41
  3870. en:oedema -- r_associated #0: 41 / 0.651 -> en:external ear
    n1=en:oedema | n2=en:external ear | rel=r_associated | relid=0 | w=41
  3871. en:oedema -- r_associated #0: 41 / 0.651 -> en:extravasation of lymph onto skin
    n1=en:oedema | n2=en:extravasation of lymph onto skin | rel=r_associated | relid=0 | w=41
  3872. en:oedema -- r_associated #0: 41 / 0.651 -> en:extrusion of calcium deposits ('perforating pxe')
    n1=en:oedema | n2=en:extrusion of calcium deposits ('perforating pxe') | rel=r_associated | relid=0 | w=41
  3873. en:oedema -- r_associated #0: 41 / 0.651 -> en:facial milia tend to disappear in adulthood
    n1=en:oedema | n2=en:facial milia tend to disappear in adulthood | rel=r_associated | relid=0 | w=41
  3874. en:oedema -- r_associated #0: 41 / 0.651 -> en:facial telangiectasia in butterfly midface distribution (exacerbated by sun)
    n1=en:oedema | n2=en:facial telangiectasia in butterfly midface distribution (exacerbated by sun) | rel=r_associated | relid=0 | w=41
  3875. en:oedema -- r_associated #0: 41 / 0.651 -> en:fades in adolescence
    n1=en:oedema | n2=en:fades in adolescence | rel=r_associated | relid=0 | w=41
  3876. en:oedema -- r_associated #0: 41 / 0.651 -> en:fiber necrosis
    n1=en:oedema | n2=en:fiber necrosis | rel=r_associated | relid=0 | w=41
  3877. en:oedema -- r_associated #0: 41 / 0.651 -> en:fibrillation
    n1=en:oedema | n2=en:fibrillation | rel=r_associated | relid=0 | w=41
  3878. en:oedema -- r_associated #0: 41 / 0.651 -> en:fibrous dysplasia (rare)
    n1=en:oedema | n2=en:fibrous dysplasia (rare) | rel=r_associated | relid=0 | w=41
  3879. en:oedema -- r_associated #0: 41 / 0.651 -> en:fine white or light brown scales on scalp, face, trunk, and limbs
    n1=en:oedema | n2=en:fine white or light brown scales on scalp, face, trunk, and limbs | rel=r_associated | relid=0 | w=41
  3880. en:oedema -- r_associated #0: 41 / 0.651 -> en:finely wrinkled palms
    n1=en:oedema | n2=en:finely wrinkled palms | rel=r_associated | relid=0 | w=41
  3881. en:oedema -- r_associated #0: 41 / 0.651 -> en:finger and wrist extensor weakness
    n1=en:oedema | n2=en:finger and wrist extensor weakness | rel=r_associated | relid=0 | w=41
  3882. en:oedema -- r_associated #0: 41 / 0.651 -> en:fistula, enterocutaneous
    n1=en:oedema | n2=en:fistula, enterocutaneous | rel=r_associated | relid=0 | w=41
  3883. en:oedema -- r_associated #0: 41 / 0.651 -> en:flexural lichenification in adults (major feature)
    n1=en:oedema | n2=en:flexural lichenification in adults (major feature) | rel=r_associated | relid=0 | w=41
  3884. en:oedema -- r_associated #0: 41 / 0.651 -> en:fluid loss
    n1=en:oedema | n2=en:fluid loss | rel=r_associated | relid=0 | w=41
  3885. en:oedema -- r_associated #0: 41 / 0.651 -> en:flushing attacks
    n1=en:oedema | n2=en:flushing attacks | rel=r_associated | relid=0 | w=41
  3886. en:oedema -- r_associated #0: 41 / 0.651 -> en:foot dorsiflexor weakness
    n1=en:oedema | n2=en:foot dorsiflexor weakness | rel=r_associated | relid=0 | w=41
  3887. en:oedema -- r_associated #0: 41 / 0.651 -> en:frequent bleeding may occur with trauma
    n1=en:oedema | n2=en:frequent bleeding may occur with trauma | rel=r_associated | relid=0 | w=41
  3888. en:oedema -- r_associated #0: 41 / 0.651 -> en:frequent falls
    n1=en:oedema | n2=en:frequent falls | rel=r_associated | relid=0 | w=41
  3889. en:oedema -- r_associated #0: 41 / 0.651 -> en:frequent staphylococcus aureus infections
    n1=en:oedema | n2=en:frequent staphylococcus aureus infections | rel=r_associated | relid=0 | w=41
  3890. en:oedema -- r_associated #0: 41 / 0.651 -> en:frostbite
    n1=en:oedema | n2=en:frostbite | rel=r_associated | relid=0 | w=41
  3891. en:oedema -- r_associated #0: 41 / 0.651 -> en:generalized hyperkeratosis
    n1=en:oedema | n2=en:generalized hyperkeratosis | rel=r_associated | relid=0 | w=41
  3892. en:oedema -- r_associated #0: 41 / 0.651 -> en:generalized muscle weakness also seen in symptomatic carrier females
    n1=en:oedema | n2=en:generalized muscle weakness also seen in symptomatic carrier females | rel=r_associated | relid=0 | w=41
  3893. en:oedema -- r_associated #0: 41 / 0.651 -> en:glabrous skin
    n1=en:oedema | n2=en:glabrous skin | rel=r_associated | relid=0 | w=41
  3894. en:oedema -- r_associated #0: 41 / 0.651 -> en:global muscle weakness
    n1=en:oedema | n2=en:global muscle weakness | rel=r_associated | relid=0 | w=41
  3895. en:oedema -- r_associated #0: 41 / 0.651 -> en:groups of atrophic fibers seen on muscle biopsy (type i fiber predominance)
    n1=en:oedema | n2=en:groups of atrophic fibers seen on muscle biopsy (type i fiber predominance) | rel=r_associated | relid=0 | w=41
  3896. en:oedema -- r_associated #0: 41 / 0.651 -> en:hamman's sign
    n1=en:oedema | n2=en:hamman's sign | rel=r_associated | relid=0 | w=41
  3897. en:oedema -- r_associated #0: 41 / 0.651 -> en:hamstring muscle affected
    n1=en:oedema | n2=en:hamstring muscle affected | rel=r_associated | relid=0 | w=41
  3898. en:oedema -- r_associated #0: 41 / 0.651 -> en:hang weakness
    n1=en:oedema | n2=en:hang weakness | rel=r_associated | relid=0 | w=41
  3899. en:oedema -- r_associated #0: 41 / 0.651 -> en:hard scaly skin
    n1=en:oedema | n2=en:hard scaly skin | rel=r_associated | relid=0 | w=41
  3900. en:oedema -- r_associated #0: 41 / 0.651 -> en:healed areas are atrophic and hypopigmented
    n1=en:oedema | n2=en:healed areas are atrophic and hypopigmented | rel=r_associated | relid=0 | w=41
  3901. en:oedema -- r_associated #0: 41 / 0.651 -> en:heart transplantation
    n1=en:oedema | n2=en:heart transplantation | rel=r_associated | relid=0 | w=41
  3902. en:oedema -- r_associated #0: 41 / 0.651 -> en:hemangioma (neck and forehead)
    n1=en:oedema | n2=en:hemangioma (neck and forehead) | rel=r_associated | relid=0 | w=41
  3903. en:oedema -- r_associated #0: 41 / 0.651 -> en:hemangiomas and lymphangiomas of any site
    n1=en:oedema | n2=en:hemangiomas and lymphangiomas of any site | rel=r_associated | relid=0 | w=41
  3904. en:oedema -- r_associated #0: 41 / 0.651 -> en:hemangiomata in at least first branch (ophthalmic) of trigeminal nerve distribution, unilateral, occasionally bilateral
    n1=en:oedema | n2=en:hemangiomata in at least first branch (ophthalmic) of trigeminal nerve distribution, unilateral, occasionally bilateral | rel=r_associated | relid=0 | w=41
  3905. en:oedema -- r_associated #0: 41 / 0.651 -> en:hematuria
    n1=en:oedema | n2=en:hematuria | rel=r_associated | relid=0 | w=41
  3906. en:oedema -- r_associated #0: 41 / 0.651 -> en:high altitude pulmonary edema
    n1=en:oedema | n2=en:high altitude pulmonary edema | rel=r_associated | relid=0 | w=41
  3907. en:oedema -- r_associated #0: 41 / 0.651 -> en:hip girdle muscle atrophy
    n1=en:oedema | n2=en:hip girdle muscle atrophy | rel=r_associated | relid=0 | w=41
  3908. en:oedema -- r_associated #0: 41 / 0.651 -> en:hip girdle muscle weakness (usually presenting symptom)
    n1=en:oedema | n2=en:hip girdle muscle weakness (usually presenting symptom) | rel=r_associated | relid=0 | w=41
  3909. en:oedema -- r_associated #0: 41 / 0.651 -> en:horny papules (face, leg, buttocks)
    n1=en:oedema | n2=en:horny papules (face, leg, buttocks) | rel=r_associated | relid=0 | w=41
  3910. en:oedema -- r_associated #0: 41 / 0.651 -> en:hydropericardium
    n1=en:oedema | n2=en:hydropericardium | rel=r_associated | relid=0 | w=41
  3911. en:oedema -- r_associated #0: 41 / 0.651 -> en:hydrothorax
    n1=en:oedema | n2=en:hydrothorax | rel=r_associated | relid=0 | w=41
  3912. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyperelasticity (in some patients)
    n1=en:oedema | n2=en:hyperelasticity (in some patients) | rel=r_associated | relid=0 | w=41
  3913. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyperkeratosis (in some patients)
    n1=en:oedema | n2=en:hyperkeratosis (in some patients) | rel=r_associated | relid=0 | w=41
  3914. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyperkeratosis of skin at nipples and umbilicus
    n1=en:oedema | n2=en:hyperkeratosis of skin at nipples and umbilicus | rel=r_associated | relid=0 | w=41
  3915. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyperkeratotic dark-brown papules
    n1=en:oedema | n2=en:hyperkeratotic dark-brown papules | rel=r_associated | relid=0 | w=41
  3916. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypermelanotic macule
    n1=en:oedema | n2=en:hypermelanotic macule | rel=r_associated | relid=0 | w=41
  3917. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyperpigmentation (in patients with kit mutations)
    n1=en:oedema | n2=en:hyperpigmentation (in patients with kit mutations) | rel=r_associated | relid=0 | w=41
  3918. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyperpigmentation in flexure areas
    n1=en:oedema | n2=en:hyperpigmentation in flexure areas | rel=r_associated | relid=0 | w=41
  3919. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyperpigmented erythematous lesions
    n1=en:oedema | n2=en:hyperpigmented erythematous lesions | rel=r_associated | relid=0 | w=41
  3920. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyperpigmented streaks
    n1=en:oedema | n2=en:hyperpigmented streaks | rel=r_associated | relid=0 | w=41
  3921. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypertension in the puerperium with pulmonary edema
    n1=en:oedema | n2=en:hypertension in the puerperium with pulmonary edema | rel=r_associated | relid=0 | w=41
  3922. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypoglycosylation of alpha-dystroglycan
    n1=en:oedema | n2=en:hypoglycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=41
  3923. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy
    n1=en:oedema | n2=en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=41
  3924. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypohidrosis, localized, often on face
    n1=en:oedema | n2=en:hypohidrosis, localized, often on face | rel=r_associated | relid=0 | w=41
  3925. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypopigmentation (seen only in deletion cases)
    n1=en:oedema | n2=en:hypopigmentation (seen only in deletion cases) | rel=r_associated | relid=0 | w=41
  3926. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypopigmented patches (in some patients)
    n1=en:oedema | n2=en:hypopigmented patches (in some patients) | rel=r_associated | relid=0 | w=41
  3927. en:oedema -- r_associated #0: 41 / 0.651 -> en:hyporeflexia of lower limbs
    n1=en:oedema | n2=en:hyporeflexia of lower limbs | rel=r_associated | relid=0 | w=41
  3928. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypotonia (untreated hypothyroidism)
    n1=en:oedema | n2=en:hypotonia (untreated hypothyroidism) | rel=r_associated | relid=0 | w=41
  3929. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypotonia at birth
    n1=en:oedema | n2=en:hypotonia at birth | rel=r_associated | relid=0 | w=41
  3930. en:oedema -- r_associated #0: 41 / 0.651 -> en:hypotonia, severe, neonatal
    n1=en:oedema | n2=en:hypotonia, severe, neonatal | rel=r_associated | relid=0 | w=41
  3931. en:oedema -- r_associated #0: 41 / 0.651 -> en:idiopathic nephrotic syndrome
    n1=en:oedema | n2=en:idiopathic nephrotic syndrome | rel=r_associated | relid=0 | w=41
  3932. en:oedema -- r_associated #0: 41 / 0.651 -> en:immune hydrops fetalis
    n1=en:oedema | n2=en:immune hydrops fetalis | rel=r_associated | relid=0 | w=41
  3933. en:oedema -- r_associated #0: 41 / 0.651 -> en:impaired would healing
    n1=en:oedema | n2=en:impaired would healing | rel=r_associated | relid=0 | w=41
  3934. en:oedema -- r_associated #0: 41 / 0.651 -> en:in blood
    n1=en:oedema | n2=en:in blood | rel=r_associated | relid=0 | w=41
  3935. en:oedema -- r_associated #0: 41 / 0.651 -> en:increased fibrosis
    n1=en:oedema | n2=en:increased fibrosis | rel=r_associated | relid=0 | w=41
  3936. en:oedema -- r_associated #0: 41 / 0.651 -> en:increased intermyofibrillar and subsarcolemmal glycogen
    n1=en:oedema | n2=en:increased intermyofibrillar and subsarcolemmal glycogen | rel=r_associated | relid=0 | w=41
  3937. en:oedema -- r_associated #0: 41 / 0.651 -> en:increased tolerance
    n1=en:oedema | n2=en:increased tolerance | rel=r_associated | relid=0 | w=41
  3938. en:oedema -- r_associated #0: 41 / 0.651 -> en:infantile hemangioma
    n1=en:oedema | n2=en:infantile hemangioma | rel=r_associated | relid=0 | w=41
  3939. en:oedema -- r_associated #0: 41 / 0.651 -> en:itching ( in some patients)
    n1=en:oedema | n2=en:itching ( in some patients) | rel=r_associated | relid=0 | w=41
  3940. en:oedema -- r_associated #0: 41 / 0.651 -> en:jaundice (in some)
    n1=en:oedema | n2=en:jaundice (in some) | rel=r_associated | relid=0 | w=41
  3941. en:oedema -- r_associated #0: 41 / 0.651 -> en:keratoderma (palms and soles)
    n1=en:oedema | n2=en:keratoderma (palms and soles) | rel=r_associated | relid=0 | w=41
  3942. en:oedema -- r_associated #0: 41 / 0.651 -> en:keratotic plaques (palms)
    n1=en:oedema | n2=en:keratotic plaques (palms) | rel=r_associated | relid=0 | w=41
  3943. en:oedema -- r_associated #0: 41 / 0.651 -> en:kernig's sign
    n1=en:oedema | n2=en:kernig's sign | rel=r_associated | relid=0 | w=41
  3944. en:oedema -- r_associated #0: 41 / 0.651 -> en:knee and hip flexor weakness due to peripheral neuropathy
    n1=en:oedema | n2=en:knee and hip flexor weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=41
  3945. en:oedema -- r_associated #0: 41 / 0.651 -> en:large diamond-shaped plaques
    n1=en:oedema | n2=en:large diamond-shaped plaques | rel=r_associated | relid=0 | w=41
  3946. en:oedema -- r_associated #0: 41 / 0.651 -> en:lesions become purpuric
    n1=en:oedema | n2=en:lesions become purpuric | rel=r_associated | relid=0 | w=41
  3947. en:oedema -- r_associated #0: 41 / 0.651 -> en:lichenification of palms
    n1=en:oedema | n2=en:lichenification of palms | rel=r_associated | relid=0 | w=41
  3948. en:oedema -- r_associated #0: 41 / 0.651 -> en:limb-girdle myopathy
    n1=en:oedema | n2=en:limb-girdle myopathy | rel=r_associated | relid=0 | w=41
  3949. en:oedema -- r_associated #0: 41 / 0.651 -> en:lip pit
    n1=en:oedema | n2=en:lip pit | rel=r_associated | relid=0 | w=41
  3950. en:oedema -- r_associated #0: 41 / 0.651 -> en:lipid droplet accumulation
    n1=en:oedema | n2=en:lipid droplet accumulation | rel=r_associated | relid=0 | w=41
  3951. en:oedema -- r_associated #0: 41 / 0.651 -> en:lipoatrophic appearance
    n1=en:oedema | n2=en:lipoatrophic appearance | rel=r_associated | relid=0 | w=41
  3952. en:oedema -- r_associated #0: 41 / 0.651 -> en:livedo reticularis (1 patient)
    n1=en:oedema | n2=en:livedo reticularis (1 patient) | rel=r_associated | relid=0 | w=41
  3953. en:oedema -- r_associated #0: 41 / 0.651 -> en:localised rash
    n1=en:oedema | n2=en:localised rash | rel=r_associated | relid=0 | w=41
  3954. en:oedema -- r_associated #0: 41 / 0.651 -> en:loose, elastic skin
    n1=en:oedema | n2=en:loose, elastic skin | rel=r_associated | relid=0 | w=41
  3955. en:oedema -- r_associated #0: 41 / 0.651 -> en:loose, redundant skin on fingers
    n1=en:oedema | n2=en:loose, redundant skin on fingers | rel=r_associated | relid=0 | w=41
  3956. en:oedema -- r_associated #0: 41 / 0.651 -> en:loss of subcutaneous adipose tissue in limbs
    n1=en:oedema | n2=en:loss of subcutaneous adipose tissue in limbs | rel=r_associated | relid=0 | w=41
  3957. en:oedema -- r_associated #0: 41 / 0.651 -> en:lower limb muscle weakness (in 2 of 3 families)
    n1=en:oedema | n2=en:lower limb muscle weakness (in 2 of 3 families) | rel=r_associated | relid=0 | w=41
  3958. en:oedema -- r_associated #0: 41 / 0.651 -> en:lower limbs more affected than upper limbs
    n1=en:oedema | n2=en:lower limbs more affected than upper limbs | rel=r_associated | relid=0 | w=41
  3959. en:oedema -- r_associated #0: 41 / 0.651 -> en:lymphadenopathy
    n1=en:oedema | n2=en:lymphadenopathy | rel=r_associated | relid=0 | w=41
  3960. en:oedema -- r_associated #0: 41 / 0.651 -> en:lymphangitis, episodic
    n1=en:oedema | n2=en:lymphangitis, episodic | rel=r_associated | relid=0 | w=41
  3961. en:oedema -- r_associated #0: 41 / 0.651 -> en:lymphedema, dorsa of feet
    n1=en:oedema | n2=en:lymphedema, dorsa of feet | rel=r_associated | relid=0 | w=41
  3962. en:oedema -- r_associated #0: 41 / 0.651 -> en:maceration of palms and soles
    n1=en:oedema | n2=en:maceration of palms and soles | rel=r_associated | relid=0 | w=41
  3963. en:oedema -- r_associated #0: 41 / 0.651 -> en:maculopapular rash, episodic
    n1=en:oedema | n2=en:maculopapular rash, episodic | rel=r_associated | relid=0 | w=41
  3964. en:oedema -- r_associated #0: 41 / 0.651 -> en:malignant skin neoplasm
    n1=en:oedema | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=41
  3965. en:oedema -- r_associated #0: 41 / 0.651 -> en:marked fetal hydrops
    n1=en:oedema | n2=en:marked fetal hydrops | rel=r_associated | relid=0 | w=41
  3966. en:oedema -- r_associated #0: 41 / 0.651 -> en:marked lack of adipose tissue
    n1=en:oedema | n2=en:marked lack of adipose tissue | rel=r_associated | relid=0 | w=41
  3967. en:oedema -- r_associated #0: 41 / 0.651 -> en:melanocytic skin tumors/papules, skin-colored to reddish-brown, dome-shaped or pedunculated, well circumscribed with an average size of 5 mm (in 2 families)
    n1=en:oedema | n2=en:melanocytic skin tumors/papules, skin-colored to reddish-brown, dome-shaped or pedunculated, well circumscribed with an average size of 5 mm (in 2 families) | rel=r_associated | relid=0 | w=41
  3968. en:oedema -- r_associated #0: 41 / 0.651 -> en:methods time measurement score
    n1=en:oedema | n2=en:methods time measurement score | rel=r_associated | relid=0 | w=41
  3969. en:oedema -- r_associated #0: 41 / 0.651 -> en:microcystic edema of cornea of left eye
    n1=en:oedema | n2=en:microcystic edema of cornea of left eye | rel=r_associated | relid=0 | w=41
  3970. en:oedema -- r_associated #0: 41 / 0.651 -> en:microcystic edema of cornea of right eye
    n1=en:oedema | n2=en:microcystic edema of cornea of right eye | rel=r_associated | relid=0 | w=41
  3971. en:oedema -- r_associated #0: 41 / 0.651 -> en:mild hypopigmentation (in light-skinned individuals)
    n1=en:oedema | n2=en:mild hypopigmentation (in light-skinned individuals) | rel=r_associated | relid=0 | w=41
  3972. en:oedema -- r_associated #0: 41 / 0.651 -> en:mild muscle atrophy in forearm muscles
    n1=en:oedema | n2=en:mild muscle atrophy in forearm muscles | rel=r_associated | relid=0 | w=41
  3973. en:oedema -- r_associated #0: 41 / 0.651 -> en:mild/severe skin hypopigmentation
    n1=en:oedema | n2=en:mild/severe skin hypopigmentation | rel=r_associated | relid=0 | w=41
  3974. en:oedema -- r_associated #0: 41 / 0.651 -> en:minicore myopathy with external ophthalmoplegia (disorder)
    n1=en:oedema | n2=en:minicore myopathy with external ophthalmoplegia (disorder) | rel=r_associated | relid=0 | w=41
  3975. en:oedema -- r_associated #0: 41 / 0.651 -> en:minicores or core-like regions may be present
    n1=en:oedema | n2=en:minicores or core-like regions may be present | rel=r_associated | relid=0 | w=41
  3976. en:oedema -- r_associated #0: 41 / 0.651 -> en:minipolymyoclonus
    n1=en:oedema | n2=en:minipolymyoclonus | rel=r_associated | relid=0 | w=41
  3977. en:oedema -- r_associated #0: 41 / 0.651 -> en:mitochondrial complex i deficiency
    n1=en:oedema | n2=en:mitochondrial complex i deficiency | rel=r_associated | relid=0 | w=41
  3978. en:oedema -- r_associated #0: 41 / 0.651 -> en:mitochondrial dna deletion (1 patient)
    n1=en:oedema | n2=en:mitochondrial dna deletion (1 patient) | rel=r_associated | relid=0 | w=41
  3979. en:oedema -- r_associated #0: 41 / 0.651 -> en:mitochondrial proliferation
    n1=en:oedema | n2=en:mitochondrial proliferation | rel=r_associated | relid=0 | w=41
  3980. en:oedema -- r_associated #0: 41 / 0.651 -> en:mitochondrial vacuolization seen on muscle biopsy
    n1=en:oedema | n2=en:mitochondrial vacuolization seen on muscle biopsy | rel=r_associated | relid=0 | w=41
  3981. en:oedema -- r_associated #0: 41 / 0.651 -> en:mottled pigmentation of photoexposed areas
    n1=en:oedema | n2=en:mottled pigmentation of photoexposed areas | rel=r_associated | relid=0 | w=41
  3982. en:oedema -- r_associated #0: 41 / 0.651 -> en:mri shows fatty infiltration of affected muscles
    n1=en:oedema | n2=en:mri shows fatty infiltration of affected muscles | rel=r_associated | relid=0 | w=41
  3983. en:oedema -- r_associated #0: 41 / 0.651 -> en:mucous membrane edema
    n1=en:oedema | n2=en:mucous membrane edema | rel=r_associated | relid=0 | w=41
  3984. en:oedema -- r_associated #0: 41 / 0.651 -> en:multiple pterygia
    n1=en:oedema | n2=en:multiple pterygia | rel=r_associated | relid=0 | w=41
  3985. en:oedema -- r_associated #0: 41 / 0.651 -> en:muromonab-cd3 1mg/ml injection solution 5ml vial
    n1=en:oedema | n2=en:muromonab-cd3 1mg/ml injection solution 5ml vial | rel=r_associated | relid=0 | w=41
  3986. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle atrophy
    n1=en:oedema | n2=en:muscle atrophy | rel=r_associated | relid=0 | w=41
  3987. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle atrophy affecting the upper back and neck muscles
    n1=en:oedema | n2=en:muscle atrophy affecting the upper back and neck muscles | rel=r_associated | relid=0 | w=41
  3988. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle atrophy, proximal and distal (predominant lower limb involvement)
    n1=en:oedema | n2=en:muscle atrophy, proximal and distal (predominant lower limb involvement) | rel=r_associated | relid=0 | w=41
  3989. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle biopsy shows decrease or absence of cytochrome c oxidase
    n1=en:oedema | n2=en:muscle biopsy shows decrease or absence of cytochrome c oxidase | rel=r_associated | relid=0 | w=41
  3990. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle biopsy shows intranuclear tubulofilamentous inclusions
    n1=en:oedema | n2=en:muscle biopsy shows intranuclear tubulofilamentous inclusions | rel=r_associated | relid=0 | w=41
  3991. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle biopsy shows myofiber degeneration
    n1=en:oedema | n2=en:muscle biopsy shows myofiber degeneration | rel=r_associated | relid=0 | w=41
  3992. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle biopsy shows myofibrillar myopathy
    n1=en:oedema | n2=en:muscle biopsy shows myofibrillar myopathy | rel=r_associated | relid=0 | w=41
  3993. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle biopsy shows myopathic changes
    n1=en:oedema | n2=en:muscle biopsy shows myopathic changes | rel=r_associated | relid=0 | w=41
  3994. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle biopsy shows sarcoplasmic rods in myofibers
    n1=en:oedema | n2=en:muscle biopsy shows sarcoplasmic rods in myofibers | rel=r_associated | relid=0 | w=41
  3995. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle fiber atrophy, profound (rare)
    n1=en:oedema | n2=en:muscle fiber atrophy, profound (rare) | rel=r_associated | relid=0 | w=41
  3996. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle weakness and atrophy may be asymmetric
    n1=en:oedema | n2=en:muscle weakness and atrophy may be asymmetric | rel=r_associated | relid=0 | w=41
  3997. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle weakness and atrophy, proximal
    n1=en:oedema | n2=en:muscle weakness and atrophy, proximal | rel=r_associated | relid=0 | w=41
  3998. en:oedema -- r_associated #0: 41 / 0.651 -> en:muscle weakness, severe
    n1=en:oedema | n2=en:muscle weakness, severe | rel=r_associated | relid=0 | w=41
  3999. en:oedema -- r_associated #0: 41 / 0.651 -> en:myopathic changes early in disease seen on emg
    n1=en:oedema | n2=en:myopathic changes early in disease seen on emg | rel=r_associated | relid=0 | w=41
  4000. en:oedema -- r_associated #0: 41 / 0.651 -> en:myopathic changes on pathology
    n1=en:oedema | n2=en:myopathic changes on pathology | rel=r_associated | relid=0 | w=41
  4001. en:oedema -- r_associated #0: 41 / 0.651 -> en:myopathy, nonprogressive
    n1=en:oedema | n2=en:myopathy, nonprogressive | rel=r_associated | relid=0 | w=41
  4002. en:oedema -- r_associated #0: 41 / 0.651 -> en:myotonia is most pronounced in the extremities
    n1=en:oedema | n2=en:myotonia is most pronounced in the extremities | rel=r_associated | relid=0 | w=41
  4003. en:oedema -- r_associated #0: 41 / 0.651 -> en:myotonia, potassium-sensitive (may be responsive to acetazolamide)
    n1=en:oedema | n2=en:myotonia, potassium-sensitive (may be responsive to acetazolamide) | rel=r_associated | relid=0 | w=41
  4004. en:oedema -- r_associated #0: 41 / 0.651 -> en:nail observable
    n1=en:oedema | n2=en:nail observable | rel=r_associated | relid=0 | w=41
  4005. en:oedema -- r_associated #0: 41 / 0.651 -> en:named sign of skin
    n1=en:oedema | n2=en:named sign of skin | rel=r_associated | relid=0 | w=41
  4006. en:oedema -- r_associated #0: 41 / 0.651 -> en:named sign of wrist
    n1=en:oedema | n2=en:named sign of wrist | rel=r_associated | relid=0 | w=41
  4007. en:oedema -- r_associated #0: 41 / 0.651 -> en:necrotic change
    n1=en:oedema | n2=en:necrotic change | rel=r_associated | relid=0 | w=41
  4008. en:oedema -- r_associated #0: 41 / 0.651 -> en:nemaline bodies (rods) on gomori trichrome staining
    n1=en:oedema | n2=en:nemaline bodies (rods) on gomori trichrome staining | rel=r_associated | relid=0 | w=41
  4009. en:oedema -- r_associated #0: 41 / 0.651 -> en:nemaline bodies (rods) on gomori trichrome staining seen on muscle biopsy
    n1=en:oedema | n2=en:nemaline bodies (rods) on gomori trichrome staining seen on muscle biopsy | rel=r_associated | relid=0 | w=41
  4010. en:oedema -- r_associated #0: 41 / 0.651 -> en:neoplasm
    n1=en:oedema | n2=en:neoplasm | rel=r_associated | relid=0 | w=41
  4011. en:oedema -- r_associated #0: 41 / 0.651 -> en:nephrotic syndrome, type 8
    n1=en:oedema | n2=en:nephrotic syndrome, type 8 | rel=r_associated | relid=0 | w=41
  4012. en:oedema -- r_associated #0: 41 / 0.651 -> en:neuroleptic malignant syndrome
    n1=en:oedema | n2=en:neuroleptic malignant syndrome | rel=r_associated | relid=0 | w=41
  4013. en:oedema -- r_associated #0: 41 / 0.651 -> en:neuropathic or myopathic changes seen on emg
    n1=en:oedema | n2=en:neuropathic or myopathic changes seen on emg | rel=r_associated | relid=0 | w=41
  4014. en:oedema -- r_associated #0: 41 / 0.651 -> en:no cutaneous photosensitivity
    n1=en:oedema | n2=en:no cutaneous photosensitivity | rel=r_associated | relid=0 | w=41
  4015. en:oedema -- r_associated #0: 41 / 0.651 -> en:no facial muscle involvement
    n1=en:oedema | n2=en:no facial muscle involvement | rel=r_associated | relid=0 | w=41
  4016. en:oedema -- r_associated #0: 41 / 0.651 -> en:no pruritis
    n1=en:oedema | n2=en:no pruritis | rel=r_associated | relid=0 | w=41
  4017. en:oedema -- r_associated #0: 41 / 0.651 -> en:nodular skin lesions
    n1=en:oedema | n2=en:nodular skin lesions | rel=r_associated | relid=0 | w=41
  4018. en:oedema -- r_associated #0: 41 / 0.651 -> en:noncystoid edema of macula of retina
    n1=en:oedema | n2=en:noncystoid edema of macula of retina | rel=r_associated | relid=0 | w=41
  4019. en:oedema -- r_associated #0: 41 / 0.651 -> en:nonspecific myopathic changes
    n1=en:oedema | n2=en:nonspecific myopathic changes | rel=r_associated | relid=0 | w=41
  4020. en:oedema -- r_associated #0: 41 / 0.651 -> en:nonspecific myopathy
    n1=en:oedema | n2=en:nonspecific myopathy | rel=r_associated | relid=0 | w=41
  4021. en:oedema -- r_associated #0: 41 / 0.651 -> en:o/e - genital edema
    n1=en:oedema | n2=en:o/e - genital edema | rel=r_associated | relid=0 | w=41
  4022. en:oedema -- r_associated #0: 41 / 0.651 -> en:obstetric delivery
    n1=en:oedema | n2=en:obstetric delivery | rel=r_associated | relid=0 | w=41
  4023. en:oedema -- r_associated #0: 41 / 0.651 -> en:oedema due to renal disease
    n1=en:oedema | n2=en:oedema due to renal disease | rel=r_associated | relid=0 | w=41
  4024. en:oedema -- r_associated #0: 41 / 0.651 -> en:oedema nec
    n1=en:oedema | n2=en:oedema nec | rel=r_associated | relid=0 | w=41
  4025. en:oedema -- r_associated #0: 41 / 0.651 -> en:orthokeratosis
    n1=en:oedema | n2=en:orthokeratosis | rel=r_associated | relid=0 | w=41
  4026. en:oedema -- r_associated #0: 41 / 0.651 -> en:other benign neoplasm of skin, unspecified
    n1=en:oedema | n2=en:other benign neoplasm of skin, unspecified | rel=r_associated | relid=0 | w=41
  4027. en:oedema -- r_associated #0: 41 / 0.651 -> en:painful swelling in aponeuroses
    n1=en:oedema | n2=en:painful swelling in aponeuroses | rel=r_associated | relid=0 | w=41
  4028. en:oedema -- r_associated #0: 41 / 0.651 -> en:pale, sensitive skin
    n1=en:oedema | n2=en:pale, sensitive skin | rel=r_associated | relid=0 | w=41
  4029. en:oedema -- r_associated #0: 41 / 0.651 -> en:palmar hyperhidrosis
    n1=en:oedema | n2=en:palmar hyperhidrosis | rel=r_associated | relid=0 | w=41
  4030. en:oedema -- r_associated #0: 41 / 0.651 -> en:palmoplantar hyperkeratosis, mild (in some patients)
    n1=en:oedema | n2=en:palmoplantar hyperkeratosis, mild (in some patients) | rel=r_associated | relid=0 | w=41
  4031. en:oedema -- r_associated #0: 41 / 0.651 -> en:panniculitis
    n1=en:oedema | n2=en:panniculitis | rel=r_associated | relid=0 | w=41
  4032. en:oedema -- r_associated #0: 41 / 0.651 -> en:papules enlarge centrifugally to form central atrophic area with an irregular keratotic ridge
    n1=en:oedema | n2=en:papules enlarge centrifugally to form central atrophic area with an irregular keratotic ridge | rel=r_associated | relid=0 | w=41
  4033. en:oedema -- r_associated #0: 41 / 0.651 -> en:papules enlarge centrifugally to form central atrophic area with an irregular peripheral keratotic ridge
    n1=en:oedema | n2=en:papules enlarge centrifugally to form central atrophic area with an irregular peripheral keratotic ridge | rel=r_associated | relid=0 | w=41
  4034. en:oedema -- r_associated #0: 41 / 0.651 -> en:patchy vitiligo
    n1=en:oedema | n2=en:patchy vitiligo | rel=r_associated | relid=0 | w=41
  4035. en:oedema -- r_associated #0: 41 / 0.651 -> en:pathological aspects
    n1=en:oedema | n2=en:pathological aspects | rel=r_associated | relid=0 | w=41
  4036. en:oedema -- r_associated #0: 41 / 0.651 -> en:pathophysiologic finding
    n1=en:oedema | n2=en:pathophysiologic finding | rel=r_associated | relid=0 | w=41
  4037. en:oedema -- r_associated #0: 41 / 0.651 -> en:peau d'orange
    n1=en:oedema | n2=en:peau d'orange | rel=r_associated | relid=0 | w=41
  4038. en:oedema -- r_associated #0: 41 / 0.651 -> en:pediatric terminology
    n1=en:oedema | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=41
  4039. en:oedema -- r_associated #0: 41 / 0.651 -> en:pelvic girdle muscle weakness (occurs earlier)
    n1=en:oedema | n2=en:pelvic girdle muscle weakness (occurs earlier) | rel=r_associated | relid=0 | w=41
  4040. en:oedema -- r_associated #0: 41 / 0.651 -> en:perianal skin tags
    n1=en:oedema | n2=en:perianal skin tags | rel=r_associated | relid=0 | w=41
  4041. en:oedema -- r_associated #0: 41 / 0.651 -> en:petechiae and purpura do not occur
    n1=en:oedema | n2=en:petechiae and purpura do not occur | rel=r_associated | relid=0 | w=41
  4042. en:oedema -- r_associated #0: 41 / 0.651 -> en:pharyngeal muscle weakness
    n1=en:oedema | n2=en:pharyngeal muscle weakness | rel=r_associated | relid=0 | w=41
  4043. en:oedema -- r_associated #0: 41 / 0.651 -> en:physical findings:find:pt:macula.right:nom:ophthalmoscopy
    n1=en:oedema | n2=en:physical findings:find:pt:macula.right:nom:ophthalmoscopy | rel=r_associated | relid=0 | w=41
  4044. en:oedema -- r_associated #0: 41 / 0.651 -> en:plantar fibromatosis
    n1=en:oedema | n2=en:plantar fibromatosis | rel=r_associated | relid=0 | w=41
  4045. en:oedema -- r_associated #0: 41 / 0.651 -> en:plexiform neurofibroma
    n1=en:oedema | n2=en:plexiform neurofibroma | rel=r_associated | relid=0 | w=41
  4046. en:oedema -- r_associated #0: 41 / 0.651 -> en:polydipsia
    n1=en:oedema | n2=en:polydipsia | rel=r_associated | relid=0 | w=41
  4047. en:oedema -- r_associated #0: 41 / 0.651 -> en:poor sweating in response to heat
    n1=en:oedema | n2=en:poor sweating in response to heat | rel=r_associated | relid=0 | w=41
  4048. en:oedema -- r_associated #0: 41 / 0.651 -> en:poorly developed palmar creases
    n1=en:oedema | n2=en:poorly developed palmar creases | rel=r_associated | relid=0 | w=41
  4049. en:oedema -- r_associated #0: 41 / 0.651 -> en:positive staining for slow myosin heavy chain
    n1=en:oedema | n2=en:positive staining for slow myosin heavy chain | rel=r_associated | relid=0 | w=41
  4050. en:oedema -- r_associated #0: 41 / 0.651 -> en:post-radiotherapy laryngeal edema
    n1=en:oedema | n2=en:post-radiotherapy laryngeal edema | rel=r_associated | relid=0 | w=41
  4051. en:oedema -- r_associated #0: 41 / 0.651 -> en:prenatal manifestations
    n1=en:oedema | n2=en:prenatal manifestations | rel=r_associated | relid=0 | w=41
  4052. en:oedema -- r_associated #0: 41 / 0.651 -> en:presynaptic defect at the neuromuscular junction
    n1=en:oedema | n2=en:presynaptic defect at the neuromuscular junction | rel=r_associated | relid=0 | w=41
  4053. en:oedema -- r_associated #0: 41 / 0.651 -> en:pretibial dimples
    n1=en:oedema | n2=en:pretibial dimples | rel=r_associated | relid=0 | w=41
  4054. en:oedema -- r_associated #0: 41 / 0.651 -> en:prodromal symptoms
    n1=en:oedema | n2=en:prodromal symptoms | rel=r_associated | relid=0 | w=41
  4055. en:oedema -- r_associated #0: 41 / 0.651 -> en:progressive distal muscle weakness
    n1=en:oedema | n2=en:progressive distal muscle weakness | rel=r_associated | relid=0 | w=41
  4056. en:oedema -- r_associated #0: 41 / 0.651 -> en:prominent involvement of the biceps brachii muscles
    n1=en:oedema | n2=en:prominent involvement of the biceps brachii muscles | rel=r_associated | relid=0 | w=41
  4057. en:oedema -- r_associated #0: 41 / 0.651 -> en:prominent scalp veins
    n1=en:oedema | n2=en:prominent scalp veins | rel=r_associated | relid=0 | w=41
  4058. en:oedema -- r_associated #0: 41 / 0.651 -> en:prominent veins
    n1=en:oedema | n2=en:prominent veins | rel=r_associated | relid=0 | w=41
  4059. en:oedema -- r_associated #0: 41 / 0.651 -> en:prominent venous pattern
    n1=en:oedema | n2=en:prominent venous pattern | rel=r_associated | relid=0 | w=41
  4060. en:oedema -- r_associated #0: 41 / 0.651 -> en:protein aggregates resembling myofibrillar myopathy may be present
    n1=en:oedema | n2=en:protein aggregates resembling myofibrillar myopathy may be present | rel=r_associated | relid=0 | w=41
  4061. en:oedema -- r_associated #0: 41 / 0.651 -> en:proximal limb muscle weakness initially
    n1=en:oedema | n2=en:proximal limb muscle weakness initially | rel=r_associated | relid=0 | w=41
  4062. en:oedema -- r_associated #0: 41 / 0.651 -> en:proximal muscle weakness, less severe
    n1=en:oedema | n2=en:proximal muscle weakness, less severe | rel=r_associated | relid=0 | w=41
  4063. en:oedema -- r_associated #0: 41 / 0.651 -> en:proximal muscle weakness, mild
    n1=en:oedema | n2=en:proximal muscle weakness, mild | rel=r_associated | relid=0 | w=41
  4064. en:oedema -- r_associated #0: 41 / 0.651 -> en:pruritus of scalp
    n1=en:oedema | n2=en:pruritus of scalp | rel=r_associated | relid=0 | w=41
  4065. en:oedema -- r_associated #0: 41 / 0.651 -> en:pterygium of bilateral (in some patients)
    n1=en:oedema | n2=en:pterygium of bilateral (in some patients) | rel=r_associated | relid=0 | w=41
  4066. en:oedema -- r_associated #0: 41 / 0.651 -> en:pterygium of wrist, bilateral (in some patients)
    n1=en:oedema | n2=en:pterygium of wrist, bilateral (in some patients) | rel=r_associated | relid=0 | w=41
  4067. en:oedema -- r_associated #0: 41 / 0.651 -> en:purpura
    n1=en:oedema | n2=en:purpura | rel=r_associated | relid=0 | w=41
  4068. en:oedema -- r_associated #0: 41 / 0.651 -> en:quadriceps aplasia
    n1=en:oedema | n2=en:quadriceps aplasia | rel=r_associated | relid=0 | w=41
  4069. en:oedema -- r_associated #0: 41 / 0.651 -> en:quadriceps atrophy
    n1=en:oedema | n2=en:quadriceps atrophy | rel=r_associated | relid=0 | w=41
  4070. en:oedema -- r_associated #0: 41 / 0.651 -> en:raised, firm, hairless posterior scalp nodules
    n1=en:oedema | n2=en:raised, firm, hairless posterior scalp nodules | rel=r_associated | relid=0 | w=41
  4071. en:oedema -- r_associated #0: 41 / 0.651 -> en:rectus fascia separation
    n1=en:oedema | n2=en:rectus fascia separation | rel=r_associated | relid=0 | w=41
  4072. en:oedema -- r_associated #0: 41 / 0.651 -> en:recurrent skin abscesses (1 patient)
    n1=en:oedema | n2=en:recurrent skin abscesses (1 patient) | rel=r_associated | relid=0 | w=41
  4073. en:oedema -- r_associated #0: 41 / 0.651 -> en:reduced muscle tone but normal power
    n1=en:oedema | n2=en:reduced muscle tone but normal power | rel=r_associated | relid=0 | w=41
  4074. en:oedema -- r_associated #0: 41 / 0.651 -> en:reduced subcutaneous adipose tissue
    n1=en:oedema | n2=en:reduced subcutaneous adipose tissue | rel=r_associated | relid=0 | w=41
  4075. en:oedema -- r_associated #0: 41 / 0.651 -> en:redundant palmar skin
    n1=en:oedema | n2=en:redundant palmar skin | rel=r_associated | relid=0 | w=41
  4076. en:oedema -- r_associated #0: 41 / 0.651 -> en:renal anasarca
    n1=en:oedema | n2=en:renal anasarca | rel=r_associated | relid=0 | w=41
  4077. en:oedema -- r_associated #0: 41 / 0.651 -> en:retroperitoneal edema
    n1=en:oedema | n2=en:retroperitoneal edema | rel=r_associated | relid=0 | w=41
  4078. en:oedema -- r_associated #0: 41 / 0.651 -> en:rhabdomyolysis
    n1=en:oedema | n2=en:rhabdomyolysis | rel=r_associated | relid=0 | w=41
  4079. en:oedema -- r_associated #0: 41 / 0.651 -> en:rhabdomyolysis (in some patients)
    n1=en:oedema | n2=en:rhabdomyolysis (in some patients) | rel=r_associated | relid=0 | w=41
  4080. en:oedema -- r_associated #0: 41 / 0.651 -> en:risk factor
    n1=en:oedema | n2=en:risk factor | rel=r_associated | relid=0 | w=41
  4081. en:oedema -- r_associated #0: 41 / 0.651 -> en:secondary raynaud phenomenon
    n1=en:oedema | n2=en:secondary raynaud phenomenon | rel=r_associated | relid=0 | w=41
  4082. en:oedema -- r_associated #0: 41 / 0.651 -> en:sickle cell disease
    n1=en:oedema | n2=en:sickle cell disease | rel=r_associated | relid=0 | w=41
  4083. en:oedema -- r_associated #0: 41 / 0.651 -> en:silo filler's disease
    n1=en:oedema | n2=en:silo filler's disease | rel=r_associated | relid=0 | w=41
  4084. en:oedema -- r_associated #0: 41 / 0.651 -> en:skeletal muscle biopsy shows enlarged mitochondria with abnormal cristae decreased mitochondrial complex i activity
    n1=en:oedema | n2=en:skeletal muscle biopsy shows enlarged mitochondria with abnormal cristae decreased mitochondrial complex i activity | rel=r_associated | relid=0 | w=41
  4085. en:oedema -- r_associated #0: 41 / 0.651 -> en:skeletal muscle biopsy shows reducing bodies
    n1=en:oedema | n2=en:skeletal muscle biopsy shows reducing bodies | rel=r_associated | relid=0 | w=41
  4086. en:oedema -- r_associated #0: 41 / 0.651 -> en:skin cell
    n1=en:oedema | n2=en:skin cell | rel=r_associated | relid=0 | w=41
  4087. en:oedema -- r_associated #0: 41 / 0.651 -> en:skin dimples on upper thighs (1 patient)
    n1=en:oedema | n2=en:skin dimples on upper thighs (1 patient) | rel=r_associated | relid=0 | w=41
  4088. en:oedema -- r_associated #0: 41 / 0.651 -> en:skin folds or creases (neck or forearm)
    n1=en:oedema | n2=en:skin folds or creases (neck or forearm) | rel=r_associated | relid=0 | w=41
  4089. en:oedema -- r_associated #0: 41 / 0.651 -> en:skin foreign body
    n1=en:oedema | n2=en:skin foreign body | rel=r_associated | relid=0 | w=41
  4090. en:oedema -- r_associated #0: 41 / 0.651 -> en:skin lesions are usually symmetrical
    n1=en:oedema | n2=en:skin lesions are usually symmetrical | rel=r_associated | relid=0 | w=41
  4091. en:oedema -- r_associated #0: 41 / 0.651 -> en:skin of male human body
    n1=en:oedema | n2=en:skin of male human body | rel=r_associated | relid=0 | w=41
  4092. en:oedema -- r_associated #0: 41 / 0.651 -> en:skin tags on chest
    n1=en:oedema | n2=en:skin tags on chest | rel=r_associated | relid=0 | w=41
  4093. en:oedema -- r_associated #0: 41 / 0.651 -> en:slight erythema of face
    n1=en:oedema | n2=en:slight erythema of face | rel=r_associated | relid=0 | w=41
  4094. en:oedema -- r_associated #0: 41 / 0.651 -> en:small, red lesion, may increase in size with age
    n1=en:oedema | n2=en:small, red lesion, may increase in size with age | rel=r_associated | relid=0 | w=41
  4095. en:oedema -- r_associated #0: 41 / 0.651 -> en:sodium bicarbonate powder
    n1=en:oedema | n2=en:sodium bicarbonate powder | rel=r_associated | relid=0 | w=41
  4096. en:oedema -- r_associated #0: 41 / 0.651 -> en:sodium chloride 0.000154 meq/mg topical gel
    n1=en:oedema | n2=en:sodium chloride 0.000154 meq/mg topical gel | rel=r_associated | relid=0 | w=41
  4097. en:oedema -- r_associated #0: 41 / 0.651 -> en:sodium chloride 2 meq/ml irrigation solution
    n1=en:oedema | n2=en:sodium chloride 2 meq/ml irrigation solution | rel=r_associated | relid=0 | w=41
  4098. en:oedema -- r_associated #0: 41 / 0.651 -> en:sodium chloride 23.4% injection solution 100ml bag
    n1=en:oedema | n2=en:sodium chloride 23.4% injection solution 100ml bag | rel=r_associated | relid=0 | w=41
  4099. en:oedema -- r_associated #0: 41 / 0.651 -> en:sodium chloride 250mg tab,oph
    n1=en:oedema | n2=en:sodium chloride 250mg tab,oph | rel=r_associated | relid=0 | w=41
  4100. en:oedema -- r_associated #0: 41 / 0.651 -> en:sodium citrate 467 mg/ml injectable solution
    n1=en:oedema | n2=en:sodium citrate 467 mg/ml injectable solution | rel=r_associated | relid=0 | w=41
  4101. en:oedema -- r_associated #0: 41 / 0.651 -> en:sodium phosphate, monobasic
    n1=en:oedema | n2=en:sodium phosphate, monobasic | rel=r_associated | relid=0 | w=41
  4102. en:oedema -- r_associated #0: 41 / 0.651 -> en:soft fleshy palms (50%)
    n1=en:oedema | n2=en:soft fleshy palms (50%) | rel=r_associated | relid=0 | w=41
  4103. en:oedema -- r_associated #0: 41 / 0.651 -> en:soft tissue calcinosis
    n1=en:oedema | n2=en:soft tissue calcinosis | rel=r_associated | relid=0 | w=41
  4104. en:oedema -- r_associated #0: 41 / 0.651 -> en:some patients become wheelchair-dependent
    n1=en:oedema | n2=en:some patients become wheelchair-dependent | rel=r_associated | relid=0 | w=41
  4105. en:oedema -- r_associated #0: 41 / 0.651 -> en:sparse axillary and facial hair
    n1=en:oedema | n2=en:sparse axillary and facial hair | rel=r_associated | relid=0 | w=41
  4106. en:oedema -- r_associated #0: 41 / 0.651 -> en:squamous epitheliomas, multiple
    n1=en:oedema | n2=en:squamous epitheliomas, multiple | rel=r_associated | relid=0 | w=41
  4107. en:oedema -- r_associated #0: 41 / 0.651 -> en:static edema level
    n1=en:oedema | n2=en:static edema level | rel=r_associated | relid=0 | w=41
  4108. en:oedema -- r_associated #0: 41 / 0.651 -> en:steatocystoma multiplex
    n1=en:oedema | n2=en:steatocystoma multiplex | rel=r_associated | relid=0 | w=41
  4109. en:oedema -- r_associated #0: 41 / 0.651 -> en:stiffness (uncommon)
    n1=en:oedema | n2=en:stiffness (uncommon) | rel=r_associated | relid=0 | w=41
  4110. en:oedema -- r_associated #0: 41 / 0.651 -> en:structure at risk
    n1=en:oedema | n2=en:structure at risk | rel=r_associated | relid=0 | w=41
  4111. en:oedema -- r_associated #0: 41 / 0.651 -> en:subcutaneous calcification
    n1=en:oedema | n2=en:subcutaneous calcification | rel=r_associated | relid=0 | w=41
  4112. en:oedema -- r_associated #0: 41 / 0.651 -> en:subcutaneous lipomatous tissue
    n1=en:oedema | n2=en:subcutaneous lipomatous tissue | rel=r_associated | relid=0 | w=41
  4113. en:oedema -- r_associated #0: 41 / 0.651 -> en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy)
    n1=en:oedema | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy) | rel=r_associated | relid=0 | w=41
  4114. en:oedema -- r_associated #0: 41 / 0.651 -> en:subsarcolemmal hyaline bodies in type 1 fibers only
    n1=en:oedema | n2=en:subsarcolemmal hyaline bodies in type 1 fibers only | rel=r_associated | relid=0 | w=41
  4115. en:oedema -- r_associated #0: 41 / 0.651 -> en:subsarcolemmal mitochondrial aggregates
    n1=en:oedema | n2=en:subsarcolemmal mitochondrial aggregates | rel=r_associated | relid=0 | w=41
  4116. en:oedema -- r_associated #0: 41 / 0.651 -> en:swelling of the hands and feet, episodic
    n1=en:oedema | n2=en:swelling of the hands and feet, episodic | rel=r_associated | relid=0 | w=41
  4117. en:oedema -- r_associated #0: 41 / 0.651 -> en:swelling, mass, or lump in head and neck
    n1=en:oedema | n2=en:swelling, mass, or lump in head and neck | rel=r_associated | relid=0 | w=41
  4118. en:oedema -- r_associated #0: 41 / 0.651 -> en:symptoms may be induced by heat
    n1=en:oedema | n2=en:symptoms may be induced by heat | rel=r_associated | relid=0 | w=41
  4119. en:oedema -- r_associated #0: 41 / 0.651 -> en:telangiectasia (soles)
    n1=en:oedema | n2=en:telangiectasia (soles) | rel=r_associated | relid=0 | w=41
  4120. en:oedema -- r_associated #0: 41 / 0.651 -> en:tenting - skin
    n1=en:oedema | n2=en:tenting - skin | rel=r_associated | relid=0 | w=41
  4121. en:oedema -- r_associated #0: 41 / 0.651 -> en:tetanus-like muscle contractions
    n1=en:oedema | n2=en:tetanus-like muscle contractions | rel=r_associated | relid=0 | w=41
  4122. en:oedema -- r_associated #0: 41 / 0.651 -> en:thick skin (74%)
    n1=en:oedema | n2=en:thick skin (74%) | rel=r_associated | relid=0 | w=41
  4123. en:oedema -- r_associated #0: 41 / 0.651 -> en:thickening of the skin over the palms and soles (nola3 patient)
    n1=en:oedema | n2=en:thickening of the skin over the palms and soles (nola3 patient) | rel=r_associated | relid=0 | w=41
  4124. en:oedema -- r_associated #0: 41 / 0.651 -> en:thin, hypotrophic skin
    n1=en:oedema | n2=en:thin, hypotrophic skin | rel=r_associated | relid=0 | w=41
  4125. en:oedema -- r_associated #0: 41 / 0.651 -> en:tinea capitis, severe or recurrent
    n1=en:oedema | n2=en:tinea capitis, severe or recurrent | rel=r_associated | relid=0 | w=41
  4126. en:oedema -- r_associated #0: 41 / 0.651 -> en:tortuous lymphatic tracts
    n1=en:oedema | n2=en:tortuous lymphatic tracts | rel=r_associated | relid=0 | w=41
  4127. en:oedema -- r_associated #0: 41 / 0.651 -> en:transgressive keratosis
    n1=en:oedema | n2=en:transgressive keratosis | rel=r_associated | relid=0 | w=41
  4128. en:oedema -- r_associated #0: 41 / 0.651 -> en:tremor of the upper limb
    n1=en:oedema | n2=en:tremor of the upper limb | rel=r_associated | relid=0 | w=41
  4129. en:oedema -- r_associated #0: 41 / 0.651 -> en:trichilemmal cyst
    n1=en:oedema | n2=en:trichilemmal cyst | rel=r_associated | relid=0 | w=41
  4130. en:oedema -- r_associated #0: 41 / 0.651 -> en:trichoepithelioma (brown, flat-topped papules) (rare)
    n1=en:oedema | n2=en:trichoepithelioma (brown, flat-topped papules) (rare) | rel=r_associated | relid=0 | w=41
  4131. en:oedema -- r_associated #0: 41 / 0.651 -> en:trichoepitheliomas, multiple (usually occur in the nasolabial folds, nose, or face)
    n1=en:oedema | n2=en:trichoepitheliomas, multiple (usually occur in the nasolabial folds, nose, or face) | rel=r_associated | relid=0 | w=41
  4132. en:oedema -- r_associated #0: 41 / 0.651 -> en:trichoepitheliomas, multiple (usually occur in thenasolabial folds, the nose, and upper lip)
    n1=en:oedema | n2=en:trichoepitheliomas, multiple (usually occur in thenasolabial folds, the nose, and upper lip) | rel=r_associated | relid=0 | w=41
  4133. en:oedema -- r_associated #0: 41 / 0.651 -> en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy
    n1=en:oedema | n2=en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy | rel=r_associated | relid=0 | w=41
  4134. en:oedema -- r_associated #0: 41 / 0.651 -> en:tylosis
    n1=en:oedema | n2=en:tylosis | rel=r_associated | relid=0 | w=41
  4135. en:oedema -- r_associated #0: 41 / 0.651 -> en:type 1 fiber predominance
    n1=en:oedema | n2=en:type 1 fiber predominance | rel=r_associated | relid=0 | w=41
  4136. en:oedema -- r_associated #0: 41 / 0.651 -> en:type 2 muscle fiber atrophy
    n1=en:oedema | n2=en:type 2 muscle fiber atrophy | rel=r_associated | relid=0 | w=41
  4137. en:oedema -- r_associated #0: 41 / 0.651 -> en:unexpected therapeutic effect
    n1=en:oedema | n2=en:unexpected therapeutic effect | rel=r_associated | relid=0 | w=41
  4138. en:oedema -- r_associated #0: 41 / 0.651 -> en:upper arm and pelvic muscle weakness and atrophy (later onset)
    n1=en:oedema | n2=en:upper arm and pelvic muscle weakness and atrophy (later onset) | rel=r_associated | relid=0 | w=41
  4139. en:oedema -- r_associated #0: 41 / 0.651 -> en:upper limb muscle hypoplasia
    n1=en:oedema | n2=en:upper limb muscle hypoplasia | rel=r_associated | relid=0 | w=41
  4140. en:oedema -- r_associated #0: 41 / 0.651 -> en:vacuolar degeneration
    n1=en:oedema | n2=en:vacuolar degeneration | rel=r_associated | relid=0 | w=41
  4141. en:oedema -- r_associated #0: 41 / 0.651 -> en:vacuoles appear to be exocytosing material at the cell surface
    n1=en:oedema | n2=en:vacuoles appear to be exocytosing material at the cell surface | rel=r_associated | relid=0 | w=41
  4142. en:oedema -- r_associated #0: 41 / 0.651 -> en:vaginal hemorrhage
    n1=en:oedema | n2=en:vaginal hemorrhage | rel=r_associated | relid=0 | w=41
  4143. en:oedema -- r_associated #0: 41 / 0.651 -> en:variation of myofiber diameter
    n1=en:oedema | n2=en:variation of myofiber diameter | rel=r_associated | relid=0 | w=41
  4144. en:oedema -- r_associated #0: 41 / 0.651 -> en:varicose veins of lower limb co-occurrent with edema
    n1=en:oedema | n2=en:varicose veins of lower limb co-occurrent with edema | rel=r_associated | relid=0 | w=41
  4145. en:oedema -- r_associated #0: 41 / 0.651 -> en:vernix-like skin covering, present at birth, shed during first month of life (in some patients)
    n1=en:oedema | n2=en:vernix-like skin covering, present at birth, shed during first month of life (in some patients) | rel=r_associated | relid=0 | w=41
  4146. en:oedema -- r_associated #0: 41 / 0.651 -> en:vertigo
    n1=en:oedema | n2=en:vertigo | rel=r_associated | relid=0 | w=41
  4147. en:oedema -- r_associated #0: 41 / 0.651 -> en:virtually no active movement at birth (wws)
    n1=en:oedema | n2=en:virtually no active movement at birth (wws) | rel=r_associated | relid=0 | w=41
  4148. en:oedema -- r_associated #0: 41 / 0.651 -> en:vitiligo
    n1=en:oedema | n2=en:vitiligo | rel=r_associated | relid=0 | w=41
  4149. en:oedema -- r_associated #0: 41 / 0.651 -> en:wegener granulomatosis
    n1=en:oedema | n2=en:wegener granulomatosis | rel=r_associated | relid=0 | w=41
  4150. en:oedema -- r_associated #0: 41 / 0.651 -> en:wheelchair dependency in 20% of patients by age 40
    n1=en:oedema | n2=en:wheelchair dependency in 20% of patients by age 40 | rel=r_associated | relid=0 | w=41
  4151. en:oedema -- r_associated #0: 41 / 0.651 -> en:wrinkly skin
    n1=en:oedema | n2=en:wrinkly skin | rel=r_associated | relid=0 | w=41
  4152. en:oedema -- r_associated #0: 41 / 0.651 -> en:yawning
    n1=en:oedema | n2=en:yawning | rel=r_associated | relid=0 | w=41
  4153. en:oedema -- r_associated #0: 41 / 0.651 -> en:yellow, papular lesions of the lip, soft palate, pharynx
    n1=en:oedema | n2=en:yellow, papular lesions of the lip, soft palate, pharynx | rel=r_associated | relid=0 | w=41
  4154. en:oedema -- r_associated #0: 41 / 0.651 -> en:z-disk degeneration
    n1=en:oedema | n2=en:z-disk degeneration | rel=r_associated | relid=0 | w=41
  4155. en:oedema -- r_associated #0: 41 / 0.651 -> enflure
    (gonflement)
    n1=en:oedema | n2=enflure
    (gonflement)
    | rel=r_associated | relid=0 | w=41
  4156. en:oedema -- r_associated #0: 41 / 0.651 -> épanchement
    n1=en:oedema | n2=épanchement | rel=r_associated | relid=0 | w=41
  4157. en:oedema -- r_associated #0: 41 / 0.651 -> épanchement au niveau d'une articulation non précisée
    n1=en:oedema | n2=épanchement au niveau d'une articulation non précisée | rel=r_associated | relid=0 | w=41
  4158. en:oedema -- r_associated #0: 41 / 0.651 -> grosseur
    n1=en:oedema | n2=grosseur | rel=r_associated | relid=0 | w=41
  4159. en:oedema -- r_associated #0: 41 / 0.651 -> hydropisie
    n1=en:oedema | n2=hydropisie | rel=r_associated | relid=0 | w=41
  4160. en:oedema -- r_associated #0: 41 / 0.651 -> maladie
    n1=en:oedema | n2=maladie | rel=r_associated | relid=0 | w=41
  4161. en:oedema -- r_associated #0: 41 / 0.651 -> oedème aigu pulmonaire
    n1=en:oedema | n2=oedème aigu pulmonaire | rel=r_associated | relid=0 | w=41
  4162. en:oedema -- r_associated #0: 41 / 0.651 -> oedème périphérique
    n1=en:oedema | n2=oedème périphérique | rel=r_associated | relid=0 | w=41
  4163. en:oedema -- r_associated #0: 41 / 0.651 -> plage hypodense
    n1=en:oedema | n2=plage hypodense | rel=r_associated | relid=0 | w=41
  4164. en:oedema -- r_associated #0: 41 / 0.651 -> turgescence
    n1=en:oedema | n2=turgescence | rel=r_associated | relid=0 | w=41
  4165. en:oedema -- r_associated #0: 39 / 0.619 -> en:'hanging' big toe
    n1=en:oedema | n2=en:'hanging' big toe | rel=r_associated | relid=0 | w=39
  4166. en:oedema -- r_associated #0: 39 / 0.619 -> en:agnosia
    n1=en:oedema | n2=en:agnosia | rel=r_associated | relid=0 | w=39
  4167. en:oedema -- r_associated #0: 39 / 0.619 -> en:atrophy of the intrinsic foot and hand muscles
    n1=en:oedema | n2=en:atrophy of the intrinsic foot and hand muscles | rel=r_associated | relid=0 | w=39
  4168. en:oedema -- r_associated #0: 39 / 0.619 -> en:buffalo hump
    n1=en:oedema | n2=en:buffalo hump | rel=r_associated | relid=0 | w=39
  4169. en:oedema -- r_associated #0: 39 / 0.619 -> en:distal muscle weakness in lower limbs, severe
    n1=en:oedema | n2=en:distal muscle weakness in lower limbs, severe | rel=r_associated | relid=0 | w=39
  4170. en:oedema -- r_associated #0: 39 / 0.619 -> en:eczema-like lesions (in some patients)
    n1=en:oedema | n2=en:eczema-like lesions (in some patients) | rel=r_associated | relid=0 | w=39
  4171. en:oedema -- r_associated #0: 39 / 0.619 -> en:finding of measures of urine output
    n1=en:oedema | n2=en:finding of measures of urine output | rel=r_associated | relid=0 | w=39
  4172. en:oedema -- r_associated #0: 39 / 0.619 -> en:genitourinary signs and symptoms
    n1=en:oedema | n2=en:genitourinary signs and symptoms | rel=r_associated | relid=0 | w=39
  4173. en:oedema -- r_associated #0: 39 / 0.619 -> en:heat illness
    n1=en:oedema | n2=en:heat illness | rel=r_associated | relid=0 | w=39
  4174. en:oedema -- r_associated #0: 39 / 0.619 -> en:increased centralized internal nuclei
    n1=en:oedema | n2=en:increased centralized internal nuclei | rel=r_associated | relid=0 | w=39
  4175. en:oedema -- r_associated #0: 39 / 0.619 -> en:keratosis palmaris
    n1=en:oedema | n2=en:keratosis palmaris | rel=r_associated | relid=0 | w=39
  4176. en:oedema -- r_associated #0: 39 / 0.619 -> en:muscle atrophy later in the disease
    n1=en:oedema | n2=en:muscle atrophy later in the disease | rel=r_associated | relid=0 | w=39
  4177. en:oedema -- r_associated #0: 39 / 0.619 -> en:muscle soreness
    n1=en:oedema | n2=en:muscle soreness | rel=r_associated | relid=0 | w=39
  4178. en:oedema -- r_associated #0: 39 / 0.619 -> en:other infectious skin disease
    n1=en:oedema | n2=en:other infectious skin disease | rel=r_associated | relid=0 | w=39
  4179. en:oedema -- r_associated #0: 39 / 0.619 -> en:psoriasis
    n1=en:oedema | n2=en:psoriasis | rel=r_associated | relid=0 | w=39
  4180. en:oedema -- r_associated #0: 39 / 0.619 -> en:pulmonary stenosis
    n1=en:oedema | n2=en:pulmonary stenosis | rel=r_associated | relid=0 | w=39
  4181. en:oedema -- r_associated #0: 39 / 0.619 -> en:scapuloperoneal muscular atrophy due to denervation
    n1=en:oedema | n2=en:scapuloperoneal muscular atrophy due to denervation | rel=r_associated | relid=0 | w=39
  4182. en:oedema -- r_associated #0: 39 / 0.619 -> en:thick calluses on soles of feet
    n1=en:oedema | n2=en:thick calluses on soles of feet | rel=r_associated | relid=0 | w=39
  4183. en:oedema -- r_associated #0: 39 / 0.619 -> en:type 1 fibers are at least 12% smaller than type 2 fibers
    n1=en:oedema | n2=en:type 1 fibers are at least 12% smaller than type 2 fibers | rel=r_associated | relid=0 | w=39
  4184. en:oedema -- r_associated #0: 39 / 0.619 -> en:varicose vein
    n1=en:oedema | n2=en:varicose vein | rel=r_associated | relid=0 | w=39
  4185. en:oedema -- r_associated #0: 38 / 0.603 -> en:edema of shoulder
    n1=en:oedema | n2=en:edema of shoulder | rel=r_associated | relid=0 | w=38
  4186. en:oedema -- r_associated #0: 38 / 0.603 -> en:edema of structure within eye
    n1=en:oedema | n2=en:edema of structure within eye | rel=r_associated | relid=0 | w=38
  4187. en:oedema -- r_associated #0: 38 / 0.603 -> en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria
    n1=en:oedema | n2=en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria | rel=r_associated | relid=0 | w=38
  4188. en:oedema -- r_associated #0: 38 / 0.603 -> en:facial or extensor involvement in infants and children (major feature)
    n1=en:oedema | n2=en:facial or extensor involvement in infants and children (major feature) | rel=r_associated | relid=0 | w=38
  4189. en:oedema -- r_associated #0: 38 / 0.603 -> en:finding related to physiologic substance
    n1=en:oedema | n2=en:finding related to physiologic substance | rel=r_associated | relid=0 | w=38
  4190. en:oedema -- r_associated #0: 38 / 0.603 -> en:finger subcutaneous nodule
    n1=en:oedema | n2=en:finger subcutaneous nodule | rel=r_associated | relid=0 | w=38
  4191. en:oedema -- r_associated #0: 38 / 0.603 -> en:milium cyst
    n1=en:oedema | n2=en:milium cyst | rel=r_associated | relid=0 | w=38
  4192. en:oedema -- r_associated #0: 38 / 0.603 -> en:mitochondrial dna deletions (in some patients)
    n1=en:oedema | n2=en:mitochondrial dna deletions (in some patients) | rel=r_associated | relid=0 | w=38
  4193. en:oedema -- r_associated #0: 38 / 0.603 -> en:premature birth (30%)
    n1=en:oedema | n2=en:premature birth (30%) | rel=r_associated | relid=0 | w=38
  4194. en:oedema -- r_associated #0: 38 / 0.603 -> en:sciatica
    n1=en:oedema | n2=en:sciatica | rel=r_associated | relid=0 | w=38
  4195. en:oedema -- r_associated #0: 38 / 0.603 -> en:tight, shiny skin over the forearms and hands
    n1=en:oedema | n2=en:tight, shiny skin over the forearms and hands | rel=r_associated | relid=0 | w=38
  4196. en:oedema -- r_associated #0: 38 / 0.603 -> en:toxemia of pregnancy
    n1=en:oedema | n2=en:toxemia of pregnancy | rel=r_associated | relid=0 | w=38
  4197. en:oedema -- r_associated #0: 38 / 0.603 -> en:traumatic cerebral edema without open intracranial wound
    n1=en:oedema | n2=en:traumatic cerebral edema without open intracranial wound | rel=r_associated | relid=0 | w=38
  4198. en:oedema -- r_associated #0: 38 / 0.603 -> en:wound healing normal
    n1=en:oedema | n2=en:wound healing normal | rel=r_associated | relid=0 | w=38
  4199. en:oedema -- r_associated #0: 37 / 0.587 -> en:aberrant melanosome maturation
    n1=en:oedema | n2=en:aberrant melanosome maturation | rel=r_associated | relid=0 | w=37
  4200. en:oedema -- r_associated #0: 37 / 0.587 -> en:amyotrophy, distal, upper and lower limbs
    n1=en:oedema | n2=en:amyotrophy, distal, upper and lower limbs | rel=r_associated | relid=0 | w=37
  4201. en:oedema -- r_associated #0: 37 / 0.587 -> en:chronic lymphocytic leukemia
    n1=en:oedema | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=37
  4202. en:oedema -- r_associated #0: 37 / 0.587 -> en:distal limb muscle weakness due to peripheral neuropathy (lower limbs are more affected than upper limbs)
    n1=en:oedema | n2=en:distal limb muscle weakness due to peripheral neuropathy (lower limbs are more affected than upper limbs) | rel=r_associated | relid=0 | w=37
  4203. en:oedema -- r_associated #0: 37 / 0.587 -> en:facial hyperpigmentation
    n1=en:oedema | n2=en:facial hyperpigmentation | rel=r_associated | relid=0 | w=37
  4204. en:oedema -- r_associated #0: 37 / 0.587 -> en:fine erythrodermic scales, generalized
    n1=en:oedema | n2=en:fine erythrodermic scales, generalized | rel=r_associated | relid=0 | w=37
  4205. en:oedema -- r_associated #0: 37 / 0.587 -> en:hypopigmented macules, primarily on extremities
    n1=en:oedema | n2=en:hypopigmented macules, primarily on extremities | rel=r_associated | relid=0 | w=37
  4206. en:oedema -- r_associated #0: 37 / 0.587 -> en:isolated necrotic fibers
    n1=en:oedema | n2=en:isolated necrotic fibers | rel=r_associated | relid=0 | w=37
  4207. en:oedema -- r_associated #0: 37 / 0.587 -> en:muscle biopsy shows neurogenic changes
    n1=en:oedema | n2=en:muscle biopsy shows neurogenic changes | rel=r_associated | relid=0 | w=37
  4208. en:oedema -- r_associated #0: 37 / 0.587 -> en:muscle weakness, mainly proximal and axial
    n1=en:oedema | n2=en:muscle weakness, mainly proximal and axial | rel=r_associated | relid=0 | w=37
  4209. en:oedema -- r_associated #0: 37 / 0.587 -> en:pelvic girdle weakness and atrophy
    n1=en:oedema | n2=en:pelvic girdle weakness and atrophy | rel=r_associated | relid=0 | w=37
  4210. en:oedema -- r_associated #0: 37 / 0.587 -> en:percussion-induced rapid rolling muscle contractions (pirc)
    n1=en:oedema | n2=en:percussion-induced rapid rolling muscle contractions (pirc) | rel=r_associated | relid=0 | w=37
  4211. en:oedema -- r_associated #0: 37 / 0.587 -> en:peroneal muscle atrophy
    n1=en:oedema | n2=en:peroneal muscle atrophy | rel=r_associated | relid=0 | w=37
  4212. en:oedema -- r_associated #0: 37 / 0.587 -> en:proximal muscle weakness, mild, of shoulder and hip girdle muscles (in some patients)
    n1=en:oedema | n2=en:proximal muscle weakness, mild, of shoulder and hip girdle muscles (in some patients) | rel=r_associated | relid=0 | w=37
  4213. en:oedema -- r_associated #0: 37 / 0.587 -> en:reddish or purplish skin discoloration, episodic, associated with pain
    n1=en:oedema | n2=en:reddish or purplish skin discoloration, episodic, associated with pain | rel=r_associated | relid=0 | w=37
  4214. en:oedema -- r_associated #0: 37 / 0.587 -> en:reduced o-mannosyl glycans on alpha-dystroglycan
    n1=en:oedema | n2=en:reduced o-mannosyl glycans on alpha-dystroglycan | rel=r_associated | relid=0 | w=37
  4215. en:oedema -- r_associated #0: 37 / 0.587 -> en:retroperitoneal fibrosis (rare)
    n1=en:oedema | n2=en:retroperitoneal fibrosis (rare) | rel=r_associated | relid=0 | w=37
  4216. en:oedema -- r_associated #0: 37 / 0.587 -> en:single transverse palmar crease (in some patients)
    n1=en:oedema | n2=en:single transverse palmar crease (in some patients) | rel=r_associated | relid=0 | w=37
  4217. en:oedema -- r_associated #0: 37 / 0.587 -> en:tissue observable
    n1=en:oedema | n2=en:tissue observable | rel=r_associated | relid=0 | w=37
  4218. en:oedema -- r_associated #0: 36 / 0.571 -> en:angiokeratoma
    n1=en:oedema | n2=en:angiokeratoma | rel=r_associated | relid=0 | w=36
  4219. en:oedema -- r_associated #0: 36 / 0.571 -> en:atrophic fibers
    n1=en:oedema | n2=en:atrophic fibers | rel=r_associated | relid=0 | w=36
  4220. en:oedema -- r_associated #0: 36 / 0.571 -> en:basal cell nevus
    n1=en:oedema | n2=en:basal cell nevus | rel=r_associated | relid=0 | w=36
  4221. en:oedema -- r_associated #0: 36 / 0.571 -> en:cigarette-paper scars
    n1=en:oedema | n2=en:cigarette-paper scars | rel=r_associated | relid=0 | w=36
  4222. en:oedema -- r_associated #0: 36 / 0.571 -> en:cutaneous dimpling over bowed tibia
    n1=en:oedema | n2=en:cutaneous dimpling over bowed tibia | rel=r_associated | relid=0 | w=36
  4223. en:oedema -- r_associated #0: 36 / 0.571 -> en:deficiency of the interleukin-36 receptor antagonist
    n1=en:oedema | n2=en:deficiency of the interleukin-36 receptor antagonist | rel=r_associated | relid=0 | w=36
  4224. en:oedema -- r_associated #0: 36 / 0.571 -> en:diaper dermatitis
    n1=en:oedema | n2=en:diaper dermatitis | rel=r_associated | relid=0 | w=36
  4225. en:oedema -- r_associated #0: 36 / 0.571 -> en:ear / auditory observable
    n1=en:oedema | n2=en:ear / auditory observable | rel=r_associated | relid=0 | w=36
  4226. en:oedema -- r_associated #0: 36 / 0.571 -> en:enteropathy, familial, with villous edema and immunoglobulin g2 deficiency
    n1=en:oedema | n2=en:enteropathy, familial, with villous edema and immunoglobulin g2 deficiency | rel=r_associated | relid=0 | w=36
  4227. en:oedema -- r_associated #0: 36 / 0.571 -> en:enteroviral dermatomyositis syndrome
    n1=en:oedema | n2=en:enteroviral dermatomyositis syndrome | rel=r_associated | relid=0 | w=36
  4228. en:oedema -- r_associated #0: 36 / 0.571 -> en:episodic, nonerythematous, nonpruritic, nontender edema, episodic
    n1=en:oedema | n2=en:episodic, nonerythematous, nonpruritic, nontender edema, episodic | rel=r_associated | relid=0 | w=36
  4229. en:oedema -- r_associated #0: 36 / 0.571 -> en:fetal demise, male
    n1=en:oedema | n2=en:fetal demise, male | rel=r_associated | relid=0 | w=36
  4230. en:oedema -- r_associated #0: 36 / 0.571 -> en:fistula formation (late complication)
    n1=en:oedema | n2=en:fistula formation (late complication) | rel=r_associated | relid=0 | w=36
  4231. en:oedema -- r_associated #0: 36 / 0.571 -> en:heart: muscle/valve
    n1=en:oedema | n2=en:heart: muscle/valve | rel=r_associated | relid=0 | w=36
  4232. en:oedema -- r_associated #0: 36 / 0.571 -> en:hemangiomatous branchial clefts (extend along sternocleidomastoid muscle)
    n1=en:oedema | n2=en:hemangiomatous branchial clefts (extend along sternocleidomastoid muscle) | rel=r_associated | relid=0 | w=36
  4233. en:oedema -- r_associated #0: 36 / 0.571 -> en:increased mitochondria with abnormal cristae
    n1=en:oedema | n2=en:increased mitochondria with abnormal cristae | rel=r_associated | relid=0 | w=36
  4234. en:oedema -- r_associated #0: 36 / 0.571 -> en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles
    n1=en:oedema | n2=en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles | rel=r_associated | relid=0 | w=36
  4235. en:oedema -- r_associated #0: 36 / 0.571 -> en:limb lymphedema (in some patients)
    n1=en:oedema | n2=en:limb lymphedema (in some patients) | rel=r_associated | relid=0 | w=36
  4236. en:oedema -- r_associated #0: 36 / 0.571 -> en:mucocutaneous candidiasis
    n1=en:oedema | n2=en:mucocutaneous candidiasis | rel=r_associated | relid=0 | w=36
  4237. en:oedema -- r_associated #0: 36 / 0.571 -> en:muscle biopsy shows mitochondrial aggregates
    n1=en:oedema | n2=en:muscle biopsy shows mitochondrial aggregates | rel=r_associated | relid=0 | w=36
  4238. en:oedema -- r_associated #0: 36 / 0.571 -> en:painful, fleshy papules or nodules (hands, scalp, ears, perinasal area)
    n1=en:oedema | n2=en:painful, fleshy papules or nodules (hands, scalp, ears, perinasal area) | rel=r_associated | relid=0 | w=36
  4239. en:oedema -- r_associated #0: 36 / 0.571 -> en:palmoplantar keratoderma, mild
    n1=en:oedema | n2=en:palmoplantar keratoderma, mild | rel=r_associated | relid=0 | w=36
  4240. en:oedema -- r_associated #0: 36 / 0.571 -> en:proliferation of spindle cells
    n1=en:oedema | n2=en:proliferation of spindle cells | rel=r_associated | relid=0 | w=36
  4241. en:oedema -- r_associated #0: 36 / 0.571 -> en:psychology qualifier
    n1=en:oedema | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=36
  4242. en:oedema -- r_associated #0: 36 / 0.571 -> en:replacement of affected muscle tissue with fatty tissue
    n1=en:oedema | n2=en:replacement of affected muscle tissue with fatty tissue | rel=r_associated | relid=0 | w=36
  4243. en:oedema -- r_associated #0: 36 / 0.571 -> en:skin basal cell carcinoma
    n1=en:oedema | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=36
  4244. en:oedema -- r_associated #0: 36 / 0.571 -> en:stage 1 - skin erythema, vesicles, pustules
    n1=en:oedema | n2=en:stage 1 - skin erythema, vesicles, pustules | rel=r_associated | relid=0 | w=36
  4245. en:oedema -- r_associated #0: 36 / 0.571 -> en:swelling of the affected areas
    n1=en:oedema | n2=en:swelling of the affected areas | rel=r_associated | relid=0 | w=36
  4246. en:oedema -- r_associated #0: 35 / 0.556 -> accumulation
    n1=en:oedema | n2=accumulation | rel=r_associated | relid=0 | w=35
  4247. en:oedema -- r_associated #0: 35 / 0.556 -> liq
    n1=en:oedema | n2=liq | rel=r_associated | relid=0 | w=35
  4248. en:oedema -- r_associated #0: 30 / 0.476 -> loge (syndrome de)
    n1=en:oedema | n2=loge (syndrome de) | rel=r_associated | relid=0 | w=30
  4249. en:oedema -- r_associated #0: 30 / 0.476 -> œdème
    n1=en:oedema | n2=œdème | rel=r_associated | relid=0 | w=30
  4250. en:oedema -- r_associated #0: 30 / 0.476 -> oedème aigu cardiogénique du poumon
    n1=en:oedema | n2=oedème aigu cardiogénique du poumon | rel=r_associated | relid=0 | w=30
  4251. en:oedema -- r_associated #0: 30 / 0.476 -> oedème de stase
    n1=en:oedema | n2=oedème de stase | rel=r_associated | relid=0 | w=30
  4252. en:oedema -- r_associated #0: 30 / 0.476 -> pathologie
    n1=en:oedema | n2=pathologie | rel=r_associated | relid=0 | w=30
  4253. en:oedema -- r_associated #0: 30 / 0.476 -> rétention hydrochlorurée sodique
    n1=en:oedema | n2=rétention hydrochlorurée sodique | rel=r_associated | relid=0 | w=30
  4254. en:oedema -- r_associated #0: 30 / 0.476 -> syndrome oedémato-ascitique
    n1=en:oedema | n2=syndrome oedémato-ascitique | rel=r_associated | relid=0 | w=30
  4255. en:oedema -- r_associated #0: 29 / 0.46 -> en:tumor
    n1=en:oedema | n2=en:tumor | rel=r_associated | relid=0 | w=29
  4256. en:oedema -- r_associated #0: 29 / 0.46 -> exsudat
    n1=en:oedema | n2=exsudat | rel=r_associated | relid=0 | w=29
  4257. en:oedema -- r_associated #0: 29 / 0.46 -> mort cellulaire
    n1=en:oedema | n2=mort cellulaire | rel=r_associated | relid=0 | w=29
  4258. en:oedema -- r_associated #0: 29 / 0.46 -> oedémateux (syndrome)
    n1=en:oedema | n2=oedémateux (syndrome) | rel=r_associated | relid=0 | w=29
  4259. en:oedema -- r_associated #0: 29 / 0.46 -> oedème
    n1=en:oedema | n2=oedème | rel=r_associated | relid=0 | w=29
  4260. en:oedema -- r_associated #0: 28 / 0.444 -> 363-364 oedèmes
    n1=en:oedema | n2=363-364 oedèmes | rel=r_associated | relid=0 | w=28
  4261. en:oedema -- r_associated #0: 28 / 0.444 -> drainage lymphatique
    n1=en:oedema | n2=drainage lymphatique | rel=r_associated | relid=0 | w=28
  4262. en:oedema -- r_associated #0: 28 / 0.444 -> enfler
    n1=en:oedema | n2=enfler | rel=r_associated | relid=0 | w=28
  4263. en:oedema -- r_associated #0: 28 / 0.444 -> mal des montagnes
    n1=en:oedema | n2=mal des montagnes | rel=r_associated | relid=0 | w=28
  4264. en:oedema -- r_associated #0: 28 / 0.444 -> myxomatose
    n1=en:oedema | n2=myxomatose | rel=r_associated | relid=0 | w=28
  4265. en:oedema -- r_associated #0: 28 / 0.444 -> oedème inflammatoire
    n1=en:oedema | n2=oedème inflammatoire | rel=r_associated | relid=0 | w=28
  4266. en:oedema -- r_associated #0: 28 / 0.444 -> transport aqueux transmembranaire
    n1=en:oedema | n2=transport aqueux transmembranaire | rel=r_associated | relid=0 | w=28
  4267. en:oedema -- r_associated #0: 27 / 0.429 -> oedème localisé
    n1=en:oedema | n2=oedème localisé | rel=r_associated | relid=0 | w=27
  4268. en:oedema -- r_associated #0: 26 / 0.413 -> fluxion
    n1=en:oedema | n2=fluxion | rel=r_associated | relid=0 | w=26
  4269. en:oedema -- r_associated #0: 26 / 0.413 -> lymphoedème
    n1=en:oedema | n2=lymphoedème | rel=r_associated | relid=0 | w=26
  4270. en:oedema -- r_associated #0: 26 / 0.413 -> oedématié
    n1=en:oedema | n2=oedématié | rel=r_associated | relid=0 | w=26
  4271. en:oedema -- r_associated #0: 26 / 0.413 -> oedème laryngé
    n1=en:oedema | n2=oedème laryngé | rel=r_associated | relid=0 | w=26
  4272. en:oedema -- r_associated #0: 26 / 0.413 -> Syndrome prémenstruel
    n1=en:oedema | n2=Syndrome prémenstruel | rel=r_associated | relid=0 | w=26
  4273. en:oedema -- r_associated #0: 25 / 0.397 -> exsudat inflammatoire
    n1=en:oedema | n2=exsudat inflammatoire | rel=r_associated | relid=0 | w=25
  4274. en:oedema -- r_associated #0: 24 / 0.381 -> infiltration
    n1=en:oedema | n2=infiltration | rel=r_associated | relid=0 | w=24
  4275. en:oedema -- r_associated #0: 24 / 0.381 -> pression osmotique
    n1=en:oedema | n2=pression osmotique | rel=r_associated | relid=0 | w=24
  4276. en:oedema -- r_associated #0: 24 / 0.381 -> syndrome prémenstruel
    n1=en:oedema | n2=syndrome prémenstruel | rel=r_associated | relid=0 | w=24
  4277. en:oedema -- r_associated #0: 23 / 0.365 -> en:edematous
    n1=en:oedema | n2=en:edematous | rel=r_associated | relid=0 | w=23
  4278. en:oedema -- r_associated #0: 23 / 0.365 -> rétention d'eau
    n1=en:oedema | n2=rétention d'eau | rel=r_associated | relid=0 | w=23
  4279. en:oedema -- r_associated #0: 22 / 0.349 -> hypoalbuminémie
    n1=en:oedema | n2=hypoalbuminémie | rel=r_associated | relid=0 | w=22
  4280. en:oedema -- r_associated #0: 21 / 0.333 -> boursouflé
    n1=en:oedema | n2=boursouflé | rel=r_associated | relid=0 | w=21
  4281. en:oedema -- r_associated #0: 21 / 0.333 -> congestion
    n1=en:oedema | n2=congestion | rel=r_associated | relid=0 | w=21
  4282. en:oedema -- r_associated #0: 21 / 0.333 -> infarctus
    n1=en:oedema | n2=infarctus | rel=r_associated | relid=0 | w=21
  4283. en:oedema -- r_associated #0: 21 / 0.333 -> pression oncotique
    n1=en:oedema | n2=pression oncotique | rel=r_associated | relid=0 | w=21
  4284. en:oedema -- r_associated #0: 10 / 0.159 -> œdématier
    n1=en:oedema | n2=œdématier | rel=r_associated | relid=0 | w=10
  4285. en:oedema -- r_associated #0: 10 / 0.159 -> angio-oedème pharyngé
    n1=en:oedema | n2=angio-oedème pharyngé | rel=r_associated | relid=0 | w=10
  4286. en:oedema -- r_associated #0: 10 / 0.159 -> angiooedème
    n1=en:oedema | n2=angiooedème | rel=r_associated | relid=0 | w=10
  4287. en:oedema -- r_associated #0: 10 / 0.159 -> atélectasie congestive
    n1=en:oedema | n2=atélectasie congestive | rel=r_associated | relid=0 | w=10
  4288. en:oedema -- r_associated #0: 10 / 0.159 -> atteinte rénale
    n1=en:oedema | n2=atteinte rénale | rel=r_associated | relid=0 | w=10
  4289. en:oedema -- r_associated #0: 10 / 0.159 -> autre oedème non précisé du nouveau-né
    n1=en:oedema | n2=autre oedème non précisé du nouveau-né | rel=r_associated | relid=0 | w=10
  4290. en:oedema -- r_associated #0: 10 / 0.159 -> boule d'oedème
    n1=en:oedema | n2=boule d'oedème | rel=r_associated | relid=0 | w=10
  4291. en:oedema -- r_associated #0: 10 / 0.159 -> chémosis
    n1=en:oedema | n2=chémosis | rel=r_associated | relid=0 | w=10
  4292. en:oedema -- r_associated #0: 10 / 0.159 -> chemosis
    n1=en:oedema | n2=chemosis | rel=r_associated | relid=0 | w=10
  4293. en:oedema -- r_associated #0: 10 / 0.159 -> choc au poumon
    n1=en:oedema | n2=choc au poumon | rel=r_associated | relid=0 | w=10
  4294. en:oedema -- r_associated #0: 10 / 0.159 -> commotion cérébrale
    n1=en:oedema | n2=commotion cérébrale | rel=r_associated | relid=0 | w=10
  4295. en:oedema -- r_associated #0: 10 / 0.159 -> commotion de l'encéphale
    n1=en:oedema | n2=commotion de l'encéphale | rel=r_associated | relid=0 | w=10
  4296. en:oedema -- r_associated #0: 10 / 0.159 -> commotion encéphalique
    n1=en:oedema | n2=commotion encéphalique | rel=r_associated | relid=0 | w=10
  4297. en:oedema -- r_associated #0: 10 / 0.159 -> complication rénale
    n1=en:oedema | n2=complication rénale | rel=r_associated | relid=0 | w=10
  4298. en:oedema -- r_associated #0: 10 / 0.159 -> don de rein
    n1=en:oedema | n2=don de rein | rel=r_associated | relid=0 | w=10
  4299. en:oedema -- r_associated #0: 10 / 0.159 -> dourine
    n1=en:oedema | n2=dourine | rel=r_associated | relid=0 | w=10
  4300. en:oedema -- r_associated #0: 10 / 0.159 -> éléphantiasis
    n1=en:oedema | n2=éléphantiasis | rel=r_associated | relid=0 | w=10
  4301. en:oedema -- r_associated #0: 10 / 0.159 -> en:brain concussion
    n1=en:oedema | n2=en:brain concussion | rel=r_associated | relid=0 | w=10
  4302. en:oedema -- r_associated #0: 10 / 0.159 -> en:decreased intraocular pressure associated papilledema
    n1=en:oedema | n2=en:decreased intraocular pressure associated papilledema | rel=r_associated | relid=0 | w=10
  4303. en:oedema -- r_associated #0: 10 / 0.159 -> en:dourine
    n1=en:oedema | n2=en:dourine | rel=r_associated | relid=0 | w=10
  4304. en:oedema -- r_associated #0: 10 / 0.159 -> en:edema of optic disk
    n1=en:oedema | n2=en:edema of optic disk | rel=r_associated | relid=0 | w=10
  4305. en:oedema -- r_associated #0: 10 / 0.159 -> en:epiglottitis
    n1=en:oedema | n2=en:epiglottitis | rel=r_associated | relid=0 | w=10
  4306. en:oedema -- r_associated #0: 10 / 0.159 -> en:new growth
    n1=en:oedema | n2=en:new growth | rel=r_associated | relid=0 | w=10
  4307. en:oedema -- r_associated #0: 10 / 0.159 -> en:PMS
    n1=en:oedema | n2=en:PMS | rel=r_associated | relid=0 | w=10
  4308. en:oedema -- r_associated #0: 10 / 0.159 -> en:pre-menstrual syndrome
    n1=en:oedema | n2=en:pre-menstrual syndrome | rel=r_associated | relid=0 | w=10
  4309. en:oedema -- r_associated #0: 10 / 0.159 -> en:premenstrual syndrome
    n1=en:oedema | n2=en:premenstrual syndrome | rel=r_associated | relid=0 | w=10
  4310. en:oedema -- r_associated #0: 10 / 0.159 -> en:pulmonary shunting
    n1=en:oedema | n2=en:pulmonary shunting | rel=r_associated | relid=0 | w=10
  4311. en:oedema -- r_associated #0: 10 / 0.159 -> enflé
    n1=en:oedema | n2=enflé | rel=r_associated | relid=0 | w=10
  4312. en:oedema -- r_associated #0: 10 / 0.159 -> enfler
    (oedème)
    n1=en:oedema | n2=enfler
    (oedème)
    | rel=r_associated | relid=0 | w=10
  4313. en:oedema -- r_associated #0: 10 / 0.159 -> épiglottite
    n1=en:oedema | n2=épiglottite | rel=r_associated | relid=0 | w=10
  4314. en:oedema -- r_associated #0: 10 / 0.159 -> Épiglottite
    n1=en:oedema | n2=Épiglottite | rel=r_associated | relid=0 | w=10
  4315. en:oedema -- r_associated #0: 10 / 0.159 -> expansion
    n1=en:oedema | n2=expansion | rel=r_associated | relid=0 | w=10
  4316. en:oedema -- r_associated #0: 10 / 0.159 -> extraire un liquide
    n1=en:oedema | n2=extraire un liquide | rel=r_associated | relid=0 | w=10
  4317. en:oedema -- r_associated #0: 10 / 0.159 -> faire de la rétention d'eau
    n1=en:oedema | n2=faire de la rétention d'eau | rel=r_associated | relid=0 | w=10
  4318. en:oedema -- r_associated #0: 10 / 0.159 -> filariose lymphatique
    n1=en:oedema | n2=filariose lymphatique | rel=r_associated | relid=0 | w=10
  4319. en:oedema -- r_associated #0: 10 / 0.159 -> fracture de Segond
    n1=en:oedema | n2=fracture de Segond | rel=r_associated | relid=0 | w=10
  4320. en:oedema -- r_associated #0: 10 / 0.159 -> fracture du scaphoïde
    n1=en:oedema | n2=fracture du scaphoïde | rel=r_associated | relid=0 | w=10
  4321. en:oedema -- r_associated #0: 10 / 0.159 -> gonflé
    n1=en:oedema | n2=gonflé | rel=r_associated | relid=0 | w=10
  4322. en:oedema -- r_associated #0: 10 / 0.159 -> gonflé
    (gonfler)
    n1=en:oedema | n2=gonflé
    (gonfler)
    | rel=r_associated | relid=0 | w=10
  4323. en:oedema -- r_associated #0: 10 / 0.159 -> gonflement du cerveau
    n1=en:oedema | n2=gonflement du cerveau | rel=r_associated | relid=0 | w=10
  4324. en:oedema -- r_associated #0: 10 / 0.159 -> hémorragie intra-cérébrale
    n1=en:oedema | n2=hémorragie intra-cérébrale | rel=r_associated | relid=0 | w=10
  4325. en:oedema -- r_associated #0: 10 / 0.159 -> hémorragie intracérébrale
    n1=en:oedema | n2=hémorragie intracérébrale | rel=r_associated | relid=0 | w=10
  4326. en:oedema -- r_associated #0: 10 / 0.159 -> hypertension artérielle gravidique
    n1=en:oedema | n2=hypertension artérielle gravidique | rel=r_associated | relid=0 | w=10
  4327. en:oedema -- r_associated #0: 10 / 0.159 -> hypertension intra-cranienne
    n1=en:oedema | n2=hypertension intra-cranienne | rel=r_associated | relid=0 | w=10
  4328. en:oedema -- r_associated #0: 10 / 0.159 -> hypertension intra-crânienne
    n1=en:oedema | n2=hypertension intra-crânienne | rel=r_associated | relid=0 | w=10
  4329. en:oedema -- r_associated #0: 10 / 0.159 -> hypertension intracrânienne
    n1=en:oedema | n2=hypertension intracrânienne | rel=r_associated | relid=0 | w=10
  4330. en:oedema -- r_associated #0: 10 / 0.159 -> insuffisance pulmonaire post-traumatique
    n1=en:oedema | n2=insuffisance pulmonaire post-traumatique | rel=r_associated | relid=0 | w=10
  4331. en:oedema -- r_associated #0: 10 / 0.159 -> leuko-oedème
    n1=en:oedema | n2=leuko-oedème | rel=r_associated | relid=0 | w=10
  4332. en:oedema -- r_associated #0: 10 / 0.159 -> maladie de Clarkson
    n1=en:oedema | n2=maladie de Clarkson | rel=r_associated | relid=0 | w=10
  4333. en:oedema -- r_associated #0: 10 / 0.159 -> Modic 1
    n1=en:oedema | n2=Modic 1 | rel=r_associated | relid=0 | w=10
  4334. en:oedema -- r_associated #0: 10 / 0.159 -> myxœdème
    n1=en:oedema | n2=myxœdème | rel=r_associated | relid=0 | w=10
  4335. en:oedema -- r_associated #0: 10 / 0.159 -> myxoedème
    n1=en:oedema | n2=myxoedème | rel=r_associated | relid=0 | w=10
  4336. en:oedema -- r_associated #0: 10 / 0.159 -> oedématier
    n1=en:oedema | n2=oedématier | rel=r_associated | relid=0 | w=10
  4337. en:oedema -- r_associated #0: 10 / 0.159 -> Œdème
    n1=en:oedema | n2=Œdème | rel=r_associated | relid=0 | w=10
  4338. en:oedema -- r_associated #0: 10 / 0.159 -> oedème aigu du poumon avec mention de maladie cardiaque ou d'insuffisance cardiaque
    n1=en:oedema | n2=oedème aigu du poumon avec mention de maladie cardiaque ou d'insuffisance cardiaque | rel=r_associated | relid=0 | w=10
  4339. en:oedema -- r_associated #0: 10 / 0.159 -> oedème aigu du poumon non précisé
    n1=en:oedema | n2=oedème aigu du poumon non précisé | rel=r_associated | relid=0 | w=10
  4340. en:oedema -- r_associated #0: 10 / 0.159 -> oedème au site de greffe artério-veineuse
    n1=en:oedema | n2=oedème au site de greffe artério-veineuse | rel=r_associated | relid=0 | w=10
  4341. en:oedema -- r_associated #0: 10 / 0.159 -> oedème bucco-facial
    n1=en:oedema | n2=oedème bucco-facial | rel=r_associated | relid=0 | w=10
  4342. en:oedema -- r_associated #0: 10 / 0.159 -> oedème cérébral cytotoxique
    n1=en:oedema | n2=oedème cérébral cytotoxique | rel=r_associated | relid=0 | w=10
  4343. en:oedema -- r_associated #0: 10 / 0.159 -> oedème cornéen post-opératoire
    n1=en:oedema | n2=oedème cornéen post-opératoire | rel=r_associated | relid=0 | w=10
  4344. en:oedema -- r_associated #0: 10 / 0.159 -> oedème cutané
    n1=en:oedema | n2=oedème cutané | rel=r_associated | relid=0 | w=10
  4345. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de berlin
    n1=en:oedema | n2=oedème de berlin | rel=r_associated | relid=0 | w=10
  4346. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de calabar
    n1=en:oedema | n2=oedème de calabar | rel=r_associated | relid=0 | w=10
  4347. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de l'avant-bras
    n1=en:oedema | n2=oedème de l'avant-bras | rel=r_associated | relid=0 | w=10
  4348. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de l'encéphale
    n1=en:oedema | n2=oedème de l'encéphale | rel=r_associated | relid=0 | w=10
  4349. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de l'épiglotte
    n1=en:oedema | n2=oedème de l'épiglotte | rel=r_associated | relid=0 | w=10
  4350. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de la peau
    n1=en:oedema | n2=oedème de la peau | rel=r_associated | relid=0 | w=10
  4351. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de Quincke forme héréditaire
    n1=en:oedema | n2=oedème de Quincke forme héréditaire | rel=r_associated | relid=0 | w=10
  4352. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de quincke forme héréditaire
    n1=en:oedema | n2=oedème de quincke forme héréditaire | rel=r_associated | relid=0 | w=10
  4353. en:oedema -- r_associated #0: 10 / 0.159 -> oedème de Reinke
    n1=en:oedema | n2=oedème de Reinke | rel=r_associated | relid=0 | w=10
  4354. en:oedema -- r_associated #0: 10 / 0.159 -> oedème des cordes vocales
    n1=en:oedema | n2=oedème des cordes vocales | rel=r_associated | relid=0 | w=10
  4355. en:oedema -- r_associated #0: 10 / 0.159 -> oedème du cerveau
    n1=en:oedema | n2=oedème du cerveau | rel=r_associated | relid=0 | w=10
  4356. en:oedema -- r_associated #0: 10 / 0.159 -> oedème du poumon non cardiogénique
    n1=en:oedema | n2=oedème du poumon non cardiogénique | rel=r_associated | relid=0 | w=10
  4357. en:oedema -- r_associated #0: 10 / 0.159 -> oedème gastro-intestinal
    n1=en:oedema | n2=oedème gastro-intestinal | rel=r_associated | relid=0 | w=10
  4358. en:oedema -- r_associated #0: 10 / 0.159 -> oedème insterstitiel
    n1=en:oedema | n2=oedème insterstitiel | rel=r_associated | relid=0 | w=10
  4359. en:oedema -- r_associated #0: 10 / 0.159 -> oedème intercellulaire ou interstitiel
    n1=en:oedema | n2=oedème intercellulaire ou interstitiel | rel=r_associated | relid=0 | w=10
  4360. en:oedema -- r_associated #0: 10 / 0.159 -> oedème lymphatique
    n1=en:oedema | n2=oedème lymphatique | rel=r_associated | relid=0 | w=10
  4361. en:oedema -- r_associated #0: 10 / 0.159 -> oedème palmo-plantaire
    n1=en:oedema | n2=oedème palmo-plantaire | rel=r_associated | relid=0 | w=10
  4362. en:oedema -- r_associated #0: 10 / 0.159 -> oedème papillaire associé à une baisse de la pression intra-oculaire
    n1=en:oedema | n2=oedème papillaire associé à une baisse de la pression intra-oculaire | rel=r_associated | relid=0 | w=10
  4363. en:oedema -- r_associated #0: 10 / 0.159 -> oedème papillaire congénital
    n1=en:oedema | n2=oedème papillaire congénital | rel=r_associated | relid=0 | w=10
  4364. en:oedema -- r_associated #0: 10 / 0.159 -> oedème péri-lésionnel
    n1=en:oedema | n2=oedème péri-lésionnel | rel=r_associated | relid=0 | w=10
  4365. en:oedema -- r_associated #0: 10 / 0.159 -> oedème péri-oral
    n1=en:oedema | n2=oedème péri-oral | rel=r_associated | relid=0 | w=10
  4366. en:oedema -- r_associated #0: 10 / 0.159 -> oedème péri-orbitaire
    n1=en:oedema | n2=oedème péri-orbitaire | rel=r_associated | relid=0 | w=10
  4367. en:oedema -- r_associated #0: 10 / 0.159 -> oedème post-chirurgical
    n1=en:oedema | n2=oedème post-chirurgical | rel=r_associated | relid=0 | w=10
  4368. en:oedema -- r_associated #0: 10 / 0.159 -> oedème pulmonaire aigu avec mention de maladie cardiaque ou d'insuffisance cardiaque
    n1=en:oedema | n2=oedème pulmonaire aigu avec mention de maladie cardiaque ou d'insuffisance cardiaque | rel=r_associated | relid=0 | w=10
  4369. en:oedema -- r_associated #0: 10 / 0.159 -> oedème pulmonaire aigu non précisé
    n1=en:oedema | n2=oedème pulmonaire aigu non précisé | rel=r_associated | relid=0 | w=10
  4370. en:oedema -- r_associated #0: 10 / 0.159 -> oedème pulmonaire avec mention de cardiopathie ou d'insuffisance cardiaque
    n1=en:oedema | n2=oedème pulmonaire avec mention de cardiopathie ou d'insuffisance cardiaque | rel=r_associated | relid=0 | w=10
  4371. en:oedema -- r_associated #0: 10 / 0.159 -> oedème pulmonaire du nouveau-né
    n1=en:oedema | n2=oedème pulmonaire du nouveau-né | rel=r_associated | relid=0 | w=10
  4372. en:oedema -- r_associated #0: 10 / 0.159 -> oedème pulmonaire lésionnel
    n1=en:oedema | n2=oedème pulmonaire lésionnel | rel=r_associated | relid=0 | w=10
  4373. en:oedema -- r_associated #0: 10 / 0.159 -> oedème pulmonaire non cardiogénique
    n1=en:oedema | n2=oedème pulmonaire non cardiogénique | rel=r_associated | relid=0 | w=10
  4374. en:oedema -- r_associated #0: 10 / 0.159 -> pathologie rénale
    n1=en:oedema | n2=pathologie rénale | rel=r_associated | relid=0 | w=10
  4375. en:oedema -- r_associated #0: 10 / 0.159 -> poumon de choc
    n1=en:oedema | n2=poumon de choc | rel=r_associated | relid=0 | w=10
  4376. en:oedema -- r_associated #0: 10 / 0.159 -> poumon de choc traumatique
    n1=en:oedema | n2=poumon de choc traumatique | rel=r_associated | relid=0 | w=10
  4377. en:oedema -- r_associated #0: 10 / 0.159 -> poumon du vietnam
    n1=en:oedema | n2=poumon du vietnam | rel=r_associated | relid=0 | w=10
  4378. en:oedema -- r_associated #0: 10 / 0.159 -> Sars
    n1=en:oedema | n2=Sars | rel=r_associated | relid=0 | w=10
  4379. en:oedema -- r_associated #0: 10 / 0.159 -> se faire greffer un rein
    n1=en:oedema | n2=se faire greffer un rein | rel=r_associated | relid=0 | w=10
  4380. en:oedema -- r_associated #0: 10 / 0.159 -> sémiologie clinique
    n1=en:oedema | n2=sémiologie clinique | rel=r_associated | relid=0 | w=10
  4381. en:oedema -- r_associated #0: 10 / 0.159 -> syndrome de berlin
    n1=en:oedema | n2=syndrome de berlin | rel=r_associated | relid=0 | w=10
  4382. en:oedema -- r_associated #0: 10 / 0.159 -> syndrome de détresse respiratoire aiguë
    n1=en:oedema | n2=syndrome de détresse respiratoire aiguë | rel=r_associated | relid=0 | w=10
  4383. en:oedema -- r_associated #0: 10 / 0.159 -> syndrome de détresse respiratoire aigüe
    n1=en:oedema | n2=syndrome de détresse respiratoire aigüe | rel=r_associated | relid=0 | w=10
  4384. en:oedema -- r_associated #0: 10 / 0.159 -> traumatisme du crâne
    n1=en:oedema | n2=traumatisme du crâne | rel=r_associated | relid=0 | w=10
  4385. en:oedema -- r_associated #0: 10 / 0.159 -> trophoedème
    n1=en:oedema | n2=trophoedème | rel=r_associated | relid=0 | w=10
  4386. en:oedema -- r_associated #0: 10 / 0.159 -> tuméfié
    n1=en:oedema | n2=tuméfié | rel=r_associated | relid=0 | w=10
  4387. en:oedema -- r_associated #0: 5 / 0.079 -> œdémateux
    n1=en:oedema | n2=œdémateux | rel=r_associated | relid=0 | w=5
  4388. en:oedema -- r_associated #0: 5 / 0.079 -> œdème
    n1=en:oedema | n2=œdème | rel=r_associated | relid=0 | w=5
  4389. en:oedema -- r_associated #0: 5 / 0.079 -> en:dropsy
    n1=en:oedema | n2=en:dropsy | rel=r_associated | relid=0 | w=5
  4390. en:oedema -- r_associated #0: 5 / 0.079 -> en:hydrops
    n1=en:oedema | n2=en:hydrops | rel=r_associated | relid=0 | w=5
≈ 4724 relations entrantes

  1. oedème --- r_associated #0: 89 --> en:oedema
    n1=oedème | n2=en:oedema | rel=r_associated | relid=0 | w=89
  2. œdème --- r_associated #0: 88 --> en:oedema
    n1=œdème | n2=en:oedema | rel=r_associated | relid=0 | w=88
  3. œdème --- r_associated #0: 85 --> en:oedema
    n1=œdème | n2=en:oedema | rel=r_associated | relid=0 | w=85
  4. en:edema --- r_associated #0: 64 --> en:oedema
    n1=en:edema | n2=en:oedema | rel=r_associated | relid=0 | w=64
  5. Oedème --- r_associated #0: 61 --> en:oedema
    n1=Oedème | n2=en:oedema | rel=r_associated | relid=0 | w=61
  6. anasarque --- r_associated #0: 26 --> en:oedema
    n1=anasarque | n2=en:oedema | rel=r_associated | relid=0 | w=26
  7. en:hydrops fetalis --- r_associated #0: 25 --> en:oedema
    n1=en:hydrops fetalis | n2=en:oedema | rel=r_associated | relid=0 | w=25
  8. en:water thesaurismosis --- r_associated #0: 25 --> en:oedema
    n1=en:water thesaurismosis | n2=en:oedema | rel=r_associated | relid=0 | w=25
  9. bleu --- r_associated #0: 21 --> en:oedema
    n1=bleu | n2=en:oedema | rel=r_associated | relid=0 | w=21
  10. bouffissure --- r_associated #0: 21 --> en:oedema
    n1=bouffissure | n2=en:oedema | rel=r_associated | relid=0 | w=21
  11. boursouflement --- r_associated #0: 21 --> en:oedema
    n1=boursouflement | n2=en:oedema | rel=r_associated | relid=0 | w=21
  12. boursouflure --- r_associated #0: 21 --> en:oedema
    n1=boursouflure | n2=en:oedema | rel=r_associated | relid=0 | w=21
  13. hyperhydratation --- r_associated #0: 21 --> en:oedema
    n1=hyperhydratation | n2=en:oedema | rel=r_associated | relid=0 | w=21
  14. rétention hydrochlorurée sodique --- r_associated #0: 21 --> en:oedema
    n1=rétention hydrochlorurée sodique | n2=en:oedema | rel=r_associated | relid=0 | w=21
  15. stase --- r_associated #0: 21 --> en:oedema
    n1=stase | n2=en:oedema | rel=r_associated | relid=0 | w=21
  16. œdème aigu cardiogénique du poumon --- r_associated #0: 20 --> en:oedema
    n1=œdème aigu cardiogénique du poumon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  17. œdème aigu du poumon --- r_associated #0: 20 --> en:oedema
    n1=œdème aigu du poumon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  18. œdème angioneurotique --- r_associated #0: 20 --> en:oedema
    n1=œdème angioneurotique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  19. œdème conjonctival --- r_associated #0: 20 --> en:oedema
    n1=œdème conjonctival | n2=en:oedema | rel=r_associated | relid=0 | w=20
  20. œdème cérébral --- r_associated #0: 20 --> en:oedema
    n1=œdème cérébral | n2=en:oedema | rel=r_associated | relid=0 | w=20
  21. œdème de Berlin --- r_associated #0: 20 --> en:oedema
    n1=œdème de Berlin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  22. œdème de Calabar --- r_associated #0: 20 --> en:oedema
    n1=œdème de Calabar | n2=en:oedema | rel=r_associated | relid=0 | w=20
  23. œdème de Quincke --- r_associated #0: 20 --> en:oedema
    n1=œdème de Quincke | n2=en:oedema | rel=r_associated | relid=0 | w=20
  24. œdème de la moelle osseuse transitoire --- r_associated #0: 20 --> en:oedema
    n1=œdème de la moelle osseuse transitoire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  25. œdème localisé --- r_associated #0: 20 --> en:oedema
    n1=œdème localisé | n2=en:oedema | rel=r_associated | relid=0 | w=20
  26. œdème maculaire cystoïde --- r_associated #0: 20 --> en:oedema
    n1=œdème maculaire cystoïde | n2=en:oedema | rel=r_associated | relid=0 | w=20
  27. œdème malin --- r_associated #0: 20 --> en:oedema
    n1=œdème malin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  28. œdème pulmonaire --- r_associated #0: 20 --> en:oedema
    n1=œdème pulmonaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  29. œdèmes --- r_associated #0: 20 --> en:oedema
    n1=œdèmes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  30. œdémateux --- r_associated #0: 20 --> en:oedema
    n1=œdémateux | n2=en:oedema | rel=r_associated | relid=0 | w=20
  31. œdématié --- r_associated #0: 20 --> en:oedema
    n1=œdématié | n2=en:oedema | rel=r_associated | relid=0 | w=20
  32. 363-364 oedèmes --- r_associated #0: 20 --> en:oedema
    n1=363-364 oedèmes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  33. Syndrome prémenstruel --- r_associated #0: 20 --> en:oedema
    n1=Syndrome prémenstruel | n2=en:oedema | rel=r_associated | relid=0 | w=20
  34. absence de sécrétion salivaire --- r_associated #0: 20 --> en:oedema
    n1=absence de sécrétion salivaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  35. accumulation --- r_associated #0: 20 --> en:oedema
    n1=accumulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  36. adiposité localisée --- r_associated #0: 20 --> en:oedema
    n1=adiposité localisée | n2=en:oedema | rel=r_associated | relid=0 | w=20
  37. adénopathies --- r_associated #0: 20 --> en:oedema
    n1=adénopathies | n2=en:oedema | rel=r_associated | relid=0 | w=20
  38. affection cardiaque --- r_associated #0: 20 --> en:oedema
    n1=affection cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=20
  39. anasarque
    (Nom)
     --- r_associated #0: 20 --> en:oedema
    n1=anasarque
    (Nom)
    | n2=en:oedema | rel=r_associated | relid=0 | w=20
  40. anomalie cardiaque --- r_associated #0: 20 --> en:oedema
    n1=anomalie cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=20
  41. anomalie du coeur --- r_associated #0: 20 --> en:oedema
    n1=anomalie du coeur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  42. anémie drépanocytaire non précisée --- r_associated #0: 20 --> en:oedema
    n1=anémie drépanocytaire non précisée | n2=en:oedema | rel=r_associated | relid=0 | w=20
  43. anémie ss --- r_associated #0: 20 --> en:oedema
    n1=anémie ss | n2=en:oedema | rel=r_associated | relid=0 | w=20
  44. anémie à hématies falciformes --- r_associated #0: 20 --> en:oedema
    n1=anémie à hématies falciformes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  45. asialie --- r_associated #0: 20 --> en:oedema
    n1=asialie | n2=en:oedema | rel=r_associated | relid=0 | w=20
  46. autres tuméfactions et masses localisées de la peau et du tissu cellulaire sous-cutané --- r_associated #0: 20 --> en:oedema
    n1=autres tuméfactions et masses localisées de la peau et du tissu cellulaire sous-cutané | n2=en:oedema | rel=r_associated | relid=0 | w=20
  47. ballonnement --- r_associated #0: 20 --> en:oedema
    n1=ballonnement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  48. un/le
    bleu
    --- r_associated #0: 20 --> en:oedema
    n1=
    un/le
    bleu
    | n2=en:oedema | rel=r_associated | relid=0 | w=20
  49. bosse --- r_associated #0: 20 --> en:oedema
    n1=bosse | n2=en:oedema | rel=r_associated | relid=0 | w=20
  50. bouche devenue sèche --- r_associated #0: 20 --> en:oedema
    n1=bouche devenue sèche | n2=en:oedema | rel=r_associated | relid=0 | w=20
  51. bouche sèche --- r_associated #0: 20 --> en:oedema
    n1=bouche sèche | n2=en:oedema | rel=r_associated | relid=0 | w=20
  52. boursoufflure --- r_associated #0: 20 --> en:oedema
    n1=boursoufflure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  53. bubon --- r_associated #0: 20 --> en:oedema
    n1=bubon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  54. bulle --- r_associated #0: 20 --> en:oedema
    n1=bulle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  55. bulle
    (vésicule)
     --- r_associated #0: 20 --> en:oedema
    n1=bulle
    (vésicule)
    | n2=en:oedema | rel=r_associated | relid=0 | w=20
  56. bêta-thalassémie à hématies falciformes --- r_associated #0: 20 --> en:oedema
    n1=bêta-thalassémie à hématies falciformes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  57. card --- r_associated #0: 20 --> en:oedema
    n1=card | n2=en:oedema | rel=r_associated | relid=0 | w=20
  58. cardiopathie --- r_associated #0: 20 --> en:oedema
    n1=cardiopathie | n2=en:oedema | rel=r_associated | relid=0 | w=20
  59. cloque --- r_associated #0: 20 --> en:oedema
    n1=cloque | n2=en:oedema | rel=r_associated | relid=0 | w=20
  60. dilatation --- r_associated #0: 20 --> en:oedema
    n1=dilatation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  61. drainage lymphatique --- r_associated #0: 20 --> en:oedema
    n1=drainage lymphatique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  62. drépanocytose homozygote --- r_associated #0: 20 --> en:oedema
    n1=drépanocytose homozygote | n2=en:oedema | rel=r_associated | relid=0 | w=20
  63. drépanocytoses --- r_associated #0: 20 --> en:oedema
    n1=drépanocytoses | n2=en:oedema | rel=r_associated | relid=0 | w=20
  64. en:'hanging' big toe --- r_associated #0: 20 --> en:oedema
    n1=en:'hanging' big toe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  65. en:'ice-pick marks' --- r_associated #0: 20 --> en:oedema
    n1=en:'ice-pick marks' | n2=en:oedema | rel=r_associated | relid=0 | w=20
  66. en:'orange peel' skin --- r_associated #0: 20 --> en:oedema
    n1=en:'orange peel' skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  67. en:'orange peel' skin (large pores) --- r_associated #0: 20 --> en:oedema
    n1=en:'orange peel' skin (large pores) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  68. en:'sloping' shoulders due to muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:'sloping' shoulders due to muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  69. en:1-5mm dark lentigines (especially neck and trunk) --- r_associated #0: 20 --> en:oedema
    n1=en:1-5mm dark lentigines (especially neck and trunk) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  70. en:1. yellowish, flat papules (neck, antecubital and popliteal fossae, axillae, inguinal, and periumbilical areas) --- r_associated #0: 20 --> en:oedema
    n1=en:1. yellowish, flat papules (neck, antecubital and popliteal fossae, axillae, inguinal, and periumbilical areas) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  71. en:10 ml sodium chloride 9 mg/ml prefilled syringe --- r_associated #0: 20 --> en:oedema
    n1=en:10 ml sodium chloride 9 mg/ml prefilled syringe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  72. en:2 ml sodium chloride 9 mg/ml prefilled syringe --- r_associated #0: 20 --> en:oedema
    n1=en:2 ml sodium chloride 9 mg/ml prefilled syringe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  73. en:2. yellowish, flat plaques --- r_associated #0: 20 --> en:oedema
    n1=en:2. yellowish, flat plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  74. en:3 ml sodium chloride 9 mg/ml prefilled syringe --- r_associated #0: 20 --> en:oedema
    n1=en:3 ml sodium chloride 9 mg/ml prefilled syringe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  75. en:3. lax, wrinkled skin --- r_associated #0: 20 --> en:oedema
    n1=en:3. lax, wrinkled skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  76. en:5 ml sodium chloride 9 mg/ml prefilled syringe --- r_associated #0: 20 --> en:oedema
    n1=en:5 ml sodium chloride 9 mg/ml prefilled syringe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  77. en:50 ml sodium bicarbonate 1 meq/ml prefilled syringe --- r_associated #0: 20 --> en:oedema
    n1=en:50 ml sodium bicarbonate 1 meq/ml prefilled syringe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  78. en:70-gene signature classification --- r_associated #0: 20 --> en:oedema
    n1=en:70-gene signature classification | n2=en:oedema | rel=r_associated | relid=0 | w=20
  79. en:a subset of patients develop bilateral weakness --- r_associated #0: 20 --> en:oedema
    n1=en:a subset of patients develop bilateral weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  80. en:a subset of patients have aggravation on cold exposure ('cold paresis') --- r_associated #0: 20 --> en:oedema
    n1=en:a subset of patients have aggravation on cold exposure ('cold paresis') | n2=en:oedema | rel=r_associated | relid=0 | w=20
  81. en:abdominal muscle hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:abdominal muscle hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  82. en:abdominal pain --- r_associated #0: 20 --> en:oedema
    n1=en:abdominal pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  83. en:abdominal wall edema --- r_associated #0: 20 --> en:oedema
    n1=en:abdominal wall edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  84. en:abdominal wall muscle weakness (later onset) --- r_associated #0: 20 --> en:oedema
    n1=en:abdominal wall muscle weakness (later onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  85. en:aberrant melanosome maturation --- r_associated #0: 20 --> en:oedema
    n1=en:aberrant melanosome maturation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  86. en:aberrant skin dimples (elbows and knees) --- r_associated #0: 20 --> en:oedema
    n1=en:aberrant skin dimples (elbows and knees) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  87. en:abnormal accumulation of fluid --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal accumulation of fluid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  88. en:abnormal aggregates of desmin and filamin c --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal aggregates of desmin and filamin c | n2=en:oedema | rel=r_associated | relid=0 | w=20
  89. en:abnormal aggregation of mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal aggregation of mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  90. en:abnormal alignment of collagen bundles --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal alignment of collagen bundles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  91. en:abnormal axons with sprouting and swelling --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal axons with sprouting and swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  92. en:abnormal blistering of the skin --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal blistering of the skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  93. en:abnormal breathing --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal breathing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  94. en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton | n2=en:oedema | rel=r_associated | relid=0 | w=20
  95. en:abnormal distribution of subcutaneous fat --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal distribution of subcutaneous fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  96. en:abnormal fat accumulation below the triceps (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal fat accumulation below the triceps (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  97. en:abnormal fat accumulation in axillae (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal fat accumulation in axillae (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  98. en:abnormal fat accumulation in the back (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal fat accumulation in the back (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  99. en:abnormal fat distribution --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal fat distribution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  100. en:abnormal fiber size variation seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal fiber size variation seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  101. en:abnormal finger flexion creases --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal finger flexion creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  102. en:abnormal glycosylation of alpha-dystroglycan seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal glycosylation of alpha-dystroglycan seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  103. en:abnormal granulation tissue --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal granulation tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  104. en:abnormal iron deposition in mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal iron deposition in mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  105. en:abnormal irregular myofibrillar network --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal irregular myofibrillar network | n2=en:oedema | rel=r_associated | relid=0 | w=20
  106. en:abnormal jitter seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal jitter seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  107. en:abnormal mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  108. en:abnormal mitochondria in skeletal muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal mitochondria in skeletal muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  109. en:abnormal mitochondria with loss of cristae --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal mitochondria with loss of cristae | n2=en:oedema | rel=r_associated | relid=0 | w=20
  110. en:abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  111. en:abnormal mitochondrial morphology --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal mitochondrial morphology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  112. en:abnormal mitochondrial proliferation --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal mitochondrial proliferation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  113. en:abnormal muscle fibers with amorphous, granular, or hyaline deposits --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal muscle fibers with amorphous, granular, or hyaline deposits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  114. en:abnormal pigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal pigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  115. en:abnormal sarcoplasmic reticulum elements --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal sarcoplasmic reticulum elements | n2=en:oedema | rel=r_associated | relid=0 | w=20
  116. en:abnormal secretion --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal secretion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  117. en:abnormal sensitivity to uvb wavelengths by radiation monochromator skin testing --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal sensitivity to uvb wavelengths by radiation monochromator skin testing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  118. en:abnormal subcutaneous fat tissue distribution --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal subcutaneous fat tissue distribution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  119. en:abnormal sweating due to autonomic dysfunction --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal sweating due to autonomic dysfunction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  120. en:abnormal virilization --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal virilization | n2=en:oedema | rel=r_associated | relid=0 | w=20
  121. en:abnormal vision --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal vision | n2=en:oedema | rel=r_associated | relid=0 | w=20
  122. en:abnormal z bands --- r_associated #0: 20 --> en:oedema
    n1=en:abnormal z bands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  123. en:abnormalities in myofibril organization --- r_associated #0: 20 --> en:oedema
    n1=en:abnormalities in myofibril organization | n2=en:oedema | rel=r_associated | relid=0 | w=20
  124. en:abrasion/scratch/blister --- r_associated #0: 20 --> en:oedema
    n1=en:abrasion/scratch/blister | n2=en:oedema | rel=r_associated | relid=0 | w=20
  125. en:abscess formation --- r_associated #0: 20 --> en:oedema
    n1=en:abscess formation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  126. en:abscess of skin and/or subcutaneous tissue --- r_associated #0: 20 --> en:oedema
    n1=en:abscess of skin and/or subcutaneous tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  127. en:abscesses (in skin folds that carry terminal hairs and apocrine glands including axillae, groin, anal fold, mons pubis, and scalp, but not face) --- r_associated #0: 20 --> en:oedema
    n1=en:abscesses (in skin folds that carry terminal hairs and apocrine glands including axillae, groin, anal fold, mons pubis, and scalp, but not face) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  128. en:absence of all distal creases of second to fifth digits --- r_associated #0: 20 --> en:oedema
    n1=en:absence of all distal creases of second to fifth digits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  129. en:absence of caveolin-3 staining --- r_associated #0: 20 --> en:oedema
    n1=en:absence of caveolin-3 staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  130. en:absence of collagen vi immunostaining --- r_associated #0: 20 --> en:oedema
    n1=en:absence of collagen vi immunostaining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  131. en:absence of dermopathy --- r_associated #0: 20 --> en:oedema
    n1=en:absence of dermopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  132. en:absence of gamma-sarcoglycan protein --- r_associated #0: 20 --> en:oedema
    n1=en:absence of gamma-sarcoglycan protein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  133. en:absence of interphalangeal creases --- r_associated #0: 20 --> en:oedema
    n1=en:absence of interphalangeal creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  134. en:absence of laminin alpha-2 chain in muscle --- r_associated #0: 20 --> en:oedema
    n1=en:absence of laminin alpha-2 chain in muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  135. en:absence of merosin in muscle --- r_associated #0: 20 --> en:oedema
    n1=en:absence of merosin in muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  136. en:absence of muscle pseudohypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:absence of muscle pseudohypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  137. en:absence of myotonia in infancy (congenital form) --- r_associated #0: 20 --> en:oedema
    n1=en:absence of myotonia in infancy (congenital form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  138. en:absence of necrosis --- r_associated #0: 20 --> en:oedema
    n1=en:absence of necrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  139. en:absence of normal rete ridge pattern --- r_associated #0: 20 --> en:oedema
    n1=en:absence of normal rete ridge pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  140. en:absence of pectoralis minor muscle --- r_associated #0: 20 --> en:oedema
    n1=en:absence of pectoralis minor muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  141. en:absence of pretibial myxedema --- r_associated #0: 20 --> en:oedema
    n1=en:absence of pretibial myxedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  142. en:absence of signs or symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:absence of signs or symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  143. en:absence of skin creases over distal interphalangeal (dip) joints --- r_associated #0: 20 --> en:oedema
    n1=en:absence of skin creases over distal interphalangeal (dip) joints | n2=en:oedema | rel=r_associated | relid=0 | w=20
  144. en:absence of skin creases over proximal interphalangeal (pip) joints --- r_associated #0: 20 --> en:oedema
    n1=en:absence of skin creases over proximal interphalangeal (pip) joints | n2=en:oedema | rel=r_associated | relid=0 | w=20
  145. en:absence of some scapular muscles (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:absence of some scapular muscles (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  146. en:absence of spontaneous activity at birth (severe form) --- r_associated #0: 20 --> en:oedema
    n1=en:absence of spontaneous activity at birth (severe form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  147. en:absence of subcutaneous fat --- r_associated #0: 20 --> en:oedema
    n1=en:absence of subcutaneous fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  148. en:absence of subcutaneous fat over entire body except buttocks, hips, and thighs --- r_associated #0: 20 --> en:oedema
    n1=en:absence of subcutaneous fat over entire body except buttocks, hips, and thighs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  149. en:absence of telethonin protein --- r_associated #0: 20 --> en:oedema
    n1=en:absence of telethonin protein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  150. en:absent axonal flare response after intradermal histamine injection --- r_associated #0: 20 --> en:oedema
    n1=en:absent axonal flare response after intradermal histamine injection | n2=en:oedema | rel=r_associated | relid=0 | w=20
  151. en:absent collecting duct system --- r_associated #0: 20 --> en:oedema
    n1=en:absent collecting duct system | n2=en:oedema | rel=r_associated | relid=0 | w=20
  152. en:absent dermal ridges --- r_associated #0: 20 --> en:oedema
    n1=en:absent dermal ridges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  153. en:absent distal interphalangeal creases --- r_associated #0: 20 --> en:oedema
    n1=en:absent distal interphalangeal creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  154. en:absent dorsal skin creases over affected joints --- r_associated #0: 20 --> en:oedema
    n1=en:absent dorsal skin creases over affected joints | n2=en:oedema | rel=r_associated | relid=0 | w=20
  155. en:absent fingerprints --- r_associated #0: 20 --> en:oedema
    n1=en:absent fingerprints | n2=en:oedema | rel=r_associated | relid=0 | w=20
  156. en:absent phalangeal crease --- r_associated #0: 20 --> en:oedema
    n1=en:absent phalangeal crease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  157. en:absent skin pigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:absent skin pigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  158. en:absent-mild skin hyperextensibility --- r_associated #0: 20 --> en:oedema
    n1=en:absent-mild skin hyperextensibility | n2=en:oedema | rel=r_associated | relid=0 | w=20
  159. en:acanthosis --- r_associated #0: 20 --> en:oedema
    n1=en:acanthosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  160. en:acanthosis nigricans --- r_associated #0: 20 --> en:oedema
    n1=en:acanthosis nigricans | n2=en:oedema | rel=r_associated | relid=0 | w=20
  161. en:acanthosis nigricans (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:acanthosis nigricans (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  162. en:acanthosis nigricans (uncommon) --- r_associated #0: 20 --> en:oedema
    n1=en:acanthosis nigricans (uncommon) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  163. en:acanthosis nigricans in patients with diabetes --- r_associated #0: 20 --> en:oedema
    n1=en:acanthosis nigricans in patients with diabetes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  164. en:acanthosis nigricans, axillary (in male patient) --- r_associated #0: 20 --> en:oedema
    n1=en:acanthosis nigricans, axillary (in male patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  165. en:acceptance of illness scale score --- r_associated #0: 20 --> en:oedema
    n1=en:acceptance of illness scale score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  166. en:accumulated lipid droplets seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:accumulated lipid droplets seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  167. en:accumulation of abnormal mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:accumulation of abnormal mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  168. en:accumulation of fluid --- r_associated #0: 20 --> en:oedema
    n1=en:accumulation of fluid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  169. en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin --- r_associated #0: 20 --> en:oedema
    n1=en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  170. en:accumulation of melanosomes in melanocytes --- r_associated #0: 20 --> en:oedema
    n1=en:accumulation of melanosomes in melanocytes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  171. en:accumulation of pas-positive polyglucosan material seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:accumulation of pas-positive polyglucosan material seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  172. en:acetazolamide may worsen symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:acetazolamide may worsen symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  173. en:achondrogenesis type 1a --- r_associated #0: 20 --> en:oedema
    n1=en:achondrogenesis type 1a | n2=en:oedema | rel=r_associated | relid=0 | w=20
  174. en:acne --- r_associated #0: 20 --> en:oedema
    n1=en:acne | n2=en:oedema | rel=r_associated | relid=0 | w=20
  175. en:acne, severe comedogenic --- r_associated #0: 20 --> en:oedema
    n1=en:acne, severe comedogenic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  176. en:acneform facial lesions --- r_associated #0: 20 --> en:oedema
    n1=en:acneform facial lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  177. en:acneiform lesions (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:acneiform lesions (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  178. en:acquire ability to walk and jump in childhood, but motor regression occurs later --- r_associated #0: 20 --> en:oedema
    n1=en:acquire ability to walk and jump in childhood, but motor regression occurs later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  179. en:acquired partial lipodystrophy --- r_associated #0: 20 --> en:oedema
    n1=en:acquired partial lipodystrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  180. en:acral keratosis --- r_associated #0: 20 --> en:oedema
    n1=en:acral keratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  181. en:acral ulcers --- r_associated #0: 20 --> en:oedema
    n1=en:acral ulcers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  182. en:acral violaceous plaques and nodules --- r_associated #0: 20 --> en:oedema
    n1=en:acral violaceous plaques and nodules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  183. en:acrocyanosis --- r_associated #0: 20 --> en:oedema
    n1=en:acrocyanosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  184. en:acrocyanosis of the feet (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:acrocyanosis of the feet (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  185. en:acrodermatitis enteropathica, transient, seen in breastfed offspring of affected mothers --- r_associated #0: 20 --> en:oedema
    n1=en:acrodermatitis enteropathica, transient, seen in breastfed offspring of affected mothers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  186. en:acrogeria --- r_associated #0: 20 --> en:oedema
    n1=en:acrogeria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  187. en:acrokeratosis verruciformis-like lesions on dorsum of hands --- r_associated #0: 20 --> en:oedema
    n1=en:acrokeratosis verruciformis-like lesions on dorsum of hands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  188. en:actinic (solar) keratosis --- r_associated #0: 20 --> en:oedema
    n1=en:actinic (solar) keratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  189. en:acute lymphoblastic leukemia --- r_associated #0: 20 --> en:oedema
    n1=en:acute lymphoblastic leukemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  190. en:acute myeloid leukemia --- r_associated #0: 20 --> en:oedema
    n1=en:acute myeloid leukemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  191. en:acute respiratory distress syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:acute respiratory distress syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  192. en:acute rhabdomyolysis --- r_associated #0: 20 --> en:oedema
    n1=en:acute rhabdomyolysis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  193. en:adhalin deficiency seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:adhalin deficiency seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  194. en:adipose tissue shows many adipocytes with multiple small lipid droplets rather than a normal single lipid droplet --- r_associated #0: 20 --> en:oedema
    n1=en:adipose tissue shows many adipocytes with multiple small lipid droplets rather than a normal single lipid droplet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  195. en:adiposis on mri --- r_associated #0: 20 --> en:oedema
    n1=en:adiposis on mri | n2=en:oedema | rel=r_associated | relid=0 | w=20
  196. en:administrative statuses --- r_associated #0: 20 --> en:oedema
    n1=en:administrative statuses | n2=en:oedema | rel=r_associated | relid=0 | w=20
  197. en:adson's sign --- r_associated #0: 20 --> en:oedema
    n1=en:adson's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  198. en:adverse incident contributing factor --- r_associated #0: 20 --> en:oedema
    n1=en:adverse incident contributing factor | n2=en:oedema | rel=r_associated | relid=0 | w=20
  199. en:adverse incident outcome categories --- r_associated #0: 20 --> en:oedema
    n1=en:adverse incident outcome categories | n2=en:oedema | rel=r_associated | relid=0 | w=20
  200. en:affected muscles show atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:affected muscles show atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  201. en:affects distal limb and scalp --- r_associated #0: 20 --> en:oedema
    n1=en:affects distal limb and scalp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  202. en:affects limbs and trunk --- r_associated #0: 20 --> en:oedema
    n1=en:affects limbs and trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  203. en:aggregates contain granular electron-dense material --- r_associated #0: 20 --> en:oedema
    n1=en:aggregates contain granular electron-dense material | n2=en:oedema | rel=r_associated | relid=0 | w=20
  204. en:agnosia --- r_associated #0: 20 --> en:oedema
    n1=en:agnosia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  205. en:akathisia --- r_associated #0: 20 --> en:oedema
    n1=en:akathisia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  206. en:albinism --- r_associated #0: 20 --> en:oedema
    n1=en:albinism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  207. en:albinoidism --- r_associated #0: 20 --> en:oedema
    n1=en:albinoidism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  208. en:albopapuloid lesions may occur --- r_associated #0: 20 --> en:oedema
    n1=en:albopapuloid lesions may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  209. en:alimentary edema --- r_associated #0: 20 --> en:oedema
    n1=en:alimentary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  210. en:allergic oedema --- r_associated #0: 20 --> en:oedema
    n1=en:allergic oedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  211. en:alpha fetoprotein increased --- r_associated #0: 20 --> en:oedema
    n1=en:alpha fetoprotein increased | n2=en:oedema | rel=r_associated | relid=0 | w=20
  212. en:alzheimer's disease assessment scale score --- r_associated #0: 20 --> en:oedema
    n1=en:alzheimer's disease assessment scale score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  213. en:ambulation difficulty --- r_associated #0: 20 --> en:oedema
    n1=en:ambulation difficulty | n2=en:oedema | rel=r_associated | relid=0 | w=20
  214. en:amniotic fluid --- r_associated #0: 20 --> en:oedema
    n1=en:amniotic fluid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  215. en:amorphous granulofilamentous material associated with z-discs --- r_associated #0: 20 --> en:oedema
    n1=en:amorphous granulofilamentous material associated with z-discs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  216. en:amyloid deposition in muscle fibers occurs rarely --- r_associated #0: 20 --> en:oedema
    n1=en:amyloid deposition in muscle fibers occurs rarely | n2=en:oedema | rel=r_associated | relid=0 | w=20
  217. en:amyotrophy affects c5 to t1 myotomes --- r_associated #0: 20 --> en:oedema
    n1=en:amyotrophy affects c5 to t1 myotomes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  218. en:amyotrophy of the lower limbs (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:amyotrophy of the lower limbs (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  219. en:amyotrophy of the upper limbs (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:amyotrophy of the upper limbs (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  220. en:amyotrophy, distal, upper and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:amyotrophy, distal, upper and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  221. en:amyotrophy, neurogenic --- r_associated #0: 20 --> en:oedema
    n1=en:amyotrophy, neurogenic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  222. en:anasarca --- r_associated #0: 20 --> en:oedema
    n1=en:anasarca | n2=en:oedema | rel=r_associated | relid=0 | w=20
  223. en:anatomic structures --- r_associated #0: 20 --> en:oedema
    n1=en:anatomic structures | n2=en:oedema | rel=r_associated | relid=0 | w=20
  224. en:anemia --- r_associated #0: 20 --> en:oedema
    n1=en:anemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  225. en:anemia, sickle cell --- r_associated #0: 20 --> en:oedema
    n1=en:anemia, sickle cell | n2=en:oedema | rel=r_associated | relid=0 | w=20
  226. en:aneurysm --- r_associated #0: 20 --> en:oedema
    n1=en:aneurysm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  227. en:angina --- r_associated #0: 20 --> en:oedema
    n1=en:angina | n2=en:oedema | rel=r_associated | relid=0 | w=20
  228. en:angioedema --- r_associated #0: 20 --> en:oedema
    n1=en:angioedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  229. en:angiokeratoma --- r_associated #0: 20 --> en:oedema
    n1=en:angiokeratoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  230. en:angiokeratoma corporis diffusum --- r_associated #0: 20 --> en:oedema
    n1=en:angiokeratoma corporis diffusum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  231. en:angiokeratomas (soles) --- r_associated #0: 20 --> en:oedema
    n1=en:angiokeratomas (soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  232. en:angiomatous lesions on the fingers, persistent --- r_associated #0: 20 --> en:oedema
    n1=en:angiomatous lesions on the fingers, persistent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  233. en:angioneurotic edema of larynx --- r_associated #0: 20 --> en:oedema
    n1=en:angioneurotic edema of larynx | n2=en:oedema | rel=r_associated | relid=0 | w=20
  234. en:angioplasty --- r_associated #0: 20 --> en:oedema
    n1=en:angioplasty | n2=en:oedema | rel=r_associated | relid=0 | w=20
  235. en:angular atrophic fibers --- r_associated #0: 20 --> en:oedema
    n1=en:angular atrophic fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  236. en:angulated atrophic fibers --- r_associated #0: 20 --> en:oedema
    n1=en:angulated atrophic fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  237. en:angulated atrophic muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:angulated atrophic muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  238. en:angulated fibers --- r_associated #0: 20 --> en:oedema
    n1=en:angulated fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  239. en:anhidrosis --- r_associated #0: 20 --> en:oedema
    n1=en:anhidrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  240. en:anhidrosis (in patients with hsan2d) --- r_associated #0: 20 --> en:oedema
    n1=en:anhidrosis (in patients with hsan2d) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  241. en:anhidrosis of the trunk and limbs 100% of the time --- r_associated #0: 20 --> en:oedema
    n1=en:anhidrosis of the trunk and limbs 100% of the time | n2=en:oedema | rel=r_associated | relid=0 | w=20
  242. en:anhidrosis over skin lesions (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:anhidrosis over skin lesions (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  243. en:anhidrosis, patchy --- r_associated #0: 20 --> en:oedema
    n1=en:anhidrosis, patchy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  244. en:anhidrosis, patchy, in some patients --- r_associated #0: 20 --> en:oedema
    n1=en:anhidrosis, patchy, in some patients | n2=en:oedema | rel=r_associated | relid=0 | w=20
  245. en:anhydramnios --- r_associated #0: 20 --> en:oedema
    n1=en:anhydramnios | n2=en:oedema | rel=r_associated | relid=0 | w=20
  246. en:anhydrotic ectodermal dysplasias --- r_associated #0: 20 --> en:oedema
    n1=en:anhydrotic ectodermal dysplasias | n2=en:oedema | rel=r_associated | relid=0 | w=20
  247. en:anhydrous trisodium citrate --- r_associated #0: 20 --> en:oedema
    n1=en:anhydrous trisodium citrate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  248. en:animal/human bite --- r_associated #0: 20 --> en:oedema
    n1=en:animal/human bite | n2=en:oedema | rel=r_associated | relid=0 | w=20
  249. en:ankle clonus --- r_associated #0: 20 --> en:oedema
    n1=en:ankle clonus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  250. en:ankle edema (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:ankle edema (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  251. en:ankle reflex absent --- r_associated #0: 20 --> en:oedema
    n1=en:ankle reflex absent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  252. en:annular erythematous edematous plaques --- r_associated #0: 20 --> en:oedema
    n1=en:annular erythematous edematous plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  253. en:annular lesions (3 mm to 1 cm in diameter) located on the face, neck, trunk and limbs --- r_associated #0: 20 --> en:oedema
    n1=en:annular lesions (3 mm to 1 cm in diameter) located on the face, neck, trunk and limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  254. en:anorexia adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:anorexia adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  255. en:antecubial webbing --- r_associated #0: 20 --> en:oedema
    n1=en:antecubial webbing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  256. en:anterior draw sign --- r_associated #0: 20 --> en:oedema
    n1=en:anterior draw sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  257. en:anterior tibial muscles first involved --- r_associated #0: 20 --> en:oedema
    n1=en:anterior tibial muscles first involved | n2=en:oedema | rel=r_associated | relid=0 | w=20
  258. en:anticoagulant agent --- r_associated #0: 20 --> en:oedema
    n1=en:anticoagulant agent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  259. en:antihypertensive agent --- r_associated #0: 20 --> en:oedema
    n1=en:antihypertensive agent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  260. en:aortic aneurysm --- r_associated #0: 20 --> en:oedema
    n1=en:aortic aneurysm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  261. en:aortic valve stenosis --- r_associated #0: 20 --> en:oedema
    n1=en:aortic valve stenosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  262. en:aphakic corneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:aphakic corneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  263. en:aphasia --- r_associated #0: 20 --> en:oedema
    n1=en:aphasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  264. en:aplasia cutis congenita --- r_associated #0: 20 --> en:oedema
    n1=en:aplasia cutis congenita | n2=en:oedema | rel=r_associated | relid=0 | w=20
  265. en:aplasia cutis congenita on trunk or limbs --- r_associated #0: 20 --> en:oedema
    n1=en:aplasia cutis congenita on trunk or limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  266. en:aplasia cutis congenita over posterior parietal area --- r_associated #0: 20 --> en:oedema
    n1=en:aplasia cutis congenita over posterior parietal area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  267. en:aplasia cutis of the scalp --- r_associated #0: 20 --> en:oedema
    n1=en:aplasia cutis of the scalp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  268. en:aplasia of the sweat glands --- r_associated #0: 20 --> en:oedema
    n1=en:aplasia of the sweat glands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  269. en:aplasia/hypoplastia of the eccrine sweat glands --- r_associated #0: 20 --> en:oedema
    n1=en:aplasia/hypoplastia of the eccrine sweat glands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  270. en:aplastic anemia --- r_associated #0: 20 --> en:oedema
    n1=en:aplastic anemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  271. en:apnea adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:apnea adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  272. en:apoptotic nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:apoptotic nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  273. en:application site edema --- r_associated #0: 20 --> en:oedema
    n1=en:application site edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  274. en:apraxias --- r_associated #0: 20 --> en:oedema
    n1=en:apraxias | n2=en:oedema | rel=r_associated | relid=0 | w=20
  275. en:arborescent papillomas (axillae, periumbilical area, anus, vulva) --- r_associated #0: 20 --> en:oedema
    n1=en:arborescent papillomas (axillae, periumbilical area, anus, vulva) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  276. en:areas of hypopigmentation and hyperpigmentation that do not follow blaschko lines (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:areas of hypopigmentation and hyperpigmentation that do not follow blaschko lines (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  277. en:areflexia due to muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:areflexia due to muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  278. en:areflexia of lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:areflexia of lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  279. en:arm/shoulder muscle hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:arm/shoulder muscle hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  280. en:arrhythmia --- r_associated #0: 20 --> en:oedema
    n1=en:arrhythmia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  281. en:arteriovenous hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:arteriovenous hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  282. en:arthritis --- r_associated #0: 20 --> en:oedema
    n1=en:arthritis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  283. en:ascending muscle weakness (beginning with feet and legs) --- r_associated #0: 20 --> en:oedema
    n1=en:ascending muscle weakness (beginning with feet and legs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  284. en:ascites --- r_associated #0: 20 --> en:oedema
    n1=en:ascites | n2=en:oedema | rel=r_associated | relid=0 | w=20
  285. en:ascites (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:ascites (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  286. en:ascitis --- r_associated #0: 20 --> en:oedema
    n1=en:ascitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  287. en:aspects of mortality statistics --- r_associated #0: 20 --> en:oedema
    n1=en:aspects of mortality statistics | n2=en:oedema | rel=r_associated | relid=0 | w=20
  288. en:aspects of radionuclide imaging --- r_associated #0: 20 --> en:oedema
    n1=en:aspects of radionuclide imaging | n2=en:oedema | rel=r_associated | relid=0 | w=20
  289. en:asphyxia --- r_associated #0: 20 --> en:oedema
    n1=en:asphyxia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  290. en:associated sign --- r_associated #0: 20 --> en:oedema
    n1=en:associated sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  291. en:asthenia --- r_associated #0: 20 --> en:oedema
    n1=en:asthenia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  292. en:asthmatoid wheeze --- r_associated #0: 20 --> en:oedema
    n1=en:asthmatoid wheeze | n2=en:oedema | rel=r_associated | relid=0 | w=20
  293. en:aston index score --- r_associated #0: 20 --> en:oedema
    n1=en:aston index score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  294. en:asymmetric muscle involvement --- r_associated #0: 20 --> en:oedema
    n1=en:asymmetric muscle involvement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  295. en:asymmetric, linear skin defects (anterior face and neck) --- r_associated #0: 20 --> en:oedema
    n1=en:asymmetric, linear skin defects (anterior face and neck) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  296. en:asymptomatic --- r_associated #0: 20 --> en:oedema
    n1=en:asymptomatic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  297. en:asymptomatic soft white spongy mucosal plaques with thick folded surfaces --- r_associated #0: 20 --> en:oedema
    n1=en:asymptomatic soft white spongy mucosal plaques with thick folded surfaces | n2=en:oedema | rel=r_associated | relid=0 | w=20
  298. en:atherosclerosis --- r_associated #0: 20 --> en:oedema
    n1=en:atherosclerosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  299. en:atopic dermatitis/eczema --- r_associated #0: 20 --> en:oedema
    n1=en:atopic dermatitis/eczema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  300. en:atopy --- r_associated #0: 20 --> en:oedema
    n1=en:atopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  301. en:atrial fibrillation --- r_associated #0: 20 --> en:oedema
    n1=en:atrial fibrillation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  302. en:atrial septal defect --- r_associated #0: 20 --> en:oedema
    n1=en:atrial septal defect | n2=en:oedema | rel=r_associated | relid=0 | w=20
  303. en:atrophic calf muscles --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic calf muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  304. en:atrophic fibers --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  305. en:atrophic muscle fiber on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic muscle fiber on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  306. en:atrophic muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  307. en:atrophic scar --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic scar | n2=en:oedema | rel=r_associated | relid=0 | w=20
  308. en:atrophic scarring (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic scarring (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  309. en:atrophic scarring (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic scarring (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  310. en:atrophic scarring, severe --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic scarring, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  311. en:atrophic skin over ears --- r_associated #0: 20 --> en:oedema
    n1=en:atrophic skin over ears | n2=en:oedema | rel=r_associated | relid=0 | w=20
  312. en:atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  313. en:atrophy of ankle and toe extensor (dorsiflexor) muscles --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of ankle and toe extensor (dorsiflexor) muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  314. en:atrophy of anterior compartment tibial muscles --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of anterior compartment tibial muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  315. en:atrophy of neck muscles may occur later --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of neck muscles may occur later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  316. en:atrophy of shins --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of shins | n2=en:oedema | rel=r_associated | relid=0 | w=20
  317. en:atrophy of the intrinsic foot and hand muscles --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of the intrinsic foot and hand muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  318. en:atrophy of the muscles in the anterior compartment of the lower leg --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of the muscles in the anterior compartment of the lower leg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  319. en:atrophy of the small muscles in the hands and feet --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of the small muscles in the hands and feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  320. en:atrophy of the thenar and hypothenar muscles --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of the thenar and hypothenar muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  321. en:atrophy of type 1 and type 2 fibers --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of type 1 and type 2 fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  322. en:atrophy of upper girdle muscles --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy of upper girdle muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  323. en:atrophy, mild (in some cases) --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy, mild (in some cases) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  324. en:atrophy, neurogenic muscular --- r_associated #0: 20 --> en:oedema
    n1=en:atrophy, neurogenic muscular | n2=en:oedema | rel=r_associated | relid=0 | w=20
  325. en:attacks last 4 to 24 hours --- r_associated #0: 20 --> en:oedema
    n1=en:attacks last 4 to 24 hours | n2=en:oedema | rel=r_associated | relid=0 | w=20
  326. en:attacks may present during or after sleep --- r_associated #0: 20 --> en:oedema
    n1=en:attacks may present during or after sleep | n2=en:oedema | rel=r_associated | relid=0 | w=20
  327. en:attacks of weakness --- r_associated #0: 20 --> en:oedema
    n1=en:attacks of weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  328. en:attacks precipitated by cold temperature --- r_associated #0: 20 --> en:oedema
    n1=en:attacks precipitated by cold temperature | n2=en:oedema | rel=r_associated | relid=0 | w=20
  329. en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise --- r_associated #0: 20 --> en:oedema
    n1=en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  330. en:attacks precipitated by potassium --- r_associated #0: 20 --> en:oedema
    n1=en:attacks precipitated by potassium | n2=en:oedema | rel=r_associated | relid=0 | w=20
  331. en:attacks precipitated by rest after exercise --- r_associated #0: 20 --> en:oedema
    n1=en:attacks precipitated by rest after exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  332. en:attacks relieved by potassium administration --- r_associated #0: 20 --> en:oedema
    n1=en:attacks relieved by potassium administration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  333. en:attacks usually decrease or disappear after age 40 years --- r_associated #0: 20 --> en:oedema
    n1=en:attacks usually decrease or disappear after age 40 years | n2=en:oedema | rel=r_associated | relid=0 | w=20
  334. en:atypical nevi (>5mm with irregular edge and pigmentation) --- r_associated #0: 20 --> en:oedema
    n1=en:atypical nevi (>5mm with irregular edge and pigmentation) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  335. en:atypical nevi often present in non-sun exposed areas --- r_associated #0: 20 --> en:oedema
    n1=en:atypical nevi often present in non-sun exposed areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  336. en:autoamputation of digits --- r_associated #0: 20 --> en:oedema
    n1=en:autoamputation of digits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  337. en:autophagic rimmed vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:autophagic rimmed vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  338. en:autophagic vacuoles seen on biopsy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:autophagic vacuoles seen on biopsy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  339. en:autophagic vacuoles with multilamellar structures seen on electron microscopy --- r_associated #0: 20 --> en:oedema
    n1=en:autophagic vacuoles with multilamellar structures seen on electron microscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  340. en:autophagosome --- r_associated #0: 20 --> en:oedema
    n1=en:autophagosome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  341. en:autosomal dominant cystoid macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:autosomal dominant cystoid macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  342. en:axial hypotonia (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:axial hypotonia (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  343. en:axial muscle hyperextension, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:axial muscle hyperextension, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  344. en:axial muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:axial muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  345. en:axial weakness --- r_associated #0: 20 --> en:oedema
    n1=en:axial weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  346. en:axillary apocrine gland hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:axillary apocrine gland hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  347. en:axillary freckling --- r_associated #0: 20 --> en:oedema
    n1=en:axillary freckling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  348. en:axillary pterygia --- r_associated #0: 20 --> en:oedema
    n1=en:axillary pterygia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  349. en:axillary pterygium, bilateral (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:axillary pterygium, bilateral (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  350. en:b-symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:b-symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  351. en:balance observable --- r_associated #0: 20 --> en:oedema
    n1=en:balance observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  352. en:baldness/losing hair --- r_associated #0: 20 --> en:oedema
    n1=en:baldness/losing hair | n2=en:oedema | rel=r_associated | relid=0 | w=20
  353. en:barany's sign --- r_associated #0: 20 --> en:oedema
    n1=en:barany's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  354. en:basal cell layer contains clumped keratin filaments --- r_associated #0: 20 --> en:oedema
    n1=en:basal cell layer contains clumped keratin filaments | n2=en:oedema | rel=r_associated | relid=0 | w=20
  355. en:basal cell nevus --- r_associated #0: 20 --> en:oedema
    n1=en:basal cell nevus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  356. en:basaloid follicular harmartomas --- r_associated #0: 20 --> en:oedema
    n1=en:basaloid follicular harmartomas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  357. en:bathing suit distribution of ichthyosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:bathing suit distribution of ichthyosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  358. en:bayley scales of infant development score --- r_associated #0: 20 --> en:oedema
    n1=en:bayley scales of infant development score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  359. en:bayonet sign --- r_associated #0: 20 --> en:oedema
    n1=en:bayonet sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  360. en:beck anxiety inventory score --- r_associated #0: 20 --> en:oedema
    n1=en:beck anxiety inventory score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  361. en:behcet syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:behcet syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  362. en:below normal body height --- r_associated #0: 20 --> en:oedema
    n1=en:below normal body height | n2=en:oedema | rel=r_associated | relid=0 | w=20
  363. en:benign finding --- r_associated #0: 20 --> en:oedema
    n1=en:benign finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  364. en:benign soft tissue developmental anomalies --- r_associated #0: 20 --> en:oedema
    n1=en:benign soft tissue developmental anomalies | n2=en:oedema | rel=r_associated | relid=0 | w=20
  365. en:berardinelli-seip congenital lipodystrophy --- r_associated #0: 20 --> en:oedema
    n1=en:berardinelli-seip congenital lipodystrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  366. en:biceps aplasia --- r_associated #0: 20 --> en:oedema
    n1=en:biceps aplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  367. en:biceps brachii atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:biceps brachii atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  368. en:bilateral facial weakness (congenital form) --- r_associated #0: 20 --> en:oedema
    n1=en:bilateral facial weakness (congenital form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  369. en:bilateral foot drop --- r_associated #0: 20 --> en:oedema
    n1=en:bilateral foot drop | n2=en:oedema | rel=r_associated | relid=0 | w=20
  370. en:bilateral palmar simian creases --- r_associated #0: 20 --> en:oedema
    n1=en:bilateral palmar simian creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  371. en:bilateral single palmar creases --- r_associated #0: 20 --> en:oedema
    n1=en:bilateral single palmar creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  372. en:bilateral single transverse palmar creases --- r_associated #0: 20 --> en:oedema
    n1=en:bilateral single transverse palmar creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  373. en:bilateral transverse palmar creases --- r_associated #0: 20 --> en:oedema
    n1=en:bilateral transverse palmar creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  374. en:biological regulation --- r_associated #0: 20 --> en:oedema
    n1=en:biological regulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  375. en:biopsy muscle normal --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy muscle normal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  376. en:biopsy of adipose tissue shows reduced adipocyte size --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy of adipose tissue shows reduced adipocyte size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  377. en:biopsy shows defects in pyruvate oxidation --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows defects in pyruvate oxidation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  378. en:biopsy shows degenerative changes consistent with myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows degenerative changes consistent with myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  379. en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  380. en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers or in vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows deposition of complement proteins c5b-9 of the membrane attack complex on muscle fibers or in vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  381. en:biopsy shows dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  382. en:biopsy shows myopathic and dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows myopathic and dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  383. en:biopsy shows myopathy without vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows myopathy without vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  384. en:biopsy shows nonspecific myopathy without rimmed vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows nonspecific myopathy without rimmed vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  385. en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  386. en:blanching of the fingers in response to cold --- r_associated #0: 20 --> en:oedema
    n1=en:blanching of the fingers in response to cold | n2=en:oedema | rel=r_associated | relid=0 | w=20
  387. en:bleeding diathesis --- r_associated #0: 20 --> en:oedema
    n1=en:bleeding diathesis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  388. en:blister --- r_associated #0: 20 --> en:oedema
    n1=en:blister | n2=en:oedema | rel=r_associated | relid=0 | w=20
  389. en:blistering (fingers, toes, pinnae) --- r_associated #0: 20 --> en:oedema
    n1=en:blistering (fingers, toes, pinnae) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  390. en:blistering at acral sites --- r_associated #0: 20 --> en:oedema
    n1=en:blistering at acral sites | n2=en:oedema | rel=r_associated | relid=0 | w=20
  391. en:blistering erythematous rash --- r_associated #0: 20 --> en:oedema
    n1=en:blistering erythematous rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  392. en:blistering may be generalized or localized --- r_associated #0: 20 --> en:oedema
    n1=en:blistering may be generalized or localized | n2=en:oedema | rel=r_associated | relid=0 | w=20
  393. en:blistering occurs in clusters ('herpetiform', 'arcuate') --- r_associated #0: 20 --> en:oedema
    n1=en:blistering occurs in clusters ('herpetiform', 'arcuate') | n2=en:oedema | rel=r_associated | relid=0 | w=20
  394. en:blistering of hands, elbows, feet, knees --- r_associated #0: 20 --> en:oedema
    n1=en:blistering of hands, elbows, feet, knees | n2=en:oedema | rel=r_associated | relid=0 | w=20
  395. en:blistering of palms in hot weather (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:blistering of palms in hot weather (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  396. en:blistering skin lesions, recurrent --- r_associated #0: 20 --> en:oedema
    n1=en:blistering skin lesions, recurrent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  397. en:blistering, generalized, neonatal onset --- r_associated #0: 20 --> en:oedema
    n1=en:blistering, generalized, neonatal onset | n2=en:oedema | rel=r_associated | relid=0 | w=20
  398. en:blistering, generalized, recurrent (occurs after mild physical trauma) --- r_associated #0: 20 --> en:oedema
    n1=en:blistering, generalized, recurrent (occurs after mild physical trauma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  399. en:blistering, generalized, recurrent, severe (occurs after mild physical trauma) --- r_associated #0: 20 --> en:oedema
    n1=en:blistering, generalized, recurrent, severe (occurs after mild physical trauma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  400. en:blistering, mild (occurs mainly on ankles and feet and in response to trauma) --- r_associated #0: 20 --> en:oedema
    n1=en:blistering, mild (occurs mainly on ankles and feet and in response to trauma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  401. en:blistering, recurrent --- r_associated #0: 20 --> en:oedema
    n1=en:blistering, recurrent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  402. en:blistering, recurrent, of the palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:blistering, recurrent, of the palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  403. en:blisters in sun-exposed areas --- r_associated #0: 20 --> en:oedema
    n1=en:blisters in sun-exposed areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  404. en:blood --- r_associated #0: 20 --> en:oedema
    n1=en:blood | n2=en:oedema | rel=r_associated | relid=0 | w=20
  405. en:blood clot --- r_associated #0: 20 --> en:oedema
    n1=en:blood clot | n2=en:oedema | rel=r_associated | relid=0 | w=20
  406. en:blood platelet disorders --- r_associated #0: 20 --> en:oedema
    n1=en:blood platelet disorders | n2=en:oedema | rel=r_associated | relid=0 | w=20
  407. en:blood transfusion and donation --- r_associated #0: 20 --> en:oedema
    n1=en:blood transfusion and donation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  408. en:blood vessel structure of skin --- r_associated #0: 20 --> en:oedema
    n1=en:blood vessel structure of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  409. en:blood, heart and circulation --- r_associated #0: 20 --> en:oedema
    n1=en:blood, heart and circulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  410. en:blood, lymphatics/immune system observable --- r_associated #0: 20 --> en:oedema
    n1=en:blood, lymphatics/immune system observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  411. en:blotching pigmentation of the skin (in older children) --- r_associated #0: 20 --> en:oedema
    n1=en:blotching pigmentation of the skin (in older children) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  412. en:blue nevus --- r_associated #0: 20 --> en:oedema
    n1=en:blue nevus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  413. en:bluish skin nodules --- r_associated #0: 20 --> en:oedema
    n1=en:bluish skin nodules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  414. en:bluish-red border demarcating transition to normal skin --- r_associated #0: 20 --> en:oedema
    n1=en:bluish-red border demarcating transition to normal skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  415. en:body odor --- r_associated #0: 20 --> en:oedema
    n1=en:body odor | n2=en:oedema | rel=r_associated | relid=0 | w=20
  416. en:body region observable --- r_associated #0: 20 --> en:oedema
    n1=en:body region observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  417. en:body substance discharge --- r_associated #0: 20 --> en:oedema
    n1=en:body substance discharge | n2=en:oedema | rel=r_associated | relid=0 | w=20
  418. en:body temperature associated symptom --- r_associated #0: 20 --> en:oedema
    n1=en:body temperature associated symptom | n2=en:oedema | rel=r_associated | relid=0 | w=20
  419. en:body temperature changes --- r_associated #0: 20 --> en:oedema
    n1=en:body temperature changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  420. en:body water (substance) --- r_associated #0: 20 --> en:oedema
    n1=en:body water (substance) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  421. en:body water excess --- r_associated #0: 20 --> en:oedema
    n1=en:body water excess | n2=en:oedema | rel=r_associated | relid=0 | w=20
  422. en:body weight --- r_associated #0: 20 --> en:oedema
    n1=en:body weight | n2=en:oedema | rel=r_associated | relid=0 | w=20
  423. en:both type 1 and type 2 fiber predominance has been reported --- r_associated #0: 20 --> en:oedema
    n1=en:both type 1 and type 2 fiber predominance has been reported | n2=en:oedema | rel=r_associated | relid=0 | w=20
  424. en:bovine atypical interstitial pneumonia --- r_associated #0: 20 --> en:oedema
    n1=en:bovine atypical interstitial pneumonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  425. en:brain aneurysm --- r_associated #0: 20 --> en:oedema
    n1=en:brain aneurysm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  426. en:brain edema --- r_associated #0: 20 --> en:oedema
    n1=en:brain edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  427. en:breaks in epidermal ridges of palms and fingers --- r_associated #0: 20 --> en:oedema
    n1=en:breaks in epidermal ridges of palms and fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  428. en:breast observable --- r_associated #0: 20 --> en:oedema
    n1=en:breast observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  429. en:bridge between vertical and transverse proximal palmar flexion creases --- r_associated #0: 20 --> en:oedema
    n1=en:bridge between vertical and transverse proximal palmar flexion creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  430. en:bright copper-red coloration of skin (in darker-skinned individuals) --- r_associated #0: 20 --> en:oedema
    n1=en:bright copper-red coloration of skin (in darker-skinned individuals) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  431. en:broad-based gait --- r_associated #0: 20 --> en:oedema
    n1=en:broad-based gait | n2=en:oedema | rel=r_associated | relid=0 | w=20
  432. en:bronchial anastomotic edema --- r_associated #0: 20 --> en:oedema
    n1=en:bronchial anastomotic edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  433. en:brown macules in a reticulate pattern (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:brown macules in a reticulate pattern (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  434. en:brown, warty keratotic papules (trunk, scalp, forehead, flexural areas) --- r_associated #0: 20 --> en:oedema
    n1=en:brown, warty keratotic papules (trunk, scalp, forehead, flexural areas) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  435. en:brown-mclean syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:brown-mclean syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  436. en:brownish macular and lentiginous lesions, disseminated, present on extremities, trunk, and neck --- r_associated #0: 20 --> en:oedema
    n1=en:brownish macular and lentiginous lesions, disseminated, present on extremities, trunk, and neck | n2=en:oedema | rel=r_associated | relid=0 | w=20
  437. en:brownish-black macules on dorsa of hands and feet (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:brownish-black macules on dorsa of hands and feet (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  438. en:brudzinski's sign --- r_associated #0: 20 --> en:oedema
    n1=en:brudzinski's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  439. en:bruise --- r_associated #0: 20 --> en:oedema
    n1=en:bruise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  440. en:bruise/contusion intact skin --- r_associated #0: 20 --> en:oedema
    n1=en:bruise/contusion intact skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  441. en:bryant's sign - shoulder --- r_associated #0: 20 --> en:oedema
    n1=en:bryant's sign - shoulder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  442. en:buffalo hump --- r_associated #0: 20 --> en:oedema
    n1=en:buffalo hump | n2=en:oedema | rel=r_associated | relid=0 | w=20
  443. en:buffalo hump (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:buffalo hump (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  444. en:bulbar weakness --- r_associated #0: 20 --> en:oedema
    n1=en:bulbar weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  445. en:bullous, pustular dermatitis of extremities, oral, anal, and genital areas --- r_associated #0: 20 --> en:oedema
    n1=en:bullous, pustular dermatitis of extremities, oral, anal, and genital areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  446. en:burning sensation --- r_associated #0: 20 --> en:oedema
    n1=en:burning sensation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  447. en:by fourth decade, many patients need help with ambulation --- r_associated #0: 20 --> en:oedema
    n1=en:by fourth decade, many patients need help with ambulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  448. en:c/o: a swelling --- r_associated #0: 20 --> en:oedema
    n1=en:c/o: a swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  449. en:cachexia --- r_associated #0: 20 --> en:oedema
    n1=en:cachexia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  450. en:cafe au lait spot --- r_associated #0: 20 --> en:oedema
    n1=en:cafe au lait spot | n2=en:oedema | rel=r_associated | relid=0 | w=20
  451. en:cafe au lait spots (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:cafe au lait spots (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  452. en:cafe au lait spots on trunk and extremities --- r_associated #0: 20 --> en:oedema
    n1=en:cafe au lait spots on trunk and extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  453. en:cafe au lait spots, multiple --- r_associated #0: 20 --> en:oedema
    n1=en:cafe au lait spots, multiple | n2=en:oedema | rel=r_associated | relid=0 | w=20
  454. en:cafe-au-lait spot (in 1/4 patients) --- r_associated #0: 20 --> en:oedema
    n1=en:cafe-au-lait spot (in 1/4 patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  455. en:cafe-au-lait spots (93%) --- r_associated #0: 20 --> en:oedema
    n1=en:cafe-au-lait spots (93%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  456. en:cafe-au-lait spots may or may not be present --- r_associated #0: 20 --> en:oedema
    n1=en:cafe-au-lait spots may or may not be present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  457. en:cafe-au-lait spots on chest and abdomen (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:cafe-au-lait spots on chest and abdomen (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  458. en:cafe-noir spots (trunk) --- r_associated #0: 20 --> en:oedema
    n1=en:cafe-noir spots (trunk) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  459. en:calcific tendinopathy, early-onset (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:calcific tendinopathy, early-onset (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  460. en:calcification may occur --- r_associated #0: 20 --> en:oedema
    n1=en:calcification may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  461. en:calcified, ulcerating nodules --- r_associated #0: 20 --> en:oedema
    n1=en:calcified, ulcerating nodules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  462. en:calcinosis cutis --- r_associated #0: 20 --> en:oedema
    n1=en:calcinosis cutis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  463. en:calcinosis cutis metastatica --- r_associated #0: 20 --> en:oedema
    n1=en:calcinosis cutis metastatica | n2=en:oedema | rel=r_associated | relid=0 | w=20
  464. en:calculus finding --- r_associated #0: 20 --> en:oedema
    n1=en:calculus finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  465. en:calf and thigh cramping muscle pains --- r_associated #0: 20 --> en:oedema
    n1=en:calf and thigh cramping muscle pains | n2=en:oedema | rel=r_associated | relid=0 | w=20
  466. en:calf atrophy (later onset) --- r_associated #0: 20 --> en:oedema
    n1=en:calf atrophy (later onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  467. en:calf hypertrophy (early in the disease) --- r_associated #0: 20 --> en:oedema
    n1=en:calf hypertrophy (early in the disease) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  468. en:calf hypertrophy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:calf hypertrophy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  469. en:calf hypertrophy (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:calf hypertrophy (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  470. en:calf hypertrophy (reported in 1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:calf hypertrophy (reported in 1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  471. en:calf hypertrophy (uncommon) --- r_associated #0: 20 --> en:oedema
    n1=en:calf hypertrophy (uncommon) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  472. en:calf muscle discomfort --- r_associated #0: 20 --> en:oedema
    n1=en:calf muscle discomfort | n2=en:oedema | rel=r_associated | relid=0 | w=20
  473. en:calf muscle enlargement --- r_associated #0: 20 --> en:oedema
    n1=en:calf muscle enlargement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  474. en:calf muscle hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:calf muscle hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  475. en:calf muscle hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:calf muscle hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  476. en:calf muscle pseudohypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:calf muscle pseudohypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  477. en:calf muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:calf muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  478. en:calf pseudohypertrophy rare --- r_associated #0: 20 --> en:oedema
    n1=en:calf pseudohypertrophy rare | n2=en:oedema | rel=r_associated | relid=0 | w=20
  479. en:callier-azusa scale score --- r_associated #0: 20 --> en:oedema
    n1=en:callier-azusa scale score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  480. en:calluses on weight-bearing areas of soles --- r_associated #0: 20 --> en:oedema
    n1=en:calluses on weight-bearing areas of soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  481. en:candida diaper dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:candida diaper dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  482. en:candidiasis --- r_associated #0: 20 --> en:oedema
    n1=en:candidiasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  483. en:cap structures, when present, contain disorganized myofibrils and thickened z bands --- r_associated #0: 20 --> en:oedema
    n1=en:cap structures, when present, contain disorganized myofibrils and thickened z bands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  484. en:capillary hemangioma (forehead) --- r_associated #0: 20 --> en:oedema
    n1=en:capillary hemangioma (forehead) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  485. en:capillary hemangioma (in 1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:capillary hemangioma (in 1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  486. en:capillary leak syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:capillary leak syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  487. en:capillary malformations, small, multiple, diffuse --- r_associated #0: 20 --> en:oedema
    n1=en:capillary malformations, small, multiple, diffuse | n2=en:oedema | rel=r_associated | relid=0 | w=20
  488. en:carbuncle/furuncle --- r_associated #0: 20 --> en:oedema
    n1=en:carbuncle/furuncle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  489. en:cardiac arrest --- r_associated #0: 20 --> en:oedema
    n1=en:cardiac arrest | n2=en:oedema | rel=r_associated | relid=0 | w=20
  490. en:cardiac output, high --- r_associated #0: 20 --> en:oedema
    n1=en:cardiac output, high | n2=en:oedema | rel=r_associated | relid=0 | w=20
  491. en:cardiac rehabilitation --- r_associated #0: 20 --> en:oedema
    n1=en:cardiac rehabilitation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  492. en:cardiac resuscitation --- r_associated #0: 20 --> en:oedema
    n1=en:cardiac resuscitation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  493. en:cardiac surgery procedures --- r_associated #0: 20 --> en:oedema
    n1=en:cardiac surgery procedures | n2=en:oedema | rel=r_associated | relid=0 | w=20
  494. en:cardiomyopathy --- r_associated #0: 20 --> en:oedema
    n1=en:cardiomyopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  495. en:cardiomyopathy is not a feature --- r_associated #0: 20 --> en:oedema
    n1=en:cardiomyopathy is not a feature | n2=en:oedema | rel=r_associated | relid=0 | w=20
  496. en:cardiovascular disorder --- r_associated #0: 20 --> en:oedema
    n1=en:cardiovascular disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  497. en:cardiovascular observable --- r_associated #0: 20 --> en:oedema
    n1=en:cardiovascular observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  498. en:cardiovascular occlusion --- r_associated #0: 20 --> en:oedema
    n1=en:cardiovascular occlusion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  499. en:cardiovascular system signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:cardiovascular system signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  500. en:career interest test score --- r_associated #0: 20 --> en:oedema
    n1=en:career interest test score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  501. en:carotid artery disorder --- r_associated #0: 20 --> en:oedema
    n1=en:carotid artery disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  502. en:carpopedal spasm --- r_associated #0: 20 --> en:oedema
    n1=en:carpopedal spasm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  503. en:casq1-immunopositive inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:casq1-immunopositive inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  504. en:cavernous hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:cavernous hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  505. en:cdisc send fetal pathology findings result terminology --- r_associated #0: 20 --> en:oedema
    n1=en:cdisc send fetal pathology findings result terminology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  506. en:cdisc send non-neoplastic finding type terminology --- r_associated #0: 20 --> en:oedema
    n1=en:cdisc send non-neoplastic finding type terminology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  507. en:cdisc send terminology --- r_associated #0: 20 --> en:oedema
    n1=en:cdisc send terminology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  508. en:cellulitis --- r_associated #0: 20 --> en:oedema
    n1=en:cellulitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  509. en:cellulitis due to immunodeficiency --- r_associated #0: 20 --> en:oedema
    n1=en:cellulitis due to immunodeficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  510. en:cellulitis or infection may occur --- r_associated #0: 20 --> en:oedema
    n1=en:cellulitis or infection may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  511. en:cellulitis over affected area --- r_associated #0: 20 --> en:oedema
    n1=en:cellulitis over affected area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  512. en:cellulitis, recurrent (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:cellulitis, recurrent (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  513. en:centor criteria score --- r_associated #0: 20 --> en:oedema
    n1=en:centor criteria score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  514. en:central atrophic area has a peripheral keratotic ridge --- r_associated #0: 20 --> en:oedema
    n1=en:central atrophic area has a peripheral keratotic ridge | n2=en:oedema | rel=r_associated | relid=0 | w=20
  515. en:central cores seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:central cores seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  516. en:central nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:central nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  517. en:centralized myonuclei --- r_associated #0: 20 --> en:oedema
    n1=en:centralized myonuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  518. en:centralized nuclei may be seen --- r_associated #0: 20 --> en:oedema
    n1=en:centralized nuclei may be seen | n2=en:oedema | rel=r_associated | relid=0 | w=20
  519. en:centralized nuclei, rare --- r_associated #0: 20 --> en:oedema
    n1=en:centralized nuclei, rare | n2=en:oedema | rel=r_associated | relid=0 | w=20
  520. en:centrally located nuclei seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:centrally located nuclei seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  521. en:centrally nucleated skeletal muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:centrally nucleated skeletal muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  522. en:centrofacial/mucosal lentigines --- r_associated #0: 20 --> en:oedema
    n1=en:centrofacial/mucosal lentigines | n2=en:oedema | rel=r_associated | relid=0 | w=20
  523. en:cerebral edema --- r_associated #0: 20 --> en:oedema
    n1=en:cerebral edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  524. en:cerebral edema due to birth injury --- r_associated #0: 20 --> en:oedema
    n1=en:cerebral edema due to birth injury | n2=en:oedema | rel=r_associated | relid=0 | w=20
  525. en:cerebral edemas, vasogenic --- r_associated #0: 20 --> en:oedema
    n1=en:cerebral edemas, vasogenic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  526. en:cerebriform connective tissue nevus --- r_associated #0: 20 --> en:oedema
    n1=en:cerebriform connective tissue nevus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  527. en:cerebrovascular accident --- r_associated #0: 20 --> en:oedema
    n1=en:cerebrovascular accident | n2=en:oedema | rel=r_associated | relid=0 | w=20
  528. en:chaddock's reflex --- r_associated #0: 20 --> en:oedema
    n1=en:chaddock's reflex | n2=en:oedema | rel=r_associated | relid=0 | w=20
  529. en:chadwick's sign --- r_associated #0: 20 --> en:oedema
    n1=en:chadwick's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  530. en:changes in sarcoplasmic reticulum and t-tubules --- r_associated #0: 20 --> en:oedema
    n1=en:changes in sarcoplasmic reticulum and t-tubules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  531. en:changes in skin texture --- r_associated #0: 20 --> en:oedema
    n1=en:changes in skin texture | n2=en:oedema | rel=r_associated | relid=0 | w=20
  532. en:chemically induced --- r_associated #0: 20 --> en:oedema
    n1=en:chemically induced | n2=en:oedema | rel=r_associated | relid=0 | w=20
  533. en:chemosis --- r_associated #0: 20 --> en:oedema
    n1=en:chemosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  534. en:chest pain --- r_associated #0: 20 --> en:oedema
    n1=en:chest pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  535. en:chest tightness or pressure --- r_associated #0: 20 --> en:oedema
    n1=en:chest tightness or pressure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  536. en:chewing difficulty --- r_associated #0: 20 --> en:oedema
    n1=en:chewing difficulty | n2=en:oedema | rel=r_associated | relid=0 | w=20
  537. en:chief complaint --- r_associated #0: 20 --> en:oedema
    n1=en:chief complaint | n2=en:oedema | rel=r_associated | relid=0 | w=20
  538. en:chilblains --- r_associated #0: 20 --> en:oedema
    n1=en:chilblains | n2=en:oedema | rel=r_associated | relid=0 | w=20
  539. en:childhood health assessment questionnaire score --- r_associated #0: 20 --> en:oedema
    n1=en:childhood health assessment questionnaire score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  540. en:childhood leukemia --- r_associated #0: 20 --> en:oedema
    n1=en:childhood leukemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  541. en:chills --- r_associated #0: 20 --> en:oedema
    n1=en:chills | n2=en:oedema | rel=r_associated | relid=0 | w=20
  542. en:chin dimples --- r_associated #0: 20 --> en:oedema
    n1=en:chin dimples | n2=en:oedema | rel=r_associated | relid=0 | w=20
  543. en:choking --- r_associated #0: 20 --> en:oedema
    n1=en:choking | n2=en:oedema | rel=r_associated | relid=0 | w=20
  544. en:cholesterol --- r_associated #0: 20 --> en:oedema
    n1=en:cholesterol | n2=en:oedema | rel=r_associated | relid=0 | w=20
  545. en:chondrodysplasia punctata, x-linked dominant type --- r_associated #0: 20 --> en:oedema
    n1=en:chondrodysplasia punctata, x-linked dominant type | n2=en:oedema | rel=r_associated | relid=0 | w=20
  546. en:chronic candidiasis --- r_associated #0: 20 --> en:oedema
    n1=en:chronic candidiasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  547. en:chronic denervation seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:chronic denervation seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  548. en:chronic denervation seen on skeletal muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:chronic denervation seen on skeletal muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  549. en:chronic eczematoid rash --- r_associated #0: 20 --> en:oedema
    n1=en:chronic eczematoid rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  550. en:chronic edema --- r_associated #0: 20 --> en:oedema
    n1=en:chronic edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  551. en:chronic folliculitis --- r_associated #0: 20 --> en:oedema
    n1=en:chronic folliculitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  552. en:chronic granulomatous nodules (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:chronic granulomatous nodules (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  553. en:chronic lymphocytic leukemia --- r_associated #0: 20 --> en:oedema
    n1=en:chronic lymphocytic leukemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  554. en:chronic mucocutaneous candidiasis --- r_associated #0: 20 --> en:oedema
    n1=en:chronic mucocutaneous candidiasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  555. en:chronic myelogenous leukemia, bcr-abl1 positive --- r_associated #0: 20 --> en:oedema
    n1=en:chronic myelogenous leukemia, bcr-abl1 positive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  556. en:chronic pain --- r_associated #0: 20 --> en:oedema
    n1=en:chronic pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  557. en:chronic skin ulcer --- r_associated #0: 20 --> en:oedema
    n1=en:chronic skin ulcer | n2=en:oedema | rel=r_associated | relid=0 | w=20
  558. en:chronic weakness --- r_associated #0: 20 --> en:oedema
    n1=en:chronic weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  559. en:chronobiologic state --- r_associated #0: 20 --> en:oedema
    n1=en:chronobiologic state | n2=en:oedema | rel=r_associated | relid=0 | w=20
  560. en:chylothorax --- r_associated #0: 20 --> en:oedema
    n1=en:chylothorax | n2=en:oedema | rel=r_associated | relid=0 | w=20
  561. en:cicatrization --- r_associated #0: 20 --> en:oedema
    n1=en:cicatrization | n2=en:oedema | rel=r_associated | relid=0 | w=20
  562. en:cigarette-paper scars --- r_associated #0: 20 --> en:oedema
    n1=en:cigarette-paper scars | n2=en:oedema | rel=r_associated | relid=0 | w=20
  563. en:cinema sign --- r_associated #0: 20 --> en:oedema
    n1=en:cinema sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  564. en:circumscribed nodular and tuberous pretibial myxedema --- r_associated #0: 20 --> en:oedema
    n1=en:circumscribed nodular and tuberous pretibial myxedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  565. en:circumscribed transparent membrane on the scalp vertex may be ulcerated (other areas of the body are rarely involved) --- r_associated #0: 20 --> en:oedema
    n1=en:circumscribed transparent membrane on the scalp vertex may be ulcerated (other areas of the body are rarely involved) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  566. en:claudication --- r_associated #0: 20 --> en:oedema
    n1=en:claudication | n2=en:oedema | rel=r_associated | relid=0 | w=20
  567. en:clavus formation (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:clavus formation (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  568. en:clear gelatinous pterygia-like plaques of the nasal and temporal perilimbal bulbar conjunctiva --- r_associated #0: 20 --> en:oedema
    n1=en:clear gelatinous pterygia-like plaques of the nasal and temporal perilimbal bulbar conjunctiva | n2=en:oedema | rel=r_associated | relid=0 | w=20
  569. en:cleavage within basal keratinocytes --- r_associated #0: 20 --> en:oedema
    n1=en:cleavage within basal keratinocytes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  570. en:clinical data interchange standards consortium terminology --- r_associated #0: 20 --> en:oedema
    n1=en:clinical data interchange standards consortium terminology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  571. en:clinical history and observation findings --- r_associated #0: 20 --> en:oedema
    n1=en:clinical history and observation findings | n2=en:oedema | rel=r_associated | relid=0 | w=20
  572. en:clinical sign related to pregnancy --- r_associated #0: 20 --> en:oedema
    n1=en:clinical sign related to pregnancy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  573. en:clinical signs of congenital syphilis:find:pt:^patient:nom:cdc.cs --- r_associated #0: 20 --> en:oedema
    n1=en:clinical signs of congenital syphilis:find:pt:^patient:nom:cdc.cs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  574. en:clinical stage finding --- r_associated #0: 20 --> en:oedema
    n1=en:clinical stage finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  575. en:clinically significant macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:clinically significant macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  576. en:clumsiness --- r_associated #0: 20 --> en:oedema
    n1=en:clumsiness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  577. en:coarse skin --- r_associated #0: 20 --> en:oedema
    n1=en:coarse skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  578. en:coarse, thick skin (especially upper face and scalp) --- r_associated #0: 20 --> en:oedema
    n1=en:coarse, thick skin (especially upper face and scalp) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  579. en:coccygeal skin tags --- r_associated #0: 20 --> en:oedema
    n1=en:coccygeal skin tags | n2=en:oedema | rel=r_associated | relid=0 | w=20
  580. en:coenzyme q10 deficiency --- r_associated #0: 20 --> en:oedema
    n1=en:coenzyme q10 deficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  581. en:coenzyme q10 deficiency, primary, 3 --- r_associated #0: 20 --> en:oedema
    n1=en:coenzyme q10 deficiency, primary, 3 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  582. en:cold sensitivity has been reported --- r_associated #0: 20 --> en:oedema
    n1=en:cold sensitivity has been reported | n2=en:oedema | rel=r_associated | relid=0 | w=20
  583. en:collagen-rich connective tissue nevi (dermatofibrosis lenticularis disseminata) --- r_associated #0: 20 --> en:oedema
    n1=en:collagen-rich connective tissue nevi (dermatofibrosis lenticularis disseminata) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  584. en:collar of stokes --- r_associated #0: 20 --> en:oedema
    n1=en:collar of stokes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  585. en:collodion membrane at birth --- r_associated #0: 20 --> en:oedema
    n1=en:collodion membrane at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  586. en:collodion membrane at birth (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:collodion membrane at birth (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  587. en:collodion membrane at birth (in most patients) --- r_associated #0: 20 --> en:oedema
    n1=en:collodion membrane at birth (in most patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  588. en:collodion membrane at birth (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:collodion membrane at birth (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  589. en:collodion membrane, self-healing (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:collodion membrane, self-healing (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  590. en:collodion skin --- r_associated #0: 20 --> en:oedema
    n1=en:collodion skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  591. en:color of skin or mucosa --- r_associated #0: 20 --> en:oedema
    n1=en:color of skin or mucosa | n2=en:oedema | rel=r_associated | relid=0 | w=20
  592. en:combined mitochondrial respiratory chain deficiency (in most patients) --- r_associated #0: 20 --> en:oedema
    n1=en:combined mitochondrial respiratory chain deficiency (in most patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  593. en:combined oxidative phosphorylation deficiency 5 --- r_associated #0: 20 --> en:oedema
    n1=en:combined oxidative phosphorylation deficiency 5 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  594. en:combined oxidative phosphorylation deficiency, complexes i and iv --- r_associated #0: 20 --> en:oedema
    n1=en:combined oxidative phosphorylation deficiency, complexes i and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  595. en:comedo --- r_associated #0: 20 --> en:oedema
    n1=en:comedo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  596. en:commotio retinae --- r_associated #0: 20 --> en:oedema
    n1=en:commotio retinae | n2=en:oedema | rel=r_associated | relid=0 | w=20
  597. en:communication speech and language observable --- r_associated #0: 20 --> en:oedema
    n1=en:communication speech and language observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  598. en:complete mevalonate kinase deficiency --- r_associated #0: 20 --> en:oedema
    n1=en:complete mevalonate kinase deficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  599. en:complex v deficiency --- r_associated #0: 20 --> en:oedema
    n1=en:complex v deficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  600. en:complication aspects --- r_associated #0: 20 --> en:oedema
    n1=en:complication aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  601. en:concussion and edema of cervical spinal cord --- r_associated #0: 20 --> en:oedema
    n1=en:concussion and edema of cervical spinal cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  602. en:concussion and edema of lumbar spinal cord --- r_associated #0: 20 --> en:oedema
    n1=en:concussion and edema of lumbar spinal cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  603. en:concussion and edema of thoracic spinal cord --- r_associated #0: 20 --> en:oedema
    n1=en:concussion and edema of thoracic spinal cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  604. en:confetti-like hypopigmented macules --- r_associated #0: 20 --> en:oedema
    n1=en:confetti-like hypopigmented macules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  605. en:congenital absence of gluteal muscles --- r_associated #0: 20 --> en:oedema
    n1=en:congenital absence of gluteal muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  606. en:congenital absence of skin in areas --- r_associated #0: 20 --> en:oedema
    n1=en:congenital absence of skin in areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  607. en:congenital absence of skin in some areas (aplasia cutis) --- r_associated #0: 20 --> en:oedema
    n1=en:congenital absence of skin in some areas (aplasia cutis) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  608. en:congenital absence of skin on some areas (aplasia cutis) --- r_associated #0: 20 --> en:oedema
    n1=en:congenital absence of skin on some areas (aplasia cutis) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  609. en:congenital erythrokeratodermia --- r_associated #0: 20 --> en:oedema
    n1=en:congenital erythrokeratodermia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  610. en:congenital fiber-type disproportion --- r_associated #0: 20 --> en:oedema
    n1=en:congenital fiber-type disproportion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  611. en:congenital ichthyosis --- r_associated #0: 20 --> en:oedema
    n1=en:congenital ichthyosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  612. en:congenital localized absence of skin --- r_associated #0: 20 --> en:oedema
    n1=en:congenital localized absence of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  613. en:congenital mesh qualifier --- r_associated #0: 20 --> en:oedema
    n1=en:congenital mesh qualifier | n2=en:oedema | rel=r_associated | relid=0 | w=20
  614. en:congenital muscular dystrophy (disorder) --- r_associated #0: 20 --> en:oedema
    n1=en:congenital muscular dystrophy (disorder) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  615. en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years) --- r_associated #0: 20 --> en:oedema
    n1=en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  616. en:congenital or acquired anatomic abnormality --- r_associated #0: 20 --> en:oedema
    n1=en:congenital or acquired anatomic abnormality | n2=en:oedema | rel=r_associated | relid=0 | w=20
  617. en:congenital palmoplantar keratosis --- r_associated #0: 20 --> en:oedema
    n1=en:congenital palmoplantar keratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  618. en:congenital poikiloderma on face and exposed skin --- r_associated #0: 20 --> en:oedema
    n1=en:congenital poikiloderma on face and exposed skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  619. en:congenital symmetrical palmoplantar keratosis --- r_associated #0: 20 --> en:oedema
    n1=en:congenital symmetrical palmoplantar keratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  620. en:congenital, nonprogressive myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:congenital, nonprogressive myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  621. en:congestion --- r_associated #0: 20 --> en:oedema
    n1=en:congestion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  622. en:congestive heart failure --- r_associated #0: 20 --> en:oedema
    n1=en:congestive heart failure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  623. en:congophilic amyloid material --- r_associated #0: 20 --> en:oedema
    n1=en:congophilic amyloid material | n2=en:oedema | rel=r_associated | relid=0 | w=20
  624. en:congophilic deposits --- r_associated #0: 20 --> en:oedema
    n1=en:congophilic deposits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  625. en:congophilic eosinophilic inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:congophilic eosinophilic inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  626. en:congophilic inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:congophilic inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  627. en:congophilic staining --- r_associated #0: 20 --> en:oedema
    n1=en:congophilic staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  628. en:conjunctival edema --- r_associated #0: 20 --> en:oedema
    n1=en:conjunctival edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  629. en:connective tissue dysplasia --- r_associated #0: 20 --> en:oedema
    n1=en:connective tissue dysplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  630. en:connective tissue nevus --- r_associated #0: 20 --> en:oedema
    n1=en:connective tissue nevus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  631. en:constipation --- r_associated #0: 20 --> en:oedema
    n1=en:constipation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  632. en:constitutional symptom --- r_associated #0: 20 --> en:oedema
    n1=en:constitutional symptom | n2=en:oedema | rel=r_associated | relid=0 | w=20
  633. en:contact dermatitis and other eczema --- r_associated #0: 20 --> en:oedema
    n1=en:contact dermatitis and other eczema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  634. en:contact lens overwear syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:contact lens overwear syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  635. en:contraception method of partner --- r_associated #0: 20 --> en:oedema
    n1=en:contraception method of partner | n2=en:oedema | rel=r_associated | relid=0 | w=20
  636. en:contractures of distal lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:contractures of distal lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  637. en:contractures of upper limbs (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:contractures of upper limbs (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  638. en:coprophagia --- r_associated #0: 20 --> en:oedema
    n1=en:coprophagia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  639. en:cor pulmonale --- r_associated #0: 20 --> en:oedema
    n1=en:cor pulmonale | n2=en:oedema | rel=r_associated | relid=0 | w=20
  640. en:cord sign --- r_associated #0: 20 --> en:oedema
    n1=en:cord sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  641. en:cores contain densely packed myofilaments --- r_associated #0: 20 --> en:oedema
    n1=en:cores contain densely packed myofilaments | n2=en:oedema | rel=r_associated | relid=0 | w=20
  642. en:cores extend along length of muscle fiber --- r_associated #0: 20 --> en:oedema
    n1=en:cores extend along length of muscle fiber | n2=en:oedema | rel=r_associated | relid=0 | w=20
  643. en:cores have abrupt borders within normal regions of the muscle fiber --- r_associated #0: 20 --> en:oedema
    n1=en:cores have abrupt borders within normal regions of the muscle fiber | n2=en:oedema | rel=r_associated | relid=0 | w=20
  644. en:cores or minicores --- r_associated #0: 20 --> en:oedema
    n1=en:cores or minicores | n2=en:oedema | rel=r_associated | relid=0 | w=20
  645. en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber --- r_associated #0: 20 --> en:oedema
    n1=en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber | n2=en:oedema | rel=r_associated | relid=0 | w=20
  646. en:cormack and lehane system score --- r_associated #0: 20 --> en:oedema
    n1=en:cormack and lehane system score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  647. en:corneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:corneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  648. en:corneal edema due to wearing of contact lenses --- r_associated #0: 20 --> en:oedema
    n1=en:corneal edema due to wearing of contact lenses | n2=en:oedema | rel=r_associated | relid=0 | w=20
  649. en:corneal sensitivity --- r_associated #0: 20 --> en:oedema
    n1=en:corneal sensitivity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  650. en:corneal stromal wrinkles --- r_associated #0: 20 --> en:oedema
    n1=en:corneal stromal wrinkles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  651. en:corns and callus --- r_associated #0: 20 --> en:oedema
    n1=en:corns and callus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  652. en:coronary artery bypass surgery --- r_associated #0: 20 --> en:oedema
    n1=en:coronary artery bypass surgery | n2=en:oedema | rel=r_associated | relid=0 | w=20
  653. en:coronary artery disease --- r_associated #0: 20 --> en:oedema
    n1=en:coronary artery disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  654. en:cough --- r_associated #0: 20 --> en:oedema
    n1=en:cough | n2=en:oedema | rel=r_associated | relid=0 | w=20
  655. en:courvoisier's sign --- r_associated #0: 20 --> en:oedema
    n1=en:courvoisier's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  656. en:cox-deficient fibers --- r_associated #0: 20 --> en:oedema
    n1=en:cox-deficient fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  657. en:cox-depleted fibers --- r_associated #0: 20 --> en:oedema
    n1=en:cox-depleted fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  658. en:cox-negative fibers --- r_associated #0: 20 --> en:oedema
    n1=en:cox-negative fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  659. en:cox-negative fibers seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:cox-negative fibers seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  660. en:cranial muscles spared --- r_associated #0: 20 --> en:oedema
    n1=en:cranial muscles spared | n2=en:oedema | rel=r_associated | relid=0 | w=20
  661. en:creamy white skin --- r_associated #0: 20 --> en:oedema
    n1=en:creamy white skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  662. en:crossed leg raising sign --- r_associated #0: 20 --> en:oedema
    n1=en:crossed leg raising sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  663. en:crusting erythematous dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:crusting erythematous dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  664. en:cutaneous 0.5 to 1.0 cm bluish and flesh-colored papules (rarely reported) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous 0.5 to 1.0 cm bluish and flesh-colored papules (rarely reported) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  665. en:cutaneous albinism, tyrosinase-positive --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous albinism, tyrosinase-positive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  666. en:cutaneous and mucosal skin tags --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous and mucosal skin tags | n2=en:oedema | rel=r_associated | relid=0 | w=20
  667. en:cutaneous candidiasis --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous candidiasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  668. en:cutaneous capillary malformation --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous capillary malformation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  669. en:cutaneous dimples (knees, elbows, shoulders) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous dimples (knees, elbows, shoulders) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  670. en:cutaneous dimpling over bowed tibia --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous dimpling over bowed tibia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  671. en:cutaneous folliculitis --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous folliculitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  672. en:cutaneous hyperpigmentation (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous hyperpigmentation (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  673. en:cutaneous infections (staphylococcus aureus, herpes simplex) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous infections (staphylococcus aureus, herpes simplex) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  674. en:cutaneous laxity (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous laxity (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  675. en:cutaneous leiomyomata (heterozygote carriers) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous leiomyomata (heterozygote carriers) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  676. en:cutaneous leiomyosarcoma (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous leiomyosarcoma (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  677. en:cutaneous lichen amyloidosis --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous lichen amyloidosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  678. en:cutaneous mastocytosis --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous mastocytosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  679. en:cutaneous melanoma --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous melanoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  680. en:cutaneous nevi flammei (limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous nevi flammei (limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  681. en:cutaneous piloleiomyomas (may be single or multiple) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous piloleiomyomas (may be single or multiple) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  682. en:cutaneous syndactyly --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous syndactyly | n2=en:oedema | rel=r_associated | relid=0 | w=20
  683. en:cutaneous syndactyly (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous syndactyly (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  684. en:cutaneous telangiectases of face, upper chest, upper mid-back, upper extremities, and hands --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous telangiectases of face, upper chest, upper mid-back, upper extremities, and hands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  685. en:cutaneous vascular malformation --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous vascular malformation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  686. en:cutaneous vasculitis --- r_associated #0: 20 --> en:oedema
    n1=en:cutaneous vasculitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  687. en:cutis aplasia, occipital --- r_associated #0: 20 --> en:oedema
    n1=en:cutis aplasia, occipital | n2=en:oedema | rel=r_associated | relid=0 | w=20
  688. en:cutis gyrata --- r_associated #0: 20 --> en:oedema
    n1=en:cutis gyrata | n2=en:oedema | rel=r_associated | relid=0 | w=20
  689. en:cutis laxa --- r_associated #0: 20 --> en:oedema
    n1=en:cutis laxa | n2=en:oedema | rel=r_associated | relid=0 | w=20
  690. en:cutis laxa (especially hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:cutis laxa (especially hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  691. en:cutis laxa (infancy) --- r_associated #0: 20 --> en:oedema
    n1=en:cutis laxa (infancy) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  692. en:cutis laxa, hands and feet (present at birth) --- r_associated #0: 20 --> en:oedema
    n1=en:cutis laxa, hands and feet (present at birth) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  693. en:cutis marmorata --- r_associated #0: 20 --> en:oedema
    n1=en:cutis marmorata | n2=en:oedema | rel=r_associated | relid=0 | w=20
  694. en:cutis marmorata (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:cutis marmorata (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  695. en:cutis marmorata (in some) --- r_associated #0: 20 --> en:oedema
    n1=en:cutis marmorata (in some) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  696. en:cutis marmorata (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:cutis marmorata (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  697. en:cutis marmorata telangiectatica congenita --- r_associated #0: 20 --> en:oedema
    n1=en:cutis marmorata telangiectatica congenita | n2=en:oedema | rel=r_associated | relid=0 | w=20
  698. en:cutis verticis gyrata (onset age 40) --- r_associated #0: 20 --> en:oedema
    n1=en:cutis verticis gyrata (onset age 40) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  699. en:cyanosis --- r_associated #0: 20 --> en:oedema
    n1=en:cyanosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  700. en:cyanosis (25%) --- r_associated #0: 20 --> en:oedema
    n1=en:cyanosis (25%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  701. en:cyanosis due to methemoglobinemia --- r_associated #0: 20 --> en:oedema
    n1=en:cyanosis due to methemoglobinemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  702. en:cyanosis during episodes --- r_associated #0: 20 --> en:oedema
    n1=en:cyanosis during episodes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  703. en:cyanotic attacks in children --- r_associated #0: 20 --> en:oedema
    n1=en:cyanotic attacks in children | n2=en:oedema | rel=r_associated | relid=0 | w=20
  704. en:cylindromas usually occur on the scalp may coalesce into large 'turban tumors' --- r_associated #0: 20 --> en:oedema
    n1=en:cylindromas usually occur on the scalp may coalesce into large 'turban tumors' | n2=en:oedema | rel=r_associated | relid=0 | w=20
  705. en:cylindromas, multiple (face, trunk and extremities) --- r_associated #0: 20 --> en:oedema
    n1=en:cylindromas, multiple (face, trunk and extremities) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  706. en:cylindromas, multiple (usually occur on the scalp, but may also occur on the face, trunk, and extremities) --- r_associated #0: 20 --> en:oedema
    n1=en:cylindromas, multiple (usually occur on the scalp, but may also occur on the face, trunk, and extremities) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  707. en:cyst occur most often on the scalp (89%) --- r_associated #0: 20 --> en:oedema
    n1=en:cyst occur most often on the scalp (89%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  708. en:cystoid macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:cystoid macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  709. en:cysts are firm and smooth --- r_associated #0: 20 --> en:oedema
    n1=en:cysts are firm and smooth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  710. en:cysts may be multiple (70%) --- r_associated #0: 20 --> en:oedema
    n1=en:cysts may be multiple (70%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  711. en:cysts may be solitary (30%) --- r_associated #0: 20 --> en:oedema
    n1=en:cysts may be solitary (30%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  712. en:cysts may become infected (15%) --- r_associated #0: 20 --> en:oedema
    n1=en:cysts may become infected (15%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  713. en:cysts may disappear on their own (10%) --- r_associated #0: 20 --> en:oedema
    n1=en:cysts may disappear on their own (10%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  714. en:cysts may gradually increase in size --- r_associated #0: 20 --> en:oedema
    n1=en:cysts may gradually increase in size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  715. en:cysts occur less commonly on any part of the body where hair grows --- r_associated #0: 20 --> en:oedema
    n1=en:cysts occur less commonly on any part of the body where hair grows | n2=en:oedema | rel=r_associated | relid=0 | w=20
  716. en:cysts over wrist and ankle joints --- r_associated #0: 20 --> en:oedema
    n1=en:cysts over wrist and ankle joints | n2=en:oedema | rel=r_associated | relid=0 | w=20
  717. en:cytochemical and em muscle studies show large, bizarre mitochondria in striated muscle --- r_associated #0: 20 --> en:oedema
    n1=en:cytochemical and em muscle studies show large, bizarre mitochondria in striated muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  718. en:cytochrome c oxidase-negative fibers --- r_associated #0: 20 --> en:oedema
    n1=en:cytochrome c oxidase-negative fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  719. en:cytochrome-c oxidase deficiency --- r_associated #0: 20 --> en:oedema
    n1=en:cytochrome-c oxidase deficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  720. en:cytoplasmic inclusion bodies (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:cytoplasmic inclusion bodies (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  721. en:darier disease --- r_associated #0: 20 --> en:oedema
    n1=en:darier disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  722. en:dark pigmentation of knees and dorsum of hands and feet --- r_associated #0: 20 --> en:oedema
    n1=en:dark pigmentation of knees and dorsum of hands and feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  723. en:dark skin pigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:dark skin pigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  724. en:darkly pigmented skin --- r_associated #0: 20 --> en:oedema
    n1=en:darkly pigmented skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  725. en:dawbarn's sign --- r_associated #0: 20 --> en:oedema
    n1=en:dawbarn's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  726. en:de- or hypo-pigmented macules (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:de- or hypo-pigmented macules (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  727. en:deafferentation --- r_associated #0: 20 --> en:oedema
    n1=en:deafferentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  728. en:deauville five point scale score --- r_associated #0: 20 --> en:oedema
    n1=en:deauville five point scale score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  729. en:decreased ability to run --- r_associated #0: 20 --> en:oedema
    n1=en:decreased ability to run | n2=en:oedema | rel=r_associated | relid=0 | w=20
  730. en:decreased acetylcholine receptors (achr) at endplate junctional folds (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased acetylcholine receptors (achr) at endplate junctional folds (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  731. en:decreased achilles reflex --- r_associated #0: 20 --> en:oedema
    n1=en:decreased achilles reflex | n2=en:oedema | rel=r_associated | relid=0 | w=20
  732. en:decreased achr at the endplate --- r_associated #0: 20 --> en:oedema
    n1=en:decreased achr at the endplate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  733. en:decreased activities of complexes i and iv --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activities of complexes i and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  734. en:decreased activities of complexes i, iii, and iv, variable --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activities of complexes i, iii, and iv, variable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  735. en:decreased activities of mitochondrial complexes i, ii, and iii --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activities of mitochondrial complexes i, ii, and iii | n2=en:oedema | rel=r_associated | relid=0 | w=20
  736. en:decreased activities of mitochondrial complexes i, iii, and iv --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activities of mitochondrial complexes i, iii, and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  737. en:decreased activities of mitochondrial-encoded respiratory chain complexes --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activities of mitochondrial-encoded respiratory chain complexes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  738. en:decreased activities of several mitochondrial respiratory enzymes --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activities of several mitochondrial respiratory enzymes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  739. en:decreased activity and protein levels of respiratory chain complexes i, ii, iii, and iv --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity and protein levels of respiratory chain complexes i, ii, iii, and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  740. en:decreased activity of complex i and complex iv --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of complex i and complex iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  741. en:decreased activity of complexes ii+iii --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of complexes ii+iii | n2=en:oedema | rel=r_associated | relid=0 | w=20
  742. en:decreased activity of cytochrome c oxidase (in most cases) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of cytochrome c oxidase (in most cases) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  743. en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  744. en:decreased activity of cytochrome c oxidase seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of cytochrome c oxidase seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  745. en:decreased activity of mitochondrial complex i --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of mitochondrial complex i | n2=en:oedema | rel=r_associated | relid=0 | w=20
  746. en:decreased activity of mitochondrial complex iii --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of mitochondrial complex iii | n2=en:oedema | rel=r_associated | relid=0 | w=20
  747. en:decreased activity of mitochondrial complexes i and iv seen on skeletal muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of mitochondrial complexes i and iv seen on skeletal muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  748. en:decreased activity of mitochondrial respiratory complexes i, iii, and iv in muscle tissue --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv in muscle tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  749. en:decreased activity of multiple mitochondrial respiratory complex enzymes --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of multiple mitochondrial respiratory complex enzymes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  750. en:decreased activity of respiratory complex i+iii --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of respiratory complex i+iii | n2=en:oedema | rel=r_associated | relid=0 | w=20
  751. en:decreased activity of respiratory complex ii+iii --- r_associated #0: 20 --> en:oedema
    n1=en:decreased activity of respiratory complex ii+iii | n2=en:oedema | rel=r_associated | relid=0 | w=20
  752. en:decreased adipose tissue around neck --- r_associated #0: 20 --> en:oedema
    n1=en:decreased adipose tissue around neck | n2=en:oedema | rel=r_associated | relid=0 | w=20
  753. en:decreased amplitude of miniature endplate potentials (mepp) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased amplitude of miniature endplate potentials (mepp) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  754. en:decreased ant1 protein (103220) in muscle tissue --- r_associated #0: 20 --> en:oedema
    n1=en:decreased ant1 protein (103220) in muscle tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  755. en:decreased caveolae in muscle tissue --- r_associated #0: 20 --> en:oedema
    n1=en:decreased caveolae in muscle tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  756. en:decreased caveolin-3 expression on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:decreased caveolin-3 expression on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  757. en:decreased caveolin-3 expression seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:decreased caveolin-3 expression seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  758. en:decreased coenzyme q10 --- r_associated #0: 20 --> en:oedema
    n1=en:decreased coenzyme q10 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  759. en:decreased coenzyme q10 content --- r_associated #0: 20 --> en:oedema
    n1=en:decreased coenzyme q10 content | n2=en:oedema | rel=r_associated | relid=0 | w=20
  760. en:decreased coenzyme q10 levels in muscle --- r_associated #0: 20 --> en:oedema
    n1=en:decreased coenzyme q10 levels in muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  761. en:decreased collagen vi --- r_associated #0: 20 --> en:oedema
    n1=en:decreased collagen vi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  762. en:decreased complex i activity (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased complex i activity (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  763. en:decreased core body temperature --- r_associated #0: 20 --> en:oedema
    n1=en:decreased core body temperature | n2=en:oedema | rel=r_associated | relid=0 | w=20
  764. en:decreased cytochrome c oxidase (cox) activity and protein --- r_associated #0: 20 --> en:oedema
    n1=en:decreased cytochrome c oxidase (cox) activity and protein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  765. en:decreased cytochrome c oxidase activity --- r_associated #0: 20 --> en:oedema
    n1=en:decreased cytochrome c oxidase activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  766. en:decreased cytochrome c oxidase staining --- r_associated #0: 20 --> en:oedema
    n1=en:decreased cytochrome c oxidase staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  767. en:decreased density of calcium release units --- r_associated #0: 20 --> en:oedema
    n1=en:decreased density of calcium release units | n2=en:oedema | rel=r_associated | relid=0 | w=20
  768. en:decreased distal reflexes --- r_associated #0: 20 --> en:oedema
    n1=en:decreased distal reflexes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  769. en:decreased endplate potential and amplitudes --- r_associated #0: 20 --> en:oedema
    n1=en:decreased endplate potential and amplitudes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  770. en:decreased exercise tolerance --- r_associated #0: 20 --> en:oedema
    n1=en:decreased exercise tolerance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  771. en:decreased expression of the vdac1 protein --- r_associated #0: 20 --> en:oedema
    n1=en:decreased expression of the vdac1 protein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  772. en:decreased fibrinolysis (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased fibrinolysis (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  773. en:decreased flexion creases --- r_associated #0: 20 --> en:oedema
    n1=en:decreased flexion creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  774. en:decreased glutamate oxidation (about 63% of normal) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased glutamate oxidation (about 63% of normal) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  775. en:decreased glycosylation of alpha-dystroglycan --- r_associated #0: 20 --> en:oedema
    n1=en:decreased glycosylation of alpha-dystroglycan | n2=en:oedema | rel=r_associated | relid=0 | w=20
  776. en:decreased glycosylation of alpha-dystroglycan (dag1, 128239) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased glycosylation of alpha-dystroglycan (dag1, 128239) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  777. en:decreased glycosylation of alpha-dystroglycan seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:decreased glycosylation of alpha-dystroglycan seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  778. en:decreased hand grip strength --- r_associated #0: 20 --> en:oedema
    n1=en:decreased hand grip strength | n2=en:oedema | rel=r_associated | relid=0 | w=20
  779. en:decreased histidase activity --- r_associated #0: 20 --> en:oedema
    n1=en:decreased histidase activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  780. en:decreased immunostaining for alpha-sarcoglycan --- r_associated #0: 20 --> en:oedema
    n1=en:decreased immunostaining for alpha-sarcoglycan | n2=en:oedema | rel=r_associated | relid=0 | w=20
  781. en:decreased intraepithelial nerve fiber density --- r_associated #0: 20 --> en:oedema
    n1=en:decreased intraepithelial nerve fiber density | n2=en:oedema | rel=r_associated | relid=0 | w=20
  782. en:decreased lactate clearance from muscle after exercise (reported in 1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased lactate clearance from muscle after exercise (reported in 1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  783. en:decreased levels and activity of mitochondrial respiratory complexes i and iv --- r_associated #0: 20 --> en:oedema
    n1=en:decreased levels and activity of mitochondrial respiratory complexes i and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  784. en:decreased lipoic acid --- r_associated #0: 20 --> en:oedema
    n1=en:decreased lipoic acid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  785. en:decreased mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:decreased mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  786. en:decreased mitochondrial complex iii activity seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:decreased mitochondrial complex iii activity seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  787. en:decreased mitochondrial complex iv activity (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased mitochondrial complex iv activity (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  788. en:decreased mitochondrial complex v activity --- r_associated #0: 20 --> en:oedema
    n1=en:decreased mitochondrial complex v activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  789. en:decreased mitochondrial respiratory activities (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased mitochondrial respiratory activities (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  790. en:decreased mitochondrial respiratory chain complex activity --- r_associated #0: 20 --> en:oedema
    n1=en:decreased mitochondrial respiratory chain complex activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  791. en:decreased mtdna --- r_associated #0: 20 --> en:oedema
    n1=en:decreased mtdna | n2=en:oedema | rel=r_associated | relid=0 | w=20
  792. en:decreased muscle action potential after warming affected muscle --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle action potential after warming affected muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  793. en:decreased muscle bulk --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle bulk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  794. en:decreased muscle density on imaging --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle density on imaging | n2=en:oedema | rel=r_associated | relid=0 | w=20
  795. en:decreased muscle mass --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle mass | n2=en:oedema | rel=r_associated | relid=0 | w=20
  796. en:decreased muscle mass (especially in lower limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle mass (especially in lower limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  797. en:decreased muscle mass (especially of limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle mass (especially of limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  798. en:decreased muscle mass (predominantly in lower extremities) --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle mass (predominantly in lower extremities) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  799. en:decreased muscle mass in the thighs --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle mass in the thighs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  800. en:decreased muscle mass, especially distally --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle mass, especially distally | n2=en:oedema | rel=r_associated | relid=0 | w=20
  801. en:decreased muscle mitochondrial aconitase --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle mitochondrial aconitase | n2=en:oedema | rel=r_associated | relid=0 | w=20
  802. en:decreased muscle succinate dehydrogenase --- r_associated #0: 20 --> en:oedema
    n1=en:decreased muscle succinate dehydrogenase | n2=en:oedema | rel=r_associated | relid=0 | w=20
  803. en:decreased number of sweat pores --- r_associated #0: 20 --> en:oedema
    n1=en:decreased number of sweat pores | n2=en:oedema | rel=r_associated | relid=0 | w=20
  804. en:decreased numbers of type 2b fibers --- r_associated #0: 20 --> en:oedema
    n1=en:decreased numbers of type 2b fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  805. en:decreased or absent ankle reflexes --- r_associated #0: 20 --> en:oedema
    n1=en:decreased or absent ankle reflexes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  806. en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma --- r_associated #0: 20 --> en:oedema
    n1=en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  807. en:decreased palmar creases --- r_associated #0: 20 --> en:oedema
    n1=en:decreased palmar creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  808. en:decreased postsynaptic folding at the neuromuscular junction --- r_associated #0: 20 --> en:oedema
    n1=en:decreased postsynaptic folding at the neuromuscular junction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  809. en:decreased postsynaptic length --- r_associated #0: 20 --> en:oedema
    n1=en:decreased postsynaptic length | n2=en:oedema | rel=r_associated | relid=0 | w=20
  810. en:decreased respiratory complex i+iii and ii+iii activity --- r_associated #0: 20 --> en:oedema
    n1=en:decreased respiratory complex i+iii and ii+iii activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  811. en:decreased sarcolemmal immunostaining for ptrf --- r_associated #0: 20 --> en:oedema
    n1=en:decreased sarcolemmal immunostaining for ptrf | n2=en:oedema | rel=r_associated | relid=0 | w=20
  812. en:decreased shank muscle mass --- r_associated #0: 20 --> en:oedema
    n1=en:decreased shank muscle mass | n2=en:oedema | rel=r_associated | relid=0 | w=20
  813. en:decreased shoulder muscle mass --- r_associated #0: 20 --> en:oedema
    n1=en:decreased shoulder muscle mass | n2=en:oedema | rel=r_associated | relid=0 | w=20
  814. en:decreased sweating due to autonomic dysfunction --- r_associated #0: 20 --> en:oedema
    n1=en:decreased sweating due to autonomic dysfunction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  815. en:decreased sweating of palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:decreased sweating of palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  816. en:decreased thiamine pyrophosphate --- r_associated #0: 20 --> en:oedema
    n1=en:decreased thiamine pyrophosphate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  817. en:decreased urocanic acid in stratum corneum --- r_associated #0: 20 --> en:oedema
    n1=en:decreased urocanic acid in stratum corneum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  818. en:decrement of the compound muscle action potential on repetitive stimulation --- r_associated #0: 20 --> en:oedema
    n1=en:decrement of the compound muscle action potential on repetitive stimulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  819. en:decremental response of compound muscle action potential on repetitive nerve stimulation --- r_associated #0: 20 --> en:oedema
    n1=en:decremental response of compound muscle action potential on repetitive nerve stimulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  820. en:decremental response on 3-hz repetitive nerve stimulation --- r_associated #0: 20 --> en:oedema
    n1=en:decremental response on 3-hz repetitive nerve stimulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  821. en:decremental response to repetitive stimulation at neuromuscular junction --- r_associated #0: 20 --> en:oedema
    n1=en:decremental response to repetitive stimulation at neuromuscular junction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  822. en:deep finger muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:deep finger muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  823. en:deep fissures of skin creases --- r_associated #0: 20 --> en:oedema
    n1=en:deep fissures of skin creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  824. en:deep foot creases --- r_associated #0: 20 --> en:oedema
    n1=en:deep foot creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  825. en:deep palmar crease --- r_associated #0: 20 --> en:oedema
    n1=en:deep palmar crease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  826. en:deep plantar creases --- r_associated #0: 20 --> en:oedema
    n1=en:deep plantar creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  827. en:deep skin creases in toes --- r_associated #0: 20 --> en:oedema
    n1=en:deep skin creases in toes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  828. en:deep skin ulcers --- r_associated #0: 20 --> en:oedema
    n1=en:deep skin ulcers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  829. en:deep vein thrombosis --- r_associated #0: 20 --> en:oedema
    n1=en:deep vein thrombosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  830. en:defect in glycosylation of alpha-dystroglycan seen on skeletal muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:defect in glycosylation of alpha-dystroglycan seen on skeletal muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  831. en:defective glycosylation of alpha-dystroglycan seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:defective glycosylation of alpha-dystroglycan seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  832. en:defective mitochondrial oxidative phosphorylation of multiple enzymes --- r_associated #0: 20 --> en:oedema
    n1=en:defective mitochondrial oxidative phosphorylation of multiple enzymes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  833. en:defects in lipoate-containing mitochondrial enzyme complexes --- r_associated #0: 20 --> en:oedema
    n1=en:defects in lipoate-containing mitochondrial enzyme complexes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  834. en:defects in mitochondria respiratory activities, mainly complexes i, ii, and iv --- r_associated #0: 20 --> en:oedema
    n1=en:defects in mitochondria respiratory activities, mainly complexes i, ii, and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  835. en:deficiency of mitochondrial complexes i, iii, and iv --- r_associated #0: 20 --> en:oedema
    n1=en:deficiency of mitochondrial complexes i, iii, and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  836. en:deficiency of mitochondrial respiratory enzymes seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:deficiency of mitochondrial respiratory enzymes seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  837. en:deficiency of the interleukin-36 receptor antagonist --- r_associated #0: 20 --> en:oedema
    n1=en:deficiency of the interleukin-36 receptor antagonist | n2=en:oedema | rel=r_associated | relid=0 | w=20
  838. en:degenerate mitochondrial on em --- r_associated #0: 20 --> en:oedema
    n1=en:degenerate mitochondrial on em | n2=en:oedema | rel=r_associated | relid=0 | w=20
  839. en:degenerating fibers --- r_associated #0: 20 --> en:oedema
    n1=en:degenerating fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  840. en:degenerating nerve terminals --- r_associated #0: 20 --> en:oedema
    n1=en:degenerating nerve terminals | n2=en:oedema | rel=r_associated | relid=0 | w=20
  841. en:degeneration of basal epidermal cells --- r_associated #0: 20 --> en:oedema
    n1=en:degeneration of basal epidermal cells | n2=en:oedema | rel=r_associated | relid=0 | w=20
  842. en:degenerative changes with increased connective tissue --- r_associated #0: 20 --> en:oedema
    n1=en:degenerative changes with increased connective tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  843. en:degrading mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:degrading mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  844. en:degree of physical and psychological healing following burn --- r_associated #0: 20 --> en:oedema
    n1=en:degree of physical and psychological healing following burn | n2=en:oedema | rel=r_associated | relid=0 | w=20
  845. en:dehydration --- r_associated #0: 20 --> en:oedema
    n1=en:dehydration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  846. en:delayed ambulation --- r_associated #0: 20 --> en:oedema
    n1=en:delayed ambulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  847. en:delayed motor development (cvs+) --- r_associated #0: 20 --> en:oedema
    n1=en:delayed motor development (cvs+) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  848. en:deltoid muscle hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:deltoid muscle hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  849. en:denervation of skeletal muscles --- r_associated #0: 20 --> en:oedema
    n1=en:denervation of skeletal muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  850. en:dense membranous structure surrounding nuclei on electron microscopy --- r_associated #0: 20 --> en:oedema
    n1=en:dense membranous structure surrounding nuclei on electron microscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  851. en:denuded postsynaptic regions --- r_associated #0: 20 --> en:oedema
    n1=en:denuded postsynaptic regions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  852. en:dependent acrocyanosis --- r_associated #0: 20 --> en:oedema
    n1=en:dependent acrocyanosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  853. en:dependent edema --- r_associated #0: 20 --> en:oedema
    n1=en:dependent edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  854. en:dependent edema after excess fat has been present for several years --- r_associated #0: 20 --> en:oedema
    n1=en:dependent edema after excess fat has been present for several years | n2=en:oedema | rel=r_associated | relid=0 | w=20
  855. en:depigmentation/hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:depigmentation/hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  856. en:depigmented spots --- r_associated #0: 20 --> en:oedema
    n1=en:depigmented spots | n2=en:oedema | rel=r_associated | relid=0 | w=20
  857. en:depletion of mitochondrial dna --- r_associated #0: 20 --> en:oedema
    n1=en:depletion of mitochondrial dna | n2=en:oedema | rel=r_associated | relid=0 | w=20
  858. en:deposition of calcium phosphate crystals in skin and subcutaneous tissues --- r_associated #0: 20 --> en:oedema
    n1=en:deposition of calcium phosphate crystals in skin and subcutaneous tissues | n2=en:oedema | rel=r_associated | relid=0 | w=20
  859. en:deposits immunoreactive to beta-amyloid protein --- r_associated #0: 20 --> en:oedema
    n1=en:deposits immunoreactive to beta-amyloid protein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  860. en:depth of history --- r_associated #0: 20 --> en:oedema
    n1=en:depth of history | n2=en:oedema | rel=r_associated | relid=0 | w=20
  861. en:derived from hair matrix cells --- r_associated #0: 20 --> en:oedema
    n1=en:derived from hair matrix cells | n2=en:oedema | rel=r_associated | relid=0 | w=20
  862. en:dermal contractures (late complication) --- r_associated #0: 20 --> en:oedema
    n1=en:dermal contractures (late complication) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  863. en:dermal melanocytosis --- r_associated #0: 20 --> en:oedema
    n1=en:dermal melanocytosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  864. en:dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology --- r_associated #0: 20 --> en:oedema
    n1=en:dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  865. en:dermal ossification (osteoma cutis) --- r_associated #0: 20 --> en:oedema
    n1=en:dermal ossification (osteoma cutis) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  866. en:dermal translucency --- r_associated #0: 20 --> en:oedema
    n1=en:dermal translucency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  867. en:dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  868. en:dermatitis (chronic or chronically relapsing, major feature) --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis (chronic or chronically relapsing, major feature) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  869. en:dermatitis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  870. en:dermatitis acidemica --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis acidemica | n2=en:oedema | rel=r_associated | relid=0 | w=20
  871. en:dermatitis herpetiformis --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis herpetiformis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  872. en:dermatitis ichthyosiform --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis ichthyosiform | n2=en:oedema | rel=r_associated | relid=0 | w=20
  873. en:dermatitis, atopic --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis, atopic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  874. en:dermatitis, infectious, due to immunodeficiency --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis, infectious, due to immunodeficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  875. en:dermatitis, infectious, due to immunodeficiency impetigo --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis, infectious, due to immunodeficiency impetigo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  876. en:dermatitis, symmetric pattern --- r_associated #0: 20 --> en:oedema
    n1=en:dermatitis, symmetric pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  877. en:dermatographism (dermatographic urticaria) --- r_associated #0: 20 --> en:oedema
    n1=en:dermatographism (dermatographic urticaria) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  878. en:dermatomycoses --- r_associated #0: 20 --> en:oedema
    n1=en:dermatomycoses | n2=en:oedema | rel=r_associated | relid=0 | w=20
  879. en:dermatophytosis --- r_associated #0: 20 --> en:oedema
    n1=en:dermatophytosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  880. en:dermatophytosis, chronic deep dermatophytosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:dermatophytosis, chronic deep dermatophytosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  881. en:dermis --- r_associated #0: 20 --> en:oedema
    n1=en:dermis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  882. en:dermis thinning --- r_associated #0: 20 --> en:oedema
    n1=en:dermis thinning | n2=en:oedema | rel=r_associated | relid=0 | w=20
  883. en:dermo-epidermal junction --- r_associated #0: 20 --> en:oedema
    n1=en:dermo-epidermal junction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  884. en:desquamation --- r_associated #0: 20 --> en:oedema
    n1=en:desquamation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  885. en:desquamation of skin soon after birth --- r_associated #0: 20 --> en:oedema
    n1=en:desquamation of skin soon after birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  886. en:developmental dimensional and diagnostic interview score --- r_associated #0: 20 --> en:oedema
    n1=en:developmental dimensional and diagnostic interview score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  887. en:diabetic foot --- r_associated #0: 20 --> en:oedema
    n1=en:diabetic foot | n2=en:oedema | rel=r_associated | relid=0 | w=20
  888. en:diabetic heart disease --- r_associated #0: 20 --> en:oedema
    n1=en:diabetic heart disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  889. en:diabetic macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:diabetic macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  890. en:diabetic macular edema not clinically significant --- r_associated #0: 20 --> en:oedema
    n1=en:diabetic macular edema not clinically significant | n2=en:oedema | rel=r_associated | relid=0 | w=20
  891. en:diagnosis aspect --- r_associated #0: 20 --> en:oedema
    n1=en:diagnosis aspect | n2=en:oedema | rel=r_associated | relid=0 | w=20
  892. en:diaper dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:diaper dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  893. en:diaphoresis --- r_associated #0: 20 --> en:oedema
    n1=en:diaphoresis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  894. en:diaphoresis (with pheochromocytoma) --- r_associated #0: 20 --> en:oedema
    n1=en:diaphoresis (with pheochromocytoma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  895. en:diarrhea --- r_associated #0: 20 --> en:oedema
    n1=en:diarrhea | n2=en:oedema | rel=r_associated | relid=0 | w=20
  896. en:diastasis recti --- r_associated #0: 20 --> en:oedema
    n1=en:diastasis recti | n2=en:oedema | rel=r_associated | relid=0 | w=20
  897. en:dietary approaches to stop hypertension diet --- r_associated #0: 20 --> en:oedema
    n1=en:dietary approaches to stop hypertension diet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  898. en:difficulty climbing stairs, jumping, running --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty climbing stairs, jumping, running | n2=en:oedema | rel=r_associated | relid=0 | w=20
  899. en:difficulty in toe walking --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty in toe walking | n2=en:oedema | rel=r_associated | relid=0 | w=20
  900. en:difficulty raising arms --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty raising arms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  901. en:difficulty rising from a squatting position --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty rising from a squatting position | n2=en:oedema | rel=r_associated | relid=0 | w=20
  902. en:difficulty rising from chair --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty rising from chair | n2=en:oedema | rel=r_associated | relid=0 | w=20
  903. en:difficulty running --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty running | n2=en:oedema | rel=r_associated | relid=0 | w=20
  904. en:difficulty running and jumping --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty running and jumping | n2=en:oedema | rel=r_associated | relid=0 | w=20
  905. en:difficulty running or inability to run --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty running or inability to run | n2=en:oedema | rel=r_associated | relid=0 | w=20
  906. en:difficulty standing --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty standing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  907. en:difficulty walking and climbing stairs --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty walking and climbing stairs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  908. en:difficulty walking on heels occurs prior to difficulty walking on toes --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty walking on heels occurs prior to difficulty walking on toes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  909. en:difficulty walking up stairs --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty walking up stairs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  910. en:difficulty walking, running --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty walking, running | n2=en:oedema | rel=r_associated | relid=0 | w=20
  911. en:difficulty walking, running, climbing stairs --- r_associated #0: 20 --> en:oedema
    n1=en:difficulty walking, running, climbing stairs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  912. en:diffuse erythematous maculopapular rash --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse erythematous maculopapular rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  913. en:diffuse fetal skin edema --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse fetal skin edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  914. en:diffuse hyperkeratosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse hyperkeratosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  915. en:diffuse pigmentary skin mottling, mild, on trunk and proximal limbs --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse pigmentary skin mottling, mild, on trunk and proximal limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  916. en:diffuse pretibial myxedema --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse pretibial myxedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  917. en:diffuse skin atrophy (especially dorsa of hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse skin atrophy (especially dorsa of hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  918. en:diffuse skin wrinkling (especially dorsa of hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse skin wrinkling (especially dorsa of hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  919. en:diffuse telangiectasis --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse telangiectasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  920. en:diffuse yellow-orange non-epidermolytic hyperkeratosis on palms and soles (palmoplantar keratoderma) --- r_associated #0: 20 --> en:oedema
    n1=en:diffuse yellow-orange non-epidermolytic hyperkeratosis on palms and soles (palmoplantar keratoderma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  921. en:digestive system observable --- r_associated #0: 20 --> en:oedema
    n1=en:digestive system observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  922. en:digestive system signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:digestive system signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  923. en:dilated scalp veins radiating from periphery of scalp defect --- r_associated #0: 20 --> en:oedema
    n1=en:dilated scalp veins radiating from periphery of scalp defect | n2=en:oedema | rel=r_associated | relid=0 | w=20
  924. en:diminished sweating --- r_associated #0: 20 --> en:oedema
    n1=en:diminished sweating | n2=en:oedema | rel=r_associated | relid=0 | w=20
  925. en:dimple overlying knee --- r_associated #0: 20 --> en:oedema
    n1=en:dimple overlying knee | n2=en:oedema | rel=r_associated | relid=0 | w=20
  926. en:dimples (chin, buttocks) --- r_associated #0: 20 --> en:oedema
    n1=en:dimples (chin, buttocks) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  927. en:dimples (medial and lateral aspect of lower leg) --- r_associated #0: 20 --> en:oedema
    n1=en:dimples (medial and lateral aspect of lower leg) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  928. en:dimples (over bowed limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:dimples (over bowed limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  929. en:dimples over large joints --- r_associated #0: 20 --> en:oedema
    n1=en:dimples over large joints | n2=en:oedema | rel=r_associated | relid=0 | w=20
  930. en:dimples overlying contractures --- r_associated #0: 20 --> en:oedema
    n1=en:dimples overlying contractures | n2=en:oedema | rel=r_associated | relid=0 | w=20
  931. en:discoid lupus in carriers or adults with mild disease --- r_associated #0: 20 --> en:oedema
    n1=en:discoid lupus in carriers or adults with mild disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  932. en:discoid rash --- r_associated #0: 20 --> en:oedema
    n1=en:discoid rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  933. en:discomfort --- r_associated #0: 20 --> en:oedema
    n1=en:discomfort | n2=en:oedema | rel=r_associated | relid=0 | w=20
  934. en:discrete 2 to 5-mm hyper- and hypopigmented macules --- r_associated #0: 20 --> en:oedema
    n1=en:discrete 2 to 5-mm hyper- and hypopigmented macules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  935. en:disease or disorder --- r_associated #0: 20 --> en:oedema
    n1=en:disease or disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  936. en:disorder characterized by edema --- r_associated #0: 20 --> en:oedema
    n1=en:disorder characterized by edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  937. en:disorder of pericardium --- r_associated #0: 20 --> en:oedema
    n1=en:disorder of pericardium | n2=en:oedema | rel=r_associated | relid=0 | w=20
  938. en:disorganization of the myofibrillar pattern --- r_associated #0: 20 --> en:oedema
    n1=en:disorganization of the myofibrillar pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  939. en:disorganization of the neuromuscular junction --- r_associated #0: 20 --> en:oedema
    n1=en:disorganization of the neuromuscular junction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  940. en:disorganized myofilaments seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:disorganized myofilaments seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  941. en:disruption in the basal lamina seen on skeletal muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:disruption in the basal lamina seen on skeletal muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  942. en:disruption of sarcomeres with disorganization of the z band --- r_associated #0: 20 --> en:oedema
    n1=en:disruption of sarcomeres with disorganization of the z band | n2=en:oedema | rel=r_associated | relid=0 | w=20
  943. en:disruption of the m-line --- r_associated #0: 20 --> en:oedema
    n1=en:disruption of the m-line | n2=en:oedema | rel=r_associated | relid=0 | w=20
  944. en:disruption of the sarcolemmal membrane seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:disruption of the sarcolemmal membrane seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  945. en:disruption plasma membrane (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:disruption plasma membrane (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  946. en:distal amyotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:distal amyotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  947. en:distal amyotrophy (hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:distal amyotrophy (hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  948. en:distal atrophy of the legs --- r_associated #0: 20 --> en:oedema
    n1=en:distal atrophy of the legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  949. en:distal leg muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:distal leg muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  950. en:distal limb atrophy (upper and lower) --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb atrophy (upper and lower) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  951. en:distal limb muscle atrophy (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle atrophy (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  952. en:distal limb muscle atrophy due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle atrophy due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  953. en:distal limb muscle atrophy due to peripheral neuropathy (lower limbs are more affected than upper limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle atrophy due to peripheral neuropathy (lower limbs are more affected than upper limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  954. en:distal limb muscle atrophy, lower more than upper --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle atrophy, lower more than upper | n2=en:oedema | rel=r_associated | relid=0 | w=20
  955. en:distal limb muscle weakness (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle weakness (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  956. en:distal limb muscle weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  957. en:distal limb muscle weakness due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle weakness due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  958. en:distal limb muscle weakness due to peripheral neuropathy (lower limbs are more affected than upper limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle weakness due to peripheral neuropathy (lower limbs are more affected than upper limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  959. en:distal limb muscle weakness occurs later --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle weakness occurs later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  960. en:distal limb muscle weakness, lower more than upper --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscle weakness, lower more than upper | n2=en:oedema | rel=r_associated | relid=0 | w=20
  961. en:distal limb muscular atrophy due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscular atrophy due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  962. en:distal limb muscular weakness due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal limb muscular weakness due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  963. en:distal lower limb amyotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:distal lower limb amyotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  964. en:distal lower limb anterior compartment weakness --- r_associated #0: 20 --> en:oedema
    n1=en:distal lower limb anterior compartment weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  965. en:distal lower limb muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:distal lower limb muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  966. en:distal lower limb muscle weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:distal lower limb muscle weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  967. en:distal muscle atrophy (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  968. en:distal muscle atrophy (lower limbs more affected than upper limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy (lower limbs more affected than upper limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  969. en:distal muscle atrophy due to denervation --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy due to denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  970. en:distal muscle atrophy due to neurologic disease --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy due to neurologic disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  971. en:distal muscle atrophy due to neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy due to neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  972. en:distal muscle atrophy due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  973. en:distal muscle atrophy, affecting the lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy, affecting the lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  974. en:distal muscle atrophy, lower limbs more severely affected than upper limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy, lower limbs more severely affected than upper limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  975. en:distal muscle atrophy, predominantly affecting the lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy, predominantly affecting the lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  976. en:distal muscle atrophy, predominantly lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle atrophy, predominantly lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  977. en:distal muscle wasting due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle wasting due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  978. en:distal muscle wasting, mild --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle wasting, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  979. en:distal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  980. en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles) --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  981. en:distal muscle weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  982. en:distal muscle weakness and atrophy may occur, upper and lower limbs affected --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness and atrophy may occur, upper and lower limbs affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  983. en:distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  984. en:distal muscle weakness and atrophy, upper and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness and atrophy, upper and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  985. en:distal muscle weakness due to neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness due to neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  986. en:distal muscle weakness due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  987. en:distal muscle weakness in lower limbs, severe --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness in lower limbs, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  988. en:distal muscle weakness may occur --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  989. en:distal muscle weakness occurs later --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness occurs later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  990. en:distal muscle weakness, affecting the lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness, affecting the lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  991. en:distal muscle weakness, lower limbs more severely affected than upper limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness, lower limbs more severely affected than upper limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  992. en:distal muscle weakness, mild --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  993. en:distal muscle weakness, occurs initially --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness, occurs initially | n2=en:oedema | rel=r_associated | relid=0 | w=20
  994. en:distal muscle weakness, predominantly affecting the lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness, predominantly affecting the lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  995. en:distal muscle weakness, predominantly lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness, predominantly lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  996. en:distal muscle weakness, upper and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscle weakness, upper and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  997. en:distal muscles may be affected --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscles may be affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  998. en:distal muscular atrophy due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:distal muscular atrophy due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  999. en:distal myopathy (in 1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:distal myopathy (in 1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1000. en:distal painless ulcers --- r_associated #0: 20 --> en:oedema
    n1=en:distal painless ulcers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1001. en:distal skeletal muscle atrophy (after long disease duration) --- r_associated #0: 20 --> en:oedema
    n1=en:distal skeletal muscle atrophy (after long disease duration) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1002. en:distal weakness, upper and lower limbs (variable) --- r_associated #0: 20 --> en:oedema
    n1=en:distal weakness, upper and lower limbs (variable) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1003. en:distinct odor of palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:distinct odor of palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1004. en:distorted triradii of palmar skin --- r_associated #0: 20 --> en:oedema
    n1=en:distorted triradii of palmar skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1005. en:distress --- r_associated #0: 20 --> en:oedema
    n1=en:distress | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1006. en:disturbance of skin sensation --- r_associated #0: 20 --> en:oedema
    n1=en:disturbance of skin sensation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1007. en:dizziness --- r_associated #0: 20 --> en:oedema
    n1=en:dizziness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1008. en:dizziness adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:dizziness adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1009. en:dizziness and vertigo --- r_associated #0: 20 --> en:oedema
    n1=en:dizziness and vertigo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1010. en:doorbell sign --- r_associated #0: 20 --> en:oedema
    n1=en:doorbell sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1011. en:dorsal and flexor muscles of the forearm are involved --- r_associated #0: 20 --> en:oedema
    n1=en:dorsal and flexor muscles of the forearm are involved | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1012. en:dorsal hand wrinkling --- r_associated #0: 20 --> en:oedema
    n1=en:dorsal hand wrinkling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1013. en:doughy or puffy skin (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:doughy or puffy skin (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1014. en:doughy skin --- r_associated #0: 20 --> en:oedema
    n1=en:doughy skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1015. en:draining sinuses (late complication) --- r_associated #0: 20 --> en:oedema
    n1=en:draining sinuses (late complication) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1016. en:drug effect disorder --- r_associated #0: 20 --> en:oedema
    n1=en:drug effect disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1017. en:drug interaction --- r_associated #0: 20 --> en:oedema
    n1=en:drug interaction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1018. en:dry palmar skin --- r_associated #0: 20 --> en:oedema
    n1=en:dry palmar skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1019. en:dry skin --- r_associated #0: 20 --> en:oedema
    n1=en:dry skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1020. en:dry, bumpy skin --- r_associated #0: 20 --> en:oedema
    n1=en:dry, bumpy skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1021. en:dry, rough skin --- r_associated #0: 20 --> en:oedema
    n1=en:dry, rough skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1022. en:dry, scaly skin --- r_associated #0: 20 --> en:oedema
    n1=en:dry, scaly skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1023. en:dry, stiff skin --- r_associated #0: 20 --> en:oedema
    n1=en:dry, stiff skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1024. en:dry, thick skin --- r_associated #0: 20 --> en:oedema
    n1=en:dry, thick skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1025. en:duchenne muscular dystrophy (dmd, 310200) in 'complex' form --- r_associated #0: 20 --> en:oedema
    n1=en:duchenne muscular dystrophy (dmd, 310200) in 'complex' form | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1026. en:duration of recurrence-free survival --- r_associated #0: 20 --> en:oedema
    n1=en:duration of recurrence-free survival | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1027. en:duroziez's murmur --- r_associated #0: 20 --> en:oedema
    n1=en:duroziez's murmur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1028. en:dysarthria --- r_associated #0: 20 --> en:oedema
    n1=en:dysarthria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1029. en:dyshidrosis [pompholyx] --- r_associated #0: 20 --> en:oedema
    n1=en:dyshidrosis [pompholyx] | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1030. en:dyspepsia --- r_associated #0: 20 --> en:oedema
    n1=en:dyspepsia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1031. en:dysphagia --- r_associated #0: 20 --> en:oedema
    n1=en:dysphagia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1032. en:dysphasia --- r_associated #0: 20 --> en:oedema
    n1=en:dysphasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1033. en:dysphonia --- r_associated #0: 20 --> en:oedema
    n1=en:dysphonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1034. en:dyspnea --- r_associated #0: 20 --> en:oedema
    n1=en:dyspnea | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1035. en:dysseborrheic dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:dysseborrheic dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1036. en:dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1037. en:dystrophic changes may be present --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic changes may be present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1038. en:dystrophic changes occur later --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic changes occur later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1039. en:dystrophic changes on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic changes on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1040. en:dystrophic changes seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic changes seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1041. en:dystrophic changes seen on skeletal muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic changes seen on skeletal muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1042. en:dystrophic changes, mild, seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic changes, mild, seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1043. en:dystrophic features --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic features | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1044. en:dystrophic features and atrophic fibers seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic features and atrophic fibers seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1045. en:dystrophic features seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:dystrophic features seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1046. en:ear / auditory observable --- r_associated #0: 20 --> en:oedema
    n1=en:ear / auditory observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1047. en:ear skin --- r_associated #0: 20 --> en:oedema
    n1=en:ear skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1048. en:ear, nose / throat observable --- r_associated #0: 20 --> en:oedema
    n1=en:ear, nose / throat observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1049. en:early freckle-like lesions in exposed areas --- r_associated #0: 20 --> en:oedema
    n1=en:early freckle-like lesions in exposed areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1050. en:early onset skin cancer (basal cell, squamous cell and malignant melanoma) --- r_associated #0: 20 --> en:oedema
    n1=en:early onset skin cancer (basal cell, squamous cell and malignant melanoma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1051. en:easily fatigued (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:easily fatigued (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1052. en:easy bruisability of lower extremities --- r_associated #0: 20 --> en:oedema
    n1=en:easy bruisability of lower extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1053. en:easy bruising --- r_associated #0: 20 --> en:oedema
    n1=en:easy bruising | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1054. en:easy bruising (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:easy bruising (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1055. en:easy bruising (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:easy bruising (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1056. en:easy fatigability --- r_associated #0: 20 --> en:oedema
    n1=en:easy fatigability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1057. en:easy fatigability with exercise --- r_associated #0: 20 --> en:oedema
    n1=en:easy fatigability with exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1058. en:easy fatigue --- r_associated #0: 20 --> en:oedema
    n1=en:easy fatigue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1059. en:eating feeding / drinking observable --- r_associated #0: 20 --> en:oedema
    n1=en:eating feeding / drinking observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1060. en:ecchymoses common --- r_associated #0: 20 --> en:oedema
    n1=en:ecchymoses common | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1061. en:ecchymosis --- r_associated #0: 20 --> en:oedema
    n1=en:ecchymosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1062. en:ectodermal dysplasia --- r_associated #0: 20 --> en:oedema
    n1=en:ectodermal dysplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1063. en:ectodermal dystrophy --- r_associated #0: 20 --> en:oedema
    n1=en:ectodermal dystrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1064. en:ectodermal symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:ectodermal symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1065. en:eczema --- r_associated #0: 20 --> en:oedema
    n1=en:eczema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1066. en:eczema (8 of 23) --- r_associated #0: 20 --> en:oedema
    n1=en:eczema (8 of 23) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1067. en:eczema (face and flexural areas) --- r_associated #0: 20 --> en:oedema
    n1=en:eczema (face and flexural areas) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1068. en:eczema (in 1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:eczema (in 1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1069. en:eczema (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:eczema (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1070. en:eczema (perifollicular accentuation) --- r_associated #0: 20 --> en:oedema
    n1=en:eczema (perifollicular accentuation) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1071. en:eczema (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:eczema (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1072. en:eczema, severe --- r_associated #0: 20 --> en:oedema
    n1=en:eczema, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1073. en:eczema-like lesions (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:eczema-like lesions (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1074. en:edema (hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:edema (hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1075. en:edema at birth --- r_associated #0: 20 --> en:oedema
    n1=en:edema at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1076. en:edema bullosum vesicae --- r_associated #0: 20 --> en:oedema
    n1=en:edema bullosum vesicae | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1077. en:edema co-occurrent and due to nutritional deficiency --- r_associated #0: 20 --> en:oedema
    n1=en:edema co-occurrent and due to nutritional deficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1078. en:edema is present at birth and then slowly decreases --- r_associated #0: 20 --> en:oedema
    n1=en:edema is present at birth and then slowly decreases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1079. en:edema limbs --- r_associated #0: 20 --> en:oedema
    n1=en:edema limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1080. en:edema of all toes --- r_associated #0: 20 --> en:oedema
    n1=en:edema of all toes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1081. en:edema of back --- r_associated #0: 20 --> en:oedema
    n1=en:edema of back | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1082. en:edema of breast --- r_associated #0: 20 --> en:oedema
    n1=en:edema of breast | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1083. en:edema of buttock --- r_associated #0: 20 --> en:oedema
    n1=en:edema of buttock | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1084. en:edema of calf --- r_associated #0: 20 --> en:oedema
    n1=en:edema of calf | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1085. en:edema of cervical cord --- r_associated #0: 20 --> en:oedema
    n1=en:edema of cervical cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1086. en:edema of cervix --- r_associated #0: 20 --> en:oedema
    n1=en:edema of cervix | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1087. en:edema of chest wall --- r_associated #0: 20 --> en:oedema
    n1=en:edema of chest wall | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1088. en:edema of clitoris --- r_associated #0: 20 --> en:oedema
    n1=en:edema of clitoris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1089. en:edema of cornea of bilateral eyes --- r_associated #0: 20 --> en:oedema
    n1=en:edema of cornea of bilateral eyes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1090. en:edema of cornea of left eye --- r_associated #0: 20 --> en:oedema
    n1=en:edema of cornea of left eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1091. en:edema of cornea of right eye --- r_associated #0: 20 --> en:oedema
    n1=en:edema of cornea of right eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1092. en:edema of dorsum of foot --- r_associated #0: 20 --> en:oedema
    n1=en:edema of dorsum of foot | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1093. en:edema of dorsum of hand --- r_associated #0: 20 --> en:oedema
    n1=en:edema of dorsum of hand | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1094. en:edema of dorsum of hands and feet --- r_associated #0: 20 --> en:oedema
    n1=en:edema of dorsum of hands and feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1095. en:edema of ear canal --- r_associated #0: 20 --> en:oedema
    n1=en:edema of ear canal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1096. en:edema of elbow --- r_associated #0: 20 --> en:oedema
    n1=en:edema of elbow | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1097. en:edema of entire limb --- r_associated #0: 20 --> en:oedema
    n1=en:edema of entire limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1098. en:edema of extremity --- r_associated #0: 20 --> en:oedema
    n1=en:edema of extremity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1099. en:edema of extremity of sudden onset --- r_associated #0: 20 --> en:oedema
    n1=en:edema of extremity of sudden onset | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1100. en:edema of extremity with extension to trunk --- r_associated #0: 20 --> en:oedema
    n1=en:edema of extremity with extension to trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1101. en:edema of eyelid --- r_associated #0: 20 --> en:oedema
    n1=en:edema of eyelid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1102. en:edema of fetal chest wall --- r_associated #0: 20 --> en:oedema
    n1=en:edema of fetal chest wall | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1103. en:edema of fetal scalp --- r_associated #0: 20 --> en:oedema
    n1=en:edema of fetal scalp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1104. en:edema of finger --- r_associated #0: 20 --> en:oedema
    n1=en:edema of finger | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1105. en:edema of forearm --- r_associated #0: 20 --> en:oedema
    n1=en:edema of forearm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1106. en:edema of glottis --- r_associated #0: 20 --> en:oedema
    n1=en:edema of glottis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1107. en:edema of hand --- r_associated #0: 20 --> en:oedema
    n1=en:edema of hand | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1108. en:edema of knee --- r_associated #0: 20 --> en:oedema
    n1=en:edema of knee | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1109. en:edema of lower extremity --- r_associated #0: 20 --> en:oedema
    n1=en:edema of lower extremity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1110. en:edema of lower eyelid --- r_associated #0: 20 --> en:oedema
    n1=en:edema of lower eyelid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1111. en:edema of lower leg --- r_associated #0: 20 --> en:oedema
    n1=en:edema of lower leg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1112. en:edema of lumbar cord --- r_associated #0: 20 --> en:oedema
    n1=en:edema of lumbar cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1113. en:edema of male genital organs --- r_associated #0: 20 --> en:oedema
    n1=en:edema of male genital organs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1114. en:edema of mouth --- r_associated #0: 20 --> en:oedema
    n1=en:edema of mouth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1115. en:edema of nasopharynx --- r_associated #0: 20 --> en:oedema
    n1=en:edema of nasopharynx | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1116. en:edema of newborn --- r_associated #0: 20 --> en:oedema
    n1=en:edema of newborn | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1117. en:edema of nipple --- r_associated #0: 20 --> en:oedema
    n1=en:edema of nipple | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1118. en:edema of oral vestibule --- r_associated #0: 20 --> en:oedema
    n1=en:edema of oral vestibule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1119. en:edema of palm of hand --- r_associated #0: 20 --> en:oedema
    n1=en:edema of palm of hand | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1120. en:edema of penis --- r_associated #0: 20 --> en:oedema
    n1=en:edema of penis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1121. en:edema of pharynx --- r_associated #0: 20 --> en:oedema
    n1=en:edema of pharynx | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1122. en:edema of prepuce --- r_associated #0: 20 --> en:oedema
    n1=en:edema of prepuce | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1123. en:edema of sacral cord --- r_associated #0: 20 --> en:oedema
    n1=en:edema of sacral cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1124. en:edema of scrotum --- r_associated #0: 20 --> en:oedema
    n1=en:edema of scrotum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1125. en:edema of shoulder --- r_associated #0: 20 --> en:oedema
    n1=en:edema of shoulder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1126. en:edema of sole of foot --- r_associated #0: 20 --> en:oedema
    n1=en:edema of sole of foot | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1127. en:edema of spinal cord --- r_associated #0: 20 --> en:oedema
    n1=en:edema of spinal cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1128. en:edema of structure within eye --- r_associated #0: 20 --> en:oedema
    n1=en:edema of structure within eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1129. en:edema of suprapubic region --- r_associated #0: 20 --> en:oedema
    n1=en:edema of suprapubic region | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1130. en:edema of the tongue --- r_associated #0: 20 --> en:oedema
    n1=en:edema of the tongue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1131. en:edema of the upper extremity --- r_associated #0: 20 --> en:oedema
    n1=en:edema of the upper extremity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1132. en:edema of thigh --- r_associated #0: 20 --> en:oedema
    n1=en:edema of thigh | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1133. en:edema of thoracic cord --- r_associated #0: 20 --> en:oedema
    n1=en:edema of thoracic cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1134. en:edema of thumb --- r_associated #0: 20 --> en:oedema
    n1=en:edema of thumb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1135. en:edema of upper arm --- r_associated #0: 20 --> en:oedema
    n1=en:edema of upper arm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1136. en:edema of upper eyelid --- r_associated #0: 20 --> en:oedema
    n1=en:edema of upper eyelid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1137. en:edema of uvula --- r_associated #0: 20 --> en:oedema
    n1=en:edema of uvula | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1138. en:edema of vulva --- r_associated #0: 20 --> en:oedema
    n1=en:edema of vulva | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1139. en:edema of wrist --- r_associated #0: 20 --> en:oedema
    n1=en:edema of wrist | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1140. en:edema reoccurs with infections --- r_associated #0: 20 --> en:oedema
    n1=en:edema reoccurs with infections | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1141. en:edema trunk --- r_associated #0: 20 --> en:oedema
    n1=en:edema trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1142. en:edema, cardiac --- r_associated #0: 20 --> en:oedema
    n1=en:edema, cardiac | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1143. en:edema, cytotoxic cerebral --- r_associated #0: 20 --> en:oedema
    n1=en:edema, cytotoxic cerebral | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1144. en:edema, familial idiopathic, prepubertal --- r_associated #0: 20 --> en:oedema
    n1=en:edema, familial idiopathic, prepubertal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1145. en:edema, generalized --- r_associated #0: 20 --> en:oedema
    n1=en:edema, generalized | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1146. en:edema, generalized perinatal (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:edema, generalized perinatal (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1147. en:edema, not elsewhere classified in icd10cm --- r_associated #0: 20 --> en:oedema
    n1=en:edema, not elsewhere classified in icd10cm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1148. en:edema, subcutaneous, generalized --- r_associated #0: 20 --> en:oedema
    n1=en:edema, subcutaneous, generalized | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1149. en:edema:find:pt:^patient:ord:mds --- r_associated #0: 20 --> en:oedema
    n1=en:edema:find:pt:^patient:ord:mds | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1150. en:edema:finding:point in time:^patient:ordinal --- r_associated #0: 20 --> en:oedema
    n1=en:edema:finding:point in time:^patient:ordinal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1151. en:edematous hands and feet (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:edematous hands and feet (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1152. en:edematous skin --- r_associated #0: 20 --> en:oedema
    n1=en:edematous skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1153. en:effect of exposure to physical force --- r_associated #0: 20 --> en:oedema
    n1=en:effect of exposure to physical force | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1154. en:effusion --- r_associated #0: 20 --> en:oedema
    n1=en:effusion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1155. en:effusion of joint --- r_associated #0: 20 --> en:oedema
    n1=en:effusion of joint | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1156. en:effusion, joint --- r_associated #0: 20 --> en:oedema
    n1=en:effusion, joint | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1157. en:effusion, unspecified joint --- r_associated #0: 20 --> en:oedema
    n1=en:effusion, unspecified joint | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1158. en:elastin-rich connective tissue nevi (elastoma) --- r_associated #0: 20 --> en:oedema
    n1=en:elastin-rich connective tissue nevi (elastoma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1159. en:elastosis perforans serpiginosa --- r_associated #0: 20 --> en:oedema
    n1=en:elastosis perforans serpiginosa | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1160. en:elbow dimples --- r_associated #0: 20 --> en:oedema
    n1=en:elbow dimples | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1161. en:electromyogram abnormal --- r_associated #0: 20 --> en:oedema
    n1=en:electromyogram abnormal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1162. en:electromyogram normal --- r_associated #0: 20 --> en:oedema
    n1=en:electromyogram normal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1163. en:electromyographic decrements in some muscles --- r_associated #0: 20 --> en:oedema
    n1=en:electromyographic decrements in some muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1164. en:electromyography shows myotonic discharges --- r_associated #0: 20 --> en:oedema
    n1=en:electromyography shows myotonic discharges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1165. en:electron microscopy showed z-disk streaming --- r_associated #0: 20 --> en:oedema
    n1=en:electron microscopy showed z-disk streaming | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1166. en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae --- r_associated #0: 20 --> en:oedema
    n1=en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1167. en:electron microscopy shows dense material emanating from the z-disk --- r_associated #0: 20 --> en:oedema
    n1=en:electron microscopy shows dense material emanating from the z-disk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1168. en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1169. en:electrophysiologic studies show abnormal inactivation and delayed repolarization of the scn4a sodium channel --- r_associated #0: 20 --> en:oedema
    n1=en:electrophysiologic studies show abnormal inactivation and delayed repolarization of the scn4a sodium channel | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1170. en:elephantiasic pretibial myxedema --- r_associated #0: 20 --> en:oedema
    n1=en:elephantiasic pretibial myxedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1171. en:elephantiasis --- r_associated #0: 20 --> en:oedema
    n1=en:elephantiasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1172. en:elevated amniotic alpha-fetoprotein in affected fetuses with encephalocele --- r_associated #0: 20 --> en:oedema
    n1=en:elevated amniotic alpha-fetoprotein in affected fetuses with encephalocele | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1173. en:elevated amniotic fluid alpha-fetoprotein --- r_associated #0: 20 --> en:oedema
    n1=en:elevated amniotic fluid alpha-fetoprotein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1174. en:elevated chloride levels --- r_associated #0: 20 --> en:oedema
    n1=en:elevated chloride levels | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1175. en:elevated maternal serum alpha-fetoprotein --- r_associated #0: 20 --> en:oedema
    n1=en:elevated maternal serum alpha-fetoprotein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1176. en:elevated sed rate --- r_associated #0: 20 --> en:oedema
    n1=en:elevated sed rate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1177. en:embryologic --- r_associated #0: 20 --> en:oedema
    n1=en:embryologic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1178. en:emg - repetitive muscle discharges --- r_associated #0: 20 --> en:oedema
    n1=en:emg - repetitive muscle discharges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1179. en:emg and muscle biopsy shows chronic denervation of the peripheral nerves --- r_associated #0: 20 --> en:oedema
    n1=en:emg and muscle biopsy shows chronic denervation of the peripheral nerves | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1180. en:emg in myotonia permanens shows continuous myotonic activity --- r_associated #0: 20 --> en:oedema
    n1=en:emg in myotonia permanens shows continuous myotonic activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1181. en:emg may show myopathic features --- r_associated #0: 20 --> en:oedema
    n1=en:emg may show myopathic features | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1182. en:emg may show neurogenic changes --- r_associated #0: 20 --> en:oedema
    n1=en:emg may show neurogenic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1183. en:emg may showed myotonic discharges --- r_associated #0: 20 --> en:oedema
    n1=en:emg may showed myotonic discharges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1184. en:emg shows chronic denervation --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows chronic denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1185. en:emg shows decremental compound muscle action potential (cmap) in response to repetitive nerve stimulation --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows decremental compound muscle action potential (cmap) in response to repetitive nerve stimulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1186. en:emg shows denervation --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1187. en:emg shows fasciculations --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows fasciculations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1188. en:emg shows fibrillation potentials --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows fibrillation potentials | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1189. en:emg shows fibrillations --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows fibrillations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1190. en:emg shows high-frequency spontaneous discharges --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows high-frequency spontaneous discharges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1191. en:emg shows increased insertion activity and fibrillation --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows increased insertion activity and fibrillation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1192. en:emg shows myopathic and neurogenic changes --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows myopathic and neurogenic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1193. en:emg shows myopathic changes --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows myopathic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1194. en:emg shows myopathic features --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows myopathic features | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1195. en:emg shows myopathic or neurogenic changes --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows myopathic or neurogenic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1196. en:emg shows myopathic pattern --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows myopathic pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1197. en:emg shows myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1198. en:emg shows myotonic changes --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows myotonic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1199. en:emg shows myotonic discharges in the absence of clinical myotonia --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows myotonic discharges in the absence of clinical myotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1200. en:emg shows neurogenic changes --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows neurogenic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1201. en:emg shows neurogenic changes consistent with denervation --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows neurogenic changes consistent with denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1202. en:emg shows polyphasic continuous motor unit discharges --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows polyphasic continuous motor unit discharges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1203. en:emg shows reduction of voluntary recruitment --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows reduction of voluntary recruitment | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1204. en:emg shows spontaneous, repetitive electrical activity ('myotonic runs') --- r_associated #0: 20 --> en:oedema
    n1=en:emg shows spontaneous, repetitive electrical activity ('myotonic runs') | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1205. en:empty delta sign --- r_associated #0: 20 --> en:oedema
    n1=en:empty delta sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1206. en:endocarditis --- r_associated #0: 20 --> en:oedema
    n1=en:endocarditis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1207. en:endocrine system signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:endocrine system signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1208. en:endocrine, nutritional and metabolic observable --- r_associated #0: 20 --> en:oedema
    n1=en:endocrine, nutritional and metabolic observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1209. en:endolymphatic hydrops --- r_associated #0: 20 --> en:oedema
    n1=en:endolymphatic hydrops | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1210. en:endomysial fibrosis --- r_associated #0: 20 --> en:oedema
    n1=en:endomysial fibrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1211. en:enhanced secondary hyperalgesia and flare response on mustard oil application --- r_associated #0: 20 --> en:oedema
    n1=en:enhanced secondary hyperalgesia and flare response on mustard oil application | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1212. en:enlarged mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:enlarged mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1213. en:enlarged nuclei with central pallor --- r_associated #0: 20 --> en:oedema
    n1=en:enlarged nuclei with central pallor | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1214. en:enlarged terminal cisternae of the sarcoplasmic reticulum --- r_associated #0: 20 --> en:oedema
    n1=en:enlarged terminal cisternae of the sarcoplasmic reticulum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1215. en:enlarged vesicles of sarcoplasmic reticulum origin --- r_associated #0: 20 --> en:oedema
    n1=en:enlarged vesicles of sarcoplasmic reticulum origin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1216. en:enlarging abdomen --- r_associated #0: 20 --> en:oedema
    n1=en:enlarging abdomen | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1217. en:enophthalmos --- r_associated #0: 20 --> en:oedema
    n1=en:enophthalmos | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1218. en:enteropathy, familial, with villous edema and immunoglobulin g2 deficiency --- r_associated #0: 20 --> en:oedema
    n1=en:enteropathy, familial, with villous edema and immunoglobulin g2 deficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1219. en:enteroviral dermatomyositis syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:enteroviral dermatomyositis syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1220. en:entire skin --- r_associated #0: 20 --> en:oedema
    n1=en:entire skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1221. en:enuresis --- r_associated #0: 20 --> en:oedema
    n1=en:enuresis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1222. en:enzyme activity finding --- r_associated #0: 20 --> en:oedema
    n1=en:enzyme activity finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1223. en:enzymology --- r_associated #0: 20 --> en:oedema
    n1=en:enzymology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1224. en:eosinophilic disorder --- r_associated #0: 20 --> en:oedema
    n1=en:eosinophilic disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1225. en:eosinophilic inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:eosinophilic inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1226. en:epidemiologic --- r_associated #0: 20 --> en:oedema
    n1=en:epidemiologic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1227. en:epidermal derivative --- r_associated #0: 20 --> en:oedema
    n1=en:epidermal derivative | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1228. en:epidermal hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:epidermal hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1229. en:epidermal inclusion cyst --- r_associated #0: 20 --> en:oedema
    n1=en:epidermal inclusion cyst | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1230. en:epidermal nevus --- r_associated #0: 20 --> en:oedema
    n1=en:epidermal nevus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1231. en:epidermal ridges absent from palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:epidermal ridges absent from palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1232. en:epidermis --- r_associated #0: 20 --> en:oedema
    n1=en:epidermis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1233. en:epidermoid inclusion cysts --- r_associated #0: 20 --> en:oedema
    n1=en:epidermoid inclusion cysts | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1234. en:epidermolysis bullosa dystrophica --- r_associated #0: 20 --> en:oedema
    n1=en:epidermolysis bullosa dystrophica | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1235. en:epidermolysis bullosa simplex --- r_associated #0: 20 --> en:oedema
    n1=en:epidermolysis bullosa simplex | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1236. en:epidermolytic hyperkeratosis, mild --- r_associated #0: 20 --> en:oedema
    n1=en:epidermolytic hyperkeratosis, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1237. en:epidermolytic palmoplantar keratoderma --- r_associated #0: 20 --> en:oedema
    n1=en:epidermolytic palmoplantar keratoderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1238. en:episodic cold-triggered erythrocyanosis of toes and fingers --- r_associated #0: 20 --> en:oedema
    n1=en:episodic cold-triggered erythrocyanosis of toes and fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1239. en:episodic hyperhidrosis --- r_associated #0: 20 --> en:oedema
    n1=en:episodic hyperhidrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1240. en:episodic urticaria --- r_associated #0: 20 --> en:oedema
    n1=en:episodic urticaria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1241. en:episodic weakness may or may not occur independent of myotonia --- r_associated #0: 20 --> en:oedema
    n1=en:episodic weakness may or may not occur independent of myotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1242. en:episodic, nonerythematous, nonpruritic, nontender edema, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:episodic, nonerythematous, nonpruritic, nontender edema, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1243. en:episodic, nonpruritic, nonurticarial, nonpitting edema --- r_associated #0: 20 --> en:oedema
    n1=en:episodic, nonpruritic, nonurticarial, nonpitting edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1244. en:epithelial cyst --- r_associated #0: 20 --> en:oedema
    n1=en:epithelial cyst | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1245. en:equipment observable --- r_associated #0: 20 --> en:oedema
    n1=en:equipment observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1246. en:erdheim-chester disease --- r_associated #0: 20 --> en:oedema
    n1=en:erdheim-chester disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1247. en:erosion --- r_associated #0: 20 --> en:oedema
    n1=en:erosion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1248. en:erosion, generalized --- r_associated #0: 20 --> en:oedema
    n1=en:erosion, generalized | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1249. en:eruptive xanthoma --- r_associated #0: 20 --> en:oedema
    n1=en:eruptive xanthoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1250. en:erysipelas --- r_associated #0: 20 --> en:oedema
    n1=en:erysipelas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1251. en:erysipelas (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:erysipelas (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1252. en:erythema --- r_associated #0: 20 --> en:oedema
    n1=en:erythema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1253. en:erythema in affected areas --- r_associated #0: 20 --> en:oedema
    n1=en:erythema in affected areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1254. en:erythema marginatum --- r_associated #0: 20 --> en:oedema
    n1=en:erythema marginatum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1255. en:erythema nodosum --- r_associated #0: 20 --> en:oedema
    n1=en:erythema nodosum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1256. en:erythema, blisters, pustules (cyclical, explosive episodes) --- r_associated #0: 20 --> en:oedema
    n1=en:erythema, blisters, pustules (cyclical, explosive episodes) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1257. en:erythema, cold-induced --- r_associated #0: 20 --> en:oedema
    n1=en:erythema, cold-induced | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1258. en:erythema, mild to moderate (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:erythema, mild to moderate (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1259. en:erythema, residual painless --- r_associated #0: 20 --> en:oedema
    n1=en:erythema, residual painless | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1260. en:erythematous blotching, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous blotching, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1261. en:erythematous ichthyotic skin with reticulate pattern --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous ichthyotic skin with reticulate pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1262. en:erythematous malar rash --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous malar rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1263. en:erythematous nodular skin lesions --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous nodular skin lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1264. en:erythematous palmoplantar hyperkeratosis, progressive extending onto dorsum of hands and achilles tendon area --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous palmoplantar hyperkeratosis, progressive extending onto dorsum of hands and achilles tendon area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1265. en:erythematous papular skin eruption (infancy) --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous papular skin eruption (infancy) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1266. en:erythematous plaque --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous plaque | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1267. en:erythematous rash (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous rash (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1268. en:erythematous skin blotching --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous skin blotching | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1269. en:erythematous skin lesions in infancy --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous skin lesions in infancy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1270. en:erythematous squamous skin lesions --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous squamous skin lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1271. en:erythematous, irregular netlike pattern of vessels --- r_associated #0: 20 --> en:oedema
    n1=en:erythematous, irregular netlike pattern of vessels | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1272. en:erythroderma --- r_associated #0: 20 --> en:oedema
    n1=en:erythroderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1273. en:erythroderma (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:erythroderma (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1274. en:erythroderma, generalized congenital --- r_associated #0: 20 --> en:oedema
    n1=en:erythroderma, generalized congenital | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1275. en:erythroderma, patchy, on cheeks and chin (1/4 patients) --- r_associated #0: 20 --> en:oedema
    n1=en:erythroderma, patchy, on cheeks and chin (1/4 patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1276. en:erythroderma, psoriasiform --- r_associated #0: 20 --> en:oedema
    n1=en:erythroderma, psoriasiform | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1277. en:erythrokeratodermia --- r_associated #0: 20 --> en:oedema
    n1=en:erythrokeratodermia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1278. en:erythropoietic protoporphyria --- r_associated #0: 20 --> en:oedema
    n1=en:erythropoietic protoporphyria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1279. en:eschar formation --- r_associated #0: 20 --> en:oedema
    n1=en:eschar formation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1280. en:ethnologic --- r_associated #0: 20 --> en:oedema
    n1=en:ethnologic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1281. en:etiology aspects --- r_associated #0: 20 --> en:oedema
    n1=en:etiology aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1282. en:european league against rheumatism response criteria score --- r_associated #0: 20 --> en:oedema
    n1=en:european league against rheumatism response criteria score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1283. en:evaluation finding --- r_associated #0: 20 --> en:oedema
    n1=en:evaluation finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1284. en:evidence of lymphatic rerouting --- r_associated #0: 20 --> en:oedema
    n1=en:evidence of lymphatic rerouting | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1285. en:evidence of reinnervation seen on emg (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:evidence of reinnervation seen on emg (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1286. en:excess fat, symmetrically located in buttocks and lower extremities to ankles --- r_associated #0: 20 --> en:oedema
    n1=en:excess fat, symmetrically located in buttocks and lower extremities to ankles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1287. en:excess interdialytic weight gain --- r_associated #0: 20 --> en:oedema
    n1=en:excess interdialytic weight gain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1288. en:excessive neutral fat and free fatty acids in type-i fibers --- r_associated #0: 20 --> en:oedema
    n1=en:excessive neutral fat and free fatty acids in type-i fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1289. en:excessive salt in sweat --- r_associated #0: 20 --> en:oedema
    n1=en:excessive salt in sweat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1290. en:excessive skin folds --- r_associated #0: 20 --> en:oedema
    n1=en:excessive skin folds | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1291. en:excessive skin wrinkling of palms and soles (in one patient) --- r_associated #0: 20 --> en:oedema
    n1=en:excessive skin wrinkling of palms and soles (in one patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1292. en:excessive skin wrinkling on dorsum of hands and fingers --- r_associated #0: 20 --> en:oedema
    n1=en:excessive skin wrinkling on dorsum of hands and fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1293. en:excessive sucking --- r_associated #0: 20 --> en:oedema
    n1=en:excessive sucking | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1294. en:exercise capacity decreased --- r_associated #0: 20 --> en:oedema
    n1=en:exercise capacity decreased | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1295. en:exercise intolerance (also seen in some heterozygotes) --- r_associated #0: 20 --> en:oedema
    n1=en:exercise intolerance (also seen in some heterozygotes) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1296. en:exercise intolerance (cvs+) --- r_associated #0: 20 --> en:oedema
    n1=en:exercise intolerance (cvs+) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1297. en:exercise intolerance (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:exercise intolerance (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1298. en:exercise-induced muscle cramps --- r_associated #0: 20 --> en:oedema
    n1=en:exercise-induced muscle cramps | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1299. en:exercise-induced muscle fatigue --- r_associated #0: 20 --> en:oedema
    n1=en:exercise-induced muscle fatigue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1300. en:exercise-induced muscle stiffness --- r_associated #0: 20 --> en:oedema
    n1=en:exercise-induced muscle stiffness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1301. en:exercise-induced myalgia --- r_associated #0: 20 --> en:oedema
    n1=en:exercise-induced myalgia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1302. en:exercise-induced weakness --- r_associated #0: 20 --> en:oedema
    n1=en:exercise-induced weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1303. en:exertional fatigue --- r_associated #0: 20 --> en:oedema
    n1=en:exertional fatigue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1304. en:exertional leg pain --- r_associated #0: 20 --> en:oedema
    n1=en:exertional leg pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1305. en:exophthalmos --- r_associated #0: 20 --> en:oedema
    n1=en:exophthalmos | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1306. en:exophytic, red lesion --- r_associated #0: 20 --> en:oedema
    n1=en:exophytic, red lesion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1307. en:exposure as collected domain --- r_associated #0: 20 --> en:oedema
    n1=en:exposure as collected domain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1308. en:extensive cutaneous involvement rarely occurs --- r_associated #0: 20 --> en:oedema
    n1=en:extensive cutaneous involvement rarely occurs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1309. en:extensive fatty infiltration on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:extensive fatty infiltration on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1310. en:extensor muscle weakness more severe than flexor muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:extensor muscle weakness more severe than flexor muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1311. en:external ear --- r_associated #0: 20 --> en:oedema
    n1=en:external ear | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1312. en:extravasation --- r_associated #0: 20 --> en:oedema
    n1=en:extravasation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1313. en:extravasation of lymph onto skin --- r_associated #0: 20 --> en:oedema
    n1=en:extravasation of lymph onto skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1314. en:extreme skin fragility --- r_associated #0: 20 --> en:oedema
    n1=en:extreme skin fragility | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1315. en:extrusion of calcium deposits ('perforating pxe') --- r_associated #0: 20 --> en:oedema
    n1=en:extrusion of calcium deposits ('perforating pxe') | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1316. en:exudate observable --- r_associated #0: 20 --> en:oedema
    n1=en:exudate observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1317. en:exudative edema --- r_associated #0: 20 --> en:oedema
    n1=en:exudative edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1318. en:eye manifestations --- r_associated #0: 20 --> en:oedema
    n1=en:eye manifestations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1319. en:eye/vision observable --- r_associated #0: 20 --> en:oedema
    n1=en:eye/vision observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1320. en:eyelid --- r_associated #0: 20 --> en:oedema
    n1=en:eyelid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1321. en:eyelid margin cysts (apocrine hidrocystoma) --- r_associated #0: 20 --> en:oedema
    n1=en:eyelid margin cysts (apocrine hidrocystoma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1322. en:eysenck personality inventory score --- r_associated #0: 20 --> en:oedema
    n1=en:eysenck personality inventory score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1323. en:face arm speech test score --- r_associated #0: 20 --> en:oedema
    n1=en:face arm speech test score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1324. en:face edema --- r_associated #0: 20 --> en:oedema
    n1=en:face edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1325. en:facial angiofibroma (adenoma sebaceum) --- r_associated #0: 20 --> en:oedema
    n1=en:facial angiofibroma (adenoma sebaceum) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1326. en:facial capillary hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:facial capillary hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1327. en:facial diplegia --- r_associated #0: 20 --> en:oedema
    n1=en:facial diplegia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1328. en:facial erythema --- r_associated #0: 20 --> en:oedema
    n1=en:facial erythema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1329. en:facial hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:facial hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1330. en:facial hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:facial hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1331. en:facial midline hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:facial midline hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1332. en:facial milia --- r_associated #0: 20 --> en:oedema
    n1=en:facial milia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1333. en:facial milia tend to disappear in adulthood --- r_associated #0: 20 --> en:oedema
    n1=en:facial milia tend to disappear in adulthood | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1334. en:facial milia, congenital, especially on chin --- r_associated #0: 20 --> en:oedema
    n1=en:facial milia, congenital, especially on chin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1335. en:facial muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:facial muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1336. en:facial muscle atrophy of involved side --- r_associated #0: 20 --> en:oedema
    n1=en:facial muscle atrophy of involved side | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1337. en:facial muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:facial muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1338. en:facial muscle weakness and atrophy, progressive --- r_associated #0: 20 --> en:oedema
    n1=en:facial muscle weakness and atrophy, progressive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1339. en:facial or extensor involvement in infants and children (major feature) --- r_associated #0: 20 --> en:oedema
    n1=en:facial or extensor involvement in infants and children (major feature) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1340. en:facial pallor --- r_associated #0: 20 --> en:oedema
    n1=en:facial pallor | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1341. en:facial telangiectasia in butterfly midface distribution (exacerbated by sun) --- r_associated #0: 20 --> en:oedema
    n1=en:facial telangiectasia in butterfly midface distribution (exacerbated by sun) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1342. en:facial trichilemmomas --- r_associated #0: 20 --> en:oedema
    n1=en:facial trichilemmomas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1343. en:facial xanthomatous eruptions (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:facial xanthomatous eruptions (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1344. en:fades in adolescence --- r_associated #0: 20 --> en:oedema
    n1=en:fades in adolescence | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1345. en:fair skin --- r_associated #0: 20 --> en:oedema
    n1=en:fair skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1346. en:falls risk assessment score for the elderly (observable entity) --- r_associated #0: 20 --> en:oedema
    n1=en:falls risk assessment score for the elderly (observable entity) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1347. en:familial progressive hyperpigmentation and hypopigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:familial progressive hyperpigmentation and hypopigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1348. en:fasciculation --- r_associated #0: 20 --> en:oedema
    n1=en:fasciculation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1349. en:fasciculations (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:fasciculations (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1350. en:fasciculations (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:fasciculations (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1351. en:fat accumulation in the suprabuttock area --- r_associated #0: 20 --> en:oedema
    n1=en:fat accumulation in the suprabuttock area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1352. en:fat pad --- r_associated #0: 20 --> en:oedema
    n1=en:fat pad | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1353. en:fat pad anterior to malleolus --- r_associated #0: 20 --> en:oedema
    n1=en:fat pad anterior to malleolus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1354. en:fat pad between achilles tendon and medial malleolus --- r_associated #0: 20 --> en:oedema
    n1=en:fat pad between achilles tendon and medial malleolus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1355. en:fat pads on the hands and feet --- r_associated #0: 20 --> en:oedema
    n1=en:fat pads on the hands and feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1356. en:fatigue --- r_associated #0: 20 --> en:oedema
    n1=en:fatigue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1357. en:fatigue impact scale score --- r_associated #0: 20 --> en:oedema
    n1=en:fatigue impact scale score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1358. en:fatty degeneration of muscle seen on mri --- r_associated #0: 20 --> en:oedema
    n1=en:fatty degeneration of muscle seen on mri | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1359. en:fatty deposition --- r_associated #0: 20 --> en:oedema
    n1=en:fatty deposition | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1360. en:fatty infiltration --- r_associated #0: 20 --> en:oedema
    n1=en:fatty infiltration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1361. en:fatty infiltration of affected muscles --- r_associated #0: 20 --> en:oedema
    n1=en:fatty infiltration of affected muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1362. en:fatty infiltration seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:fatty infiltration seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1363. en:fatty replacement --- r_associated #0: 20 --> en:oedema
    n1=en:fatty replacement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1364. en:fatty replacement in hip muscles and proximal muscles of the lower limb seen on mri --- r_associated #0: 20 --> en:oedema
    n1=en:fatty replacement in hip muscles and proximal muscles of the lower limb seen on mri | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1365. en:fear of cancer of skin --- r_associated #0: 20 --> en:oedema
    n1=en:fear of cancer of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1366. en:fear of having other skin disease --- r_associated #0: 20 --> en:oedema
    n1=en:fear of having other skin disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1367. en:fecal incontinence --- r_associated #0: 20 --> en:oedema
    n1=en:fecal incontinence | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1368. en:feminization --- r_associated #0: 20 --> en:oedema
    n1=en:feminization | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1369. en:fetal akinesia deformation sequence --- r_associated #0: 20 --> en:oedema
    n1=en:fetal akinesia deformation sequence | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1370. en:fetal anuria --- r_associated #0: 20 --> en:oedema
    n1=en:fetal anuria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1371. en:fetal ascites --- r_associated #0: 20 --> en:oedema
    n1=en:fetal ascites | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1372. en:fetal ascites without hydrops --- r_associated #0: 20 --> en:oedema
    n1=en:fetal ascites without hydrops | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1373. en:fetal bradycardia (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:fetal bradycardia (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1374. en:fetal demise, male --- r_associated #0: 20 --> en:oedema
    n1=en:fetal demise, male | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1375. en:fetal distress --- r_associated #0: 20 --> en:oedema
    n1=en:fetal distress | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1376. en:fetal finding --- r_associated #0: 20 --> en:oedema
    n1=en:fetal finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1377. en:fetal growth retardation --- r_associated #0: 20 --> en:oedema
    n1=en:fetal growth retardation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1378. en:fetal hydrops (in perinatal or congenital neuromuscular forms) --- r_associated #0: 20 --> en:oedema
    n1=en:fetal hydrops (in perinatal or congenital neuromuscular forms) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1379. en:fetal pads of digits --- r_associated #0: 20 --> en:oedema
    n1=en:fetal pads of digits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1380. en:fetal pleural effusion --- r_associated #0: 20 --> en:oedema
    n1=en:fetal pleural effusion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1381. en:fetal polyuria --- r_associated #0: 20 --> en:oedema
    n1=en:fetal polyuria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1382. en:fever --- r_associated #0: 20 --> en:oedema
    n1=en:fever | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1383. en:fever, sweat, and hot flashes --- r_associated #0: 20 --> en:oedema
    n1=en:fever, sweat, and hot flashes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1384. en:fiber necrosis --- r_associated #0: 20 --> en:oedema
    n1=en:fiber necrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1385. en:fiber size variation --- r_associated #0: 20 --> en:oedema
    n1=en:fiber size variation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1386. en:fiber size variation seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:fiber size variation seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1387. en:fiber type grouping --- r_associated #0: 20 --> en:oedema
    n1=en:fiber type grouping | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1388. en:fiber type variation seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:fiber type variation seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1389. en:fiber-type grouping pattern --- r_associated #0: 20 --> en:oedema
    n1=en:fiber-type grouping pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1390. en:fiber-type variability --- r_associated #0: 20 --> en:oedema
    n1=en:fiber-type variability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1391. en:fibrillation --- r_associated #0: 20 --> en:oedema
    n1=en:fibrillation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1392. en:fibrillations in affected muscles --- r_associated #0: 20 --> en:oedema
    n1=en:fibrillations in affected muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1393. en:fibrinogen in blood above reference range --- r_associated #0: 20 --> en:oedema
    n1=en:fibrinogen in blood above reference range | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1394. en:fibrochondrogenesis 1 --- r_associated #0: 20 --> en:oedema
    n1=en:fibrochondrogenesis 1 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1395. en:fibrofolliculoma --- r_associated #0: 20 --> en:oedema
    n1=en:fibrofolliculoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1396. en:fibroma --- r_associated #0: 20 --> en:oedema
    n1=en:fibroma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1397. en:fibromyalgia --- r_associated #0: 20 --> en:oedema
    n1=en:fibromyalgia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1398. en:fibrosis --- r_associated #0: 20 --> en:oedema
    n1=en:fibrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1399. en:fibrosis over affected area --- r_associated #0: 20 --> en:oedema
    n1=en:fibrosis over affected area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1400. en:fibrous dysplasia (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:fibrous dysplasia (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1401. en:fibrous nodule --- r_associated #0: 20 --> en:oedema
    n1=en:fibrous nodule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1402. en:fibrous skin tumor of tuberous sclerosis --- r_associated #0: 20 --> en:oedema
    n1=en:fibrous skin tumor of tuberous sclerosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1403. en:filamentous inclusions in muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:filamentous inclusions in muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1404. en:finding --- r_associated #0: 20 --> en:oedema
    n1=en:finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1405. en:finding by method --- r_associated #0: 20 --> en:oedema
    n1=en:finding by method | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1406. en:finding by site --- r_associated #0: 20 --> en:oedema
    n1=en:finding by site | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1407. en:finding of grade --- r_associated #0: 20 --> en:oedema
    n1=en:finding of grade | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1408. en:finding of measures of urine output --- r_associated #0: 20 --> en:oedema
    n1=en:finding of measures of urine output | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1409. en:finding related to physiologic substance --- r_associated #0: 20 --> en:oedema
    n1=en:finding related to physiologic substance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1410. en:finding reported by subject or history provider --- r_associated #0: 20 --> en:oedema
    n1=en:finding reported by subject or history provider | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1411. en:fine erythrodermic scales, generalized --- r_associated #0: 20 --> en:oedema
    n1=en:fine erythrodermic scales, generalized | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1412. en:fine greyish-white scales --- r_associated #0: 20 --> en:oedema
    n1=en:fine greyish-white scales | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1413. en:fine white or greyish-white scales --- r_associated #0: 20 --> en:oedema
    n1=en:fine white or greyish-white scales | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1414. en:fine white or light brown scales on scalp, face, trunk, and limbs --- r_associated #0: 20 --> en:oedema
    n1=en:fine white or light brown scales on scalp, face, trunk, and limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1415. en:fine white scales --- r_associated #0: 20 --> en:oedema
    n1=en:fine white scales | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1416. en:fine whitish scales (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:fine whitish scales (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1417. en:fine whitish scales over entire surface of skin --- r_associated #0: 20 --> en:oedema
    n1=en:fine whitish scales over entire surface of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1418. en:fine whitish scaling on face and trunk --- r_associated #0: 20 --> en:oedema
    n1=en:fine whitish scaling on face and trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1419. en:fine, reticulate skin pigmentation (trunk, palm, and soles) --- r_associated #0: 20 --> en:oedema
    n1=en:fine, reticulate skin pigmentation (trunk, palm, and soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1420. en:finely wrinkled palms --- r_associated #0: 20 --> en:oedema
    n1=en:finely wrinkled palms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1421. en:finger and wrist extensor weakness --- r_associated #0: 20 --> en:oedema
    n1=en:finger and wrist extensor weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1422. en:finger subcutaneous nodule --- r_associated #0: 20 --> en:oedema
    n1=en:finger subcutaneous nodule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1423. en:fingerprints, absence of --- r_associated #0: 20 --> en:oedema
    n1=en:fingerprints, absence of | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1424. en:firm muscles --- r_associated #0: 20 --> en:oedema
    n1=en:firm muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1425. en:fissures of soles (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:fissures of soles (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1426. en:fissuring of palms and/or soles in hot or cold weather --- r_associated #0: 20 --> en:oedema
    n1=en:fissuring of palms and/or soles in hot or cold weather | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1427. en:fistula formation (late complication) --- r_associated #0: 20 --> en:oedema
    n1=en:fistula formation (late complication) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1428. en:fistula, enterocutaneous --- r_associated #0: 20 --> en:oedema
    n1=en:fistula, enterocutaneous | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1429. en:flaccid weakness or paralysis, episodic attacks --- r_associated #0: 20 --> en:oedema
    n1=en:flaccid weakness or paralysis, episodic attacks | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1430. en:flares of erythema, scaling, and pustules --- r_associated #0: 20 --> en:oedema
    n1=en:flares of erythema, scaling, and pustules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1431. en:flexion contractures of hands due to severe hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:flexion contractures of hands due to severe hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1432. en:flexural acanthosis nigricans (females, childhood-early adolescence) --- r_associated #0: 20 --> en:oedema
    n1=en:flexural acanthosis nigricans (females, childhood-early adolescence) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1433. en:flexural lichenification in adults (major feature) --- r_associated #0: 20 --> en:oedema
    n1=en:flexural lichenification in adults (major feature) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1434. en:flexural skin --- r_associated #0: 20 --> en:oedema
    n1=en:flexural skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1435. en:floppy infant --- r_associated #0: 20 --> en:oedema
    n1=en:floppy infant | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1436. en:florid red complexion (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:florid red complexion (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1437. en:flu-like symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:flu-like symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1438. en:fluctuating edema level --- r_associated #0: 20 --> en:oedema
    n1=en:fluctuating edema level | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1439. en:fluid loss --- r_associated #0: 20 --> en:oedema
    n1=en:fluid loss | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1440. en:fluid overload pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:fluid overload pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1441. en:flushing --- r_associated #0: 20 --> en:oedema
    n1=en:flushing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1442. en:flushing attacks --- r_associated #0: 20 --> en:oedema
    n1=en:flushing attacks | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1443. en:focal areas of z-band disarray devoid of mitochondria seen on electron microscopy --- r_associated #0: 20 --> en:oedema
    n1=en:focal areas of z-band disarray devoid of mitochondria seen on electron microscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1444. en:focal dermal aplasia/hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:focal dermal aplasia/hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1445. en:focal excision of swollen brain --- r_associated #0: 20 --> en:oedema
    n1=en:focal excision of swollen brain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1446. en:focal friction-related palmoplantar hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:focal friction-related palmoplantar hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1447. en:focal hyperkeratosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:focal hyperkeratosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1448. en:focal keratoderma of soles (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:focal keratoderma of soles (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1449. en:focal loss of cross striations on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:focal loss of cross striations on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1450. en:focal lymphocytic and macrophage infiltrates on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:focal lymphocytic and macrophage infiltrates on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1451. en:focal scalp defects with alopecia --- r_associated #0: 20 --> en:oedema
    n1=en:focal scalp defects with alopecia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1452. en:focal segmental glomerulosclerosis 6 --- r_associated #0: 20 --> en:oedema
    n1=en:focal segmental glomerulosclerosis 6 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1453. en:focal skin hypoplasia in face --- r_associated #0: 20 --> en:oedema
    n1=en:focal skin hypoplasia in face | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1454. en:follicular atrophoderma --- r_associated #0: 20 --> en:oedema
    n1=en:follicular atrophoderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1455. en:follicular atrophoderma (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:follicular atrophoderma (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1456. en:follicular atrophoderma affecting the dorsa of the hands and feet, the face, and extensor surfaces of the elbows and knees --- r_associated #0: 20 --> en:oedema
    n1=en:follicular atrophoderma affecting the dorsa of the hands and feet, the face, and extensor surfaces of the elbows and knees | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1457. en:follicular hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:follicular hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1458. en:follicular hyperkeratosis (trunk and limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:follicular hyperkeratosis (trunk and limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1459. en:follicular hyperkeratosis of occipital scalp, nape of neck, and extensor surfaces of upper limbs --- r_associated #0: 20 --> en:oedema
    n1=en:follicular hyperkeratosis of occipital scalp, nape of neck, and extensor surfaces of upper limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1460. en:follicular hyperkeratotic papules --- r_associated #0: 20 --> en:oedema
    n1=en:follicular hyperkeratotic papules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1461. en:follicular keratosis, generalized (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:follicular keratosis, generalized (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1462. en:follicular papule --- r_associated #0: 20 --> en:oedema
    n1=en:follicular papule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1463. en:folliculitis --- r_associated #0: 20 --> en:oedema
    n1=en:folliculitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1464. en:folliculitis (back, axilla, pubic region) --- r_associated #0: 20 --> en:oedema
    n1=en:folliculitis (back, axilla, pubic region) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1465. en:folliculitis of the scalp, trunk, and extensor surfaces of the extremities --- r_associated #0: 20 --> en:oedema
    n1=en:folliculitis of the scalp, trunk, and extensor surfaces of the extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1466. en:follows blaschko's lines --- r_associated #0: 20 --> en:oedema
    n1=en:follows blaschko's lines | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1467. en:foot callus --- r_associated #0: 20 --> en:oedema
    n1=en:foot callus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1468. en:foot dorsiflexor weakness --- r_associated #0: 20 --> en:oedema
    n1=en:foot dorsiflexor weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1469. en:foot extensor muscle weakness (later onset) --- r_associated #0: 20 --> en:oedema
    n1=en:foot extensor muscle weakness (later onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1470. en:foot-drop --- r_associated #0: 20 --> en:oedema
    n1=en:foot-drop | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1471. en:forearm muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:forearm muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1472. en:forehead hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:forehead hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1473. en:foreign body sensation --- r_associated #0: 20 --> en:oedema
    n1=en:foreign body sensation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1474. en:forewater --- r_associated #0: 20 --> en:oedema
    n1=en:forewater | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1475. en:foster-kennedy syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:foster-kennedy syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1476. en:fragile skin --- r_associated #0: 20 --> en:oedema
    n1=en:fragile skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1477. en:fragile skin with atrophic scarring --- r_associated #0: 20 --> en:oedema
    n1=en:fragile skin with atrophic scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1478. en:fragility with blistering (neonatal onset) --- r_associated #0: 20 --> en:oedema
    n1=en:fragility with blistering (neonatal onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1479. en:fragmentation of the neuromuscular junction with pre- and postsynaptic defects --- r_associated #0: 20 --> en:oedema
    n1=en:fragmentation of the neuromuscular junction with pre- and postsynaptic defects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1480. en:fragmented mitochondrial network --- r_associated #0: 20 --> en:oedema
    n1=en:fragmented mitochondrial network | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1481. en:freckled skin (in some less dark-skinned individuals) --- r_associated #0: 20 --> en:oedema
    n1=en:freckled skin (in some less dark-skinned individuals) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1482. en:freckles --- r_associated #0: 20 --> en:oedema
    n1=en:freckles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1483. en:freckles in sun-exposed areas --- r_associated #0: 20 --> en:oedema
    n1=en:freckles in sun-exposed areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1484. en:freckling may or may not be present --- r_associated #0: 20 --> en:oedema
    n1=en:freckling may or may not be present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1485. en:frequent bleeding may occur with trauma --- r_associated #0: 20 --> en:oedema
    n1=en:frequent bleeding may occur with trauma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1486. en:frequent falls --- r_associated #0: 20 --> en:oedema
    n1=en:frequent falls | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1487. en:frequent staphylococcus aureus infections --- r_associated #0: 20 --> en:oedema
    n1=en:frequent staphylococcus aureus infections | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1488. en:frontal cutaneous lipoma --- r_associated #0: 20 --> en:oedema
    n1=en:frontal cutaneous lipoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1489. en:frontal hirsutism --- r_associated #0: 20 --> en:oedema
    n1=en:frontal hirsutism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1490. en:frontalis muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:frontalis muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1491. en:frostbite --- r_associated #0: 20 --> en:oedema
    n1=en:frostbite | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1492. en:frostbitten hands --- r_associated #0: 20 --> en:oedema
    n1=en:frostbitten hands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1493. en:functional independence measure score --- r_associated #0: 20 --> en:oedema
    n1=en:functional independence measure score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1494. en:functional observable --- r_associated #0: 20 --> en:oedema
    n1=en:functional observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1495. en:furrowed facial skin --- r_associated #0: 20 --> en:oedema
    n1=en:furrowed facial skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1496. en:gait abnormalities (occurs later) --- r_associated #0: 20 --> en:oedema
    n1=en:gait abnormalities (occurs later) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1497. en:gait disturbance --- r_associated #0: 20 --> en:oedema
    n1=en:gait disturbance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1498. en:gait unsteady --- r_associated #0: 20 --> en:oedema
    n1=en:gait unsteady | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1499. en:gait, drop foot --- r_associated #0: 20 --> en:oedema
    n1=en:gait, drop foot | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1500. en:gangrene --- r_associated #0: 20 --> en:oedema
    n1=en:gangrene | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1501. en:gastrocnemius and soleus muscles most affected --- r_associated #0: 20 --> en:oedema
    n1=en:gastrocnemius and soleus muscles most affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1502. en:gastrointestinal gas --- r_associated #0: 20 --> en:oedema
    n1=en:gastrointestinal gas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1503. en:gastrointestinal hemorrhage --- r_associated #0: 20 --> en:oedema
    n1=en:gastrointestinal hemorrhage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1504. en:general characteristic of patient --- r_associated #0: 20 --> en:oedema
    n1=en:general characteristic of patient | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1505. en:general clinical state finding --- r_associated #0: 20 --> en:oedema
    n1=en:general clinical state finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1506. en:general physiological development observable --- r_associated #0: 20 --> en:oedema
    n1=en:general physiological development observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1507. en:general symptom --- r_associated #0: 20 --> en:oedema
    n1=en:general symptom | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1508. en:generalized amyoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:generalized amyoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1509. en:generalized amyotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:generalized amyotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1510. en:generalized bronze hyperpigmentation (present at birth) --- r_associated #0: 20 --> en:oedema
    n1=en:generalized bronze hyperpigmentation (present at birth) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1511. en:generalized bruising tendency --- r_associated #0: 20 --> en:oedema
    n1=en:generalized bruising tendency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1512. en:generalized darkening of the skin --- r_associated #0: 20 --> en:oedema
    n1=en:generalized darkening of the skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1513. en:generalized dry skin with fine scaling but without erythema or blisters. (sparing of face) --- r_associated #0: 20 --> en:oedema
    n1=en:generalized dry skin with fine scaling but without erythema or blisters. (sparing of face) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1514. en:generalized erythema (inflammatory type b) --- r_associated #0: 20 --> en:oedema
    n1=en:generalized erythema (inflammatory type b) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1515. en:generalized hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:generalized hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1516. en:generalized hypopigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:generalized hypopigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1517. en:generalized hypotonia --- r_associated #0: 20 --> en:oedema
    n1=en:generalized hypotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1518. en:generalized ichthyosis --- r_associated #0: 20 --> en:oedema
    n1=en:generalized ichthyosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1519. en:generalized limb muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:generalized limb muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1520. en:generalized muscle contractions, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:generalized muscle contractions, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1521. en:generalized muscle hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:generalized muscle hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1522. en:generalized muscle wasting --- r_associated #0: 20 --> en:oedema
    n1=en:generalized muscle wasting | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1523. en:generalized muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:generalized muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1524. en:generalized muscle weakness (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:generalized muscle weakness (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1525. en:generalized muscle weakness also seen in symptomatic carrier females --- r_associated #0: 20 --> en:oedema
    n1=en:generalized muscle weakness also seen in symptomatic carrier females | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1526. en:generalized muscle weakness, proximal and distal --- r_associated #0: 20 --> en:oedema
    n1=en:generalized muscle weakness, proximal and distal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1527. en:generalized muscular appearance from birth --- r_associated #0: 20 --> en:oedema
    n1=en:generalized muscular appearance from birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1528. en:generalized neonatal hypotonia --- r_associated #0: 20 --> en:oedema
    n1=en:generalized neonatal hypotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1529. en:generalized rash --- r_associated #0: 20 --> en:oedema
    n1=en:generalized rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1530. en:generalized skin wrinkling --- r_associated #0: 20 --> en:oedema
    n1=en:generalized skin wrinkling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1531. en:generalized swelling/papules/lumps/masses --- r_associated #0: 20 --> en:oedema
    n1=en:generalized swelling/papules/lumps/masses | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1532. en:generalized weakness (adult-onset) --- r_associated #0: 20 --> en:oedema
    n1=en:generalized weakness (adult-onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1533. en:genetic aspects --- r_associated #0: 20 --> en:oedema
    n1=en:genetic aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1534. en:genital edema --- r_associated #0: 20 --> en:oedema
    n1=en:genital edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1535. en:genitourinary signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:genitourinary signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1536. en:gesell developmental observation revised score --- r_associated #0: 20 --> en:oedema
    n1=en:gesell developmental observation revised score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1537. en:gestational edema --- r_associated #0: 20 --> en:oedema
    n1=en:gestational edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1538. en:gestational edema without hypertension --- r_associated #0: 20 --> en:oedema
    n1=en:gestational edema without hypertension | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1539. en:giant granules in muscle cells --- r_associated #0: 20 --> en:oedema
    n1=en:giant granules in muscle cells | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1540. en:giant pigmented hairy nevus, often in lumbosacral distribution hair may not be present --- r_associated #0: 20 --> en:oedema
    n1=en:giant pigmented hairy nevus, often in lumbosacral distribution hair may not be present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1541. en:giant pigmented nevi, often in lumbosacral region --- r_associated #0: 20 --> en:oedema
    n1=en:giant pigmented nevi, often in lumbosacral region | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1542. en:gilbert syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:gilbert syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1543. en:gingival edema --- r_associated #0: 20 --> en:oedema
    n1=en:gingival edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1544. en:gingival hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:gingival hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1545. en:glabellar hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:glabellar hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1546. en:glabrous skin --- r_associated #0: 20 --> en:oedema
    n1=en:glabrous skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1547. en:global muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:global muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1548. en:glossocele --- r_associated #0: 20 --> en:oedema
    n1=en:glossocele | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1549. en:gluteal hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:gluteal hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1550. en:gluteus maximus and thigh adductors most affected --- r_associated #0: 20 --> en:oedema
    n1=en:gluteus maximus and thigh adductors most affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1551. en:glycogen accumulation seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:glycogen accumulation seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1552. en:glycogen deficiency in muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:glycogen deficiency in muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1553. en:glycogen depletion in skeletal muscle --- r_associated #0: 20 --> en:oedema
    n1=en:glycogen depletion in skeletal muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1554. en:glycogenosis of skeletal muscle, mild (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:glycogenosis of skeletal muscle, mild (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1555. en:glycosuria --- r_associated #0: 20 --> en:oedema
    n1=en:glycosuria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1556. en:goodenough draw-a-man test score --- r_associated #0: 20 --> en:oedema
    n1=en:goodenough draw-a-man test score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1557. en:gower's eye sign --- r_associated #0: 20 --> en:oedema
    n1=en:gower's eye sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1558. en:gowers sign --- r_associated #0: 20 --> en:oedema
    n1=en:gowers sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1559. en:gowers sign (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:gowers sign (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1560. en:gowers sign present --- r_associated #0: 20 --> en:oedema
    n1=en:gowers sign present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1561. en:granular deposits in the sarcomeres --- r_associated #0: 20 --> en:oedema
    n1=en:granular deposits in the sarcomeres | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1562. en:granular layer hyperplasia --- r_associated #0: 20 --> en:oedema
    n1=en:granular layer hyperplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1563. en:granulomatous dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:granulomatous dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1564. en:granulomatous dermatitis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:granulomatous dermatitis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1565. en:graves' disease with pretibial myxedema and with thyrotoxic crisis --- r_associated #0: 20 --> en:oedema
    n1=en:graves' disease with pretibial myxedema and with thyrotoxic crisis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1566. en:gravitational edema of leg --- r_associated #0: 20 --> en:oedema
    n1=en:gravitational edema of leg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1567. en:greater sartorius involvement than gracilis involvement seen on mri --- r_associated #0: 20 --> en:oedema
    n1=en:greater sartorius involvement than gracilis involvement seen on mri | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1568. en:greater soleus involvement than gastrocnemii involvement seen on mri --- r_associated #0: 20 --> en:oedema
    n1=en:greater soleus involvement than gastrocnemii involvement seen on mri | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1569. en:grip strength decreased --- r_associated #0: 20 --> en:oedema
    n1=en:grip strength decreased | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1570. en:groups of atrophic fibers seen on muscle biopsy (type i fiber predominance) --- r_associated #0: 20 --> en:oedema
    n1=en:groups of atrophic fibers seen on muscle biopsy (type i fiber predominance) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1571. en:gynecological history --- r_associated #0: 20 --> en:oedema
    n1=en:gynecological history | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1572. en:haemo-pak unit for plasmapheresis --- r_associated #0: 20 --> en:oedema
    n1=en:haemo-pak unit for plasmapheresis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1573. en:haemorrhage subcutaneous --- r_associated #0: 20 --> en:oedema
    n1=en:haemorrhage subcutaneous | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1574. en:hair observable --- r_associated #0: 20 --> en:oedema
    n1=en:hair observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1575. en:halitosis --- r_associated #0: 20 --> en:oedema
    n1=en:halitosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1576. en:hamman's sign --- r_associated #0: 20 --> en:oedema
    n1=en:hamman's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1577. en:hamstring and quadriceps muscles mildly affected --- r_associated #0: 20 --> en:oedema
    n1=en:hamstring and quadriceps muscles mildly affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1578. en:hamstring muscle affected --- r_associated #0: 20 --> en:oedema
    n1=en:hamstring muscle affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1579. en:hand and foot weakness --- r_associated #0: 20 --> en:oedema
    n1=en:hand and foot weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1580. en:hand dermatitis (non-allergic, irritant) --- r_associated #0: 20 --> en:oedema
    n1=en:hand dermatitis (non-allergic, irritant) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1581. en:hand muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:hand muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1582. en:handgrip myotonia --- r_associated #0: 20 --> en:oedema
    n1=en:handgrip myotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1583. en:hang weakness --- r_associated #0: 20 --> en:oedema
    n1=en:hang weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1584. en:hangover from any alcohol or other drugs substance --- r_associated #0: 20 --> en:oedema
    n1=en:hangover from any alcohol or other drugs substance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1585. en:hangrip myotonia --- r_associated #0: 20 --> en:oedema
    n1=en:hangrip myotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1586. en:hard scaly skin --- r_associated #0: 20 --> en:oedema
    n1=en:hard scaly skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1587. en:harlequin ichthyosis --- r_associated #0: 20 --> en:oedema
    n1=en:harlequin ichthyosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1588. en:head drop due to neck muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:head drop due to neck muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1589. en:head skin --- r_associated #0: 20 --> en:oedema
    n1=en:head skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1590. en:headache --- r_associated #0: 20 --> en:oedema
    n1=en:headache | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1591. en:healed areas are atrophic and hypopigmented --- r_associated #0: 20 --> en:oedema
    n1=en:healed areas are atrophic and hypopigmented | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1592. en:health assessment questionnaire score --- r_associated #0: 20 --> en:oedema
    n1=en:health assessment questionnaire score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1593. en:heart disease in women --- r_associated #0: 20 --> en:oedema
    n1=en:heart disease in women | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1594. en:heart diseases--prevention --- r_associated #0: 20 --> en:oedema
    n1=en:heart diseases--prevention | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1595. en:heart disorder --- r_associated #0: 20 --> en:oedema
    n1=en:heart disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1596. en:heart failure --- r_associated #0: 20 --> en:oedema
    n1=en:heart failure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1597. en:heart malformation --- r_associated #0: 20 --> en:oedema
    n1=en:heart malformation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1598. en:heart murmur --- r_associated #0: 20 --> en:oedema
    n1=en:heart murmur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1599. en:heart transplantation --- r_associated #0: 20 --> en:oedema
    n1=en:heart transplantation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1600. en:heart: muscle/valve --- r_associated #0: 20 --> en:oedema
    n1=en:heart: muscle/valve | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1601. en:heartburn --- r_associated #0: 20 --> en:oedema
    n1=en:heartburn | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1602. en:heat edema --- r_associated #0: 20 --> en:oedema
    n1=en:heat edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1603. en:heat illness --- r_associated #0: 20 --> en:oedema
    n1=en:heat illness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1604. en:heat stroke --- r_associated #0: 20 --> en:oedema
    n1=en:heat stroke | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1605. en:heel spur --- r_associated #0: 20 --> en:oedema
    n1=en:heel spur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1606. en:hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1607. en:hemangioma (neck and forehead) --- r_associated #0: 20 --> en:oedema
    n1=en:hemangioma (neck and forehead) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1608. en:hemangiomas (facial, glabellar) --- r_associated #0: 20 --> en:oedema
    n1=en:hemangiomas (facial, glabellar) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1609. en:hemangiomas and lymphangiomas of any site --- r_associated #0: 20 --> en:oedema
    n1=en:hemangiomas and lymphangiomas of any site | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1610. en:hemangiomata in at least first branch (ophthalmic) of trigeminal nerve distribution, unilateral, occasionally bilateral --- r_associated #0: 20 --> en:oedema
    n1=en:hemangiomata in at least first branch (ophthalmic) of trigeminal nerve distribution, unilateral, occasionally bilateral | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1611. en:hemangiomata, especially thorax and upper abdomen --- r_associated #0: 20 --> en:oedema
    n1=en:hemangiomata, especially thorax and upper abdomen | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1612. en:hemangiomatous branchial clefts (extend along sternocleidomastoid muscle) --- r_associated #0: 20 --> en:oedema
    n1=en:hemangiomatous branchial clefts (extend along sternocleidomastoid muscle) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1613. en:hematologic and lymphocytic disorder --- r_associated #0: 20 --> en:oedema
    n1=en:hematologic and lymphocytic disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1614. en:hematoma --- r_associated #0: 20 --> en:oedema
    n1=en:hematoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1615. en:hematomas, recurrent large subcutaneous --- r_associated #0: 20 --> en:oedema
    n1=en:hematomas, recurrent large subcutaneous | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1616. en:hematuria --- r_associated #0: 20 --> en:oedema
    n1=en:hematuria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1617. en:hemoglobin barts --- r_associated #0: 20 --> en:oedema
    n1=en:hemoglobin barts | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1618. en:hemophilia --- r_associated #0: 20 --> en:oedema
    n1=en:hemophilia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1619. en:hemorrhage --- r_associated #0: 20 --> en:oedema
    n1=en:hemorrhage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1620. en:hemorrhagic blisters --- r_associated #0: 20 --> en:oedema
    n1=en:hemorrhagic blisters | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1621. en:hemorrhagic cerebrovascular accident --- r_associated #0: 20 --> en:oedema
    n1=en:hemorrhagic cerebrovascular accident | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1622. en:hemorrhagic palmar and plantar macules (uncommon) --- r_associated #0: 20 --> en:oedema
    n1=en:hemorrhagic palmar and plantar macules (uncommon) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1623. en:hemorrhagic pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:hemorrhagic pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1624. en:hereditary neuraxial edema --- r_associated #0: 20 --> en:oedema
    n1=en:hereditary neuraxial edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1625. en:hernia --- r_associated #0: 20 --> en:oedema
    n1=en:hernia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1626. en:herpes simplex infections --- r_associated #0: 20 --> en:oedema
    n1=en:herpes simplex infections | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1627. en:herpes zoster --- r_associated #0: 20 --> en:oedema
    n1=en:herpes zoster | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1628. en:heterotopic bone formation in subcutaneous fat --- r_associated #0: 20 --> en:oedema
    n1=en:heterotopic bone formation in subcutaneous fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1629. en:hidradenitis suppurativa (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:hidradenitis suppurativa (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1630. en:hidrocystoma --- r_associated #0: 20 --> en:oedema
    n1=en:hidrocystoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1631. en:high altitude cerebral edema --- r_associated #0: 20 --> en:oedema
    n1=en:high altitude cerebral edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1632. en:high altitude pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:high altitude pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1633. en:high sweat electrolyte --- r_associated #0: 20 --> en:oedema
    n1=en:high sweat electrolyte | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1634. en:hindwater --- r_associated #0: 20 --> en:oedema
    n1=en:hindwater | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1635. en:hip abductor weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:hip abductor weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1636. en:hip flexor weakness --- r_associated #0: 20 --> en:oedema
    n1=en:hip flexor weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1637. en:hip fracture probability score using world health organization fracture risk assessment tool --- r_associated #0: 20 --> en:oedema
    n1=en:hip fracture probability score using world health organization fracture risk assessment tool | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1638. en:hip girdle muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:hip girdle muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1639. en:hip girdle muscle weakness (usually presenting symptom) --- r_associated #0: 20 --> en:oedema
    n1=en:hip girdle muscle weakness (usually presenting symptom) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1640. en:hirsutism --- r_associated #0: 20 --> en:oedema
    n1=en:hirsutism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1641. en:histochemically normal type-ii muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:histochemically normal type-ii muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1642. en:histology shows 'cannonball' distribution of capillary-sized vessels in the dermis --- r_associated #0: 20 --> en:oedema
    n1=en:histology shows 'cannonball' distribution of capillary-sized vessels in the dermis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1643. en:histology shows exterior zone of densely packed, small basophilic cells --- r_associated #0: 20 --> en:oedema
    n1=en:histology shows exterior zone of densely packed, small basophilic cells | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1644. en:historical aspects qualifier --- r_associated #0: 20 --> en:oedema
    n1=en:historical aspects qualifier | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1645. en:hiv cdc category --- r_associated #0: 20 --> en:oedema
    n1=en:hiv cdc category | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1646. en:hiv who class --- r_associated #0: 20 --> en:oedema
    n1=en:hiv who class | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1647. en:hoarseness --- r_associated #0: 20 --> en:oedema
    n1=en:hoarseness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1648. en:hoehn and yahr scale score --- r_associated #0: 20 --> en:oedema
    n1=en:hoehn and yahr scale score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1649. en:homans' sign --- r_associated #0: 20 --> en:oedema
    n1=en:homans' sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1650. en:home falls and accidents screening tool score --- r_associated #0: 20 --> en:oedema
    n1=en:home falls and accidents screening tool score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1651. en:honeycomb keratoderma --- r_associated #0: 20 --> en:oedema
    n1=en:honeycomb keratoderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1652. en:honeycomb palmoplantar keratoderma --- r_associated #0: 20 --> en:oedema
    n1=en:honeycomb palmoplantar keratoderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1653. en:hoover's sign --- r_associated #0: 20 --> en:oedema
    n1=en:hoover's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1654. en:horny papules (face, leg, buttocks) --- r_associated #0: 20 --> en:oedema
    n1=en:horny papules (face, leg, buttocks) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1655. en:hot flashes --- r_associated #0: 20 --> en:oedema
    n1=en:hot flashes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1656. en:housing dependency scale score --- r_associated #0: 20 --> en:oedema
    n1=en:housing dependency scale score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1657. en:humeroperoneal weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:humeroperoneal weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1658. en:hutchinson's sign --- r_associated #0: 20 --> en:oedema
    n1=en:hutchinson's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1659. en:hyaline deposition in dermis --- r_associated #0: 20 --> en:oedema
    n1=en:hyaline deposition in dermis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1660. en:hyaline inclusion --- r_associated #0: 20 --> en:oedema
    n1=en:hyaline inclusion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1661. en:hyaline plaques with absent oxidative activity --- r_associated #0: 20 --> en:oedema
    n1=en:hyaline plaques with absent oxidative activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1662. en:hydropericardium --- r_associated #0: 20 --> en:oedema
    n1=en:hydropericardium | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1663. en:hydrops fetalis (type ii, congenital) --- r_associated #0: 20 --> en:oedema
    n1=en:hydrops fetalis (type ii, congenital) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1664. en:hydrops fetalis, non-immune (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:hydrops fetalis, non-immune (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1665. en:hydrops of allantois --- r_associated #0: 20 --> en:oedema
    n1=en:hydrops of allantois | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1666. en:hydrops of gallbladder --- r_associated #0: 20 --> en:oedema
    n1=en:hydrops of gallbladder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1667. en:hydrops of placenta --- r_associated #0: 20 --> en:oedema
    n1=en:hydrops of placenta | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1668. en:hydrosalpinx (disease) --- r_associated #0: 20 --> en:oedema
    n1=en:hydrosalpinx (disease) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1669. en:hydrothorax --- r_associated #0: 20 --> en:oedema
    n1=en:hydrothorax | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1670. en:hyperactive deep tendon reflexes --- r_associated #0: 20 --> en:oedema
    n1=en:hyperactive deep tendon reflexes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1671. en:hyperactivity --- r_associated #0: 20 --> en:oedema
    n1=en:hyperactivity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1672. en:hyperalgesia --- r_associated #0: 20 --> en:oedema
    n1=en:hyperalgesia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1673. en:hyperalgesia to pressure --- r_associated #0: 20 --> en:oedema
    n1=en:hyperalgesia to pressure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1674. en:hyperchloremia --- r_associated #0: 20 --> en:oedema
    n1=en:hyperchloremia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1675. en:hyperelasticity (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperelasticity (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1676. en:hyperemia --- r_associated #0: 20 --> en:oedema
    n1=en:hyperemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1677. en:hyperextensible skin --- r_associated #0: 20 --> en:oedema
    n1=en:hyperextensible skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1678. en:hyperextensible skin (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperextensible skin (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1679. en:hypergammaglobulinemia --- r_associated #0: 20 --> en:oedema
    n1=en:hypergammaglobulinemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1680. en:hyperglycemia --- r_associated #0: 20 --> en:oedema
    n1=en:hyperglycemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1681. en:hyperhidrosis --- r_associated #0: 20 --> en:oedema
    n1=en:hyperhidrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1682. en:hyperhidrosis (hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperhidrosis (hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1683. en:hyperhidrosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperhidrosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1684. en:hyperhidrosis occurs during pain episodes --- r_associated #0: 20 --> en:oedema
    n1=en:hyperhidrosis occurs during pain episodes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1685. en:hyperhidrosis of plantar surface (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperhidrosis of plantar surface (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1686. en:hyperhidrosis palmaris et plantaris --- r_associated #0: 20 --> en:oedema
    n1=en:hyperhidrosis palmaris et plantaris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1687. en:hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1688. en:hyperkeratosis (especially extensor surfaces) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis (especially extensor surfaces) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1689. en:hyperkeratosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1690. en:hyperkeratosis (palms, soles, elbows, knees) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis (palms, soles, elbows, knees) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1691. en:hyperkeratosis of pressure sites of palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis of pressure sites of palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1692. en:hyperkeratosis of skin at nipples and umbilicus --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis of skin at nipples and umbilicus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1693. en:hyperkeratosis of the palms (seen in recessive form) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis of the palms (seen in recessive form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1694. en:hyperkeratosis of the palms and soles and esophageal papillomas --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis of the palms and soles and esophageal papillomas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1695. en:hyperkeratosis of weight-bearing areas of soles --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis of weight-bearing areas of soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1696. en:hyperkeratosis on dorsal surface of fingers and toes (knuckle pads, in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis on dorsal surface of fingers and toes (knuckle pads, in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1697. en:hyperkeratosis over affected area --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis over affected area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1698. en:hyperkeratosis over edematous areas --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis over edematous areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1699. en:hyperkeratosis pilaris may occur --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis pilaris may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1700. en:hyperkeratosis, focal, on the palms and soles (in adulthood in some) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis, focal, on the palms and soles (in adulthood in some) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1701. en:hyperkeratosis, particularly on palms and soles of feet --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratosis, particularly on palms and soles of feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1702. en:hyperkeratotic cutaneous vascular lesions --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic cutaneous vascular lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1703. en:hyperkeratotic dark-brown papules --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic dark-brown papules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1704. en:hyperkeratotic lesions of neck, elbows, knees, groin, genitalia, and buttocks --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic lesions of neck, elbows, knees, groin, genitalia, and buttocks | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1705. en:hyperkeratotic papules, dark brown, on neck, chest, and back (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic papules, dark brown, on neck, chest, and back (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1706. en:hyperkeratotic plaques --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1707. en:hyperkeratotic plaques (face, elbow, knees) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic plaques (face, elbow, knees) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1708. en:hyperkeratotic plaques on anterior knee area (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic plaques on anterior knee area (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1709. en:hyperkeratotic plaques on anterolateral ankle area (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic plaques on anterolateral ankle area (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1710. en:hyperkeratotic plaques on trunk and limbs --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic plaques on trunk and limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1711. en:hyperkeratotic yellowish papules and plaques arranged linearly on palms and fingers --- r_associated #0: 20 --> en:oedema
    n1=en:hyperkeratotic yellowish papules and plaques arranged linearly on palms and fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1712. en:hyperlactemia --- r_associated #0: 20 --> en:oedema
    n1=en:hyperlactemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1713. en:hyperlinearity of palms (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperlinearity of palms (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1714. en:hypermelanotic macule --- r_associated #0: 20 --> en:oedema
    n1=en:hypermelanotic macule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1715. en:hyperpigmentation (in patients with kit mutations) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmentation (in patients with kit mutations) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1716. en:hyperpigmentation (knuckles, elbows, axillae, areolae, pubic area) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmentation (knuckles, elbows, axillae, areolae, pubic area) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1717. en:hyperpigmentation associated with increased adrenocorticotropic hormone (acth) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmentation associated with increased adrenocorticotropic hormone (acth) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1718. en:hyperpigmentation in a reticular pattern primarily on flexural skin --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmentation in a reticular pattern primarily on flexural skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1719. en:hyperpigmentation in flexure areas --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmentation in flexure areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1720. en:hyperpigmentation in sun-exposed areas --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmentation in sun-exposed areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1721. en:hyperpigmented 2 to 5-mm macules mainly on the extremities --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented 2 to 5-mm macules mainly on the extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1722. en:hyperpigmented erythematous lesions --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented erythematous lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1723. en:hyperpigmented lesions, 0.2-0.5 cm --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented lesions, 0.2-0.5 cm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1724. en:hyperpigmented macules of variable size and shape located in a symmetrical pattern primarily on face, neck, trunk, and dorsa of hands and feet --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented macules of variable size and shape located in a symmetrical pattern primarily on face, neck, trunk, and dorsa of hands and feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1725. en:hyperpigmented nevi --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented nevi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1726. en:hyperpigmented nevi and streak --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented nevi and streak | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1727. en:hyperpigmented patches (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented patches (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1728. en:hyperpigmented rim with long fine hairs encircling the lesions (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented rim with long fine hairs encircling the lesions (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1729. en:hyperpigmented skin lesions (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented skin lesions (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1730. en:hyperpigmented skin patches (face, neck, trunk, limbs, lip, oral mucosa, palms, and soles) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented skin patches (face, neck, trunk, limbs, lip, oral mucosa, palms, and soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1731. en:hyperpigmented spots on hands (especially palms), arms, feet (especially plantar areas), legs, and lips --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented spots on hands (especially palms), arms, feet (especially plantar areas), legs, and lips | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1732. en:hyperpigmented streaks --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented streaks | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1733. en:hyperpigmented streaks following lines of blaschko --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented streaks following lines of blaschko | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1734. en:hyperpigmented whorls --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented whorls | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1735. en:hyperpigmented/hypopigmented macules (dorsum hands and feet, face) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented/hypopigmented macules (dorsum hands and feet, face) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1736. en:hyperpigmented/hypopigmented macules (trunk, extremities, occasionally face) --- r_associated #0: 20 --> en:oedema
    n1=en:hyperpigmented/hypopigmented macules (trunk, extremities, occasionally face) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1737. en:hyperplasia --- r_associated #0: 20 --> en:oedema
    n1=en:hyperplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1738. en:hypertension --- r_associated #0: 20 --> en:oedema
    n1=en:hypertension | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1739. en:hypertension in the puerperium with pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:hypertension in the puerperium with pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1740. en:hyperthermia --- r_associated #0: 20 --> en:oedema
    n1=en:hyperthermia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1741. en:hypertonia --- r_associated #0: 20 --> en:oedema
    n1=en:hypertonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1742. en:hypertonia at birth --- r_associated #0: 20 --> en:oedema
    n1=en:hypertonia at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1743. en:hypertonia late --- r_associated #0: 20 --> en:oedema
    n1=en:hypertonia late | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1744. en:hypertonicity (uncommon) --- r_associated #0: 20 --> en:oedema
    n1=en:hypertonicity (uncommon) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1745. en:hypertonicity of the lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:hypertonicity of the lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1746. en:hypertrichosis --- r_associated #0: 20 --> en:oedema
    n1=en:hypertrichosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1747. en:hypertrichosis (scalp, arms, legs, back) --- r_associated #0: 20 --> en:oedema
    n1=en:hypertrichosis (scalp, arms, legs, back) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1748. en:hypertriglyceridemic waist --- r_associated #0: 20 --> en:oedema
    n1=en:hypertriglyceridemic waist | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1749. en:hypertrophic scar --- r_associated #0: 20 --> en:oedema
    n1=en:hypertrophic scar | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1750. en:hypertrophic scarring (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:hypertrophic scarring (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1751. en:hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1752. en:hypertrophy of calves (in 3 of 6 patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypertrophy of calves (in 3 of 6 patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1753. en:hypertrophy of skin of soles --- r_associated #0: 20 --> en:oedema
    n1=en:hypertrophy of skin of soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1754. en:hypertrophy of the extensor digitorum brevis muscles --- r_associated #0: 20 --> en:oedema
    n1=en:hypertrophy of the extensor digitorum brevis muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1755. en:hyperuricemia --- r_associated #0: 20 --> en:oedema
    n1=en:hyperuricemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1756. en:hyperventilation --- r_associated #0: 20 --> en:oedema
    n1=en:hyperventilation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1757. en:hypervolemia --- r_associated #0: 20 --> en:oedema
    n1=en:hypervolemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1758. en:hypoactive gag reflex --- r_associated #0: 20 --> en:oedema
    n1=en:hypoactive gag reflex | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1759. en:hypoalgesia --- r_associated #0: 20 --> en:oedema
    n1=en:hypoalgesia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1760. en:hypoglycosylation of alpha-dystroglycan --- r_associated #0: 20 --> en:oedema
    n1=en:hypoglycosylation of alpha-dystroglycan | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1761. en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1762. en:hypohidrosis --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1763. en:hypohidrosis (in most patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis (in most patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1764. en:hypohidrosis (in patients with hsan2d) --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis (in patients with hsan2d) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1765. en:hypohidrosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1766. en:hypohidrosis and/or heat intolerance --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis and/or heat intolerance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1767. en:hypohidrosis may be present --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis may be present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1768. en:hypohidrosis or anhidrosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis or anhidrosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1769. en:hypohidrosis, localized, often on face --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis, localized, often on face | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1770. en:hypohidrosis/hyperhidrosis --- r_associated #0: 20 --> en:oedema
    n1=en:hypohidrosis/hyperhidrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1771. en:hyponatremia with excess extracellular fluid volume --- r_associated #0: 20 --> en:oedema
    n1=en:hyponatremia with excess extracellular fluid volume | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1772. en:hypopigmentation (seen only in deletion cases) --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmentation (seen only in deletion cases) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1773. en:hypopigmentation in a reticular pattern primarily on flexural skin --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmentation in a reticular pattern primarily on flexural skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1774. en:hypopigmentation spots --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmentation spots | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1775. en:hypopigmented macules --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented macules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1776. en:hypopigmented macules on neck, chest, and back (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented macules on neck, chest, and back (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1777. en:hypopigmented macules, primarily on extremities --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented macules, primarily on extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1778. en:hypopigmented patches (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented patches (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1779. en:hypopigmented skin lesions --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented skin lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1780. en:hypopigmented skin patch --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented skin patch | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1781. en:hypopigmented skin patches on arms (vitiligo) --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented skin patches on arms (vitiligo) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1782. en:hypopigmented spots (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented spots (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1783. en:hypopigmented streaks --- r_associated #0: 20 --> en:oedema
    n1=en:hypopigmented streaks | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1784. en:hypoplasia of cervical paravertebral muscles --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplasia of cervical paravertebral muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1785. en:hypoplasia of infraspinatus muscle --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplasia of infraspinatus muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1786. en:hypoplasia of latissimus dorsi muscle --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplasia of latissimus dorsi muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1787. en:hypoplasia of muscle --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplasia of muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1788. en:hypoplasia of serratus anterior muscle --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplasia of serratus anterior muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1789. en:hypoplasia of supraspinatus muscle --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplasia of supraspinatus muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1790. en:hypoplasia of the hand muscles (29%) --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplasia of the hand muscles (29%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1791. en:hypoplastic biceps --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic biceps | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1792. en:hypoplastic deltoids --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic deltoids | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1793. en:hypoplastic dermal ridges --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic dermal ridges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1794. en:hypoplastic fingertip epidermal ridges --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic fingertip epidermal ridges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1795. en:hypoplastic flexion creases --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic flexion creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1796. en:hypoplastic flexion creases dorsum of hand --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic flexion creases dorsum of hand | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1797. en:hypoplastic pilosebaceous units --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic pilosebaceous units | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1798. en:hypoplastic sweat glands --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic sweat glands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1799. en:hypoplastic-absent sebaceous glands --- r_associated #0: 20 --> en:oedema
    n1=en:hypoplastic-absent sebaceous glands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1800. en:hypoptyalism --- r_associated #0: 20 --> en:oedema
    n1=en:hypoptyalism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1801. en:hyporeflexia --- r_associated #0: 20 --> en:oedema
    n1=en:hyporeflexia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1802. en:hyporeflexia in affected muscles --- r_associated #0: 20 --> en:oedema
    n1=en:hyporeflexia in affected muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1803. en:hyporeflexia of lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:hyporeflexia of lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1804. en:hyporeflexia or areflexia --- r_associated #0: 20 --> en:oedema
    n1=en:hyporeflexia or areflexia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1805. en:hypotension --- r_associated #0: 20 --> en:oedema
    n1=en:hypotension | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1806. en:hypothenar muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:hypothenar muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1807. en:hypothermia --- r_associated #0: 20 --> en:oedema
    n1=en:hypothermia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1808. en:hypothermia adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:hypothermia adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1809. en:hypotonia --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1810. en:hypotonia (2 patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia (2 patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1811. en:hypotonia (45%) --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia (45%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1812. en:hypotonia (cvs+) --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia (cvs+) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1813. en:hypotonia (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1814. en:hypotonia (patient a) --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia (patient a) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1815. en:hypotonia (untreated hypothyroidism) --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia (untreated hypothyroidism) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1816. en:hypotonia at birth --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1817. en:hypotonia, axial, severe --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, axial, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1818. en:hypotonia, fixed --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, fixed | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1819. en:hypotonia, generalized (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, generalized (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1820. en:hypotonia, infantile, severe --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, infantile, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1821. en:hypotonia, mild --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1822. en:hypotonia, mild (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, mild (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1823. en:hypotonia, neonatal and later --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, neonatal and later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1824. en:hypotonia, severe, neonatal --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, severe, neonatal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1825. en:hypotonia, truncal and appendicular --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonia, truncal and appendicular | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1826. en:hypotonic --- r_associated #0: 20 --> en:oedema
    n1=en:hypotonic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1827. en:hypotrophy of type 1 fibers --- r_associated #0: 20 --> en:oedema
    n1=en:hypotrophy of type 1 fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1828. en:hypovolemia --- r_associated #0: 20 --> en:oedema
    n1=en:hypovolemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1829. en:hypoxia --- r_associated #0: 20 --> en:oedema
    n1=en:hypoxia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1830. en:hypoxia adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:hypoxia adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1831. en:ichthyosiform areas of skin (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosiform areas of skin (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1832. en:ichthyosiform erythroderma, congenital --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosiform erythroderma, congenital | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1833. en:ichthyosis --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1834. en:ichthyosis (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1835. en:ichthyosis (in contiguous gene syndrome patients) --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis (in contiguous gene syndrome patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1836. en:ichthyosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1837. en:ichthyosis (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1838. en:ichthyosis hystrix --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis hystrix | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1839. en:ichthyosis of scalp and flexural areas --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis of scalp and flexural areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1840. en:ichthyosis, diffuse lamellar --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis, diffuse lamellar | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1841. en:ichthyosis, generalized, including flexures --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis, generalized, including flexures | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1842. en:ichthyosis, generalized, with involvement of flexural folds --- r_associated #0: 20 --> en:oedema
    n1=en:ichthyosis, generalized, with involvement of flexural folds | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1843. en:idiopathic corneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:idiopathic corneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1844. en:idiopathic edema --- r_associated #0: 20 --> en:oedema
    n1=en:idiopathic edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1845. en:idiopathic nephrotic syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:idiopathic nephrotic syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1846. en:idiopathic optic disc swelling --- r_associated #0: 20 --> en:oedema
    n1=en:idiopathic optic disc swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1847. en:idiopathic scrotal edema --- r_associated #0: 20 --> en:oedema
    n1=en:idiopathic scrotal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1848. en:imaging shows muscle atrophy and fatty replacement --- r_associated #0: 20 --> en:oedema
    n1=en:imaging shows muscle atrophy and fatty replacement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1849. en:imaging shows progressive fatty infiltration of muscle --- r_associated #0: 20 --> en:oedema
    n1=en:imaging shows progressive fatty infiltration of muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1850. en:immune hydrops fetalis --- r_associated #0: 20 --> en:oedema
    n1=en:immune hydrops fetalis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1851. en:immunology aspects --- r_associated #0: 20 --> en:oedema
    n1=en:immunology aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1852. en:immunoreactivity for z-disk proteins --- r_associated #0: 20 --> en:oedema
    n1=en:immunoreactivity for z-disk proteins | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1853. en:impaired healing --- r_associated #0: 20 --> en:oedema
    n1=en:impaired healing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1854. en:impaired heel-walking --- r_associated #0: 20 --> en:oedema
    n1=en:impaired heel-walking | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1855. en:impaired mitochondrial respiration --- r_associated #0: 20 --> en:oedema
    n1=en:impaired mitochondrial respiration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1856. en:impaired toe-walking --- r_associated #0: 20 --> en:oedema
    n1=en:impaired toe-walking | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1857. en:impaired would healing --- r_associated #0: 20 --> en:oedema
    n1=en:impaired would healing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1858. en:impetigo --- r_associated #0: 20 --> en:oedema
    n1=en:impetigo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1859. en:impetigo-like eruptions --- r_associated #0: 20 --> en:oedema
    n1=en:impetigo-like eruptions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1860. en:impingement sign --- r_associated #0: 20 --> en:oedema
    n1=en:impingement sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1861. en:in blood --- r_associated #0: 20 --> en:oedema
    n1=en:in blood | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1862. en:in cerebrospinal fluid --- r_associated #0: 20 --> en:oedema
    n1=en:in cerebrospinal fluid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1863. en:in urine --- r_associated #0: 20 --> en:oedema
    n1=en:in urine | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1864. en:inability to jump or squat --- r_associated #0: 20 --> en:oedema
    n1=en:inability to jump or squat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1865. en:inability to run --- r_associated #0: 20 --> en:oedema
    n1=en:inability to run | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1866. en:inability to sit or hold head up --- r_associated #0: 20 --> en:oedema
    n1=en:inability to sit or hold head up | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1867. en:inability to stand on tiptoes --- r_associated #0: 20 --> en:oedema
    n1=en:inability to stand on tiptoes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1868. en:inclusion body myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:inclusion body myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1869. en:inclusions are dnajb6-immunoreactive --- r_associated #0: 20 --> en:oedema
    n1=en:inclusions are dnajb6-immunoreactive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1870. en:inclusions are tdp43-immunoreactive --- r_associated #0: 20 --> en:oedema
    n1=en:inclusions are tdp43-immunoreactive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1871. en:inclusions form a lobulated structure seen on electron microscopy --- r_associated #0: 20 --> en:oedema
    n1=en:inclusions form a lobulated structure seen on electron microscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1872. en:inclusions show positive immunostaining for sqstm1 and ubiquitin --- r_associated #0: 20 --> en:oedema
    n1=en:inclusions show positive immunostaining for sqstm1 and ubiquitin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1873. en:inclusions stain positively with nitroblue tetrazolium (nbt) --- r_associated #0: 20 --> en:oedema
    n1=en:inclusions stain positively with nitroblue tetrazolium (nbt) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1874. en:incontinence --- r_associated #0: 20 --> en:oedema
    n1=en:incontinence | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1875. en:increased adipose fibrosis --- r_associated #0: 20 --> en:oedema
    n1=en:increased adipose fibrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1876. en:increased amniotic fluid --- r_associated #0: 20 --> en:oedema
    n1=en:increased amniotic fluid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1877. en:increased antibody level in blood --- r_associated #0: 20 --> en:oedema
    n1=en:increased antibody level in blood | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1878. en:increased appetite (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:increased appetite (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1879. en:increased blood volume --- r_associated #0: 20 --> en:oedema
    n1=en:increased blood volume | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1880. en:increased central nucleation --- r_associated #0: 20 --> en:oedema
    n1=en:increased central nucleation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1881. en:increased centralized internal nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:increased centralized internal nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1882. en:increased centralized nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:increased centralized nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1883. en:increased chloride levels in sweat --- r_associated #0: 20 --> en:oedema
    n1=en:increased chloride levels in sweat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1884. en:increased connective tissue --- r_associated #0: 20 --> en:oedema
    n1=en:increased connective tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1885. en:increased connective tissue (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:increased connective tissue (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1886. en:increased connective tissue and fat in muscles --- r_associated #0: 20 --> en:oedema
    n1=en:increased connective tissue and fat in muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1887. en:increased echo intensity in affected muscles --- r_associated #0: 20 --> en:oedema
    n1=en:increased echo intensity in affected muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1888. en:increased endo- and perimysial connective tissue --- r_associated #0: 20 --> en:oedema
    n1=en:increased endo- and perimysial connective tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1889. en:increased endomysial connective tissue around muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:increased endomysial connective tissue around muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1890. en:increased endomysial fibrosis --- r_associated #0: 20 --> en:oedema
    n1=en:increased endomysial fibrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1891. en:increased fat and fibrous tissue --- r_associated #0: 20 --> en:oedema
    n1=en:increased fat and fibrous tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1892. en:increased fatigue --- r_associated #0: 20 --> en:oedema
    n1=en:increased fatigue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1893. en:increased fatty and connective tissue in skeletal muscle --- r_associated #0: 20 --> en:oedema
    n1=en:increased fatty and connective tissue in skeletal muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1894. en:increased fatty infiltration --- r_associated #0: 20 --> en:oedema
    n1=en:increased fatty infiltration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1895. en:increased fiber size variability --- r_associated #0: 20 --> en:oedema
    n1=en:increased fiber size variability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1896. en:increased fibrinolysis (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:increased fibrinolysis (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1897. en:increased fibrosis --- r_associated #0: 20 --> en:oedema
    n1=en:increased fibrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1898. en:increased focal mitochondrial density --- r_associated #0: 20 --> en:oedema
    n1=en:increased focal mitochondrial density | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1899. en:increased globulin --- r_associated #0: 20 --> en:oedema
    n1=en:increased globulin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1900. en:increased glycogen --- r_associated #0: 20 --> en:oedema
    n1=en:increased glycogen | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1901. en:increased glycogen in muscle --- r_associated #0: 20 --> en:oedema
    n1=en:increased glycogen in muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1902. en:increased intermyofibrillar and subsarcolemmal glycogen --- r_associated #0: 20 --> en:oedema
    n1=en:increased intermyofibrillar and subsarcolemmal glycogen | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1903. en:increased internal nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:increased internal nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1904. en:increased internal nuclei in skeletal muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:increased internal nuclei in skeletal muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1905. en:increased intraabdominal fat --- r_associated #0: 20 --> en:oedema
    n1=en:increased intraabdominal fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1906. en:increased intramuscular fat --- r_associated #0: 20 --> en:oedema
    n1=en:increased intramuscular fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1907. en:increased lipid --- r_associated #0: 20 --> en:oedema
    n1=en:increased lipid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1908. en:increased lipid droplets and abnormal mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:increased lipid droplets and abnormal mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1909. en:increased lysosomal glycogen --- r_associated #0: 20 --> en:oedema
    n1=en:increased lysosomal glycogen | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1910. en:increased mast cells --- r_associated #0: 20 --> en:oedema
    n1=en:increased mast cells | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1911. en:increased mitochondria seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:increased mitochondria seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1912. en:increased mitochondria with abnormal cristae --- r_associated #0: 20 --> en:oedema
    n1=en:increased mitochondria with abnormal cristae | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1913. en:increased mitochondria with rare paracrystalline inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:increased mitochondria with rare paracrystalline inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1914. en:increased muscle glycogen content --- r_associated #0: 20 --> en:oedema
    n1=en:increased muscle glycogen content | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1915. en:increased muscle lipid content --- r_associated #0: 20 --> en:oedema
    n1=en:increased muscle lipid content | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1916. en:increased muscle tone (early in life) --- r_associated #0: 20 --> en:oedema
    n1=en:increased muscle tone (early in life) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1917. en:increased muscle tone at birth --- r_associated #0: 20 --> en:oedema
    n1=en:increased muscle tone at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1918. en:increased muscle tone in the lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:increased muscle tone in the lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1919. en:increased number of skin folds (neck, abdomen, axillae) --- r_associated #0: 20 --> en:oedema
    n1=en:increased number of skin folds (neck, abdomen, axillae) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1920. en:increased numbers of abnormally-shaped mitochondria in subsarcolemmal areas --- r_associated #0: 20 --> en:oedema
    n1=en:increased numbers of abnormally-shaped mitochondria in subsarcolemmal areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1921. en:increased numbers of type 1 fibers --- r_associated #0: 20 --> en:oedema
    n1=en:increased numbers of type 1 fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1922. en:increased perisarcolemmal calcium deposition --- r_associated #0: 20 --> en:oedema
    n1=en:increased perisarcolemmal calcium deposition | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1923. en:increased pigmented nevi --- r_associated #0: 20 --> en:oedema
    n1=en:increased pigmented nevi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1924. en:increased sputum excretion --- r_associated #0: 20 --> en:oedema
    n1=en:increased sputum excretion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1925. en:increased staining for myotilin, dystrophin, desmin --- r_associated #0: 20 --> en:oedema
    n1=en:increased staining for myotilin, dystrophin, desmin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1926. en:increased subcutaneous truncal adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:increased subcutaneous truncal adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1927. en:increased t-2 signal in muscles of lower extremities on mri (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:increased t-2 signal in muscles of lower extremities on mri (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1928. en:increased tolerance --- r_associated #0: 20 --> en:oedema
    n1=en:increased tolerance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1929. en:increased variability in muscle fiber diameter --- r_associated #0: 20 --> en:oedema
    n1=en:increased variability in muscle fiber diameter | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1930. en:increased variability of fiber size seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:increased variability of fiber size seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1931. en:increased variation in fiber size seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:increased variation in fiber size seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1932. en:increased variation in muscle fiber diameter --- r_associated #0: 20 --> en:oedema
    n1=en:increased variation in muscle fiber diameter | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1933. en:increased venous pressure --- r_associated #0: 20 --> en:oedema
    n1=en:increased venous pressure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1934. en:increased visceral fat --- r_associated #0: 20 --> en:oedema
    n1=en:increased visceral fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1935. en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1936. en:independent walking may not be achieved --- r_associated #0: 20 --> en:oedema
    n1=en:independent walking may not be achieved | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1937. en:infantile axial hypotonia --- r_associated #0: 20 --> en:oedema
    n1=en:infantile axial hypotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1938. en:infantile hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:infantile hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1939. en:infantile muscular hypotonia --- r_associated #0: 20 --> en:oedema
    n1=en:infantile muscular hypotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1940. en:infected finger/toe/paronychia --- r_associated #0: 20 --> en:oedema
    n1=en:infected finger/toe/paronychia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1941. en:inflammatory breast carcinoma --- r_associated #0: 20 --> en:oedema
    n1=en:inflammatory breast carcinoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1942. en:inflammatory cells absent --- r_associated #0: 20 --> en:oedema
    n1=en:inflammatory cells absent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1943. en:inflammatory edema reaction --- r_associated #0: 20 --> en:oedema
    n1=en:inflammatory edema reaction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1944. en:inflammatory swelling --- r_associated #0: 20 --> en:oedema
    n1=en:inflammatory swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1945. en:influenza --- r_associated #0: 20 --> en:oedema
    n1=en:influenza | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1946. en:infra-orbital crease --- r_associated #0: 20 --> en:oedema
    n1=en:infra-orbital crease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1947. en:infraorbital fold (dennie-morgan lines) --- r_associated #0: 20 --> en:oedema
    n1=en:infraorbital fold (dennie-morgan lines) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1948. en:ingrown toenail/other disease of nail --- r_associated #0: 20 --> en:oedema
    n1=en:ingrown toenail/other disease of nail | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1949. en:inguinal freckling --- r_associated #0: 20 --> en:oedema
    n1=en:inguinal freckling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1950. en:inguinal hernia --- r_associated #0: 20 --> en:oedema
    n1=en:inguinal hernia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1951. en:inguinal pterygium, bilateral (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:inguinal pterygium, bilateral (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1952. en:injection site edema --- r_associated #0: 20 --> en:oedema
    n1=en:injection site edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1953. en:inner zone of enucleated 'shadow' cells --- r_associated #0: 20 --> en:oedema
    n1=en:inner zone of enucleated 'shadow' cells | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1954. en:insect bites --- r_associated #0: 20 --> en:oedema
    n1=en:insect bites | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1955. en:integumentary system signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:integumentary system signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1956. en:intercrural pterygium --- r_associated #0: 20 --> en:oedema
    n1=en:intercrural pterygium | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1957. en:interfibrillar and subsarcolemmal vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:interfibrillar and subsarcolemmal vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1958. en:intermittent claudication --- r_associated #0: 20 --> en:oedema
    n1=en:intermittent claudication | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1959. en:intermittent generalized erythematous papular rash --- r_associated #0: 20 --> en:oedema
    n1=en:intermittent generalized erythematous papular rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1960. en:intermyofibrillar and subsarcolemmal accumulation of electron-dense material (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:intermyofibrillar and subsarcolemmal accumulation of electron-dense material (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1961. en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates --- r_associated #0: 20 --> en:oedema
    n1=en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1962. en:internal nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:internal nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1963. en:internal nuclei seen on biopsy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:internal nuclei seen on biopsy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1964. en:internal nuclei seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:internal nuclei seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1965. en:interosseus muscles involved --- r_associated #0: 20 --> en:oedema
    n1=en:interosseus muscles involved | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1966. en:intolerant of heat --- r_associated #0: 20 --> en:oedema
    n1=en:intolerant of heat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1967. en:intracytoplasmic vacuoles in basal keratinocytes (with negative oil red o-staining) --- r_associated #0: 20 --> en:oedema
    n1=en:intracytoplasmic vacuoles in basal keratinocytes (with negative oil red o-staining) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1968. en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin --- r_associated #0: 20 --> en:oedema
    n1=en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1969. en:intrauterine growth retardation (less than tenth percentile) --- r_associated #0: 20 --> en:oedema
    n1=en:intrauterine growth retardation (less than tenth percentile) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1970. en:intravasation --- r_associated #0: 20 --> en:oedema
    n1=en:intravasation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1971. en:involves upper and lower proximal muscles --- r_associated #0: 20 --> en:oedema
    n1=en:involves upper and lower proximal muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1972. en:irregular hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:irregular hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1973. en:irvine gass syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:irvine gass syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1974. en:ischemic cerebrovascular accident --- r_associated #0: 20 --> en:oedema
    n1=en:ischemic cerebrovascular accident | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1975. en:islands of uninvolved skin --- r_associated #0: 20 --> en:oedema
    n1=en:islands of uninvolved skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1976. en:isolated mitochondrial complex iv deficiency seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:isolated mitochondrial complex iv deficiency seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1977. en:isolated necrotic fibers --- r_associated #0: 20 --> en:oedema
    n1=en:isolated necrotic fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1978. en:itching ( in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:itching ( in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1979. en:jaundice --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1980. en:jaundice (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1981. en:jaundice (harderoporphyria) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice (harderoporphyria) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1982. en:jaundice (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1983. en:jaundice (in some patients), resolved postpartum --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice (in some patients), resolved postpartum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1984. en:jaundice (in some) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice (in some) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1985. en:jaundice (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1986. en:jaundice (not of newborn) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice (not of newborn) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1987. en:jaundice (sometimes onset in the neonatal period) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice (sometimes onset in the neonatal period) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1988. en:jaundice due to hemolytic anemia --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice due to hemolytic anemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1989. en:jaundice, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1990. en:jaundice, green --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice, green | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1991. en:jaundice, intermittent (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice, intermittent (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1992. en:jaundice, neonatal (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:jaundice, neonatal (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1993. en:jitter --- r_associated #0: 20 --> en:oedema
    n1=en:jitter | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1994. en:joint effusion --- r_associated #0: 20 --> en:oedema
    n1=en:joint effusion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1995. en:joint pain adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:joint pain adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1996. en:joint protection knowledge assessment score --- r_associated #0: 20 --> en:oedema
    n1=en:joint protection knowledge assessment score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1997. en:junctional epidermolysis bullosa --- r_associated #0: 20 --> en:oedema
    n1=en:junctional epidermolysis bullosa | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1998. en:juvenile colloid milium --- r_associated #0: 20 --> en:oedema
    n1=en:juvenile colloid milium | n2=en:oedema | rel=r_associated | relid=0 | w=20
  1999. en:kanavel's four cardinal signs --- r_associated #0: 20 --> en:oedema
    n1=en:kanavel's four cardinal signs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2000. en:kawasaki disease --- r_associated #0: 20 --> en:oedema
    n1=en:kawasaki disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2001. en:kehr's sign --- r_associated #0: 20 --> en:oedema
    n1=en:kehr's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2002. en:keloid --- r_associated #0: 20 --> en:oedema
    n1=en:keloid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2003. en:keloid formation --- r_associated #0: 20 --> en:oedema
    n1=en:keloid formation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2004. en:keloid formation in surgical scars --- r_associated #0: 20 --> en:oedema
    n1=en:keloid formation in surgical scars | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2005. en:keratinized, purple, nodular skin lesions (in 2 of 4 patients) --- r_associated #0: 20 --> en:oedema
    n1=en:keratinized, purple, nodular skin lesions (in 2 of 4 patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2006. en:keratinocyte --- r_associated #0: 20 --> en:oedema
    n1=en:keratinocyte | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2007. en:keratoacanthoma --- r_associated #0: 20 --> en:oedema
    n1=en:keratoacanthoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2008. en:keratoatrophoderma --- r_associated #0: 20 --> en:oedema
    n1=en:keratoatrophoderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2009. en:keratoderma (palms and soles) --- r_associated #0: 20 --> en:oedema
    n1=en:keratoderma (palms and soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2010. en:keratoderma of soles at pressure points --- r_associated #0: 20 --> en:oedema
    n1=en:keratoderma of soles at pressure points | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2011. en:keratoderma, mutilating, of palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:keratoderma, mutilating, of palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2012. en:keratoderma, striated, on palms --- r_associated #0: 20 --> en:oedema
    n1=en:keratoderma, striated, on palms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2013. en:keratosis palmaris --- r_associated #0: 20 --> en:oedema
    n1=en:keratosis palmaris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2014. en:keratosis pilaris --- r_associated #0: 20 --> en:oedema
    n1=en:keratosis pilaris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2015. en:keratosis pilaris (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:keratosis pilaris (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2016. en:keratosis pilaris of arms and legs --- r_associated #0: 20 --> en:oedema
    n1=en:keratosis pilaris of arms and legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2017. en:keratosis plantaris --- r_associated #0: 20 --> en:oedema
    n1=en:keratosis plantaris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2018. en:keratotic plaque, periorificial --- r_associated #0: 20 --> en:oedema
    n1=en:keratotic plaque, periorificial | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2019. en:keratotic plaques (palms) --- r_associated #0: 20 --> en:oedema
    n1=en:keratotic plaques (palms) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2020. en:kernig's sign --- r_associated #0: 20 --> en:oedema
    n1=en:kernig's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2021. en:ketoadipicaciduria --- r_associated #0: 20 --> en:oedema
    n1=en:ketoadipicaciduria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2022. en:kidney sweat --- r_associated #0: 20 --> en:oedema
    n1=en:kidney sweat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2023. en:knee and hip flexor weakness due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:knee and hip flexor weakness due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2024. en:knee dimple --- r_associated #0: 20 --> en:oedema
    n1=en:knee dimple | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2025. en:kniest like dysplasia lethal --- r_associated #0: 20 --> en:oedema
    n1=en:kniest like dysplasia lethal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2026. en:knuckle pads on dorsal finger and toe joints --- r_associated #0: 20 --> en:oedema
    n1=en:knuckle pads on dorsal finger and toe joints | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2027. en:kocher's sign --- r_associated #0: 20 --> en:oedema
    n1=en:kocher's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2028. en:laceration/cut --- r_associated #0: 20 --> en:oedema
    n1=en:laceration/cut | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2029. en:lack of adipose tissue on limbs and femorogluteal regions --- r_associated #0: 20 --> en:oedema
    n1=en:lack of adipose tissue on limbs and femorogluteal regions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2030. en:lack of chilblain lesions --- r_associated #0: 20 --> en:oedema
    n1=en:lack of chilblain lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2031. en:lack of epidermal ridges on palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:lack of epidermal ridges on palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2032. en:lack of facial subcutaneous fat --- r_associated #0: 20 --> en:oedema
    n1=en:lack of facial subcutaneous fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2033. en:lack of integrin alpha-7 staining --- r_associated #0: 20 --> en:oedema
    n1=en:lack of integrin alpha-7 staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2034. en:lack of perspiration --- r_associated #0: 20 --> en:oedema
    n1=en:lack of perspiration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2035. en:lack of scarring --- r_associated #0: 20 --> en:oedema
    n1=en:lack of scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2036. en:lamellar ichthyosis --- r_associated #0: 20 --> en:oedema
    n1=en:lamellar ichthyosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2037. en:landy donnai syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:landy donnai syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2038. en:langerhans cell --- r_associated #0: 20 --> en:oedema
    n1=en:langerhans cell | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2039. en:large adherent dark pigmented scales --- r_associated #0: 20 --> en:oedema
    n1=en:large adherent dark pigmented scales | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2040. en:large brownish scales on lower extremities (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:large brownish scales on lower extremities (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2041. en:large cafe au lait spots with irregular margins --- r_associated #0: 20 --> en:oedema
    n1=en:large cafe au lait spots with irregular margins | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2042. en:large dark plate-like scales --- r_associated #0: 20 --> en:oedema
    n1=en:large dark plate-like scales | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2043. en:large diamond-shaped plaques --- r_associated #0: 20 --> en:oedema
    n1=en:large diamond-shaped plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2044. en:large hard compact painful masses of keratin at sites of recurrent friction on palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:large hard compact painful masses of keratin at sites of recurrent friction on palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2045. en:large hypertrophied fibers --- r_associated #0: 20 --> en:oedema
    n1=en:large hypertrophied fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2046. en:large lipid droplets --- r_associated #0: 20 --> en:oedema
    n1=en:large lipid droplets | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2047. en:large nevus (greater than 10 cm) --- r_associated #0: 20 --> en:oedema
    n1=en:large nevus (greater than 10 cm) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2048. en:larger and darker scales on neck, elbows, and knees (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:larger and darker scales on neck, elbows, and knees (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2049. en:larger brownish scaling on neck, buttocks, and legs --- r_associated #0: 20 --> en:oedema
    n1=en:larger brownish scaling on neck, buttocks, and legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2050. en:laryngeal edema --- r_associated #0: 20 --> en:oedema
    n1=en:laryngeal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2051. en:lasegue test response --- r_associated #0: 20 --> en:oedema
    n1=en:lasegue test response | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2052. en:lassitude --- r_associated #0: 20 --> en:oedema
    n1=en:lassitude | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2053. en:leak --- r_associated #0: 20 --> en:oedema
    n1=en:leak | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2054. en:left ventricular failure --- r_associated #0: 20 --> en:oedema
    n1=en:left ventricular failure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2055. en:leg cramps may occur with exercise --- r_associated #0: 20 --> en:oedema
    n1=en:leg cramps may occur with exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2056. en:leg edema --- r_associated #0: 20 --> en:oedema
    n1=en:leg edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2057. en:leiomyomas are sensitive to light touch --- r_associated #0: 20 --> en:oedema
    n1=en:leiomyomas are sensitive to light touch | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2058. en:lentigenes --- r_associated #0: 20 --> en:oedema
    n1=en:lentigenes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2059. en:lentigines may be absent --- r_associated #0: 20 --> en:oedema
    n1=en:lentigines may be absent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2060. en:lentigines may be congenital or develop in first months to years of life --- r_associated #0: 20 --> en:oedema
    n1=en:lentigines may be congenital or develop in first months to years of life | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2061. en:lentiginosis, generalized (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:lentiginosis, generalized (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2062. en:lesion observable --- r_associated #0: 20 --> en:oedema
    n1=en:lesion observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2063. en:lesions appear on the trunk and limbs but the face, palms, soles, and mucosa are spared --- r_associated #0: 20 --> en:oedema
    n1=en:lesions appear on the trunk and limbs but the face, palms, soles, and mucosa are spared | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2064. en:lesions are often brownish colored --- r_associated #0: 20 --> en:oedema
    n1=en:lesions are often brownish colored | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2065. en:lesions become purpuric --- r_associated #0: 20 --> en:oedema
    n1=en:lesions become purpuric | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2066. en:lesions become soft and paler with age --- r_associated #0: 20 --> en:oedema
    n1=en:lesions become soft and paler with age | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2067. en:lesions follow the lines of blaschko --- r_associated #0: 20 --> en:oedema
    n1=en:lesions follow the lines of blaschko | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2068. en:lesions occur mainly on extremities, scalp, neck, and trunk --- r_associated #0: 20 --> en:oedema
    n1=en:lesions occur mainly on extremities, scalp, neck, and trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2069. en:lesions occur on the trunk, back, arms, legs, abdomen, buttocks --- r_associated #0: 20 --> en:oedema
    n1=en:lesions occur on the trunk, back, arms, legs, abdomen, buttocks | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2070. en:lesions often follow blaschko lines --- r_associated #0: 20 --> en:oedema
    n1=en:lesions often follow blaschko lines | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2071. en:lesions predominantly on face and limbs --- r_associated #0: 20 --> en:oedema
    n1=en:lesions predominantly on face and limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2072. en:lethal multiple pterygium syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:lethal multiple pterygium syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2073. en:leukemia --- r_associated #0: 20 --> en:oedema
    n1=en:leukemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2074. en:leukoplakia --- r_associated #0: 20 --> en:oedema
    n1=en:leukoplakia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2075. en:leukoplakia (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:leukoplakia (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2076. en:leukoplakia (seen in recessive form) --- r_associated #0: 20 --> en:oedema
    n1=en:leukoplakia (seen in recessive form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2077. en:levator palpebrae superioris atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:levator palpebrae superioris atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2078. en:lichenification --- r_associated #0: 20 --> en:oedema
    n1=en:lichenification | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2079. en:lichenification of palms --- r_associated #0: 20 --> en:oedema
    n1=en:lichenification of palms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2080. en:lichenified lesions --- r_associated #0: 20 --> en:oedema
    n1=en:lichenified lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2081. en:lichenified skin --- r_associated #0: 20 --> en:oedema
    n1=en:lichenified skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2082. en:lichenoid plaques --- r_associated #0: 20 --> en:oedema
    n1=en:lichenoid plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2083. en:light complexion --- r_associated #0: 20 --> en:oedema
    n1=en:light complexion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2084. en:light skin pigmentation compared to unaffected sibs --- r_associated #0: 20 --> en:oedema
    n1=en:light skin pigmentation compared to unaffected sibs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2085. en:light-sensitive dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:light-sensitive dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2086. en:lighter skin color --- r_associated #0: 20 --> en:oedema
    n1=en:lighter skin color | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2087. en:limb lymphedema (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:limb lymphedema (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2088. en:limb muscle weakness and atrophy, distal, neurogenic --- r_associated #0: 20 --> en:oedema
    n1=en:limb muscle weakness and atrophy, distal, neurogenic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2089. en:limb muscle weakness, proximal, upper and lower --- r_associated #0: 20 --> en:oedema
    n1=en:limb muscle weakness, proximal, upper and lower | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2090. en:limb muscular atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:limb muscular atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2091. en:limb weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:limb weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2092. en:limb weakness, proximal followed by distal --- r_associated #0: 20 --> en:oedema
    n1=en:limb weakness, proximal followed by distal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2093. en:limb-girdle muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:limb-girdle muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2094. en:limb-girdle muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:limb-girdle muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2095. en:limb-girdle muscle weakness (2 families) --- r_associated #0: 20 --> en:oedema
    n1=en:limb-girdle muscle weakness (2 families) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2096. en:limb-girdle muscle weakness, proximal, upper greater than lower --- r_associated #0: 20 --> en:oedema
    n1=en:limb-girdle muscle weakness, proximal, upper greater than lower | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2097. en:limb-girdle muscular dystrophy --- r_associated #0: 20 --> en:oedema
    n1=en:limb-girdle muscular dystrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2098. en:limb-girdle myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:limb-girdle myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2099. en:limited dermatologic function --- r_associated #0: 20 --> en:oedema
    n1=en:limited dermatologic function | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2100. en:linear arrays of macular hyperkeratoses in flexural areas --- r_associated #0: 20 --> en:oedema
    n1=en:linear arrays of macular hyperkeratoses in flexural areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2101. en:linear epidermal nevus (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:linear epidermal nevus (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2102. en:linear hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:linear hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2103. en:linear nevus sebaceous, often in midfacial area --- r_associated #0: 20 --> en:oedema
    n1=en:linear nevus sebaceous, often in midfacial area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2104. en:linear or reticular hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:linear or reticular hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2105. en:linear plaque-like scales (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:linear plaque-like scales (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2106. en:linear porokeratosis (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:linear porokeratosis (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2107. en:lip pit --- r_associated #0: 20 --> en:oedema
    n1=en:lip pit | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2108. en:lipedema --- r_associated #0: 20 --> en:oedema
    n1=en:lipedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2109. en:lipid accumulation in muscle tissue --- r_associated #0: 20 --> en:oedema
    n1=en:lipid accumulation in muscle tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2110. en:lipid and glycogen accumulation --- r_associated #0: 20 --> en:oedema
    n1=en:lipid and glycogen accumulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2111. en:lipid droplet accumulation --- r_associated #0: 20 --> en:oedema
    n1=en:lipid droplet accumulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2112. en:lipid droplets seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:lipid droplets seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2113. en:lipoatrophic appearance --- r_associated #0: 20 --> en:oedema
    n1=en:lipoatrophic appearance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2114. en:lipoatrophy (lower face, upper limb, buttock) --- r_associated #0: 20 --> en:oedema
    n1=en:lipoatrophy (lower face, upper limb, buttock) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2115. en:lipoatrophy of trunk --- r_associated #0: 20 --> en:oedema
    n1=en:lipoatrophy of trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2116. en:lipoatrophy, generalized --- r_associated #0: 20 --> en:oedema
    n1=en:lipoatrophy, generalized | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2117. en:lipodystrophy --- r_associated #0: 20 --> en:oedema
    n1=en:lipodystrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2118. en:lipodystrophy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:lipodystrophy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2119. en:lipodystrophy, generalized, panniculitis-induced (in some) --- r_associated #0: 20 --> en:oedema
    n1=en:lipodystrophy, generalized, panniculitis-induced (in some) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2120. en:lipofibroma --- r_associated #0: 20 --> en:oedema
    n1=en:lipofibroma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2121. en:lipohypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:lipohypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2122. en:lipohypoplasia, regional --- r_associated #0: 20 --> en:oedema
    n1=en:lipohypoplasia, regional | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2123. en:lipoma --- r_associated #0: 20 --> en:oedema
    n1=en:lipoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2124. en:lipoma of skin and subcutaneous tissue of scalp --- r_associated #0: 20 --> en:oedema
    n1=en:lipoma of skin and subcutaneous tissue of scalp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2125. en:lipomas or lipomatous masses (most cases) --- r_associated #0: 20 --> en:oedema
    n1=en:lipomas or lipomatous masses (most cases) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2126. en:livedo --- r_associated #0: 20 --> en:oedema
    n1=en:livedo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2127. en:livedo racemosa (usually on trunk and/or lower extremities) --- r_associated #0: 20 --> en:oedema
    n1=en:livedo racemosa (usually on trunk and/or lower extremities) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2128. en:livedo reticularis --- r_associated #0: 20 --> en:oedema
    n1=en:livedo reticularis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2129. en:livedo reticularis (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:livedo reticularis (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2130. en:local swelling/papules/lump/mass --- r_associated #0: 20 --> en:oedema
    n1=en:local swelling/papules/lump/mass | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2131. en:localised rash --- r_associated #0: 20 --> en:oedema
    n1=en:localised rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2132. en:localized cellulitis --- r_associated #0: 20 --> en:oedema
    n1=en:localized cellulitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2133. en:localized cutaneous deposits of superficial fat --- r_associated #0: 20 --> en:oedema
    n1=en:localized cutaneous deposits of superficial fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2134. en:localized cutaneous necrobiosis lipoidica --- r_associated #0: 20 --> en:oedema
    n1=en:localized cutaneous necrobiosis lipoidica | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2135. en:localized edema --- r_associated #0: 20 --> en:oedema
    n1=en:localized edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2136. en:localized superficial swelling, mass, or lump --- r_associated #0: 20 --> en:oedema
    n1=en:localized superficial swelling, mass, or lump | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2137. en:localized symmetric fixed, yellow- or red-brown hyperkeratotic plaques (extensor surface of extremities, buttocks, and lateral trunk) --- r_associated #0: 20 --> en:oedema
    n1=en:localized symmetric fixed, yellow- or red-brown hyperkeratotic plaques (extensor surface of extremities, buttocks, and lateral trunk) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2138. en:longitudinal hyperkeratotic lesions along flexor surface of each finger, extending to palm --- r_associated #0: 20 --> en:oedema
    n1=en:longitudinal hyperkeratotic lesions along flexor surface of each finger, extending to palm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2139. en:loose connective tissue --- r_associated #0: 20 --> en:oedema
    n1=en:loose connective tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2140. en:loose redundant skin (especially of dorsum of hands and feet and anterior abdominal wall) --- r_associated #0: 20 --> en:oedema
    n1=en:loose redundant skin (especially of dorsum of hands and feet and anterior abdominal wall) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2141. en:loose skin at birth --- r_associated #0: 20 --> en:oedema
    n1=en:loose skin at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2142. en:loose volor skin of hands --- r_associated #0: 20 --> en:oedema
    n1=en:loose volor skin of hands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2143. en:loose, elastic skin --- r_associated #0: 20 --> en:oedema
    n1=en:loose, elastic skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2144. en:loose, redundant skin on fingers --- r_associated #0: 20 --> en:oedema
    n1=en:loose, redundant skin on fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2145. en:loss of ability to walk in early childhood --- r_associated #0: 20 --> en:oedema
    n1=en:loss of ability to walk in early childhood | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2146. en:loss of adipose tissue occurs around puberty --- r_associated #0: 20 --> en:oedema
    n1=en:loss of adipose tissue occurs around puberty | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2147. en:loss of ambulation (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:loss of ambulation (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2148. en:loss of ambulation between third and sixth decade --- r_associated #0: 20 --> en:oedema
    n1=en:loss of ambulation between third and sixth decade | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2149. en:loss of antigravity strength --- r_associated #0: 20 --> en:oedema
    n1=en:loss of antigravity strength | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2150. en:loss of consciousness --- r_associated #0: 20 --> en:oedema
    n1=en:loss of consciousness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2151. en:loss of facial adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:loss of facial adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2152. en:loss of gluteal adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:loss of gluteal adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2153. en:loss of independent ambulation around age 12 years --- r_associated #0: 20 --> en:oedema
    n1=en:loss of independent ambulation around age 12 years | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2154. en:loss of lower-limb tendon reflexes --- r_associated #0: 20 --> en:oedema
    n1=en:loss of lower-limb tendon reflexes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2155. en:loss of sarcomeric striations --- r_associated #0: 20 --> en:oedema
    n1=en:loss of sarcomeric striations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2156. en:loss of subcutaneous adipose tissue from gluteal region --- r_associated #0: 20 --> en:oedema
    n1=en:loss of subcutaneous adipose tissue from gluteal region | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2157. en:loss of subcutaneous adipose tissue from upper limbs and trunk --- r_associated #0: 20 --> en:oedema
    n1=en:loss of subcutaneous adipose tissue from upper limbs and trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2158. en:loss of subcutaneous adipose tissue in limbs --- r_associated #0: 20 --> en:oedema
    n1=en:loss of subcutaneous adipose tissue in limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2159. en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2160. en:loss of subcutaneous and visceral adipose tissue, mild --- r_associated #0: 20 --> en:oedema
    n1=en:loss of subcutaneous and visceral adipose tissue, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2161. en:loss of subcutaneous fat --- r_associated #0: 20 --> en:oedema
    n1=en:loss of subcutaneous fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2162. en:loss of subcutaneous fat, generalized --- r_associated #0: 20 --> en:oedema
    n1=en:loss of subcutaneous fat, generalized | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2163. en:loss of subcutaneous fat, particularly affecting the limbs --- r_associated #0: 20 --> en:oedema
    n1=en:loss of subcutaneous fat, particularly affecting the limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2164. en:loss of truncal subcutaneous adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:loss of truncal subcutaneous adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2165. en:low cardiac output --- r_associated #0: 20 --> en:oedema
    n1=en:low cardiac output | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2166. en:low erythrocyte sedimentation rate --- r_associated #0: 20 --> en:oedema
    n1=en:low erythrocyte sedimentation rate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2167. en:low maximum workload on exercise testing --- r_associated #0: 20 --> en:oedema
    n1=en:low maximum workload on exercise testing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2168. en:low muscle mass --- r_associated #0: 20 --> en:oedema
    n1=en:low muscle mass | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2169. en:low-amplitude compound muscle action potential (cmap) --- r_associated #0: 20 --> en:oedema
    n1=en:low-amplitude compound muscle action potential (cmap) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2170. en:lowenstein occupational therapy cognitive assessment score --- r_associated #0: 20 --> en:oedema
    n1=en:lowenstein occupational therapy cognitive assessment score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2171. en:lower and upper limbs affected --- r_associated #0: 20 --> en:oedema
    n1=en:lower and upper limbs affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2172. en:lower limb atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:lower limb atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2173. en:lower limb lymphedema (variable onset, age four to teens) --- r_associated #0: 20 --> en:oedema
    n1=en:lower limb lymphedema (variable onset, age four to teens) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2174. en:lower limb muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:lower limb muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2175. en:lower limb muscle atrophy (in 2 of 3 families) --- r_associated #0: 20 --> en:oedema
    n1=en:lower limb muscle atrophy (in 2 of 3 families) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2176. en:lower limb muscle hypotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:lower limb muscle hypotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2177. en:lower limb muscle weakness (in 2 of 3 families) --- r_associated #0: 20 --> en:oedema
    n1=en:lower limb muscle weakness (in 2 of 3 families) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2178. en:lower limbs more affected than upper limbs --- r_associated #0: 20 --> en:oedema
    n1=en:lower limbs more affected than upper limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2179. en:lower limbs more often affected --- r_associated #0: 20 --> en:oedema
    n1=en:lower limbs more often affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2180. en:ludington's sign --- r_associated #0: 20 --> en:oedema
    n1=en:ludington's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2181. en:lumbar cushion (edema) --- r_associated #0: 20 --> en:oedema
    n1=en:lumbar cushion (edema) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2182. en:lymphadenopathy --- r_associated #0: 20 --> en:oedema
    n1=en:lymphadenopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2183. en:lymphangiectasia --- r_associated #0: 20 --> en:oedema
    n1=en:lymphangiectasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2184. en:lymphangioma --- r_associated #0: 20 --> en:oedema
    n1=en:lymphangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2185. en:lymphangitis, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:lymphangitis, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2186. en:lymphatic diseases --- r_associated #0: 20 --> en:oedema
    n1=en:lymphatic diseases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2187. en:lymphatic vessels present at the periphery of lesion --- r_associated #0: 20 --> en:oedema
    n1=en:lymphatic vessels present at the periphery of lesion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2188. en:lymphedema --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2189. en:lymphedema (lower limb) --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema (lower limb) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2190. en:lymphedema of lower extremity --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema of lower extremity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2191. en:lymphedema of lower limbs (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema of lower limbs (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2192. en:lymphedema of the extremities --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema of the extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2193. en:lymphedema of the hands (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema of the hands (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2194. en:lymphedema of the lower limbs (swelling is confined to below the knees) --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema of the lower limbs (swelling is confined to below the knees) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2195. en:lymphedema of upper and/or lower limbs (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema of upper and/or lower limbs (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2196. en:lymphedema quality of life tool (arm) score --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema quality of life tool (arm) score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2197. en:lymphedema quality of life tool (leg) score --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema quality of life tool (leg) score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2198. en:lymphedema, dorsa of feet --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema, dorsa of feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2199. en:lymphedema, hands (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema, hands (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2200. en:lymphedema, of upper and/or lower extremity (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:lymphedema, of upper and/or lower extremity (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2201. en:lymphography shows hypoplasia of lymphatic vessels --- r_associated #0: 20 --> en:oedema
    n1=en:lymphography shows hypoplasia of lymphatic vessels | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2202. en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia) --- r_associated #0: 20 --> en:oedema
    n1=en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2203. en:lymphoscintigraphy shows impaired lymphatic uptake and drainage --- r_associated #0: 20 --> en:oedema
    n1=en:lymphoscintigraphy shows impaired lymphatic uptake and drainage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2204. en:maceration of palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:maceration of palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2205. en:macroglossia --- r_associated #0: 20 --> en:oedema
    n1=en:macroglossia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2206. en:macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2207. en:macular edema and retinopathy due to type 2 diabetes mellitus --- r_associated #0: 20 --> en:oedema
    n1=en:macular edema and retinopathy due to type 2 diabetes mellitus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2208. en:macular hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:macular hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2209. en:macular hypopigmented whorls, streaks, and patches --- r_associated #0: 20 --> en:oedema
    n1=en:macular hypopigmented whorls, streaks, and patches | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2210. en:maculopapular eruption, diffuse --- r_associated #0: 20 --> en:oedema
    n1=en:maculopapular eruption, diffuse | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2211. en:maculopapular rash, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:maculopapular rash, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2212. en:malaise --- r_associated #0: 20 --> en:oedema
    n1=en:malaise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2213. en:malar flush --- r_associated #0: 20 --> en:oedema
    n1=en:malar flush | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2214. en:malar rash --- r_associated #0: 20 --> en:oedema
    n1=en:malar rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2215. en:malaria --- r_associated #0: 20 --> en:oedema
    n1=en:malaria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2216. en:malignant hyperthermia syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:malignant hyperthermia syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2217. en:malignant skin neoplasm --- r_associated #0: 20 --> en:oedema
    n1=en:malignant skin neoplasm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2218. en:mallory-like bodies --- r_associated #0: 20 --> en:oedema
    n1=en:mallory-like bodies | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2219. en:manchester foot pain and disability index score --- r_associated #0: 20 --> en:oedema
    n1=en:manchester foot pain and disability index score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2220. en:many fibers with internal nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:many fibers with internal nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2221. en:marbled skin due to telangiectasia --- r_associated #0: 20 --> en:oedema
    n1=en:marbled skin due to telangiectasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2222. en:marked bruisability --- r_associated #0: 20 --> en:oedema
    n1=en:marked bruisability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2223. en:marked fetal hydrops --- r_associated #0: 20 --> en:oedema
    n1=en:marked fetal hydrops | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2224. en:marked lack of adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:marked lack of adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2225. en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest --- r_associated #0: 20 --> en:oedema
    n1=en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2226. en:marked muscular hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:marked muscular hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2227. en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2228. en:marked skin pallor --- r_associated #0: 20 --> en:oedema
    n1=en:marked skin pallor | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2229. en:marked variability of fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:marked variability of fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2230. en:massengill disposable douche baking soda,vag --- r_associated #0: 20 --> en:oedema
    n1=en:massengill disposable douche baking soda,vag | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2231. en:mast cell degranulation --- r_associated #0: 20 --> en:oedema
    n1=en:mast cell degranulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2232. en:maternal --- r_associated #0: 20 --> en:oedema
    n1=en:maternal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2233. en:mature adipocytes --- r_associated #0: 20 --> en:oedema
    n1=en:mature adipocytes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2234. en:may have proximal muscle weakness later in the disease --- r_associated #0: 20 --> en:oedema
    n1=en:may have proximal muscle weakness later in the disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2235. en:mayers' lifestyle questionnaire (1) interpretation --- r_associated #0: 20 --> en:oedema
    n1=en:mayers' lifestyle questionnaire (1) interpretation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2236. en:mayers' lifestyle questionnaire (2) interpretation --- r_associated #0: 20 --> en:oedema
    n1=en:mayers' lifestyle questionnaire (2) interpretation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2237. en:mcburney's sign (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:mcburney's sign (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2238. en:mechanically fragile skin --- r_associated #0: 20 --> en:oedema
    n1=en:mechanically fragile skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2239. en:mediastinal shift --- r_associated #0: 20 --> en:oedema
    n1=en:mediastinal shift | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2240. en:melanocytic nevus --- r_associated #0: 20 --> en:oedema
    n1=en:melanocytic nevus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2241. en:melanocytic skin tumors/papules, skin-colored to reddish-brown, dome-shaped or pedunculated, well circumscribed with an average size of 5 mm (in 2 families) --- r_associated #0: 20 --> en:oedema
    n1=en:melanocytic skin tumors/papules, skin-colored to reddish-brown, dome-shaped or pedunculated, well circumscribed with an average size of 5 mm (in 2 families) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2242. en:membrane breakage --- r_associated #0: 20 --> en:oedema
    n1=en:membrane breakage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2243. en:menstrual edema --- r_associated #0: 20 --> en:oedema
    n1=en:menstrual edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2244. en:mental and behavioral signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:mental and behavioral signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2245. en:mental state, behavior / psychosocial function observable --- r_associated #0: 20 --> en:oedema
    n1=en:mental state, behavior / psychosocial function observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2246. en:merosin-positive biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:merosin-positive biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2247. en:metabolic aspects --- r_associated #0: 20 --> en:oedema
    n1=en:metabolic aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2248. en:metabolic syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:metabolic syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2249. en:metaplasia --- r_associated #0: 20 --> en:oedema
    n1=en:metaplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2250. en:methods time measurement score --- r_associated #0: 20 --> en:oedema
    n1=en:methods time measurement score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2251. en:michigan hand outcomes questionnaire score --- r_associated #0: 20 --> en:oedema
    n1=en:michigan hand outcomes questionnaire score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2252. en:microbiological --- r_associated #0: 20 --> en:oedema
    n1=en:microbiological | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2253. en:microcystic corneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:microcystic corneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2254. en:microcystic edema of cornea of left eye --- r_associated #0: 20 --> en:oedema
    n1=en:microcystic edema of cornea of left eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2255. en:microcystic edema of cornea of right eye --- r_associated #0: 20 --> en:oedema
    n1=en:microcystic edema of cornea of right eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2256. en:midface capillary hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:midface capillary hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2257. en:midfrontal capillary hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:midfrontal capillary hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2258. en:midline facial capillary hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:midline facial capillary hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2259. en:migratory ichthyosiform dermatosis --- r_associated #0: 20 --> en:oedema
    n1=en:migratory ichthyosiform dermatosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2260. en:migratory plaques of thickened, sharply demarcated erythema and hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:migratory plaques of thickened, sharply demarcated erythema and hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2261. en:migratory rashes, painful --- r_associated #0: 20 --> en:oedema
    n1=en:migratory rashes, painful | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2262. en:mild atrophic scarring --- r_associated #0: 20 --> en:oedema
    n1=en:mild atrophic scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2263. en:mild atrophy of the proximal lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:mild atrophy of the proximal lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2264. en:mild cutaneous changes --- r_associated #0: 20 --> en:oedema
    n1=en:mild cutaneous changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2265. en:mild decrease in mitochondrial respiratory chain activity --- r_associated #0: 20 --> en:oedema
    n1=en:mild decrease in mitochondrial respiratory chain activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2266. en:mild diffuse ichthyosis --- r_associated #0: 20 --> en:oedema
    n1=en:mild diffuse ichthyosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2267. en:mild distal muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:mild distal muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2268. en:mild eczema --- r_associated #0: 20 --> en:oedema
    n1=en:mild eczema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2269. en:mild hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:mild hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2270. en:mild hyperkeratosis of palms --- r_associated #0: 20 --> en:oedema
    n1=en:mild hyperkeratosis of palms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2271. en:mild hypopigmentation (in light-skinned individuals) --- r_associated #0: 20 --> en:oedema
    n1=en:mild hypopigmentation (in light-skinned individuals) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2272. en:mild lamellar ichthyosis --- r_associated #0: 20 --> en:oedema
    n1=en:mild lamellar ichthyosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2273. en:mild localized pigmentation abnormalities --- r_associated #0: 20 --> en:oedema
    n1=en:mild localized pigmentation abnormalities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2274. en:mild muscle atrophy in forearm muscles --- r_associated #0: 20 --> en:oedema
    n1=en:mild muscle atrophy in forearm muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2275. en:mild muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:mild muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2276. en:mild proximal muscle weakness (<10% of patients) --- r_associated #0: 20 --> en:oedema
    n1=en:mild proximal muscle weakness (<10% of patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2277. en:mild scarring --- r_associated #0: 20 --> en:oedema
    n1=en:mild scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2278. en:mild skin hyperextensibility --- r_associated #0: 20 --> en:oedema
    n1=en:mild skin hyperextensibility | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2279. en:mild tissue fragility --- r_associated #0: 20 --> en:oedema
    n1=en:mild tissue fragility | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2280. en:mild variability in muscle fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:mild variability in muscle fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2281. en:mild weakness --- r_associated #0: 20 --> en:oedema
    n1=en:mild weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2282. en:mild weakness of the small hand muscles --- r_associated #0: 20 --> en:oedema
    n1=en:mild weakness of the small hand muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2283. en:mild-moderate bruisability --- r_associated #0: 20 --> en:oedema
    n1=en:mild-moderate bruisability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2284. en:mild-to-severe pterygia --- r_associated #0: 20 --> en:oedema
    n1=en:mild-to-severe pterygia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2285. en:mild/severe skin hypopigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:mild/severe skin hypopigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2286. en:mildly decreased cytochrome c oxidase activity --- r_associated #0: 20 --> en:oedema
    n1=en:mildly decreased cytochrome c oxidase activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2287. en:mildly decreased laminin alpha-2 expression (lama2, 156225) --- r_associated #0: 20 --> en:oedema
    n1=en:mildly decreased laminin alpha-2 expression (lama2, 156225) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2288. en:mildly extensible skin --- r_associated #0: 20 --> en:oedema
    n1=en:mildly extensible skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2289. en:mildly reduced respiratory enzyme activities except for complex ii --- r_associated #0: 20 --> en:oedema
    n1=en:mildly reduced respiratory enzyme activities except for complex ii | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2290. en:milia (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:milia (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2291. en:milia (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:milia (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2292. en:milia of upper face and ears (infancy) --- r_associated #0: 20 --> en:oedema
    n1=en:milia of upper face and ears (infancy) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2293. en:milium cyst --- r_associated #0: 20 --> en:oedema
    n1=en:milium cyst | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2294. en:milking sign --- r_associated #0: 20 --> en:oedema
    n1=en:milking sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2295. en:milky white skin --- r_associated #0: 20 --> en:oedema
    n1=en:milky white skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2296. en:minicore myopathy with external ophthalmoplegia (disorder) --- r_associated #0: 20 --> en:oedema
    n1=en:minicore myopathy with external ophthalmoplegia (disorder) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2297. en:minicore regions are poorly defined and do not extend through entire fiber length --- r_associated #0: 20 --> en:oedema
    n1=en:minicore regions are poorly defined and do not extend through entire fiber length | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2298. en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization --- r_associated #0: 20 --> en:oedema
    n1=en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2299. en:minicores (in some) --- r_associated #0: 20 --> en:oedema
    n1=en:minicores (in some) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2300. en:minicores extend full fiber diameter --- r_associated #0: 20 --> en:oedema
    n1=en:minicores extend full fiber diameter | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2301. en:minicores or core-like regions may be present --- r_associated #0: 20 --> en:oedema
    n1=en:minicores or core-like regions may be present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2302. en:minimal or absent scarring --- r_associated #0: 20 --> en:oedema
    n1=en:minimal or absent scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2303. en:minimal subcutaneous fat --- r_associated #0: 20 --> en:oedema
    n1=en:minimal subcutaneous fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2304. en:minipolymyoclonus --- r_associated #0: 20 --> en:oedema
    n1=en:minipolymyoclonus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2305. en:mirror syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:mirror syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2306. en:mitochondria are placed at the periphery of muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondria are placed at the periphery of muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2307. en:mitochondria dna deletion --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondria dna deletion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2308. en:mitochondria show paracrystalline inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondria show paracrystalline inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2309. en:mitochondrial complex i deficiency --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial complex i deficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2310. en:mitochondrial complex iii deficiency (disorder) --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial complex iii deficiency (disorder) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2311. en:mitochondrial complex iii deficiency, isolated, seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial complex iii deficiency, isolated, seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2312. en:mitochondrial dna deletion (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial dna deletion (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2313. en:mitochondrial dna deletions (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial dna deletions (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2314. en:mitochondrial dna depletion (20 to 35% of normal) seen on skeletal muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial dna depletion (20 to 35% of normal) seen on skeletal muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2315. en:mitochondrial dna depletion (in some) --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial dna depletion (in some) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2316. en:mitochondrial dna depletion, severe --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial dna depletion, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2317. en:mitochondrial myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2318. en:mitochondrial myopathy, severe --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial myopathy, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2319. en:mitochondrial paracrystalline inclusion bodies --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial paracrystalline inclusion bodies | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2320. en:mitochondrial proliferation --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial proliferation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2321. en:mitochondrial respiratory chain complex i, ii, and iii defect --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial respiratory chain complex i, ii, and iii defect | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2322. en:mitochondrial swelling --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2323. en:mitochondrial vacuolization seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:mitochondrial vacuolization seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2324. en:mitral valve prolapse --- r_associated #0: 20 --> en:oedema
    n1=en:mitral valve prolapse | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2325. en:mobility limitation --- r_associated #0: 20 --> en:oedema
    n1=en:mobility limitation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2326. en:moderate erythroderma --- r_associated #0: 20 --> en:oedema
    n1=en:moderate erythroderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2327. en:moderate scarring --- r_associated #0: 20 --> en:oedema
    n1=en:moderate scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2328. en:moderate to severe acne --- r_associated #0: 20 --> en:oedema
    n1=en:moderate to severe acne | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2329. en:modified health assessment questionnaire score --- r_associated #0: 20 --> en:oedema
    n1=en:modified health assessment questionnaire score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2330. en:molluscoid pseudotumors --- r_associated #0: 20 --> en:oedema
    n1=en:molluscoid pseudotumors | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2331. en:molluscum contagiosum --- r_associated #0: 20 --> en:oedema
    n1=en:molluscum contagiosum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2332. en:moniliasis/candida (excluding x72 y75) --- r_associated #0: 20 --> en:oedema
    n1=en:moniliasis/candida (excluding x72 y75) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2333. en:morbihan disease --- r_associated #0: 20 --> en:oedema
    n1=en:morbihan disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2334. en:morbilliform eruption --- r_associated #0: 20 --> en:oedema
    n1=en:morbilliform eruption | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2335. en:most evident on lower legs --- r_associated #0: 20 --> en:oedema
    n1=en:most evident on lower legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2336. en:motion sickness --- r_associated #0: 20 --> en:oedema
    n1=en:motion sickness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2337. en:motor clumsiness --- r_associated #0: 20 --> en:oedema
    n1=en:motor clumsiness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2338. en:motor developmental delay --- r_associated #0: 20 --> en:oedema
    n1=en:motor developmental delay | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2339. en:mottled pigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:mottled pigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2340. en:mottled pigmentation of photoexposed areas --- r_associated #0: 20 --> en:oedema
    n1=en:mottled pigmentation of photoexposed areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2341. en:mottled pigmentation of the trunk and proximal extremities --- r_associated #0: 20 --> en:oedema
    n1=en:mottled pigmentation of the trunk and proximal extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2342. en:movement --- r_associated #0: 20 --> en:oedema
    n1=en:movement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2343. en:mri may show cervical spinal cord atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:mri may show cervical spinal cord atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2344. en:mri of the calves shows fatty atrophy with preservation of the medial gastrocnemius in the posteromedial compartment --- r_associated #0: 20 --> en:oedema
    n1=en:mri of the calves shows fatty atrophy with preservation of the medial gastrocnemius in the posteromedial compartment | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2345. en:mri of the thighs shows fatty atrophy with preservation of the biceps femoris in the lateral compartment --- r_associated #0: 20 --> en:oedema
    n1=en:mri of the thighs shows fatty atrophy with preservation of the biceps femoris in the lateral compartment | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2346. en:mri shows fatty infiltration of affected muscles --- r_associated #0: 20 --> en:oedema
    n1=en:mri shows fatty infiltration of affected muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2347. en:mri shows fatty replacement --- r_associated #0: 20 --> en:oedema
    n1=en:mri shows fatty replacement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2348. en:mri shows increased connective tissue and fat --- r_associated #0: 20 --> en:oedema
    n1=en:mri shows increased connective tissue and fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2349. en:mri shows increased signal intensity in affected muscles consistent with fatty infiltration --- r_associated #0: 20 --> en:oedema
    n1=en:mri shows increased signal intensity in affected muscles consistent with fatty infiltration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2350. en:mtdna deletions seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:mtdna deletions seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2351. en:mtdna depletion seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:mtdna depletion seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2352. en:mucocutaneous candidiasis --- r_associated #0: 20 --> en:oedema
    n1=en:mucocutaneous candidiasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2353. en:mucosal lesions --- r_associated #0: 20 --> en:oedema
    n1=en:mucosal lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2354. en:mucosal lesions affecting all regions (i.e., oral, nasal, vaginal, anal, bladder, conjunctival regions) --- r_associated #0: 20 --> en:oedema
    n1=en:mucosal lesions affecting all regions (i.e., oral, nasal, vaginal, anal, bladder, conjunctival regions) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2355. en:mucosal observable --- r_associated #0: 20 --> en:oedema
    n1=en:mucosal observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2356. en:mucous membrane edema --- r_associated #0: 20 --> en:oedema
    n1=en:mucous membrane edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2357. en:mulitple papules (1-2 mm skin colored and hyperpigmented) --- r_associated #0: 20 --> en:oedema
    n1=en:mulitple papules (1-2 mm skin colored and hyperpigmented) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2358. en:multi-core congenital myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:multi-core congenital myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2359. en:multiple asymptomatic papules with atrophic white scar-like centers surrounded by telangiectatic borders --- r_associated #0: 20 --> en:oedema
    n1=en:multiple asymptomatic papules with atrophic white scar-like centers surrounded by telangiectatic borders | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2360. en:multiple facial papules --- r_associated #0: 20 --> en:oedema
    n1=en:multiple facial papules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2361. en:multiple gingival papules --- r_associated #0: 20 --> en:oedema
    n1=en:multiple gingival papules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2362. en:multiple lentigines --- r_associated #0: 20 --> en:oedema
    n1=en:multiple lentigines | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2363. en:multiple mitochondrial dna (mtdna) deletions (in most cases) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple mitochondrial dna (mtdna) deletions (in most cases) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2364. en:multiple mitochondrial dna (mtdna) deletions seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:multiple mitochondrial dna (mtdna) deletions seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2365. en:multiple mitochondrial dna deletions --- r_associated #0: 20 --> en:oedema
    n1=en:multiple mitochondrial dna deletions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2366. en:multiple mitochondrial respiratory enzymes deficiencies seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:multiple mitochondrial respiratory enzymes deficiencies seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2367. en:multiple nevi --- r_associated #0: 20 --> en:oedema
    n1=en:multiple nevi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2368. en:multiple nevi (face and torso) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple nevi (face and torso) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2369. en:multiple nevi (up to hundreds) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple nevi (up to hundreds) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2370. en:multiple palmar creases --- r_associated #0: 20 --> en:oedema
    n1=en:multiple palmar creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2371. en:multiple papules (milium-like, comedo-like) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple papules (milium-like, comedo-like) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2372. en:multiple pigmented moles --- r_associated #0: 20 --> en:oedema
    n1=en:multiple pigmented moles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2373. en:multiple pterygia --- r_associated #0: 20 --> en:oedema
    n1=en:multiple pterygia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2374. en:multiple skin tags --- r_associated #0: 20 --> en:oedema
    n1=en:multiple skin tags | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2375. en:multiple small nevi (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple small nevi (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2376. en:multiple, asymptomatic dermal cysts (trunk, proximal extremities, neck, axillae, inguinal region, scalp) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple, asymptomatic dermal cysts (trunk, proximal extremities, neck, axillae, inguinal region, scalp) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2377. en:multiple, flat, skin-colored warty papules (2-4mm in diameter on dorsum hands, feet, knees, and elbows) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple, flat, skin-colored warty papules (2-4mm in diameter on dorsum hands, feet, knees, and elbows) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2378. en:multiple, red-blue, soft, compressible vascular papules or macules (especially on trunk or upper arms) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple, red-blue, soft, compressible vascular papules or macules (especially on trunk or upper arms) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2379. en:multiple, small punctate keratoses (palms and soles) --- r_associated #0: 20 --> en:oedema
    n1=en:multiple, small punctate keratoses (palms and soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2380. en:muromonab-cd3 --- r_associated #0: 20 --> en:oedema
    n1=en:muromonab-cd3 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2381. en:muromonab-cd3 1mg/ml injection solution 5ml vial --- r_associated #0: 20 --> en:oedema
    n1=en:muromonab-cd3 1mg/ml injection solution 5ml vial | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2382. en:muscle --- r_associated #0: 20 --> en:oedema
    n1=en:muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2383. en:muscle aches, cramps --- r_associated #0: 20 --> en:oedema
    n1=en:muscle aches, cramps | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2384. en:muscle aches, intermittent --- r_associated #0: 20 --> en:oedema
    n1=en:muscle aches, intermittent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2385. en:muscle activity is electrically silent on emg --- r_associated #0: 20 --> en:oedema
    n1=en:muscle activity is electrically silent on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2386. en:muscle amyotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle amyotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2387. en:muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2388. en:muscle atrophy (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2389. en:muscle atrophy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2390. en:muscle atrophy (type i) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy (type i) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2391. en:muscle atrophy (variable) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy (variable) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2392. en:muscle atrophy affecting the upper back and neck muscles --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy affecting the upper back and neck muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2393. en:muscle atrophy appears later in disease course --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy appears later in disease course | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2394. en:muscle atrophy in the limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy in the limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2395. en:muscle atrophy later in the disease --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy later in the disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2396. en:muscle atrophy restricted to the upper limb --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy restricted to the upper limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2397. en:muscle atrophy, diffuse, severe --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, diffuse, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2398. en:muscle atrophy, distal, particularly affecting the hands muscle biopsy shows variation in fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, distal, particularly affecting the hands muscle biopsy shows variation in fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2399. en:muscle atrophy, especially quadriceps and forearm muscles --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, especially quadriceps and forearm muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2400. en:muscle atrophy, limb-girdle and proximal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, limb-girdle and proximal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2401. en:muscle atrophy, mild --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2402. en:muscle atrophy, mild, more proximal than distal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, mild, more proximal than distal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2403. en:muscle atrophy, primarily in the legs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, primarily in the legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2404. en:muscle atrophy, progressive --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, progressive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2405. en:muscle atrophy, proximal and distal (predominant lower limb involvement) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, proximal and distal (predominant lower limb involvement) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2406. en:muscle atrophy, severe --- r_associated #0: 20 --> en:oedema
    n1=en:muscle atrophy, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2407. en:muscle biopsies show variation in fibrodiameter, internal nuclei, atrophy of type i fibers, focal loss of cross- striations, and cores of myofibrillar disruption with associated absence of mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsies show variation in fibrodiameter, internal nuclei, atrophy of type i fibers, focal loss of cross- striations, and cores of myofibrillar disruption with associated absence of mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2408. en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2409. en:muscle biopsy is immunopositive for merosin (156225) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy is immunopositive for merosin (156225) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2410. en:muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2411. en:muscle biopsy may show inflammatory changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy may show inflammatory changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2412. en:muscle biopsy may show mild kinetic abnormalities of the achr --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy may show mild kinetic abnormalities of the achr | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2413. en:muscle biopsy shows 'spheroid bodies' in type 1 muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows 'spheroid bodies' in type 1 muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2414. en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2415. en:muscle biopsy shows abnormal fiber size and variation --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows abnormal fiber size and variation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2416. en:muscle biopsy shows abnormal mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows abnormal mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2417. en:muscle biopsy shows atrophic fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows atrophic fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2418. en:muscle biopsy shows atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2419. en:muscle biopsy shows centralized nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows centralized nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2420. en:muscle biopsy shows chronic and active denervation --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows chronic and active denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2421. en:muscle biopsy shows core-like regions devoid of oxidative activity --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows core-like regions devoid of oxidative activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2422. en:muscle biopsy shows cytochrome c oxidase-negative fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows cytochrome c oxidase-negative fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2423. en:muscle biopsy shows decrease or absence of cytochrome c oxidase --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decrease or absence of cytochrome c oxidase | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2424. en:muscle biopsy shows decreased activity of cytochrome c oxidase --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decreased activity of cytochrome c oxidase | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2425. en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2426. en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan (dag1, 128239) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan (dag1, 128239) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2427. en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2428. en:muscle biopsy shows decreased numbers of acetylcholine receptors (achr) in the postsynaptic membrane (less than 50% of normal) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decreased numbers of acetylcholine receptors (achr) in the postsynaptic membrane (less than 50% of normal) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2429. en:muscle biopsy shows decreased or absent dysferlin staining --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decreased or absent dysferlin staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2430. en:muscle biopsy shows decreased postsynaptic areas of clefts and folds --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decreased postsynaptic areas of clefts and folds | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2431. en:muscle biopsy shows decreased secondary clefts --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows decreased secondary clefts | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2432. en:muscle biopsy shows deficiency of mitochondrial respiratory enzymes i, iii, iv, and iv --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows deficiency of mitochondrial respiratory enzymes i, iii, iv, and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2433. en:muscle biopsy shows degenerating endplates and junctional folds --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows degenerating endplates and junctional folds | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2434. en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2435. en:muscle biopsy shows disruption of the sarcolemmal membrane --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows disruption of the sarcolemmal membrane | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2436. en:muscle biopsy shows dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2437. en:muscle biopsy shows dystrophic features --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows dystrophic features | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2438. en:muscle biopsy shows dystrophic features (later in disease course) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows dystrophic features (later in disease course) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2439. en:muscle biopsy shows dystrophic pattern --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows dystrophic pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2440. en:muscle biopsy shows endplate myopathy (see details under neurologic heading) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows endplate myopathy (see details under neurologic heading) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2441. en:muscle biopsy shows enlargement of type i muscle fibers, consistent with denervation --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows enlargement of type i muscle fibers, consistent with denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2442. en:muscle biopsy shows fiber type disproportion --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows fiber type disproportion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2443. en:muscle biopsy shows fiber type variation (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows fiber type variation (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2444. en:muscle biopsy shows fibrosis and increased connective tissue --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows fibrosis and increased connective tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2445. en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2446. en:muscle biopsy shows glycogen storage --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows glycogen storage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2447. en:muscle biopsy shows grouped atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows grouped atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2448. en:muscle biopsy shows groups of small angulated fibers consistent with denervation --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows groups of small angulated fibers consistent with denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2449. en:muscle biopsy shows hypoglycosylation of alpha-dystroglycan --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows hypoglycosylation of alpha-dystroglycan | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2450. en:muscle biopsy shows hypotrophy of type 1 muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows hypotrophy of type 1 muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2451. en:muscle biopsy shows increased number of endplate regions distributed over increased span of muscle fiber --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows increased number of endplate regions distributed over increased span of muscle fiber | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2452. en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2453. en:muscle biopsy shows increased variation in fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows increased variation in fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2454. en:muscle biopsy shows inflammation with t cells --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows inflammation with t cells | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2455. en:muscle biopsy shows intranuclear tubulofilamentous inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows intranuclear tubulofilamentous inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2456. en:muscle biopsy shows lipid deposition --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows lipid deposition | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2457. en:muscle biopsy shows lipid droplets --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows lipid droplets | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2458. en:muscle biopsy shows loss of myofibrillar organization --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows loss of myofibrillar organization | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2459. en:muscle biopsy shows merosin (156225)-positive muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows merosin (156225)-positive muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2460. en:muscle biopsy shows mild dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows mild dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2461. en:muscle biopsy shows mitochondrial aggregates --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows mitochondrial aggregates | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2462. en:muscle biopsy shows mitochondrial paracrystalline inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows mitochondrial paracrystalline inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2463. en:muscle biopsy shows multiple mitochondrial dna (mtdna) deletions --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows multiple mitochondrial dna (mtdna) deletions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2464. en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2465. en:muscle biopsy shows myofiber degeneration --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows myofiber degeneration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2466. en:muscle biopsy shows myofibrillar changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows myofibrillar changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2467. en:muscle biopsy shows myofibrillar disruption --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows myofibrillar disruption | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2468. en:muscle biopsy shows myofibrillar myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows myofibrillar myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2469. en:muscle biopsy shows myopathic changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows myopathic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2470. en:muscle biopsy shows myopathic or dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows myopathic or dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2471. en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2472. en:muscle biopsy shows necrotic and regenerating fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows necrotic and regenerating fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2473. en:muscle biopsy shows nemaline bodies (rods) on gomori trichrome staining --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows nemaline bodies (rods) on gomori trichrome staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2474. en:muscle biopsy shows nemaline rods --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows nemaline rods | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2475. en:muscle biopsy shows neurogenic angulated fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows neurogenic angulated fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2476. en:muscle biopsy shows neurogenic atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows neurogenic atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2477. en:muscle biopsy shows neurogenic atrophy affecting both fibers types --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows neurogenic atrophy affecting both fibers types | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2478. en:muscle biopsy shows neurogenic changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows neurogenic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2479. en:muscle biopsy shows no dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows no dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2480. en:muscle biopsy shows nonspecific myopathic changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows nonspecific myopathic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2481. en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2482. en:muscle biopsy shows pas-positive glycogen-containing vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows pas-positive glycogen-containing vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2483. en:muscle biopsy shows peripheral accumulation of abnormal mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows peripheral accumulation of abnormal mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2484. en:muscle biopsy shows pleomorphic hyaline, granular, and amorphous deposits that stain with gomori trichrome --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows pleomorphic hyaline, granular, and amorphous deposits that stain with gomori trichrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2485. en:muscle biopsy shows poor development of the postsynaptic membrane --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows poor development of the postsynaptic membrane | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2486. en:muscle biopsy shows preserved junctional folds --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows preserved junctional folds | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2487. en:muscle biopsy shows ragged red fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows ragged red fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2488. en:muscle biopsy shows ragged-red fibers with decreased cox activity --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows ragged-red fibers with decreased cox activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2489. en:muscle biopsy shows rimmed vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows rimmed vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2490. en:muscle biopsy shows sarcoplasmic or subsarcolemmal vacuoles in muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows sarcoplasmic or subsarcolemmal vacuoles in muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2491. en:muscle biopsy shows sarcoplasmic pas-positive vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows sarcoplasmic pas-positive vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2492. en:muscle biopsy shows sarcoplasmic rods in myofibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows sarcoplasmic rods in myofibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2493. en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2494. en:muscle biopsy shows small nerve terminals --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows small nerve terminals | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2495. en:muscle biopsy shows small rounded fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows small rounded fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2496. en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2497. en:muscle biopsy shows subsarcolemmal nemaline bodies (rods) on gomori trichrome staining --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows subsarcolemmal nemaline bodies (rods) on gomori trichrome staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2498. en:muscle biopsy shows type 1 fiber predominance --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows type 1 fiber predominance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2499. en:muscle biopsy shows type 1 fiber predominance and hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows type 1 fiber predominance and hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2500. en:muscle biopsy shows type 2 fiber atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows type 2 fiber atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2501. en:muscle biopsy shows type 2 fiber atrophy (see details under neurologic heading) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows type 2 fiber atrophy (see details under neurologic heading) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2502. en:muscle biopsy shows type i fiber predominance --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows type i fiber predominance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2503. en:muscle biopsy shows variation in fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy shows variation in fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2504. en:muscle biopsy with small a-fibers, increased pas-positive material, and ringbinden (disoriented myofibrils) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle biopsy with small a-fibers, increased pas-positive material, and ringbinden (disoriented myofibrils) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2505. en:muscle coenzyme q deficiency --- r_associated #0: 20 --> en:oedema
    n1=en:muscle coenzyme q deficiency | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2506. en:muscle cramp --- r_associated #0: 20 --> en:oedema
    n1=en:muscle cramp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2507. en:muscle cramps (also seen in some heterozygotes) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle cramps (also seen in some heterozygotes) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2508. en:muscle cramps affect the upper and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle cramps affect the upper and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2509. en:muscle cramps at rest --- r_associated #0: 20 --> en:oedema
    n1=en:muscle cramps at rest | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2510. en:muscle cramps during exercise --- r_associated #0: 20 --> en:oedema
    n1=en:muscle cramps during exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2511. en:muscle cramps may affect jaw muscles --- r_associated #0: 20 --> en:oedema
    n1=en:muscle cramps may affect jaw muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2512. en:muscle cramps, painful, recurrent --- r_associated #0: 20 --> en:oedema
    n1=en:muscle cramps, painful, recurrent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2513. en:muscle fatigability --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fatigability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2514. en:muscle fatigue --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fatigue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2515. en:muscle fiber atrophy, profound (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fiber atrophy, profound (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2516. en:muscle fiber necrosis --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fiber necrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2517. en:muscle fiber regeneration --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fiber regeneration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2518. en:muscle fiber splitting --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fiber splitting | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2519. en:muscle fiber splitting (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fiber splitting (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2520. en:muscle fiber splitting and fibrosis seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fiber splitting and fibrosis seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2521. en:muscle fibers appear as fetal myotubules --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fibers appear as fetal myotubules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2522. en:muscle fibers are immunoreactive for desmin and vimentin --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fibers are immunoreactive for desmin and vimentin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2523. en:muscle fibers contain internal nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fibers contain internal nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2524. en:muscle fibers may contain abnormal polysaccharide --- r_associated #0: 20 --> en:oedema
    n1=en:muscle fibers may contain abnormal polysaccharide | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2525. en:muscle hematoma --- r_associated #0: 20 --> en:oedema
    n1=en:muscle hematoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2526. en:muscle hyperirritability --- r_associated #0: 20 --> en:oedema
    n1=en:muscle hyperirritability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2527. en:muscle hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2528. en:muscle hypertrophy (meb) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle hypertrophy (meb) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2529. en:muscle hypertrophy in affected area --- r_associated #0: 20 --> en:oedema
    n1=en:muscle hypertrophy in affected area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2530. en:muscle hypertrophy may occur --- r_associated #0: 20 --> en:oedema
    n1=en:muscle hypertrophy may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2531. en:muscle hypertrophy of the lower extremities --- r_associated #0: 20 --> en:oedema
    n1=en:muscle hypertrophy of the lower extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2532. en:muscle mitochondria normal by histochemical analysis --- r_associated #0: 20 --> en:oedema
    n1=en:muscle mitochondria normal by histochemical analysis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2533. en:muscle mounding --- r_associated #0: 20 --> en:oedema
    n1=en:muscle mounding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2534. en:muscle mri shows fatty infiltration --- r_associated #0: 20 --> en:oedema
    n1=en:muscle mri shows fatty infiltration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2535. en:muscle pain (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle pain (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2536. en:muscle pain after exercise --- r_associated #0: 20 --> en:oedema
    n1=en:muscle pain after exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2537. en:muscle pain and cramping on exertion --- r_associated #0: 20 --> en:oedema
    n1=en:muscle pain and cramping on exertion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2538. en:muscle pain and cramps following exercise --- r_associated #0: 20 --> en:oedema
    n1=en:muscle pain and cramps following exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2539. en:muscle pain with exercise (in older patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle pain with exercise (in older patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2540. en:muscle paralysis, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:muscle paralysis, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2541. en:muscle shows lipid accumulation --- r_associated #0: 20 --> en:oedema
    n1=en:muscle shows lipid accumulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2542. en:muscle soft, tissue --- r_associated #0: 20 --> en:oedema
    n1=en:muscle soft, tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2543. en:muscle soreness --- r_associated #0: 20 --> en:oedema
    n1=en:muscle soreness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2544. en:muscle spasm --- r_associated #0: 20 --> en:oedema
    n1=en:muscle spasm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2545. en:muscle stiffness --- r_associated #0: 20 --> en:oedema
    n1=en:muscle stiffness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2546. en:muscle stiffness (in older patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle stiffness (in older patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2547. en:muscle stiffness or aching --- r_associated #0: 20 --> en:oedema
    n1=en:muscle stiffness or aching | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2548. en:muscle strength and bulk is preserved --- r_associated #0: 20 --> en:oedema
    n1=en:muscle strength and bulk is preserved | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2549. en:muscle wasting (especially legs and arms) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle wasting (especially legs and arms) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2550. en:muscle wasting due to chronic denervation --- r_associated #0: 20 --> en:oedema
    n1=en:muscle wasting due to chronic denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2551. en:muscle wasting in lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle wasting in lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2552. en:muscle wasting, progressive --- r_associated #0: 20 --> en:oedema
    n1=en:muscle wasting, progressive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2553. en:muscle wasting, severe, primarily in the legs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle wasting, severe, primarily in the legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2554. en:muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2555. en:muscle weakness (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2556. en:muscle weakness (cvs+) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness (cvs+) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2557. en:muscle weakness (in 90% of patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness (in 90% of patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2558. en:muscle weakness (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2559. en:muscle weakness (type i) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness (type i) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2560. en:muscle weakness after cooling or on warming affected muscle --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness after cooling or on warming affected muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2561. en:muscle weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2562. en:muscle weakness and atrophy may be asymmetric --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness and atrophy may be asymmetric | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2563. en:muscle weakness and atrophy, distal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness and atrophy, distal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2564. en:muscle weakness and atrophy, progressive --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness and atrophy, progressive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2565. en:muscle weakness and atrophy, proximal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness and atrophy, proximal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2566. en:muscle weakness and atrophy, upper and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness and atrophy, upper and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2567. en:muscle weakness associated with fasting or infection --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness associated with fasting or infection | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2568. en:muscle weakness due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2569. en:muscle weakness following prolonged exercise --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness following prolonged exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2570. en:muscle weakness in forearm muscles --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness in forearm muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2571. en:muscle weakness increases with age --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness increases with age | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2572. en:muscle weakness is not a feature --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness is not a feature | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2573. en:muscle weakness is predominantly of extremities and tongue --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness is predominantly of extremities and tongue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2574. en:muscle weakness lower limb --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness lower limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2575. en:muscle weakness may affect upper limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness may affect upper limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2576. en:muscle weakness of limb --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness of limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2577. en:muscle weakness of proximal and distal upper and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness of proximal and distal upper and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2578. en:muscle weakness of the face and neck, mild to moderate --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness of the face and neck, mild to moderate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2579. en:muscle weakness restricted to the upper limb --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness restricted to the upper limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2580. en:muscle weakness trunk --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2581. en:muscle weakness usually does not occur --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness usually does not occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2582. en:muscle weakness, congenital --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, congenital | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2583. en:muscle weakness, distal (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, distal (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2584. en:muscle weakness, distal more than proximal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, distal more than proximal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2585. en:muscle weakness, distal, particularly affecting the hands --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, distal, particularly affecting the hands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2586. en:muscle weakness, distal, restricted to the lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, distal, restricted to the lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2587. en:muscle weakness, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2588. en:muscle weakness, hypokalemia-related --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, hypokalemia-related | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2589. en:muscle weakness, limb-girdle (lower and upper limbs may be affected) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, limb-girdle (lower and upper limbs may be affected) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2590. en:muscle weakness, limb-girdle, mild --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, limb-girdle, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2591. en:muscle weakness, lower limbs, during exercise --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, lower limbs, during exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2592. en:muscle weakness, mainly proximal and axial --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, mainly proximal and axial | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2593. en:muscle weakness, mild, proximal and distal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, mild, proximal and distal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2594. en:muscle weakness, predominantly proximal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, predominantly proximal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2595. en:muscle weakness, predominantly proximal (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, predominantly proximal (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2596. en:muscle weakness, primarily proximal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, primarily proximal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2597. en:muscle weakness, proximal and distal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal and distal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2598. en:muscle weakness, proximal and distal (predominant lower limb involvement) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal and distal (predominant lower limb involvement) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2599. en:muscle weakness, proximal and distal, affecting upper and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal and distal, affecting upper and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2600. en:muscle weakness, proximal greater than distal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal greater than distal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2601. en:muscle weakness, proximal limb muscle, mild to moderate --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal limb muscle, mild to moderate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2602. en:muscle weakness, proximal, distal, and axial, severe --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal, distal, and axial, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2603. en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal, due to neuronopathy begins in the lower limbs and then progresses to upper limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2604. en:muscle weakness, proximal, limb-girdle --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal, limb-girdle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2605. en:muscle weakness, proximal, lower limbs (upper limbs may become affected later) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal, lower limbs (upper limbs may become affected later) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2606. en:muscle weakness, proximal, pelvic girdle (in severe cases) --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal, pelvic girdle (in severe cases) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2607. en:muscle weakness, proximal, slowly progressive --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal, slowly progressive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2608. en:muscle weakness, proximal, upper and lower limbs affected --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, proximal, upper and lower limbs affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2609. en:muscle weakness, severe --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2610. en:muscle weakness, severe, axial and proximal predominance --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, severe, axial and proximal predominance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2611. en:muscle weakness, severe, diffuse --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, severe, diffuse | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2612. en:muscle weakness, severe, proximal and distal --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, severe, proximal and distal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2613. en:muscle weakness, symmetric, proximal, lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, symmetric, proximal, lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2614. en:muscle weakness, upper and lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, upper and lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2615. en:muscle weakness, variable --- r_associated #0: 20 --> en:oedema
    n1=en:muscle weakness, variable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2616. en:muscles become hard and tender during exercise --- r_associated #0: 20 --> en:oedema
    n1=en:muscles become hard and tender during exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2617. en:muscles have a woody consistency on palpation --- r_associated #0: 20 --> en:oedema
    n1=en:muscles have a woody consistency on palpation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2618. en:muscular appearance --- r_associated #0: 20 --> en:oedema
    n1=en:muscular appearance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2619. en:muscular dystrophy --- r_associated #0: 20 --> en:oedema
    n1=en:muscular dystrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2620. en:muscular dystrophy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:muscular dystrophy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2621. en:muscular dystrophy with variable age of onset (infancy to young adult) --- r_associated #0: 20 --> en:oedema
    n1=en:muscular dystrophy with variable age of onset (infancy to young adult) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2622. en:muscular hypotonia of the trunk --- r_associated #0: 20 --> en:oedema
    n1=en:muscular hypotonia of the trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2623. en:muscular rigidity --- r_associated #0: 20 --> en:oedema
    n1=en:muscular rigidity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2624. en:muscular weakness, improving in infancy (medical research council muscle score of 3 to 4) --- r_associated #0: 20 --> en:oedema
    n1=en:muscular weakness, improving in infancy (medical research council muscle score of 3 to 4) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2625. en:musculoskeletal observable --- r_associated #0: 20 --> en:oedema
    n1=en:musculoskeletal observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2626. en:musset's sign --- r_associated #0: 20 --> en:oedema
    n1=en:musset's sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2627. en:mutilating skin deformity --- r_associated #0: 20 --> en:oedema
    n1=en:mutilating skin deformity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2628. en:myalgia --- r_associated #0: 20 --> en:oedema
    n1=en:myalgia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2629. en:myalgia (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:myalgia (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2630. en:myalgia with febrile episodes (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:myalgia with febrile episodes (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2631. en:myalgia, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:myalgia, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2632. en:myasthenias --- r_associated #0: 20 --> en:oedema
    n1=en:myasthenias | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2633. en:myocardial infarction --- r_associated #0: 20 --> en:oedema
    n1=en:myocardial infarction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2634. en:myocardial stunning --- r_associated #0: 20 --> en:oedema
    n1=en:myocardial stunning | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2635. en:myoclonic spasms --- r_associated #0: 20 --> en:oedema
    n1=en:myoclonic spasms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2636. en:myofibrillar disintegration --- r_associated #0: 20 --> en:oedema
    n1=en:myofibrillar disintegration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2637. en:myofibrillar disorganization --- r_associated #0: 20 --> en:oedema
    n1=en:myofibrillar disorganization | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2638. en:myofibrillar lesions --- r_associated #0: 20 --> en:oedema
    n1=en:myofibrillar lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2639. en:myofibrillar myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:myofibrillar myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2640. en:myofibromatosis --- r_associated #0: 20 --> en:oedema
    n1=en:myofibromatosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2641. en:myofibromatosis affecting skin, muscle, bone, and viscera --- r_associated #0: 20 --> en:oedema
    n1=en:myofibromatosis affecting skin, muscle, bone, and viscera | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2642. en:myogenic changes seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:myogenic changes seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2643. en:myogenic profile on electromyography --- r_associated #0: 20 --> en:oedema
    n1=en:myogenic profile on electromyography | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2644. en:myokymia --- r_associated #0: 20 --> en:oedema
    n1=en:myokymia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2645. en:myopathic and neurogenic changes seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic and neurogenic changes seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2646. en:myopathic changes early in disease seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic changes early in disease seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2647. en:myopathic changes on pathology --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic changes on pathology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2648. en:myopathic changes seen muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic changes seen muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2649. en:myopathic changes seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic changes seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2650. en:myopathic changes seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic changes seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2651. en:myopathic changes seen on emg and muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic changes seen on emg and muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2652. en:myopathic changes seen on emg of affected muscle --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic changes seen on emg of affected muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2653. en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2654. en:myopathic features seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic features seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2655. en:myopathic findings on biopsy have been occasionally reported --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic findings on biopsy have been occasionally reported | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2656. en:myopathic pattern on emg --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic pattern on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2657. en:myopathic pattern seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic pattern seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2658. en:myopathic pattern seen on emg (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:myopathic pattern seen on emg (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2659. en:myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2660. en:myopathy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:myopathy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2661. en:myopathy (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:myopathy (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2662. en:myopathy in approximately 45% of patients --- r_associated #0: 20 --> en:oedema
    n1=en:myopathy in approximately 45% of patients | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2663. en:myopathy with abnormal lipid metabolism --- r_associated #0: 20 --> en:oedema
    n1=en:myopathy with abnormal lipid metabolism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2664. en:myopathy, mild --- r_associated #0: 20 --> en:oedema
    n1=en:myopathy, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2665. en:myopathy, mild to severe --- r_associated #0: 20 --> en:oedema
    n1=en:myopathy, mild to severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2666. en:myopathy, nonprogressive --- r_associated #0: 20 --> en:oedema
    n1=en:myopathy, nonprogressive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2667. en:myosin storage myopathy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:myosin storage myopathy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2668. en:myositis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:myositis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2669. en:myotonia --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2670. en:myotonia (delayed muscle relaxation after contraction) --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia (delayed muscle relaxation after contraction) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2671. en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest) --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2672. en:myotonia improves with continued activity ('warm-up phenomenon') --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia improves with continued activity ('warm-up phenomenon') | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2673. en:myotonia is most pronounced in the extremities --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia is most pronounced in the extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2674. en:myotonia is present in majority of cases --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia is present in majority of cases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2675. en:myotonia is usually not seen --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia is usually not seen | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2676. en:myotonia seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2677. en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2678. en:myotonia, potassium-sensitive (may be responsive to acetazolamide) --- r_associated #0: 20 --> en:oedema
    n1=en:myotonia, potassium-sensitive (may be responsive to acetazolamide) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2679. en:myotonic discharges --- r_associated #0: 20 --> en:oedema
    n1=en:myotonic discharges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2680. en:myxedema (untreated hypothyroidism) --- r_associated #0: 20 --> en:oedema
    n1=en:myxedema (untreated hypothyroidism) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2681. en:myxedematous appearance --- r_associated #0: 20 --> en:oedema
    n1=en:myxedematous appearance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2682. en:nail observable --- r_associated #0: 20 --> en:oedema
    n1=en:nail observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2683. en:named respiratory sign of chest --- r_associated #0: 20 --> en:oedema
    n1=en:named respiratory sign of chest | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2684. en:named sensory sign --- r_associated #0: 20 --> en:oedema
    n1=en:named sensory sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2685. en:named sign of abdomen --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of abdomen | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2686. en:named sign of anus --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of anus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2687. en:named sign of balance --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of balance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2688. en:named sign of coordination --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of coordination | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2689. en:named sign of foot --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of foot | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2690. en:named sign of gallbladder --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of gallbladder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2691. en:named sign of hand --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of hand | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2692. en:named sign of heart --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of heart | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2693. en:named sign of hip --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of hip | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2694. en:named sign of joint --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of joint | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2695. en:named sign of knee --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of knee | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2696. en:named sign of lumbar spine --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of lumbar spine | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2697. en:named sign of pelvis --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of pelvis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2698. en:named sign of skeletal muscle --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of skeletal muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2699. en:named sign of skin --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2700. en:named sign of wrist --- r_associated #0: 20 --> en:oedema
    n1=en:named sign of wrist | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2701. en:nausea and vomiting --- r_associated #0: 20 --> en:oedema
    n1=en:nausea and vomiting | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2702. en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles) --- r_associated #0: 20 --> en:oedema
    n1=en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2703. en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic) --- r_associated #0: 20 --> en:oedema
    n1=en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2704. en:neck and proximal limb muscle myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:neck and proximal limb muscle myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2705. en:neck flexor weakness --- r_associated #0: 20 --> en:oedema
    n1=en:neck flexor weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2706. en:neck muscle hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:neck muscle hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2707. en:neck muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:neck muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2708. en:neck skin --- r_associated #0: 20 --> en:oedema
    n1=en:neck skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2709. en:necrosis and degeneration seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:necrosis and degeneration seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2710. en:necrosis leading to amputation (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:necrosis leading to amputation (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2711. en:necrotic and atrophic fibers with centralized nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:necrotic and atrophic fibers with centralized nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2712. en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2713. en:necrotic and regenerating fibers --- r_associated #0: 20 --> en:oedema
    n1=en:necrotic and regenerating fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2714. en:necrotic and regenerating muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:necrotic and regenerating muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2715. en:necrotic change --- r_associated #0: 20 --> en:oedema
    n1=en:necrotic change | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2716. en:necrotic fibers --- r_associated #0: 20 --> en:oedema
    n1=en:necrotic fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2717. en:necrotic process --- r_associated #0: 20 --> en:oedema
    n1=en:necrotic process | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2718. en:necrotic skin ulcers (in 1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:necrotic skin ulcers (in 1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2719. en:negative pressure pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:negative pressure pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2720. en:nemaline bodies --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline bodies | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2721. en:nemaline bodies (rods) on gomori trichrome staining --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline bodies (rods) on gomori trichrome staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2722. en:nemaline bodies (rods) on gomori trichrome staining seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline bodies (rods) on gomori trichrome staining seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2723. en:nemaline bodies are rarely intranuclear --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline bodies are rarely intranuclear | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2724. en:nemaline bodies are usually subsarcolemmal or sarcoplasmic --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline bodies are usually subsarcolemmal or sarcoplasmic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2725. en:nemaline bodies occur in type 1 fibers --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline bodies occur in type 1 fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2726. en:nemaline myopathy (in 1 reported male) --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline myopathy (in 1 reported male) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2727. en:nemaline rod formation --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline rod formation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2728. en:nemaline rods (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline rods (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2729. en:nemaline rods may be observed --- r_associated #0: 20 --> en:oedema
    n1=en:nemaline rods may be observed | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2730. en:neonatal acral blistering --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal acral blistering | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2731. en:neonatal blisters and erosions --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal blisters and erosions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2732. en:neonatal collodion skin --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal collodion skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2733. en:neonatal cyanosis --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal cyanosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2734. en:neonatal hypertonias --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal hypertonias | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2735. en:neonatal hypotonia --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal hypotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2736. en:neonatal hypotonia muscle biopsy shows pas-positive vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal hypotonia muscle biopsy shows pas-positive vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2737. en:neonatal jaundice --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal jaundice | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2738. en:neonatal purpura fulminans --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal purpura fulminans | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2739. en:neonatal research network terminology --- r_associated #0: 20 --> en:oedema
    n1=en:neonatal research network terminology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2740. en:neoplasm --- r_associated #0: 20 --> en:oedema
    n1=en:neoplasm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2741. en:nephrotic syndrome - nphs1 associated --- r_associated #0: 20 --> en:oedema
    n1=en:nephrotic syndrome - nphs1 associated | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2742. en:nephrotic syndrome, type 3 --- r_associated #0: 20 --> en:oedema
    n1=en:nephrotic syndrome, type 3 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2743. en:nephrotic syndrome, type 6 --- r_associated #0: 20 --> en:oedema
    n1=en:nephrotic syndrome, type 6 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2744. en:nephrotic syndrome, type 8 --- r_associated #0: 20 --> en:oedema
    n1=en:nephrotic syndrome, type 8 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2745. en:nephrotic syndrome, type 9 --- r_associated #0: 20 --> en:oedema
    n1=en:nephrotic syndrome, type 9 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2746. en:nerve conduction studies normal --- r_associated #0: 20 --> en:oedema
    n1=en:nerve conduction studies normal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2747. en:nervous system finding --- r_associated #0: 20 --> en:oedema
    n1=en:nervous system finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2748. en:netherton syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:netherton syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2749. en:neurofibroma --- r_associated #0: 20 --> en:oedema
    n1=en:neurofibroma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2750. en:neurofibromas may or may not be present --- r_associated #0: 20 --> en:oedema
    n1=en:neurofibromas may or may not be present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2751. en:neurofibromas, cutaneous (86%) --- r_associated #0: 20 --> en:oedema
    n1=en:neurofibromas, cutaneous (86%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2752. en:neurofibromas, subcutaneous (76%) --- r_associated #0: 20 --> en:oedema
    n1=en:neurofibromas, subcutaneous (76%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2753. en:neurogenic abnormalities seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:neurogenic abnormalities seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2754. en:neurogenic atrophy seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:neurogenic atrophy seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2755. en:neurogenic changes --- r_associated #0: 20 --> en:oedema
    n1=en:neurogenic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2756. en:neurogenic changes later in disease seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:neurogenic changes later in disease seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2757. en:neurogenic changes seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:neurogenic changes seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2758. en:neurogenic changes seen on emg and biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:neurogenic changes seen on emg and biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2759. en:neurogenic pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:neurogenic pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2760. en:neuroleptic malignant syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:neuroleptic malignant syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2761. en:neurologic manifestations --- r_associated #0: 20 --> en:oedema
    n1=en:neurologic manifestations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2762. en:neurological observable --- r_associated #0: 20 --> en:oedema
    n1=en:neurological observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2763. en:neurological signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:neurological signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2764. en:neuropathic or myopathic changes seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:neuropathic or myopathic changes seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2765. en:neuropathic process seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:neuropathic process seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2766. en:nevi flammei (philtrum, nape of neck, forehead) --- r_associated #0: 20 --> en:oedema
    n1=en:nevi flammei (philtrum, nape of neck, forehead) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2767. en:nevus araneus --- r_associated #0: 20 --> en:oedema
    n1=en:nevus araneus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2768. en:nevus flammeus (eyelids and nape of neck) --- r_associated #0: 20 --> en:oedema
    n1=en:nevus flammeus (eyelids and nape of neck) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2769. en:nevus flammeus of the forehead --- r_associated #0: 20 --> en:oedema
    n1=en:nevus flammeus of the forehead | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2770. en:nevus flammus --- r_associated #0: 20 --> en:oedema
    n1=en:nevus flammus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2771. en:nevus/mole --- r_associated #0: 20 --> en:oedema
    n1=en:nevus/mole | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2772. en:new or worsening symptom --- r_associated #0: 20 --> en:oedema
    n1=en:new or worsening symptom | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2773. en:nipple dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:nipple dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2774. en:no ability to tan --- r_associated #0: 20 --> en:oedema
    n1=en:no ability to tan | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2775. en:no abnormal skin pigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:no abnormal skin pigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2776. en:no abnormalities of sweating --- r_associated #0: 20 --> en:oedema
    n1=en:no abnormalities of sweating | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2777. en:no cutaneous photosensitivity --- r_associated #0: 20 --> en:oedema
    n1=en:no cutaneous photosensitivity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2778. en:no dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:no dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2779. en:no easy bruisability --- r_associated #0: 20 --> en:oedema
    n1=en:no easy bruisability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2780. en:no eczema --- r_associated #0: 20 --> en:oedema
    n1=en:no eczema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2781. en:no edema present --- r_associated #0: 20 --> en:oedema
    n1=en:no edema present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2782. en:no erythema --- r_associated #0: 20 --> en:oedema
    n1=en:no erythema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2783. en:no facial muscle involvement --- r_associated #0: 20 --> en:oedema
    n1=en:no facial muscle involvement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2784. en:no fetal hydrops --- r_associated #0: 20 --> en:oedema
    n1=en:no fetal hydrops | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2785. en:no hemorrhage --- r_associated #0: 20 --> en:oedema
    n1=en:no hemorrhage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2786. en:no hyperhidrosis --- r_associated #0: 20 --> en:oedema
    n1=en:no hyperhidrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2787. en:no ichthyosis --- r_associated #0: 20 --> en:oedema
    n1=en:no ichthyosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2788. en:no increased bruisability --- r_associated #0: 20 --> en:oedema
    n1=en:no increased bruisability | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2789. en:no inflammatory or bullous skin lesions --- r_associated #0: 20 --> en:oedema
    n1=en:no inflammatory or bullous skin lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2790. en:no lipodystrophy in face and neck --- r_associated #0: 20 --> en:oedema
    n1=en:no lipodystrophy in face and neck | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2791. en:no mucosal vesicles --- r_associated #0: 20 --> en:oedema
    n1=en:no mucosal vesicles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2792. en:no muscle fiber necrosis --- r_associated #0: 20 --> en:oedema
    n1=en:no muscle fiber necrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2793. en:no muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:no muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2794. en:no myofibrillar abnormalities or protein aggregation --- r_associated #0: 20 --> en:oedema
    n1=en:no myofibrillar abnormalities or protein aggregation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2795. en:no palmoplantar hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:no palmoplantar hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2796. en:no palmoplantar keratosis --- r_associated #0: 20 --> en:oedema
    n1=en:no palmoplantar keratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2797. en:no pruritis --- r_associated #0: 20 --> en:oedema
    n1=en:no pruritis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2798. en:no ragged-red fibers --- r_associated #0: 20 --> en:oedema
    n1=en:no ragged-red fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2799. en:no rods --- r_associated #0: 20 --> en:oedema
    n1=en:no rods | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2800. en:no scarring --- r_associated #0: 20 --> en:oedema
    n1=en:no scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2801. en:no skin hyperelasticity --- r_associated #0: 20 --> en:oedema
    n1=en:no skin hyperelasticity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2802. en:no staining for oxidative enzymes --- r_associated #0: 20 --> en:oedema
    n1=en:no staining for oxidative enzymes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2803. en:no staining for periodic acid schiff (pas) --- r_associated #0: 20 --> en:oedema
    n1=en:no staining for periodic acid schiff (pas) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2804. en:no systemic vascular lesions --- r_associated #0: 20 --> en:oedema
    n1=en:no systemic vascular lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2805. en:no tanning --- r_associated #0: 20 --> en:oedema
    n1=en:no tanning | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2806. en:no uv-induced skin tumors --- r_associated #0: 20 --> en:oedema
    n1=en:no uv-induced skin tumors | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2807. en:nocturia --- r_associated #0: 20 --> en:oedema
    n1=en:nocturia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2808. en:nodular lesion --- r_associated #0: 20 --> en:oedema
    n1=en:nodular lesion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2809. en:nodular skin lesions --- r_associated #0: 20 --> en:oedema
    n1=en:nodular skin lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2810. en:nodule --- r_associated #0: 20 --> en:oedema
    n1=en:nodule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2811. en:nodule show lipid-laden macrophages --- r_associated #0: 20 --> en:oedema
    n1=en:nodule show lipid-laden macrophages | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2812. en:non immune hydrops in newborn --- r_associated #0: 20 --> en:oedema
    n1=en:non immune hydrops in newborn | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2813. en:non pruritic --- r_associated #0: 20 --> en:oedema
    n1=en:non pruritic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2814. en:non-glabrous skin --- r_associated #0: 20 --> en:oedema
    n1=en:non-glabrous skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2815. en:non-high-risk proliferative diabetic retinopathy with clinically significant macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:non-high-risk proliferative diabetic retinopathy with clinically significant macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2816. en:non-immune fetal hydrops (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:non-immune fetal hydrops (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2817. en:non-immune hydrops fetalis --- r_associated #0: 20 --> en:oedema
    n1=en:non-immune hydrops fetalis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2818. en:non-pitting edema --- r_associated #0: 20 --> en:oedema
    n1=en:non-pitting edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2819. en:non-purpuric punctate and linear erythematous rash --- r_associated #0: 20 --> en:oedema
    n1=en:non-purpuric punctate and linear erythematous rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2820. en:non-scarring skin blistering (hands, feet, elbow, knee - onset in adolescence) --- r_associated #0: 20 --> en:oedema
    n1=en:non-scarring skin blistering (hands, feet, elbow, knee - onset in adolescence) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2821. en:noncystoid edema of macula of retina --- r_associated #0: 20 --> en:oedema
    n1=en:noncystoid edema of macula of retina | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2822. en:noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2823. en:nonmelanoma skin cancer (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:nonmelanoma skin cancer (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2824. en:nonscarring blisters (hand, feet, forearms) --- r_associated #0: 20 --> en:oedema
    n1=en:nonscarring blisters (hand, feet, forearms) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2825. en:nonspecific muscle fiber atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:nonspecific muscle fiber atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2826. en:nonspecific myopathic changes --- r_associated #0: 20 --> en:oedema
    n1=en:nonspecific myopathic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2827. en:nonspecific myopathic changes seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:nonspecific myopathic changes seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2828. en:nonspecific myopathic changes without dystrophic or inflammatory changes seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:nonspecific myopathic changes without dystrophic or inflammatory changes seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2829. en:nonspecific myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:nonspecific myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2830. en:normal alpha-glucosidase or acid maltase activity (gaa, 606800) --- r_associated #0: 20 --> en:oedema
    n1=en:normal alpha-glucosidase or acid maltase activity (gaa, 606800) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2831. en:normal dystrophin immunostaining --- r_associated #0: 20 --> en:oedema
    n1=en:normal dystrophin immunostaining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2832. en:normal lamp2 staining (309060) --- r_associated #0: 20 --> en:oedema
    n1=en:normal lamp2 staining (309060) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2833. en:normal mitochondrial morphology (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:normal mitochondrial morphology (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2834. en:normal muscle fiber (hcs) --- r_associated #0: 20 --> en:oedema
    n1=en:normal muscle fiber (hcs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2835. en:normal neonatal period may occur before weakness is apparent --- r_associated #0: 20 --> en:oedema
    n1=en:normal neonatal period may occur before weakness is apparent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2836. en:normal numbers of sweat glands --- r_associated #0: 20 --> en:oedema
    n1=en:normal numbers of sweat glands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2837. en:normal or decreased facial and neck adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:normal or decreased facial and neck adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2838. en:normal or increased abdominal adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:normal or increased abdominal adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2839. en:normal or increased adipose tissue around the neck --- r_associated #0: 20 --> en:oedema
    n1=en:normal or increased adipose tissue around the neck | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2840. en:normal or increased facial adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:normal or increased facial adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2841. en:normal or increased facial and neck adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:normal or increased facial and neck adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2842. en:normal or increased truncal adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:normal or increased truncal adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2843. en:normal phosphorylase kinase activity in muscle --- r_associated #0: 20 --> en:oedema
    n1=en:normal phosphorylase kinase activity in muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2844. en:normal scarring --- r_associated #0: 20 --> en:oedema
    n1=en:normal scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2845. en:normal sensation --- r_associated #0: 20 --> en:oedema
    n1=en:normal sensation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2846. en:normal skin --- r_associated #0: 20 --> en:oedema
    n1=en:normal skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2847. en:normal skin (no palmoplantar keratoderma) --- r_associated #0: 20 --> en:oedema
    n1=en:normal skin (no palmoplantar keratoderma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2848. en:normal sweat electrolytes --- r_associated #0: 20 --> en:oedema
    n1=en:normal sweat electrolytes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2849. en:normal sweat glands --- r_associated #0: 20 --> en:oedema
    n1=en:normal sweat glands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2850. en:normal sweating --- r_associated #0: 20 --> en:oedema
    n1=en:normal sweating | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2851. en:normal sweating capacity --- r_associated #0: 20 --> en:oedema
    n1=en:normal sweating capacity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2852. en:nose hemorrhage adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:nose hemorrhage adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2853. en:nuclear clumps --- r_associated #0: 20 --> en:oedema
    n1=en:nuclear clumps | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2854. en:numbness, pain, and tingling of the fingers in response to cold --- r_associated #0: 20 --> en:oedema
    n1=en:numbness, pain, and tingling of the fingers in response to cold | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2855. en:numerous 'confetti-like' scattered patches of normal skin --- r_associated #0: 20 --> en:oedema
    n1=en:numerous 'confetti-like' scattered patches of normal skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2856. en:numerous congenital melanocytic nevi --- r_associated #0: 20 --> en:oedema
    n1=en:numerous congenital melanocytic nevi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2857. en:numerous nevi --- r_associated #0: 20 --> en:oedema
    n1=en:numerous nevi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2858. en:numerous pigmented freckles --- r_associated #0: 20 --> en:oedema
    n1=en:numerous pigmented freckles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2859. en:numerous vacuole-like areas --- r_associated #0: 20 --> en:oedema
    n1=en:numerous vacuole-like areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2860. en:nursing therapy --- r_associated #0: 20 --> en:oedema
    n1=en:nursing therapy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2861. en:nutritional and metabolic diseases --- r_associated #0: 20 --> en:oedema
    n1=en:nutritional and metabolic diseases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2862. en:nutritional management --- r_associated #0: 20 --> en:oedema
    n1=en:nutritional management | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2863. en:o/e - a swelling --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - a swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2864. en:o/e - abdominal edema --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - abdominal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2865. en:o/e - edema --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2866. en:o/e - edema of ankles --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - edema of ankles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2867. en:o/e - edema of arms --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - edema of arms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2868. en:o/e - edema of feet --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - edema of feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2869. en:o/e - edema of legs --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - edema of legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2870. en:o/e - edema of thighs --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - edema of thighs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2871. en:o/e - genital edema --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - genital edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2872. en:o/e - localization of sign --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - localization of sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2873. en:o/e - nasal mucosa edematous --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - nasal mucosa edematous | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2874. en:o/e - periorbital edema --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - periorbital edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2875. en:o/e - pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2876. en:o/e - right eye clinically significant macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - right eye clinically significant macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2877. en:o/e - sacral edema --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - sacral edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2878. en:o/e - scrotal edema --- r_associated #0: 20 --> en:oedema
    n1=en:o/e - scrotal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2879. en:obesity --- r_associated #0: 20 --> en:oedema
    n1=en:obesity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2880. en:obesity adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:obesity adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2881. en:obligatory exercise questionnaire score --- r_associated #0: 20 --> en:oedema
    n1=en:obligatory exercise questionnaire score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2882. en:observation parameter --- r_associated #0: 20 --> en:oedema
    n1=en:observation parameter | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2883. en:obstetric delivery --- r_associated #0: 20 --> en:oedema
    n1=en:obstetric delivery | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2884. en:occasional cafe-au-lait spots --- r_associated #0: 20 --> en:oedema
    n1=en:occasional cafe-au-lait spots | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2885. en:occasional neurofibromas --- r_associated #0: 20 --> en:oedema
    n1=en:occasional neurofibromas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2886. en:occurs in linear distribution --- r_associated #0: 20 --> en:oedema
    n1=en:occurs in linear distribution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2887. en:ocular bruit --- r_associated #0: 20 --> en:oedema
    n1=en:ocular bruit | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2888. en:odoriferous,, hypertrophic plaques --- r_associated #0: 20 --> en:oedema
    n1=en:odoriferous,, hypertrophic plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2889. en:oedema aggravated --- r_associated #0: 20 --> en:oedema
    n1=en:oedema aggravated | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2890. en:oedema due to hepatic disease --- r_associated #0: 20 --> en:oedema
    n1=en:oedema due to hepatic disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2891. en:oedema due to renal disease --- r_associated #0: 20 --> en:oedema
    n1=en:oedema due to renal disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2892. en:oedema like --- r_associated #0: 20 --> en:oedema
    n1=en:oedema like | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2893. en:oedema nec --- r_associated #0: 20 --> en:oedema
    n1=en:oedema nec | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2894. en:oedema neonatal --- r_associated #0: 20 --> en:oedema
    n1=en:oedema neonatal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2895. en:oedematous weight gain --- r_associated #0: 20 --> en:oedema
    n1=en:oedematous weight gain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2896. en:oily skin --- r_associated #0: 20 --> en:oedema
    n1=en:oily skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2897. en:oligohydramnios --- r_associated #0: 20 --> en:oedema
    n1=en:oligohydramnios | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2898. en:oligohydramnios (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:oligohydramnios (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2899. en:oligohydramnios in some cases --- r_associated #0: 20 --> en:oedema
    n1=en:oligohydramnios in some cases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2900. en:oligohydramnios, severe --- r_associated #0: 20 --> en:oedema
    n1=en:oligohydramnios, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2901. en:omega sign (skin finding) --- r_associated #0: 20 --> en:oedema
    n1=en:omega sign (skin finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2902. en:on examination - scrotal swelling - no transillumination --- r_associated #0: 20 --> en:oedema
    n1=en:on examination - scrotal swelling - no transillumination | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2903. en:onset birth-newborn period --- r_associated #0: 20 --> en:oedema
    n1=en:onset birth-newborn period | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2904. en:onset of lymphedema around puberty --- r_associated #0: 20 --> en:oedema
    n1=en:onset of lymphedema around puberty | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2905. en:onset of weakness in hands and feet --- r_associated #0: 20 --> en:oedema
    n1=en:onset of weakness in hands and feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2906. en:optic disc edema --- r_associated #0: 20 --> en:oedema
    n1=en:optic disc edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2907. en:optic disc edema due to hypotony --- r_associated #0: 20 --> en:oedema
    n1=en:optic disc edema due to hypotony | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2908. en:oral cavity, dental / salivary observable --- r_associated #0: 20 --> en:oedema
    n1=en:oral cavity, dental / salivary observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2909. en:oral manifestations --- r_associated #0: 20 --> en:oedema
    n1=en:oral manifestations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2910. en:orbital swelling --- r_associated #0: 20 --> en:oedema
    n1=en:orbital swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2911. en:orthokeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:orthokeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2912. en:orthostatic acrocyanosis --- r_associated #0: 20 --> en:oedema
    n1=en:orthostatic acrocyanosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2913. en:osteoporotic fracture probability score using world health organization fracture risk assessment tool --- r_associated #0: 20 --> en:oedema
    n1=en:osteoporotic fracture probability score using world health organization fracture risk assessment tool | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2914. en:other benign neoplasm of skin, unspecified --- r_associated #0: 20 --> en:oedema
    n1=en:other benign neoplasm of skin, unspecified | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2915. en:other changes in skin color --- r_associated #0: 20 --> en:oedema
    n1=en:other changes in skin color | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2916. en:other dermatologic congenital anomalies --- r_associated #0: 20 --> en:oedema
    n1=en:other dermatologic congenital anomalies | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2917. en:other disorders of the skin and subcutaneous tissue --- r_associated #0: 20 --> en:oedema
    n1=en:other disorders of the skin and subcutaneous tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2918. en:other fluid overload --- r_associated #0: 20 --> en:oedema
    n1=en:other fluid overload | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2919. en:other infectious skin disease --- r_associated #0: 20 --> en:oedema
    n1=en:other infectious skin disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2920. en:other injury to skin --- r_associated #0: 20 --> en:oedema
    n1=en:other injury to skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2921. en:other localized skin infection --- r_associated #0: 20 --> en:oedema
    n1=en:other localized skin infection | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2922. en:other mitochondrial complex enzyme activities may also be decreased --- r_associated #0: 20 --> en:oedema
    n1=en:other mitochondrial complex enzyme activities may also be decreased | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2923. en:other symptom/complaint skin --- r_associated #0: 20 --> en:oedema
    n1=en:other symptom/complaint skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2924. en:other symptoms involving abdomen and pelvis --- r_associated #0: 20 --> en:oedema
    n1=en:other symptoms involving abdomen and pelvis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2925. en:other symptoms involving skin and integumentary tissues --- r_associated #0: 20 --> en:oedema
    n1=en:other symptoms involving skin and integumentary tissues | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2926. en:other/unspecified neoplasm skin --- r_associated #0: 20 --> en:oedema
    n1=en:other/unspecified neoplasm skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2927. en:overhydration --- r_associated #0: 20 --> en:oedema
    n1=en:overhydration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2928. en:overlapping lesion of skin --- r_associated #0: 20 --> en:oedema
    n1=en:overlapping lesion of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2929. en:overweight --- r_associated #0: 20 --> en:oedema
    n1=en:overweight | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2930. en:pacemakers and implantable defibrillators --- r_associated #0: 20 --> en:oedema
    n1=en:pacemakers and implantable defibrillators | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2931. en:pachyderma --- r_associated #0: 20 --> en:oedema
    n1=en:pachyderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2932. en:pain --- r_associated #0: 20 --> en:oedema
    n1=en:pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2933. en:pain / sensation observable --- r_associated #0: 20 --> en:oedema
    n1=en:pain / sensation observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2934. en:pain or cramping during sustained manual activity --- r_associated #0: 20 --> en:oedema
    n1=en:pain or cramping during sustained manual activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2935. en:pain/tenderness of skin --- r_associated #0: 20 --> en:oedema
    n1=en:pain/tenderness of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2936. en:painful adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:painful adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2937. en:painful bluish-red papules or nodules (fingers, toes, nose, cheek, ears) --- r_associated #0: 20 --> en:oedema
    n1=en:painful bluish-red papules or nodules (fingers, toes, nose, cheek, ears) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2938. en:painful muscle cramps --- r_associated #0: 20 --> en:oedema
    n1=en:painful muscle cramps | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2939. en:painful swelling in aponeuroses --- r_associated #0: 20 --> en:oedema
    n1=en:painful swelling in aponeuroses | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2940. en:painful swelling in fasciae --- r_associated #0: 20 --> en:oedema
    n1=en:painful swelling in fasciae | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2941. en:painful, fleshy papules or nodules (hands, scalp, ears, perinasal area) --- r_associated #0: 20 --> en:oedema
    n1=en:painful, fleshy papules or nodules (hands, scalp, ears, perinasal area) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2942. en:pale, sensitive skin --- r_associated #0: 20 --> en:oedema
    n1=en:pale, sensitive skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2943. en:pale-gray skin --- r_associated #0: 20 --> en:oedema
    n1=en:pale-gray skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2944. en:pallor --- r_associated #0: 20 --> en:oedema
    n1=en:pallor | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2945. en:pallor (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pallor (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2946. en:pallor and flushing --- r_associated #0: 20 --> en:oedema
    n1=en:pallor and flushing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2947. en:pallor during episodes --- r_associated #0: 20 --> en:oedema
    n1=en:pallor during episodes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2948. en:pallor of skin --- r_associated #0: 20 --> en:oedema
    n1=en:pallor of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2949. en:palmar creases, fine to acrogeria-like --- r_associated #0: 20 --> en:oedema
    n1=en:palmar creases, fine to acrogeria-like | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2950. en:palmar erythema --- r_associated #0: 20 --> en:oedema
    n1=en:palmar erythema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2951. en:palmar hyperhidrosis --- r_associated #0: 20 --> en:oedema
    n1=en:palmar hyperhidrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2952. en:palmar hyperlinearity --- r_associated #0: 20 --> en:oedema
    n1=en:palmar hyperlinearity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2953. en:palmar keratosis --- r_associated #0: 20 --> en:oedema
    n1=en:palmar keratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2954. en:palmar nevi --- r_associated #0: 20 --> en:oedema
    n1=en:palmar nevi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2955. en:palmar pit --- r_associated #0: 20 --> en:oedema
    n1=en:palmar pit | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2956. en:palmar telangiectasias (described in 1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:palmar telangiectasias (described in 1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2957. en:palmar wrinkling --- r_associated #0: 20 --> en:oedema
    n1=en:palmar wrinkling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2958. en:palmar xanthomas --- r_associated #0: 20 --> en:oedema
    n1=en:palmar xanthomas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2959. en:palmoplantar cutis gyrata --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar cutis gyrata | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2960. en:palmoplantar cutis laxa --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar cutis laxa | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2961. en:palmoplantar epidermolytic hyperkeratosis along blaschko lines (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar epidermolytic hyperkeratosis along blaschko lines (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2962. en:palmoplantar hyperhidrosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar hyperhidrosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2963. en:palmoplantar hyperkeratosis, mild (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar hyperkeratosis, mild (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2964. en:palmoplantar hyperkeratosis, severe --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar hyperkeratosis, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2965. en:palmoplantar hyperlinearity --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar hyperlinearity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2966. en:palmoplantar hyperlinearity, marked --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar hyperlinearity, marked | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2967. en:palmoplantar keratoderma --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar keratoderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2968. en:palmoplantar keratoderma (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar keratoderma (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2969. en:palmoplantar keratoderma, diffuse (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar keratoderma, diffuse (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2970. en:palmoplantar keratoderma, mild --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar keratoderma, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2971. en:palmoplantar keratoderma, mild (in homozygous patients) --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar keratoderma, mild (in homozygous patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2972. en:palmoplantar keratoderma, patchy (>50%) --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar keratoderma, patchy (>50%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2973. en:palmoplantar keratosis with erythema and scale --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar keratosis with erythema and scale | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2974. en:palmoplantar pits --- r_associated #0: 20 --> en:oedema
    n1=en:palmoplantar pits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2975. en:palms, soles, and oral mucosa are not involved --- r_associated #0: 20 --> en:oedema
    n1=en:palms, soles, and oral mucosa are not involved | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2976. en:pancreatic sign --- r_associated #0: 20 --> en:oedema
    n1=en:pancreatic sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2977. en:panniculitis --- r_associated #0: 20 --> en:oedema
    n1=en:panniculitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2978. en:papilledema --- r_associated #0: 20 --> en:oedema
    n1=en:papilledema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2979. en:papilledema associated with increased intracranial pressure --- r_associated #0: 20 --> en:oedema
    n1=en:papilledema associated with increased intracranial pressure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2980. en:papilledema associated with retinal disorder --- r_associated #0: 20 --> en:oedema
    n1=en:papilledema associated with retinal disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2981. en:papilledema left eye --- r_associated #0: 20 --> en:oedema
    n1=en:papilledema left eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2982. en:papilledema of bilateral eyes due to raised intracranial pressure --- r_associated #0: 20 --> en:oedema
    n1=en:papilledema of bilateral eyes due to raised intracranial pressure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2983. en:papilledema of the right eye --- r_associated #0: 20 --> en:oedema
    n1=en:papilledema of the right eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2984. en:papillomas (perioral, nasal, and anal regions) --- r_associated #0: 20 --> en:oedema
    n1=en:papillomas (perioral, nasal, and anal regions) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2985. en:papillomatosis --- r_associated #0: 20 --> en:oedema
    n1=en:papillomatosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2986. en:papillomatosis of affected area --- r_associated #0: 20 --> en:oedema
    n1=en:papillomatosis of affected area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2987. en:papillomatosis over affected area --- r_associated #0: 20 --> en:oedema
    n1=en:papillomatosis over affected area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2988. en:papillomatosis over edematous areas --- r_associated #0: 20 --> en:oedema
    n1=en:papillomatosis over edematous areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2989. en:papillomatosis, confluent centrally, erythematous turning brown later --- r_associated #0: 20 --> en:oedema
    n1=en:papillomatosis, confluent centrally, erythematous turning brown later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2990. en:papillomatosis, reticular on the periphery, 1 to 2-mm growing to 4-5-mm and coalescing --- r_associated #0: 20 --> en:oedema
    n1=en:papillomatosis, reticular on the periphery, 1 to 2-mm growing to 4-5-mm and coalescing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2991. en:papular keratoderma, mild --- r_associated #0: 20 --> en:oedema
    n1=en:papular keratoderma, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2992. en:papular lesion --- r_associated #0: 20 --> en:oedema
    n1=en:papular lesion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2993. en:papules enlarge centrifugally to form central atrophic area with an irregular keratotic ridge --- r_associated #0: 20 --> en:oedema
    n1=en:papules enlarge centrifugally to form central atrophic area with an irregular keratotic ridge | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2994. en:papules enlarge centrifugally to form central atrophic area with an irregular peripheral keratotic ridge --- r_associated #0: 20 --> en:oedema
    n1=en:papules enlarge centrifugally to form central atrophic area with an irregular peripheral keratotic ridge | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2995. en:papules, firm, flat or dome-shaped, skin-colored some with a hair at or just outside the periphery and/or telangiectatic surface --- r_associated #0: 20 --> en:oedema
    n1=en:papules, firm, flat or dome-shaped, skin-colored some with a hair at or just outside the periphery and/or telangiectatic surface | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2996. en:papules, keratotic follicular --- r_associated #0: 20 --> en:oedema
    n1=en:papules, keratotic follicular | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2997. en:papulosquamous erythematous plaques --- r_associated #0: 20 --> en:oedema
    n1=en:papulosquamous erythematous plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2998. en:paracrystalline inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:paracrystalline inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  2999. en:paradoxical myotonia (myotonia increases with exercise) --- r_associated #0: 20 --> en:oedema
    n1=en:paradoxical myotonia (myotonia increases with exercise) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3000. en:paradoxical sweating response (sweating induced by cold exposure, inability to sweat in hot weather) --- r_associated #0: 20 --> en:oedema
    n1=en:paradoxical sweating response (sweating induced by cold exposure, inability to sweat in hot weather) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3001. en:parakeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:parakeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3002. en:paralysis of the lower limbs (later) --- r_associated #0: 20 --> en:oedema
    n1=en:paralysis of the lower limbs (later) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3003. en:paraparesis --- r_associated #0: 20 --> en:oedema
    n1=en:paraparesis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3004. en:parasitology --- r_associated #0: 20 --> en:oedema
    n1=en:parasitology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3005. en:parkinsonism --- r_associated #0: 20 --> en:oedema
    n1=en:parkinsonism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3006. en:partial anhidrosis --- r_associated #0: 20 --> en:oedema
    n1=en:partial anhidrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3007. en:partial lipodystrophy (abnormal distribution of adipose tissue) --- r_associated #0: 20 --> en:oedema
    n1=en:partial lipodystrophy (abnormal distribution of adipose tissue) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3008. en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue) --- r_associated #0: 20 --> en:oedema
    n1=en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3009. en:passive congestion --- r_associated #0: 20 --> en:oedema
    n1=en:passive congestion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3010. en:patchy muscle fiber degeneration --- r_associated #0: 20 --> en:oedema
    n1=en:patchy muscle fiber degeneration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3011. en:patchy vitiligo --- r_associated #0: 20 --> en:oedema
    n1=en:patchy vitiligo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3012. en:patchy, reticular stains --- r_associated #0: 20 --> en:oedema
    n1=en:patchy, reticular stains | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3013. en:patent ductus arteriosus - persisting type --- r_associated #0: 20 --> en:oedema
    n1=en:patent ductus arteriosus - persisting type | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3014. en:pathologic keratinization --- r_associated #0: 20 --> en:oedema
    n1=en:pathologic keratinization | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3015. en:pathological aspects --- r_associated #0: 20 --> en:oedema
    n1=en:pathological aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3016. en:pathophysiologic finding --- r_associated #0: 20 --> en:oedema
    n1=en:pathophysiologic finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3017. en:patient problem codes fda cdrh --- r_associated #0: 20 --> en:oedema
    n1=en:patient problem codes fda cdrh | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3018. en:patients achieve independent ambulation, but may lose it --- r_associated #0: 20 --> en:oedema
    n1=en:patients achieve independent ambulation, but may lose it | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3019. en:patients may have distal or proximal muscle weakness, or both --- r_associated #0: 20 --> en:oedema
    n1=en:patients may have distal or proximal muscle weakness, or both | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3020. en:paucity or absence of lymph nodes in the axillae and above the inguinal ligaments seen on scintilymphangiography --- r_associated #0: 20 --> en:oedema
    n1=en:paucity or absence of lymph nodes in the axillae and above the inguinal ligaments seen on scintilymphangiography | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3021. en:peau d'orange --- r_associated #0: 20 --> en:oedema
    n1=en:peau d'orange | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3022. en:pebbly skin lesions on back, upper arms, and thigh --- r_associated #0: 20 --> en:oedema
    n1=en:pebbly skin lesions on back, upper arms, and thigh | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3023. en:pectoralis hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:pectoralis hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3024. en:pectoralis major hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:pectoralis major hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3025. en:pectoralis muscles may be less involved, leading to inward shrugging posture --- r_associated #0: 20 --> en:oedema
    n1=en:pectoralis muscles may be less involved, leading to inward shrugging posture | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3026. en:pedal edema --- r_associated #0: 20 --> en:oedema
    n1=en:pedal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3027. en:pediatric adverse events terminology --- r_associated #0: 20 --> en:oedema
    n1=en:pediatric adverse events terminology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3028. en:pediatric failure to thrive --- r_associated #0: 20 --> en:oedema
    n1=en:pediatric failure to thrive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3029. en:pediatric terminology --- r_associated #0: 20 --> en:oedema
    n1=en:pediatric terminology | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3030. en:pediculosis/other skin infestation --- r_associated #0: 20 --> en:oedema
    n1=en:pediculosis/other skin infestation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3031. en:pelvic girdle muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:pelvic girdle muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3032. en:pelvic girdle muscle weakness (occurs earlier) --- r_associated #0: 20 --> en:oedema
    n1=en:pelvic girdle muscle weakness (occurs earlier) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3033. en:pelvic girdle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:pelvic girdle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3034. en:pelvic girdle weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:pelvic girdle weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3035. en:pelvic muscle involvement occurs later --- r_associated #0: 20 --> en:oedema
    n1=en:pelvic muscle involvement occurs later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3036. en:pelvic pain --- r_associated #0: 20 --> en:oedema
    n1=en:pelvic pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3037. en:penile swelling --- r_associated #0: 20 --> en:oedema
    n1=en:penile swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3038. en:penile venereal edema --- r_associated #0: 20 --> en:oedema
    n1=en:penile venereal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3039. en:percussion myotonias --- r_associated #0: 20 --> en:oedema
    n1=en:percussion myotonias | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3040. en:percussion-induced muscle mounding (muscle rippling) --- r_associated #0: 20 --> en:oedema
    n1=en:percussion-induced muscle mounding (muscle rippling) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3041. en:percussion-induced rapid rolling muscle contractions (pirc) --- r_associated #0: 20 --> en:oedema
    n1=en:percussion-induced rapid rolling muscle contractions (pirc) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3042. en:perfusion / dialysis observable --- r_associated #0: 20 --> en:oedema
    n1=en:perfusion / dialysis observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3043. en:perianal erythema --- r_associated #0: 20 --> en:oedema
    n1=en:perianal erythema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3044. en:perianal skin tags --- r_associated #0: 20 --> en:oedema
    n1=en:perianal skin tags | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3045. en:periarticular subcutaneous nodules --- r_associated #0: 20 --> en:oedema
    n1=en:periarticular subcutaneous nodules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3046. en:pericardial effusion body substance --- r_associated #0: 20 --> en:oedema
    n1=en:pericardial effusion body substance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3047. en:perinasal or perioral nonhealing crusting of the skin --- r_associated #0: 20 --> en:oedema
    n1=en:perinasal or perioral nonhealing crusting of the skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3048. en:perinatal observable --- r_associated #0: 20 --> en:oedema
    n1=en:perinatal observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3049. en:perineal intertrigo --- r_associated #0: 20 --> en:oedema
    n1=en:perineal intertrigo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3050. en:periodic edema --- r_associated #0: 20 --> en:oedema
    n1=en:periodic edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3051. en:perioral erythema --- r_associated #0: 20 --> en:oedema
    n1=en:perioral erythema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3052. en:periorbital edema --- r_associated #0: 20 --> en:oedema
    n1=en:periorbital edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3053. en:periorbital edema of left eye --- r_associated #0: 20 --> en:oedema
    n1=en:periorbital edema of left eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3054. en:periorbital edema of right eye --- r_associated #0: 20 --> en:oedema
    n1=en:periorbital edema of right eye | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3055. en:periorbital hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:periorbital hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3056. en:periorbital wrinkles --- r_associated #0: 20 --> en:oedema
    n1=en:periorbital wrinkles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3057. en:periorificial hyperkeratotic lesions --- r_associated #0: 20 --> en:oedema
    n1=en:periorificial hyperkeratotic lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3058. en:peripheral arterial disorder --- r_associated #0: 20 --> en:oedema
    n1=en:peripheral arterial disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3059. en:peripheral oedema neonatal --- r_associated #0: 20 --> en:oedema
    n1=en:peripheral oedema neonatal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3060. en:peripheral retinal edema --- r_associated #0: 20 --> en:oedema
    n1=en:peripheral retinal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3061. en:peristomal skin --- r_associated #0: 20 --> en:oedema
    n1=en:peristomal skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3062. en:peritumoural oedema --- r_associated #0: 20 --> en:oedema
    n1=en:peritumoural oedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3063. en:periventricular cerebrospinal fluid edema --- r_associated #0: 20 --> en:oedema
    n1=en:periventricular cerebrospinal fluid edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3064. en:periwound description:find:pt:periwound:nom --- r_associated #0: 20 --> en:oedema
    n1=en:periwound description:find:pt:periwound:nom | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3065. en:peroneal muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:peroneal muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3066. en:peroneal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:peroneal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3067. en:peroneal muscle weakness and atrophy due to peripheral neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:peroneal muscle weakness and atrophy due to peripheral neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3068. en:personality change --- r_associated #0: 20 --> en:oedema
    n1=en:personality change | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3069. en:petechia --- r_associated #0: 20 --> en:oedema
    n1=en:petechia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3070. en:petechiae (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:petechiae (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3071. en:petechiae and purpura do not occur --- r_associated #0: 20 --> en:oedema
    n1=en:petechiae and purpura do not occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3072. en:phagocytic vacuoles with degraded membranous material --- r_associated #0: 20 --> en:oedema
    n1=en:phagocytic vacuoles with degraded membranous material | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3073. en:phakic corneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:phakic corneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3074. en:pharmacotherapeutic --- r_associated #0: 20 --> en:oedema
    n1=en:pharmacotherapeutic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3075. en:pharyngeal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:pharyngeal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3076. en:pharynx or nasopharynx edema --- r_associated #0: 20 --> en:oedema
    n1=en:pharynx or nasopharynx edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3077. en:photosensitivity (harderoporphyria and hcp) --- r_associated #0: 20 --> en:oedema
    n1=en:photosensitivity (harderoporphyria and hcp) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3078. en:photosensitivity bullous dermatitis (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:photosensitivity bullous dermatitis (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3079. en:physical findings:find:pt:extremity:nom:nemsis --- r_associated #0: 20 --> en:oedema
    n1=en:physical findings:find:pt:extremity:nom:nemsis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3080. en:physical findings:find:pt:macula.left:nom:ophthalmoscopy --- r_associated #0: 20 --> en:oedema
    n1=en:physical findings:find:pt:macula.left:nom:ophthalmoscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3081. en:physical findings:find:pt:macula.right:nom:ophthalmoscopy --- r_associated #0: 20 --> en:oedema
    n1=en:physical findings:find:pt:macula.right:nom:ophthalmoscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3082. en:physical symptom --- r_associated #0: 20 --> en:oedema
    n1=en:physical symptom | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3083. en:physiopathological --- r_associated #0: 20 --> en:oedema
    n1=en:physiopathological | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3084. en:piebaldism --- r_associated #0: 20 --> en:oedema
    n1=en:piebaldism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3085. en:pierson syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:pierson syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3086. en:pigmentary abnormalities --- r_associated #0: 20 --> en:oedema
    n1=en:pigmentary abnormalities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3087. en:pigmentary abnormalities (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pigmentary abnormalities (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3088. en:pigmentary change in skin --- r_associated #0: 20 --> en:oedema
    n1=en:pigmentary change in skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3089. en:pigmentary changes on the shins (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:pigmentary changes on the shins (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3090. en:pigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:pigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3091. en:pigmentation abnormalities (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:pigmentation abnormalities (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3092. en:pigmented nevus --- r_associated #0: 20 --> en:oedema
    n1=en:pigmented nevus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3093. en:pilo-sebaceous apparatus --- r_associated #0: 20 --> en:oedema
    n1=en:pilo-sebaceous apparatus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3094. en:pilomatricoma --- r_associated #0: 20 --> en:oedema
    n1=en:pilomatricoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3095. en:pilonidal cyst --- r_associated #0: 20 --> en:oedema
    n1=en:pilonidal cyst | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3096. en:pilonidal cyst/fistula --- r_associated #0: 20 --> en:oedema
    n1=en:pilonidal cyst/fistula | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3097. en:pits of palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:pits of palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3098. en:pitted, perioral acneiform scars --- r_associated #0: 20 --> en:oedema
    n1=en:pitted, perioral acneiform scars | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3099. en:pitting edema --- r_associated #0: 20 --> en:oedema
    n1=en:pitting edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3100. en:pityriasis alba --- r_associated #0: 20 --> en:oedema
    n1=en:pityriasis alba | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3101. en:pityriasis rosea --- r_associated #0: 20 --> en:oedema
    n1=en:pityriasis rosea | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3102. en:placenta edematous --- r_associated #0: 20 --> en:oedema
    n1=en:placenta edematous | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3103. en:planar xanthomas (detroit type 107680.0011) --- r_associated #0: 20 --> en:oedema
    n1=en:planar xanthomas (detroit type 107680.0011) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3104. en:planar xanthomas in homozygotes --- r_associated #0: 20 --> en:oedema
    n1=en:planar xanthomas in homozygotes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3105. en:plantar blistering --- r_associated #0: 20 --> en:oedema
    n1=en:plantar blistering | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3106. en:plantar fibromatosis --- r_associated #0: 20 --> en:oedema
    n1=en:plantar fibromatosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3107. en:plantar hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:plantar hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3108. en:plantar keratoderma (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:plantar keratoderma (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3109. en:plantar pits --- r_associated #0: 20 --> en:oedema
    n1=en:plantar pits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3110. en:plantar softness --- r_associated #0: 20 --> en:oedema
    n1=en:plantar softness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3111. en:plaque-like facial hemangioma --- r_associated #0: 20 --> en:oedema
    n1=en:plaque-like facial hemangioma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3112. en:plaques immunoreactive for desmin and alpha-beta-crystallin --- r_associated #0: 20 --> en:oedema
    n1=en:plaques immunoreactive for desmin and alpha-beta-crystallin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3113. en:plaques, erythematous, covered with fine powdery scales --- r_associated #0: 20 --> en:oedema
    n1=en:plaques, erythematous, covered with fine powdery scales | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3114. en:plethoric face --- r_associated #0: 20 --> en:oedema
    n1=en:plethoric face | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3115. en:pleural effusion --- r_associated #0: 20 --> en:oedema
    n1=en:pleural effusion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3116. en:pleural effusion fluid --- r_associated #0: 20 --> en:oedema
    n1=en:pleural effusion fluid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3117. en:plexiform neurofibroma --- r_associated #0: 20 --> en:oedema
    n1=en:plexiform neurofibroma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3118. en:plexiform neurofibroma (76%) --- r_associated #0: 20 --> en:oedema
    n1=en:plexiform neurofibroma (76%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3119. en:pneumatosis --- r_associated #0: 20 --> en:oedema
    n1=en:pneumatosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3120. en:poikiloderma --- r_associated #0: 20 --> en:oedema
    n1=en:poikiloderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3121. en:poikiloderma (atrophic plaques with telangiectasia) --- r_associated #0: 20 --> en:oedema
    n1=en:poikiloderma (atrophic plaques with telangiectasia) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3122. en:polydipsia --- r_associated #0: 20 --> en:oedema
    n1=en:polydipsia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3123. en:polyglucosan accumulation --- r_associated #0: 20 --> en:oedema
    n1=en:polyglucosan accumulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3124. en:polyhydramnios --- r_associated #0: 20 --> en:oedema
    n1=en:polyhydramnios | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3125. en:polyhydramnios (congenital form) --- r_associated #0: 20 --> en:oedema
    n1=en:polyhydramnios (congenital form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3126. en:polyhydramnios (in perinatal or congenital neuromuscular forms) --- r_associated #0: 20 --> en:oedema
    n1=en:polyhydramnios (in perinatal or congenital neuromuscular forms) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3127. en:polyhydramnios (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:polyhydramnios (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3128. en:polyhydramnios (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:polyhydramnios (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3129. en:polyhydramnios (severe form) --- r_associated #0: 20 --> en:oedema
    n1=en:polyhydramnios (severe form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3130. en:polymyositis --- r_associated #0: 20 --> en:oedema
    n1=en:polymyositis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3131. en:polypoid degeneration of vocal cord --- r_associated #0: 20 --> en:oedema
    n1=en:polypoid degeneration of vocal cord | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3132. en:poor exercise tolerance --- r_associated #0: 20 --> en:oedema
    n1=en:poor exercise tolerance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3133. en:poor head control --- r_associated #0: 20 --> en:oedema
    n1=en:poor head control | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3134. en:poor head control in infancy --- r_associated #0: 20 --> en:oedema
    n1=en:poor head control in infancy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3135. en:poor healing with abnormal scarring (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:poor healing with abnormal scarring (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3136. en:poor muscle build --- r_associated #0: 20 --> en:oedema
    n1=en:poor muscle build | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3137. en:poor muscle bulk --- r_associated #0: 20 --> en:oedema
    n1=en:poor muscle bulk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3138. en:poor muscle mass --- r_associated #0: 20 --> en:oedema
    n1=en:poor muscle mass | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3139. en:poor musculature --- r_associated #0: 20 --> en:oedema
    n1=en:poor musculature | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3140. en:poor sarcomeric structure (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:poor sarcomeric structure (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3141. en:poor sweating in response to heat --- r_associated #0: 20 --> en:oedema
    n1=en:poor sweating in response to heat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3142. en:poor wound healing --- r_associated #0: 20 --> en:oedema
    n1=en:poor wound healing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3143. en:poorly defined palmar creases --- r_associated #0: 20 --> en:oedema
    n1=en:poorly defined palmar creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3144. en:poorly developed palmar creases --- r_associated #0: 20 --> en:oedema
    n1=en:poorly developed palmar creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3145. en:popeye sign --- r_associated #0: 20 --> en:oedema
    n1=en:popeye sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3146. en:popliteal pterygium --- r_associated #0: 20 --> en:oedema
    n1=en:popliteal pterygium | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3147. en:popliteal pterygium, bilateral --- r_associated #0: 20 --> en:oedema
    n1=en:popliteal pterygium, bilateral | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3148. en:porokeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:porokeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3149. en:poroma --- r_associated #0: 20 --> en:oedema
    n1=en:poroma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3150. en:port wine stain --- r_associated #0: 20 --> en:oedema
    n1=en:port wine stain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3151. en:positive skin test reaction to seminal fluid --- r_associated #0: 20 --> en:oedema
    n1=en:positive skin test reaction to seminal fluid | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3152. en:positive staining for atpase activity at ph of 4.3 --- r_associated #0: 20 --> en:oedema
    n1=en:positive staining for atpase activity at ph of 4.3 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3153. en:positive staining for complement c5b-9 membrane attack complex proteins within vacuoles, but not on muscle fiber membrane --- r_associated #0: 20 --> en:oedema
    n1=en:positive staining for complement c5b-9 membrane attack complex proteins within vacuoles, but not on muscle fiber membrane | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3154. en:positive staining for slow myosin heavy chain --- r_associated #0: 20 --> en:oedema
    n1=en:positive staining for slow myosin heavy chain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3155. en:post vaccination syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:post vaccination syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3156. en:post-radiotherapy laryngeal edema --- r_associated #0: 20 --> en:oedema
    n1=en:post-radiotherapy laryngeal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3157. en:post-upper airway obstruction pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:post-upper airway obstruction pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3158. en:postauricular crescent-shaped hypoplastic skin lesion --- r_associated #0: 20 --> en:oedema
    n1=en:postauricular crescent-shaped hypoplastic skin lesion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3159. en:posterior midline scalp defects --- r_associated #0: 20 --> en:oedema
    n1=en:posterior midline scalp defects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3160. en:postexercise cmap amplitude facilitation --- r_associated #0: 20 --> en:oedema
    n1=en:postexercise cmap amplitude facilitation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3161. en:postimmersion-submersion syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:postimmersion-submersion syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3162. en:postoperative hemorrhage --- r_associated #0: 20 --> en:oedema
    n1=en:postoperative hemorrhage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3163. en:postoperative pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:postoperative pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3164. en:potassium sensitivity has been reported --- r_associated #0: 20 --> en:oedema
    n1=en:potassium sensitivity has been reported | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3165. en:potential for excess fluid volume --- r_associated #0: 20 --> en:oedema
    n1=en:potential for excess fluid volume | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3166. en:predominance of oxidative fibers --- r_associated #0: 20 --> en:oedema
    n1=en:predominance of oxidative fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3167. en:predominantly lower limb lymphedema --- r_associated #0: 20 --> en:oedema
    n1=en:predominantly lower limb lymphedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3168. en:pregnancy induced hypertension with pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:pregnancy induced hypertension with pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3169. en:pregnancy risk factors:find:pt:^patient:nom:rhea --- r_associated #0: 20 --> en:oedema
    n1=en:pregnancy risk factors:find:pt:^patient:nom:rhea | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3170. en:pregnancy, childbirth / puerperium observable --- r_associated #0: 20 --> en:oedema
    n1=en:pregnancy, childbirth / puerperium observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3171. en:premature aging (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:premature aging (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3172. en:premature aging syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:premature aging syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3173. en:premature aging, mild --- r_associated #0: 20 --> en:oedema
    n1=en:premature aging, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3174. en:premature birth (30%) --- r_associated #0: 20 --> en:oedema
    n1=en:premature birth (30%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3175. en:premature exertional muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:premature exertional muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3176. en:prenatal diagnosis by ultrasound --- r_associated #0: 20 --> en:oedema
    n1=en:prenatal diagnosis by ultrasound | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3177. en:prenatal manifestations --- r_associated #0: 20 --> en:oedema
    n1=en:prenatal manifestations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3178. en:prepuce --- r_associated #0: 20 --> en:oedema
    n1=en:prepuce | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3179. en:preservation of visceral, neck, and axillary fat pads --- r_associated #0: 20 --> en:oedema
    n1=en:preservation of visceral, neck, and axillary fat pads | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3180. en:preserved heel standing --- r_associated #0: 20 --> en:oedema
    n1=en:preserved heel standing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3181. en:presynaptic defect at the neuromuscular junction --- r_associated #0: 20 --> en:oedema
    n1=en:presynaptic defect at the neuromuscular junction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3182. en:presyncope --- r_associated #0: 20 --> en:oedema
    n1=en:presyncope | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3183. en:pretibial dimples --- r_associated #0: 20 --> en:oedema
    n1=en:pretibial dimples | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3184. en:pretibial myxedema --- r_associated #0: 20 --> en:oedema
    n1=en:pretibial myxedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3185. en:pretibial pigmented granulomatous plaques --- r_associated #0: 20 --> en:oedema
    n1=en:pretibial pigmented granulomatous plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3186. en:primarily affects lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:primarily affects lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3187. en:primarily affects trunk --- r_associated #0: 20 --> en:oedema
    n1=en:primarily affects trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3188. en:primary myopathic changes seen on emg --- r_associated #0: 20 --> en:oedema
    n1=en:primary myopathic changes seen on emg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3189. en:procedure related observable --- r_associated #0: 20 --> en:oedema
    n1=en:procedure related observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3190. en:prodromal symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:prodromal symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3191. en:profuse pigmented skin lesions --- r_associated #0: 20 --> en:oedema
    n1=en:profuse pigmented skin lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3192. en:profuse sweating of the upper body induced by cold exposure --- r_associated #0: 20 --> en:oedema
    n1=en:profuse sweating of the upper body induced by cold exposure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3193. en:progeric skin changes --- r_associated #0: 20 --> en:oedema
    n1=en:progeric skin changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3194. en:prognosis/outlook finding --- r_associated #0: 20 --> en:oedema
    n1=en:prognosis/outlook finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3195. en:progression of skin lesions - --- r_associated #0: 20 --> en:oedema
    n1=en:progression of skin lesions - | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3196. en:progression to proximal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:progression to proximal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3197. en:progression to wheelchair in fourth decade --- r_associated #0: 20 --> en:oedema
    n1=en:progression to wheelchair in fourth decade | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3198. en:progressive cutis verticis gyrata --- r_associated #0: 20 --> en:oedema
    n1=en:progressive cutis verticis gyrata | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3199. en:progressive distal and proximal symmetric limb weakness --- r_associated #0: 20 --> en:oedema
    n1=en:progressive distal and proximal symmetric limb weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3200. en:progressive distal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:progressive distal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3201. en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters) --- r_associated #0: 20 --> en:oedema
    n1=en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3202. en:progressive generalized skin erosions --- r_associated #0: 20 --> en:oedema
    n1=en:progressive generalized skin erosions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3203. en:progressive interictal weakness is common --- r_associated #0: 20 --> en:oedema
    n1=en:progressive interictal weakness is common | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3204. en:progressive loss of facial adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:progressive loss of facial adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3205. en:progressive muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:progressive muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3206. en:progressive proximal muscle involvement --- r_associated #0: 20 --> en:oedema
    n1=en:progressive proximal muscle involvement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3207. en:progressive proximal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:progressive proximal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3208. en:progressive reticulate hyperpigmentation (axillae, groin, perineal, perianal) --- r_associated #0: 20 --> en:oedema
    n1=en:progressive reticulate hyperpigmentation (axillae, groin, perineal, perianal) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3209. en:progressive vitiligo --- r_associated #0: 20 --> en:oedema
    n1=en:progressive vitiligo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3210. en:proliferating cells show nuclear expression of lymphoid enhancer binding factor-1 (lef1, 153245) --- r_associated #0: 20 --> en:oedema
    n1=en:proliferating cells show nuclear expression of lymphoid enhancer binding factor-1 (lef1, 153245) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3211. en:proliferation of fatty tissue in muscle (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:proliferation of fatty tissue in muscle (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3212. en:proliferation of spindle cells --- r_associated #0: 20 --> en:oedema
    n1=en:proliferation of spindle cells | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3213. en:proliferative diabetic retinopathy - high risk with clinically significant macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:proliferative diabetic retinopathy - high risk with clinically significant macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3214. en:proliferative retinopathy with retinal edema due to type 2 diabetes mellitus --- r_associated #0: 20 --> en:oedema
    n1=en:proliferative retinopathy with retinal edema due to type 2 diabetes mellitus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3215. en:prolonged capillary refill --- r_associated #0: 20 --> en:oedema
    n1=en:prolonged capillary refill | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3216. en:prominent fingertip pads --- r_associated #0: 20 --> en:oedema
    n1=en:prominent fingertip pads | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3217. en:prominent involvement of the biceps brachii muscles --- r_associated #0: 20 --> en:oedema
    n1=en:prominent involvement of the biceps brachii muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3218. en:prominent involvement of the quadriceps femoris muscles --- r_associated #0: 20 --> en:oedema
    n1=en:prominent involvement of the quadriceps femoris muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3219. en:prominent muscular appearance --- r_associated #0: 20 --> en:oedema
    n1=en:prominent muscular appearance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3220. en:prominent musculature --- r_associated #0: 20 --> en:oedema
    n1=en:prominent musculature | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3221. en:prominent palmar flexion creases --- r_associated #0: 20 --> en:oedema
    n1=en:prominent palmar flexion creases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3222. en:prominent scalp veins --- r_associated #0: 20 --> en:oedema
    n1=en:prominent scalp veins | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3223. en:prominent superficial blood vessels --- r_associated #0: 20 --> en:oedema
    n1=en:prominent superficial blood vessels | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3224. en:prominent superficial blood vessels due to thin skin --- r_associated #0: 20 --> en:oedema
    n1=en:prominent superficial blood vessels due to thin skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3225. en:prominent superficial veins --- r_associated #0: 20 --> en:oedema
    n1=en:prominent superficial veins | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3226. en:prominent superficial venous pattern --- r_associated #0: 20 --> en:oedema
    n1=en:prominent superficial venous pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3227. en:prominent vasculature (nose and forehead) --- r_associated #0: 20 --> en:oedema
    n1=en:prominent vasculature (nose and forehead) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3228. en:prominent veins --- r_associated #0: 20 --> en:oedema
    n1=en:prominent veins | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3229. en:prominent veins (especially over scalp and limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:prominent veins (especially over scalp and limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3230. en:prominent veins on scalp, trunk, and/or extremities --- r_associated #0: 20 --> en:oedema
    n1=en:prominent veins on scalp, trunk, and/or extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3231. en:prominent veins, lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:prominent veins, lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3232. en:prominent venous markings --- r_associated #0: 20 --> en:oedema
    n1=en:prominent venous markings | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3233. en:prominent venous pattern --- r_associated #0: 20 --> en:oedema
    n1=en:prominent venous pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3234. en:prostration --- r_associated #0: 20 --> en:oedema
    n1=en:prostration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3235. en:protein aggregates immunopositive for actin and desmin --- r_associated #0: 20 --> en:oedema
    n1=en:protein aggregates immunopositive for actin and desmin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3236. en:protein aggregates resembling myofibrillar myopathy may be present --- r_associated #0: 20 --> en:oedema
    n1=en:protein aggregates resembling myofibrillar myopathy may be present | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3237. en:proteinuria --- r_associated #0: 20 --> en:oedema
    n1=en:proteinuria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3238. en:proximal amyotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:proximal amyotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3239. en:proximal and distal muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:proximal and distal muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3240. en:proximal and distal muscle atrophy in lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:proximal and distal muscle atrophy in lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3241. en:proximal limb muscle weakness (occurs later) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal limb muscle weakness (occurs later) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3242. en:proximal limb muscle weakness initially --- r_associated #0: 20 --> en:oedema
    n1=en:proximal limb muscle weakness initially | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3243. en:proximal lower limb amyotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:proximal lower limb amyotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3244. en:proximal lower limb muscle weakness, later (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal lower limb muscle weakness, later (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3245. en:proximal lower limb muscle weakness, upper and lower (later onset) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal lower limb muscle weakness, upper and lower (later onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3246. en:proximal muscle atrophy (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle atrophy (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3247. en:proximal muscle involvement may occur --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle involvement may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3248. en:proximal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3249. en:proximal muscle weakness (120270.0002) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness (120270.0002) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3250. en:proximal muscle weakness (85% of patients) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness (85% of patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3251. en:proximal muscle weakness (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3252. en:proximal muscle weakness (occasional) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness (occasional) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3253. en:proximal muscle weakness and atrophy (may occur later) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness and atrophy (may occur later) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3254. en:proximal muscle weakness in lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness in lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3255. en:proximal muscle weakness in upper limbs --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness in upper limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3256. en:proximal muscle weakness more severe than distal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness more severe than distal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3257. en:proximal muscle weakness occurs later --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness occurs later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3258. en:proximal muscle weakness, less severe --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness, less severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3259. en:proximal muscle weakness, limb-girdle distribution --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness, limb-girdle distribution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3260. en:proximal muscle weakness, lower limbs, mild --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness, lower limbs, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3261. en:proximal muscle weakness, mild --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness, mild | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3262. en:proximal muscle weakness, mild (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness, mild (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3263. en:proximal muscle weakness, mild, of shoulder and hip girdle muscles (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscle weakness, mild, of shoulder and hip girdle muscles (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3264. en:proximal muscles may be mildly affected --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscles may be mildly affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3265. en:proximal muscles more often affected --- r_associated #0: 20 --> en:oedema
    n1=en:proximal muscles more often affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3266. en:proximal myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:proximal myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3267. en:proximal upper limb amyotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:proximal upper limb amyotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3268. en:proximal weakness --- r_associated #0: 20 --> en:oedema
    n1=en:proximal weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3269. en:proximal weakness of the lower limbs with longer disease duration --- r_associated #0: 20 --> en:oedema
    n1=en:proximal weakness of the lower limbs with longer disease duration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3270. en:prurigo --- r_associated #0: 20 --> en:oedema
    n1=en:prurigo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3271. en:pruritic eczematous lesions --- r_associated #0: 20 --> en:oedema
    n1=en:pruritic eczematous lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3272. en:pruritic hyperkeratotic scars (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pruritic hyperkeratotic scars (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3273. en:pruritic ichthyosis (onset birth to first several months) --- r_associated #0: 20 --> en:oedema
    n1=en:pruritic ichthyosis (onset birth to first several months) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3274. en:pruritis, cold-induced --- r_associated #0: 20 --> en:oedema
    n1=en:pruritis, cold-induced | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3275. en:pruritis, intense --- r_associated #0: 20 --> en:oedema
    n1=en:pruritis, intense | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3276. en:pruritus --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3277. en:pruritus (inflammatory type b) --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus (inflammatory type b) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3278. en:pruritus (major feature) --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus (major feature) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3279. en:pruritus during pregnancy, resolves postpartum --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus during pregnancy, resolves postpartum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3280. en:pruritus in affected areas --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus in affected areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3281. en:pruritus of scalp --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus of scalp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3282. en:pruritus of skin lesions, severe --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus of skin lesions, severe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3283. en:pruritus secondary to liver disease --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus secondary to liver disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3284. en:pruritus, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:pruritus, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3285. en:pseudoainhum --- r_associated #0: 20 --> en:oedema
    n1=en:pseudoainhum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3286. en:pseudoainhum of fifth toes --- r_associated #0: 20 --> en:oedema
    n1=en:pseudoainhum of fifth toes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3287. en:pseudoathletic appearance with prominent muscles before disease onset --- r_associated #0: 20 --> en:oedema
    n1=en:pseudoathletic appearance with prominent muscles before disease onset | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3288. en:pseudohypertrophy of muscle --- r_associated #0: 20 --> en:oedema
    n1=en:pseudohypertrophy of muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3289. en:pseudophakia --- r_associated #0: 20 --> en:oedema
    n1=en:pseudophakia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3290. en:pseudophakic corneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:pseudophakic corneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3291. en:pseudoxanthomatous skin lesions (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pseudoxanthomatous skin lesions (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3292. en:psoriasiform dermatitis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:psoriasiform dermatitis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3293. en:psoriasiform lesions (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:psoriasiform lesions (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3294. en:psoriasiform plaques --- r_associated #0: 20 --> en:oedema
    n1=en:psoriasiform plaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3295. en:psoriasiform skin lesions --- r_associated #0: 20 --> en:oedema
    n1=en:psoriasiform skin lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3296. en:psoriasis --- r_associated #0: 20 --> en:oedema
    n1=en:psoriasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3297. en:psoriasis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:psoriasis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3298. en:psychology qualifier --- r_associated #0: 20 --> en:oedema
    n1=en:psychology qualifier | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3299. en:pterygia of axillae (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pterygia of axillae (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3300. en:pterygia of digits, neck, axillae, antecubital, popliteal, intercrural areas --- r_associated #0: 20 --> en:oedema
    n1=en:pterygia of digits, neck, axillae, antecubital, popliteal, intercrural areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3301. en:pterygia of elbows (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pterygia of elbows (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3302. en:pterygia of groin (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pterygia of groin (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3303. en:pterygia of neck (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pterygia of neck (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3304. en:pterygium --- r_associated #0: 20 --> en:oedema
    n1=en:pterygium | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3305. en:pterygium (elbows and knees) --- r_associated #0: 20 --> en:oedema
    n1=en:pterygium (elbows and knees) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3306. en:pterygium of bilateral (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pterygium of bilateral (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3307. en:pterygium of elbow, bilateral (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pterygium of elbow, bilateral (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3308. en:pterygium of wrist, bilateral (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:pterygium of wrist, bilateral (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3309. en:pulmonary edema --- r_associated #0: 20 --> en:oedema
    n1=en:pulmonary edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3310. en:pulmonary edema caused by chemical fumes --- r_associated #0: 20 --> en:oedema
    n1=en:pulmonary edema caused by chemical fumes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3311. en:pulmonary edema due to hypoproteinemia --- r_associated #0: 20 --> en:oedema
    n1=en:pulmonary edema due to hypoproteinemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3312. en:pulmonary hypertension --- r_associated #0: 20 --> en:oedema
    n1=en:pulmonary hypertension | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3313. en:pulmonary insufficiency following shock --- r_associated #0: 20 --> en:oedema
    n1=en:pulmonary insufficiency following shock | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3314. en:pulmonary insufficiency following surgery --- r_associated #0: 20 --> en:oedema
    n1=en:pulmonary insufficiency following surgery | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3315. en:pulmonary insufficiency following trauma --- r_associated #0: 20 --> en:oedema
    n1=en:pulmonary insufficiency following trauma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3316. en:pulmonary stenosis --- r_associated #0: 20 --> en:oedema
    n1=en:pulmonary stenosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3317. en:punch-like skin defects --- r_associated #0: 20 --> en:oedema
    n1=en:punch-like skin defects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3318. en:punctate keratitis --- r_associated #0: 20 --> en:oedema
    n1=en:punctate keratitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3319. en:punctate keratoses (palms and soles) --- r_associated #0: 20 --> en:oedema
    n1=en:punctate keratoses (palms and soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3320. en:punctate palmoplantar hyperkeratosis (later onset) --- r_associated #0: 20 --> en:oedema
    n1=en:punctate palmoplantar hyperkeratosis (later onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3321. en:punctate palmoplantar keratoderma --- r_associated #0: 20 --> en:oedema
    n1=en:punctate palmoplantar keratoderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3322. en:punctate vasculitis skin lesions --- r_associated #0: 20 --> en:oedema
    n1=en:punctate vasculitis skin lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3323. en:purpura --- r_associated #0: 20 --> en:oedema
    n1=en:purpura | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3324. en:purpuric rash --- r_associated #0: 20 --> en:oedema
    n1=en:purpuric rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3325. en:pustular eruption --- r_associated #0: 20 --> en:oedema
    n1=en:pustular eruption | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3326. en:pustular lesion --- r_associated #0: 20 --> en:oedema
    n1=en:pustular lesion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3327. en:pustulosis or pustular psoriasis, generalized --- r_associated #0: 20 --> en:oedema
    n1=en:pustulosis or pustular psoriasis, generalized | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3328. en:pyoderma --- r_associated #0: 20 --> en:oedema
    n1=en:pyoderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3329. en:pyoderma gangrenosum --- r_associated #0: 20 --> en:oedema
    n1=en:pyoderma gangrenosum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3330. en:pyramidal skinfold of halluces --- r_associated #0: 20 --> en:oedema
    n1=en:pyramidal skinfold of halluces | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3331. en:pyrogenic reaction --- r_associated #0: 20 --> en:oedema
    n1=en:pyrogenic reaction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3332. en:pyruvate oxidation defect --- r_associated #0: 20 --> en:oedema
    n1=en:pyruvate oxidation defect | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3333. en:quadriceps aplasia --- r_associated #0: 20 --> en:oedema
    n1=en:quadriceps aplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3334. en:quadriceps atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:quadriceps atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3335. en:quadriceps atrophy (later onset) --- r_associated #0: 20 --> en:oedema
    n1=en:quadriceps atrophy (later onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3336. en:quadriceps muscle spared --- r_associated #0: 20 --> en:oedema
    n1=en:quadriceps muscle spared | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3337. en:quadriceps weakness --- r_associated #0: 20 --> en:oedema
    n1=en:quadriceps weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3338. en:radiotherapeutic --- r_associated #0: 20 --> en:oedema
    n1=en:radiotherapeutic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3339. en:ragged red fibers (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:ragged red fibers (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3340. en:ragged red fibers seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:ragged red fibers seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3341. en:ragged-red fibers on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:ragged-red fibers on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3342. en:ragged-red fibers seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:ragged-red fibers seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3343. en:ragged-red muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:ragged-red muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3344. en:raised, firm, hairless posterior scalp nodules --- r_associated #0: 20 --> en:oedema
    n1=en:raised, firm, hairless posterior scalp nodules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3345. en:rare disorder --- r_associated #0: 20 --> en:oedema
    n1=en:rare disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3346. en:rare necrotic fibers --- r_associated #0: 20 --> en:oedema
    n1=en:rare necrotic fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3347. en:rare skin cancers --- r_associated #0: 20 --> en:oedema
    n1=en:rare skin cancers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3348. en:rash (erythematous macules or papules) --- r_associated #0: 20 --> en:oedema
    n1=en:rash (erythematous macules or papules) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3349. en:rash erythematous --- r_associated #0: 20 --> en:oedema
    n1=en:rash erythematous | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3350. en:rash may or may not be pruritic --- r_associated #0: 20 --> en:oedema
    n1=en:rash may or may not be pruritic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3351. en:rash scaly --- r_associated #0: 20 --> en:oedema
    n1=en:rash scaly | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3352. en:rash, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:rash, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3353. en:rash, urticarial, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:rash, urticarial, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3354. en:raynaud phenomenon --- r_associated #0: 20 --> en:oedema
    n1=en:raynaud phenomenon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3355. en:raynaud phenomenon (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:raynaud phenomenon (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3356. en:reason for assessment --- r_associated #0: 20 --> en:oedema
    n1=en:reason for assessment | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3357. en:reason for nonvaccination --- r_associated #0: 20 --> en:oedema
    n1=en:reason for nonvaccination | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3358. en:recovery between attacks --- r_associated #0: 20 --> en:oedema
    n1=en:recovery between attacks | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3359. en:rectus abdominis muscle separation --- r_associated #0: 20 --> en:oedema
    n1=en:rectus abdominis muscle separation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3360. en:rectus fascia separation --- r_associated #0: 20 --> en:oedema
    n1=en:rectus fascia separation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3361. en:rectus medial atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:rectus medial atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3362. en:recurrent bacterial skin infections --- r_associated #0: 20 --> en:oedema
    n1=en:recurrent bacterial skin infections | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3363. en:recurrent cellulitis --- r_associated #0: 20 --> en:oedema
    n1=en:recurrent cellulitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3364. en:recurrent inflammatory breast carcinoma --- r_associated #0: 20 --> en:oedema
    n1=en:recurrent inflammatory breast carcinoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3365. en:recurrent shingles --- r_associated #0: 20 --> en:oedema
    n1=en:recurrent shingles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3366. en:recurrent skin abscesses --- r_associated #0: 20 --> en:oedema
    n1=en:recurrent skin abscesses | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3367. en:recurrent skin abscesses (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:recurrent skin abscesses (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3368. en:recurrent skin infections --- r_associated #0: 20 --> en:oedema
    n1=en:recurrent skin infections | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3369. en:recurrent skin ulcerations (face, trunk, limbs) --- r_associated #0: 20 --> en:oedema
    n1=en:recurrent skin ulcerations (face, trunk, limbs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3370. en:red mucosa --- r_associated #0: 20 --> en:oedema
    n1=en:red mucosa | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3371. en:red, cracking, peeling skin at birth --- r_associated #0: 20 --> en:oedema
    n1=en:red, cracking, peeling skin at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3372. en:red, raised, scaly skin patches (elbows, knees, scalp) --- r_associated #0: 20 --> en:oedema
    n1=en:red, raised, scaly skin patches (elbows, knees, scalp) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3373. en:red-ragged fibers (2p21del) --- r_associated #0: 20 --> en:oedema
    n1=en:red-ragged fibers (2p21del) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3374. en:red-violet macular atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:red-violet macular atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3375. en:reddish discoloration, episodic, associated with pain --- r_associated #0: 20 --> en:oedema
    n1=en:reddish discoloration, episodic, associated with pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3376. en:reddish or purplish skin discoloration, episodic, associated with pain --- r_associated #0: 20 --> en:oedema
    n1=en:reddish or purplish skin discoloration, episodic, associated with pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3377. en:reduced activity of mitochondrial respiratory chains (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:reduced activity of mitochondrial respiratory chains (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3378. en:reduced ankle dorsiflexion --- r_associated #0: 20 --> en:oedema
    n1=en:reduced ankle dorsiflexion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3379. en:reduced axillary apocrine secretion --- r_associated #0: 20 --> en:oedema
    n1=en:reduced axillary apocrine secretion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3380. en:reduced lower limb subcutaneous fat --- r_associated #0: 20 --> en:oedema
    n1=en:reduced lower limb subcutaneous fat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3381. en:reduced muscle bulk --- r_associated #0: 20 --> en:oedema
    n1=en:reduced muscle bulk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3382. en:reduced muscle mass --- r_associated #0: 20 --> en:oedema
    n1=en:reduced muscle mass | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3383. en:reduced muscle tone but normal power --- r_associated #0: 20 --> en:oedema
    n1=en:reduced muscle tone but normal power | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3384. en:reduced o-mannosyl glycans on alpha-dystroglycan --- r_associated #0: 20 --> en:oedema
    n1=en:reduced o-mannosyl glycans on alpha-dystroglycan | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3385. en:reduced skin elasticity --- r_associated #0: 20 --> en:oedema
    n1=en:reduced skin elasticity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3386. en:reduced subcutaneous adipose tissue --- r_associated #0: 20 --> en:oedema
    n1=en:reduced subcutaneous adipose tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3387. en:reduced sweating of palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:reduced sweating of palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3388. en:redundancy of basal lamina with accumulated debris --- r_associated #0: 20 --> en:oedema
    n1=en:redundancy of basal lamina with accumulated debris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3389. en:redundant connective tissue --- r_associated #0: 20 --> en:oedema
    n1=en:redundant connective tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3390. en:redundant folds --- r_associated #0: 20 --> en:oedema
    n1=en:redundant folds | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3391. en:redundant palmar skin --- r_associated #0: 20 --> en:oedema
    n1=en:redundant palmar skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3392. en:redundant skin --- r_associated #0: 20 --> en:oedema
    n1=en:redundant skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3393. en:redundant skin in infancy --- r_associated #0: 20 --> en:oedema
    n1=en:redundant skin in infancy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3394. en:refusal to bear weight --- r_associated #0: 20 --> en:oedema
    n1=en:refusal to bear weight | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3395. en:regurgitation --- r_associated #0: 20 --> en:oedema
    n1=en:regurgitation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3396. en:rehabilitation aspects --- r_associated #0: 20 --> en:oedema
    n1=en:rehabilitation aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3397. en:reinke's edema --- r_associated #0: 20 --> en:oedema
    n1=en:reinke's edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3398. en:relative muscle weakness, especially in pelvic girdle --- r_associated #0: 20 --> en:oedema
    n1=en:relative muscle weakness, especially in pelvic girdle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3399. en:relative sparing of the rectus femoris --- r_associated #0: 20 --> en:oedema
    n1=en:relative sparing of the rectus femoris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3400. en:relative sparing of the tibialis anterior --- r_associated #0: 20 --> en:oedema
    n1=en:relative sparing of the tibialis anterior | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3401. en:relatively preserved limb strength --- r_associated #0: 20 --> en:oedema
    n1=en:relatively preserved limb strength | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3402. en:renal anasarca --- r_associated #0: 20 --> en:oedema
    n1=en:renal anasarca | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3403. en:renal colic --- r_associated #0: 20 --> en:oedema
    n1=en:renal colic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3404. en:replacement of affected muscle tissue with fatty tissue --- r_associated #0: 20 --> en:oedema
    n1=en:replacement of affected muscle tissue with fatty tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3405. en:replacement of myofibers with connective tissue --- r_associated #0: 20 --> en:oedema
    n1=en:replacement of myofibers with connective tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3406. en:reproductive observable --- r_associated #0: 20 --> en:oedema
    n1=en:reproductive observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3407. en:residual hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:residual hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3408. en:residual postinflammatory hyperpigmentation, moderate --- r_associated #0: 20 --> en:oedema
    n1=en:residual postinflammatory hyperpigmentation, moderate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3409. en:residual slightly atrophic scarring --- r_associated #0: 20 --> en:oedema
    n1=en:residual slightly atrophic scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3410. en:respiratory distress (congenital form) --- r_associated #0: 20 --> en:oedema
    n1=en:respiratory distress (congenital form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3411. en:respiratory muscles may be involved (more common in juvenile-onset) --- r_associated #0: 20 --> en:oedema
    n1=en:respiratory muscles may be involved (more common in juvenile-onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3412. en:respiratory observable --- r_associated #0: 20 --> en:oedema
    n1=en:respiratory observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3413. en:respiratory system disorder --- r_associated #0: 20 --> en:oedema
    n1=en:respiratory system disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3414. en:respiratory system signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:respiratory system signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3415. en:respiratory tract diseases --- r_associated #0: 20 --> en:oedema
    n1=en:respiratory tract diseases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3416. en:restlessness --- r_associated #0: 20 --> en:oedema
    n1=en:restlessness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3417. en:retain some mechanical adipose tissue (joints, orbits, palms, soles) --- r_associated #0: 20 --> en:oedema
    n1=en:retain some mechanical adipose tissue (joints, orbits, palms, soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3418. en:reticular hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:reticular hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3419. en:reticular hyperpigmentation (neck) --- r_associated #0: 20 --> en:oedema
    n1=en:reticular hyperpigmentation (neck) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3420. en:reticular pigmentation pattern --- r_associated #0: 20 --> en:oedema
    n1=en:reticular pigmentation pattern | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3421. en:reticular skin pigmentation (classic feature, nola3 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:reticular skin pigmentation (classic feature, nola3 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3422. en:reticulate hyperpigmentation (periocular, perioral, chest, neck, abdomen) --- r_associated #0: 20 --> en:oedema
    n1=en:reticulate hyperpigmentation (periocular, perioral, chest, neck, abdomen) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3423. en:reticulate hyperpigmentation (primarily trunk) --- r_associated #0: 20 --> en:oedema
    n1=en:reticulate hyperpigmentation (primarily trunk) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3424. en:reticulate hyperpigmentation composed of 1- to 5-mm light brown spots with clearly defined borders that may coalesce --- r_associated #0: 20 --> en:oedema
    n1=en:reticulate hyperpigmentation composed of 1- to 5-mm light brown spots with clearly defined borders that may coalesce | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3425. en:reticulate hyperpigmented macules which darken over time and appear initially on dorsa of hands and feet but progress to flexor aspects of proximal extremities --- r_associated #0: 20 --> en:oedema
    n1=en:reticulate hyperpigmented macules which darken over time and appear initially on dorsa of hands and feet but progress to flexor aspects of proximal extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3426. en:reticulate ichthyosis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:reticulate ichthyosis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3427. en:reticulate pigmented skin abnormalities --- r_associated #0: 20 --> en:oedema
    n1=en:reticulate pigmented skin abnormalities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3428. en:reticulate skin pigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:reticulate skin pigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3429. en:reticulated pigmentation (seen in recessive form) --- r_associated #0: 20 --> en:oedema
    n1=en:reticulated pigmentation (seen in recessive form) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3430. en:reticulated skin pigmentation, predominantly on face, neck, chest, arms (94% male patients) --- r_associated #0: 20 --> en:oedema
    n1=en:reticulated skin pigmentation, predominantly on face, neck, chest, arms (94% male patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3431. en:reticulocytosis --- r_associated #0: 20 --> en:oedema
    n1=en:reticulocytosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3432. en:reticulolinear skin defects over face and neck (4/4 patients) --- r_associated #0: 20 --> en:oedema
    n1=en:reticulolinear skin defects over face and neck (4/4 patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3433. en:retinal edema due to type 1 diabetes mellitus --- r_associated #0: 20 --> en:oedema
    n1=en:retinal edema due to type 1 diabetes mellitus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3434. en:retinal edema due to type 2 diabetes mellitus --- r_associated #0: 20 --> en:oedema
    n1=en:retinal edema due to type 2 diabetes mellitus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3435. en:retinal edemas --- r_associated #0: 20 --> en:oedema
    n1=en:retinal edemas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3436. en:retroperitoneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:retroperitoneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3437. en:retroperitoneal fibrosis (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:retroperitoneal fibrosis (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3438. en:reversal of disease phenotype --- r_associated #0: 20 --> en:oedema
    n1=en:reversal of disease phenotype | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3439. en:rh incompatibility --- r_associated #0: 20 --> en:oedema
    n1=en:rh incompatibility | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3440. en:rhabdomyolysis --- r_associated #0: 20 --> en:oedema
    n1=en:rhabdomyolysis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3441. en:rhabdomyolysis (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:rhabdomyolysis (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3442. en:rhabdomyolysis (in some patients) endocrine : hypogonadotropic hypogonadism (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:rhabdomyolysis (in some patients) endocrine : hypogonadotropic hypogonadism (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3443. en:rhabdomyolysis may occur --- r_associated #0: 20 --> en:oedema
    n1=en:rhabdomyolysis may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3444. en:rhabdomyolysis with exercise (in older patients) --- r_associated #0: 20 --> en:oedema
    n1=en:rhabdomyolysis with exercise (in older patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3445. en:rhabdomyolysis, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:rhabdomyolysis, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3446. en:rhabdomyolysis, episodic and recurrent --- r_associated #0: 20 --> en:oedema
    n1=en:rhabdomyolysis, episodic and recurrent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3447. en:rhytide of forehead --- r_associated #0: 20 --> en:oedema
    n1=en:rhytide of forehead | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3448. en:rigidity (uncommon) --- r_associated #0: 20 --> en:oedema
    n1=en:rigidity (uncommon) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3449. en:rimmed vacuoles --- r_associated #0: 20 --> en:oedema
    n1=en:rimmed vacuoles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3450. en:rimmed vacuoles on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:rimmed vacuoles on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3451. en:rimmed vacuoles with basophilic granular material --- r_associated #0: 20 --> en:oedema
    n1=en:rimmed vacuoles with basophilic granular material | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3452. en:ring fibers --- r_associated #0: 20 --> en:oedema
    n1=en:ring fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3453. en:risk factor --- r_associated #0: 20 --> en:oedema
    n1=en:risk factor | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3454. en:roentgenographic --- r_associated #0: 20 --> en:oedema
    n1=en:roentgenographic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3455. en:rough, thick palmar skin --- r_associated #0: 20 --> en:oedema
    n1=en:rough, thick palmar skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3456. en:rubbery feel of the nose and chin --- r_associated #0: 20 --> en:oedema
    n1=en:rubbery feel of the nose and chin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3457. en:rupture of muscle --- r_associated #0: 20 --> en:oedema
    n1=en:rupture of muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3458. en:s. epidermidis only microorganism isolated --- r_associated #0: 20 --> en:oedema
    n1=en:s. epidermidis only microorganism isolated | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3459. en:sacral dimple --- r_associated #0: 20 --> en:oedema
    n1=en:sacral dimple | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3460. en:sacral dimple (2 patients) --- r_associated #0: 20 --> en:oedema
    n1=en:sacral dimple (2 patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3461. en:sacral dimple (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:sacral dimple (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3462. en:sacral edema --- r_associated #0: 20 --> en:oedema
    n1=en:sacral edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3463. en:sacral striae --- r_associated #0: 20 --> en:oedema
    n1=en:sacral striae | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3464. en:sarcomere disappearance seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:sarcomere disappearance seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3465. en:sarcoplasmic accumulation of electron-dense granulofilamentous material --- r_associated #0: 20 --> en:oedema
    n1=en:sarcoplasmic accumulation of electron-dense granulofilamentous material | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3466. en:sarcoplasmic inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:sarcoplasmic inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3467. en:scabies and other acariases --- r_associated #0: 20 --> en:oedema
    n1=en:scabies and other acariases | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3468. en:scalding burn --- r_associated #0: 20 --> en:oedema
    n1=en:scalding burn | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3469. en:scales on scalp (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:scales on scalp (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3470. en:scalp --- r_associated #0: 20 --> en:oedema
    n1=en:scalp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3471. en:scalp defect --- r_associated #0: 20 --> en:oedema
    n1=en:scalp defect | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3472. en:scalp dryness --- r_associated #0: 20 --> en:oedema
    n1=en:scalp dryness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3473. en:scalp erosions --- r_associated #0: 20 --> en:oedema
    n1=en:scalp erosions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3474. en:scalp sinus formation --- r_associated #0: 20 --> en:oedema
    n1=en:scalp sinus formation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3475. en:scaly skin --- r_associated #0: 20 --> en:oedema
    n1=en:scaly skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3476. en:scaly skin rash over the perineum --- r_associated #0: 20 --> en:oedema
    n1=en:scaly skin rash over the perineum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3477. en:scapular muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:scapular muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3478. en:scapular muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:scapular muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3479. en:scapuloperoneal amyotrophy --- r_associated #0: 20 --> en:oedema
    n1=en:scapuloperoneal amyotrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3480. en:scapuloperoneal muscular atrophy due to denervation --- r_associated #0: 20 --> en:oedema
    n1=en:scapuloperoneal muscular atrophy due to denervation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3481. en:scapuloperoneal weakness --- r_associated #0: 20 --> en:oedema
    n1=en:scapuloperoneal weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3482. en:scarring (late complication) --- r_associated #0: 20 --> en:oedema
    n1=en:scarring (late complication) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3483. en:schwannoma --- r_associated #0: 20 --> en:oedema
    n1=en:schwannoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3484. en:sciatica --- r_associated #0: 20 --> en:oedema
    n1=en:sciatica | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3485. en:scleredema adultorum --- r_associated #0: 20 --> en:oedema
    n1=en:scleredema adultorum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3486. en:sclerodactyly --- r_associated #0: 20 --> en:oedema
    n1=en:sclerodactyly | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3487. en:scleroderma --- r_associated #0: 20 --> en:oedema
    n1=en:scleroderma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3488. en:scleroderma assessment questionnaire score --- r_associated #0: 20 --> en:oedema
    n1=en:scleroderma assessment questionnaire score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3489. en:scleroderma-like change --- r_associated #0: 20 --> en:oedema
    n1=en:scleroderma-like change | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3490. en:scleroderma-like secondary cutaneous sclerosis --- r_associated #0: 20 --> en:oedema
    n1=en:scleroderma-like secondary cutaneous sclerosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3491. en:scleroderma-like skin, especially of face and distal extremities --- r_associated #0: 20 --> en:oedema
    n1=en:scleroderma-like skin, especially of face and distal extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3492. en:sclerodermatous skin changes --- r_associated #0: 20 --> en:oedema
    n1=en:sclerodermatous skin changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3493. en:sclerosis --- r_associated #0: 20 --> en:oedema
    n1=en:sclerosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3494. en:sclerosis of digits (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:sclerosis of digits (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3495. en:sclerotic soft tissue over affected bones --- r_associated #0: 20 --> en:oedema
    n1=en:sclerotic soft tissue over affected bones | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3496. en:scrotum --- r_associated #0: 20 --> en:oedema
    n1=en:scrotum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3497. en:seatbelt sign --- r_associated #0: 20 --> en:oedema
    n1=en:seatbelt sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3498. en:sebaceous cyst --- r_associated #0: 20 --> en:oedema
    n1=en:sebaceous cyst | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3499. en:sebaceous cysts (buttocks and perineum) --- r_associated #0: 20 --> en:oedema
    n1=en:sebaceous cysts (buttocks and perineum) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3500. en:sebaceous gland --- r_associated #0: 20 --> en:oedema
    n1=en:sebaceous gland | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3501. en:sebaceous gland tumors --- r_associated #0: 20 --> en:oedema
    n1=en:sebaceous gland tumors | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3502. en:sebaceous hyperplasia --- r_associated #0: 20 --> en:oedema
    n1=en:sebaceous hyperplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3503. en:seborrhea (35% of adults) --- r_associated #0: 20 --> en:oedema
    n1=en:seborrhea (35% of adults) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3504. en:seborrheic dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:seborrheic dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3505. en:seborrheic dermatitis (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:seborrheic dermatitis (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3506. en:seborrheic dermatitis in infancy --- r_associated #0: 20 --> en:oedema
    n1=en:seborrheic dermatitis in infancy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3507. en:seborrheic dermatitis of scalp --- r_associated #0: 20 --> en:oedema
    n1=en:seborrheic dermatitis of scalp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3508. en:seborrheic keratosis-like papules --- r_associated #0: 20 --> en:oedema
    n1=en:seborrheic keratosis-like papules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3509. en:secondary corneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:secondary corneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3510. en:secondary decrease of calpain-3 (capn3, 114240) protein expression in muscle --- r_associated #0: 20 --> en:oedema
    n1=en:secondary decrease of calpain-3 (capn3, 114240) protein expression in muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3511. en:secondary endolymphatic hydrops --- r_associated #0: 20 --> en:oedema
    n1=en:secondary endolymphatic hydrops | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3512. en:secondary hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:secondary hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3513. en:secondary loss of merosin and desmin --- r_associated #0: 20 --> en:oedema
    n1=en:secondary loss of merosin and desmin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3514. en:secondary loss of sarcolemmal caveolin-3 --- r_associated #0: 20 --> en:oedema
    n1=en:secondary loss of sarcolemmal caveolin-3 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3515. en:secondary lymphedema --- r_associated #0: 20 --> en:oedema
    n1=en:secondary lymphedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3516. en:secondary myopathic changes --- r_associated #0: 20 --> en:oedema
    n1=en:secondary myopathic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3517. en:secondary myopathic features --- r_associated #0: 20 --> en:oedema
    n1=en:secondary myopathic features | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3518. en:secondary raynaud phenomenon --- r_associated #0: 20 --> en:oedema
    n1=en:secondary raynaud phenomenon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3519. en:seizure --- r_associated #0: 20 --> en:oedema
    n1=en:seizure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3520. en:self-healing collodion baby (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:self-healing collodion baby (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3521. en:self-injury --- r_associated #0: 20 --> en:oedema
    n1=en:self-injury | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3522. en:sensation of swelling --- r_associated #0: 20 --> en:oedema
    n1=en:sensation of swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3523. en:sensitivity to cold with paresthesias --- r_associated #0: 20 --> en:oedema
    n1=en:sensitivity to cold with paresthesias | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3524. en:seroma --- r_associated #0: 20 --> en:oedema
    n1=en:seroma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3525. en:severe acne (23% of adults) --- r_associated #0: 20 --> en:oedema
    n1=en:severe acne (23% of adults) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3526. en:severe atopic dermatitis --- r_associated #0: 20 --> en:oedema
    n1=en:severe atopic dermatitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3527. en:severe bullous blistering lesions --- r_associated #0: 20 --> en:oedema
    n1=en:severe bullous blistering lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3528. en:severe cystic acne --- r_associated #0: 20 --> en:oedema
    n1=en:severe cystic acne | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3529. en:severe disability within 20 years of onset --- r_associated #0: 20 --> en:oedema
    n1=en:severe disability within 20 years of onset | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3530. en:severe facial acne (in female patient) --- r_associated #0: 20 --> en:oedema
    n1=en:severe facial acne (in female patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3531. en:severe form shows absence of spontaneous activity at birth --- r_associated #0: 20 --> en:oedema
    n1=en:severe form shows absence of spontaneous activity at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3532. en:severe hydrops fetalis --- r_associated #0: 20 --> en:oedema
    n1=en:severe hydrops fetalis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3533. en:severe muscle hypotonia at birth --- r_associated #0: 20 --> en:oedema
    n1=en:severe muscle hypotonia at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3534. en:severe muscle wasting and atrophy, primarily in the legs --- r_associated #0: 20 --> en:oedema
    n1=en:severe muscle wasting and atrophy, primarily in the legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3535. en:severe muscular hypotonia --- r_associated #0: 20 --> en:oedema
    n1=en:severe muscular hypotonia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3536. en:severe nonproliferative diabetic retinopathy with clinically significant macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:severe nonproliferative diabetic retinopathy with clinically significant macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3537. en:severe photosensitivity --- r_associated #0: 20 --> en:oedema
    n1=en:severe photosensitivity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3538. en:severe polyhydramnios --- r_associated #0: 20 --> en:oedema
    n1=en:severe polyhydramnios | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3539. en:severe progressive ulceration of lower extremities --- r_associated #0: 20 --> en:oedema
    n1=en:severe progressive ulceration of lower extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3540. en:severely decreased or absent lamp2 protein --- r_associated #0: 20 --> en:oedema
    n1=en:severely decreased or absent lamp2 protein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3541. en:shagreen patch --- r_associated #0: 20 --> en:oedema
    n1=en:shagreen patch | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3542. en:shallow indolent cutaneous ulcers (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:shallow indolent cutaneous ulcers (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3543. en:sharp midline demarcation --- r_associated #0: 20 --> en:oedema
    n1=en:sharp midline demarcation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3544. en:shiny, taut, erythematous skin --- r_associated #0: 20 --> en:oedema
    n1=en:shiny, taut, erythematous skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3545. en:shivering --- r_associated #0: 20 --> en:oedema
    n1=en:shivering | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3546. en:shock --- r_associated #0: 20 --> en:oedema
    n1=en:shock | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3547. en:short and thickened z-discs --- r_associated #0: 20 --> en:oedema
    n1=en:short and thickened z-discs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3548. en:short rib-polydactyly syndrome, beemer type --- r_associated #0: 20 --> en:oedema
    n1=en:short rib-polydactyly syndrome, beemer type | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3549. en:shortening of flexor profundus muscle-tendon unit --- r_associated #0: 20 --> en:oedema
    n1=en:shortening of flexor profundus muscle-tendon unit | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3550. en:shortening of the fascial structures of the palm and fingers --- r_associated #0: 20 --> en:oedema
    n1=en:shortening of the fascial structures of the palm and fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3551. en:shortening of various muscle-tendon groups in feet --- r_associated #0: 20 --> en:oedema
    n1=en:shortening of various muscle-tendon groups in feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3552. en:shortening of various muscle-tendon groups in legs --- r_associated #0: 20 --> en:oedema
    n1=en:shortening of various muscle-tendon groups in legs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3553. en:shoulder girdle muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:shoulder girdle muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3554. en:shoulder girdle muscle weakness and atrophy, progressive --- r_associated #0: 20 --> en:oedema
    n1=en:shoulder girdle muscle weakness and atrophy, progressive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3555. en:shoulder girdle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:shoulder girdle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3556. en:shoulder muscle hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:shoulder muscle hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3557. en:shoulder muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:shoulder muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3558. en:shoulder weakness --- r_associated #0: 20 --> en:oedema
    n1=en:shoulder weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3559. en:shoulder weakness and atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:shoulder weakness and atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3560. en:shoulder-pad sign --- r_associated #0: 20 --> en:oedema
    n1=en:shoulder-pad sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3561. en:shrug sign --- r_associated #0: 20 --> en:oedema
    n1=en:shrug sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3562. en:sickle cell disease --- r_associated #0: 20 --> en:oedema
    n1=en:sickle cell disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3563. en:sickness --- r_associated #0: 20 --> en:oedema
    n1=en:sickness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3564. en:sign --- r_associated #0: 20 --> en:oedema
    n1=en:sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3565. en:sign or symptom --- r_associated #0: 20 --> en:oedema
    n1=en:sign or symptom | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3566. en:signs and symptoms, respiratory --- r_associated #0: 20 --> en:oedema
    n1=en:signs and symptoms, respiratory | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3567. en:signs of denervation seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:signs of denervation seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3568. en:silo filler's disease --- r_associated #0: 20 --> en:oedema
    n1=en:silo filler's disease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3569. en:simian crease (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:simian crease (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3570. en:single palmar crease --- r_associated #0: 20 --> en:oedema
    n1=en:single palmar crease | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3571. en:single transverse palmar crease (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:single transverse palmar crease (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3572. en:single, bilateral, symmetric papular/nodular lesion in the midline plantar region of the heel (0.5 - 1 cm diameter) --- r_associated #0: 20 --> en:oedema
    n1=en:single, bilateral, symmetric papular/nodular lesion in the midline plantar region of the heel (0.5 - 1 cm diameter) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3573. en:size variation (1 x 1 to 6 x 4 cm) --- r_associated #0: 20 --> en:oedema
    n1=en:size variation (1 x 1 to 6 x 4 cm) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3574. en:skeletal muscle biopsy showed mitochondrial complex i deficiency (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy showed mitochondrial complex i deficiency (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3575. en:skeletal muscle biopsy shows decreased cytochrome c oxidase activity --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows decreased cytochrome c oxidase activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3576. en:skeletal muscle biopsy shows dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3577. en:skeletal muscle biopsy shows enlarged mitochondria with abnormal cristae decreased mitochondrial complex i activity --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows enlarged mitochondria with abnormal cristae decreased mitochondrial complex i activity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3578. en:skeletal muscle biopsy shows fat droplets in sarcoplasm and mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows fat droplets in sarcoplasm and mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3579. en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3580. en:skeletal muscle biopsy shows impaired respiratory oxidation --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows impaired respiratory oxidation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3581. en:skeletal muscle biopsy shows minor variation in fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows minor variation in fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3582. en:skeletal muscle biopsy shows misplaced mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows misplaced mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3583. en:skeletal muscle biopsy shows reducing bodies --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle biopsy shows reducing bodies | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3584. en:skeletal muscle damage --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle damage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3585. en:skeletal muscle may show less severe mtdna deletion --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle may show less severe mtdna deletion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3586. en:skeletal muscle shows decreased sarcoglycan proteins --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle shows decreased sarcoglycan proteins | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3587. en:skeletal muscle shows dystrophic changes --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle shows dystrophic changes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3588. en:skeletal muscle tissue shows 14 to 45% depletion of mitochondrial dna (mtdna) --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle tissue shows 14 to 45% depletion of mitochondrial dna (mtdna) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3589. en:skeletal muscle tissue shows depletion of mitochondrial dna (mtdna) --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle tissue shows depletion of mitochondrial dna (mtdna) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3590. en:skeletal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3591. en:skeletal myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:skeletal myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3592. en:skin --- r_associated #0: 20 --> en:oedema
    n1=en:skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3593. en:skin absorption --- r_associated #0: 20 --> en:oedema
    n1=en:skin absorption | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3594. en:skin appendage structure --- r_associated #0: 20 --> en:oedema
    n1=en:skin appendage structure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3595. en:skin appendages (periorbital, face, thorax, rarely on trunk) --- r_associated #0: 20 --> en:oedema
    n1=en:skin appendages (periorbital, face, thorax, rarely on trunk) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3596. en:skin atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:skin atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3597. en:skin atrophy (especially over hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:skin atrophy (especially over hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3598. en:skin atrophy (over nose and scalp sutural areas) --- r_associated #0: 20 --> en:oedema
    n1=en:skin atrophy (over nose and scalp sutural areas) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3599. en:skin atrophy over affected bones --- r_associated #0: 20 --> en:oedema
    n1=en:skin atrophy over affected bones | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3600. en:skin basal cell carcinoma --- r_associated #0: 20 --> en:oedema
    n1=en:skin basal cell carcinoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3601. en:skin biopsy shows noncaseating granulomas --- r_associated #0: 20 --> en:oedema
    n1=en:skin biopsy shows noncaseating granulomas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3602. en:skin blistering, intermittent --- r_associated #0: 20 --> en:oedema
    n1=en:skin blistering, intermittent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3603. en:skin blisters --- r_associated #0: 20 --> en:oedema
    n1=en:skin blisters | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3604. en:skin blisters and erosions (neck, perianal, submaxillary, groin, axilla, popliteal fossa) --- r_associated #0: 20 --> en:oedema
    n1=en:skin blisters and erosions (neck, perianal, submaxillary, groin, axilla, popliteal fossa) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3605. en:skin cell --- r_associated #0: 20 --> en:oedema
    n1=en:skin cell | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3606. en:skin changes worse in areas of lower skin temperature --- r_associated #0: 20 --> en:oedema
    n1=en:skin changes worse in areas of lower skin temperature | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3607. en:skin cyst --- r_associated #0: 20 --> en:oedema
    n1=en:skin cyst | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3608. en:skin derivative --- r_associated #0: 20 --> en:oedema
    n1=en:skin derivative | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3609. en:skin dimple (lower back) --- r_associated #0: 20 --> en:oedema
    n1=en:skin dimple (lower back) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3610. en:skin dimple over apex of long bone angulation --- r_associated #0: 20 --> en:oedema
    n1=en:skin dimple over apex of long bone angulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3611. en:skin dimples on upper thighs (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:skin dimples on upper thighs (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3612. en:skin erosion --- r_associated #0: 20 --> en:oedema
    n1=en:skin erosion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3613. en:skin fissure --- r_associated #0: 20 --> en:oedema
    n1=en:skin fissure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3614. en:skin fissures (groin, axilla, neck) --- r_associated #0: 20 --> en:oedema
    n1=en:skin fissures (groin, axilla, neck) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3615. en:skin flushing, episodic, associated with pain --- r_associated #0: 20 --> en:oedema
    n1=en:skin flushing, episodic, associated with pain | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3616. en:skin folds or creases (neck or forearm) --- r_associated #0: 20 --> en:oedema
    n1=en:skin folds or creases (neck or forearm) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3617. en:skin foreign body --- r_associated #0: 20 --> en:oedema
    n1=en:skin foreign body | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3618. en:skin fragility with non-scarring blistering --- r_associated #0: 20 --> en:oedema
    n1=en:skin fragility with non-scarring blistering | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3619. en:skin hyperlaxity (males) --- r_associated #0: 20 --> en:oedema
    n1=en:skin hyperlaxity (males) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3620. en:skin hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:skin hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3621. en:skin hypopigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:skin hypopigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3622. en:skin infection --- r_associated #0: 20 --> en:oedema
    n1=en:skin infection | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3623. en:skin lacks elastic recoil --- r_associated #0: 20 --> en:oedema
    n1=en:skin lacks elastic recoil | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3624. en:skin lesions are usually symmetrical --- r_associated #0: 20 --> en:oedema
    n1=en:skin lesions are usually symmetrical | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3625. en:skin lesions follow the lines of blaschko --- r_associated #0: 20 --> en:oedema
    n1=en:skin lesions follow the lines of blaschko | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3626. en:skin manifestations --- r_associated #0: 20 --> en:oedema
    n1=en:skin manifestations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3627. en:skin may redden during episodes --- r_associated #0: 20 --> en:oedema
    n1=en:skin may redden during episodes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3628. en:skin mottling due to poor perfusion --- r_associated #0: 20 --> en:oedema
    n1=en:skin mottling due to poor perfusion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3629. en:skin necrosis --- r_associated #0: 20 --> en:oedema
    n1=en:skin necrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3630. en:skin nodules - fingers, elbows, nose, ears (onset infancy-childhood) --- r_associated #0: 20 --> en:oedema
    n1=en:skin nodules - fingers, elbows, nose, ears (onset infancy-childhood) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3631. en:skin observable --- r_associated #0: 20 --> en:oedema
    n1=en:skin observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3632. en:skin of female human body --- r_associated #0: 20 --> en:oedema
    n1=en:skin of female human body | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3633. en:skin of left lower limb --- r_associated #0: 20 --> en:oedema
    n1=en:skin of left lower limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3634. en:skin of left upper limb --- r_associated #0: 20 --> en:oedema
    n1=en:skin of left upper limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3635. en:skin of male human body --- r_associated #0: 20 --> en:oedema
    n1=en:skin of male human body | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3636. en:skin of right lower limb --- r_associated #0: 20 --> en:oedema
    n1=en:skin of right lower limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3637. en:skin of right upper limb --- r_associated #0: 20 --> en:oedema
    n1=en:skin of right upper limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3638. en:skin of the axilla --- r_associated #0: 20 --> en:oedema
    n1=en:skin of the axilla | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3639. en:skin of the extremity --- r_associated #0: 20 --> en:oedema
    n1=en:skin of the extremity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3640. en:skin of the face --- r_associated #0: 20 --> en:oedema
    n1=en:skin of the face | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3641. en:skin of the lip --- r_associated #0: 20 --> en:oedema
    n1=en:skin of the lip | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3642. en:skin of the lower limb and hip --- r_associated #0: 20 --> en:oedema
    n1=en:skin of the lower limb and hip | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3643. en:skin of the scalp and neck --- r_associated #0: 20 --> en:oedema
    n1=en:skin of the scalp and neck | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3644. en:skin of the trunk --- r_associated #0: 20 --> en:oedema
    n1=en:skin of the trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3645. en:skin of the upper limb and shoulder --- r_associated #0: 20 --> en:oedema
    n1=en:skin of the upper limb and shoulder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3646. en:skin over joint surfaces of hands and feet is thick, red, and edematous --- r_associated #0: 20 --> en:oedema
    n1=en:skin over joint surfaces of hands and feet is thick, red, and edematous | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3647. en:skin part --- r_associated #0: 20 --> en:oedema
    n1=en:skin part | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3648. en:skin peeling/scaling (newborn) --- r_associated #0: 20 --> en:oedema
    n1=en:skin peeling/scaling (newborn) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3649. en:skin photosensitivity --- r_associated #0: 20 --> en:oedema
    n1=en:skin photosensitivity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3650. en:skin pigmentation - finding --- r_associated #0: 20 --> en:oedema
    n1=en:skin pigmentation - finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3651. en:skin rash --- r_associated #0: 20 --> en:oedema
    n1=en:skin rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3652. en:skin rough --- r_associated #0: 20 --> en:oedema
    n1=en:skin rough | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3653. en:skin sign from acute arsenic toxicity --- r_associated #0: 20 --> en:oedema
    n1=en:skin sign from acute arsenic toxicity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3654. en:skin structure of back --- r_associated #0: 20 --> en:oedema
    n1=en:skin structure of back | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3655. en:skin tag --- r_associated #0: 20 --> en:oedema
    n1=en:skin tag | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3656. en:skin tags on chest --- r_associated #0: 20 --> en:oedema
    n1=en:skin tags on chest | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3657. en:skin tags on genitalia (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:skin tags on genitalia (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3658. en:skin tags on palms (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:skin tags on palms (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3659. en:skin tags on the upper part of the auricle --- r_associated #0: 20 --> en:oedema
    n1=en:skin tags on the upper part of the auricle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3660. en:skin ulcer --- r_associated #0: 20 --> en:oedema
    n1=en:skin ulcer | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3661. en:skin vesicle --- r_associated #0: 20 --> en:oedema
    n1=en:skin vesicle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3662. en:skin vessels with inversion of the usual osmiophilic pattern on electron microscopy --- r_associated #0: 20 --> en:oedema
    n1=en:skin vessels with inversion of the usual osmiophilic pattern on electron microscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3663. en:skin wrinkling (limited to dorsum of hands and feet and abdomen) --- r_associated #0: 20 --> en:oedema
    n1=en:skin wrinkling (limited to dorsum of hands and feet and abdomen) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3664. en:sleep disorder --- r_associated #0: 20 --> en:oedema
    n1=en:sleep disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3665. en:sleepiness --- r_associated #0: 20 --> en:oedema
    n1=en:sleepiness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3666. en:slight erythema of face --- r_associated #0: 20 --> en:oedema
    n1=en:slight erythema of face | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3667. en:slim, muscular build (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:slim, muscular build (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3668. en:slow motor responses to sudden events (i.e., falling) --- r_associated #0: 20 --> en:oedema
    n1=en:slow motor responses to sudden events (i.e., falling) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3669. en:slow-healing wounds due to painless injuries --- r_associated #0: 20 --> en:oedema
    n1=en:slow-healing wounds due to painless injuries | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3670. en:slowly progressive limb-girdle myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:slowly progressive limb-girdle myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3671. en:slowly-progressive muscle wasting and weakness with humeroperoneal and scapuloperoneal distribution --- r_associated #0: 20 --> en:oedema
    n1=en:slowly-progressive muscle wasting and weakness with humeroperoneal and scapuloperoneal distribution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3672. en:small and incompletely fused muscle fibers seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:small and incompletely fused muscle fibers seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3673. en:small areas of alopecia --- r_associated #0: 20 --> en:oedema
    n1=en:small areas of alopecia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3674. en:small conically shaped papules (1 to 3 mm in diameter) located on face, neck, trunk, and limbs --- r_associated #0: 20 --> en:oedema
    n1=en:small conically shaped papules (1 to 3 mm in diameter) located on face, neck, trunk, and limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3675. en:small endplate --- r_associated #0: 20 --> en:oedema
    n1=en:small endplate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3676. en:small hemorrhagic blisters on hands --- r_associated #0: 20 --> en:oedema
    n1=en:small hemorrhagic blisters on hands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3677. en:small nodular skin-tags --- r_associated #0: 20 --> en:oedema
    n1=en:small nodular skin-tags | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3678. en:small or absent axon terminals --- r_associated #0: 20 --> en:oedema
    n1=en:small or absent axon terminals | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3679. en:small papules on sun-exposed areas --- r_associated #0: 20 --> en:oedema
    n1=en:small papules on sun-exposed areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3680. en:small pterygia (axillary, popliteal) --- r_associated #0: 20 --> en:oedema
    n1=en:small pterygia (axillary, popliteal) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3681. en:small rounded fibers --- r_associated #0: 20 --> en:oedema
    n1=en:small rounded fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3682. en:small, angulated muscle fibers seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:small, angulated muscle fibers seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3683. en:small, annular, anhidrotic keratotic lesions located predominantly on sun-exposed areas --- r_associated #0: 20 --> en:oedema
    n1=en:small, annular, anhidrotic keratotic lesions located predominantly on sun-exposed areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3684. en:small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk --- r_associated #0: 20 --> en:oedema
    n1=en:small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3685. en:small, red lesion, may increase in size with age --- r_associated #0: 20 --> en:oedema
    n1=en:small, red lesion, may increase in size with age | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3686. en:small, yellow papules (mouth, neck, axilla, elbows, groin, periumbilical region) --- r_associated #0: 20 --> en:oedema
    n1=en:small, yellow papules (mouth, neck, axilla, elbows, groin, periumbilical region) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3687. en:smooth muscle may also become involved --- r_associated #0: 20 --> en:oedema
    n1=en:smooth muscle may also become involved | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3688. en:smooth, thin, dry skin --- r_associated #0: 20 --> en:oedema
    n1=en:smooth, thin, dry skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3689. en:smooth, waxy, thick skin over palms and soles, desquamating in large flakes --- r_associated #0: 20 --> en:oedema
    n1=en:smooth, waxy, thick skin over palms and soles, desquamating in large flakes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3690. en:sodium acetate --- r_associated #0: 20 --> en:oedema
    n1=en:sodium acetate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3691. en:sodium acetate 2 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium acetate 2 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3692. en:sodium acetate 4 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium acetate 4 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3693. en:sodium acetate 5 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium acetate 5 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3694. en:sodium acetate anhydrous --- r_associated #0: 20 --> en:oedema
    n1=en:sodium acetate anhydrous | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3695. en:sodium bicarbonate --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3696. en:sodium bicarbonate 0.476 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate 0.476 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3697. en:sodium bicarbonate 0.893 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate 0.893 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3698. en:sodium bicarbonate 1.26% infusion solution bag --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate 1.26% infusion solution bag | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3699. en:sodium bicarbonate 325 mg oral tablet --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate 325 mg oral tablet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3700. en:sodium bicarbonate 4.2% infusion solution bag --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate 4.2% infusion solution bag | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3701. en:sodium bicarbonate 42 mg/ml inhalant solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate 42 mg/ml inhalant solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3702. en:sodium bicarbonate 5% injection solution ampule --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate 5% injection solution ampule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3703. en:sodium bicarbonate 650 mg oral tablet --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate 650 mg oral tablet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3704. en:sodium bicarbonate powder --- r_associated #0: 20 --> en:oedema
    n1=en:sodium bicarbonate powder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3705. en:sodium chloride --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3706. en:sodium chloride 0.000154 meq/mg topical gel --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.000154 meq/mg topical gel | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3707. en:sodium chloride 0.00342 meq/mg topical gel --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.00342 meq/mg topical gel | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3708. en:sodium chloride 0.0256 meq/ml irrigation solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.0256 meq/ml irrigation solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3709. en:sodium chloride 0.0684 meq/ml nasal solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.0684 meq/ml nasal solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3710. en:sodium chloride 0.0684 meq/ml nasal spray --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.0684 meq/ml nasal spray | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3711. en:sodium chloride 0.0769 meq/ml inhalant solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.0769 meq/ml inhalant solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3712. en:sodium chloride 0.0769 meq/ml irrigation solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.0769 meq/ml irrigation solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3713. en:sodium chloride 0.0855 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.0855 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3714. en:sodium chloride 0.111 meq/ml nasal solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.111 meq/ml nasal solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3715. en:sodium chloride 0.111 meq/ml nasal spray --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.111 meq/ml nasal spray | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3716. en:sodium chloride 0.154 meq/ml inhalant solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.154 meq/ml inhalant solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3717. en:sodium chloride 0.154 meq/ml inhalant solution [broncho saline] --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.154 meq/ml inhalant solution [broncho saline] | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3718. en:sodium chloride 0.154 meq/ml inhalant solution [nebu-sol] --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.154 meq/ml inhalant solution [nebu-sol] | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3719. en:sodium chloride 0.154 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.154 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3720. en:sodium chloride 0.154 meq/ml nasal spray --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.154 meq/ml nasal spray | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3721. en:sodium chloride 0.2% soln --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.2% soln | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3722. en:sodium chloride 0.274 meq/ml irrigation solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.274 meq/ml irrigation solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3723. en:sodium chloride 0.342 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.342 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3724. en:sodium chloride 0.45g/100 ml injection solution 1000ml bag --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.45g/100 ml injection solution 1000ml bag | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3725. en:sodium chloride 0.513 meq/ml inhalant solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.513 meq/ml inhalant solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3726. en:sodium chloride 0.513 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.513 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3727. en:sodium chloride 0.598 meq/ml inhalant solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.598 meq/ml inhalant solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3728. en:sodium chloride 0.65% gel,nasal --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.65% gel,nasal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3729. en:sodium chloride 0.854 meq/ml ophthalmic solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.854 meq/ml ophthalmic solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3730. en:sodium chloride 0.9% eye drops --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.9% eye drops | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3731. en:sodium chloride 0.9% irrigation fluid 100ml sachet --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.9% irrigation fluid 100ml sachet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3732. en:sodium chloride 0.9% nose drops --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.9% nose drops | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3733. en:sodium chloride 0.9% processing soln --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.9% processing soln | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3734. en:sodium chloride 0.9%/methylparaben/propylparaben inj,tubex,2.5ml --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 0.9%/methylparaben/propylparaben inj,tubex,2.5ml | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3735. en:sodium chloride 1.2 meq/ml inhalant solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 1.2 meq/ml inhalant solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3736. en:sodium chloride 1.71 meq/ml inhalant solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 1.71 meq/ml inhalant solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3737. en:sodium chloride 1000 mg delayed release oral tablet --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 1000 mg delayed release oral tablet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3738. en:sodium chloride 1000 mg oral tablet --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 1000 mg oral tablet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3739. en:sodium chloride 1080 mg oral tablet --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 1080 mg oral tablet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3740. en:sodium chloride 1gm (topical) tab,soluble --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 1gm (topical) tab,soluble | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3741. en:sodium chloride 2 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 2 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3742. en:sodium chloride 2 meq/ml irrigation solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 2 meq/ml irrigation solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3743. en:sodium chloride 2% ophthalmic solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 2% ophthalmic solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3744. en:sodium chloride 2.5 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 2.5 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3745. en:sodium chloride 2250 mg oral tablet --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 2250 mg oral tablet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3746. en:sodium chloride 23.4% injection solution 100ml bag --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 23.4% injection solution 100ml bag | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3747. en:sodium chloride 250mg tab,oph --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 250mg tab,oph | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3748. en:sodium chloride 5% eye ointment --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 5% eye ointment | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3749. en:sodium chloride 5% infusion solution bag --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride 5% infusion solution bag | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3750. en:sodium chloride granules --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride granules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3751. en:sodium chloride nasal solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride nasal solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3752. en:sodium chloride soln,oph --- r_associated #0: 20 --> en:oedema
    n1=en:sodium chloride soln,oph | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3753. en:sodium citrate --- r_associated #0: 20 --> en:oedema
    n1=en:sodium citrate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3754. en:sodium citrate 3.5 meq/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium citrate 3.5 meq/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3755. en:sodium citrate 4% soln --- r_associated #0: 20 --> en:oedema
    n1=en:sodium citrate 4% soln | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3756. en:sodium citrate 40 mg/ml oral solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium citrate 40 mg/ml oral solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3757. en:sodium citrate 46.7% soln --- r_associated #0: 20 --> en:oedema
    n1=en:sodium citrate 46.7% soln | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3758. en:sodium citrate 467 mg/ml injectable solution --- r_associated #0: 20 --> en:oedema
    n1=en:sodium citrate 467 mg/ml injectable solution | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3759. en:sodium citrate pwdr --- r_associated #0: 20 --> en:oedema
    n1=en:sodium citrate pwdr | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3760. en:sodium phosphate, monobasic --- r_associated #0: 20 --> en:oedema
    n1=en:sodium phosphate, monobasic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3761. en:soft fleshy palms (50%) --- r_associated #0: 20 --> en:oedema
    n1=en:soft fleshy palms (50%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3762. en:soft skin --- r_associated #0: 20 --> en:oedema
    n1=en:soft skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3763. en:soft thin skin --- r_associated #0: 20 --> en:oedema
    n1=en:soft thin skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3764. en:soft tissue calcinosis --- r_associated #0: 20 --> en:oedema
    n1=en:soft tissue calcinosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3765. en:soft tissue or tendinous calcinosis may occur --- r_associated #0: 20 --> en:oedema
    n1=en:soft tissue or tendinous calcinosis may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3766. en:soft tissue vascular malformations --- r_associated #0: 20 --> en:oedema
    n1=en:soft tissue vascular malformations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3767. en:soft with easy bruising (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:soft with easy bruising (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3768. en:soft, doughy skin --- r_associated #0: 20 --> en:oedema
    n1=en:soft, doughy skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3769. en:soft, redundant skin (especially facial) --- r_associated #0: 20 --> en:oedema
    n1=en:soft, redundant skin (especially facial) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3770. en:soft, thin skin (1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:soft, thin skin (1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3771. en:soft, velvety skin --- r_associated #0: 20 --> en:oedema
    n1=en:soft, velvety skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3772. en:some patients become wheelchair-dependent --- r_associated #0: 20 --> en:oedema
    n1=en:some patients become wheelchair-dependent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3773. en:some patients never achieve ambulation --- r_associated #0: 20 --> en:oedema
    n1=en:some patients never achieve ambulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3774. en:some subcutaneous adipose tissue may remain on upper arms --- r_associated #0: 20 --> en:oedema
    n1=en:some subcutaneous adipose tissue may remain on upper arms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3775. en:sparing of anterior tibialis muscle --- r_associated #0: 20 --> en:oedema
    n1=en:sparing of anterior tibialis muscle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3776. en:sparing of flexure areas, palms, and soles --- r_associated #0: 20 --> en:oedema
    n1=en:sparing of flexure areas, palms, and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3777. en:sparing of small hand and finger muscles --- r_associated #0: 20 --> en:oedema
    n1=en:sparing of small hand and finger muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3778. en:sparing of the anterior tibial compartment --- r_associated #0: 20 --> en:oedema
    n1=en:sparing of the anterior tibial compartment | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3779. en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy') --- r_associated #0: 20 --> en:oedema
    n1=en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy') | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3780. en:sparse axillary and facial hair --- r_associated #0: 20 --> en:oedema
    n1=en:sparse axillary and facial hair | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3781. en:spasticity --- r_associated #0: 20 --> en:oedema
    n1=en:spasticity | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3782. en:speech and communication disorders --- r_associated #0: 20 --> en:oedema
    n1=en:speech and communication disorders | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3783. en:spheroid bodies are composed of fine filamentous (myofibrillar) material --- r_associated #0: 20 --> en:oedema
    n1=en:spheroid bodies are composed of fine filamentous (myofibrillar) material | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3784. en:spheroids --- r_associated #0: 20 --> en:oedema
    n1=en:spheroids | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3785. en:spiky hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:spiky hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3786. en:spiny follicular plugging --- r_associated #0: 20 --> en:oedema
    n1=en:spiny follicular plugging | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3787. en:spiradenoma --- r_associated #0: 20 --> en:oedema
    n1=en:spiradenoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3788. en:splenomegaly --- r_associated #0: 20 --> en:oedema
    n1=en:splenomegaly | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3789. en:split anchoring plaques of desmosomes in the granular layer (transmission electron microscopy (tem)) --- r_associated #0: 20 --> en:oedema
    n1=en:split anchoring plaques of desmosomes in the granular layer (transmission electron microscopy (tem)) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3790. en:spontaneous bruising --- r_associated #0: 20 --> en:oedema
    n1=en:spontaneous bruising | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3791. en:spontaneous hematomas --- r_associated #0: 20 --> en:oedema
    n1=en:spontaneous hematomas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3792. en:spontaneous, non-scarring healing --- r_associated #0: 20 --> en:oedema
    n1=en:spontaneous, non-scarring healing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3793. en:spotted and reticulate pigmentation of flexural areas of skin --- r_associated #0: 20 --> en:oedema
    n1=en:spotted and reticulate pigmentation of flexural areas of skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3794. en:spotty hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:spotty hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3795. en:spotty hypopigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:spotty hypopigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3796. en:spurling sign --- r_associated #0: 20 --> en:oedema
    n1=en:spurling sign | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3797. en:sputum excretion difficulty --- r_associated #0: 20 --> en:oedema
    n1=en:sputum excretion difficulty | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3798. en:squamous epitheliomas, multiple --- r_associated #0: 20 --> en:oedema
    n1=en:squamous epitheliomas, multiple | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3799. en:squamous pityriasiform appearance of scalp --- r_associated #0: 20 --> en:oedema
    n1=en:squamous pityriasiform appearance of scalp | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3800. en:stage 1 - skin erythema, vesicles, pustules --- r_associated #0: 20 --> en:oedema
    n1=en:stage 1 - skin erythema, vesicles, pustules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3801. en:stage 2 - skin papules, verrucous lesions, hyperkeratosis --- r_associated #0: 20 --> en:oedema
    n1=en:stage 2 - skin papules, verrucous lesions, hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3802. en:stage 3 - skin hyperpigmentation --- r_associated #0: 20 --> en:oedema
    n1=en:stage 3 - skin hyperpigmentation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3803. en:stage 4 - skin pallor, atrophy, and scarring --- r_associated #0: 20 --> en:oedema
    n1=en:stage 4 - skin pallor, atrophy, and scarring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3804. en:stage iiib inflammatory breast carcinoma --- r_associated #0: 20 --> en:oedema
    n1=en:stage iiib inflammatory breast carcinoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3805. en:stage iv inflammatory breast carcinoma --- r_associated #0: 20 --> en:oedema
    n1=en:stage iv inflammatory breast carcinoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3806. en:starfish-like acral keratoses (knuckles) --- r_associated #0: 20 --> en:oedema
    n1=en:starfish-like acral keratoses (knuckles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3807. en:stasis --- r_associated #0: 20 --> en:oedema
    n1=en:stasis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3808. en:stasis ulcers --- r_associated #0: 20 --> en:oedema
    n1=en:stasis ulcers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3809. en:static edema level --- r_associated #0: 20 --> en:oedema
    n1=en:static edema level | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3810. en:steatocystoma multiplex --- r_associated #0: 20 --> en:oedema
    n1=en:steatocystoma multiplex | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3811. en:steatocystomas --- r_associated #0: 20 --> en:oedema
    n1=en:steatocystomas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3812. en:sterile abscesses at site of parenteral injection --- r_associated #0: 20 --> en:oedema
    n1=en:sterile abscesses at site of parenteral injection | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3813. en:sterile pustules --- r_associated #0: 20 --> en:oedema
    n1=en:sterile pustules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3814. en:stevens-johnson syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:stevens-johnson syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3815. en:stiff skin --- r_associated #0: 20 --> en:oedema
    n1=en:stiff skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3816. en:stiffness --- r_associated #0: 20 --> en:oedema
    n1=en:stiffness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3817. en:stiffness (uncommon) --- r_associated #0: 20 --> en:oedema
    n1=en:stiffness (uncommon) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3818. en:stokes-adams syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:stokes-adams syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3819. en:stoma site oedema --- r_associated #0: 20 --> en:oedema
    n1=en:stoma site oedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3820. en:streaks and whorls --- r_associated #0: 20 --> en:oedema
    n1=en:streaks and whorls | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3821. en:streaming of the z-disk seen on electron microscopy --- r_associated #0: 20 --> en:oedema
    n1=en:streaming of the z-disk seen on electron microscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3822. en:stress --- r_associated #0: 20 --> en:oedema
    n1=en:stress | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3823. en:stretched skin --- r_associated #0: 20 --> en:oedema
    n1=en:stretched skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3824. en:striae --- r_associated #0: 20 --> en:oedema
    n1=en:striae | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3825. en:striated keratoderma of palms (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:striated keratoderma of palms (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3826. en:stromal corneal edema --- r_associated #0: 20 --> en:oedema
    n1=en:stromal corneal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3827. en:structurally abnormal mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:structurally abnormal mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3828. en:structure at risk --- r_associated #0: 20 --> en:oedema
    n1=en:structure at risk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3829. en:stutter --- r_associated #0: 20 --> en:oedema
    n1=en:stutter | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3830. en:subconjunctival edema --- r_associated #0: 20 --> en:oedema
    n1=en:subconjunctival edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3831. en:subcutaneous calcification --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous calcification | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3832. en:subcutaneous connective tissue nevi --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous connective tissue nevi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3833. en:subcutaneous edema --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3834. en:subcutaneous fat markedly reduced --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous fat markedly reduced | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3835. en:subcutaneous infections, recurrent, with fistula formation --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous infections, recurrent, with fistula formation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3836. en:subcutaneous lipoma --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous lipoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3837. en:subcutaneous lipomas, well-circumscribed and painful --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous lipomas, well-circumscribed and painful | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3838. en:subcutaneous lipomatous tissue --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous lipomatous tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3839. en:subcutaneous nodule --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous nodule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3840. en:subcutaneous nodules (interphalangeal joints, knees, feet, elbows, pretibial) --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous nodules (interphalangeal joints, knees, feet, elbows, pretibial) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3841. en:subcutaneous nodules (localized)(superficial) --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous nodules (localized)(superficial) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3842. en:subcutaneous nontender firm nodules --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous nontender firm nodules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3843. en:subcutaneous ossifications --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous ossifications | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3844. en:subcutaneous papules in infancy --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous papules in infancy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3845. en:subcutaneous scalp cysts --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous scalp cysts | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3846. en:subcutaneous spheroids --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous spheroids | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3847. en:subcutaneous tumors, recurring --- r_associated #0: 20 --> en:oedema
    n1=en:subcutaneous tumors, recurring | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3848. en:subepidermal capillary ectasia --- r_associated #0: 20 --> en:oedema
    n1=en:subepidermal capillary ectasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3849. en:subglottic edema --- r_associated #0: 20 --> en:oedema
    n1=en:subglottic edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3850. en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3851. en:subsarcolemmal accumulation of normal mitochondria (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal accumulation of normal mitochondria (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3852. en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy) --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3853. en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3854. en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3855. en:subsarcolemmal hyaline bodies in 25-30% type i fibers only --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal hyaline bodies in 25-30% type i fibers only | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3856. en:subsarcolemmal hyaline bodies in type 1 fibers only --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal hyaline bodies in type 1 fibers only | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3857. en:subsarcolemmal lipofuscin-positive deposits --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal lipofuscin-positive deposits | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3858. en:subsarcolemmal mitochondrial accumulation --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal mitochondrial accumulation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3859. en:subsarcolemmal mitochondrial aggregates --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal mitochondrial aggregates | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3860. en:subsarcolemmal nemaline bodies (rods) on gomori trichrome staining --- r_associated #0: 20 --> en:oedema
    n1=en:subsarcolemmal nemaline bodies (rods) on gomori trichrome staining | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3861. en:subungual fibroma --- r_associated #0: 20 --> en:oedema
    n1=en:subungual fibroma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3862. en:suffocation --- r_associated #0: 20 --> en:oedema
    n1=en:suffocation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3863. en:superficial generalized lifelong skin peeling (sparing palms and soles) --- r_associated #0: 20 --> en:oedema
    n1=en:superficial generalized lifelong skin peeling (sparing palms and soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3864. en:superficial skin peeling (limited to dorsa of hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:superficial skin peeling (limited to dorsa of hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3865. en:superficial swelling --- r_associated #0: 20 --> en:oedema
    n1=en:superficial swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3866. en:superficial traumatic edema --- r_associated #0: 20 --> en:oedema
    n1=en:superficial traumatic edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3867. en:superficial, firm, circumscribed nodule --- r_associated #0: 20 --> en:oedema
    n1=en:superficial, firm, circumscribed nodule | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3868. en:superior rectus atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:superior rectus atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3869. en:suppurative scalp nodules --- r_associated #0: 20 --> en:oedema
    n1=en:suppurative scalp nodules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3870. en:supraglottic edema --- r_associated #0: 20 --> en:oedema
    n1=en:supraglottic edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3871. en:suprapubic skin --- r_associated #0: 20 --> en:oedema
    n1=en:suprapubic skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3872. en:surgical aspects --- r_associated #0: 20 --> en:oedema
    n1=en:surgical aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3873. en:survival time --- r_associated #0: 20 --> en:oedema
    n1=en:survival time | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3874. en:sweat gland --- r_associated #0: 20 --> en:oedema
    n1=en:sweat gland | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3875. en:sweat pore aplasia --- r_associated #0: 20 --> en:oedema
    n1=en:sweat pore aplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3876. en:sweating --- r_associated #0: 20 --> en:oedema
    n1=en:sweating | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3877. en:sweating, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:sweating, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3878. en:swelling --- r_associated #0: 20 --> en:oedema
    n1=en:swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3879. en:swelling non-inflammatory --- r_associated #0: 20 --> en:oedema
    n1=en:swelling non-inflammatory | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3880. en:swelling of body structure --- r_associated #0: 20 --> en:oedema
    n1=en:swelling of body structure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3881. en:swelling of the affected areas --- r_associated #0: 20 --> en:oedema
    n1=en:swelling of the affected areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3882. en:swelling of the extremities, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:swelling of the extremities, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3883. en:swelling of the hands and feet (in 1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:swelling of the hands and feet (in 1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3884. en:swelling of the hands and feet, episodic --- r_associated #0: 20 --> en:oedema
    n1=en:swelling of the hands and feet, episodic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3885. en:swelling on flushing of implanted venous access device --- r_associated #0: 20 --> en:oedema
    n1=en:swelling on flushing of implanted venous access device | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3886. en:swelling, mass, or lump in head and neck --- r_associated #0: 20 --> en:oedema
    n1=en:swelling, mass, or lump in head and neck | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3887. en:swollen nasal mucosa (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:swollen nasal mucosa (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3888. en:symbol digit modalities test score --- r_associated #0: 20 --> en:oedema
    n1=en:symbol digit modalities test score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3889. en:symmetrical muscle wasting --- r_associated #0: 20 --> en:oedema
    n1=en:symmetrical muscle wasting | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3890. en:symmetrical, proximal limb muscle atrophy (pelvic, scapular, trunk muscles) --- r_associated #0: 20 --> en:oedema
    n1=en:symmetrical, proximal limb muscle atrophy (pelvic, scapular, trunk muscles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3891. en:symptom --- r_associated #0: 20 --> en:oedema
    n1=en:symptom | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3892. en:symptom of head and neck region --- r_associated #0: 20 --> en:oedema
    n1=en:symptom of head and neck region | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3893. en:symptom/complaint nails --- r_associated #0: 20 --> en:oedema
    n1=en:symptom/complaint nails | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3894. en:symptom/complaint of skin texture --- r_associated #0: 20 --> en:oedema
    n1=en:symptom/complaint of skin texture | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3895. en:symptoms are progressive for a few years, and then become stationary --- r_associated #0: 20 --> en:oedema
    n1=en:symptoms are progressive for a few years, and then become stationary | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3896. en:symptoms concerning nutrition, metabolism, and development --- r_associated #0: 20 --> en:oedema
    n1=en:symptoms concerning nutrition, metabolism, and development | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3897. en:symptoms involving cardiovascular system --- r_associated #0: 20 --> en:oedema
    n1=en:symptoms involving cardiovascular system | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3898. en:symptoms involving digestive system --- r_associated #0: 20 --> en:oedema
    n1=en:symptoms involving digestive system | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3899. en:symptoms involving nervous and musculoskeletal systems --- r_associated #0: 20 --> en:oedema
    n1=en:symptoms involving nervous and musculoskeletal systems | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3900. en:symptoms involving respiratory system and other chest symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:symptoms involving respiratory system and other chest symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3901. en:symptoms may be induced by heat --- r_associated #0: 20 --> en:oedema
    n1=en:symptoms may be induced by heat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3902. en:syncope --- r_associated #0: 20 --> en:oedema
    n1=en:syncope | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3903. en:syncope adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:syncope adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3904. en:systematized epidermal nevus --- r_associated #0: 20 --> en:oedema
    n1=en:systematized epidermal nevus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3905. en:tachycardia --- r_associated #0: 20 --> en:oedema
    n1=en:tachycardia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3906. en:tan macules on glans penis and penile shaft --- r_associated #0: 20 --> en:oedema
    n1=en:tan macules on glans penis and penile shaft | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3907. en:tanning possible --- r_associated #0: 20 --> en:oedema
    n1=en:tanning possible | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3908. en:taunt skin --- r_associated #0: 20 --> en:oedema
    n1=en:taunt skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3909. en:taxonomic --- r_associated #0: 20 --> en:oedema
    n1=en:taxonomic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3910. en:tearing --- r_associated #0: 20 --> en:oedema
    n1=en:tearing | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3911. en:telangiectases (especially on tongue, lips, palate, face, conjunctiva, trunk, nail beds, fingers, and finger pads) --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectases (especially on tongue, lips, palate, face, conjunctiva, trunk, nail beds, fingers, and finger pads) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3912. en:telangiectases (especially on tongue, lips, palate, fingers, face, conjunctiva, trunk, nail beds, and fingertips) --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectases (especially on tongue, lips, palate, fingers, face, conjunctiva, trunk, nail beds, and fingertips) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3913. en:telangiectases (palms, soles, scalp, scrotum, legs) --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectases (palms, soles, scalp, scrotum, legs) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3914. en:telangiectases in sun-exposed and nonexposed skin --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectases in sun-exposed and nonexposed skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3915. en:telangiectasia --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3916. en:telangiectasia (soles) --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectasia (soles) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3917. en:telangiectasia on lips and oral mucosa --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectasia on lips and oral mucosa | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3918. en:telangiectasia on the cheeks --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectasia on the cheeks | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3919. en:telangiectasia, particularly of the fingerpads and lips --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectasia, particularly of the fingerpads and lips | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3920. en:telangiectasias in both sun-exposed and sun-protected areas --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectasias in both sun-exposed and sun-protected areas | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3921. en:telangiectatic lesions --- r_associated #0: 20 --> en:oedema
    n1=en:telangiectatic lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3922. en:temporal arteritis --- r_associated #0: 20 --> en:oedema
    n1=en:temporal arteritis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3923. en:tendency to overheat --- r_associated #0: 20 --> en:oedema
    n1=en:tendency to overheat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3924. en:tenderness --- r_associated #0: 20 --> en:oedema
    n1=en:tenderness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3925. en:tenderness of lower extremities --- r_associated #0: 20 --> en:oedema
    n1=en:tenderness of lower extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3926. en:tendinous and tuberous xanthoma --- r_associated #0: 20 --> en:oedema
    n1=en:tendinous and tuberous xanthoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3927. en:tendinous xanthomas presenting after age 20 years in heterozygotes, during first 4 years of life in homozygotes --- r_associated #0: 20 --> en:oedema
    n1=en:tendinous xanthomas presenting after age 20 years in heterozygotes, during first 4 years of life in homozygotes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3928. en:tendon tears --- r_associated #0: 20 --> en:oedema
    n1=en:tendon tears | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3929. en:tenting - skin --- r_associated #0: 20 --> en:oedema
    n1=en:tenting - skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3930. en:testicular hydrocele --- r_associated #0: 20 --> en:oedema
    n1=en:testicular hydrocele | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3931. en:testicular mass --- r_associated #0: 20 --> en:oedema
    n1=en:testicular mass | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3932. en:tetanus-like muscle contractions --- r_associated #0: 20 --> en:oedema
    n1=en:tetanus-like muscle contractions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3933. en:tetany --- r_associated #0: 20 --> en:oedema
    n1=en:tetany | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3934. en:thalassemia --- r_associated #0: 20 --> en:oedema
    n1=en:thalassemia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3935. en:thenar amyotrophy (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:thenar amyotrophy (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3936. en:thenar eminence hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:thenar eminence hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3937. en:thenar muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:thenar muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3938. en:therapeutic aspects --- r_associated #0: 20 --> en:oedema
    n1=en:therapeutic aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3939. en:therapy outcome measure score --- r_associated #0: 20 --> en:oedema
    n1=en:therapy outcome measure score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3940. en:thick calluses on soles of feet --- r_associated #0: 20 --> en:oedema
    n1=en:thick calluses on soles of feet | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3941. en:thick facial skin --- r_associated #0: 20 --> en:oedema
    n1=en:thick facial skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3942. en:thick palmar fascia --- r_associated #0: 20 --> en:oedema
    n1=en:thick palmar fascia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3943. en:thick skin --- r_associated #0: 20 --> en:oedema
    n1=en:thick skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3944. en:thick skin (66%) --- r_associated #0: 20 --> en:oedema
    n1=en:thick skin (66%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3945. en:thick skin (74%) --- r_associated #0: 20 --> en:oedema
    n1=en:thick skin (74%) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3946. en:thick, calloused skin --- r_associated #0: 20 --> en:oedema
    n1=en:thick, calloused skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3947. en:thick, indurated skin over entire body --- r_associated #0: 20 --> en:oedema
    n1=en:thick, indurated skin over entire body | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3948. en:thick, loose, doughy skin --- r_associated #0: 20 --> en:oedema
    n1=en:thick, loose, doughy skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3949. en:thick, relatively tight skin --- r_associated #0: 20 --> en:oedema
    n1=en:thick, relatively tight skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3950. en:thick, waxy skin of palms and soles with well-defined erythematous border --- r_associated #0: 20 --> en:oedema
    n1=en:thick, waxy skin of palms and soles with well-defined erythematous border | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3951. en:thickened nuchal skin fold --- r_associated #0: 20 --> en:oedema
    n1=en:thickened nuchal skin fold | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3952. en:thickened skin over flexor surface of proximal phalanges --- r_associated #0: 20 --> en:oedema
    n1=en:thickened skin over flexor surface of proximal phalanges | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3953. en:thickened skin over the elbows and along the fingers --- r_associated #0: 20 --> en:oedema
    n1=en:thickened skin over the elbows and along the fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3954. en:thickened subcutaneous tissue --- r_associated #0: 20 --> en:oedema
    n1=en:thickened subcutaneous tissue | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3955. en:thickened, furrowed skin --- r_associated #0: 20 --> en:oedema
    n1=en:thickened, furrowed skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3956. en:thickening of fascia of forearm --- r_associated #0: 20 --> en:oedema
    n1=en:thickening of fascia of forearm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3957. en:thickening of skin on the plantar and palmar surfaces --- r_associated #0: 20 --> en:oedema
    n1=en:thickening of skin on the plantar and palmar surfaces | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3958. en:thickening of the fascial structures of the palm and fingers --- r_associated #0: 20 --> en:oedema
    n1=en:thickening of the fascial structures of the palm and fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3959. en:thickening of the skin over the palms and soles (nola3 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:thickening of the skin over the palms and soles (nola3 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3960. en:thigh hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:thigh hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3961. en:thin filament shortening and disorganization (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:thin filament shortening and disorganization (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3962. en:thin skin --- r_associated #0: 20 --> en:oedema
    n1=en:thin skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3963. en:thin, dry skin --- r_associated #0: 20 --> en:oedema
    n1=en:thin, dry skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3964. en:thin, hyperpigmented skin --- r_associated #0: 20 --> en:oedema
    n1=en:thin, hyperpigmented skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3965. en:thin, hypotrophic skin --- r_associated #0: 20 --> en:oedema
    n1=en:thin, hypotrophic skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3966. en:thin, translucent skin --- r_associated #0: 20 --> en:oedema
    n1=en:thin, translucent skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3967. en:thin, transparent skin (hands and feet) --- r_associated #0: 20 --> en:oedema
    n1=en:thin, transparent skin (hands and feet) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3968. en:thin, velvety skin --- r_associated #0: 20 --> en:oedema
    n1=en:thin, velvety skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3969. en:thin, wrinkled skin --- r_associated #0: 20 --> en:oedema
    n1=en:thin, wrinkled skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3970. en:throat tightening --- r_associated #0: 20 --> en:oedema
    n1=en:throat tightening | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3971. en:tibialis anterior muscle affected --- r_associated #0: 20 --> en:oedema
    n1=en:tibialis anterior muscle affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3972. en:tight, glistening facial skin --- r_associated #0: 20 --> en:oedema
    n1=en:tight, glistening facial skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3973. en:tight, rigid skin --- r_associated #0: 20 --> en:oedema
    n1=en:tight, rigid skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3974. en:tight, shiny skin over the forearms and hands --- r_associated #0: 20 --> en:oedema
    n1=en:tight, shiny skin over the forearms and hands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3975. en:tinea capitis, severe or recurrent --- r_associated #0: 20 --> en:oedema
    n1=en:tinea capitis, severe or recurrent | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3976. en:tissue observable --- r_associated #0: 20 --> en:oedema
    n1=en:tissue observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3977. en:toe and foot dorsiflexor weakness --- r_associated #0: 20 --> en:oedema
    n1=en:toe and foot dorsiflexor weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3978. en:toe-walking gait --- r_associated #0: 20 --> en:oedema
    n1=en:toe-walking gait | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3979. en:tone does not appreciably change with age --- r_associated #0: 20 --> en:oedema
    n1=en:tone does not appreciably change with age | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3980. en:tortuous lymphatic tracts --- r_associated #0: 20 --> en:oedema
    n1=en:tortuous lymphatic tracts | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3981. en:total fluid volume increased --- r_associated #0: 20 --> en:oedema
    n1=en:total fluid volume increased | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3982. en:toxemia of pregnancy --- r_associated #0: 20 --> en:oedema
    n1=en:toxemia of pregnancy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3983. en:toxic diffuse goiter with pretibial myxedema --- r_associated #0: 20 --> en:oedema
    n1=en:toxic diffuse goiter with pretibial myxedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3984. en:toxic exposure status --- r_associated #0: 20 --> en:oedema
    n1=en:toxic exposure status | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3985. en:transfusion associated circulatory overload --- r_associated #0: 20 --> en:oedema
    n1=en:transfusion associated circulatory overload | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3986. en:transfusion reaction due to excess volume --- r_associated #0: 20 --> en:oedema
    n1=en:transfusion reaction due to excess volume | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3987. en:transgression of hyperkeratosis to dorsum of hands and feet (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:transgression of hyperkeratosis to dorsum of hands and feet (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3988. en:transgressive keratosis --- r_associated #0: 20 --> en:oedema
    n1=en:transgressive keratosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3989. en:transient eczema --- r_associated #0: 20 --> en:oedema
    n1=en:transient eczema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3990. en:transient edema --- r_associated #0: 20 --> en:oedema
    n1=en:transient edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3991. en:transient eosinophilic myositis (seen on muscle biopsy) in the first decade --- r_associated #0: 20 --> en:oedema
    n1=en:transient eosinophilic myositis (seen on muscle biopsy) in the first decade | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3992. en:transient erysipelas-like erythematous rash --- r_associated #0: 20 --> en:oedema
    n1=en:transient erysipelas-like erythematous rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3993. en:transient ischemic attack --- r_associated #0: 20 --> en:oedema
    n1=en:transient ischemic attack | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3994. en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands --- r_associated #0: 20 --> en:oedema
    n1=en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3995. en:transient neonatal hypotonia (less common) --- r_associated #0: 20 --> en:oedema
    n1=en:transient neonatal hypotonia (less common) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3996. en:transient painful erysipelas-like lesions on lower leg and ankle --- r_associated #0: 20 --> en:oedema
    n1=en:transient painful erysipelas-like lesions on lower leg and ankle | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3997. en:transient, migratory sharply outlined erythema (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:transient, migratory sharply outlined erythema (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3998. en:transitional zone of cells with gradual loss of nuclei --- r_associated #0: 20 --> en:oedema
    n1=en:transitional zone of cells with gradual loss of nuclei | n2=en:oedema | rel=r_associated | relid=0 | w=20
  3999. en:translucency, nuchal --- r_associated #0: 20 --> en:oedema
    n1=en:translucency, nuchal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4000. en:transplanted skin --- r_associated #0: 20 --> en:oedema
    n1=en:transplanted skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4001. en:transurethral resection syndrome --- r_associated #0: 20 --> en:oedema
    n1=en:transurethral resection syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4002. en:transverse distal crease across palm --- r_associated #0: 20 --> en:oedema
    n1=en:transverse distal crease across palm | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4003. en:traumatic cerebral edema --- r_associated #0: 20 --> en:oedema
    n1=en:traumatic cerebral edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4004. en:traumatic cerebral edema with open intracranial wound --- r_associated #0: 20 --> en:oedema
    n1=en:traumatic cerebral edema with open intracranial wound | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4005. en:traumatic cerebral edema without open intracranial wound --- r_associated #0: 20 --> en:oedema
    n1=en:traumatic cerebral edema without open intracranial wound | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4006. en:traumatic generalized cerebral edema --- r_associated #0: 20 --> en:oedema
    n1=en:traumatic generalized cerebral edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4007. en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles --- r_associated #0: 20 --> en:oedema
    n1=en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4008. en:tremor of the upper limb --- r_associated #0: 20 --> en:oedema
    n1=en:tremor of the upper limb | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4009. en:tremors subside over the first 2 to 3 months of life --- r_associated #0: 20 --> en:oedema
    n1=en:tremors subside over the first 2 to 3 months of life | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4010. en:triceps aplasia --- r_associated #0: 20 --> en:oedema
    n1=en:triceps aplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4011. en:triceps weakness --- r_associated #0: 20 --> en:oedema
    n1=en:triceps weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4012. en:trichilemmal cyst --- r_associated #0: 20 --> en:oedema
    n1=en:trichilemmal cyst | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4013. en:trichoepithelioma (brown, flat-topped papules) (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:trichoepithelioma (brown, flat-topped papules) (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4014. en:trichoepitheliomas, multiple (usually occur in the nasolabial folds, nose, or face) --- r_associated #0: 20 --> en:oedema
    n1=en:trichoepitheliomas, multiple (usually occur in the nasolabial folds, nose, or face) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4015. en:trichoepitheliomas, multiple (usually occur in thenasolabial folds, the nose, and upper lip) --- r_associated #0: 20 --> en:oedema
    n1=en:trichoepitheliomas, multiple (usually occur in thenasolabial folds, the nose, and upper lip) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4016. en:triglycerides --- r_associated #0: 20 --> en:oedema
    n1=en:triglycerides | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4017. en:trisodium citrate dihydrate --- r_associated #0: 20 --> en:oedema
    n1=en:trisodium citrate dihydrate | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4018. en:trunk muscle atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:trunk muscle atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4019. en:tuberous xanthoma --- r_associated #0: 20 --> en:oedema
    n1=en:tuberous xanthoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4020. en:tubular aggregates (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:tubular aggregates (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4021. en:tubular aggregates in muscle fibers may occur --- r_associated #0: 20 --> en:oedema
    n1=en:tubular aggregates in muscle fibers may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4022. en:tubular aggregates in type 2 skeletal muscle fibers --- r_associated #0: 20 --> en:oedema
    n1=en:tubular aggregates in type 2 skeletal muscle fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4023. en:tubular aggregates mainly in type 1 fibers --- r_associated #0: 20 --> en:oedema
    n1=en:tubular aggregates mainly in type 1 fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4024. en:tubular aggregates mainly in type 2 fibers and are subsarcolemmal or intermyofibrillar and stain for nadh-tetrazolium reductase --- r_associated #0: 20 --> en:oedema
    n1=en:tubular aggregates mainly in type 2 fibers and are subsarcolemmal or intermyofibrillar and stain for nadh-tetrazolium reductase | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4025. en:tubular aggregates seen on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:tubular aggregates seen on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4026. en:tubular aggregates seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:tubular aggregates seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4027. en:tubulofilamentous inclusions --- r_associated #0: 20 --> en:oedema
    n1=en:tubulofilamentous inclusions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4028. en:tubulofilamentous nuclear or cytoplasmic inclusions (15-18 nm) --- r_associated #0: 20 --> en:oedema
    n1=en:tubulofilamentous nuclear or cytoplasmic inclusions (15-18 nm) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4029. en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4030. en:tumor --- r_associated #0: 20 --> en:oedema
    n1=en:tumor | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4031. en:tumors appear most often on sun-exposed regions --- r_associated #0: 20 --> en:oedema
    n1=en:tumors appear most often on sun-exposed regions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4032. en:tumors are locally invasive --- r_associated #0: 20 --> en:oedema
    n1=en:tumors are locally invasive | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4033. en:tumors leave pitting scars --- r_associated #0: 20 --> en:oedema
    n1=en:tumors leave pitting scars | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4034. en:tumors undergo spontaneous resolution over a period of months --- r_associated #0: 20 --> en:oedema
    n1=en:tumors undergo spontaneous resolution over a period of months | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4035. en:tylosis --- r_associated #0: 20 --> en:oedema
    n1=en:tylosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4036. en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4037. en:type 1 fiber atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 fiber atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4038. en:type 1 fiber atrophy seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 fiber atrophy seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4039. en:type 1 fiber predominance --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 fiber predominance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4040. en:type 1 fiber predominance seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 fiber predominance seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4041. en:type 1 fibers are at least 12% smaller than type 2 fibers --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 fibers are at least 12% smaller than type 2 fibers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4042. en:type 1 fibers with inclusions containing myh7 protein aggregates --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 fibers with inclusions containing myh7 protein aggregates | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4043. en:type 1 muscle fiber predominance --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 muscle fiber predominance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4044. en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria --- r_associated #0: 20 --> en:oedema
    n1=en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4045. en:type 2 fiber atrophy see on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:type 2 fiber atrophy see on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4046. en:type 2 fiber hypertrophy --- r_associated #0: 20 --> en:oedema
    n1=en:type 2 fiber hypertrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4047. en:type 2 fiber predominance --- r_associated #0: 20 --> en:oedema
    n1=en:type 2 fiber predominance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4048. en:type 2 muscle fiber atrophy --- r_associated #0: 20 --> en:oedema
    n1=en:type 2 muscle fiber atrophy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4049. en:type 2 muscle fiber predominance --- r_associated #0: 20 --> en:oedema
    n1=en:type 2 muscle fiber predominance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4050. en:type i fibers with large, irregularly polygonal congophilic hyaline masses and nemaline rods consistent with nonlysosomal protein degradation --- r_associated #0: 20 --> en:oedema
    n1=en:type i fibers with large, irregularly polygonal congophilic hyaline masses and nemaline rods consistent with nonlysosomal protein degradation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4051. en:type ii fiber atrophy seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:type ii fiber atrophy seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4052. en:type ii fiber predominance --- r_associated #0: 20 --> en:oedema
    n1=en:type ii fiber predominance | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4053. en:ubiquinone decreased --- r_associated #0: 20 --> en:oedema
    n1=en:ubiquinone decreased | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4054. en:ulcer observable --- r_associated #0: 20 --> en:oedema
    n1=en:ulcer observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4055. en:ulceration --- r_associated #0: 20 --> en:oedema
    n1=en:ulceration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4056. en:ulcerations of distal extremities --- r_associated #0: 20 --> en:oedema
    n1=en:ulcerations of distal extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4057. en:ulcers often lead to infection and amputation --- r_associated #0: 20 --> en:oedema
    n1=en:ulcers often lead to infection and amputation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4058. en:ulcers, distal, due to sensory neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:ulcers, distal, due to sensory neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4059. en:ulcers, distal, painless, due to sensory neuropathy --- r_associated #0: 20 --> en:oedema
    n1=en:ulcers, distal, painless, due to sensory neuropathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4060. en:ulcers, plantar --- r_associated #0: 20 --> en:oedema
    n1=en:ulcers, plantar | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4061. en:umbilical bleeding after birth --- r_associated #0: 20 --> en:oedema
    n1=en:umbilical bleeding after birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4062. en:umbilical cord bleeding --- r_associated #0: 20 --> en:oedema
    n1=en:umbilical cord bleeding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4063. en:umbilical cord.placenta --- r_associated #0: 20 --> en:oedema
    n1=en:umbilical cord.placenta | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4064. en:umbilical depression --- r_associated #0: 20 --> en:oedema
    n1=en:umbilical depression | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4065. en:umbilical hernia --- r_associated #0: 20 --> en:oedema
    n1=en:umbilical hernia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4066. en:unable to walk --- r_associated #0: 20 --> en:oedema
    n1=en:unable to walk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4067. en:unexpected therapeutic effect --- r_associated #0: 20 --> en:oedema
    n1=en:unexpected therapeutic effect | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4068. en:unilateral erythema and scaling (present at birth or soon after birth, face is spared) --- r_associated #0: 20 --> en:oedema
    n1=en:unilateral erythema and scaling (present at birth or soon after birth, face is spared) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4069. en:unprovoked bruising --- r_associated #0: 20 --> en:oedema
    n1=en:unprovoked bruising | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4070. en:upper and/or lower limbs may be affected --- r_associated #0: 20 --> en:oedema
    n1=en:upper and/or lower limbs may be affected | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4071. en:upper arm and pelvic muscle weakness and atrophy (later onset) --- r_associated #0: 20 --> en:oedema
    n1=en:upper arm and pelvic muscle weakness and atrophy (later onset) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4072. en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade) --- r_associated #0: 20 --> en:oedema
    n1=en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4073. en:upper limb involvement may occur later --- r_associated #0: 20 --> en:oedema
    n1=en:upper limb involvement may occur later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4074. en:upper limb involvement occurs later or not at all --- r_associated #0: 20 --> en:oedema
    n1=en:upper limb involvement occurs later or not at all | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4075. en:upper limb muscle hypoplasia --- r_associated #0: 20 --> en:oedema
    n1=en:upper limb muscle hypoplasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4076. en:upper limb muscle weakness may be more severe than lower limb weakness --- r_associated #0: 20 --> en:oedema
    n1=en:upper limb muscle weakness may be more severe than lower limb weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4077. en:upper limb weakness --- r_associated #0: 20 --> en:oedema
    n1=en:upper limb weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4078. en:uric acid tophi --- r_associated #0: 20 --> en:oedema
    n1=en:uric acid tophi | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4079. en:urinary incontinence --- r_associated #0: 20 --> en:oedema
    n1=en:urinary incontinence | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4080. en:urinary system symptoms nos --- r_associated #0: 20 --> en:oedema
    n1=en:urinary system symptoms nos | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4081. en:urogenital observable --- r_associated #0: 20 --> en:oedema
    n1=en:urogenital observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4082. en:urological manifestations --- r_associated #0: 20 --> en:oedema
    n1=en:urological manifestations | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4083. en:urticaria --- r_associated #0: 20 --> en:oedema
    n1=en:urticaria | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4084. en:urticaria due to cold --- r_associated #0: 20 --> en:oedema
    n1=en:urticaria due to cold | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4085. en:urticaria pigmentosa or cutaneous mastocytosis (in patients with kit mutations) --- r_associated #0: 20 --> en:oedema
    n1=en:urticaria pigmentosa or cutaneous mastocytosis (in patients with kit mutations) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4086. en:urticaria pigmentosa/maculopapular cutaneous mastocytosis --- r_associated #0: 20 --> en:oedema
    n1=en:urticaria pigmentosa/maculopapular cutaneous mastocytosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4087. en:use of ultrasonography --- r_associated #0: 20 --> en:oedema
    n1=en:use of ultrasonography | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4088. en:usually a unilateral disorder --- r_associated #0: 20 --> en:oedema
    n1=en:usually a unilateral disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4089. en:usually no myopathic changes on biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:usually no myopathic changes on biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4090. en:usually occurs in the head and neck area --- r_associated #0: 20 --> en:oedema
    n1=en:usually occurs in the head and neck area | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4091. en:usually present on skin of neck, shoulders, or trunk --- r_associated #0: 20 --> en:oedema
    n1=en:usually present on skin of neck, shoulders, or trunk | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4092. en:uterine muscle may be stiff during pregnancy --- r_associated #0: 20 --> en:oedema
    n1=en:uterine muscle may be stiff during pregnancy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4093. en:uveitis related cystoid macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:uveitis related cystoid macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4094. en:vacuolar degeneration --- r_associated #0: 20 --> en:oedema
    n1=en:vacuolar degeneration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4095. en:vacuolar membranes immunostain with sarcolemmal proteins --- r_associated #0: 20 --> en:oedema
    n1=en:vacuolar membranes immunostain with sarcolemmal proteins | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4096. en:vacuolar myopathy --- r_associated #0: 20 --> en:oedema
    n1=en:vacuolar myopathy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4097. en:vacuolar myopathy may occur --- r_associated #0: 20 --> en:oedema
    n1=en:vacuolar myopathy may occur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4098. en:vacuolated muscle fibers show reduplication of the basement membrane --- r_associated #0: 20 --> en:oedema
    n1=en:vacuolated muscle fibers show reduplication of the basement membrane | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4099. en:vacuole membranes show atpase reactivity consistent with origin from the sarcoplasmic reticulum --- r_associated #0: 20 --> en:oedema
    n1=en:vacuole membranes show atpase reactivity consistent with origin from the sarcoplasmic reticulum | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4100. en:vacuoles appear to be exocytosing material at the cell surface --- r_associated #0: 20 --> en:oedema
    n1=en:vacuoles appear to be exocytosing material at the cell surface | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4101. en:vacuoles are autophagocytic --- r_associated #0: 20 --> en:oedema
    n1=en:vacuoles are autophagocytic | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4102. en:vacuoles are autophagocytic and contain granular and membranous cellular debris --- r_associated #0: 20 --> en:oedema
    n1=en:vacuoles are autophagocytic and contain granular and membranous cellular debris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4103. en:vacuoles containing neutral lipids seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:vacuoles containing neutral lipids seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4104. en:vacuoles predominantly in type 2 fibers seen on muscle biopsy --- r_associated #0: 20 --> en:oedema
    n1=en:vacuoles predominantly in type 2 fibers seen on muscle biopsy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4105. en:vaginal hemorrhage --- r_associated #0: 20 --> en:oedema
    n1=en:vaginal hemorrhage | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4106. en:valpar component work sample 17 pre-vocational readiness battery score --- r_associated #0: 20 --> en:oedema
    n1=en:valpar component work sample 17 pre-vocational readiness battery score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4107. en:valvular heart disorder --- r_associated #0: 20 --> en:oedema
    n1=en:valvular heart disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4108. en:variability in fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:variability in fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4109. en:variable deficiencies of mitochondrial respiratory chain complexes i, iii, and iv --- r_associated #0: 20 --> en:oedema
    n1=en:variable deficiencies of mitochondrial respiratory chain complexes i, iii, and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4110. en:variable deficiencies of mitochondrial respiratory chain enzymes --- r_associated #0: 20 --> en:oedema
    n1=en:variable deficiencies of mitochondrial respiratory chain enzymes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4111. en:variable fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:variable fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4112. en:variable involvement of palms and soles --- r_associated #0: 20 --> en:oedema
    n1=en:variable involvement of palms and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4113. en:variable number of lesions (1 to greater than 10) --- r_associated #0: 20 --> en:oedema
    n1=en:variable number of lesions (1 to greater than 10) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4114. en:variable skin syndactyly fingers and toes --- r_associated #0: 20 --> en:oedema
    n1=en:variable skin syndactyly fingers and toes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4115. en:variably decreased activities of mitochondrial respiratory complexes i, ii, and iv --- r_associated #0: 20 --> en:oedema
    n1=en:variably decreased activities of mitochondrial respiratory complexes i, ii, and iv | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4116. en:variably decreased alpha-dystroglycan expression (dag, 128239) --- r_associated #0: 20 --> en:oedema
    n1=en:variably decreased alpha-dystroglycan expression (dag, 128239) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4117. en:variation of fiber size and shape --- r_associated #0: 20 --> en:oedema
    n1=en:variation of fiber size and shape | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4118. en:variation of myofiber diameter --- r_associated #0: 20 --> en:oedema
    n1=en:variation of myofiber diameter | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4119. en:varicose vein --- r_associated #0: 20 --> en:oedema
    n1=en:varicose vein | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4120. en:varicose veins (reported in 1 family) --- r_associated #0: 20 --> en:oedema
    n1=en:varicose veins (reported in 1 family) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4121. en:varicose veins of lower limb co-occurrent with edema --- r_associated #0: 20 --> en:oedema
    n1=en:varicose veins of lower limb co-occurrent with edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4122. en:vascular access site oedema --- r_associated #0: 20 --> en:oedema
    n1=en:vascular access site oedema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4123. en:vascular disorder --- r_associated #0: 20 --> en:oedema
    n1=en:vascular disorder | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4124. en:vasculitis --- r_associated #0: 20 --> en:oedema
    n1=en:vasculitis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4125. en:vasculitis rash --- r_associated #0: 20 --> en:oedema
    n1=en:vasculitis rash | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4126. en:velopharyngeal muscle weakness --- r_associated #0: 20 --> en:oedema
    n1=en:velopharyngeal muscle weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4127. en:velvety skin --- r_associated #0: 20 --> en:oedema
    n1=en:velvety skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4128. en:velvety texture --- r_associated #0: 20 --> en:oedema
    n1=en:velvety texture | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4129. en:velvety, smooth skin --- r_associated #0: 20 --> en:oedema
    n1=en:velvety, smooth skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4130. en:venous angiectasia --- r_associated #0: 20 --> en:oedema
    n1=en:venous angiectasia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4131. en:venous stasis ulcer co-occurrent with edema of lower leg --- r_associated #0: 20 --> en:oedema
    n1=en:venous stasis ulcer co-occurrent with edema of lower leg | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4132. en:ventilation or perfusion signs and symptoms --- r_associated #0: 20 --> en:oedema
    n1=en:ventilation or perfusion signs and symptoms | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4133. en:vernix-like skin covering, present at birth, shed during first month of life (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:vernix-like skin covering, present at birth, shed during first month of life (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4134. en:verruca plantaris --- r_associated #0: 20 --> en:oedema
    n1=en:verruca plantaris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4135. en:verruca vulgaris --- r_associated #0: 20 --> en:oedema
    n1=en:verruca vulgaris | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4136. en:verrucae (warts), multiple --- r_associated #0: 20 --> en:oedema
    n1=en:verrucae (warts), multiple | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4137. en:verrucous lesion --- r_associated #0: 20 --> en:oedema
    n1=en:verrucous lesion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4138. en:vertical crease in fourth interdigital space --- r_associated #0: 20 --> en:oedema
    n1=en:vertical crease in fourth interdigital space | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4139. en:vertical creases of plantar surface between first and second toes --- r_associated #0: 20 --> en:oedema
    n1=en:vertical creases of plantar surface between first and second toes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4140. en:vertigo --- r_associated #0: 20 --> en:oedema
    n1=en:vertigo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4141. en:very severe nonproliferative diabetic retinopathy with clinically significant macular edema --- r_associated #0: 20 --> en:oedema
    n1=en:very severe nonproliferative diabetic retinopathy with clinically significant macular edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4142. en:vesicles on scalp and skin filled with clear fluid and less than 1cm in diameter --- r_associated #0: 20 --> en:oedema
    n1=en:vesicles on scalp and skin filled with clear fluid and less than 1cm in diameter | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4143. en:vesicles, congenital, on fingers and soles --- r_associated #0: 20 --> en:oedema
    n1=en:vesicles, congenital, on fingers and soles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4144. en:vesicular lesions (inflammatory type b) --- r_associated #0: 20 --> en:oedema
    n1=en:vesicular lesions (inflammatory type b) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4145. en:vesicular lesions, congenital bilateral, between ear and corner of mouth --- r_associated #0: 20 --> en:oedema
    n1=en:vesicular lesions, congenital bilateral, between ear and corner of mouth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4146. en:vesiculopustular lesions --- r_associated #0: 20 --> en:oedema
    n1=en:vesiculopustular lesions | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4147. en:vessels may form rounded nodules ('tufts') --- r_associated #0: 20 --> en:oedema
    n1=en:vessels may form rounded nodules ('tufts') | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4148. en:veterinary aspects --- r_associated #0: 20 --> en:oedema
    n1=en:veterinary aspects | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4149. en:virtually no active movement at birth (wws) --- r_associated #0: 20 --> en:oedema
    n1=en:virtually no active movement at birth (wws) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4150. en:viruses --- r_associated #0: 20 --> en:oedema
    n1=en:viruses | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4151. en:visceral edema --- r_associated #0: 20 --> en:oedema
    n1=en:visceral edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4152. en:visual analog scale score --- r_associated #0: 20 --> en:oedema
    n1=en:visual analog scale score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4153. en:visual discomfort --- r_associated #0: 20 --> en:oedema
    n1=en:visual discomfort | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4154. en:vitiligo --- r_associated #0: 20 --> en:oedema
    n1=en:vitiligo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4155. en:vitiligo (1 patient) --- r_associated #0: 20 --> en:oedema
    n1=en:vitiligo (1 patient) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4156. en:vitiligo (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:vitiligo (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4157. en:voice alteration --- r_associated #0: 20 --> en:oedema
    n1=en:voice alteration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4158. en:voice handicap index score --- r_associated #0: 20 --> en:oedema
    n1=en:voice handicap index score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4159. en:volume excess, disturbed starling forces --- r_associated #0: 20 --> en:oedema
    n1=en:volume excess, disturbed starling forces | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4160. en:volume excess, primary hormone excess --- r_associated #0: 20 --> en:oedema
    n1=en:volume excess, primary hormone excess | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4161. en:volume excess, primary renal sodium retention --- r_associated #0: 20 --> en:oedema
    n1=en:volume excess, primary renal sodium retention | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4162. en:waddling gait --- r_associated #0: 20 --> en:oedema
    n1=en:waddling gait | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4163. en:walking delay --- r_associated #0: 20 --> en:oedema
    n1=en:walking delay | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4164. en:walking may be limited --- r_associated #0: 20 --> en:oedema
    n1=en:walking may be limited | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4165. en:warfarin-induced skin necrosis --- r_associated #0: 20 --> en:oedema
    n1=en:warfarin-induced skin necrosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4166. en:warts, generalized (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:warts, generalized (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4167. en:warty thickening of flexural skin --- r_associated #0: 20 --> en:oedema
    n1=en:warty thickening of flexural skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4168. en:wasted lower leg muscles --- r_associated #0: 20 --> en:oedema
    n1=en:wasted lower leg muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4169. en:wasting, especially temporal, neck, and facial muscles --- r_associated #0: 20 --> en:oedema
    n1=en:wasting, especially temporal, neck, and facial muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4170. en:water balance disorders --- r_associated #0: 20 --> en:oedema
    n1=en:water balance disorders | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4171. en:water intoxication --- r_associated #0: 20 --> en:oedema
    n1=en:water intoxication | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4172. en:water retention (finding) --- r_associated #0: 20 --> en:oedema
    n1=en:water retention (finding) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4173. en:weak extraocular muscles --- r_associated #0: 20 --> en:oedema
    n1=en:weak extraocular muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4174. en:weakness --- r_associated #0: 20 --> en:oedema
    n1=en:weakness | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4175. en:weakness and wasting of the lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:weakness and wasting of the lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4176. en:weakness may be exacerbated by illness or stress --- r_associated #0: 20 --> en:oedema
    n1=en:weakness may be exacerbated by illness or stress | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4177. en:weakness of all intrinsic hand muscles (later) --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of all intrinsic hand muscles (later) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4178. en:weakness of ankle and toe extensor (dorsiflexor) muscles --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of ankle and toe extensor (dorsiflexor) muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4179. en:weakness of ankle plantar flexion --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of ankle plantar flexion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4180. en:weakness of anterior compartment tibial muscles --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of anterior compartment tibial muscles | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4181. en:weakness of long finger extensor muscles (occurs later) --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of long finger extensor muscles (occurs later) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4182. en:weakness of neck extensors (rare) --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of neck extensors (rare) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4183. en:weakness of neck muscles may occur later --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of neck muscles may occur later | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4184. en:weakness of the anterior tibial muscle and toe extensors --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of the anterior tibial muscle and toe extensors | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4185. en:weakness of the extensor muscles of the hands (initially) --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of the extensor muscles of the hands (initially) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4186. en:weakness of the intrinsic hand muscles (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of the intrinsic hand muscles (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4187. en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) --- r_associated #0: 20 --> en:oedema
    n1=en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4188. en:weakness, axial and limb muscles, upper limb muscles more affected than lower limbs --- r_associated #0: 20 --> en:oedema
    n1=en:weakness, axial and limb muscles, upper limb muscles more affected than lower limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4189. en:wegener granulomatosis --- r_associated #0: 20 --> en:oedema
    n1=en:wegener granulomatosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4190. en:weight change --- r_associated #0: 20 --> en:oedema
    n1=en:weight change | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4191. en:weight gain adverse event --- r_associated #0: 20 --> en:oedema
    n1=en:weight gain adverse event | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4192. en:weight loss --- r_associated #0: 20 --> en:oedema
    n1=en:weight loss | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4193. en:well-circumscribed areas of nontender denuded skin on extremities --- r_associated #0: 20 --> en:oedema
    n1=en:well-circumscribed areas of nontender denuded skin on extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4194. en:well-circumscribed peeling of the skin on the hands, feet and neck (easily elicited by moisture and minor trauma) --- r_associated #0: 20 --> en:oedema
    n1=en:well-circumscribed peeling of the skin on the hands, feet and neck (easily elicited by moisture and minor trauma) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4195. en:well-defined erythematous border --- r_associated #0: 20 --> en:oedema
    n1=en:well-defined erythematous border | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4196. en:wheelchair dependency in 20% of patients by age 40 --- r_associated #0: 20 --> en:oedema
    n1=en:wheelchair dependency in 20% of patients by age 40 | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4197. en:white ash leaf-shaped macules --- r_associated #0: 20 --> en:oedema
    n1=en:white ash leaf-shaped macules | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4198. en:white at birth --- r_associated #0: 20 --> en:oedema
    n1=en:white at birth | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4199. en:white dermatographism --- r_associated #0: 20 --> en:oedema
    n1=en:white dermatographism | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4200. en:white scaling skin, most prominent over upper and lower extremities --- r_associated #0: 20 --> en:oedema
    n1=en:white scaling skin, most prominent over upper and lower extremities | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4201. en:white skin --- r_associated #0: 20 --> en:oedema
    n1=en:white skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4202. en:wide variation in fiber size --- r_associated #0: 20 --> en:oedema
    n1=en:wide variation in fiber size | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4203. en:wide, thin scars --- r_associated #0: 20 --> en:oedema
    n1=en:wide, thin scars | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4204. en:widespread retinal edema --- r_associated #0: 20 --> en:oedema
    n1=en:widespread retinal edema | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4205. en:winged scapula --- r_associated #0: 20 --> en:oedema
    n1=en:winged scapula | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4206. en:wound finding --- r_associated #0: 20 --> en:oedema
    n1=en:wound finding | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4207. en:wound healing normal --- r_associated #0: 20 --> en:oedema
    n1=en:wound healing normal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4208. en:wound observable --- r_associated #0: 20 --> en:oedema
    n1=en:wound observable | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4209. en:wrinkled abdominal skin --- r_associated #0: 20 --> en:oedema
    n1=en:wrinkled abdominal skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4210. en:wrinkled face --- r_associated #0: 20 --> en:oedema
    n1=en:wrinkled face | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4211. en:wrinkled skin over dorsa of fingers --- r_associated #0: 20 --> en:oedema
    n1=en:wrinkled skin over dorsa of fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4212. en:wrinkled skin over fingers --- r_associated #0: 20 --> en:oedema
    n1=en:wrinkled skin over fingers | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4213. en:wrinkling of skin on limbs --- r_associated #0: 20 --> en:oedema
    n1=en:wrinkling of skin on limbs | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4214. en:wrinkly skin --- r_associated #0: 20 --> en:oedema
    n1=en:wrinkly skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4215. en:wrinkly skin (13 of 22) --- r_associated #0: 20 --> en:oedema
    n1=en:wrinkly skin (13 of 22) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4216. en:wrist swelling --- r_associated #0: 20 --> en:oedema
    n1=en:wrist swelling | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4217. en:xanthoma --- r_associated #0: 20 --> en:oedema
    n1=en:xanthoma | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4218. en:xanthomas (in some patients) --- r_associated #0: 20 --> en:oedema
    n1=en:xanthomas (in some patients) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4219. en:xerosis --- r_associated #0: 20 --> en:oedema
    n1=en:xerosis | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4220. en:xerosis (buttocks, extensor surfaces of extremities) --- r_associated #0: 20 --> en:oedema
    n1=en:xerosis (buttocks, extensor surfaces of extremities) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4221. en:xerostomia --- r_associated #0: 20 --> en:oedema
    n1=en:xerostomia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4222. en:yale swallow protocol score --- r_associated #0: 20 --> en:oedema
    n1=en:yale swallow protocol score | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4223. en:yawning --- r_associated #0: 20 --> en:oedema
    n1=en:yawning | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4224. en:yellow subcutaneous tissue covered by thin, scaly skin --- r_associated #0: 20 --> en:oedema
    n1=en:yellow subcutaneous tissue covered by thin, scaly skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4225. en:yellow, papular lesions of the lip, soft palate, pharynx --- r_associated #0: 20 --> en:oedema
    n1=en:yellow, papular lesions of the lip, soft palate, pharynx | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4226. en:yellow-orange colored skin --- r_associated #0: 20 --> en:oedema
    n1=en:yellow-orange colored skin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4227. en:z-band streaming --- r_associated #0: 20 --> en:oedema
    n1=en:z-band streaming | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4228. en:z-disk degeneration --- r_associated #0: 20 --> en:oedema
    n1=en:z-disk degeneration | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4229. en:z-disk streaming --- r_associated #0: 20 --> en:oedema
    n1=en:z-disk streaming | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4230. en:z-disks with abnormal homogeneous material --- r_associated #0: 20 --> en:oedema
    n1=en:z-disks with abnormal homogeneous material | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4231. en:z-line streaming see on electron microscopy --- r_associated #0: 20 --> en:oedema
    n1=en:z-line streaming see on electron microscopy | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4232. enfler --- r_associated #0: 20 --> en:oedema
    n1=enfler | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4233. enflure --- r_associated #0: 20 --> en:oedema
    n1=enflure | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4234. enflure
    (gonflement)
     --- r_associated #0: 20 --> en:oedema
    n1=enflure
    (gonflement)
    | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4235. exsudat --- r_associated #0: 20 --> en:oedema
    n1=exsudat | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4236. fluxion --- r_associated #0: 20 --> en:oedema
    n1=fluxion | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4237. gonflement --- r_associated #0: 20 --> en:oedema
    n1=gonflement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4238. gonflement d'un organe --- r_associated #0: 20 --> en:oedema
    n1=gonflement d'un organe | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4239. grosseur --- r_associated #0: 20 --> en:oedema
    n1=grosseur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4240. hydropisie --- r_associated #0: 20 --> en:oedema
    n1=hydropisie | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4241. hydrops --- r_associated #0: 20 --> en:oedema
    n1=hydrops | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4242. hypoptyalisme --- r_associated #0: 20 --> en:oedema
    n1=hypoptyalisme | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4243. hyposécrétion des glandes salivaires --- r_associated #0: 20 --> en:oedema
    n1=hyposécrétion des glandes salivaires | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4244. hyposécrétion salivaire --- r_associated #0: 20 --> en:oedema
    n1=hyposécrétion salivaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4245. hématome --- r_associated #0: 20 --> en:oedema
    n1=hématome | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4246. hémoglobinopathie à hématies falciformes --- r_associated #0: 20 --> en:oedema
    n1=hémoglobinopathie à hématies falciformes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4247. hémoglobinose S --- r_associated #0: 20 --> en:oedema
    n1=hémoglobinose S | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4248. hémoglobinose ss --- r_associated #0: 20 --> en:oedema
    n1=hémoglobinose ss | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4249. inflammation --- r_associated #0: 20 --> en:oedema
    n1=inflammation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4250. inflation --- r_associated #0: 20 --> en:oedema
    n1=inflation | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4251. kyste pilaire --- r_associated #0: 20 --> en:oedema
    n1=kyste pilaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4252. kyste sébacé --- r_associated #0: 20 --> en:oedema
    n1=kyste sébacé | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4253. kyste trichilemmal --- r_associated #0: 20 --> en:oedema
    n1=kyste trichilemmal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4254. kyste épidermique --- r_associated #0: 20 --> en:oedema
    n1=kyste épidermique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4255. kyste épidermoïde --- r_associated #0: 20 --> en:oedema
    n1=kyste épidermoïde | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4256. liq --- r_associated #0: 20 --> en:oedema
    n1=liq | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4257. loge (syndrome de) --- r_associated #0: 20 --> en:oedema
    n1=loge (syndrome de) | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4258. lymphœdème --- r_associated #0: 20 --> en:oedema
    n1=lymphœdème | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4259. lymphoedème --- r_associated #0: 20 --> en:oedema
    n1=lymphoedème | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4260. lymphœdème --- r_associated #0: 20 --> en:oedema
    n1=lymphœdème | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4261. mal des montagnes --- r_associated #0: 20 --> en:oedema
    n1=mal des montagnes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4262. maladie --- r_associated #0: 20 --> en:oedema
    n1=maladie | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4263. maladie cardiaque --- r_associated #0: 20 --> en:oedema
    n1=maladie cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4264. maladie cardiaque non précisée --- r_associated #0: 20 --> en:oedema
    n1=maladie cardiaque non précisée | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4265. maladie des hématies falciformes --- r_associated #0: 20 --> en:oedema
    n1=maladie des hématies falciformes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4266. maladie drépanocytaire --- r_associated #0: 20 --> en:oedema
    n1=maladie drépanocytaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4267. maladie du coeur --- r_associated #0: 20 --> en:oedema
    n1=maladie du coeur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4268. maladie
    (médecine)
     --- r_associated #0: 20 --> en:oedema
    n1=maladie
    (médecine)
    | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4269. maladies --- r_associated #0: 20 --> en:oedema
    n1=maladies | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4270. malformation cardiaque --- r_associated #0: 20 --> en:oedema
    n1=malformation cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4271. masse et tuméfaction intra-abdominales ou pelviennes --- r_associated #0: 20 --> en:oedema
    n1=masse et tuméfaction intra-abdominales ou pelviennes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4272. masse et tuméfaction mammaire --- r_associated #0: 20 --> en:oedema
    n1=masse et tuméfaction mammaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4273. mort cellulaire --- r_associated #0: 20 --> en:oedema
    n1=mort cellulaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4274. myxomatose --- r_associated #0: 20 --> en:oedema
    n1=myxomatose | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4275. médecine --- r_associated #0: 20 --> en:oedema
    n1=médecine | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4276. non précisée, anémie drépanocytaire --- r_associated #0: 20 --> en:oedema
    n1=non précisée, anémie drépanocytaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4277. néoplasme --- r_associated #0: 20 --> en:oedema
    n1=néoplasme | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4278. oedème aigu cardiogénique du poumon --- r_associated #0: 20 --> en:oedema
    n1=oedème aigu cardiogénique du poumon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4279. oedème aigu du poumon --- r_associated #0: 20 --> en:oedema
    n1=oedème aigu du poumon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4280. oedème aigu pulmonaire --- r_associated #0: 20 --> en:oedema
    n1=oedème aigu pulmonaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4281. oedème angioneurotique --- r_associated #0: 20 --> en:oedema
    n1=oedème angioneurotique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4282. oedème bleu --- r_associated #0: 20 --> en:oedema
    n1=oedème bleu | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4283. oedème cardio-rénal --- r_associated #0: 20 --> en:oedema
    n1=oedème cardio-rénal | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4284. oedème conjonctival --- r_associated #0: 20 --> en:oedema
    n1=oedème conjonctival | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4285. oedème cérébral --- r_associated #0: 20 --> en:oedema
    n1=oedème cérébral | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4286. oedème de Berlin --- r_associated #0: 20 --> en:oedema
    n1=oedème de Berlin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4287. oedème de Calabar --- r_associated #0: 20 --> en:oedema
    n1=oedème de Calabar | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4288. oedème de Quincke --- r_associated #0: 20 --> en:oedema
    n1=oedème de Quincke | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4289. oedème de la moelle osseuse transitoire --- r_associated #0: 20 --> en:oedema
    n1=oedème de la moelle osseuse transitoire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4290. oedème de stase --- r_associated #0: 20 --> en:oedema
    n1=oedème de stase | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4291. oedème du poumon --- r_associated #0: 20 --> en:oedema
    n1=oedème du poumon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4292. oedème généralisé --- r_associated #0: 20 --> en:oedema
    n1=oedème généralisé | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4293. oedème inflammatoire --- r_associated #0: 20 --> en:oedema
    n1=oedème inflammatoire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4294. oedème laryngé --- r_associated #0: 20 --> en:oedema
    n1=oedème laryngé | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4295. oedème localisé --- r_associated #0: 20 --> en:oedema
    n1=oedème localisé | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4296. oedème maculaire cystoïde --- r_associated #0: 20 --> en:oedema
    n1=oedème maculaire cystoïde | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4297. oedème malin --- r_associated #0: 20 --> en:oedema
    n1=oedème malin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4298. oedème osseux --- r_associated #0: 20 --> en:oedema
    n1=oedème osseux | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4299. oedème papillaire --- r_associated #0: 20 --> en:oedema
    n1=oedème papillaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4300. oedème pulmonaire --- r_associated #0: 20 --> en:oedema
    n1=oedème pulmonaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4301. oedème périphérique --- r_associated #0: 20 --> en:oedema
    n1=oedème périphérique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4302. oedème rétinien --- r_associated #0: 20 --> en:oedema
    n1=oedème rétinien | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4303. oedème rétinien du pôle postérieur --- r_associated #0: 20 --> en:oedema
    n1=oedème rétinien du pôle postérieur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4304. oedème vasogénique --- r_associated #0: 20 --> en:oedema
    n1=oedème vasogénique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4305. oedèmes --- r_associated #0: 20 --> en:oedema
    n1=oedèmes | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4306. oedémacié --- r_associated #0: 20 --> en:oedema
    n1=oedémacié | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4307. oedémateux --- r_associated #0: 20 --> en:oedema
    n1=oedémateux | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4308. oedématie --- r_associated #0: 20 --> en:oedema
    n1=oedématie | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4309. oedématié --- r_associated #0: 20 --> en:oedema
    n1=oedématié | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4310. pathologie --- r_associated #0: 20 --> en:oedema
    n1=pathologie | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4311. phlébite --- r_associated #0: 20 --> en:oedema
    n1=phlébite | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4312. plage hypodense --- r_associated #0: 20 --> en:oedema
    n1=plage hypodense | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4313. processus pathologique --- r_associated #0: 20 --> en:oedema
    n1=processus pathologique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4314. résultats anormaux d'imagerie diagnostique --- r_associated #0: 20 --> en:oedema
    n1=résultats anormaux d'imagerie diagnostique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4315. rétention --- r_associated #0: 20 --> en:oedema
    n1=rétention | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4316. rétention de liquide dans les tissus --- r_associated #0: 20 --> en:oedema
    n1=rétention de liquide dans les tissus | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4317. salive diminuée --- r_associated #0: 20 --> en:oedema
    n1=salive diminuée | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4318. section 3-1 maladies cardiaques --- r_associated #0: 20 --> en:oedema
    n1=section 3-1 maladies cardiaques | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4319. sicklémie --- r_associated #0: 20 --> en:oedema
    n1=sicklémie | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4320. syndrome de Berlin --- r_associated #0: 20 --> en:oedema
    n1=syndrome de Berlin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4321. syndrome oedémato-ascitique --- r_associated #0: 20 --> en:oedema
    n1=syndrome oedémato-ascitique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4322. sècheresse de la bouche --- r_associated #0: 20 --> en:oedema
    n1=sècheresse de la bouche | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4323. sécheresse buccale --- r_associated #0: 20 --> en:oedema
    n1=sécheresse buccale | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4324. sécheresse de la bouche --- r_associated #0: 20 --> en:oedema
    n1=sécheresse de la bouche | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4325. sécrétion salivaire insuffisante --- r_associated #0: 20 --> en:oedema
    n1=sécrétion salivaire insuffisante | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4326. transport aqueux transmembranaire --- r_associated #0: 20 --> en:oedema
    n1=transport aqueux transmembranaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4327. trouble cardiaque --- r_associated #0: 20 --> en:oedema
    n1=trouble cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4328. tumeur --- r_associated #0: 20 --> en:oedema
    n1=tumeur | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4329. tuméfaction --- r_associated #0: 20 --> en:oedema
    n1=tuméfaction | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4330. tuméfaction intra-abdominale ou pelvienne --- r_associated #0: 20 --> en:oedema
    n1=tuméfaction intra-abdominale ou pelvienne | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4331. turgescence --- r_associated #0: 20 --> en:oedema
    n1=turgescence | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4332. vitiligo --- r_associated #0: 20 --> en:oedema
    n1=vitiligo | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4333. xerostomia --- r_associated #0: 20 --> en:oedema
    n1=xerostomia | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4334. épanchement --- r_associated #0: 20 --> en:oedema
    n1=épanchement | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4335. épanchement articulaire --- r_associated #0: 20 --> en:oedema
    n1=épanchement articulaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4336. épanchement au niveau d'une articulation non précisée --- r_associated #0: 20 --> en:oedema
    n1=épanchement au niveau d'une articulation non précisée | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4337. œdème aigu cardiogénique du poumon --- r_associated #0: 20 --> en:oedema
    n1=œdème aigu cardiogénique du poumon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4338. œdème aigu du poumon --- r_associated #0: 20 --> en:oedema
    n1=œdème aigu du poumon | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4339. œdème angioneurotique --- r_associated #0: 20 --> en:oedema
    n1=œdème angioneurotique | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4340. œdème conjonctival --- r_associated #0: 20 --> en:oedema
    n1=œdème conjonctival | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4341. œdème cérébral --- r_associated #0: 20 --> en:oedema
    n1=œdème cérébral | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4342. œdème de Berlin --- r_associated #0: 20 --> en:oedema
    n1=œdème de Berlin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4343. œdème de Calabar --- r_associated #0: 20 --> en:oedema
    n1=œdème de Calabar | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4344. œdème de Quincke --- r_associated #0: 20 --> en:oedema
    n1=œdème de Quincke | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4345. œdème de stase --- r_associated #0: 20 --> en:oedema
    n1=œdème de stase | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4346. œdème inflammatoire --- r_associated #0: 20 --> en:oedema
    n1=œdème inflammatoire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4347. œdème laryngé --- r_associated #0: 20 --> en:oedema
    n1=œdème laryngé | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4348. œdème localisé --- r_associated #0: 20 --> en:oedema
    n1=œdème localisé | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4349. œdème maculaire cystoïde --- r_associated #0: 20 --> en:oedema
    n1=œdème maculaire cystoïde | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4350. œdème malin --- r_associated #0: 20 --> en:oedema
    n1=œdème malin | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4351. œdème papillaire --- r_associated #0: 20 --> en:oedema
    n1=œdème papillaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4352. œdème pulmonaire --- r_associated #0: 20 --> en:oedema
    n1=œdème pulmonaire | n2=en:oedema | rel=r_associated | relid=0 | w=20
  4353. altération de l'état général --- r_associated #0: 15 --> en:oedema
    n1=altération de l'état général | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4354. anémie falciforme --- r_associated #0: 15 --> en:oedema
    n1=anémie falciforme | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4355. aptyalisme --- r_associated #0: 15 --> en:oedema
    n1=aptyalisme | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4356. chemosis --- r_associated #0: 15 --> en:oedema
    n1=chemosis | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4357. chémosis --- r_associated #0: 15 --> en:oedema
    n1=chémosis | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4358. drépanocytose --- r_associated #0: 15 --> en:oedema
    n1=drépanocytose | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4359. en:proliferating pilar tumor --- r_associated #0: 15 --> en:oedema
    n1=en:proliferating pilar tumor | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4360. en:tumour --- r_associated #0: 15 --> en:oedema
    n1=en:tumour | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4361. maladies cardiaques --- r_associated #0: 15 --> en:oedema
    n1=maladies cardiaques | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4362. maladies du coeur --- r_associated #0: 15 --> en:oedema
    n1=maladies du coeur | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4363. syndrome cachectique --- r_associated #0: 15 --> en:oedema
    n1=syndrome cachectique | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4364. xérostomie --- r_associated #0: 15 --> en:oedema
    n1=xérostomie | n2=en:oedema | rel=r_associated | relid=0 | w=15
  4365. Adénopathies --- r_associated #0: 10 --> en:oedema
    n1=Adénopathies | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4366. Anévrisme --- r_associated #0: 10 --> en:oedema
    n1=Anévrisme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4367. Ballonnement --- r_associated #0: 10 --> en:oedema
    n1=Ballonnement | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4368. Drainage lymphatique --- r_associated #0: 10 --> en:oedema
    n1=Drainage lymphatique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4369. Erdheim-Chester --- r_associated #0: 10 --> en:oedema
    n1=Erdheim-Chester | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4370. Néoplasme --- r_associated #0: 10 --> en:oedema
    n1=Néoplasme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4371. Oedème pulmonaire --- r_associated #0: 10 --> en:oedema
    n1=Oedème pulmonaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4372. Phlébite --- r_associated #0: 10 --> en:oedema
    n1=Phlébite | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4373. Sars --- r_associated #0: 10 --> en:oedema
    n1=Sars | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4374. Turgescence --- r_associated #0: 10 --> en:oedema
    n1=Turgescence | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4375. absorption cutanée --- r_associated #0: 10 --> en:oedema
    n1=absorption cutanée | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4376. absorption percutanée --- r_associated #0: 10 --> en:oedema
    n1=absorption percutanée | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4377. acanthosis --- r_associated #0: 10 --> en:oedema
    n1=acanthosis | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4378. acanthosis nigricans --- r_associated #0: 10 --> en:oedema
    n1=acanthosis nigricans | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4379. accident cérébro-vasculaire --- r_associated #0: 10 --> en:oedema
    n1=accident cérébro-vasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4380. accident ischémique cérébral --- r_associated #0: 10 --> en:oedema
    n1=accident ischémique cérébral | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4381. accidents vasculaires cérébraux --- r_associated #0: 10 --> en:oedema
    n1=accidents vasculaires cérébraux | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4382. acrogeria --- r_associated #0: 10 --> en:oedema
    n1=acrogeria | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4383. acétate de sodium --- r_associated #0: 10 --> en:oedema
    n1=acétate de sodium | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4384. affection de l'appareil respiratoire --- r_associated #0: 10 --> en:oedema
    n1=affection de l'appareil respiratoire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4385. affection vasculaire --- r_associated #0: 10 --> en:oedema
    n1=affection vasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4386. affections cardiaques --- r_associated #0: 10 --> en:oedema
    n1=affections cardiaques | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4387. albinisme --- r_associated #0: 10 --> en:oedema
    n1=albinisme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4388. albinoïdisme --- r_associated #0: 10 --> en:oedema
    n1=albinoïdisme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4389. amaigrissement pathologique --- r_associated #0: 10 --> en:oedema
    n1=amaigrissement pathologique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4390. amyotrophie --- r_associated #0: 10 --> en:oedema
    n1=amyotrophie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4391. angiokeratoma --- r_associated #0: 10 --> en:oedema
    n1=angiokeratoma | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4392. angiopathie --- r_associated #0: 10 --> en:oedema
    n1=angiopathie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4393. angioplastie --- r_associated #0: 10 --> en:oedema
    n1=angioplastie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4394. anémie --- r_associated #0: 10 --> en:oedema
    n1=anémie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4395. anémie aplasique --- r_associated #0: 10 --> en:oedema
    n1=anémie aplasique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4396. anémie aplasique non précisée --- r_associated #0: 10 --> en:oedema
    n1=anémie aplasique non précisée | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4397. anévrysme --- r_associated #0: 10 --> en:oedema
    n1=anévrysme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4398. aphasie --- r_associated #0: 10 --> en:oedema
    n1=aphasie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4399. aplasie médullaire --- r_associated #0: 10 --> en:oedema
    n1=aplasie médullaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4400. aplasie érythrocytaire --- r_associated #0: 10 --> en:oedema
    n1=aplasie érythrocytaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4401. arrêt cardiaque --- r_associated #0: 10 --> en:oedema
    n1=arrêt cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4402. arrêt cardio-circulatoire --- r_associated #0: 10 --> en:oedema
    n1=arrêt cardio-circulatoire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4403. arrêt cardiocirculatoire --- r_associated #0: 10 --> en:oedema
    n1=arrêt cardiocirculatoire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4404. arrêt du coeur --- r_associated #0: 10 --> en:oedema
    n1=arrêt du coeur | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4405. arythmie cardiaque --- r_associated #0: 10 --> en:oedema
    n1=arythmie cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4406. asthénie --- r_associated #0: 10 --> en:oedema
    n1=asthénie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4407. asystole --- r_associated #0: 10 --> en:oedema
    n1=asystole | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4408. asystolie --- r_associated #0: 10 --> en:oedema
    n1=asystolie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4409. atopie --- r_associated #0: 10 --> en:oedema
    n1=atopie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4410. atrophie des muscles --- r_associated #0: 10 --> en:oedema
    n1=atrophie des muscles | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4411. atrophie musculaire --- r_associated #0: 10 --> en:oedema
    n1=atrophie musculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4412. attaque apoplectique --- r_associated #0: 10 --> en:oedema
    n1=attaque apoplectique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4413. attaque d'apoplexie --- r_associated #0: 10 --> en:oedema
    n1=attaque d'apoplexie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4414. cachexie --- r_associated #0: 10 --> en:oedema
    n1=cachexie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4415. cardiopathies --- r_associated #0: 10 --> en:oedema
    n1=cardiopathies | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4416. choc au poumon --- r_associated #0: 10 --> en:oedema
    n1=choc au poumon | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4417. cholestérol --- r_associated #0: 10 --> en:oedema
    n1=cholestérol | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4418. chylothorax --- r_associated #0: 10 --> en:oedema
    n1=chylothorax | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4419. claudication intermittente --- r_associated #0: 10 --> en:oedema
    n1=claudication intermittente | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4420. cutis laxa --- r_associated #0: 10 --> en:oedema
    n1=cutis laxa | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4421. cutis marmorata --- r_associated #0: 10 --> en:oedema
    n1=cutis marmorata | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4422. dermatomycoses --- r_associated #0: 10 --> en:oedema
    n1=dermatomycoses | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4423. dermite séborrhéique de la tête --- r_associated #0: 10 --> en:oedema
    n1=dermite séborrhéique de la tête | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4424. desquamation cutanée --- r_associated #0: 10 --> en:oedema
    n1=desquamation cutanée | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4425. douleur abdo --- r_associated #0: 10 --> en:oedema
    n1=douleur abdo | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4426. douleur de l'abdomen --- r_associated #0: 10 --> en:oedema
    n1=douleur de l'abdomen | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4427. douleur de poitrine --- r_associated #0: 10 --> en:oedema
    n1=douleur de poitrine | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4428. douleur gastrique --- r_associated #0: 10 --> en:oedema
    n1=douleur gastrique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4429. douleur intestinale --- r_associated #0: 10 --> en:oedema
    n1=douleur intestinale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4430. douleur stomacale --- r_associated #0: 10 --> en:oedema
    n1=douleur stomacale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4431. douleur à l'abdomen --- r_associated #0: 10 --> en:oedema
    n1=douleur à l'abdomen | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4432. douleur à l'estomac --- r_associated #0: 10 --> en:oedema
    n1=douleur à l'estomac | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4433. dysfonction respiratoire --- r_associated #0: 10 --> en:oedema
    n1=dysfonction respiratoire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4434. dysphasie --- r_associated #0: 10 --> en:oedema
    n1=dysphasie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4435. dystrophie musculaire --- r_associated #0: 10 --> en:oedema
    n1=dystrophie musculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4436. déficit en cytochrome oxydase --- r_associated #0: 10 --> en:oedema
    n1=déficit en cytochrome oxydase | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4437. détresse foetale --- r_associated #0: 10 --> en:oedema
    n1=détresse foetale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4438. empreintes digitales absentes --- r_associated #0: 10 --> en:oedema
    n1=empreintes digitales absentes | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4439. en:fluid overload --- r_associated #0: 10 --> en:oedema
    n1=en:fluid overload | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4440. en:heart diseases --- r_associated #0: 10 --> en:oedema
    n1=en:heart diseases | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4441. en:muscular fasciculation --- r_associated #0: 10 --> en:oedema
    n1=en:muscular fasciculation | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4442. en:paresis --- r_associated #0: 10 --> en:oedema
    n1=en:paresis | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4443. en:pilar cyst --- r_associated #0: 10 --> en:oedema
    n1=en:pilar cyst | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4444. en:stomach ache --- r_associated #0: 10 --> en:oedema
    n1=en:stomach ache | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4445. en:stomach pain --- r_associated #0: 10 --> en:oedema
    n1=en:stomach pain | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4446. en:wasting syndrome --- r_associated #0: 10 --> en:oedema
    n1=en:wasting syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4447. endocardite --- r_associated #0: 10 --> en:oedema
    n1=endocardite | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4448. exfoliation cutanée --- r_associated #0: 10 --> en:oedema
    n1=exfoliation cutanée | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4449. exophtalmie --- r_associated #0: 10 --> en:oedema
    n1=exophtalmie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4450. faiblesse de muscle --- r_associated #0: 10 --> en:oedema
    n1=faiblesse de muscle | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4451. faiblesse du muscle --- r_associated #0: 10 --> en:oedema
    n1=faiblesse du muscle | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4452. faiblesse musculaire --- r_associated #0: 10 --> en:oedema
    n1=faiblesse musculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4453. folliculitis --- r_associated #0: 10 --> en:oedema
    n1=folliculitis | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4454. fonction respiratoire anormale --- r_associated #0: 10 --> en:oedema
    n1=fonction respiratoire anormale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4455. fonte musculaire --- r_associated #0: 10 --> en:oedema
    n1=fonte musculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4456. gonflement du cerveau --- r_associated #0: 10 --> en:oedema
    n1=gonflement du cerveau | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4457. grignotage --- r_associated #0: 10 --> en:oedema
    n1=grignotage | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4458. grignotement --- r_associated #0: 10 --> en:oedema
    n1=grignotement | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4459. herpès zoster --- r_associated #0: 10 --> en:oedema
    n1=herpès zoster | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4460. hirsutisme --- r_associated #0: 10 --> en:oedema
    n1=hirsutisme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4461. hydrocèle --- r_associated #0: 10 --> en:oedema
    n1=hydrocèle | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4462. hydrocèle testiculaire --- r_associated #0: 10 --> en:oedema
    n1=hydrocèle testiculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4463. hydrocèle vaginal --- r_associated #0: 10 --> en:oedema
    n1=hydrocèle vaginal | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4464. hyperkeratosis --- r_associated #0: 10 --> en:oedema
    n1=hyperkeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4465. hypervolémie --- r_associated #0: 10 --> en:oedema
    n1=hypervolémie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4466. hémangiome --- r_associated #0: 10 --> en:oedema
    n1=hémangiome | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4467. impétigo --- r_associated #0: 10 --> en:oedema
    n1=impétigo | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4468. incontinence urinaire --- r_associated #0: 10 --> en:oedema
    n1=incontinence urinaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4469. insuffisance pulmonaire post-traumatique --- r_associated #0: 10 --> en:oedema
    n1=insuffisance pulmonaire post-traumatique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4470. intravasation --- r_associated #0: 10 --> en:oedema
    n1=intravasation | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4471. keratosis pilaris --- r_associated #0: 10 --> en:oedema
    n1=keratosis pilaris | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4472. kératinocyte --- r_associated #0: 10 --> en:oedema
    n1=kératinocyte | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4473. kératose en rayon de miel --- r_associated #0: 10 --> en:oedema
    n1=kératose en rayon de miel | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4474. la à granulocytes --- r_associated #0: 10 --> en:oedema
    n1=la à granulocytes | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4475. leucémie aiguë granulocytaire --- r_associated #0: 10 --> en:oedema
    n1=leucémie aiguë granulocytaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4476. leucémie aiguë myéloïde --- r_associated #0: 10 --> en:oedema
    n1=leucémie aiguë myéloïde | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4477. leucémie aiguë non lymphoblastique --- r_associated #0: 10 --> en:oedema
    n1=leucémie aiguë non lymphoblastique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4478. leucémie aigüe myéloblastique --- r_associated #0: 10 --> en:oedema
    n1=leucémie aigüe myéloblastique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4479. leucémie aigüe myéloïde --- r_associated #0: 10 --> en:oedema
    n1=leucémie aigüe myéloïde | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4480. leucémie granulocytaire aiguë --- r_associated #0: 10 --> en:oedema
    n1=leucémie granulocytaire aiguë | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4481. leucémie myélocytaire aiguë --- r_associated #0: 10 --> en:oedema
    n1=leucémie myélocytaire aiguë | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4482. leucémies myéloïdes aiguës --- r_associated #0: 10 --> en:oedema
    n1=leucémies myéloïdes aiguës | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4483. lichénification --- r_associated #0: 10 --> en:oedema
    n1=lichénification | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4484. lipodystrophie --- r_associated #0: 10 --> en:oedema
    n1=lipodystrophie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4485. livedo --- r_associated #0: 10 --> en:oedema
    n1=livedo | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4486. livedo reticularis --- r_associated #0: 10 --> en:oedema
    n1=livedo reticularis | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4487. livédo --- r_associated #0: 10 --> en:oedema
    n1=livédo | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4488. mal de ventre --- r_associated #0: 10 --> en:oedema
    n1=mal de ventre | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4489. maladie cardio-vasculaire --- r_associated #0: 10 --> en:oedema
    n1=maladie cardio-vasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4490. maladie d'Erdheim-Chester --- r_associated #0: 10 --> en:oedema
    n1=maladie d'Erdheim-Chester | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4491. maladie de l'appareil cardio-vasculaire --- r_associated #0: 10 --> en:oedema
    n1=maladie de l'appareil cardio-vasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4492. maladie de l'appareil cardiovasculaire --- r_associated #0: 10 --> en:oedema
    n1=maladie de l'appareil cardiovasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4493. maladie de l'appareil circulatoire --- r_associated #0: 10 --> en:oedema
    n1=maladie de l'appareil circulatoire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4494. maladie des vaisseaux --- r_associated #0: 10 --> en:oedema
    n1=maladie des vaisseaux | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4495. maladie du myocarde --- r_associated #0: 10 --> en:oedema
    n1=maladie du myocarde | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4496. maladie vasculaire --- r_associated #0: 10 --> en:oedema
    n1=maladie vasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4497. malformation caverneuse cérébrale --- r_associated #0: 10 --> en:oedema
    n1=malformation caverneuse cérébrale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4498. molluscum contagiosum --- r_associated #0: 10 --> en:oedema
    n1=molluscum contagiosum | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4499. myocardiopathie --- r_associated #0: 10 --> en:oedema
    n1=myocardiopathie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4500. myopathie --- r_associated #0: 10 --> en:oedema
    n1=myopathie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4501. myotonia --- r_associated #0: 10 --> en:oedema
    n1=myotonia | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4502. non précisée, hydrocèle --- r_associated #0: 10 --> en:oedema
    n1=non précisée, hydrocèle | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4503. oedème de l'encéphale --- r_associated #0: 10 --> en:oedema
    n1=oedème de l'encéphale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4504. oedème de la rétine --- r_associated #0: 10 --> en:oedema
    n1=oedème de la rétine | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4505. oedème du cerveau --- r_associated #0: 10 --> en:oedema
    n1=oedème du cerveau | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4506. oedème du poumon non cardiogénique --- r_associated #0: 10 --> en:oedema
    n1=oedème du poumon non cardiogénique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4507. oedémateux (syndrome) --- r_associated #0: 10 --> en:oedema
    n1=oedémateux (syndrome) | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4508. oligohydramnios --- r_associated #0: 10 --> en:oedema
    n1=oligohydramnios | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4509. palmar pit --- r_associated #0: 10 --> en:oedema
    n1=palmar pit | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4510. palud
    (paludisme)
     --- r_associated #0: 10 --> en:oedema
    n1=palud
    (paludisme)
    | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4511. papillomatosis --- r_associated #0: 10 --> en:oedema
    n1=papillomatosis | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4512. parakeratosis --- r_associated #0: 10 --> en:oedema
    n1=parakeratosis | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4513. paralysie générale --- r_associated #0: 10 --> en:oedema
    n1=paralysie générale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4514. parkinsonisme --- r_associated #0: 10 --> en:oedema
    n1=parkinsonisme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4515. parésie --- r_associated #0: 10 --> en:oedema
    n1=parésie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4516. pause cardiaque --- r_associated #0: 10 --> en:oedema
    n1=pause cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4517. peau du cou --- r_associated #0: 10 --> en:oedema
    n1=peau du cou | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4518. piebaldisme --- r_associated #0: 10 --> en:oedema
    n1=piebaldisme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4519. pilomatrixome --- r_associated #0: 10 --> en:oedema
    n1=pilomatrixome | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4520. pityriasis alba --- r_associated #0: 10 --> en:oedema
    n1=pityriasis alba | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4521. piébaldisme --- r_associated #0: 10 --> en:oedema
    n1=piébaldisme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4522. plis de flexion anormaux des doigts --- r_associated #0: 10 --> en:oedema
    n1=plis de flexion anormaux des doigts | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4523. poikiloderma --- r_associated #0: 10 --> en:oedema
    n1=poikiloderma | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4524. polyhydramnios --- r_associated #0: 10 --> en:oedema
    n1=polyhydramnios | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4525. pontage aorto-coronarien --- r_associated #0: 10 --> en:oedema
    n1=pontage aorto-coronarien | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4526. pontage coronarien --- r_associated #0: 10 --> en:oedema
    n1=pontage coronarien | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4527. poumon de choc --- r_associated #0: 10 --> en:oedema
    n1=poumon de choc | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4528. poumon de choc traumatique --- r_associated #0: 10 --> en:oedema
    n1=poumon de choc traumatique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4529. poumon du vietnam --- r_associated #0: 10 --> en:oedema
    n1=poumon du vietnam | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4530. proptose --- r_associated #0: 10 --> en:oedema
    n1=proptose | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4531. prurigo --- r_associated #0: 10 --> en:oedema
    n1=prurigo | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4532. pruritus --- r_associated #0: 10 --> en:oedema
    n1=pruritus | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4533. purpura --- r_associated #0: 10 --> en:oedema
    n1=purpura | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4534. pyoderma gangrenosum --- r_associated #0: 10 --> en:oedema
    n1=pyoderma gangrenosum | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4535. respiration anormale --- r_associated #0: 10 --> en:oedema
    n1=respiration anormale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4536. retard de croissance staturo-pondérale --- r_associated #0: 10 --> en:oedema
    n1=retard de croissance staturo-pondérale | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4537. schwannogliome --- r_associated #0: 10 --> en:oedema
    n1=schwannogliome | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4538. sclérodactylie --- r_associated #0: 10 --> en:oedema
    n1=sclérodactylie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4539. signes et symptômes respiratoires --- r_associated #0: 10 --> en:oedema
    n1=signes et symptômes respiratoires | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4540. skin tag --- r_associated #0: 10 --> en:oedema
    n1=skin tag | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4541. sodium acetate --- r_associated #0: 10 --> en:oedema
    n1=sodium acetate | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4542. splénomégalie --- r_associated #0: 10 --> en:oedema
    n1=splénomégalie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4543. steatocystoma multiplex --- r_associated #0: 10 --> en:oedema
    n1=steatocystoma multiplex | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4544. sweating --- r_associated #0: 10 --> en:oedema
    n1=sweating | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4545. syndrome adéno-cutanéo-muqueux --- r_associated #0: 10 --> en:oedema
    n1=syndrome adéno-cutanéo-muqueux | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4546. syndrome de cachexie --- r_associated #0: 10 --> en:oedema
    n1=syndrome de cachexie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4547. syndrome malin d'un neuroleptique --- r_associated #0: 10 --> en:oedema
    n1=syndrome malin d'un neuroleptique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4548. syndrome malin de neuroleptiques --- r_associated #0: 10 --> en:oedema
    n1=syndrome malin de neuroleptiques | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4549. syndrome malin des neuroleptiques --- r_associated #0: 10 --> en:oedema
    n1=syndrome malin des neuroleptiques | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4550. triglycérides --- r_associated #0: 10 --> en:oedema
    n1=triglycérides | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4551. trouble de l'appareil respiratoire --- r_associated #0: 10 --> en:oedema
    n1=trouble de l'appareil respiratoire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4552. trouble de la conduction du coeur --- r_associated #0: 10 --> en:oedema
    n1=trouble de la conduction du coeur | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4553. trouble de la fonction respiratoire --- r_associated #0: 10 --> en:oedema
    n1=trouble de la fonction respiratoire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4554. trouble du rythme cardiaque --- r_associated #0: 10 --> en:oedema
    n1=trouble du rythme cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4555. trouble myocardique --- r_associated #0: 10 --> en:oedema
    n1=trouble myocardique | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4556. trouble vasculaire --- r_associated #0: 10 --> en:oedema
    n1=trouble vasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4557. tumeur maligne de la peau --- r_associated #0: 10 --> en:oedema
    n1=tumeur maligne de la peau | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4558. tétanie --- r_associated #0: 10 --> en:oedema
    n1=tétanie | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4559. ulcération --- r_associated #0: 10 --> en:oedema
    n1=ulcération | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4560. vascularite --- r_associated #0: 10 --> en:oedema
    n1=vascularite | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4561. verrue plantaire --- r_associated #0: 10 --> en:oedema
    n1=verrue plantaire | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4562. Épidermolyse bulleuse jonctionnelle --- r_associated #0: 10 --> en:oedema
    n1=Épidermolyse bulleuse jonctionnelle | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4563. éléphantiasis --- r_associated #0: 10 --> en:oedema
    n1=éléphantiasis | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4564. épanchement pleural --- r_associated #0: 10 --> en:oedema
    n1=épanchement pleural | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4565. épidermolyse bulleuse jonctionnelle --- r_associated #0: 10 --> en:oedema
    n1=épidermolyse bulleuse jonctionnelle | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4566. éruption cutanée morbilliforme --- r_associated #0: 10 --> en:oedema
    n1=éruption cutanée morbilliforme | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4567. érythème fessier du nourrisson --- r_associated #0: 10 --> en:oedema
    n1=érythème fessier du nourrisson | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4568. œdème Maculaire Cystoïde --- r_associated #0: 10 --> en:oedema
    n1=œdème Maculaire Cystoïde | n2=en:oedema | rel=r_associated | relid=0 | w=10
  4569. Altération de l'état général --- r_associated #0: 5 --> en:oedema
    n1=Altération de l'état général | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4570. Anasarque --- r_associated #0: 5 --> en:oedema
    n1=Anasarque | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4571. Arrêt du coeur --- r_associated #0: 5 --> en:oedema
    n1=Arrêt du coeur | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4572. Cardiopathie --- r_associated #0: 5 --> en:oedema
    n1=Cardiopathie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4573. Hématome --- r_associated #0: 5 --> en:oedema
    n1=Hématome | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4574. Maladies cardiaques --- r_associated #0: 5 --> en:oedema
    n1=Maladies cardiaques | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4575. Malformation cardiaque --- r_associated #0: 5 --> en:oedema
    n1=Malformation cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4576. Mort cellulaire --- r_associated #0: 5 --> en:oedema
    n1=Mort cellulaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4577. Sécheresse de la bouche --- r_associated #0: 5 --> en:oedema
    n1=Sécheresse de la bouche | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4578. Tuméfaction --- r_associated #0: 5 --> en:oedema
    n1=Tuméfaction | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4579. absence de croissance --- r_associated #0: 5 --> en:oedema
    n1=absence de croissance | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4580. accident cérébrovasculaire --- r_associated #0: 5 --> en:oedema
    n1=accident cérébrovasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4581. accident vasculaire cérébral --- r_associated #0: 5 --> en:oedema
    n1=accident vasculaire cérébral | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4582. affection cardio-vasculaire --- r_associated #0: 5 --> en:oedema
    n1=affection cardio-vasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4583. angiome caverneux --- r_associated #0: 5 --> en:oedema
    n1=angiome caverneux | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4584. anhémie --- r_associated #0: 5 --> en:oedema
    n1=anhémie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4585. anti-coagulant --- r_associated #0: 5 --> en:oedema
    n1=anti-coagulant | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4586. anæmie --- r_associated #0: 5 --> en:oedema
    n1=anæmie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4587. anémie aplastique --- r_associated #0: 5 --> en:oedema
    n1=anémie aplastique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4588. anémie drépanocytaire --- r_associated #0: 5 --> en:oedema
    n1=anémie drépanocytaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4589. anémie médullaire --- r_associated #0: 5 --> en:oedema
    n1=anémie médullaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4590. anémie par aplasie médullaire --- r_associated #0: 5 --> en:oedema
    n1=anémie par aplasie médullaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4591. anémie par atteinte isolée de la lignée rouge --- r_associated #0: 5 --> en:oedema
    n1=anémie par atteinte isolée de la lignée rouge | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4592. anémie à cellules falciformes --- r_associated #0: 5 --> en:oedema
    n1=anémie à cellules falciformes | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4593. aplasie de globules rouges purs --- r_associated #0: 5 --> en:oedema
    n1=aplasie de globules rouges purs | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4594. aplasie des globules rouges purs --- r_associated #0: 5 --> en:oedema
    n1=aplasie des globules rouges purs | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4595. aplasie isolée de la lignée rouge --- r_associated #0: 5 --> en:oedema
    n1=aplasie isolée de la lignée rouge | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4596. aplasie primitive de la lignée rouge --- r_associated #0: 5 --> en:oedema
    n1=aplasie primitive de la lignée rouge | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4597. apoplexie cérébrale --- r_associated #0: 5 --> en:oedema
    n1=apoplexie cérébrale | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4598. arrêt circulatoire --- r_associated #0: 5 --> en:oedema
    n1=arrêt circulatoire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4599. arrêt des contractions du coeur --- r_associated #0: 5 --> en:oedema
    n1=arrêt des contractions du coeur | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4600. arthrite --- r_associated #0: 5 --> en:oedema
    n1=arthrite | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4601. arythmie --- r_associated #0: 5 --> en:oedema
    n1=arythmie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4602. ascites --- r_associated #0: 5 --> en:oedema
    n1=ascites | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4603. asphyxia --- r_associated #0: 5 --> en:oedema
    n1=asphyxia | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4604. asystole ventriculaire --- r_associated #0: 5 --> en:oedema
    n1=asystole ventriculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4605. asystolie ventriculaire --- r_associated #0: 5 --> en:oedema
    n1=asystolie ventriculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4606. atrophie cutanée --- r_associated #0: 5 --> en:oedema
    n1=atrophie cutanée | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4607. atrophie de la peau --- r_associated #0: 5 --> en:oedema
    n1=atrophie de la peau | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4608. atrophie généralisée --- r_associated #0: 5 --> en:oedema
    n1=atrophie généralisée | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4609. atrophodermie --- r_associated #0: 5 --> en:oedema
    n1=atrophodermie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4610. atélectasie congestive --- r_associated #0: 5 --> en:oedema
    n1=atélectasie congestive | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4611. cachexie maligne --- r_associated #0: 5 --> en:oedema
    n1=cachexie maligne | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4612. cancer cutané --- r_associated #0: 5 --> en:oedema
    n1=cancer cutané | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4613. cancer de la peau --- r_associated #0: 5 --> en:oedema
    n1=cancer de la peau | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4614. candidiasis --- r_associated #0: 5 --> en:oedema
    n1=candidiasis | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4615. cicatrice hypertrophique --- r_associated #0: 5 --> en:oedema
    n1=cicatrice hypertrophique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4616. contraction clonique --- r_associated #0: 5 --> en:oedema
    n1=contraction clonique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4617. cutis laxa --- r_associated #0: 5 --> en:oedema
    n1=cutis laxa | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4618. cutis marmorata --- r_associated #0: 5 --> en:oedema
    n1=cutis marmorata | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4619. cutis marmorata telangiectatica congenita --- r_associated #0: 5 --> en:oedema
    n1=cutis marmorata telangiectatica congenita | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4620. dermatite --- r_associated #0: 5 --> en:oedema
    n1=dermatite | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4621. dermite herpétiforme --- r_associated #0: 5 --> en:oedema
    n1=dermite herpétiforme | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4622. douleur abdominale --- r_associated #0: 5 --> en:oedema
    n1=douleur abdominale | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4623. douleur estomac --- r_associated #0: 5 --> en:oedema
    n1=douleur estomac | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4624. dyspepsie --- r_associated #0: 5 --> en:oedema
    n1=dyspepsie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4625. dysphagia --- r_associated #0: 5 --> en:oedema
    n1=dysphagia | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4626. dyspnée --- r_associated #0: 5 --> en:oedema
    n1=dyspnée | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4627. dysrythmie cardiaque --- r_associated #0: 5 --> en:oedema
    n1=dysrythmie cardiaque | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4628. dysrythmie cardiaque non précisée --- r_associated #0: 5 --> en:oedema
    n1=dysrythmie cardiaque non précisée | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4629. déplétion volumique --- r_associated #0: 5 --> en:oedema
    n1=déplétion volumique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4630. effusion pleurale --- r_associated #0: 5 --> en:oedema
    n1=effusion pleurale | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4631. en:Acosta's disease --- r_associated #0: 5 --> en:oedema
    n1=en:Acosta's disease | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4632. en:Neuroleptic malignant syndrome --- r_associated #0: 5 --> en:oedema
    n1=en:Neuroleptic malignant syndrome | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4633. en:coronary disease --- r_associated #0: 5 --> en:oedema
    n1=en:coronary disease | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4634. en:dropsy --- r_associated #0: 5 --> en:oedema
    n1=en:dropsy | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4635. en:heart condition --- r_associated #0: 5 --> en:oedema
    n1=en:heart condition | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4636. en:hemangioma, cavernous --- r_associated #0: 5 --> en:oedema
    n1=en:hemangioma, cavernous | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4637. en:hydrops --- r_associated #0: 5 --> en:oedema
    n1=en:hydrops | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4638. en:malignant neoplasm of skin --- r_associated #0: 5 --> en:oedema
    n1=en:malignant neoplasm of skin | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4639. en:muscle twitch --- r_associated #0: 5 --> en:oedema
    n1=en:muscle twitch | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4640. en:thrombus --- r_associated #0: 5 --> en:oedema
    n1=en:thrombus | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4641. en:twitching --- r_associated #0: 5 --> en:oedema
    n1=en:twitching | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4642. exanthème morbilliforme --- r_associated #0: 5 --> en:oedema
    n1=exanthème morbilliforme | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4643. excès de liquide organique --- r_associated #0: 5 --> en:oedema
    n1=excès de liquide organique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4644. excès de volume liquidien --- r_associated #0: 5 --> en:oedema
    n1=excès de volume liquidien | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4645. exfoliation de la peau --- r_associated #0: 5 --> en:oedema
    n1=exfoliation de la peau | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4646. exophthalmie --- r_associated #0: 5 --> en:oedema
    n1=exophthalmie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4647. faiblesse musculaire du visage --- r_associated #0: 5 --> en:oedema
    n1=faiblesse musculaire du visage | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4648. fasciculation d'un muscle squelettique --- r_associated #0: 5 --> en:oedema
    n1=fasciculation d'un muscle squelettique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4649. fistule entérocutanée --- r_associated #0: 5 --> en:oedema
    n1=fistule entérocutanée | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4650. gastralgie --- r_associated #0: 5 --> en:oedema
    n1=gastralgie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4651. hypertension artérielle pulmonaire --- r_associated #0: 5 --> en:oedema
    n1=hypertension artérielle pulmonaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4652. hypertension pulmonaire --- r_associated #0: 5 --> en:oedema
    n1=hypertension pulmonaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4653. hypotonie du nouveau-né --- r_associated #0: 5 --> en:oedema
    n1=hypotonie du nouveau-né | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4654. hypovolémie --- r_associated #0: 5 --> en:oedema
    n1=hypovolémie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4655. hémangiome caverneux --- r_associated #0: 5 --> en:oedema
    n1=hémangiome caverneux | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4656. ichthyose congénitale --- r_associated #0: 5 --> en:oedema
    n1=ichthyose congénitale | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4657. ictus apoplectique --- r_associated #0: 5 --> en:oedema
    n1=ictus apoplectique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4658. ictus cérébral --- r_associated #0: 5 --> en:oedema
    n1=ictus cérébral | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4659. insuffisance respiratoire --- r_associated #0: 5 --> en:oedema
    n1=insuffisance respiratoire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4660. kyste de kératine --- r_associated #0: 5 --> en:oedema
    n1=kyste de kératine | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4661. kyste dentigère --- r_associated #0: 5 --> en:oedema
    n1=kyste dentigère | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4662. kyste folliculaire --- r_associated #0: 5 --> en:oedema
    n1=kyste folliculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4663. kyste gingival --- r_associated #0: 5 --> en:oedema
    n1=kyste gingival | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4664. kyste tapissé d'épithélium --- r_associated #0: 5 --> en:oedema
    n1=kyste tapissé d'épithélium | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4665. lam --- r_associated #0: 5 --> en:oedema
    n1=lam | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4666. lanl --- r_associated #0: 5 --> en:oedema
    n1=lanl | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4667. leucémie aiguë myéloblastique --- r_associated #0: 5 --> en:oedema
    n1=leucémie aiguë myéloblastique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4668. leucémie aiguë myélocytaire --- r_associated #0: 5 --> en:oedema
    n1=leucémie aiguë myélocytaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4669. leucémie aiguë non lymphocytaire --- r_associated #0: 5 --> en:oedema
    n1=leucémie aiguë non lymphocytaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4670. leucémie aigüe non lymphoblastique --- r_associated #0: 5 --> en:oedema
    n1=leucémie aigüe non lymphoblastique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4671. leucémie blastique granulocytaire --- r_associated #0: 5 --> en:oedema
    n1=leucémie blastique granulocytaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4672. leucémie granuleuse aiguë --- r_associated #0: 5 --> en:oedema
    n1=leucémie granuleuse aiguë | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4673. leucémie myéloblastique aiguë --- r_associated #0: 5 --> en:oedema
    n1=leucémie myéloblastique aiguë | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4674. leucémie myéloblastique aigüe --- r_associated #0: 5 --> en:oedema
    n1=leucémie myéloblastique aigüe | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4675. leucémie myélogène aiguë --- r_associated #0: 5 --> en:oedema
    n1=leucémie myélogène aiguë | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4676. leucémie myélogène aigüe --- r_associated #0: 5 --> en:oedema
    n1=leucémie myélogène aigüe | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4677. leucémie myéloïde aiguë --- r_associated #0: 5 --> en:oedema
    n1=leucémie myéloïde aiguë | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4678. leucémie myéloïde aigüe --- r_associated #0: 5 --> en:oedema
    n1=leucémie myéloïde aigüe | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4679. leucémie non lymphoblastique aiguë --- r_associated #0: 5 --> en:oedema
    n1=leucémie non lymphoblastique aiguë | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4680. lipome --- r_associated #0: 5 --> en:oedema
    n1=lipome | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4681. mal de montagne --- r_associated #0: 5 --> en:oedema
    n1=mal de montagne | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4682. maladie cérébrovasculaire aiguë mal définie --- r_associated #0: 5 --> en:oedema
    n1=maladie cérébrovasculaire aiguë mal définie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4683. maladie de Kawasaki --- r_associated #0: 5 --> en:oedema
    n1=maladie de Kawasaki | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4684. maladie respiratoire --- r_associated #0: 5 --> en:oedema
    n1=maladie respiratoire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4685. marasme nutritionnel --- r_associated #0: 5 --> en:oedema
    n1=marasme nutritionnel | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4686. myatrophie --- r_associated #0: 5 --> en:oedema
    n1=myatrophie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4687. myopathie primitive progressive --- r_associated #0: 5 --> en:oedema
    n1=myopathie primitive progressive | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4688. neurinome --- r_associated #0: 5 --> en:oedema
    n1=neurinome | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4689. non précisée, anomalie respiratoire --- r_associated #0: 5 --> en:oedema
    n1=non précisée, anomalie respiratoire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4690. non précisée, anémie aplasique --- r_associated #0: 5 --> en:oedema
    n1=non précisée, anémie aplasique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4691. obésité --- r_associated #0: 5 --> en:oedema
    n1=obésité | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4692. oedème pulmonaire non cardiogénique --- r_associated #0: 5 --> en:oedema
    n1=oedème pulmonaire non cardiogénique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4693. parésie musculaire --- r_associated #0: 5 --> en:oedema
    n1=parésie musculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4694. pathologie du coeur --- r_associated #0: 5 --> en:oedema
    n1=pathologie du coeur | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4695. pityriasis alba --- r_associated #0: 5 --> en:oedema
    n1=pityriasis alba | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4696. polydipsie --- r_associated #0: 5 --> en:oedema
    n1=polydipsie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4697. pyoderma --- r_associated #0: 5 --> en:oedema
    n1=pyoderma | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4698. pyoderma gangrenosum --- r_associated #0: 5 --> en:oedema
    n1=pyoderma gangrenosum | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4699. péliose --- r_associated #0: 5 --> en:oedema
    n1=péliose | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4700. pénétration percutanée --- r_associated #0: 5 --> en:oedema
    n1=pénétration percutanée | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4701. schwannome --- r_associated #0: 5 --> en:oedema
    n1=schwannome | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4702. secousse musculaire --- r_associated #0: 5 --> en:oedema
    n1=secousse musculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4703. sicklanémie --- r_associated #0: 5 --> en:oedema
    n1=sicklanémie | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4704. snm --- r_associated #0: 5 --> en:oedema
    n1=snm | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4705. soif excessive --- r_associated #0: 5 --> en:oedema
    n1=soif excessive | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4706. spasme d'un muscle --- r_associated #0: 5 --> en:oedema
    n1=spasme d'un muscle | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4707. spasme musculaire --- r_associated #0: 5 --> en:oedema
    n1=spasme musculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4708. stasis --- r_associated #0: 5 --> en:oedema
    n1=stasis | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4709. surcharge liquidienne --- r_associated #0: 5 --> en:oedema
    n1=surcharge liquidienne | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4710. syndrome adénocutanéomuqueux --- r_associated #0: 5 --> en:oedema
    n1=syndrome adénocutanéomuqueux | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4711. syndrome cachectique dû au vih --- r_associated #0: 5 --> en:oedema
    n1=syndrome cachectique dû au vih | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4712. syndrome de Kawasaki --- r_associated #0: 5 --> en:oedema
    n1=syndrome de Kawasaki | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4713. syndrome de cachexie progressive --- r_associated #0: 5 --> en:oedema
    n1=syndrome de cachexie progressive | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4714. syndrome de dépérissement --- r_associated #0: 5 --> en:oedema
    n1=syndrome de dépérissement | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4715. syndrome de détresse respiratoire aigüe --- r_associated #0: 5 --> en:oedema
    n1=syndrome de détresse respiratoire aigüe | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4716. syndrome du retard de développement --- r_associated #0: 5 --> en:oedema
    n1=syndrome du retard de développement | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4717. syndrome malin neuroleptique --- r_associated #0: 5 --> en:oedema
    n1=syndrome malin neuroleptique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4718. tache mélanique --- r_associated #0: 5 --> en:oedema
    n1=tache mélanique | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4719. thrombus --- r_associated #0: 5 --> en:oedema
    n1=thrombus | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4720. trouble cardiovasculaire --- r_associated #0: 5 --> en:oedema
    n1=trouble cardiovasculaire | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4721. trouble de la respiration --- r_associated #0: 5 --> en:oedema
    n1=trouble de la respiration | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4722. trouble fonctions respir --- r_associated #0: 5 --> en:oedema
    n1=trouble fonctions respir | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4723. épanchement pleural liquidien --- r_associated #0: 5 --> en:oedema
    n1=épanchement pleural liquidien | n2=en:oedema | rel=r_associated | relid=0 | w=5
  4724. érysipèle --- r_associated #0: 5 --> en:oedema
    n1=érysipèle | n2=en:oedema | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr